Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7404588399955391,-2.9307901457390706,0.0,0.0,0.0,71/87,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A
prerank,cytoplasmic translation (GO:0002181),-0.7314217449128169,-2.9169895340442817,0.0,0.0,0.0,62/91,13.69%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;EIF4A1;RPL23;RPL17;RPL29;GSPT2;RPL22L1;RPS5;RPS14;UBA52
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7167703248893813,-2.8449917236105846,0.0,0.0,0.0,73/91,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;ARL6IP1;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;RPS10;TRAM1;RPL23;RPL17;RPL29;RPS5;RPS14;SSR2;UBA52;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A
prerank,protein targeting to ER (GO:0045047),-0.6936445022369317,-2.7974281450839253,0.0,0.0,0.0,74/99,19.88%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRP14;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;SPCS2;RPS26;RPS10;SPCS1;RPL23;RPL17;RPL29;RPS5;RPS14;UBA52;ZFAND2B;SRP9;RPL12;RPL9;RPL37;RPS11;SEC61A1;RPL7;RPL31;RPL7A;SEC61G
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6561057088295016,-2.6951922151841976,0.0,0.0,0.0,73/110,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;RPL12;RPL9;RPL37;RPS11;RNPS1;PABPC1;RPL7;RPL31;RPL7A
prerank,peptide biosynthetic process (GO:0043043),-0.6155781418879012,-2.63675917652058,0.0,0.0,0.0,91/153,21.28%,RPS24;DMD;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;ASMT;MRPS18A;RPS10;IGHMBP2;RPL23;RPL17;GGT5;PABPC4;RPL29;GSPT2;RPS5;RPS14;SRBD1;MRPL28;COPS5;HBS1L;RPL12;RPL9;GGT7;RPL37;RPS11;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;GGT1;YARS2;FARSB;PCSK5;RPL3;MRPL52;MRPL23;MRPL9
prerank,translation (GO:0006412),-0.5644496350025132,-2.535176975729958,0.0,0.0,0.0,107/208,23.17%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;EEF1G;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;GTPBP1;RPL18;RPS13;EEF2;RPS2;RPL14;LARS2;RPL22;RPS26;ASMT;MRPS18A;KARS1;CARS1;EEF1E1;RPS10;IGHMBP2;RPL23;RPL17;PABPC4;RPL29;GSPT2;RPL22L1;RPS5;FASTKD2;RPS14;UBA52;IARS1;MRPL57;RARS2;SRBD1;MRPL28;COPS5;HBS1L;RPL12;RPL9;RPL37;RPS11;MRPL47;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;YARS2;FARSB;RPL3;MRPS2;MRPL52;MRPL23;MRPL9;GSPT1;MRPS12;RPL23A;TUFM;MRPL11;N6AMT1
prerank,chemical synaptic transmission (GO:0007268),-0.4998550059793173,-2.3286473022455207,0.0,0.0,0.0,115/284,22.09%,GRM7;NRXN1;NLGN1;DLG2;GRID2;SLC12A7;KCND2;SYT1;RIMS1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;HSPA8;GRM5;LIN7A;PTCHD1;GRIK4;GRIA1;PTPRN2;KCNQ3;KIF1B;SLC6A1;GABRA2;RIT2;AMPH;CACNB4;PLP1;HTR2C;GABBR2;HOMER1;CALM1;CHRM2;GABRB3;SNAP25;GRIN2A;SNCA;GABRA3;GRIK1;GLRA3;DLGAP1;DLGAP2;SYN3;GRIA3;GABRA4;SLC1A1;CDH8;GRIN2B;STXBP1;EXOC4;APBA2;PRKAR1A;GABARAP;MBP;RIC3;SLC1A4;CPLX1;SDCBP;GRIA2;SLC1A2;SYN1;SLC12A5;NLGN3;LRP6;GRIN1;GABRB1;SNPH;GABRG3;MINK1;DVL1;SLC12A6;PCDHB16;GAD2;RPS6KA1;PRKAR2B;NAPA;SLC6A5;SHISA6;SYN2;GABRB2;KIF5A;HRH1;STAC3;GRIK3;RPS6KA2;HTR2B;GABRA5;HTR4;SNAPIN;CHRNA4;CAMK4;CACNA1A;HTR2A;SYPL1;AKAP5;GLRA2;GLRA1;HRH2;KCNA1;SLC17A6;CHRFAM7A;CHRNA7;CAMKK2;SLC32A1;GABRA1;APBA3;KCNMB4;PENK;SLC18A2;SNCG;ATXN3;SCN2B;DTNA
prerank,zinc ion homeostasis (GO:0055069),-0.7399797880879634,-2.2956180806705473,0.0,0.0,0.0,16/28,14.55%,SLC39A10;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SLC39A6;SLC30A1;SLC39A14;SLC39A12;MT2A;SLC39A13;SLC39A8
prerank,cellular zinc ion homeostasis (GO:0006882),-0.7443421433629334,-2.28602659020152,0.0,0.0,0.0,16/26,14.55%,SLC39A10;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SLC39A6;SLC30A1;SLC39A14;SLC39A12;MT2A;SLC39A13;SLC39A8
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.5025054656442968,-2.2813856718532453,0.0,0.0,0.0,94/224,22.09%,GRM7;NRXN1;NLGN1;DLG2;SLC12A7;KCND2;SYT1;CACNA1E;GRIA4;GRM3;GRIK2;CACNB2;CHRM3;GRM5;PTCHD1;GRIK4;GRIA1;KCNQ3;SLC6A1;GABRA2;RIT2;AMPH;CACNB4;PLP1;HTR2C;GABBR2;HOMER1;CALM1;CHRM2;GABRB3;SNAP25;GRIN2A;SNCA;GABRA3;GRIK1;GLRA3;DLGAP1;GRIA3;GABRA4;SLC1A1;GRIN2B;EXOC4;APBA2;PRKAR1A;GABARAP;MBP;CPLX1;SDCBP;GRIA2;SLC1A2;SYN1;SLC12A5;NLGN3;LRP6;GRIN1;GABRB1;GABRG3;MINK1;SLC12A6;PCDHB16;GAD2;RPS6KA1;PRKAR2B;SLC6A5;SYN2;GABRB2;KIF5A;HRH1;RPS6KA2;HTR2B;GABRA5;HTR4;CHRNA4;CAMK4;CACNA1A;HTR2A;SYPL1;AKAP5;GLRA2;GLRA1;HRH2;KCNA1;CHRFAM7A;CHRNA7;CAMKK2;GABRA1;APBA3;KCNMB4;PENK;SLC18A2;SNCG;ATXN3;SCN2B;DTNA
prerank,glutamate receptor signaling pathway (GO:0007215),-0.697374285845981,-2.277057786444264,0.0,0.0,0.0,19/37,10.98%,GRM7;GRID2;GRIA4;GRM3;PLCB1;GRIK2;GRIN3A;GRM5;GRIK4;PTK2B;HOMER1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRM8;GRIN1;KCNB1
prerank,regulation of cation channel activity (GO:2001257),-0.5794995572253833,-2.270161673970029,0.0,0.0,0.0,38/89,14.20%,PDE4D;NLGN1;DLG2;GRIA4;LRRC7;KCNAB1;MEF2C;CACNB2;DMD;FGF14;FGF12;PTK2B;GRIA1;CACNB4;NETO1;FKBP1A;HOMER1;CALM1;ANK3;GRIN2A;CALM2;OPRM1;GRIA3;GRIN2B;CAMK2D;CTSS;CAMK2A;GRIA2;SELENON;SHISA9;GRIN1;MINK1;NOS1;FGF13;CAPN1;SHISA6;STAC;RELN
prerank,cellular response to copper ion (GO:0071280),-0.8502883232882187,-2.248902231793884,0.0,0.0,0.0,9/16,4.03%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SNCA
prerank,response to copper ion (GO:0046688),-0.7866463050816276,-2.2160119723812812,0.0,0.0,0.0,9/20,4.03%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SNCA
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.5415223402504338,-2.2100872993108696,0.0,6.438623394445439e-05,0.001,32/107,8.74%,GRM7;NLGN1;GRID2;LRRC4C;NRG3;SLC12A2;SYT1;RIMS1;RIMS2;GRM3;DGKI;CDH2;MEF2C;GRIK2;GRM5;ABR;GRIK4;MCTP1;HOMER1;GRIK1;DLGAP1;DLGAP2;SYN3;BTBD9;DGKZ;CPLX1;LRP8;CAMK2A;CNTNAP4;GRM8;SYN1;NLGN3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4997027132537267,-2.180218665282231,0.0,0.00024239523367324006,0.003,81/168,19.37%,RPS24;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;DIS3L2;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;RPL38;RPLP1;PPP2R1A;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPS20;RPS4X;RPL18;RPS13;RPS2;RPL14;RPL22;RPS26;ATM;PNRC2;RPS10;RPL23;RPL17;RPL29;GSPT2;RPS5;RPS14;UBA52;DCP1A;MTPAP;RPL12;PELO;RPL9;XRN2;RPL37;CNOT2;ERI1;RPS11;RNPS1;PABPC1;EXOSC4;RPL7;RPL31;RPL7A
prerank,rRNA metabolic process (GO:0016072),-0.49001864315458266,-2.1029877027578285,0.0,0.0016597340305681578,0.026,78/160,21.39%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;HELQ;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;RPS14;UBA52;NOP56;MAPT;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;DEDD2;EXOSC4;SNU13;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,rRNA processing (GO:0006364),-0.4790921171041521,-2.0910815822001334,0.0,0.0021145794727020807,0.032,81/172,21.39%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;HELQ;MAK16;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;MRPL1;THUMPD1;RPS14;UBA52;NOP56;SART1;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;ERI1;EXOSC4;SNU13;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,response to cadmium ion (GO:0046686),-0.6744580728023655,-2.0792982830209388,0.0,0.0028845032807115565,0.045,13/26,12.49%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;MAPK8;MAPK3;AKT1;EGFR;MT2A
prerank,cellular response to cadmium ion (GO:0071276),-0.6881139242675122,-2.0663689827401868,0.0,0.0033358201205507796,0.053,13/24,12.49%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;MAPK8;MAPK3;AKT1;EGFR;MT2A
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6440617918967805,-2.06592252188449,0.0,0.0031841919332530172,0.053,17/33,17.85%,NLGN1;GRID2;LRRC4C;NRG3;GRIK2;ABR;GRIK4;GRIK1;BTBD9;LRP8;NLGN3;BCR;NGF;RELN;GRIK3;NTF3;CACNA1A
prerank,ribosome biogenesis (GO:0042254),-0.4633813282371115,-2.0348819311672623,0.0,0.005016527444715751,0.095,82/187,21.39%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;RPL10A;RPL27A;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;NPM1;DDX47;WDR36;BYSL;HELQ;EXOSC2;NIP7;NVL;RPL23;RPL17;XPO1;RPL29;TEX10;RPS14;UBA52;NOP56;URB2;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;EXOSC4;SNU13;NOC2L;RPL7;MALSU1;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,neurotransmitter secretion (GO:0007269),-0.5975865899288663,-2.0328594775230386,0.0,0.005022126247667443,0.1,17/44,11.31%,NRXN1;SYT1;RIMS1;RIMS2;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,regulation of dendritic spine development (GO:0060998),-0.726015768512345,-2.0283572033154185,0.0,0.004903655577209646,0.102,6/19,2.04%,NLGN1;SHANK3;MEF2C;PPFIA2;GRIN3A;TANC2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.5651018936605432,-2.025783297058069,0.0,0.004873542630872548,0.104,26/56,18.00%,TEK;CNTNAP2;NRXN1;NLGN1;PTPRD;GRID2;PTPRJ;CLDN5;KDR;SYNDIG1;IL1RAPL1;IL1RAP;EPHB1;MYOC;NLGN3;VEGFA;LRRC4B;ACE2;CLSTN1;CAV1;RAC1;COL16A1;SLITRK2;SRPX2;EPHB3;PPM1F
prerank,angiogenesis involved in wound healing (GO:0060055),-0.8336584771728938,-2.009108739446305,0.0,0.0065244717063713785,0.143,8/11,8.85%,ADIPOR2;KDR;CD34;GATA2;PRCP;NDNF;MCAM;VEGFA
prerank,ribosomal large subunit assembly (GO:0000027),-0.6716562976947054,-2.0025272049590317,0.0,0.006916921132318529,0.153,13/24,22.72%,RPL24;RPL5;RPL6;RPL11;RPLP0;TRAF7;DHX30;PPAN;FASTKD2;NLE1;MDN1;RPL3;RPL23A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5787394278535706,-1.998910669535305,0.0,0.007033641004690741,0.16,17/46,9.60%,GRM7;NRXN1;NLGN1;SHANK3;SYT1;GRM3;DGKI;CDH2;MEF2C;GRM5;PTK2B;HOMER1;GRIK1;DGKZ;GRM8;NLGN3;ATAD1
prerank,chloride transmembrane transport (GO:1902476),-0.5587958162415099,-1.9822707301867306,0.0,0.008996903089838427,0.206,25/48,20.36%,SLC12A7;SLC12A2;ANO1;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;SLC1A1;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;ANO2;GABRB2;GABRA5;ANO5;GLRA2;GLRA1;GABRA1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5743018198825217,-1.981361267447295,0.0,0.008906070037220014,0.209,15/39,13.32%,RPS24;RPS15;RPS27;RPS19;RPS16;RPS6;RPS17;RPS7;RPS25;RPS28;NOL11;RRP7A;NPM1;RPS5;RPS14
prerank,inorganic anion transmembrane transport (GO:0098661),-0.5292595179909139,-1.980232982862788,0.0,0.008917493401306932,0.217,31/63,20.36%,SLC12A7;SLC12A2;SLC26A2;ANO1;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;XPR1;SLC5A5;GABRA4;SLC1A1;SLC5A6;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;SLC25A30;ANO2;GABRB2;GABRA5;SLC20A2;ANO5;GLRA2;GLRA1;GABRA1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.7833120461711532,-1.9687258662769076,0.0,0.011019801494493286,0.262,10/13,14.47%,PDE4D;CALM1;ANK3;CALM2;SLC8A1;CALM3;CAMK2D;SRI;CAV1;CASQ2
prerank,cellular response to zinc ion (GO:0071294),-0.7514284062940089,-1.9681925815383954,0.0,0.010725989090040872,0.262,8/15,2.74%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.4193143511887263,-1.9654284296475553,0.0,0.010978772690871538,0.275,137/306,23.29%,RPS24;THRB;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;PTMA;RPS19;RPL38;RPLP1;FUT9;RPS8;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;EEF1G;RPL39;RPS17;RPS7;RPL37A;EXT1;RPL4;RPS25;EEF1A1;RPS15A;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;MRE11;MCM9;RPL13A;RPL30;RPS20;RPS4X;GTPBP1;RPL18;RPS13;EEF2;RPS2;FAM111A;CLSPN;RPL14;RPL22;TBRG1;ALAS1;RPS26;ASMT;MRPS18A;ATM;POLA1;RPS10;IGHMBP2;BARD1;PWP1;RPL23;RPL17;PABPC4;RPL29;GCNT1;POLR3A;GSPT2;XAB2;RPS5;RPS14;ORC6;NFKBIB;ST3GAL4;POLD2;CDK2;SRBD1;MMS19;MRPL28;COPS5;HBS1L;RPL12;POLR2J;RMI2;SET;CDC45;RPL9;RRAGC;BRCA1;RPL37;RAD1;RPS11;BCL3;RNPS1;KAT7;POLE;RFC4;CHEK1;MRPL35;MRPS5;RPL7;RPL31;RPL7A;MRPL34;HARS1;POLD1;YARS2;FARSB;UPF1;RPL3;MRPL52;MRPL23;ATRIP;MRPL9;ATR;HOXD3;GSPT1;MRPS12;RPL23A;TUFM;DONSON;MRPL11;POLE3
prerank,positive regulation of synapse assembly (GO:0051965),-0.6512118482499594,-1.9577839005710178,0.0,0.011818450941804295,0.3,16/27,17.01%,NRXN1;NLGN1;PTPRD;GRID2;SYNDIG1;SEMA4D;IL1RAPL1;IL1RAP;EPHB1;NLGN3;LRRC4B;CLSTN1;AGRN;SLITRK2;SRPX2;EPHB3
prerank,signal release from synapse (GO:0099643),-0.5768133328014253,-1.9553079523665338,0.0,0.012167258047016894,0.315,16/43,11.31%,NRXN1;SYT1;RIMS1;HSPA8;LIN7A;PTPRN2;PCLO;SNAP25;SNCA;SYN3;STXBP1;CPLX1;SYN1;SNPH;DVL1;GAD2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5429466766330757,-1.952659960173185,0.0,0.012524816876773863,0.331,22/57,14.20%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;NETO1;GRIN2A;DLGAP1;DLGAP2;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;SHISA9;GRIN1;MINK1;CAPN1;SHISA6;RELN
prerank,action potential (GO:0001508),-0.5768702262569272,-1.9494697544307145,0.0,0.012758379895454962,0.344,23/44,20.63%,KCND2;DMD;KCNMB2;AKAP6;KCNJ2;SCN1A;ANK3;SCN2A;CACNA1G;YWHAH;KCNB1;SCN8A;SCN9A;KCNQ1;SRI;KCNE4;KCNA2;GNAQ;GNA14;SCN3A;CHRNA4;KCNA1;KCNMB4
prerank,neuron cell-cell adhesion (GO:0007158),-0.7448738938012434,-1.9479174050941621,0.0021645021645021645,0.012671210840268624,0.35,9/14,11.02%,NRXN1;NLGN1;CNTN4;NCAM2;ASTN1;ASTN2;NINJ2;NLGN3;RET
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7798791001856715,1.9340744490656885,0.001838235294117647,0.7739009049585853,0.474,6/16,3.96%,IGFBP3;IGFBP5;PHIP;GHRH;BMP2;IGFBP6
prerank,ribosome assembly (GO:0042255),-0.5502030904695964,-1.9319873982535671,0.0,0.015930096515427934,0.421,23/47,24.46%,RPS15;RPL24;RPL5;RPS27;RPS19;RPL6;RPL11;RPLP0;RPS28;RRP7A;NPM1;TRAF7;RPS5;PPAN;RPS14;MTERF3;NLE1;C1QBP;MDN1;RPL3;MRPS2;RPL23A;EIF6
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7860157854260871,-1.929612054592893,0.0,0.015992314107346386,0.434,8/12,12.95%,PDE4D;CALM1;CALM2;GJD3;CALM3;CAMK2D;SRI;CAV1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.525796397517104,-1.9244281303225468,0.0,0.016650579568891464,0.458,20/57,11.77%,RPS24;RPL26;RPS15;RPL5;RPS19;RPL38;RPS16;RPL35A;RPS6;RPS17;RPS7;RPS25;RPL11;RPS28;RPL14;NPM1;BYSL;NIP7;NVL;XPO1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.5902930802946821,-1.9197943037907952,0.0023752969121140144,0.017653534688770404,0.479,13/34,13.61%,PDE4D;PDE4B;ATP1B1;RYR2;SMAD7;CALM1;CALM2;SLC8A1;CALM3;NOS1;KCNQ1;SRI;ATP2A2
prerank,response to cytokine (GO:0034097),0.5080561305886544,1.9148325673353725,0.0,0.533707893369037,0.58,47/141,15.99%,ALDH1A2;PTPN13;DPYSL3;SMAD3;COL3A1;SELP;SP100;PID1;EIF2AK2;CXCL16;NFAT5;TRIM56;AFF3;IL6ST;TIMP3;ANXA1;PTPN14;PTPN4;IKBKE;BCL2;MCL1;HAX1;HDAC4;BST2;PTPN2;PTPN9;STAT1;LGALS9;NUB1;CD274;TIMP2;IFITM1;IFNLR1;PTPN6;BCL2L1;IRAK3;ADAR;TRIM21;CRNN;PTPN18;TBK1;PML;IL23R;CXCR4;APP;TAF9;IFNAR2
prerank,negative regulation of vascular permeability (GO:0043116),-0.762206554792114,-1.9142162022121183,0.0,0.019046878805968375,0.517,9/12,9.24%,SLIT2;PTPRJ;CLDN5;SH3GL2;CEACAM1;PDE3A;VEGFA;RAMP2;PDE2A
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6752348685246253,1.8882420103430022,0.0,0.5348493401315129,0.73,9/26,11.56%,EYA2;EYA1;FGFR1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,retinoid metabolic process (GO:0001523),0.5620034763597045,1.886164833477084,0.0,0.41287760036981414,0.737,11/71,5.06%,ALDH1A2;ALDH1A1;GPC6;RBP1;ABCA4;APOA2;HSPG2;RDH10;SDC2;RBP4;RDH5
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.7807385997192602,1.8733471811488474,0.0,0.4070073027342244,0.815,4/14,2.43%,ENPP3;CMPK2;ENPP1;DCTPP1
prerank,ncRNA processing (GO:0034470),-0.42281806757066215,-1.8720009408357232,0.0,0.03354802728653659,0.719,85/200,21.39%,RPS24;RPS9;RPL18A;RPL19;RPL26;RPL41;RPS15;RPL24;RPL5;RPS27;RPS19;RPL38;RPLP1;LIN28B;RPL10A;RPL27A;INTS7;RPL13;RPL27;RPS16;RPL35A;RPS6;RPL21;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;INTS10;RPL6;RPL11;RPLP0;RPLP2;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;RPL18;NOL11;RPS2;RRP7A;DDX54;RPL14;DDX49;RPL22;DDX47;WDR36;BYSL;KARS1;HELQ;SMAD1;EXOSC2;NVL;RPL23;RPL17;RPL29;TEX10;RPP30;RPS14;UBA52;NOP56;INTS12;RPL12;RPL9;ESF1;XRN2;RPL37;IMP3;DICER1;EXOSC4;SNU13;ZCCHC8;RPL7;RPL31;RPL7A;UTP6;MDN1;BMS1;RPL3;HEATR1;UTP11;PIH1D2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5915651308648076,1.87122147926344,0.0016638935108153079,0.35058721990327824,0.826,22/50,19.40%,RORA;DCDC2;GLI3;FBXL17;ZIC1;GLI1;MGRN1;CREBBP;GLIS2;IFT81;SUFU;RAB34;IHH;BTRC;TTC23;EVC;TUBD1;GAS8;DLG5;PTCH1;WDR11;GAS1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5739763617898496,-1.866170447191475,0.0,0.0354425669066154,0.745,12/34,10.05%,GRID2;MEF2C;GABRA2;GRIN2A;GABRA3;GABRA4;RAB3GAP1;GRIN2B;AKT1;NLGN3;GRIN1;GABRG3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7047372066443687,-1.8658442640131372,0.004366812227074236,0.034832952563949825,0.746,7/15,12.24%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNJ8;KCNQ1
prerank,regulation of small molecule metabolic process (GO:0062012),0.6480283355520798,1.854232299449726,0.0017331022530329288,0.3866010300009838,0.879,5/28,6.37%,PDK1;RORA;PANK2;FMO5;PPARA
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6542963572916455,1.8539743850459165,0.0,0.3392542841901257,0.88,5/26,4.73%,SULF1;RORA;IL6ST;IL6;ARNT
prerank,negative regulation of cartilage development (GO:0061037),0.7734003407376508,1.8460703564665106,0.0019801980198019802,0.3354766389524082,0.904,4/13,5.16%,EFEMP1;ADAMTS12;PTHLH;TGFBR1
prerank,epithelial structure maintenance (GO:0010669),0.802831976478668,1.8402226365766863,0.002004008016032064,0.32951937394443936,0.925,4/11,3.35%,CXADR;MUC2;PIWIL4;RBP4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6900342915064109,1.8382024197175846,0.003616636528028933,0.28193735033152,0.931,8/21,11.56%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6900342915064109,1.8382024197175846,0.003616636528028933,0.28193735033152,0.931,8/21,11.56%,EYA2;EYA1;TERT;BCL2;MCL1;BCL2L1;EYA4;MAP2K5
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.7159738376019944,1.8366526576528561,0.005366726296958855,0.2661201594800698,0.935,7/18,4.98%,PDPN;SMAD3;DDR2;BMP2;IL6;EFEMP2;CLASP1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.6239327933014934,-1.8313846636017357,0.0,0.054221093009876854,0.878,12/24,14.47%,PDE4D;DMD;AKAP6;FKBP1A;CALM1;CALM2;CALM3;CAMK2D;SELENON;NOS1;SRI;CASQ2
prerank,regulation of stress fiber assembly (GO:0051492),0.540961216491533,1.8305896353133655,0.0,0.26870588581955573,0.945,20/74,7.16%,PHLDB2;CGNL1;ARHGAP6;LPAR1;ROCK2;CCN2;PPM1E;DLC1;TACSTD2;ARHGAP28;NRP1;S100A10;ALMS1;TPM1;CLASP1;TGFBR1;EPHA1;ASAP3;CD47;ARHGEF10L
prerank,regulation of humoral immune response (GO:0002920),0.5830013881945041,1.830291629891271,0.0047694753577106515,0.2518357685668013,0.947,11/44,9.38%,CFH;VTN;CFHR2;GATA6;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,ganglioside metabolic process (GO:0001573),-0.6413981013318767,-1.8287216336358147,0.0064516129032258064,0.0549909946872796,0.886,8/20,14.23%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ST6GALNAC4;ST6GALNAC5;NEU1;GM2A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6625601648937348,1.826335859696207,0.0,0.24960994737997352,0.951,5/24,4.73%,SULF1;RORA;IL6ST;IL6;ARNT
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.4685880358878913,-1.81695069927933,0.0,0.06326515598871565,0.929,25/75,15.71%,SLC12A7;SLC12A2;SLC9A2;SLC39A10;ATP1B1;SLC24A2;ABCC9;KCNJ3;KCNJ2;SLC6A1;ATP1A1;SLC8A1;SLC39A6;HCN2;SLC39A14;SLC12A5;SLC39A12;KCNJ6;SLC12A6;KCNJ8;KCNJ15;SLC39A8;SLC9A5;ATP1A3;KCNK9
prerank,excitatory postsynaptic potential (GO:0060079),-0.6375996919489957,-1.814503633720108,0.004514672686230248,0.06416831130648855,0.933,7/19,9.11%,GRID2;MEF2C;GRIN2A;RAB3GAP1;GRIN2B;AKT1;GRIN1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6346096637436424,1.8135622125578459,0.003424657534246575,0.2778032028136455,0.968,9/30,6.51%,TGFBR3;SMAD3;FSTL1;SMURF2;FSTL3;TWSG1;LATS2;NREP;DKK3
prerank,regulation of bone mineralization (GO:0030500),0.5575840331947013,1.8061945763073544,0.0,0.28807942100579453,0.978,15/55,4.74%,BMP6;WNT4;PTN;ENPP1;DDR2;OSR1;ECM1;BMPR1A;BMP2K;NELL1;KL;ADGRV1;BMP2;BCOR;BMP7
prerank,modified amino acid transport (GO:0072337),0.7228392718984372,1.8049853136501277,0.0,0.2770883471676191,0.978,4/15,3.91%,PDPN;SLC6A13;SLC19A1;SLC16A12
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5683022278695823,-1.803790552687177,0.0024390243902439024,0.07149058670119343,0.953,14/32,9.11%,NLGN1;DLG2;GRIA4;LRRC7;MEF2C;PTK2B;GRIA1;GRIN2A;OPRM1;GRIA3;GRIN2B;CAMK2A;GRIA2;GRIN1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.6066005284075204,-1.803516376107971,0.002257336343115124,0.07051008019517138,0.955,10/24,14.08%,PDE4D;PEX5L;PDE3B;PRKAR1A;PDE11A;RAPGEF2;PDE3A;PDE2A;PRKAR2B;APLNR
prerank,positive regulation of nervous system development (GO:0051962),-0.530584385258263,-1.8034517435213258,0.0,0.06928427035942887,0.955,15/42,17.01%,NRXN1;NLGN1;PTPRD;GRID2;SYNDIG1;IL1RAPL1;IL1RAP;OPRM1;EPHB1;NLGN3;LRRC4B;CLSTN1;SLITRK2;SRPX2;EPHB3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.4614690619803993,-1.799966016472734,0.002849002849002849,0.07065929273732838,0.963,22/71,13.66%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;FCER1G;VAV1;DOCK1;SYK;HSP90AA1;RAC1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7166330993238932,1.7947357919838067,0.009328358208955223,0.29757517097743835,0.989,2/16,0.29%,PDK1;RORA
prerank,eye morphogenesis (GO:0048592),0.6925216269950586,1.7931227995636885,0.0038095238095238095,0.2899274776688505,0.993,9/19,11.59%,EFEMP1;FBN1;COL5A2;SHROOM2;COL5A1;SKI;MFAP2;NKD1;MFAP5
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7378066556730438,1.7927069727066858,0.005847953216374269,0.27834994622088177,0.993,6/14,13.84%,EFEMP1;ADAMTS12;PTHLH;TGFBR1;RFLNA;ADAMTS7
prerank,epithelial tube morphogenesis (GO:0060562),-0.5627591780330228,-1.7920632991823588,0.0025974025974025974,0.07592605440018327,0.97,15/32,13.22%,SLIT2;MEF2C;COL4A1;RYR2;PAK1;ACVRL1;SOX17;MET;RASIP1;CTNNB1;BMP4;RHOB;PRKX;ACVR1;CSF1R
prerank,ribosomal small subunit assembly (GO:0000028),-0.6665845022097812,-1.788583291258966,0.004434589800443459,0.07744109793043341,0.972,7/16,13.32%,RPS15;RPS27;RPS19;RPS28;RRP7A;RPS5;RPS14
prerank,chloride transport (GO:0006821),-0.4705180109381229,-1.7864547415464065,0.0,0.07827619980284449,0.972,30/74,19.29%,SLC4A10;SLC12A7;SLC26A7;SLC12A2;ANO1;CLIC5;SLC6A1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;SLC1A1;ANO4;SLC12A5;GABRB1;GABRG3;CLCN1;SLC12A6;TTYH3;ANO2;GABRB2;TTYH1;FXYD1;GABRA5;ANO5;GLRA2;GLRA1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6303351034007045,1.7855397986496568,0.005199306759098787,0.29066480973902126,0.995,14/29,17.59%,GHR;IL31RA;STAT2;FER;STAT5B;STAMBP;STAT1;CCL2;PIAS1;STAT4;SOCS6;PKD2;IFNAR2;STAT5A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5828181398399206,1.7801740573576315,0.0016366612111292963,0.2967353922879026,0.996,14/46,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.45558480747044006,-1.7758504130912869,0.0028653295128939827,0.08739358154060609,0.985,24/73,15.75%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;FCER1G;VAV1;DOCK1;SYK;HSP90AA1;RAC1;NR4A3;PLCG1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5857711379596396,-1.774275308326416,0.009433962264150943,0.08754838997194796,0.985,16/25,29.82%,NLGN1;SHANK3;MEF2C;NLGN3;SHISA9;MINK1;ADRB2;SHISA6;RELN;SHANK1;GSG1L;SHISA7;MAPK8IP2;CACNG5;CACNG7;SHISA8
prerank,dendrite self-avoidance (GO:0070593),-0.6630564107297294,-1.7737471362478907,0.004454342984409799,0.08660156163057968,0.985,7/16,10.36%,BSG;CNTN4;CNTN6;ROBO4;NPTN;CNTN2;EMB
prerank,diterpenoid metabolic process (GO:0016101),0.554213693055935,1.7707726705923366,0.0015455950540958269,0.32079219812619586,0.998,10/55,5.06%,ALDH1A1;GPC6;RBP1;ABCA4;APOA2;HSPG2;RDH10;SDC2;RBP4;RDH5
prerank,mesenchymal cell differentiation (GO:0048762),0.557188492964632,1.7684492065851685,0.0015360983102918587,0.31665740130440995,0.998,14/51,8.47%,RANBP3L;TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;FOXC1;FBXL17;BMP2;LOXL3;BMP7;TGFBR1;GSK3B;WNT5A
prerank,membrane repolarization during action potential (GO:0086011),-0.690154878744649,-1.7644245948802577,0.0021645021645021645,0.09484194460389472,0.988,6/13,13.29%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,vasodilation (GO:0042311),-0.6842212872470305,-1.763441793197271,0.006276150627615063,0.09439021896257012,0.988,6/13,14.97%,NOS3;KCNMA1;KLF2;NOS1;ADRB2;SOD1
prerank,regulation of T cell chemotaxis (GO:0010819),0.7625308076742968,1.761831103982872,0.00199203187250996,0.33130945235924264,1.0,5/11,14.08%,CXCL10;STK39;OXSR1;WNT5A;WNK1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7354514844544884,-1.7608796112042868,0.00641025641025641,0.09571162259459941,0.989,6/11,12.24%,ATP1B1;KCNJ3;KCNJ2;ATP1A1;KCND3;KCNQ1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.45373633901422633,-1.7595481129326336,0.002857142857142857,0.09593158638124041,0.99,21/70,13.66%,MYO10;PLCG2;ELMO1;PIK3R1;ACTB;NCKAP1;PAK1;ACTG1;WIPF3;MAPK3;HSP90AB1;ARPC3;ARPC4;ARPC2;LYN;ARPC1A;VAV1;DOCK1;SYK;HSP90AA1;RAC1
prerank,cartilage development (GO:0051216),0.5524610951857332,1.756287979823157,0.006289308176100629,0.3397434756597582,1.0,9/49,4.50%,SULF1;SOX5;CREB3L2;OSR1;WNT10B;WNT2B;ITGB8;BMP2;WNT5B
prerank,receptor signaling pathway via STAT (GO:0097696),0.6280866185128141,1.753566599204651,0.00510204081632653,0.3393639305540089,1.0,13/25,17.59%,GHR;IL31RA;STAT2;STAT5B;STAMBP;STAT1;CCL2;PIAS1;STAT4;SOCS6;PKD2;IFNAR2;STAT5A
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7597559165292148,1.7529418795598237,0.005649717514124294,0.31971029595980865,1.0,5/12,11.92%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7597559165292148,1.7529418795598237,0.005649717514124294,0.31971029595980865,1.0,5/12,11.92%,FHL2;RCAN1;ATP2B4;GSK3B;HOMER3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5838079064272026,-1.7524468661877062,0.004728132387706856,0.10195704293389303,0.993,8/25,9.11%,GRID2;MEF2C;GRIN2A;RAB3GAP1;GRIN2B;AKT1;NLGN3;GRIN1
prerank,dendritic spine morphogenesis (GO:0060997),-0.6470432851489261,-1.7509277871725735,0.002178649237472767,0.10198779456801577,0.993,7/15,17.01%,CTNND2;SHANK3;DOCK10;EPHB1;PAK3;SHANK1;EPHB3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.677109883883062,-1.7484140142056173,0.01593625498007968,0.1027343016282413,0.994,9/13,26.33%,SYT1;SCAMP5;CACNA1G;SYT4;KCNB1;SYT10;CACNA1I;DOC2B;HYAL3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6407717767201898,-1.7474347565838697,0.0,0.10245873387915234,0.994,8/18,9.11%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.5531225116791347,-1.746572439746667,0.004618937644341801,0.10182818925570272,0.994,8/31,7.15%,CTNNA2;BOC;CDH2;MEF2C;PTBP1;CTNNB1;HDAC9;TCF3
prerank,cell junction assembly (GO:0034329),-0.43116809060852423,-1.7458680417933126,0.0,0.1011150033967687,0.995,32/100,11.05%,DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;ITGA6;SHANK3;CLDN5;SPOCK2;CDH2;KIRREL3;CDH11;GPM6A;CDH12;ACTB;CDH1;ACTG1;SHANK2;GJC1;CDH10;TLN2;CDH8;NRCAM;CDH22;CDH7;CDH20;VMP1;NLGN3;DNER;VASP;DBNL;PCDHB16
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4815386739674723,-1.744884780544112,0.0,0.10070359790194552,0.995,24/54,20.89%,RPL26;RPL24;RPL5;RPL10A;RPL35A;RPL6;RPL11;RPLP0;RPL14;NPM1;TRAF7;MAK16;NIP7;NVL;MRPL1;PPAN;NLE1;SNU13;NOC2L;RPL7;MALSU1;RPL7A;MDN1;RPL3
prerank,dendritic spine organization (GO:0097061),-0.5629063102281646,-1.743415743933412,0.004750593824228029,0.10072095191094649,0.995,12/26,20.27%,CTNND2;SHANK3;INSR;DOCK10;EPHB1;LGMN;ITGA3;PAK3;SHANK1;EPHB3;MTMR2;CHRNA7
prerank,integrin-mediated signaling pathway (GO:0007229),0.5087901770647778,1.7406156725338642,0.0,0.35888309190912904,1.0,21/73,12.33%,TEC;PTN;COL3A1;FN1;PLPP3;MPIG6B;CCM2;ITGB8;NRP1;FBLN1;ITGA5;ADAMTS1;ITGBL1;ITGA10;PTPRA;CD47;ITGA11;PLEK;PTK2;CUL3;FYB1
prerank,response to peptide hormone (GO:0043434),0.5604087814347656,1.735187669031322,0.006837606837606838,0.3695322713635907,1.0,18/43,21.18%,TGFBR3;ROCK2;IGFBP5;STAT2;ANXA1;STAT5B;CRY1;EPM2AIP1;STAT1;EIF2B3;STAT4;MEAK7;KHK;TRIM16;STAT5A;SLC27A1;ROCK1;XBP1
prerank,regulation of gastrulation (GO:0010470),0.72518442230723,1.7347219635828472,0.0018796992481203006,0.36044778521273296,1.0,5/14,5.18%,PHLDB2;OSR1;DAG1;CLASP1;PHLDB1
prerank,regulation of complement activation (GO:0030449),0.5674163260146152,1.7335439871056044,0.004901960784313725,0.3544262081982989,1.0,10/40,9.38%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7420824900441677,1.7329173296843907,0.009541984732824428,0.34732594343906165,1.0,5/12,14.32%,DPYSL3;CTPS1;DPYD;UMPS;ALDH6A1
prerank,cAMP-mediated signaling (GO:0019933),-0.5782444818536301,-1.7327838223476992,0.007228915662650603,0.11011934667364072,0.997,10/24,10.76%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;RAPGEF2;PDE3A;PDE2A;ADCY2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5095812010921323,1.732721471583398,0.0015290519877675841,0.33891713871781143,1.0,17/74,6.93%,PHLDB2;PDPN;SMAD3;FOXC1;EPHA3;LDLRAD4;GLIPR2;DAG1;TGFB1I1;BMP2;IL6;CLASP1;TGFBR1;PHLDB1;BCL9L;USF3;TGFBR2
prerank,detection of calcium ion (GO:0005513),-0.6859793993383247,-1.7325459183053717,0.007952286282306162,0.1089686178272566,0.997,6/13,6.94%,SYT1;KCNMB2;RYR2;CALM1;CALM2;CALM3
prerank,negative regulation of metabolic process (GO:0009892),0.5459018275272511,1.7290125256562048,0.0,0.34385010931272564,1.0,14/54,9.50%,ALDH1A1;LGR4;RBPJ;LAMA4;WNT10B;ACOT11;FOXC2;NRDC;TLE3;TLR4;NR1H3;NOVA1;MAP2K6;DOCK7
prerank,positive regulation of behavior (GO:0048520),-0.731336421115312,-1.7290029001604266,0.004024144869215292,0.11192836014115438,0.997,3/10,1.17%,NLGN1;SGIP1;MEF2C
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.4225456037007404,-1.7283780858528743,0.0,0.11140469401466108,0.997,35/107,15.20%,SLC39A10;ATP1B1;SLC24A2;RYR2;TPT1;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;HTR2C;ATP2C1;SLC8A1;CCL14;SLC39A6;NPTN;ATP2A3;SLC30A1;SLC39A14;CXCL12;CALR;SLC39A12;SLC10A7;CD40;TMCO1;MT2A;CAV1;SLC39A13;ATP2A2;SLC39A8;CCL19;ATP13A4
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6468872136291208,-1.7281964692636944,0.008830022075055188,0.11019011176316752,0.997,11/17,27.65%,NLGN1;RAB27A;SCAMP5;CACNA1G;SYT4;KCNB1;RAB15;SYT10;CACNA1I;DOC2B;UNC13D
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5866657443144895,-1.7275032241761357,0.004484304932735426,0.1095338611863058,0.997,6/24,7.15%,CTNNA2;BOC;CDH2;MEF2C;CTNNB1;TCF3
prerank,regulation of immune effector process (GO:0002697),0.5591638330831963,1.726969322852673,0.004918032786885246,0.3421329878383476,1.0,10/41,9.38%,CFH;VTN;CFHR2;CD55;SERPING1;C5AR2;C2;PHB2;PROS1;CPB2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5612424248538876,-1.7262050808112364,0.0022935779816513763,0.1097332200440005,0.998,10/27,10.30%,PDE4D;CACNB2;DMD;CACNB4;FKBP1A;CALM1;CALM2;CAMK2D;SELENON;NOS1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5233364400690845,1.7217835035428788,0.001594896331738437,0.3524379942967211,1.0,16/65,7.91%,PDPK1;FBN1;SMAD3;LTBP1;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,negative regulation of transmembrane transport (GO:0034763),-0.7480243530541352,-1.720756306663132,0.006607929515418502,0.11492785719490121,0.999,4/10,7.21%,PRKCB;THBS1;INPP5K;AKT1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.43460629022630975,1.7204801593866437,0.0,0.3483759153738826,1.0,67/248,16.50%,BICC1;TCF7L2;RNF220;WLS;LRRK1;MCC;LGR4;PRICKLE1;ZEB2;RBMS3;TLE1;MLLT3;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;LYPD6;SIAH2;LRP4;PLEKHA4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;USP8;LZTS2;PSME4;USP47;LRRK2;PSMA5;PPM1B;NKD1;PTPRU;CUL3;DVL3;BTRC;NOG;FRMD8;WNK1;USP34;TLE6;NPHP3;ILK;STK4;RNF146;SOX4;DAB2;IGFBP4;TNKS2;AXIN2;WWTR1;TBL1X
prerank,adherens junction organization (GO:0034332),-0.4909807806883008,-1.720449842342764,0.0,0.11387830292826391,0.999,17/48,9.09%,CADM1;CADM2;CDH2;CDH11;CDH12;SMAD7;ACTB;CDH1;CDH10;CTNNB1;CDH8;CDH22;CDH4;CDH7;CDH20;JAM3;RAMP2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6340999379962708,1.719417855226686,0.006920415224913495,0.34392489798352155,1.0,2/22,0.84%,ALDH1A2;RBP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6456617483996567,-1.717579139887099,0.01279317697228145,0.11603012559018723,0.999,5/15,8.22%,GRM7;GRM3;GRM5;HOMER1;GRM8
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.675613182255139,1.717424851385564,0.013282732447817837,0.3434124116820019,1.0,5/17,7.80%,BMP6;SASH1;CD55;TRIM5;LY96
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.5141595470456637,-1.707903461349158,0.005194805194805195,0.1265303119774313,1.0,15/41,13.71%,KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2;ANK3;CTSS;NOS1;ACE2;KCNJ6;KCNQ1;KCNJ15;STAC
prerank,synapse assembly (GO:0007416),-0.457549499856879,-1.7040499550445771,0.002890173410404624,0.12989847830579784,1.0,23/67,11.23%,DNM3;ADGRL3;NRXN1;NLGN1;GRID2;SHANK3;SPOCK2;CDH2;KIRREL3;GPM6A;GABRA2;LRRTM3;CDH1;GABRB3;SHANK2;NRCAM;NLGN3;LGI2;DNER;DVL1;DBNL;PCDHB16;FGF13
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6428511101812304,1.702855428393211,0.014787430683918669,0.39117528789884587,1.0,5/18,10.16%,FBN1;FSTL3;TLR4;CARTPT;MAFB
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5956890586347485,-1.7023685226986132,0.011389521640091117,0.13061968673862553,1.0,9/21,12.95%,PDE4D;DMD;SMAD7;INPP5K;PAQR3;RASSF2;RACK1;DDIT4;CAV1
prerank,synapse organization (GO:0050808),-0.401617811414562,-1.6979869887377304,0.0,0.13443845647602076,1.0,34/125,11.05%,APBB2;DNM3;ADGRL3;NRXN1;NLGN1;CTNND2;PTPRD;LRRC4C;SHANK3;SPOCK2;CDH2;CACNB2;PPFIA2;KIRREL3;GRM5;GPM6A;SLC6A1;CACNB4;CDH1;ANK3;SNCA;GPHN;SHANK2;ARHGAP39;NRCAM;SEMA3E;NLGN3;CNTN2;L1CAM;DNER;DVL1;LRRC4B;DBNL;PCDHB16
prerank,defense response to tumor cell (GO:0002357),0.7615752423086594,1.697178436696979,0.021653543307086614,0.4058549850502011,1.0,5/10,4.86%,RBMS3;DLEC1;PRF1;DAPK1;PLK5
prerank,ganglioside biosynthetic process (GO:0001574),-0.6271756195011005,-1.6966683727867407,0.007905138339920948,0.1347104702284153,1.0,5/15,9.05%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,ethanol metabolic process (GO:0006067),0.714053343076477,1.696662744550915,0.017857142857142856,0.39901008566544993,1.0,4/12,16.54%,ALDH1A1;ALDH2;ACSS1;SULT1A1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.5521706066965407,1.6937301270637666,0.008517887563884156,0.40292723771090666,1.0,10/38,11.02%,BMP6;SASH1;DDX60;FPR2;IFI35;GBP5;OASL;LY96;ANKRD17;POLR3F
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.555664048119566,1.693256919766326,0.0017035775127768314,0.39632662231391524,1.0,11/40,6.93%,TCF7L2;PDPN;SMAD3;FOXC1;GLIPR2;TGFB1I1;BMP2;IL6;TGFBR1;BCL9L;TGFBR2
prerank,metal ion homeostasis (GO:0055065),-0.49629339518475885,-1.692833773958914,0.005141388174807198,0.13859351477323623,1.0,12/40,12.95%,TMTC2;SLC12A7;SLC12A2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;SLC12A5;GRIN1;SLC12A6;CAV1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7281792279368563,1.6918096426806248,0.02004008016032064,0.3938091165535277,1.0,5/13,3.95%,FBN1;FSTL1;LTBP1;NBL1;BMP2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.543678422668946,-1.6903646776466,0.007211538461538462,0.1402402929413452,1.0,17/31,26.68%,SYT1;SCAMP5;RAB3GAP1;STXBP1;CACNA1G;SYT4;SYT7;KCNB1;SYT9;SYT2;SYT6;SYT10;SYT5;CACNA1I;DOC2B;CBARP;SYT17
prerank,extracellular structure organization (GO:0043062),0.4394172373174497,1.6862043704842549,0.0,0.4076921707917099,1.0,42/204,6.79%,TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LAMC3;LOXL1;TGFBR1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6133767742049774,1.6853976309597474,0.014545454545454545,0.4023839637467174,1.0,6/24,5.16%,EFEMP1;SOX5;ADAMTS12;PTHLH;TGFBR1;MBOAT2
prerank,gene expression (GO:0010467),-0.3545604053013624,-1.68476324369163,0.0,0.14636390676312405,1.0,142/348,23.10%,RPS24;THRB;RPS9;RPL18A;RPL19;RPS12;ADARB1;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;PTMA;RPS19;RPL38;RPLP1;RPS8;SETX;RPL10A;RPL27A;RPL13;RPS18;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;RPL39;SORL1;RPS17;TSPAN14;RPS7;RPL37A;RPL4;RPS25;EEF1A1;RPS15A;RPL6;ADARB2;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;SRSF2;RPS20;RPS4X;RPL18;RPS13;CPSF2;RPS2;SRSF1;APOBEC1;SYMPK;DDX54;HNRNPK;RPL14;RPL22;ZC3H11A;DDX17;THOC2;RPS26;ASMT;HHEX;MRPS18A;AAAS;RPS10;IGHMBP2;PWP1;RPL23;RPL17;PABPC4;NUP93;RPL29;POLR3A;GSPT2;XAB2;RPS5;FASTKD2;RPS14;TASP1;NFKBIB;RAE1;HNRNPF;SRBD1;MMS19;MRPL28;COPS5;HBS1L;RPL12;POLR2J;RPL9;RBM3;RRAGC;XRN2;RPL37;DEDD2;RPS11;BCL3;DUSP11;RNPS1;SRSF9;MRPL35;POLDIP3;MRPS5;NXT1;RPL7;RPL31;RPL7A;TSPAN33;MRPL34;RBM15B;HARS1;YARS2;FARSB;UPF1;ALKBH5;RPL3;MRPL52;MRPL23;MRPL9;NUP62;SRSF6;HOXD3;GSPT1;CHTOP;CPSF3;ANGPT2;NUP188;MRPS12;RPL23A;U2AF1;MRPL11
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6335006343380513,1.6844690051549809,0.015625,0.39837119178955865,1.0,8/22,12.63%,ZBTB20;APOA2;SORBS1;CREBL2;PPARA;SIRT4;DISP3;EEF1A2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.720583853107184,1.6832084227911213,0.02448210922787194,0.3957651289604062,1.0,8/11,12.47%,PARP14;PARP9;PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.5018440170013095,-1.6831127666065688,0.0,0.1470830820325962,1.0,17/39,12.83%,SLIT2;TIE1;COL4A1;KDR;PAK1;SIX1;MET;RASIP1;CTNNB1;SEMA3E;BMP4;VEGFA;LRP6;NOTCH4;FGF2;PAX2;LRP5
prerank,regulation of monooxygenase activity (GO:0032768),-0.5654373657258351,-1.6829424847059307,0.009259259259259259,0.1457156368553984,1.0,10/23,12.95%,NOS3;NOSTRIN;NOS1AP;CALM1;SNCA;AKT1;CYGB;EGFR;HSP90AA1;CAV1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5581676004180028,1.6828947445667863,0.011456628477905073,0.38954135544808693,1.0,11/40,4.74%,BMP6;WNT4;PTN;WNT6;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6796286065487587,1.6824627949265234,0.013011152416356878,0.38413093073613813,1.0,4/16,2.26%,SOX5;PTN;FOXC1;TACSTD2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5794721580223323,-1.6774801194824447,0.013392857142857142,0.15194609011026441,1.0,7/19,4.93%,CSGALNACT1;HS6ST3;HS6ST2;NDST3;HS3ST5;XYLT1;EXT1
prerank,endothelial cell proliferation (GO:0001935),-0.6198704528736396,-1.6749784757122934,0.015730337078651686,0.1537865197763293,1.0,7/17,9.91%,TEK;BMPER;BMPR2;CD34;ACVRL1;BMP4;PRKX
prerank,water transport (GO:0006833),0.6956626419267544,1.672935971748686,0.013565891472868217,0.41448494377003514,1.0,1/12,0.30%,PDPN
prerank,external encapsulating structure organization (GO:0045229),0.4336686607900544,1.6723856666865224,0.0,0.4092901962591759,1.0,41/205,6.79%,TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LAMC3;LOXL1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,regulation of acute inflammatory response (GO:0002673),0.6501280923027086,1.6701306189059522,0.024253731343283583,0.41105578386221736,1.0,4/18,5.95%,IL6ST;OSM;IL6;CREB3L3
prerank,chondrocyte differentiation (GO:0002062),0.5703646163766223,1.668654356990418,0.0015772870662460567,0.4096771273650999,1.0,8/32,4.50%,SULF1;SOX5;CREB3L2;OSR1;WNT10B;WNT2B;BMP2;WNT5B
prerank,cardiac myofibril assembly (GO:0055003),0.6678908049961771,1.6670215038307052,0.0199203187250996,0.4094206473177446,1.0,5/15,8.03%,PDGFRA;CSRP3;NEBL;PDGFRB;MEF2A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.47661292452446335,1.6668311552178856,0.0014858841010401188,0.4033664350749925,1.0,22/95,8.19%,PDPK1;TGFBR3;SMAD3;ZEB2;SMURF2;PPM1A;SNX6;LDLRAD4;TGFB1I1;PMEPA1;WFIKKN1;LATS2;TGFBR1;NREP;BCL9L;PPARA;DKK3;CREBBP;TGFBR2;SKI;CDKN2B;RNF111
prerank,type I interferon signaling pathway (GO:0060337),0.5549488305826623,1.6667551226261266,0.004966887417218543,0.39085621929239006,1.0,18/41,15.99%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;BST2;OASL;STAT1;IFITM1;OAS2;IFI27;ADAR;IFIT1;JAK1;IFIT3;IRF9;IFNAR2
prerank,cellular response to type I interferon (GO:0071357),0.5549488305826623,1.6667551226261266,0.004966887417218543,0.39085621929239006,1.0,18/41,15.99%,RSAD2;SP100;GBP2;STAT2;IFIT2;IFI35;BST2;OASL;STAT1;IFITM1;OAS2;IFI27;ADAR;IFIT1;JAK1;IFIT3;IRF9;IFNAR2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.6006112546993123,1.6661957224767534,0.013816925734024179,0.38672114397790247,1.0,11/26,20.39%,KMT2A;METTL21C;ETFBKMT;SETD4;SETD1B;TET2;SETD5;ATPSCKMT;KMT5C;SETD2;KMT5B
prerank,regulation of neurotransmitter transport (GO:0051588),-0.6183884696897058,-1.6655832523265046,0.017738359201773836,0.16583769782146893,1.0,6/16,8.65%,RIMS1;MEF2C;MCTP1;CPLX1;CAMK2A;SYN1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4424931799166032,1.6641719003046196,0.0,0.3881621421194592,1.0,29/152,10.31%,RNF220;SULF1;WLS;LRRK1;LGR4;ZEB2;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;DACT1;BMP2;TERT;WNT5B;SALL1;LYPD6;PLEKHA4;CDC73;SKI;PSMB10;PSMA3;USP8;PSME4;USP47;LRRK2;PSMA5;PPM1B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6155498336737115,1.66384220922198,0.020869565217391306,0.38324445649722844,1.0,6/23,6.51%,TGFBR3;SMAD3;SMURF2;LATS2;NREP;DKK3
prerank,regulation of postsynapse organization (GO:0099175),-0.528808676903372,-1.663757969662828,0.006696428571428571,0.16706782303334097,1.0,11/28,15.56%,SHANK3;PPFIA2;TANC2;HOMER1;IL1RAPL1;ARHGAP44;ABI3;LZTS3;SRCIN1;ABHD17A;CFL1
prerank,connective tissue development (GO:0061448),0.556524024379645,1.661589772955421,0.008488964346349746,0.38587715179218857,1.0,4/35,2.91%,SULF1;SOX5;CREB3L2;ITGB8
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.5471786147219919,-1.6613549028098675,0.0070921985815602835,0.16909515985412263,1.0,14/26,20.27%,NRXN1;NLGN1;SHANK3;RIMS1;RIMS2;PTK2B;NLGN3;GRIN1;TMEM108;RELN;SHANK1;MTMR2;TMEM25;CHRNA7
prerank,embryonic heart tube development (GO:0035050),-0.6424596500012231,-1.6596890738053525,0.008547008547008548,0.17045354029519075,1.0,7/14,17.72%,RYR2;SOX17;TBX2;NDRG4;SOX18;ACVR1;HES1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6095760755809599,1.6561724312586164,0.008726003490401396,0.4000722942529639,1.0,7/24,4.98%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,response to interferon-gamma (GO:0034341),0.5000660334940975,1.6555009351997265,0.00303951367781155,0.39705331978691993,1.0,23/67,16.20%,GBP6;SP100;GBP2;CXCL16;DAPK1;TLR4;GBP5;BST2;CD47;GBP4;STAT1;CCL2;LGALS9;NUB1;WNT5A;IFITM1;GBP7;TLR2;TRIM21;SLC26A6;CCL25;IL23R;GBP3
prerank,regulation of glucose import (GO:0046324),0.5736592425549536,1.6531849872783684,0.013266998341625208,0.39973931518539896,1.0,9/30,9.78%,PRKAG2;PID1;ENPP1;OSBPL8;SORBS1;APPL2;CREBL2;RHOQ;APPL1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.7243339160297085,1.6497395913692137,0.02186878727634195,0.4068419422374472,1.0,4/10,14.08%,STK39;OXSR1;WNT5A;WNK1
prerank,carbohydrate homeostasis (GO:0033500),0.492148250305366,1.6483542520622683,0.007704160246533128,0.4062191609220387,1.0,12/67,7.53%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;CRY1;IL6;APPL2;PTPN2;NGFR
prerank,sodium ion import across plasma membrane (GO:0098719),-0.6071983984400323,-1.6447875736753337,0.018518518518518517,0.19375539010041276,1.0,5/17,6.59%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;HCN2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6608972059997753,1.6412946454842103,0.028985507246376812,0.4279286146272737,1.0,5/15,4.98%,PDPN;DPP4;DDR2;IL6;CLASP1
prerank,negative regulation of cell migration (GO:0030336),0.4404184037723707,1.6396180714100759,0.0,0.4290473616498283,1.0,39/137,13.02%,PHLDB2;SULF1;IGFBP3;ROBO1;DPYSL3;PODN;MCC;COL3A1;AFDN;IGFBP5;GJA1;DLC1;TACSTD2;KANK1;BMPR1A;LDLRAD4;DAG1;DUSP10;MIA3;TPM1;CLASP1;VCL;SERPINE1;EPHA1;BST2;CLIC4;RNF20;NGFR;EPHA4;STK24;RAP2C;IFITM1;ATP1B2;PTPRU;FOXO3;EPPK1;SLURP1;NOG;ARPIN
prerank,positive regulation of synaptic transmission (GO:0050806),-0.43702329753515057,-1.639076692482022,0.002840909090909091,0.20182433143718148,1.0,14/72,6.94%,NRXN1;NLGN1;SHANK3;SYT1;RIMS1;RIMS2;GRIK2;SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN;LGMN
prerank,negative regulation of viral genome replication (GO:0045071),0.5340753458070009,1.6378193405587174,0.006578947368421052,0.43004495967745004,1.0,19/40,20.22%,RSAD2;ZC3HAV1;EIF2AK2;BST2;PARP10;OASL;IFITM1;RESF1;OAS2;ILF3;IFIT1;SRPK1;TASOR;IFIH1;SHFL;SETDB1;TNIP1;RNASEL;MPHOSPH8
prerank,response to zinc ion (GO:0010043),-0.5515093691081512,-1.636531868961843,0.011764705882352941,0.20471571827185903,1.0,8/25,2.74%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,cellular response to metal ion (GO:0071248),-0.38974737852488905,-1.636267966892373,0.0,0.20322276547760407,1.0,29/123,8.85%,NLGN1;DLG2;SLC12A2;SYT1;MEF2C;PLCG2;ITPKB;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;CDH1;ANK3;SNCA;MAPK8;RYR3;MAPK3;KCNH1;LGMN;AKT1;CAMK2D;SYT4;SYT7;B2M;CPNE4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6119874236131592,1.6351584114358784,0.015817223198594025,0.4347109880670954,1.0,10/23,15.64%,PARP14;PARP9;NR1H3;PTPN2;STAT1;PIAS1;SUMO1;OTOP1;JAK1;TXK
prerank,negative regulation of wound healing (GO:0061045),0.5834105868968767,1.632672082280852,0.015517241379310345,0.4388873390279359,1.0,9/28,12.41%,PHLDB2;TFPI;VTN;CASK;CLASP1;SERPINE1;SERPINE2;EPPK1;CD109
prerank,neuronal action potential (GO:0019228),-0.555448597097249,-1.6314201794052396,0.016771488469601678,0.21004874400256368,1.0,11/22,20.63%,KCNMB2;SCN1A;ANK3;SCN2A;CACNA1G;SCN8A;SCN9A;KCNA2;SCN3A;KCNA1;KCNMB4
prerank,response to X-ray (GO:0010165),0.6658893190969386,1.6276532747728194,0.028688524590163935,0.45309164784780737,1.0,6/14,8.69%,PRAP1;XRRA1;ANXA1;NUCKS1;IKBIP;XRCC4
prerank,secretion (GO:0046903),-0.6338537034017888,-1.627148230952584,0.02959830866807611,0.21634746473018854,1.0,5/14,10.70%,RIMS1;TPD52;FBLN5;NPR1;SLC22A6
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6423133519503074,1.6238625500284665,0.01845018450184502,0.4626512843306481,1.0,5/17,2.99%,SULF1;FSTL1;FSTL3;CASK;TWSG1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5460631885255143,-1.6233802294600894,0.030232558139534883,0.22132497135179327,1.0,11/22,16.45%,NTRK2;SH3GL2;STMN2;RAPGEF2;AKT1;RAB35;NGF;TMEM108;MAPT;RAP1A;NTF3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.49423204569406104,1.622774874887169,0.011041009463722398,0.461234177142985,1.0,12/63,8.04%,TCF7L2;DEPTOR;SP100;FGFR1;PHIP;WWOX;SH3RF1;CFLAR;TGFBR1;SIAH2;TNFRSF12A;ZMYND11
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6658547543317884,-1.6223664239744904,0.03411513859275053,0.2191352983832836,1.0,7/11,19.53%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6658547543317884,-1.6223664239744904,0.03411513859275053,0.2191352983832836,1.0,7/11,19.53%,FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.46543315620327885,-1.6217657263581764,0.012165450121654502,0.21844493189154887,1.0,15/41,15.71%,SLC12A7;SLC12A2;ATP1B1;ABCC9;KCNJ3;KCNJ2;ATP1A1;HCN2;SLC12A5;KCNJ6;SLC12A6;KCNJ8;KCNJ15;ATP1A3;KCNK9
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.492933222541103,-1.6213148863293843,0.013333333333333334,0.21726583591202556,1.0,12/35,10.76%,PDE4D;RIMS2;ADGRG6;AKAP6;CAP2;EPHA5;HTR2C;RAPGEF2;GUCY1B1;PDE3A;PDE2A;ADCY2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4446738885937255,1.6200184996412328,0.0013568521031207597,0.4669181592620542,1.0,34/128,12.58%,TGFBR3;BMP6;SMAD3;ZMIZ1;COL3A1;RGMA;SMURF2;RGMB;BMPR1A;CDH5;TWSG1;TGFB1I1;HIVEP1;LRRC32;BMP2;PARD6A;BMP7;PRKCZ;TGFBR1;APPL2;TGFBR2;BMP8B;USP9X;SLC33A1;SKI;RNF111;SMAD6;APPL1;ZFYVE16;PTK2;TGFBRAP1;SMAD4;MAP3K7;HFE
prerank,ceramide catabolic process (GO:0046514),-0.6320445704911989,-1.6185585973865024,0.008733624454148471,0.2204676630592325,1.0,6/14,18.68%,ACER3;ACER2;HEXB;NEU1;GM2A;GLA
prerank,regulation of stem cell proliferation (GO:0072091),0.6563310692464689,1.6170694750476065,0.01981981981981982,0.4733225756175739,1.0,5/17,8.62%,EIF2AK2;GJA1;FBLN1;TERT;YAP1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.6119062762386865,1.6151281836485538,0.0166358595194085,0.47502259863252355,1.0,4/21,5.16%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4201726353479176,1.614995326261026,0.0,0.46981016950228005,1.0,48/186,16.40%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;RNF213;TLE1;MLLT3;GLI3;WWOX;APCDD1;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;LZTS2;PSME4;PSMA5;NKD1;PTPRU;CUL3;VGLL4;DVL3;NOG;FRMD8;HIC1;RNF43;TLE6;NPHP3;STK4;DAB2;IGFBP4;AXIN2;WWTR1
prerank,acylglycerol biosynthetic process (GO:0046463),0.6050520909274281,1.6144675568275848,0.017857142857142856,0.46610163226582807,1.0,7/23,17.18%,AGMO;PLA2G4A;PLCE1;MOGAT3;DGAT2;LPGAT1;LPIN2
prerank,energy reserve metabolic process (GO:0006112),0.6240824658256289,1.6133695697407386,0.025500910746812388,0.4649821801585761,1.0,5/19,9.08%,LEPR;PRKAG2;PID1;GSK3B;PYGM
prerank,actin cytoskeleton reorganization (GO:0031532),0.48871381818581366,1.6133601866735285,0.012195121951219513,0.45967129474086593,1.0,13/63,4.40%,MCU;CXADR;NRK;AUTS2;PARVA;INSRR;PTK7;NRP1;FER;ANXA1;ANTXR1;KIT;EFS
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5940953819156035,-1.6123292217888647,0.021141649048625793,0.22995799858618302,1.0,9/18,16.24%,GRID2;GRIK2;GRIK4;GRIK1;CDH8;SLC1A4;GRIA2;NAPA;GRIK3
prerank,protein ADP-ribosylation (GO:0006471),0.5639122770008929,1.610199067832278,0.02527075812274368,0.4663551223910013,1.0,11/28,12.47%,PARP14;ZC3HAV1;PARP9;PARP3;ARF4;PARP10;PARP12;PARP11;SIRT4;TIPARP;PARP16
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5705932026830027,-1.6099456211928376,0.020089285714285716,0.23253144868192285,1.0,11/20,31.13%,PLCB1;CHRM3;CHRM2;LYPD1;AGRN;GNAQ;CHRNA7;LY6H;RGS10;LY6G6D;GNA11
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6922210645779558,-1.6091307071195478,0.026748971193415638,0.23197856197921263,1.0,6/10,12.86%,PDE4B;CACNB2;NOS1AP;CALM1;CALM3;SRI
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.6468005166124191,-1.6085870428680624,0.029045643153526972,0.23091123707444944,1.0,4/12,17.04%,CEACAM1;ERLIN1;ACADVL;BRCA1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.5481822176279738,1.6083245496521859,0.020168067226890758,0.46795286470371816,1.0,10/33,9.57%,TCF7L2;PDPK1;NUPR1;IL11;CDH5;ANGPT1;SERPINE1;PPARA;YAP1;CAST
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5019402391896516,1.6074628972882807,0.019672131147540985,0.46598205212880683,1.0,13/51,7.16%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;SYNPO2;SYNPO;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,myotube differentiation (GO:0014902),-0.5792662426716745,-1.6040047438835898,0.023404255319148935,0.23817403462529796,1.0,8/17,15.36%,ADGRB3;MEF2C;JAM2;KCNH1;MYEF2;NOS1;SIX4;SORT1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4408159591520876,-1.601927624718574,0.010498687664041995,0.23988346441922354,1.0,18/54,12.95%,DPP10;KCNAB1;KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2;KCNIP4;KCNIP1;DPP6;NEDD4L;CACNA1D;KCNJ6;KCNQ1;KCNJ15;CAV1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4838184261286842,1.6011907836440569,0.0075075075075075074,0.48499839989277427,1.0,17/68,12.89%,TCF7L2;WNT4;WNT6;PLPP3;WNT10B;WNT3A;WNT2B;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;PORCN
prerank,hepaticobiliary system development (GO:0061008),0.6075447698146526,1.6010918183660958,0.03302752293577982,0.480045716069787,1.0,3/20,1.07%,TGFBR3;WNT4;PRKCSH
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6361960040970704,1.6002315372995197,0.02912621359223301,0.47830301434066147,1.0,7/17,9.50%,VTN;DOCK5;IGFBP5;NRP1;ADAMTS1;PDGFRB;DOCK7
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5510916025138175,-1.599133737032596,0.03146067415730337,0.24365915167739335,1.0,8/22,6.43%,SLIT2;SSH2;TMSB4X;KANK3;KANK4;TMSB10;HIP1R;CYRIB
prerank,positive regulation of bone mineralization (GO:0030501),0.543393808722797,1.5985246525003067,0.016556291390728478,0.47991764836774625,1.0,10/35,4.74%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5444030646266849,-1.5984342043084092,0.015021459227467811,0.2430794952182968,1.0,14/22,26.74%,AKAP6;ATP1B1;RYR2;CALM1;CALM2;CALM3;VMP1;STAC;STAC3;GSTO1;HAP1;HTT;CASQ1;JPH2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6141351718311701,1.597286068516348,0.026615969581749048,0.47960331682768453,1.0,9/21,17.23%,DCDC2;GLI1;RAB34;IHH;TTC23;EVC;TUBD1;GAS8;DLG5
prerank,positive regulation of cation channel activity (GO:2001259),-0.4738502327067952,-1.5972289523328826,0.016587677725118485,0.2434544607790642,1.0,19/40,24.60%,SHANK3;TMSB4X;AKAP6;CALM1;ANK3;CALM2;CALM3;CTSS;NLGN3;ADRB2;STAC;RELN;STAC3;GSTO1;LRRC38;HAP1;LRRC55;HTT;CASQ1
prerank,protein localization to synapse (GO:0035418),-0.6581288628514929,-1.59715570293412,0.027083333333333334,0.2416024820483579,1.0,3/12,3.28%,NRXN1;NLGN1;PCLO
prerank,histone H3-K4 trimethylation (GO:0080182),0.7081973979091342,1.596826374923923,0.04271844660194175,0.47635019355462865,1.0,3/11,12.90%,KMT2A;SETD1B;TET2
prerank,neuron development (GO:0048666),-0.3679076204790869,-1.596360785195875,0.0,0.24137195135547723,1.0,36/141,11.76%,FRY;CNTNAP2;NLGN1;MEF2C;TENM2;TGFB2;GPM6A;TENM3;CNTN4;EPHA5;MYT1L;PLP1;GPM6B;PBX3;STX3;NTRK2;PTPRM;ATP8A2;VSX1;SH3GL2;RP1;TENM4;HMGB1;MYOC;STMN2;RAPGEF2;UNK;THOC2;RAB35;L1CAM;LYN;MANF;RUNX1;MICALL2;ZFYVE27;ULK1
prerank,actin filament bundle assembly (GO:0051017),0.552796174902282,1.595413763117626,0.019434628975265017,0.4771180224335105,1.0,6/33,4.72%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1
prerank,cellular response to BMP stimulus (GO:0071773),0.4854067954340928,1.5945951879574864,0.004608294930875576,0.4755739764778138,1.0,21/66,16.33%,TGFBR3;BMP6;SMAD3;RGMA;ADAMTS12;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;BMP8B;USP9X;SLC33A1;SMAD6;ZFYVE16;SMAD4;HFE;ADAMTS7;GDF15;ACVR2B;SMAD2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6976199460266346,1.5942700687107219,0.030476190476190476,0.47204506155546394,1.0,4/11,3.95%,EFNB2;WNT3A;FRS2;BMP2
prerank,dicarboxylic acid transport (GO:0006835),0.5562597778400405,1.5941402794869541,0.022298456260720412,0.4678431538977197,1.0,5/28,2.56%,PDPN;SLC1A3;SLC13A3;GJA1;SLC19A1
prerank,negative regulation of blood coagulation (GO:0030195),0.5206052039136756,1.593280135483402,0.022108843537414966,0.4662721227582149,1.0,9/38,9.38%,TFPI;VTN;PDGFRA;SERPING1;GP1BA;SERPINE1;SERPINE2;PLAU;CPB2
prerank,negative regulation of hemostasis (GO:1900047),0.6727172133705218,1.5927407030421596,0.030360531309297913,0.4635328974507776,1.0,4/12,8.66%,TFPI;VTN;SERPINE1;SERPINE2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.42111238682012625,-1.5912270343453068,0.011396011396011397,0.25001797733218195,1.0,35/69,31.42%,COX6C;COX4I1;SDHC;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;COX7B;NDUFB7;SDHD;NDUFB10;UQCC3;NDUFC2;NDUFA13;NDUFA9;UQCR10;UQCRQ;NDUFA10;COX4I2;SDHAF2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5833203563387417,-1.5884140321704483,0.022271714922048998,0.2539928760235699,1.0,4/18,2.25%,NRXN1;NLGN1;SHANK3;PTK2B
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5250021613352016,-1.5883301024590433,0.02358490566037736,0.25212422808192253,1.0,14/27,25.52%,CTNNA2;HOMER1;IL1RAPL1;CCDC88A;EFHC2;AKT1;MBOAT1;MARK1;BRSK2;NTNG1;NTNG2;CAMK2G;TREM2;FRMD7
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4201900563739913,1.5865802207728816,0.001349527665317139,0.48293171859388306,1.0,42/161,16.40%,BICC1;TCF7L2;MCC;PRICKLE1;RBMS3;TLE1;MLLT3;GLI3;INVS;DACT1;BMP2;IGFBP6;TLE3;GLI1;TMEM64;LATS2;SIAH2;LRP4;DKK3;CTNND1;GSK3B;PSMB10;WNT5A;STK3;AMFR;PSMA3;LZTS2;PSME4;PSMA5;NKD1;PTPRU;CUL3;DVL3;NOG;FRMD8;TLE6;NPHP3;STK4;DAB2;IGFBP4;AXIN2;WWTR1
prerank,negative regulation of immune effector process (GO:0002698),0.6755436567711415,1.5855311260011071,0.04174573055028463,0.4824180492837237,1.0,6/13,9.78%,ENPP3;CD55;FER;RC3H1;CD47;APPL1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5411985264130991,-1.5852171138603988,0.02178649237472767,0.2564985327316652,1.0,9/22,17.86%,PDE4B;CACNB2;DMD;CACNB4;NOS1AP;SRI;STAC;STAC3;HPCA
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.5006467434920026,-1.58519717223475,0.017114914425427872,0.2545187827824282,1.0,13/31,15.56%,NLGN1;SHANK3;PPFIA2;TANC2;ARHGAP44;CAPRIN2;LRP8;ABI3;DBNL;LZTS3;SRCIN1;RELN;CFL1
prerank,substantia nigra development (GO:0021762),-0.47370448432400386,-1.5849404817565402,0.014184397163120567,0.25312075300507614,1.0,17/37,17.75%,GNB4;ACTB;PLP1;CALM1;CALM2;MBP;YWHAH;CALM3;INA;S100A1;BASP1;TTBK1;HSPA5;YWHAQ;SUDS3;RAD1;CKB
prerank,endothelial cell development (GO:0001885),-0.5373576190458531,-1.5843992632759496,0.011547344110854504,0.2522910190879501,1.0,8/25,9.94%,PDE4D;PECAM1;PPP1R16B;MET;ROBO4;RAPGEF2;PDE2A;SOX18
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6592118623296039,1.5832200074321334,0.032692307692307694,0.48643336153702954,1.0,4/13,5.13%,ENPP3;ENPP1;DCTPP1;ENTPD7
prerank,glucose homeostasis (GO:0042593),0.4561011209787114,1.5816733294055598,0.012030075187969926,0.487483914502632,1.0,15/83,9.01%,TCF7L2;LEPR;MCU;PRKAA2;GCGR;RBP4;CRY2;NUCKS1;CRY1;IL6;APPL2;CARTPT;PTPN2;NGFR;HKDC1
prerank,aerobic electron transport chain (GO:0019646),-0.4218249812424856,-1.5816209345172398,0.011560693641618497,0.256569803807239,1.0,35/68,31.42%,COX6C;COX4I1;SDHC;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFA11;COX7B;NDUFB7;SDHD;NDUFB10;UQCC3;NDUFC2;NDUFA13;NDUFA9;UQCR10;UQCRQ;NDUFA10;COX4I2;SDHAF2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,actin filament bundle organization (GO:0061572),0.5460518279823334,1.580679360629813,0.02112676056338028,0.4869055281856005,1.0,8/33,9.74%,DPYSL3;PAWR;CALD1;SHROOM2;MYO1B;BAIAP2L1;LIMA1;RFLNA
prerank,central nervous system neuron development (GO:0021954),-0.5956045979627204,-1.5790740364216707,0.0255863539445629,0.26001112364769,1.0,7/15,15.98%,NTRK2;LHX6;HSP90AB1;RAPGEF2;HSP90AA1;MAPT;MAP2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.495971908839936,-1.5789450672102576,0.020050125313283207,0.2582575413144058,1.0,9/29,12.90%,SLC4A10;GRIK2;NETO1;MCTP1;RAB3GAP1;CAMK2A;SHISA9;ZDHHC2;SHISA6
prerank,megakaryocyte differentiation (GO:0030219),0.693574627983131,1.5781751202567258,0.04216867469879518,0.49255239621088215,1.0,6/11,11.58%,MPIG6B;IL11;KIT;UBA5;CDKN2B;SH2B3
prerank,regulation of dendrite extension (GO:1903859),-0.5770909294562792,-1.5781449583292757,0.03225806451612903,0.25815996846027206,1.0,16/18,40.37%,SYT1;RIMS1;RIMS2;SYT4;NEDD4L;SYT2;ITSN2;PLAA;SYT17;CPNE5;CPNE9;UNC13A;SYT3;RASAL1;RNF157;CPNE6
prerank,positive regulation of telomerase activity (GO:0051973),-0.4868693594147377,-1.5774392966276267,0.016666666666666666,0.25768229307689905,1.0,11/33,16.15%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;NVL;KLF4;HSP90AA1;PNKP;PKIB
prerank,retinoic acid metabolic process (GO:0042573),0.658682067345305,1.5760317613996135,0.020637898686679174,0.4963991898180754,1.0,4/14,14.80%,ALDH1A2;SCPEP1;BCO2;ALDH8A1
prerank,regulation of microtubule-based process (GO:0032886),0.5306338342964929,1.5756256839651985,0.016611295681063124,0.49350524895560394,1.0,8/36,7.65%,PHLDB2;DIAPH1;PRKAA2;EPHA3;MAP6;CLASP1;PHLDB1;GSK3B
prerank,neural tube development (GO:0021915),0.6395116146898573,1.5755677966734956,0.0392156862745098,0.48927961223962224,1.0,3/15,3.72%,ALDH1A2;ARL13B;DACT1
prerank,positive regulation of dendrite extension (GO:1903861),-0.5868306289168139,-1.5754906873182115,0.0391304347826087,0.25973406773192903,1.0,16/17,40.37%,SYT1;RIMS1;RIMS2;SYT4;NEDD4L;SYT2;ITSN2;PLAA;SYT17;CPNE5;CPNE9;UNC13A;SYT3;RASAL1;RNF157;CPNE6
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.6463064050520362,1.575098963995629,0.051756007393715345,0.4868241323419384,1.0,4/16,4.69%,KMT2A;AUTS2;MYB;BCOR
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6650434991399921,-1.5749317262122664,0.0375,0.2588608588073392,1.0,6/10,14.08%,PDE4D;PDE3B;PDE11A;PDE3A;PDE2A;APLNR
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5707701071281516,-1.5744428257214709,0.0273972602739726,0.25808242086117994,1.0,7/18,13.59%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,cation transmembrane transport (GO:0098655),0.507083975111839,1.5734087491613569,0.01507537688442211,0.48888843066899207,1.0,5/44,2.87%,TRPM3;SLC7A2;ATP1A2;TRPM6;SLC6A9
prerank,regulation of synapse assembly (GO:0051963),-0.45106919728657985,-1.573190283192723,0.014354066985645933,0.2587233428220959,1.0,20/46,18.07%,NRXN1;NLGN1;PTPRD;GRID2;ROBO2;MEF2C;SYNDIG1;IL1RAPL1;SNCA;IL1RAP;EPHB1;NLGN3;LRRC4B;IL1RAPL2;CLSTN1;SLITRK2;SRPX2;EPHB3;SLITRK1;LRFN5
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6265542137623141,1.5727825623787424,0.033271719038817,0.48696865225292313,1.0,4/17,6.37%,PID1;NUPR1;HDAC4;PPARA
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6451302972057871,-1.5726464346596047,0.0379746835443038,0.2580232335156907,1.0,5/11,12.81%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6152532075774619,-1.5722635843815378,0.0255863539445629,0.2568727617610358,1.0,5/13,12.81%,NOS3;CALM1;AKT1;GCH1;HSP90AA1
prerank,central nervous system neuron differentiation (GO:0021953),-0.4886037962918102,-1.5721743716359984,0.017114914425427872,0.25523065874927886,1.0,15/33,27.36%,MDGA2;GRID2;NTRK2;TOX;CTNNB1;LRP6;SPOCK1;MAPT;MAP2;LHX1;CBLN1;ZC4H2;CEND1;LMX1A;CHD5
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.5120001506748867,-1.5716426441889224,0.025404157043879907,0.25454804925240293,1.0,8/25,12.95%,TMTC2;ANK3;SNCA;SLC8A1;CNNM4;SELENON;GRIN1;CAV1
prerank,neuromuscular process controlling balance (GO:0050885),-0.6253121985472125,-1.571578871441219,0.022044088176352707,0.25290912693381684,1.0,2/12,0.74%,NRXN1;PCDH15
prerank,circulatory system development (GO:0072359),0.4323236005545819,1.5713772938045103,0.0028776978417266188,0.4881705483045526,1.0,25/118,8.78%,FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HEG1;HSPG2;FOXC2;CDH5;RBP4;ADAP2;MTHFD1;BMP2;BCOR;TGFBR1;NCOA6;SALL1;PLCE1;POPDC2;TGFBR2;MEF2A;PRICKLE4;CACNA1C
prerank,proteoglycan biosynthetic process (GO:0030166),-0.49376713188457433,-1.571023994590845,0.007352941176470588,0.2521737917378719,1.0,7/31,5.42%,CSGALNACT1;BMPR2;NDST3;XYLT1;EXT1;B3GAT2;CHST9
prerank,regulation of secretion by cell (GO:1903530),-0.4294194976267816,-1.5708049669108686,0.008403361344537815,0.2509334397552473,1.0,15/54,14.48%,SYT1;RIMS1;RIMS2;MEF2C;NSF;MCTP1;STXBP5L;RAB3C;CPLX1;SCG5;CAMK2A;SYN1;CPLANE2;RAB12;RHBDF2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5817206625836273,-1.5704984019891615,0.03023758099352052,0.2498220917172147,1.0,4/17,3.91%,KCNAB1;AKAP6;NOS1AP;ANK3
prerank,retrograde axonal transport (GO:0008090),-0.5783325711479013,-1.569837600079075,0.02631578947368421,0.24947055400748597,1.0,7/16,14.97%,DLG2;ACTR10;KIF1C;DYNC1H1;TMEM108;KIF5A;SOD1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.47593836722824134,1.5682320940864038,0.010752688172043012,0.4962172712566857,1.0,8/62,4.19%,ROBO1;LPAR1;RASGRF1;AKAP13;COL3A1;AUTS2;NOTCH2;F2RL3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5741009136322803,1.5676896691295559,0.034722222222222224,0.49393286387661145,1.0,6/25,6.37%,CBLB;SNX6;SLC6A9;CNRIP1;ERRFI1;PPARA
prerank,regulation of membrane repolarization (GO:0060306),-0.6243271464999811,-1.5676590826273862,0.028455284552845527,0.25237329518823887,1.0,6/13,14.47%,AKAP6;KCNJ2;NEDD4L;KCNQ1;CAV1;CASQ2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5455864264825163,-1.5675035462888183,0.026030368763557483,0.2509311818270432,1.0,4/21,4.41%,PRKCH;SLC39A10;PRKCB;RPS3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6080446865980574,1.5669187588224285,0.02702702702702703,0.4924665650647665,1.0,8/20,8.88%,IGFBP3;VTN;IGFBP5;BMPR1A;NRP1;SERPINE1;PDGFRB;PLAU
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6415664589419396,-1.5666967122724225,0.03992015968063872,0.2508794681684155,1.0,4/11,10.30%,CACNB2;NOS1AP;CAMK2D;NOS1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6196678900554278,-1.564998566645405,0.028761061946902654,0.25263802700141913,1.0,5/13,12.90%,SLC4A10;GRIK2;RAB3GAP1;SHISA9;SHISA6
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4763473374605155,-1.5642094480566586,0.012987012987012988,0.2525421674828393,1.0,13/36,12.95%,NOS3;NOSTRIN;NOS1AP;CALM1;SCARB1;AKT1;CYGB;GCH1;NUS1;S100A1;EGFR;HSP90AA1;CAV1
prerank,positive regulation of cell differentiation (GO:0045597),0.39586305597406635,1.5636303811044123,0.0,0.5011951594755639,1.0,38/237,8.66%,TCF4;RANBP3L;MEDAG;IGFBP3;PDPN;SOX5;BMP6;WNT4;PTN;RIN2;SMAD3;CCN2;FGFR1;DDR2;FOXC1;IL6ST;GJA1;TACSTD2;BMPR1A;NBL1;GLIPR2;NELL1;TGFB1I1;KCTD11;BMP2;IL6;BMP7;TMEM64;TGFBR1;CPNE1;BCL9L;CREBL2;TGFBR2;CTNNA1;IL18;MEF2A;YAP1;ZEB1
prerank,axon development (GO:0061564),-0.4077722375220497,-1.5632524474769742,0.003067484662576687,0.2530027796377361,1.0,29/78,21.15%,GRM7;CTNNA2;CNTN4;DCC;ACTB;PLP1;KLF7;ANK3;S100B;NRCAM;MAP1B;SHTN1;RTN4RL1;L1CAM;NEFH;PAX2;PAK3;GAP43;MAPK8IP3;BRSK2;MAPT;SLITRK2;EPHB3;SLITRK1;CCK;AMIGO1;NTNG1;NTNG2;DSCAML1
prerank,protein oxidation (GO:0018158),0.6782522734468354,1.5632017272410876,0.04339622641509434,0.4986573245698697,1.0,4/11,11.77%,APOA2;LOXL3;LOXL1;LOXL4
prerank,peptidyl-methionine modification (GO:0018206),0.6790851413811577,1.56317761568206,0.03333333333333333,0.4946008761313925,1.0,5/12,15.21%,APOA2;NAA16;NAA30;NAA15;PDF
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.46018990210500405,1.562933789319835,0.020958083832335328,0.4913326847536595,1.0,17/74,11.56%,TCF7L2;EYA2;EYA1;PHIP;SH3RF1;TERT;CFLAR;BCL2;TGFBR1;MCL1;SERPINE1;SIAH2;GSK3B;ZMYND11;BCL2L1;EYA4;MAP2K5
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.42371505657647296,1.5625545805273837,0.007062146892655367,0.4888255703218618,1.0,22/129,10.31%,RNF220;WLS;LRRK1;LGR4;ZEB2;TBL1XR1;SMURF2;WNT3A;PPM1A;KANK1;PTK7;DACT1;LYPD6;PLEKHA4;PSMB10;PSMA3;USP8;PSME4;USP47;LRRK2;PSMA5;PPM1B
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.546709176747048,1.5625337280388423,0.030303030303030304,0.4850017814006289,1.0,13/29,16.37%,TCF7L2;TLE1;TERT;TLE3;BCL9L;TCF7L1;CREBBP;CDC73;TCF7;LEO1;SMARCA4;PYGO1;AXIN2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.42966951081979193,-1.5625051408595347,0.0084985835694051,0.2526997678247329,1.0,22/59,11.21%,CADM1;HMCN1;BSG;PECAM1;ROBO2;CDH2;KIRREL3;TENM3;CNTN4;CNTN6;CDH1;PTPRM;ROBO4;NPTN;CDH4;CEACAM1;CNTN2;L1CAM;PTPRT;EMB;FAT2;CD84
prerank,regulation of actomyosin structure organization (GO:0110020),0.6651207088201239,1.5621943900873674,0.03653846153846154,0.4823662702481688,1.0,4/13,6.17%,ROCK2;AKAP13;ALMS1;ASAP3
prerank,epithelial cell migration (GO:0010631),0.5193352605807855,1.5620960620414377,0.03281519861830743,0.47891068382623664,1.0,7/37,3.83%,DPP4;FSTL1;ZEB2;KANK2;KANK1;NRP1;KIT
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5456492267976766,1.5598462798511679,0.01950354609929078,0.4833596910102484,1.0,5/30,4.19%,ROBO1;LPAR1;AKAP13;COL3A1;F2RL3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5572459336870553,1.5591513880815722,0.02226027397260274,0.48187652843813306,1.0,7/27,4.98%,PHLDB2;CGNL1;ARHGAP6;DLC1;TACSTD2;ARHGAP28;CLASP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6151122751370323,1.5575277758195856,0.044145873320537425,0.4841326989310104,1.0,4/16,8.22%,SELP;NFAT5;IL6;FUT4
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4584478510185948,-1.5569914551544757,0.012437810945273632,0.26232602638046215,1.0,10/40,9.75%,SYT1;RIMS1;RIMS2;STX3;PCLO;SNAP25;SNCA;CPLX1;SYT7;SNPH
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5654995733793258,1.5568252446210085,0.03722504230118443,0.48305023518294116,1.0,7/26,14.28%,LGR4;APPL2;BIRC3;APPL1;TLR2;IRAK3;FLOT2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5730822001833541,1.5564528739880577,0.03197158081705151,0.48070717177748123,1.0,3/23,4.91%,TNNC1;TGFBR3;TPM1
prerank,epithelial to mesenchymal transition (GO:0001837),0.4986758791782164,1.5562448871650307,0.028169014084507043,0.47782147395950814,1.0,11/47,8.47%,TGFBR3;WNT4;ROCK2;RBPJ;FGFR1;BMP2;LOXL3;BMP7;TGFBR1;GSK3B;WNT5A
prerank,BMP signaling pathway (GO:0030509),0.4752515302001574,1.5561117800715183,0.00904977375565611,0.47474376968724524,1.0,17/62,12.68%,TGFBR3;BMP6;SMAD3;RGMA;RGMB;BMPR1A;HIVEP1;BMP2;BMP7;BMP8B;USP9X;SLC33A1;SMAD6;ZFYVE16;SMAD4;HFE;NOG
prerank,heart development (GO:0007507),0.410535025973302,1.5538731034061375,0.0026954177897574125,0.4796996948485674,1.0,28/150,8.78%,FLRT2;TGFBR3;FBN1;AKAP13;CXADR;COL3A1;FN1;OSR1;FOXC1;HEG1;CSRP3;DLC1;FOXC2;RBP4;ADAP2;MTHFD1;BMP2;BCOR;BMP7;TGFBR1;NCOA6;SALL1;PLCE1;POPDC2;TGFBR2;MEF2A;PRICKLE4;CACNA1C
prerank,positive regulation of transporter activity (GO:0032411),0.6482683503944751,1.552958719988509,0.04590818363273453,0.4796178113897478,1.0,3/13,6.01%,KMT2A;STK39;NR1H3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6461455038854911,1.5520693107685815,0.04448742746615087,0.47913426853621344,1.0,5/14,7.85%,CD55;PTPN22;TGFBR2;IL18;LGALS9
prerank,regulation of hormone secretion (GO:0046883),0.6488323795017735,1.5519321335403835,0.02895752895752896,0.47607970995006904,1.0,4/15,3.54%,OSM;SNX6;IL11;ANXA1
prerank,positive regulation of neuron migration (GO:2001224),-0.635813399862846,-1.5504603125877405,0.036093418259023353,0.27426403122652787,1.0,8/11,23.89%,SEMA6A;DAB2IP;ARHGEF2;RAPGEF2;SHTN1;SEMA3A;PLAA;NSMF
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.5315437268385484,-1.5482976837116444,0.02810304449648712,0.2769357873981525,1.0,5/23,10.96%,SLC12A7;SLC12A2;CLCN3;SLC12A5;SLC12A6
prerank,regulation of ossification (GO:0030278),0.5219241120557965,1.5471528613961067,0.026845637583892617,0.49020530122896583,1.0,11/36,9.65%,PTN;RBPJ;ENPP1;DDR2;ECM1;BMP2K;BMP2;CHSY1;LRP4;WNT5A;SMAD6
prerank,regulation of wound healing (GO:0061041),0.5076762182260378,1.5458530206713228,0.0297029702970297,0.491774682141188,1.0,14/42,12.53%,VTN;KANK1;CASK;ANXA1;GP1BA;SERPINE1;TNFRSF12A;CLDN1;INSL3;PLAU;PTK2;EPPK1;CD109;CADM4
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6506939465106409,1.5450139584649747,0.03663003663003663,0.4916164616319451,1.0,3/13,8.36%,DDO;ASPA;GLUL
prerank,regulation of phospholipase activity (GO:0010517),0.6922875010154523,1.5449436666293348,0.05405405405405406,0.48835880330119186,1.0,2/10,1.20%,PDPK1;FGFR1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6632278130068398,1.5447586787525975,0.03773584905660377,0.4855190885998881,1.0,3/14,3.01%,KMT2A;AUTS2;MYB
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4835541539971989,1.5446322465886797,0.026771653543307086,0.48270540651064076,1.0,9/49,7.50%,PARP14;GHR;IL31RA;IL6ST;OSM;PARP9;KIT;IL6;IL18
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4332116959156194,1.5442278890291692,0.005657708628005658,0.48079368273712364,1.0,27/112,12.25%,SOX5;TGFBR3;WNT4;SMAD3;ZMIZ1;COL3A1;CLEC3B;BMPR1A;CDH5;WWOX;TWSG1;LRRC32;PARD6A;PRKCZ;TGFBR1;APPL2;TGFBR2;USP9X;PDCD5;SKI;WNT5A;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;MAP3K7
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.6531497865498307,1.543150882177702,0.055984555984555984,0.4811754769990552,1.0,5/13,13.10%,IL6ST;OASL;STAT1;OAS2;JAK1
prerank,negative regulation of cell development (GO:0010721),0.5629978398507184,1.5427944523896233,0.04144144144144144,0.479260212673641,1.0,7/25,9.74%,FBN1;WNT3A;PTHLH;IL6;APPL2;GSK3B;RFLNA
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4519538216115932,1.542737185420625,0.016516516516516516,0.4762129204381501,1.0,18/85,12.11%,TCF7L2;TGFBR3;BMP6;MCC;LAMC1;FGF1;OSR1;NUPR1;TGFA;DUSP10;ANGPT1;CDC73;CDKN2B;YAP1;MTSS1;FGF18;NR4A1;EPPK1
prerank,axonogenesis (GO:0007409),-0.3399329493312988,-1.54271142356082,0.0,0.28765339657176775,1.0,71/237,12.81%,SLIT2;NRXN1;CTNNA2;UNC5C;BSG;ROBO2;SHANK3;NCAM1;SEMA6D;EFNA5;RPS6KA5;ENAH;DAB1;TNR;NRP2;CNTN4;EPHA5;DOK6;PIK3R1;NOTCH1;DCC;NTN4;ACTB;CNTN6;NOTCH3;SH3KBP1;GAB1;KLF7;SEMA4D;SEMA3C;ANK3;SEMA6A;LAMA1;LAMA3;PRKCQ;UNC5D;EPHB1;S100B;ROBO4;NRCAM;SEMA7A;MAPK3;HSP90AB1;NPTN;SPTB;SEMA3E;MAP1B;SHTN1;EPHA6;NLGN3;TUBB3;CNTN2;L1CAM;CXCL12;VASP;SEMA3G;SEMA6B;EMB;RET;NEFH;PAX2;PTPRO;ULK1;GFRA2;PAK3;LRTM1;KIF5C;VLDLR;PIK3CD;SEMA3A;HSP90AA1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6026112195304176,1.5420574910947418,0.044802867383512544,0.4752693448345622,1.0,4/19,6.79%,DDO;HYKK;PHYKPL;ASPA
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4479365020774103,1.5419530519727074,0.008559201141226819,0.4724013677821422,1.0,16/86,8.19%,SULF1;BMP6;FOXD1;RBPJ;ZEB2;BMPR1A;CDH5;TWSG1;TGFB1I1;BMP2;BMP7;TGFBR1;CREBBP;BMP8B;CDKN2B;RNF111
prerank,chordate embryonic development (GO:0043009),0.4737304821425469,1.541249687673803,0.02727272727272727,0.47167189246671,1.0,11/55,8.99%,ALDH1A2;SULF1;FGFR1;ARNT2;RBP4;DACT1;BMP2;BMP7;TGFBR1;WNT5A;IGF2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.5013886043515632,-1.5411235061972197,0.03464203233256351,0.28961571890555027,1.0,13/27,28.16%,SYT1;RIMS1;RIMS2;SYT4;SYT7;SYT9;SYT2;SYT6;SYT10;SYT5;DOC2B;SYT17;VAMP2
prerank,negative regulation of cell differentiation (GO:0045596),0.3998583415965626,1.5404217658169508,0.0026595744680851063,0.47148986572472046,1.0,44/181,14.83%,RANBP3L;EFEMP1;RORA;SMAD3;COL5A2;ENPP1;OSR1;ADAMTS12;WNT10B;LDLRAD4;MYB;ADGRV1;EID2B;PTHLH;SUZ12;IL6;BMP7;TMEM64;TGFBR1;DTX1;COL5A1;NR1H3;USF3;PPARA;CRP;CDC73;SKI;WNT5A;YAP1;IGF2;NOCT;SMAD6;SUFU;LRP3;DISP3;IQCB1;NOG;EFNA1;PAF1;ADAMTS7;LEO1;RUNX1T1;ABCA1;NPHP3
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3875361343165976,-1.5400267361569786,0.002967359050445104,0.29021635048791783,1.0,30/91,16.61%,ABCG2;SLC39A10;TFRC;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SLC40A1;ATOX1;FTH1;FTL;SLC39A6;SLC31A1;SLC30A1;SLC39A14;SLC22A17;SLC39A12;HMOX2;SLC31A2;MT2A;CYBRD1;SLC39A13;SLC39A8;SOD1;ATP6V0A2;SCARA5
prerank,wound healing (GO:0042060),0.4688268620143273,1.539809565030179,0.02190923317683881,0.4702353001842226,1.0,16/62,12.68%,SMAD3;COL3A1;PDGFRA;FGF1;MYOF;PPL;CFLAR;MIA3;TPM1;TGFBR1;CLDN1;WNT5A;DCBLD2;FUT10;EPPK1;NOG
prerank,extracellular matrix organization (GO:0030198),0.3868146501703795,1.5385298832136132,0.0,0.47149105148943926,1.0,46/276,6.79%,FLRT2;TNC;COL4A3;FBN1;COL23A1;COL4A6;LAMC1;COL4A4;COL5A2;VTN;COL3A1;FN1;ADAMTSL5;LAMA2;LAMA4;COL4A5;DDR2;NID1;ADAMTS12;ECM2;ADAMTS10;HSPG2;NID2;ITGB8;DAG1;ICAM4;ITGA5;ADAMTS1;ADAMTSL4;ITGA9;DCN;ADAMTS6;ITGA10;LOXL3;LAMC3;BMP1;LOXL1;TGFBR1;COL20A1;THSD4;SERPINE1;COL5A1;MMP14;VCAM1;CD47;COL18A1
prerank,ceramide biosynthetic process (GO:0046513),-0.4560237848581703,-1.538148932771262,0.0297029702970297,0.29260284271468445,1.0,9/40,11.79%,ST6GALNAC3;SGMS1;ST8SIA4;CERS4;ST8SIA6;DEGS2;ST6GALNAC4;ST6GALNAC5;SGMS2
prerank,negative regulation of viral process (GO:0048525),0.4710707087810494,1.5380951144941066,0.016,0.47000499900533715,1.0,18/57,14.99%,RSAD2;ZC3HAV1;EIF2AK2;TRIM5;BST2;PARP10;OASL;STAT1;IFITM1;OAS2;ILF3;TRIM21;IFIT1;TRIM26;SRPK1;CHMP3;IFIH1;PML
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4924245751142177,1.5365594420900592,0.03898305084745763,0.47207923641733734,1.0,11/44,7.16%,LPAR1;ROCK2;CCN2;PPM1E;NRP1;S100A10;TPM1;TGFBR1;EPHA1;CD47;ARHGEF10L
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3682502871896211,-1.5350147208047067,0.004098360655737705,0.2977598664858974,1.0,44/159,11.21%,CADM1;ADGRL3;NLGN1;HMCN1;PTPRD;GRID2;LRRC4C;BSG;PECAM1;ROBO2;CLDN5;CDH2;KIRREL3;CDH11;TENM2;TGFB2;CDH12;TENM3;CNTN4;CNTN6;CDH1;PTPRM;IL1RAPL1;UNC5D;ATP2C1;CDH10;ROBO4;CDH8;TENM4;CDH22;NPTN;CDH4;CEACAM1;CDH7;CDH20;CLDN14;CNTN2;L1CAM;PTPRT;LRRC4B;EMB;FAT2;PCDHB16;CD84
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6396657344545448,1.5347887956133757,0.06261859582542695,0.475337316345069,1.0,5/13,7.23%,CBLB;RANBP2;KPNA6;KPNA7;KPNA4
prerank,regulation of response to biotic stimulus (GO:0002831),0.5475897585995263,1.534436524887031,0.034904013961605584,0.4734999521734419,1.0,8/28,9.78%,GATA6;CD55;PTPN22;APPL2;TRIM5;BIRC3;ERAP1;APPL1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6050155005337466,1.533213025381051,0.04212454212454213,0.4746457637822698,1.0,7/18,11.50%,SMAD3;FN1;LTBP1;ITGB8;LRRC32;LGALS9;SMAD4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5050760859370492,1.5322779701743638,0.02593192868719611,0.47452187889532604,1.0,5/39,5.27%,TCF7L2;MCU;GHRH;RBP4;UCN
prerank,negative regulation of cell projection organization (GO:0031345),0.48520407474048843,1.531073175234337,0.020634920634920634,0.4755491425231054,1.0,8/48,8.24%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;PTPN9;EPHA4
prerank,positive regulation of protein secretion (GO:0050714),0.4553928832954181,1.530837575378324,0.016442451420029897,0.4733975736129183,1.0,13/69,11.27%,TCF7L2;WLS;BMP6;MCU;RBP4;APBB1;TLR4;UNC13B;PPID;DNM1L;HCAR2;TLR2;NLGN2
prerank,postsynaptic membrane organization (GO:0001941),-0.5635781148824858,-1.5307039963058804,0.04716981132075472,0.30542316749729376,1.0,5/17,8.74%,NRXN1;NLGN1;SHANK3;GPHN;NLGN3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.41275246960159795,-1.5304913321175853,0.019444444444444445,0.30404662503050084,1.0,22/54,22.62%,SMAD7;RPL5;IVNS1ABP;RPS3;RPL11;CTNNB1;AKT1;GNL3L;CAV1;COPS9;CAMLG;PARK7;PER2;N4BP1;SIRT7;MINAR1;VPS28;UFL1;PRMT3;PRR7;SH3RF2;DCUN1D3
prerank,regulation of BMP signaling pathway (GO:0030510),0.44725233153245225,1.5274481365595183,0.014970059880239521,0.48233674965676687,1.0,11/73,3.95%,SULF1;FOXD1;RBPJ;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;CDH5;TWSG1;BMP2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6105573138596486,1.5268604637331298,0.052346570397111915,0.48155047894730146,1.0,5/16,12.90%,DPYSL3;DPYD;UPP1;NT5C;TET2
prerank,regulation of macrophage migration (GO:1905521),-0.650149728500789,-1.5257383592858003,0.046413502109704644,0.31277125827147534,1.0,3/10,6.40%,MTUS1;PTK2B;EMILIN1
prerank,bone development (GO:0060348),0.5064786187932211,1.5245508282456788,0.04530201342281879,0.4866202315420959,1.0,6/39,7.91%,RANBP3L;SULF1;AKAP13;GJA1;SBDS;SKI
prerank,regulation of glucose metabolic process (GO:0010906),0.5274022414563678,1.524351663857528,0.04498269896193772,0.48438256924615464,1.0,3/34,3.26%,PDK1;RORA;GCGR
prerank,regulation of transmembrane transport (GO:0034762),-0.47388127466403823,-1.5234122781259742,0.03712871287128713,0.31624667491222985,1.0,11/31,12.30%,SLC2A1;PRKCB;KCNJ3;KCNJ2;ACTB;SNCA;NEDD4L;ACE2;KCNJ6;KCNJ8;KCNJ15
prerank,fluid transport (GO:0042044),0.6567117607471307,1.5226660423663498,0.04216867469879518,0.4872700669927199,1.0,2/12,5.93%,PDPN;SLC4A11
prerank,regulation of viral genome replication (GO:0045069),0.4729697935032204,1.5222048685183482,0.01935483870967742,0.48608056340044714,1.0,19/56,15.71%,RSAD2;ZC3HAV1;EIF2AK2;PPARA;BST2;PARP10;OASL;STAU1;IFITM1;PPID;OAS2;TMEM39A;ADAR;ILF3;IFIT1;SRPK1;TARBP2;IFIH1;PKN2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5272323958005151,1.5215811495140186,0.035897435897435895,0.4852604667515059,1.0,6/32,6.37%,ZBTB20;PID1;PRKAA2;NUPR1;ARNT;PPARA
prerank,liver development (GO:0001889),0.5242429138879686,1.520680399191699,0.03747870528109029,0.48539951208680937,1.0,17/32,23.52%,TGFBR3;WNT4;PRKCSH;ANXA1;IL6;DNAAF1;ARID5B;NPHP3;PKD2;PCK2;CEBPB;CCDC39;CITED2;XBP1;CDK5RAP3;CEBPA;CEBPG
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6088538395924552,1.5188405930537425,0.03468208092485549,0.4889267307195036,1.0,3/15,6.52%,USP18;STAT2;PTPN2
prerank,filopodium assembly (GO:0046847),-0.561505450230547,-1.5185942625742561,0.04935622317596566,0.32563491117964816,1.0,4/16,6.47%,DNM3;FGD5;SPATA13;FGD6
prerank,skeletal system development (GO:0001501),0.40340035305849475,1.5184619874891092,0.012244897959183673,0.48743495757192945,1.0,39/148,16.89%,SULF1;SOX5;BMP6;FBN1;AKAP13;FGFR1;CREB3L2;GJA1;ITGB8;WWOX;RBP4;PTHLH;BMP2;BMP1;BMP7;TGFBR1;MMP14;BMP8B;WNT5A;IGF2;COL13A1;PRELP;RFLNA;SUFU;IHH;ANKRD11;RPS6KA3;NOG;NPR3;GDF11;RAB33B;EIF2AK3;SOX4;SPEF2;EVC;INHA;SH3PXD2B;COL1A2;COL9A2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.45581031481624734,1.518085921942823,0.014684287812041116,0.4857785058908593,1.0,12/66,7.93%,SULF1;ROBO1;TGFBR3;MCC;NR2F2;NUPR1;CASK;DUSP10;KLF9;STAT1;CDC73;CDKN2B
prerank,negative regulation of growth (GO:0045926),-0.3631369500661299,-1.517958014460395,0.003355704697986577,0.32518934175004105,1.0,29/121,10.66%,APBB2;SLIT2;PTPRJ;SMARCA2;TGFB2;BMPR2;NOTCH1;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;CCAR2;RACK1;NPR1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5966152165356279,-1.5177988255833437,0.04242424242424243,0.321687179783114,1.0,3/14,10.43%,ABCG2;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.5966152165356279,-1.5177988255833437,0.04242424242424243,0.321687179783114,1.0,3/14,10.43%,ABCG2;BLVRA;HMOX2
prerank,regulation of biomineral tissue development (GO:0070167),0.5456194286724688,1.5173558449731885,0.04,0.4855041535839219,1.0,5/26,2.75%,ROCK2;ENPP1;DDR2;ECM1;BMP2K
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5099985092745485,1.5156087243365493,0.029411764705882353,0.488797867300593,1.0,15/37,21.58%,TNPO1;DYNLL1;IFT88;IFT57;DYNC2I1;IFT81;DYNC2LI1;WDR19;IFT20;TTC21B;IFT52;KIF3C;CEP131;SSX2IP;TRIP11
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.39488968150550563,1.515555063329287,0.0025906735751295338,0.4862004132181569,1.0,39/208,12.33%,PDPK1;WLS;RORA;LPAR1;AKAP13;TLE1;ZFAND6;ECM1;GJA1;PPM1A;TRAF5;LITAF;CFLAR;IKBKE;ROR1;MTDH;GOLT1B;OPTN;CPNE1;MIER1;PELI2;TRIM5;BIRC3;BST2;JMJD8;STAT1;LGALS9;VAPA;RIPK2;ZMYND11;WNT5A;ANKRD17;BRD4;NLRX1;PPM1B;UBE2V1;RHOC;MAP3K7;TRIM21
prerank,regulation of interleukin-2 production (GO:0032663),-0.43723409802377683,-1.515529774869404,0.031746031746031744,0.32524331738471696,1.0,14/43,14.81%,PDE4D;PDE4B;NAV3;PLCG2;CD34;RPS3;HDAC7;HAVCR2;MALT1;CD80;CD86;RUNX1;PNP;PTPRC
prerank,regulation of regulated secretory pathway (GO:1903305),-0.46556716684868654,-1.5154259158768675,0.0297029702970297,0.32356576127998316,1.0,18/34,27.65%,SYT1;RIMS1;RIMS2;RAB27A;SYT4;SYT7;SYN1;SYT9;SYT2;SNAPIN;RIMS4;RAB15;SYT6;VPS18;SYT10;SYT5;SYT17;UNC13D
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6420636564918347,1.5141248356956916,0.062385321100917435,0.4882186456871893,1.0,8/14,20.80%,MIA3;SEC23A;SEC24D;SEC24C;SEC24B;SAR1A;SEC31A;SEC23B
prerank,positive regulation of response to external stimulus (GO:0032103),0.40909619861115326,1.5136350418242817,0.011111111111111112,0.48706334854989924,1.0,24/128,11.68%,BMP6;PTN;SASH1;IL16;DDX60;FPR2;OSM;IFI35;TLR4;ZBP1;SERPINE1;OPTN;PDGFRB;GBP5;CD47;OASL;IL18;LY96;SETD4;WNT5A;ANKRD17;POLR3F;TLR2;NFKBIZ
prerank,regulation of platelet activation (GO:0010543),0.5709049542007658,1.5119480338775224,0.05026929982046679,0.48990601897014663,1.0,5/21,4.67%,TEC;SELP;PDGFRA;PLA2G4A;TLR4
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6507018003934404,-1.510578470685012,0.0467706013363029,0.33331051148238605,1.0,7/10,20.36%,GABRA2;GABRA3;GABRA4;GABRG3;GABRB2;GABRA5;GABRA1
prerank,positive regulation of T cell migration (GO:2000406),0.570359302863105,1.5091383554666924,0.05719557195571956,0.49655393789611196,1.0,7/20,15.86%,CXCL10;STK39;OXSR1;TNFRSF14;WNT5A;WNK1;APP
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5597501292542626,1.5085805536328143,0.03298611111111111,0.4957248934824616,1.0,5/25,2.79%,SULF1;FOXD1;RBPJ;BMPR1A;CDH5
prerank,response to sterol (GO:0036314),0.664220816794557,1.507185901625755,0.055456171735241505,0.4978563748901703,1.0,3/11,6.93%,RORA;TGFBR1;TGFBR2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5866634301588256,1.5067644079666425,0.04929577464788732,0.49657234752045265,1.0,4/18,11.07%,KMT2A;SETD4;SETD7;SETD1B
prerank,Wnt signaling pathway (GO:0016055),0.43183624606654136,1.5062291478095065,0.016200294550810016,0.495623134528305,1.0,19/92,12.89%,TCF7L2;WLS;WNT4;WNT6;PLPP3;WNT10B;WNT3A;WNT2B;FZD2;WNT5B;BCL9L;TCF7L1;GSK3B;WNT5A;LRRK2;TCF7;DVL3;BTRC;PORCN
prerank,regulation of cellular component movement (GO:0051270),0.47201520766958066,1.50600842105735,0.02866779089376054,0.49362609665067136,1.0,8/49,5.16%,PDPN;TGFBR3;ROCK2;DIAPH1;SP100;ARHGAP18;MYCBP2;TGFBR1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6705812041672695,1.5055236212336867,0.07602339181286549,0.49260258852883737,1.0,4/10,3.40%,ATP1A2;STK39;OSR1;NEDD4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5165612660176868,-1.5045807408997034,0.04608294930875576,0.3462228080648357,1.0,8/23,13.59%,ELOVL5;ACSL3;FAR2;ELOVL7;TECR;ACSL5;HSD17B12;ACSBG1
prerank,potassium ion homeostasis (GO:0055075),-0.5166957188756445,-1.5043680456395714,0.03131991051454139,0.3447414564205937,1.0,8/23,10.96%,SLC12A7;SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC12A5;SLC12A6
prerank,negative regulation of immune system process (GO:0002683),0.6027356047361081,1.5041694595371944,0.0575139146567718,0.4945410150584622,1.0,3/16,6.03%,COL3A1;IL17D;FOXP3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6696523900859835,1.5029865370537465,0.08286252354048965,0.49574715852498924,1.0,6/10,18.49%,CPEB1;CDC73;PAF1;LEO1;CPEB3;DHX36
prerank,positive regulation of cellular senescence (GO:2000774),-0.6404596009979542,-1.5023674535230422,0.05241935483870968,0.3475256071252765,1.0,4/10,10.92%,YPEL3;B2M;ABI3;EEF1E1
prerank,defense response to virus (GO:0051607),0.415484534831956,1.502150439515411,0.002857142857142857,0.49591004609307193,1.0,24/100,12.43%,RSAD2;CXCL10;EIF2AK2;STAT2;TRIM56;PRF1;IFIT2;IL6;BCL2;ZBP1;TRIM5;BST2;OASL;STAT1;ZMYND11;PHB2;MOV10;IFITM1;IFNLR1;BCL2L1;TLR2;OAS2;IFI27;IFIT1
prerank,protein modification by small protein conjugation (GO:0032446),0.36679759130853684,1.5015532552366868,0.0012004801920768306,0.49539307154380097,1.0,81/361,15.01%,RNF220;PDZRN3;EYA1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;FBXO11;FBXL17;NEDD4;UBA5;DTX4;EPAS1;MYCBP2;TRIM17;KLHL21;RANBP2;SPSB4;DTX1;TPR;CUL4A;TRIM5;DTX3L;FBXO9;MGRN1;ANAPC11;USP9X;RNF20;CDC73;FBXL3;WAC;FBH1;TRIM24;KLHL18;NUB1;RNF111;PIAS1;AMFR;UBE2Z;PJA2;UBE2C;SUMO1;FBXL7;FBXO4;WWP2;FBXO24;KEAP1;HUWE1;RFWD3;RTF1;CUL3;KLHL13;NSMCE2;TRIM21;EGR2;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;ASB5;ARRB1;PEX2;PAF1;CDC27;RNF39;RNF43;RNF103-CHMP3;RNF181;POM121;LEO1;BRAP;IFIH1;RCHY1;VHL;BIRC6;UBE2R2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5260110087178171,-1.5008217258929553,0.046460176991150445,0.34909203227519997,1.0,9/21,7.24%,PDE4D;DMD;AKAP6;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,female gamete generation (GO:0007292),0.5316829585843643,1.4994282715206404,0.03865546218487395,0.5002626449978478,1.0,4/29,7.41%,DIAPH2;PTN;NANOS2;USP9X
prerank,cardiac conduction system development (GO:0003161),0.5515023188327269,1.4985069225892633,0.0415944540727903,0.5006298419014794,1.0,5/24,2.35%,NOTCH2;GJB6;GATA6;GJA1;BMPR1A
prerank,cellular response to organic substance (GO:0071310),0.41124381574983615,1.4976473666443666,0.008571428571428572,0.5010288840486923,1.0,35/116,16.18%,PTPN13;DPYSL3;SMAD3;PID1;GHR;IGFBP5;NFAT5;CLEC3B;BMPR1A;NCOA3;PTPN14;STAT5B;PTPN4;PLK5;TGFBR1;HAX1;PTPN2;PTPN9;TGFBR2;RAMP1;IL18;CCL2;LRRK2;TIPARP;PTPN6;MAP2K5;CRNN;PTPN18;ACVR1C;NCOA2;TBK1;ADRA2A;ACVR2B;CXCR4;URI1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5197004183171123,1.4975440970674776,0.04529616724738676,0.4987421093090366,1.0,6/31,5.16%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR1
prerank,positive regulation of cell aging (GO:0090343),-0.6212801136907954,-1.496725833366288,0.045816733067729085,0.35680476834452196,1.0,4/11,10.92%,YPEL3;B2M;ABI3;EEF1E1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6160817803860025,-1.4966008350874818,0.05894308943089431,0.3551258503336351,1.0,6/11,19.16%,PINK1;RACK1;ATF4;PARK7;NR4A3;NONO
prerank,potassium ion transmembrane transport (GO:0071805),-0.35394309971185717,-1.4965793132276004,0.0035587188612099642,0.35320936186739893,1.0,38/135,15.71%,SLC12A7;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;ATP1B1;SLC24A2;ABCC9;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;ATP1A1;KCNK10;SLC9A8;HCN2;KCNH1;TMEM175;KCNH5;SLC12A5;KCND3;KCNJ6;SLC12A6;KCNB1;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1;SLC9A5;KCNA2;ATP1A3;KCNK9
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3869042235443081,1.4962110839182374,0.005249343832020997,0.5005891265538154,1.0,36/199,9.65%,ROBO1;ALDH1A1;MCC;LGR4;ROCK2;RBPJ;LAMA4;WNT10B;APOA2;GJA1;TACSTD2;ACOT11;FOXC2;LDLRAD4;TWSG1;DUSP10;BMP2;NRDC;IL17D;TLE3;TLR4;PARP3;CHSY1;WWC2;NR1H3;FOXP3;ATP2B4;LRP4;USF3;NOVA1;GSK3B;TIFAB;MAP2K6;ADM;DOCK7;SMAD6
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.47916048088496466,-1.4960473210764194,0.037383177570093455,0.3526497711830679,1.0,13/29,22.51%,ELOVL5;ACSL3;ELOVL7;TECR;ACSL5;ACACA;HSD17B12;ACLY;SCD;ACSBG1;HSD17B8;FASN;GCDH
prerank,Rac protein signal transduction (GO:0016601),-0.5347103689428986,-1.4956843804427502,0.04285714285714286,0.35162905625114355,1.0,9/18,15.87%,ELMO1;EPS8;TIAM1;NCKAP1;RHOG;DBNL;RAC1;RHOH;HACD3
prerank,protein K63-linked ubiquitination (GO:0070534),0.4901305204331622,1.495614147698289,0.03993344425956739,0.4999988381000542,1.0,12/41,13.63%,RNF152;TRIM56;TRAF5;NEDD4;TRIM5;WWP2;UBE2V1;HECTD1;TRIM21;UBE2E3;PRPF19;BFAR
prerank,positive regulation of phospholipase activity (GO:0010518),0.5527402006848716,1.4952492028262374,0.06319702602230483,0.4986708022940331,1.0,6/22,6.10%,PDPK1;PDGFRA;FGFR1;KIT;ARF4;PDGFRB
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6608035053803423,1.494751946403541,0.06374501992031872,0.49762940168228414,1.0,4/12,13.43%,MUC2;RBP4;TLR4;STRAP
prerank,cellular response to lipid (GO:0071396),0.3876128618143277,1.4947018751544516,0.00261437908496732,0.49530389233889915,1.0,30/191,8.47%,RORA;TFPI;ATP1A2;ROCK2;CXCL10;WNT6;PID1;AXL;WNT10B;LDOC1;WNT3A;EPHA3;PTK7;VIM;NCOA3;IL6;ADCY5;WNT5B;TLR4;SERPINE1;ZNF35;NR1H3;ADCY1;MAP4K1;CDC73;CCL2;LY96;CD274;FAM210B;WNT5A
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6334737623103494,-1.4942741325943998,0.04536082474226804,0.35321168181337337,1.0,5/10,16.74%,KCNAB1;ANK3;CAV1;KCNE4;KCNRG
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6623138788934205,1.4939921385182422,0.04468085106382979,0.4951994291891736,1.0,4/11,13.02%,PDPN;KANK1;ENPP2;ARPIN
prerank,response to nitric oxide (GO:0071731),-0.5950095771162519,-1.4937601318558327,0.05360824742268041,0.3524217058487896,1.0,5/13,15.18%,FOXO1;KCNC2;GUCY1B1;CDK2;CCL19
prerank,synaptic vesicle cycle (GO:0099504),-0.4746012590148114,-1.4928705014512385,0.041666666666666664,0.3527811760079159,1.0,8/30,8.10%,NLGN1;RIMS1;SYNDIG1;PCLO;SNAP25;SNCA;CPLX1;SYT7
prerank,regulation of fat cell differentiation (GO:0045598),0.44433721838712015,1.492866552745389,0.025757575757575757,0.49644617912713085,1.0,19/74,14.96%,MEDAG;RORA;SMAD3;ENPP1;WNT10B;BMP2;IL6;TMEM64;CREBL2;FTO;WNT5A;YAP1;NOCT;AAMDC;LRP3;RARRES2;RUNX1T1;CARM1;PTPRQ
prerank,histone H2B ubiquitination (GO:0033523),0.6835225639801557,1.492397207554128,0.06611570247933884,0.4954365706826153,1.0,6/10,14.19%,DTX3L;RNF20;CDC73;WAC;PAF1;LEO1
prerank,negative regulation of reproductive process (GO:2000242),0.5956601085446828,1.4913491262891547,0.0648854961832061,0.4962242024434353,1.0,3/17,7.73%,SULF1;GJA1;NPPC
prerank,regulation of protein export from nucleus (GO:0046825),0.5565102270766163,1.490704479783066,0.052083333333333336,0.49594857741991705,1.0,5/23,7.65%,TCF7L2;SP100;PTPN14;TPR;GSK3B
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6292558927882126,1.4900978816009853,0.05925925925925926,0.4954790188156987,1.0,4/14,5.95%,IL6ST;OSM;IL6;CREB3L3
prerank,regulation of steroid metabolic process (GO:0019218),0.5557338336547267,1.4895856010043997,0.059149722735674676,0.4948326824822919,1.0,3/23,6.20%,RORA;PANK2;FMO5
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6721916831717829,1.4891445255561335,0.07407407407407407,0.49400739342090194,1.0,6/10,20.20%,HNMT;SARDH;COMT;DMGDH;LRTOMT;ALDH7A1
prerank,histone ubiquitination (GO:0016574),0.5705562758397578,1.4871655505288737,0.054924242424242424,0.4984931972869423,1.0,8/21,14.19%,UBE2U;DTX3L;RNF20;CDC73;WAC;HUWE1;PAF1;LEO1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5669205140356268,1.4867937866432794,0.059336823734729496,0.497197276183582,1.0,6/22,8.34%,SH3D19;TIMP3;NRDC;PTPN3;SNX9;TIMP2
prerank,regulation of cell morphogenesis (GO:0022604),0.5138160272847929,1.4866184433581,0.04063604240282685,0.4954362679146796,1.0,13/30,16.76%,PDPN;SH3D19;PHIP;MYO9A;BCL9L;CAPZB;FMNL2;MOV10;ZMYM6;SPARC;PDZD8;ZMYM3;WTIP
prerank,xenobiotic transport (GO:0042908),-0.5525736811440684,-1.4860523071442502,0.0430327868852459,0.3681157252108994,1.0,5/17,5.48%,ABCG2;SLC47A1;SLC7A5;ABCA3;SLC15A2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6534823536261414,1.4850477062031502,0.08518518518518518,0.4982531592366257,1.0,2/11,3.95%,WNT4;BMP2
prerank,lipid translocation (GO:0034204),-0.5162674695401005,-1.4846799608102836,0.052995391705069124,0.3698674058538538,1.0,7/21,8.59%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,ameboidal-type cell migration (GO:0001667),-0.4177422324109499,-1.4825329629986073,0.012437810945273632,0.3733665726104704,1.0,19/51,12.74%,SEMA6D;ERBB4;PHACTR4;TBX1;ITGA4;SEMA4D;SEMA3C;SEMA6A;CCN3;PKN1;SEMA7A;SEMA3E;AKT1;AMOT;SEMA3G;SEMA6B;FAT2;PKN3;SEMA3A
prerank,positive regulation of response to wounding (GO:1903036),0.550737320318654,1.480808692242101,0.06593406593406594,0.5102197474977258,1.0,7/24,11.16%,PTN;VTN;KANK1;ANXA1;CLDN1;INSL3;PTK2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5015971400911949,1.4800229062845804,0.03789126853377265,0.5104943736308165,1.0,14/36,21.65%,PARP14;AXL;PARP9;ZBP1;CASP4;CPNE1;WNT5A;CSF1;TXK;CXCR4;IL7;UBE2K;HIF1A;RIPK1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5696502439467606,-1.4787330040107274,0.06060606060606061,0.38134000890790454,1.0,6/15,14.75%,SMAD7;RPL5;RPS7;RPL11;RPL23;PARK7
prerank,axon guidance (GO:0007411),-0.3311918938195795,-1.4784777148972814,0.004219409282700422,0.3800284529836492,1.0,71/201,14.99%,SLIT2;NRXN1;UNC5C;BSG;ROBO2;SHANK3;PLXNA4;NCAM1;SEMA6D;EFNA5;RPS6KA5;ENAH;DAB1;TNR;NRP2;CNTN4;EPHA5;DOK6;PIK3R1;NOTCH1;DCC;NTN4;CNTN6;NOTCH3;SH3KBP1;GAB1;KLF7;TMEFF1;PTPRM;SEMA4D;SEMA3C;SEMA6A;LAMA1;LAMA3;PRKCQ;UNC5D;EPHB1;ROBO4;SEMA7A;MAPK3;NPTN;SPTB;SEMA3E;EPHA6;VEGFA;TUBB3;CNTN2;L1CAM;CXCL12;VASP;SEMA3G;RHOG;SEMA6B;EMB;RET;PTPRO;GFRA2;LRTM1;KIF5C;VLDLR;PIK3CD;SEMA3A;GAP43;NFIB;RAC1;EVL;RELN;RHOH;GFRA1;KIF5A;LGI1
prerank,negative regulation of signal transduction (GO:0009968),0.3711603659871748,1.4781152855265671,0.0037831021437578815,0.5142343981999581,1.0,60/249,15.21%,SULF1;IGFBP3;LEPROT;LGR4;KANK2;PID1;TLE1;ENPP1;ADAMTS12;IGFBP5;MPIG6B;KANK1;FSTL3;GLI3;WWOX;APCDD1;NEDD4;DACT1;DCN;BMP2;CRY1;NTN1;BCL2;PRKCZ;DLK1;MMP14;SIAH2;DKK3;PTPN2;CD47;MGRN1;GLIS2;LRRK2;APPL1;SUFU;WWP2;PLEK;NKD1;IRAK3;PALM;RPGRIP1L;VGLL4;CADM4;BTRC;PTPN1;NOG;PTPN18;ARRB1;PIP4K2B;BDNF;HIC1;RNF43;BRAP;TRIB1;LRPAP1;NCK1;NIBAN2;CSNK2A2;TNS2;GDF15
prerank,calcineurin-mediated signaling (GO:0097720),0.6685607939707912,1.4779421466270681,0.07862903225806452,0.5099832447464422,1.0,6/10,19.05%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6685607939707912,1.4779421466270681,0.07862903225806452,0.5099832447464422,1.0,6/10,19.05%,NFAT5;NFATC4;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,negative regulation of cell motility (GO:2000146),0.41020934648577173,1.4779396604321795,0.011396011396011397,0.5076357998578837,1.0,33/108,13.02%,SULF1;ROBO1;DPYSL3;PODN;AFDN;IGFBP5;DLC1;TACSTD2;KANK1;LDLRAD4;DAG1;FBLN1;DUSP10;MIA3;TPM1;VCL;SERPINE1;EPHA1;BST2;SPINT2;CLIC4;RNF20;NGFR;EPHA4;STK24;RAP2C;IFITM1;PTPRU;FOXO3;EPPK1;SLURP1;NOG;ARPIN
prerank,histone H3-K4 methylation (GO:0051568),0.535985447510673,1.477924973715261,0.061855670103092786,0.5053325337917833,1.0,6/26,12.90%,KMT2A;WDR5B;KMT2C;SETD4;SETD1B;TET2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6298218452930123,1.477818093227053,0.06578947368421052,0.5033331423004807,1.0,3/12,4.92%,UST;DCN;DSE
prerank,positive regulation of developmental growth (GO:0048639),-0.42025827495766616,-1.4776940911637606,0.0325,0.38013632520805873,1.0,18/49,15.43%,SYT1;RIMS1;RIMS2;PLCB1;INSR;SEMA4D;MACF1;SEMA7A;SHTN1;SYT4;L1CAM;NEDD4L;DBNL;ZFYVE27;NGF;AGRN;SYT2;MAPT
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5147206990104307,1.477483817032908,0.05150976909413854,0.5021516929512376,1.0,11/29,20.33%,USP18;STAT2;ZBP1;PTPN2;WNT5A;PTPN6;PTPN1;MUL1;IFNAR2;RNASEL;UBE2K
prerank,cell-cell junction assembly (GO:0007043),-0.39245302230226425,-1.4773707491656671,0.02040816326530612,0.3790100665251754,1.0,19/63,9.09%,CTNND2;CLDN5;CDH2;CDH11;CDH12;SMAD7;ACTB;ACTG1;GJC1;GJD3;CDH10;CTNNB1;TLN2;CDH8;CDH22;CDH7;CDH20;JAM3;RAMP2
prerank,glycerolipid metabolic process (GO:0046486),-0.5987078147324736,-1.4748380815201716,0.056016597510373446,0.3836357502117202,1.0,6/11,21.10%,DGKB;DGKZ;DGKG;GAL3ST1;PGP;PNPLA3
prerank,cardiac muscle cell contraction (GO:0086003),-0.5311158569376987,-1.474662578116202,0.06623931623931624,0.3820698933412829,1.0,7/19,9.86%,FGF12;KCNJ2;SCN1A;ATP1A1;CACNA1G;CAMK2D;CACNA1D
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6121961751101165,1.474199231250428,0.08445297504798464,0.5112940296695124,1.0,6/14,17.64%,DDX60;OASL;ANKRD17;TLR2;PUM2;USP15
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.48371796760970764,-1.4736232085853374,0.04405286343612335,0.382816894947787,1.0,16/27,27.41%,PDE4D;PDE4B;CTNNA3;RYR2;CAMK2D;FGF13;SRI;CAV1;ATP2A2;DSG2;GJA5;STC1;PLN;PKP2;HCN4;RANGRF
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4080007635743211,-1.4730199381832385,0.032520325203252036,0.3804276891758074,1.0,30/56,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;BCS1L;NDUFAF3;NDUFA10;TIMM21;NDUFS6;NDUFV3;NDUFS1;NDUFA2;TMEM126B;NUBPL;NDUFA6;NDUFS2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4080007635743211,-1.4730199381832385,0.032520325203252036,0.3804276891758074,1.0,30/56,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;BCS1L;NDUFAF3;NDUFA10;TIMM21;NDUFS6;NDUFV3;NDUFS1;NDUFA2;TMEM126B;NUBPL;NDUFA6;NDUFS2
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.4620533264834869,-1.4727241936778845,0.04751131221719457,0.37937016137901114,1.0,10/32,9.49%,PTPRD;ADGRB3;TNIK;HECW1;SEMA4D;IL1RAPL1;CAPRIN2;YWHAH;RAPGEF2;NEDD4L
prerank,aminoglycan metabolic process (GO:0006022),-0.6171951380355563,-1.4724805105416552,0.07446808510638298,0.3780605130256895,1.0,5/10,24.30%,XYLT1;B3GAT2;CHST9;B3GAT1;B3GAT3
prerank,fibrinolysis (GO:0042730),0.6194961902592344,1.471983445387751,0.07894736842105263,0.5161833283686734,1.0,5/13,12.97%,GP1BA;SERPINE1;PLAU;CPB2;PLAT
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6118388014132601,-1.4710968212796878,0.06804123711340206,0.37975705505387847,1.0,4/11,4.03%,THBS1;KLF2;EPN2;SEMA6A
prerank,positive regulation of ossification (GO:0045778),0.4935111094670739,1.470807243826115,0.03915171288743882,0.5178510383443734,1.0,10/39,4.74%,BMP6;WNT4;PTN;OSR1;BMPR1A;NELL1;KL;ADGRV1;BMP2;BMP7
prerank,regulation of osteoblast differentiation (GO:0045667),0.4282602589689253,1.4696098638664818,0.028700906344410877,0.5194643049729666,1.0,19/82,11.16%,RANBP3L;BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7;TMEM64;SKI;YAP1;NOCT;IFITM1;SMAD6;SUFU;LRP3;PTK2
prerank,cellular response to cytokine stimulus (GO:0071345),0.3569539106902346,1.4695329956580134,0.0,0.5174379092227782,1.0,91/416,16.20%,PTPN13;DPYSL3;RORA;LEPR;TEC;GBP6;SMAD3;FN1;CXCL10;IL16;PID1;AXL;STK39;GHR;OXSR1;ADAMTS12;IL31RA;ZFAND6;GBP2;FOXC1;STAT2;NFAT5;IL6ST;SHMT1;GAB2;OSM;VIM;IL11;FER;IL34;ANXA1;PTPN14;KIT;DAPK1;RC3H1;STAT5B;PTPN4;IL6;GSDME;TLR4;BCL2;MCL1;HAX1;TPR;VCAM1;GBP5;NOS2;PTPN2;PTPN9;CD47;GBP4;IL18;OPRD1;STAT1;GSK3B;CCL2;LGALS9;WNT5A;ZEB1;IL13RA1;IFNLR1;PTPN6;BCL2L1;GBP7;TLR2;IRAK3;TCF7;STAT4;SH2B3;FOXO3;CSF1;IFIT1;CRNN;PTPN18;JAK1;IL22;ADAMTS7;POU2F1;RHOU;WNK1;SLC26A6;TBK1;GREM2;CCL25;IL23R;SOCS6;CXCR4;ICAM1;IFNAR2;MUC1;GBP3
prerank,nuclear migration (GO:0007097),0.6244018412935702,1.4693093049916452,0.07210626185958255,0.5158687111097725,1.0,5/13,12.78%,SYNE3;SYNE2;CLMN;DOCK7;FBXW11
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.48699762664288193,-1.468694220751389,0.052256532066508314,0.3838286526041605,1.0,6/26,10.31%,ACER3;NOS3;ACER2;AKT1;NOS1;GCH1
prerank,cellular protein metabolic process (GO:0044267),-0.3039692045854898,-1.4684244975922227,0.0,0.3827193867314264,1.0,144/396,21.35%,ST8SIA4;CDH2;RPS24;CHRM3;ST3GAL6;CST3;SPARCL1;RPS9;RPL18A;RPL19;RPS12;RPL26;RPS29;RPL41;RPS15;RPL24;RPS23;RPL5;RPS27;RPS19;CPE;RPL38;RPLP1;SCG3;IGFBP7;RPS8;RPL10A;RPL27A;GAS6;RPL13;RPS18;ABCA3;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;GOLM1;RPL39;RPS17;RPS7;RPL37A;RPL4;RPS25;EEF1A1;DAB2IP;RPS15A;MSRA;RPL6;RPL11;RPLP0;RPLP2;RPS21;RPS28;RPL28;RPL32;RPL8;RPL13A;RPL30;MSLN;MBTPS1;RPS20;RPS4X;RPN2;RPL18;LGMN;RPS13;MSRB2;BMP4;MSRB3;FBXL2;RPS2;RPL14;RPL22;MMP15;FDXR;SPCS2;SEC11C;MSRB1;RPS26;ASMT;SPP1;SCG2;MRPS18A;SERP1;QPCT;ZDHHC2;RPS10;IGHMBP2;EVA1A;SPCS1;RPL23;RPL17;PABPC4;PIGH;RPL29;MGAT4A;RAB12;GSPT2;RPS5;RPS14;UBA52;PHEX;SEPHS1;PLOD2;ERO1A;QSOX1;SRBD1;MRPL28;COPS5;HBS1L;RPL12;MEN1;PSENEN;RPL9;FUCA2;UBE2D3;MMP1;MATN3;RPL37;RPS11;MFGE8;LGALS1;LMCD1;MRPL35;MRPS5;RABGGTA;RPL7;RPL31;RPL7A;FBXO22;MRPL34;HARS1;YARS2;FARSB;PCSK5;PENK;RPL3;MRPL52;MRPL23;MRPL9;C3;NTAQ1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6197961945461312,-1.4683223648759225,0.0755939524838013,0.38109075644064705,1.0,3/10,6.63%,SHANK3;NETO1;NPTN
prerank,negative regulation of proteolysis (GO:0045861),0.49681772654964446,1.4681165008650876,0.05573770491803279,0.5175602457431152,1.0,13/34,12.97%,ECM1;TIMP3;CSTB;PTPN3;SNX12;EPHA4;TIMP2;SERPINE2;LRRK2;DNAJC1;TRIM21;EFNA1;PLAT
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6261770371598354,1.466543767167716,0.07212475633528265,0.5204652432329507,1.0,3/13,4.74%,CBLB;SNX6;ERRFI1
prerank,embryonic eye morphogenesis (GO:0048048),0.6500319824546958,1.4663931197262605,0.08806262230919765,0.5187274773998528,1.0,2/11,0.45%,EFEMP1;FBN1
prerank,regulation of telomerase activity (GO:0051972),-0.4285331128696673,-1.4661263850221555,0.02564102564102564,0.3848299246230145,1.0,14/45,16.15%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;TERF1;ATM;NVL;KLF4;HSP90AA1;PNKP;MEN1;PKIB
prerank,sphingoid biosynthetic process (GO:0046520),-0.6057461169530596,-1.465204004622349,0.05592841163310962,0.38346574669666467,1.0,2/11,2.19%,ACER3;ACER2
prerank,sphingosine biosynthetic process (GO:0046512),-0.6057461169530596,-1.465204004622349,0.05592841163310962,0.38346574669666467,1.0,2/11,2.19%,ACER3;ACER2
prerank,positive regulation of protein polymerization (GO:0032273),-0.3937516346118399,-1.4650697509040547,0.020710059171597635,0.38193913975850347,1.0,30/65,24.85%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;CDC42EP3;PINK1;VASP;CDC42EP1;CDC42EP5;FES;TTBK1;HSP90AA1;RAC1;EVL;MAPT;PYCARD;TPPP;ARF6;CDK5RAP2;PFN2;CARMIL1;DCTN1;PRKCE;ARL2;MAPRE1;PFN1;OCLN
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5079880475339992,-1.4643859210788601,0.046460176991150445,0.3817875702508447,1.0,14/22,21.71%,RPS15;RPS7;RPS20;UBB;SPRED2;ATM;EEF1E1;RPL23;EIF5A;SPRED3;RPL37;SPRED1;MSX1;ATR
prerank,negative regulation of lipid storage (GO:0010888),0.5714800429911828,1.4641943533338715,0.06951871657754011,0.5238322070628756,1.0,6/19,6.64%,OSBPL8;IL6;NR1H3;PPARA;PTPN2;CRP
prerank,response to muscle stretch (GO:0035994),-0.5641898560678493,-1.4637340517703652,0.058333333333333334,0.3815589543771172,1.0,5/15,5.50%,CDH2;DMD;RYR2;CTNNB1;SLC8A1
prerank,alanine transport (GO:0032328),-0.6246824949129562,-1.4623028125273518,0.08085106382978724,0.3834807475968323,1.0,3/10,11.13%,SLC6A6;SLC1A4;SLC36A1
prerank,negative regulation of cell communication (GO:0010648),0.5396897788720565,1.4607179849265077,0.09615384615384616,0.533593039719645,1.0,4/21,2.68%,IGFBP3;MPIG6B;OSM;IL11
prerank,anterior/posterior axis specification (GO:0009948),0.6012118397858026,1.4591913579000089,0.07303370786516854,0.5366705724426987,1.0,3/15,13.25%,WLS;SKI;TASOR
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5529524660074038,-1.4579807624495673,0.05417607223476298,0.3928094797836917,1.0,6/16,10.30%,NOS3;KCNC2;NDNF;GUCY1B1;GUCY1A1;NOS1
prerank,response to ethanol (GO:0045471),-0.5602269936208245,-1.4574288222883478,0.07188160676532769,0.39235822291154315,1.0,7/14,19.29%,GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;GLRA2;GLRA1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6442134298759976,1.4571595824520551,0.08704061895551257,0.5413873560086987,1.0,3/10,7.09%,ENPP1;ERRFI1;MVP
prerank,ceramide metabolic process (GO:0006672),-0.4071778705764898,-1.4568839008709271,0.02168021680216802,0.39195450870963894,1.0,7/49,3.39%,ST6GALNAC3;SGMS1;ACER3;ACER2;CERS4;PPP2R1A;DEGS2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.47244457300400855,1.456647776089445,0.05454545454545454,0.5407896222405836,1.0,7/46,7.58%,TCF7L2;IGFBP3;IGFBP5;IL6;PDGFRB;IL18;STAT1
prerank,regulation of cytoskeleton organization (GO:0051493),0.408134716012745,1.4563400006865244,0.027298850574712645,0.5395280175205619,1.0,24/108,11.96%,PHLDB2;ROCK2;DIAPH1;ARHGAP18;PRKAA2;DLC1;EPHA3;SMIM22;MAP6;CLASP1;PHLDB1;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;CLIC4;GSK3B;RHOQ;SYDE1;IQGAP2;TJP1;PTK2;RHOC
prerank,myofibril assembly (GO:0030239),0.4708537444494653,1.4536681548465091,0.04477611940298507,0.546366503270463,1.0,8/42,6.95%,PDGFRA;TMOD3;CSRP3;CFLAR;TPM1;CSRP1;PDGFRB;ACTN2
prerank,nucleotide metabolic process (GO:0009117),0.5374008383619933,1.45318376058038,0.05253940455341506,0.5456308990187236,1.0,4/23,9.44%,ENPP3;CMPK2;FHIT;AK5
prerank,renal system development (GO:0072001),0.4637318558357488,1.4527308198370121,0.04823151125401929,0.5447941692483452,1.0,11/52,8.79%,SULF1;WNT4;FOXC1;RBP4;IFT88;ARL3;TGFBR1;SALL1;LRP4;STAT1;GREB1L
prerank,regulation of glycolytic process (GO:0006110),0.43765750474662624,1.4524098871511224,0.04012841091492777,0.5436027157842083,1.0,10/68,7.19%,ZBTB20;PRKAG2;PRKAA2;NUPR1;ARNT;RANBP2;TPR;HDAC4;PPARA;JMJD8
prerank,negative regulation of fat cell differentiation (GO:0045599),0.48942030336127285,1.4522313485838954,0.05,0.5419177133886851,1.0,8/34,11.14%,RORA;SMAD3;ENPP1;WNT10B;IL6;WNT5A;YAP1;LRP3
prerank,cellular response to drug (GO:0035690),-0.48931853932995417,-1.4520437673679814,0.053452115812917596,0.4026852827479733,1.0,7/25,12.24%,MEF2C;PDE4B;TFRC;ACER2;GAS6;AIM2;KCNQ1
prerank,ganglion development (GO:0061548),-0.6117225398248243,-1.4497989424969921,0.07036247334754797,0.406715916450462,1.0,6/11,12.74%,UNC5C;NRP2;CTNNB1;FZD3;TUBB3;SEMA3A
prerank,negative regulation of cholesterol transport (GO:0032375),0.6609735052708431,1.4497412588116296,0.07572815533980583,0.5481390417231952,1.0,1/10,2.03%,APOA2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.48570859767990904,1.449239044111744,0.0512,0.5476346264526405,1.0,8/37,7.65%,PHLDB2;PRKAA2;EPHA3;SKA1;MAP6;CLASP1;PHLDB1;GSK3B
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4591539632638944,1.4484276482255067,0.050488599348534204,0.5480602050813949,1.0,10/48,11.58%,ROBO1;PARP14;USP18;STAT2;IL6;NR1H3;PTPN2;OTOP1;IRAK3;SH2B3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5967569568024891,1.4473802928666046,0.08256880733944955,0.549456637677411,1.0,3/15,7.65%,TCF7L2;TPR;GSK3B
prerank,regulation of response to interferon-gamma (GO:0060330),0.6112397102245546,1.4471375462843998,0.0779467680608365,0.5480949342956054,1.0,6/14,13.10%,PARP9;PTPN2;STAT1;PIAS1;SUMO1;JAK1
prerank,dermatan sulfate metabolic process (GO:0030205),0.606272614443595,1.446883070784879,0.07476635514018691,0.5467762940577904,1.0,3/13,4.92%,UST;DCN;DSE
prerank,response to calcium ion (GO:0051592),-0.35504449028340324,-1.446556063957563,0.006349206349206349,0.4132492455223495,1.0,36/102,21.52%,NLGN1;SYT1;MEF2C;KCNMB2;PLCG2;TRPC3;KCNMA1;THBS1;ITPKB;RYR2;HOMER1;CALM1;CALM2;RYR3;KCNH1;CALM3;LGMN;CAMK2D;SYT4;SYT7;CPNE4;CAV1;SYT9;SYT2;CASQ2;ADD1;ADCY8;SLC25A13;HPCA;ECT2;CPNE7;SYT6;KCNMB4;TTN;SLC25A12;TRPM2
prerank,engulfment of apoptotic cell (GO:0043652),-0.5405040751263085,-1.4465512152168174,0.07289293849658314,0.4113583323765732,1.0,8/15,17.36%,THBS1;XKR4;XKR6;RHOG;MEGF10;RAC1;RHOH;RHOBTB1
prerank,myoblast differentiation (GO:0045445),0.5992692548879452,1.4454525070706614,0.07528957528957529,0.5494256550599929,1.0,2/14,4.65%,TCF7L2;EPAS1
prerank,kidney development (GO:0001822),0.439534670434937,1.4437493644599713,0.027820710973724884,0.5532616884284762,1.0,13/65,8.79%,SULF1;WNT4;KANK2;OSR1;FOXC1;IFT88;ARL3;BMP7;TGFBR1;SALL1;LRP4;CTSH;GREB1L
prerank,negative regulation of cell population proliferation (GO:0008285),0.35226670319381254,1.4435770204658902,0.002333722287047841,0.5515436565481374,1.0,92/351,17.78%,ALDH1A2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;MCC;KANK2;EIF2AK2;TPTE;IGFBP5;NUPR1;GATA6;LDOC1;DLC1;PDS5B;OSM;NELL1;FBLN1;RBP4;ADAMTS1;TGFB1I1;DUSP10;PTHLH;PTPN14;SLC16A2;BMP2;IGFBP6;IFI35;IL6;BTG3;GSDME;BTG4;MORC3;APPL2;FOXP3;PTPN2;COL18A1;PARP10;ZBTB7C;POU1F1;CLMN;CDC73;PDCD5;SKI;CDKN2B;WNT5A;MTSS1;IFITM1;SMAD6;NUPR2;CGRRF1;IFNLR1;PTPN6;CDH13;PTPRU;SH2B3;EPPK1;VGLL4;NUDT6;SLURP1;NOG;MAP2K1;RBM5;PEX2;ACVR1C;MDM4;IFIT3;TRIB1;WDR6;FRK;ABI1;VHL;NIBAN2;PML;TNS2;KAT2B;P3H3;SOX4;KDM2B;PKD2;APP;AXIN2;NF2;S100A11;CDKN3;GAS8;OGN;DLG5;DNAJB2;PPP2R5C;TENM1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4342889884116353,-1.4428509426265115,0.059431524547803614,0.41961243664271525,1.0,20/38,31.42%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFA11;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2
prerank,polyamine metabolic process (GO:0006595),-0.572296485578377,-1.4424968632465203,0.061855670103092786,0.4186931434115959,1.0,6/13,26.92%,HDAC6;OAZ2;SMS;SRM;SAT2;PAOX
prerank,regulation of inflammatory response (GO:0050727),0.37483312230081983,1.4419593728793738,0.007712082262210797,0.5551949901697215,1.0,27/190,8.47%,ENPP3;RORA;USP18;CASP12;IL16;ADAMTS12;FPR2;OSM;SNX6;CDH5;TNFAIP8L2;ANXA1;IFI35;IL6;TLR4;LACC1;ZBP1;CASP4;SERPINE1;NR1H3;PPARA;BIRC3;PTPN2;CD47;IL18;SETD4;WNT5A
prerank,negative regulation of neuron projection development (GO:0010977),0.4405618035657648,1.4419088299251621,0.04915514592933948,0.5531464056063533,1.0,11/56,9.98%,EFNB2;DPYSL3;LPAR1;WNT3A;KANK1;CBFA2T2;LRP4;PTPN9;NGFR;EPHA4;NGEF
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.44291768901835255,1.4416239048823254,0.04503105590062112,0.5519054262453655,1.0,10/57,7.50%,PARP14;GHR;IL31RA;IL6ST;OSM;PARP9;KIT;IL6;PTPN2;IL18
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4916580113314272,-1.4405774278500687,0.04941176470588235,0.4218096596126504,1.0,9/23,15.22%,MYO10;KIF1B;KIF1C;CCDC88A;TUBA1A;KIF5C;DYNC1I2;KIF5A;TUBA1B
prerank,presynapse assembly (GO:0099054),-0.5391041082853357,-1.4399184875234903,0.06741573033707865,0.4218168407604255,1.0,7/16,10.23%,NLGN1;PTPRD;LRRTM3;PCLO;IL1RAPL1;NLGN3;DVL1
prerank,epithelium development (GO:0060429),0.40382621939864805,1.4398724045436584,0.02,0.555414794215983,1.0,17/107,8.12%,ALDH1A2;WNT4;KANK2;OSR1;GATA6;DAG1;DACT1;MTHFD1;BMP2;LOXL3;ERRFI1;VCL;SALL1;ANXA4;STAT1;GSTK1;ANXA7
prerank,regulation of interleukin-4 production (GO:0032673),-0.4959176447414215,-1.4398565683789732,0.06619385342789598,0.42008235318421644,1.0,8/21,12.61%,LEF1;SLC7A5;PRKCQ;ZFPM1;HAVCR2;FCER1G;CD86;SYK
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.49496520201948696,-1.4397876464224726,0.06888888888888889,0.41839554522119554,1.0,11/24,18.62%,TEK;PTPRJ;KDR;PIK3R1;MYOC;IQSEC1;VEGFA;RAC1;COL16A1;PPM1F;ARF6
prerank,defense response to protozoan (GO:0042832),0.6247729469105414,1.4392942767083252,0.10877862595419847,0.5551762447023549,1.0,4/12,11.04%,GBP6;GBP2;GBP4;GBP7
prerank,melanocyte differentiation (GO:0030318),0.6379476623225785,1.4392152779388845,0.09689922480620156,0.5532601445489935,1.0,3/11,3.83%,LRMDA;ENPP1;KIT
prerank,negative regulation of ossification (GO:0030279),0.5347387518517563,1.4390797373232038,0.07279693486590039,0.5515394020366209,1.0,7/23,9.65%,RBPJ;ENPP1;ECM1;BCOR;CHSY1;LRP4;SMAD6
prerank,regulation of neuron projection development (GO:0010975),-0.32917283193711566,-1.4384473783714717,0.00749063670411985,0.4200935635108678,1.0,48/163,13.08%,CTNNA2;LRRC4C;ITGA6;SHANK3;CSMD3;LRRC7;CDH2;PPFIA2;TENM3;TANC2;PTK2B;DCC;RIT2;FUT9;PAK1;NTRK2;SETX;IL1RAPL1;PRAG1;SERPINI1;TOX;DAB2IP;ARHGAP44;SNX3;STMN2;NDNF;NPTN;RAPGEF2;CCDC88A;EFHC2;AKT1;PAQR3;RTN4RL1;MBOAT1;NDRG4;SPOCK1;ABI3;LYN;RET;LZTS3;PTPRO;SCARB2;PAK3;MARK1;FES;SRCIN1;SEMA3A;MFSD2A
prerank,fat cell differentiation (GO:0045444),0.44347266842322636,1.4381016063984875,0.03650793650793651,0.5527863606847038,1.0,12/57,12.36%,TCF7L2;PID1;IL11;OSBPL8;WNT5B;FAM120B;ALOXE3;SMAD6;ERAP1;MAFB;NR4A1;EGR2
prerank,membrane lipid biosynthetic process (GO:0046467),-0.38966972708450676,-1.4372413368990438,0.0215633423180593,0.4215395225827476,1.0,11/58,4.60%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;ST8SIA6;DEGS2;ELOVL7;SPNS2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.42566341515026285,-1.4372372842317882,0.04712041884816754,0.41970067322763605,1.0,16/41,18.17%,PLCG2;SLC24A2;RYR2;HTR2C;GRIN2A;RYR3;SLC8A1;GRIN2B;GRIN1;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;HTR2A
prerank,defense response to bacterium (GO:0042742),0.39675159195956095,1.4366258685309494,0.03333333333333333,0.5556415638148544,1.0,19/105,11.24%,GBP6;SELP;COLEC12;GBP2;FPR2;ANXA3;IL6;TLR4;SERPINE1;OPTN;NOS2;CRP;GBP4;TNFRSF14;PLA2G6;ANKRD17;GBP7;TLR2;OAS2
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.4753799781244888,-1.4366102425663727,0.05568445475638051,0.4194187054124859,1.0,8/24,26.69%,AGBL4;TTLL7;TTLL5;NAA10;TTLL8;CEP41;VKORC1;TTLL3
prerank,response to glucose (GO:0009749),0.45652665980245705,1.4357906955351385,0.048465266558966075,0.5565671660740339,1.0,5/46,5.34%,TCF7L2;ZBTB20;PRKAA2;APOA2;UNC13B
prerank,cell proliferation in forebrain (GO:0021846),0.6461748780101645,1.4348423161247974,0.1079429735234216,0.5577651588080677,1.0,3/10,9.50%,WNT3A;NUMB;DOCK7
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3449560454024097,1.434642200179605,0.0022753128555176336,0.5562859611982284,1.0,108/476,16.61%,TCF4;CREB5;KMT2A;RORA;WNT4;SMAD3;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;ARNT2;MLLT3;IL31RA;TBL1XR1;TEAD1;FOXC1;TRIM56;PHIP;GATA6;WNT3A;RGMB;PPM1A;ZIC2;FOXC2;GLI3;MYB;PARP9;FZD2;TGFB1I1;PRDM11;ZIC1;BMP2;RFX3;APBB1;IL6;GLI1;BMP7;NIF3L1;TGFBR1;NCOA6;SALL1;LBHD1;NSD3;NR1H3;FOXP3;DTX3L;HDAC4;CREBL2;PPARA;CREBBP;GLIS2;NSD1;SFR1;RNF20;STAT1;WAC;ARHGEF11;NEK4;QRICH1;RNF111;CRLF3;TEAD2;WNT5A;YAP1;KAT6B;RLF;EPC1;NAA16;ELF4;BRD4;MAFB;ATF7IP;UBE2V1;NAA15;ELF2;SMAD4;HIVEP3;PPP3CB;FOXO3;ILF3;DVL3;EGR2;BTRC;MAP2K1;FBXW11;MED12;SERTAD3;KAT6A;KDM8;VHL;NIBAN2;HDAC2;RARA;MAP3K2;PML;ILK;SP3;SMARCA4;SOX4;DNAJC2;SMARCC1;SMAD2;TRIM16;NFATC2;TBL1X;PSRC1;ANKRD49
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.46404541514086406,-1.4335162630289229,0.0665083135391924,0.4255272143259309,1.0,13/26,24.85%,NAV3;PAK1;RPS3;MET;STMN2;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,carnitine shuttle (GO:0006853),0.62979996805579,1.4332440010785426,0.09568480300187618,0.5590427634649077,1.0,2/11,1.61%,PRKAG2;PRKAA2
prerank,cation transport (GO:0006812),-0.3272086909306666,-1.4329051998347686,0.004098360655737705,0.4253701740153662,1.0,36/167,12.30%,SLC6A6;SLC47A1;PIEZO2;SLC12A2;KCNB2;KCNAB1;KCNMB2;KCNK5;SLC9B2;KCNMA1;ATP1B1;ANO1;ABCC9;KCNJ3;KCNJ2;SCN1A;SLC7A1;SLC5A5;SLC38A5;SLC8A1;SLC1A1;SLC5A6;SCN2A;TRPC6;KCNH1;TMEM63C;GRIN1;KCND3;NEDD4L;KCNJ6;SLC36A1;FGF13;SCN8A;KCNJ8;SCN9A;KCNJ15
prerank,collagen fibril organization (GO:0030199),0.4129985799815841,1.4325402723250258,0.02635658914728682,0.5592877526589798,1.0,15/88,6.79%,COL4A3;COL23A1;COL4A6;COL4A4;COL5A2;COL3A1;COL4A5;DDR2;LOXL3;BMP1;LOXL1;TGFBR1;COL20A1;COL5A1;COL18A1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.55127368272349,1.4322466872142,0.07749077490774908,0.5560772851167768,1.0,3/20,4.73%,ZBTB20;PRKAA2;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.55127368272349,1.4322466872142,0.07749077490774908,0.5560772851167768,1.0,3/20,4.73%,ZBTB20;PRKAA2;ARNT
prerank,chemokine-mediated signaling pathway (GO:0070098),0.45692050214730073,1.4316733659056875,0.056818181818181816,0.5558654979350697,1.0,10/42,14.90%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3;SH2B3;WNK1;RBM15;CCL25
prerank,mesoderm formation (GO:0001707),-0.5250636366763565,-1.4314572189135049,0.06451612903225806,0.4276004074848261,1.0,4/17,10.15%,BMPR2;ITGB4;ITGA8;ITGA3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5224892282664478,-1.431359923714635,0.07586206896551724,0.42602372807578226,1.0,8/18,17.70%,NLGN1;RIMS1;RIMS2;RAB3GAP1;SYN1;RAP1A;SNAPIN;RIMS4
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.46882619344732435,1.4307898472204341,0.057755775577557754,0.5569316147168527,1.0,9/43,4.74%,BMP6;WNT4;DDR2;IL6ST;BMPR1A;NELL1;BMP2;IL6;BMP7
prerank,regulation of potassium ion transport (GO:0043266),-0.4544592772721361,-1.430715024641165,0.056372549019607844,0.4258798429000295,1.0,9/31,10.30%,DPP10;KCNAB1;PTK2B;KCNIP4;ANK3;KCNIP1;DPP6;CACNA1D;NOS1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5901029339304864,-1.4306910615866928,0.0951417004048583,0.42412588073441687,1.0,5/11,15.55%,ITPKB;IP6K2;FGF2;PPIP5K2;PPIP5K1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5936691930174569,-1.4302061787222866,0.07942973523421588,0.42364498031605596,1.0,2/10,6.40%,SLIT2;EMILIN1
prerank,heterochromatin organization (GO:0070828),-0.547706441995945,-1.4301073938627504,0.09381663113006397,0.4220899587294249,1.0,2/14,3.43%,MECOM;PRDM16
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5676141800610925,1.4297453186999713,0.09479553903345725,0.5583451880961829,1.0,3/17,4.74%,TFPI;ATP1A2;BMP7
prerank,amino acid transport (GO:0006865),0.4510562743713973,1.4292920164184206,0.04953560371517028,0.5577877958593045,1.0,5/49,4.20%,SLC7A11;PDPN;SLC7A2;SLC6A12;SLC7A14
prerank,metal ion transport (GO:0030001),-0.3678671898045761,-1.4290765896203694,0.03880597014925373,0.4231778434202435,1.0,20/86,10.29%,CACNA1E;GRIN3A;TRPC3;RYR2;TPT1;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;CNNM4;ATP2A3;SLC30A1;NIPAL3;CAMK2A;RAMP2;NIPAL4;CACNA1D;NIPA2;NIPA1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6079523865237819,-1.4290635160366492,0.07128712871287128,0.42143441314513697,1.0,7/10,28.37%,SNCA;AKT1;SLC45A3;PTH1R;PRKCE;IRS1;PMAIP1
prerank,defense response to symbiont (GO:0140546),0.40327964344407985,1.4288154293382707,0.019202363367799114,0.5572527333591177,1.0,24/92,14.41%,RSAD2;EIF2AK2;STAT2;TRIM56;PRF1;IFIT2;IL6;BCL2;ZBP1;TRIM5;BST2;OASL;STAT1;ZMYND11;MOV10;IFITM1;IFNLR1;BCL2L1;TLR2;OAS2;IFI27;IFIT1;IFIT3;IFIH1
prerank,triglyceride biosynthetic process (GO:0019432),0.5631440106503919,1.428798518945703,0.07850467289719626,0.555254059875961,1.0,7/18,20.04%,AGMO;MOGAT3;DGAT2;LPGAT1;LPIN2;PCK2;DGAT1
prerank,muscle filament sliding (GO:0030049),0.47841275908334163,1.4277515431775905,0.048986486486486486,0.5545273067972194,1.0,6/38,10.07%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,actin-myosin filament sliding (GO:0033275),0.47841275908334163,1.4277515431775905,0.048986486486486486,0.5545273067972194,1.0,6/38,10.07%,TNNC1;VIM;DES;TPM1;ACTN2;TPM4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4319594796702416,-1.426544792187926,0.05952380952380952,0.42631337787730994,1.0,11/38,13.29%,CACNB2;CTNNA3;KCNJ3;KCNJ2;CACNA1G;CAMK2D;KCND3;CACNA1D;KCNQ1;CAV1;KCNE4
prerank,regulation of response to external stimulus (GO:0032101),0.38967931127115996,1.4257941413908162,0.02631578947368421,0.5588609360768433,1.0,21/121,10.01%,EFNB2;PDGFRA;USP18;CASP12;ADAMTS12;GATA6;CD55;ANXA1;GP1BA;LACC1;PTPN22;ZBP1;CASP4;APPL2;TRIM5;BIRC3;WNT5A;STK24;ERAP1;APPL1;BRD4
prerank,regulation of exocytosis (GO:0017157),-0.4096858752637574,-1.424356224218726,0.023195876288659795,0.43022452280124795,1.0,25/46,28.16%,SYT1;RIMS2;RAB27A;NSF;CADPS;IL1RAPL1;SNCA;STXBP5L;RAB27B;RAB3C;CPLX1;STXBP6;CPLANE2;RAB12;CLASP2;EXPH5;RAB15;SYTL4;ATP6AP1;HAP1;RAB8B;RAB3B;CHMP6;UNC13D;VAMP2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5438125888375839,-1.4241329348427187,0.08731808731808732,0.42903352886552687,1.0,5/14,10.48%,NOS3;ECE1;ACE;ENPEP;ACE2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5166786598583574,-1.423670622957942,0.066815144766147,0.42841003713732234,1.0,7/17,21.97%,CALM1;CALM2;HSP90AB1;CALM3;PTPRC;PPP1R15B;PPP1R15A
prerank,positive regulation of wound healing (GO:0090303),0.483094786970065,1.422979164399927,0.07032590051457976,0.566323038504972,1.0,11/36,15.39%,VTN;PLPP3;KANK1;FOXC2;ANXA1;SERPINE1;CLDN1;INSL3;PTK2;SMOC2;ADRA2A
prerank,sphingolipid metabolic process (GO:0006665),-0.34735217995073575,-1.42291775009044,0.010752688172043012,0.428732828892357,1.0,27/108,16.98%,ST6GALNAC3;SGMS1;ACER3;SERINC1;ELOVL5;ACER2;CERS4;CERT1;PPM1L;PPP2R1A;DEGS2;ELOVL7;SPNS2;HEXB;TECR;GLTP;NEU1;SGMS2;CERK;GM2A;PLPP1;GAL3ST1;PRKD1;HACD3;SPTSSA;ORMDL3;SGPP1
prerank,T cell activation (GO:0042110),0.42059414485416063,1.4225974368569698,0.04746835443037975,0.5655195699197194,1.0,9/69,6.52%,LEPR;DPP4;CXADR;CTPS1;NHEJ1;KIT;PTPN22;FOXP3;PTPN2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3250073168861452,1.422331719072058,0.0,0.5643390780726186,1.0,358/1667,16.50%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;SOX5;FHL2;BMP6;TSHZ2;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;KANK2;ZMIZ1;NR2F2;CXCL10;SP100;ELF1;KCNIP3;RGMA;CREB3L2;FGF1;PID1;PRDM6;AUTS2;ARNT2;OSR1;TBL1XR1;TEAD1;SMURF2;FOXC1;NFIA;LBX1;STAT2;NFYC;NFAT5;PHIP;GATA6;SPIB;TCF24;WNT3A;KDM7A;MAF;HIF3A;CSRP3;PPM1A;ZBTB4;BMPR1A;ZNF395;SSBP2;OSM;NR6A1;FSTL3;ZIC2;FOXC2;IL11;GLI3;NFATC4;WWOX;MYB;NCOA3;ZIC4;MBD2;TRAK1;PARP9;CDK8;TGFA;LDB2;HIVEP2;IKZF2;TNRC6B;PRRX2;HIVEP1;CRY2;NUCKS1;HOXC6;DACT1;ZBTB8A;HOXC4;KIT;ZIC1;DCN;LITAF;BMP2;STAT5B;RFX3;CRY1;BRWD1;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;MIER3;ZFP30;EPAS1;HLF;TLR4;GLI1;BCOR;ARNT;EN2;SIM2;ZNF276;AEBP1;UXT;MTDH;GLIS3;GZF1;NCOA6;SALL1;OTP;PRRX1;ZNF3;MGA;TCF12;KDM3B;SERPINE1;KLF5;HAX1;MIER1;HDGFL3;SP9;TPR;ZNF35;MLLT10;CREB3L3;WWC2;NR1H3;FOXP3;ARF4;ATP2B4;BCL9L;ANXA4;HDAC4;ZKSCAN4;PPARA;TCF7L1;TSHZ3;VGLL3;CREBBP;RARB;POGZ;GLIS2;PCGF5;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;USP9X;HOXA2;CREBRF;IL18;DPF2;STAT1;CDC73;SKI;CDKN2B;ZSCAN21;MEF2A;RIPK2;RNF111;CRLF3;PIAS1;ZNF25;VPS72;TEAD2;ATF7;BAX;BAZ1B;CUX1;TNRC6A;WNT5A;ZNF182;ZFP37;SP8;YAP1;RHOQ;ZEB1;SAP130;CCNH;CRTC1;KAT6B;MOV10;RLF;DLG1;EPC1;GLYR1;IGF2;ZNF394;ELF4;MNAT1;ZBTB3;SUMO1;GATAD2B;CREM;SMAD6;CDK7;TOX4;HDGFL2;CDK12;SP110;E4F1;EBF4;SOX21;NUPR2;BRD4;PBX1;RFXANK;TAF7;SUFU;PFKM;MAFB;MSC;MAPK14;WWP2;CUX2;TCEA1;PPID;BAZ1A;HEYL;ZNF292;MYSM1;CIR1;CBX7;CDH13;ZNF235;TLR2;FNIP1;ELF2;RFXAP;TCF7;SMAD4;STAT4;MAP2K5;HIVEP3;EGR3;RTF1;PPP3CB;ATN1;FOXO3;NR4A1;CRTC3;ACTL6A;RBBP8;LHX9;IFI27;ZNF219;KDM5B;DVL3;EGR2;ZKSCAN7;MAML2;RPS6KA3;SS18;SRCAP;THAP1;NOG;EFNA1;HOXA10;BPTF;KDM2A;TET2;NFIC;MED12;CBX4;ARRB1;MZF1;BHLHE41;NR3C1;BRD8;GMEB1;MED20;PKNOX1;WASL;PEX2;PAF1;NRF1;NFE2L1;SENP1;HIC1;ARID5B;ZNF462;POU2F1;ZNF205;KAT6A;BRWD3;GTF2H4;PRDM5;MDM4;NCOA2;SALL2;DMTF1;RFX2;TLE6;FUS;NCK1;TBK1;FRK;VHL;THAP3;ZBTB21;ZNF569;RBM14;ZBTB12;HDAC2;IFRD1;RARA;ZNF18;MAMSTR;SP3;ZFX;ZNF383;HOXB4;TEF;SMARCA4;KAT2B;ACVR2B;SOX4;PHF20L1;IRF9;PER3;KDM2B;TXK;DAB2;VEZF1;LIN9;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9;CTDSP1;ZNF260;CPEB3;MUC1;JDP2;SMARCC1;URI1;DRGX;SMAD2;WWTR1;BCL11B;ZNF483;POU6F1;NFATC2;TBL1X
prerank,manganese ion transport (GO:0006828),-0.5575766028552659,-1.4216608599126555,0.07627118644067797,0.4302267041927805,1.0,6/14,7.84%,TRPC3;TRPC5;TRPC4;ATP2C1;TRPC6;SLC39A14
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5787669265717172,1.4216276493396087,0.09774436090225563,0.5646611745540496,1.0,3/15,8.03%,ROCK2;IL6ST;MEF2A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.38681314772259,1.421545872368661,0.02170767004341534,0.5629326844757142,1.0,31/140,9.98%,ARHGAP29;CGNL1;ARHGAP6;RASGRF1;TIAM2;AKAP13;ARHGAP21;ARHGAP10;ARHGAP20;ARHGAP18;DLC1;ARHGAP28;ARHGAP32;TRIP10;FGD4;ARHGAP12;PLCE1;MYO9A;RHOF;FAM13B;TAGAP;RALBP1;PLEKHG2;ARHGEF11;ARHGAP26;RHOQ;SYDE1;GMIP;ARHGEF12;SOS2;NGEF
prerank,peptidyl-tyrosine modification (GO:0018212),0.4339615982406241,1.4204579795190957,0.03758169934640523,0.5646461854180159,1.0,13/56,8.24%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;EPHA3;FER;KIT;TPST1;EPHA1;PDGFRB;TTL;EPHA4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5329143845795825,-1.4195715103570403,0.06581740976645435,0.43395796076652504,1.0,7/16,17.78%,PPP1R16B;THBS1;GATA2;VEGFA;FGF2;APLNR;DLL4
prerank,regulation of vasoconstriction (GO:0019229),-0.47031788880302394,-1.4185661756326546,0.08788598574821853,0.43487823415907717,1.0,8/27,12.95%,CHRM3;KCNMB2;BMPR2;ADRA1B;ECE1;ACE;ACE2;CAV1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.49549861547547913,1.4180345145352682,0.0798611111111111,0.5707676414184806,1.0,4/29,4.91%,TNNC1;TGFBR3;BMP2;TPM1
prerank,negative regulation of coagulation (GO:0050819),0.578317208474814,1.4180027995736728,0.10566037735849057,0.5688617842810965,1.0,4/14,8.66%,TFPI;VTN;SERPINE1;SERPINE2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6417044330455237,1.4178252008138474,0.10133843212237094,0.5675072075332896,1.0,4/10,17.50%,APOA2;BMP1;ABCA1;ABCA7
prerank,myelination (GO:0042552),-0.4061188935880237,-1.4177354257288175,0.03617571059431524,0.43526970992137,1.0,21/46,22.65%,ADGRG6;ACER3;PLP1;CMTM8;MAL;MYOC;MBP;EIF2B2;SCN2A;SCN8A;NFASC;ABCD2;TNFRSF21;ACSBG1;GAL3ST1;TPPP;AMIGO1;BCAS1;PLLP;B4GALT6;MAL2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5171124979354075,-1.4173383283525418,0.08744394618834081,0.43461538702622127,1.0,12/17,25.74%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;VPS9D1;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5789551476062978,-1.4173317874498104,0.0944206008583691,0.4328823555089647,1.0,4/12,8.10%,SYT1;RIMS1;RIMS2;SYT7
prerank,negative regulation by host of viral transcription (GO:0043922),-0.5815147369784743,-1.4172224079893927,0.08297872340425531,0.43155053582725594,1.0,4/12,9.20%,PSMC3;INPP5K;TFAP4;HDAC1
prerank,base conversion or substitution editing (GO:0016553),-0.5890166965813721,-1.4168469776335106,0.08739837398373984,0.4308121391052493,1.0,3/11,7.38%,ADARB1;ADARB2;APOBEC1
prerank,potassium ion transport (GO:0006813),-0.3461207845439848,-1.4163421294946732,0.02112676056338028,0.43043117195209823,1.0,28/120,12.30%,KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNMB2;KCNK5;KCNMA1;SLC24A2;ABCC9;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNK10;SLC9A8;HCN2;KCNH1;TMEM175;KCNH5;KCND3;KCNJ6;KCNB1;KCNJ8;KCNQ1;KCNJ15
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3937481784878839,1.4163393907733486,0.028050490883590462,0.5705943130527384,1.0,22/113,12.62%,TCF7L2;BMP6;PTN;LAMC1;FGF1;NOTCH2;OSR1;ECM1;NRP1;VEGFD;TGFA;BMP2;ARNT;TGFBR1;CLDN1;WNT5A;YAP1;AKT3;CDH13;EGR3;NR4A1;CRNN
prerank,acylglycerol homeostasis (GO:0055090),0.5525343083773079,1.415963312269619,0.08916083916083917,0.5698253818734521,1.0,3/20,7.50%,RORA;NR1H3;IL18
prerank,regulation of dopamine secretion (GO:0014059),-0.4634902855522917,-1.4157542400564218,0.058823529411764705,0.4304563302095175,1.0,12/25,26.68%,SYT1;SNCA;SYT4;SYT7;SYT9;SYT2;KCNA2;CHRNA4;SYT6;SYT10;SYT5;SYT17
prerank,neuron projection development (GO:0031175),-0.3250578100898054,-1.415636492905677,0.0,0.42906580718008375,1.0,53/168,17.01%,FRY;GRM7;CNTNAP2;NLGN1;CTNND2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;PLP1;GPM6B;NCKAP1;STX3;TRIO;PAK1;PTPRM;NYAP2;EPHB1;DAB2IP;SH3GL2;DCLK1;HMGB1;MYOC;STMN2;RAPGEF2;SHTN1;UBB;RAB35;L1CAM;LYN;MINK1;DBNL;MANF;NEFH;MICALL2;ZFYVE27;ALS2;ULK1;PAK3;NGF;MAPK8IP3;TMEM108;BICDL1;LGI1;MYO16;MAPT;MAP2;NTF3;STMN4;SHANK1;SNAPIN;EPHB3
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.40974831329269445,-1.4152081798591163,0.044226044226044224,0.42851033400811495,1.0,17/44,23.49%,MEF2C;RYR2;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;ACVR1;APLNR;VANGL2;HES1;DLL1;SRF;TBX6;BBS7
prerank,brain morphogenesis (GO:0048854),-0.5808008513085077,-1.4142611486911223,0.06086956521739131,0.4294561804095108,1.0,5/12,17.38%,CTNNA2;SHANK3;PAX2;VPS51;BBS2
prerank,myeloid cell development (GO:0061515),0.5563485385992972,1.413975785888092,0.09107806691449814,0.5746540776079242,1.0,8/18,18.98%,MPIG6B;ANXA2;KIT;TLR2;SH2B3;ALAS2;APP;DMTN
prerank,central nervous system development (GO:0007417),-0.3112049555597074,-1.4139421251931596,0.0,0.4285988664306862,1.0,49/250,10.51%,ADGRL3;ADGRL2;CNTNAP2;ROBO2;SLC2A1;CDH2;MEIS2;COL4A1;CNTN4;WWP1;ZFHX3;MOG;CNTN6;PBX3;NCKAP1;SHROOM4;VIT;GRIN2A;GRIK1;SERPINI1;SNTG2;ADGRG1;S100B;APOD;SH3GL2;ADAM22;AHI1;MAL;DCLK1;RAB3GAP1;NRCAM;GRIN2B;MBP;SCYL2;EIF2B2;ALDH5A1;ZIC3;ZBTB16;SOX6;LSR;NDRG4;BAG6;GRIN1;ADAM23;SPOCK1;DNER;DHX30;SEMA6B;DDIT4
prerank,cardiac muscle tissue development (GO:0048738),0.44589449745213966,1.4137272796661058,0.05,0.5735273948132473,1.0,10/50,4.74%,AKAP13;NOTCH2;GJB6;GATA6;CSRP3;GJA1;BMPR1A;RBP4;BMP2;BMP7
prerank,response to prostaglandin E (GO:0034695),0.6334556433621621,1.413381965171902,0.11614173228346457,0.5727426454458783,1.0,1/10,0.37%,TGFBR3
prerank,gonad development (GO:0008406),0.4668482471844424,1.4128385706886124,0.06382978723404255,0.5726733527904576,1.0,7/41,8.47%,WNT4;NR2F2;GATA6;WNT2B;KIT;SALL1;WNT5A
prerank,negative regulation of signaling (GO:0023057),0.5051896137581869,1.4115008699514908,0.09090909090909091,0.575102970842609,1.0,5/25,5.67%,IGFBP3;MPIG6B;OSM;IL11;OPTN
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.41293787447101826,-1.4110852287360094,0.0379746835443038,0.4344244019031782,1.0,8/44,3.31%,KCNMB2;KCNMA1;AKAP6;ATP1B1;KCNJ3;KCNJ2;NOS1AP;GABBR2
prerank,actin filament polymerization (GO:0030041),0.49727619935577916,1.4107073683931544,0.08626760563380281,0.5757142588062372,1.0,3/29,0.81%,GAS7;ARHGAP6;DIAPH1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.48809382289115144,1.4100130349250461,0.0603448275862069,0.5759918556909127,1.0,7/32,9.14%,ZBTB20;PRKAG2;PRKAA2;SORBS1;CREBL2;PPARA;SIRT4
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6336075699551603,1.4099170082240198,0.12156862745098039,0.5743007334690199,1.0,4/10,7.89%,RC3H1;FOXP3;LGALS9;CD274
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5476477131735,1.4096654014088292,0.08971962616822429,0.5732255482998602,1.0,6/18,10.34%,PDPK1;COL4A3;FGFR1;CCL2;IGF2;AKT3
prerank,cellular response to nitrogen compound (GO:1901699),0.5427210592261449,1.4094470492484448,0.09869646182495345,0.5720212361573279,1.0,3/20,7.18%,ROCK2;ATP2B4;SPIDR
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5232666255310163,-1.4090690846965057,0.06531531531531531,0.4379934469968485,1.0,6/18,15.17%,PLCB1;CHRM3;CHRM2;OPRM1;AGRN;GNAQ
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4841561904309906,1.4087140391557993,0.08571428571428572,0.5726690919419697,1.0,17/33,23.89%,GLI1;PLK5;APPL2;ATP2B4;CDC73;PHB2;SUSD2;APPL1;PTPN6;CRNN;PAF1;INO80;PTEN;FBXW7;PKD1;PSME3;TAF1
prerank,embryonic skeletal system development (GO:0048706),0.4870356242673036,1.407720184935101,0.06743421052631579,0.574029830788271,1.0,7/35,8.47%,SULF1;PDGFRA;OSR1;RBP4;HOXC4;DYNC2I1;WNT5A
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3357846806382797,1.406699237472848,0.0,0.5753089335997024,1.0,133/572,16.98%,TCF7L2;FHL2;BMP6;SMAD3;RBPJ;ZEB2;ZHX2;MXI1;ATXN1;KANK2;NR2F2;SP100;KCNIP3;PRDM6;OSR1;TBL1XR1;SMURF2;FOXC1;GATA6;PPM1A;ZBTB4;NR6A1;FOXC2;GLI3;NFATC4;WWOX;MYB;MBD2;PARP9;NEDD4;LDB2;HIVEP1;CRY2;DACT1;BMP2;CRY1;APBB1;MIER3;BCOR;AEBP1;UXT;MTDH;GLIS3;GZF1;SALL1;OTP;ZNF3;MIER1;TPR;WWC2;NR1H3;FOXP3;HDAC4;PPARA;CREBBP;RARB;GLIS2;NSD1;USP9X;DPF2;STAT1;CDC73;SKI;MEF2A;ZNF25;VPS72;CUX1;ZFP37;YAP1;ZEB1;SAP130;DLG1;EPC1;IGF2;SUMO1;GATAD2B;CREM;E4F1;NUPR2;TAF7;SUFU;WWP2;CUX2;PPID;CIR1;CBX7;FNIP1;SMAD4;MAP2K5;RTF1;ATN1;FOXO3;IFI27;ZNF219;THAP1;NOG;EFNA1;BPTF;NFIC;CBX4;MZF1;BHLHE41;NR3C1;PEX2;PAF1;HIC1;ARID5B;ZNF205;PRDM5;MDM4;TLE6;FRK;VHL;ZBTB21;HDAC2;RARA;SMARCA4;ACVR2B;PER3;KDM2B;DAB2;POU5F1;ELK4;CPEB3;JDP2;URI1;SMAD2;POU6F1;TBL1X;ZBTB5;DNMT3A;NIPBL;RNF2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.577206796607154,1.4055743844541284,0.10488245931283906,0.5772098193598449,1.0,3/15,6.32%,EIF2AK2;TLR4;GBP5
prerank,camera-type eye development (GO:0043010),0.5102549118556781,1.4053375167002922,0.10261194029850747,0.5760679480187177,1.0,6/25,11.37%,EFEMP1;FBN1;SHROOM2;SKI;CACNA1C;NES
prerank,cellular response to interferon-gamma (GO:0071346),0.40659578344483654,1.4053318965804957,0.04252199413489736,0.5741607666311791,1.0,27/88,16.20%,GBP6;SP100;GBP2;DAPK1;TLR4;TRIM5;VCAM1;GBP5;CD47;OASL;GBP4;STAT1;CCL2;LGALS9;WNT5A;GBP7;TLR2;OAS2;TRIM21;TRIM26;JAK1;SLC26A6;CCL25;PML;IRF9;ICAM1;GBP3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4577607315686561,1.4053230764278566,0.0847457627118644,0.5722792593118533,1.0,9/39,8.62%,ROBO1;TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;CREBBP;YAP1
prerank,positive regulation of tissue remodeling (GO:0034105),0.6327929526419479,1.4047110182709042,0.10721649484536082,0.572493325650097,1.0,2/10,7.50%,ROCK2;IL18
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5557728065843419,-1.404581744586608,0.09071274298056156,0.44809252818537176,1.0,6/13,16.14%,PDE8A;MET;RACK1;PARK7;NR4A3;GPR37
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5583952929060829,-1.4036362313043993,0.1023454157782516,0.44907153292238183,1.0,6/12,12.97%,CSGALNACT1;FUT8;GFPT2;PARG;GFUS;GFPT1
prerank,phospholipid transport (GO:0015914),-0.4035198024784562,-1.402238712505221,0.07756232686980609,0.45100640036011036,1.0,16/52,14.19%,ATP8A1;ATP10A;ATP11B;PITPNC1;PITPNA;ABCA3;ATP8A2;ATP11A;ATP8B2;SCARB1;PRELID2;PRELID1;ATP8B1;SCARB2;MFSD2A;TMEM30A
prerank,protein ubiquitination (GO:0016567),0.3364595394087623,1.4020781932548572,0.003374578177727784,0.5795288276912793,1.0,103/471,15.52%,RNF220;PDZRN3;SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM10;HIF3A;HERC6;RNF217;FBXO11;FBXL17;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;EPAS1;MYCBP2;BCL2;TRIM17;RNF19A;KLHL21;KLHL22;UBE2U;SPSB4;DTX1;DZIP3;SIAH2;CUL4A;PELI2;TRIM5;DTX3L;FBXO9;MGRN1;NPEPPS;ANAPC11;USP9X;RNF20;CDC73;FBXL3;WAC;FBH1;TRIM24;KLHL18;NUB1;PSMB10;RNF111;AMFR;UBE2Z;PJA2;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO4;PSMA5;WWP2;FBXO24;KEAP1;BLMH;HUWE1;UBE2V1;RFWD3;RTF1;CUL3;KLHL13;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;ASB5;ARRB1;PEX2;PAF1;CDC27;PRPF19;RNF39;BFAR;RNF43;RNF103-CHMP3;LNPEP;RNF181;FBXL4;DDA1;LEO1;BRAP;RCHY1;VHL;BIRC6;UBE2R2;FBXL13;FBXL12;RNF146;MUL1
prerank,response to hexose (GO:0009746),0.5113775066222943,1.4015595772850804,0.08571428571428572,0.5793217795473342,1.0,2/25,2.03%,TCF7L2;APOA2
prerank,positive regulation of cell growth (GO:0030307),-0.3528526818610961,-1.4014478944842779,0.017094017094017096,0.45139499397870597,1.0,28/96,15.43%,SYT1;RIMS1;RIMS2;AKAP6;TGFB2;SEMA4D;H3-3A;MACF1;SEMA7A;AKT1;SDCBP;DDX49;SHTN1;SYT4;L1CAM;NEDD4L;DBNL;EXOSC2;ZFYVE27;RPS6KA1;EGFR;NGF;CEP43;MFSD2A;SYT2;TAF9B;LGI1;MAPT
prerank,protein deneddylation (GO:0000338),-0.594625984796178,-1.4009981907070392,0.09090909090909091,0.45079729031509996,1.0,6/10,30.84%,COPS6;COPS5;COPS2;GPS1;COPS4;TOR1A
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.4354785855944525,-1.400904402427886,0.07804878048780488,0.4493177542963914,1.0,8/32,8.65%,RIMS1;RIMS2;MEF2C;MCTP1;CPLX1;SLC30A1;CAMK2A;SYN1
prerank,eye development (GO:0001654),0.4366911462126744,1.4007667606658574,0.05592105263157895,0.5800110688995948,1.0,11/54,10.06%,EFEMP1;FBN1;COL5A2;FOXC1;SHROOM2;RBP4;COL5A1;SKI;CACNA1C;MAB21L1;PBX1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5684993703059016,1.4002277805924297,0.09872029250457039,0.5799444805739736,1.0,7/16,17.01%,LEPROT;PARP14;PTPN2;SH2B3;VHL;NF2;PPP2CA
prerank,cellular response to sterol (GO:0036315),0.6006058338053426,1.3975821101019126,0.10566037735849057,0.5867556888593788,1.0,2/13,0.60%,RORA;GRAMD1C
prerank,organic anion transport (GO:0015711),-0.3697855041232798,-1.39454088731133,0.027624309392265192,0.4647040126914335,1.0,22/76,17.23%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO1C1;SLCO2A1;CA4;CA2;LRRC8C;SLC52A3;SLC22A6;SLC25A42;SLC35B1;CYB5R1;CYB5RL;SLC35A2;SLC4A7;SLC39A8;SLC25A19;SLCO4A1;ABCC5;SLC52A2
prerank,gliogenesis (GO:0042063),-0.5332148480067339,-1.3942762824713166,0.07707910750507099,0.46371978503959227,1.0,6/15,14.20%,CDH2;TGFB2;CDK6;PAX2;NFIB;RELN
prerank,triglyceride catabolic process (GO:0019433),-0.4876809264378947,-1.3939625527095802,0.10262008733624454,0.4628428451811262,1.0,9/19,42.11%,LPL;PNPLA3;LIPH;FABP3;LIPC;FABP4;FABP7;FABP12;FABP5
prerank,heart process (GO:0003015),-0.5485999591962222,-1.3934431382832344,0.09782608695652174,0.46258517163721313,1.0,4/14,14.97%,SGCZ;SGCD;ACE;SOD1
prerank,cellular defense response (GO:0006968),0.4691815398398337,1.3931299479369799,0.07802547770700637,0.5996248556180215,1.0,6/40,9.32%,DCDC2;PRF1;CCR9;ADORA2A;LY96;LSP1
prerank,neurotransmitter uptake (GO:0001504),0.6004837022286561,1.392441806202325,0.12570356472795496,0.6000115436592569,1.0,6/12,18.30%,ATP1A2;SLC1A3;GLUL;SLC38A1;SLC22A2;SLC29A1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.444693751855116,1.3921922583814934,0.06825938566552901,0.5989723475660053,1.0,7/47,3.37%,PDPN;DOCK5;TACSTD2;KANK1;NRP1;FBLN1;S100A10
prerank,regulation of defense response to virus by host (GO:0050691),0.4827367720232671,1.3920860819289727,0.08094435075885328,0.5974144647889249,1.0,9/30,15.52%,PARP9;PTPN22;RNF216;DTX3L;STAT1;IFNLR1;TARBP2;IL23R;MUL1
prerank,focal adhesion assembly (GO:0048041),-0.485865138365942,-1.3919642958788148,0.10227272727272728,0.464893409702406,1.0,9/21,11.94%,ACTN1;PTPRK;THSD1;PEAK1;TESK2;RCC2;TRIP6;BCR;ARHGEF7
prerank,regulation of osteoclast differentiation (GO:0045670),0.47577199409105964,1.3919114204660537,0.07705779334500876,0.5961299792312432,1.0,7/33,12.03%,FBN1;FSTL3;PRXL2A;TLR4;CARTPT;MAFB;CSF1
prerank,acylglycerol metabolic process (GO:0006639),-0.41151052395551896,-1.391358137459205,0.06852791878172589,0.46478592860142315,1.0,12/37,17.57%,DGKB;DGKI;DGKH;MGLL;ABHD2;SEL1L;DGKZ;CAV1;DGKG;ABHD6;PLAAT3;LPL
prerank,basement membrane organization (GO:0071711),0.5683562434641874,1.3904481194455576,0.111328125,0.5992798681563557,1.0,3/14,2.53%,FLRT2;NID1;NID2
prerank,T cell differentiation (GO:0030217),0.4606692906200692,1.3903377303725424,0.0627062706270627,0.5977483537216255,1.0,7/40,6.52%,LEPR;GLI3;NHEJ1;ANXA1;KIT;PTPN22;PTPN2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4847376009803965,-1.3899368177968274,0.09151785714285714,0.46694790569281397,1.0,10/20,23.47%,NLGN1;SHANK3;CAPRIN2;LRP8;DBNL;RELN;SHANK1;LLPH;CAPRIN1;FOXO6
prerank,anion transmembrane transport (GO:0098656),0.42001252660738214,1.389612819474541,0.05972434915773354,0.5984100654303007,1.0,8/67,3.91%,SLC7A2;SLC1A3;SLC13A3;SLC6A13;SLC13A4;SLC19A1;SLC6A9;SLC16A12
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.40250725028269807,1.3889297861738983,0.05300859598853868,0.5987301088991113,1.0,21/87,12.25%,TGFBR3;SMAD3;ZMIZ1;COL3A1;BMPR1A;CDH5;TWSG1;LRRC32;PARD6A;PRKCZ;TGFBR1;APPL2;TGFBR2;USP9X;SKI;SMAD6;APPL1;PTK2;TGFBRAP1;SMAD4;MAP3K7
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5311490622911005,1.3880322696814007,0.10074626865671642,0.6000203433424671,1.0,4/21,3.43%,IGFBP5;GJA1;BMPR1A;ADAMTS1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5955263085066107,1.3875142966685778,0.11764705882352941,0.5998379653708015,1.0,3/12,10.49%,PLEKHH2;LIMA1;PLEK
prerank,cristae formation (GO:0042407),-0.4376978719809439,-1.3874349531199264,0.09200968523002422,0.47207515034052383,1.0,15/27,31.80%,ATP5F1A;ATP5MC1;ATP5PO;SAMM50;ATP5F1B;ATP5PD;ATP5F1D;UQCC3;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF;LETM1;CHCHD3
prerank,positive regulation of biosynthetic process (GO:0009891),0.46106679506068876,1.3873614933551657,0.08493589743589744,0.5985188622752362,1.0,8/40,9.14%,ZBTB20;WNT4;VIM;SORBS1;TLR4;CREBL2;PPARA;SIRT4
prerank,inositol phosphate metabolic process (GO:0043647),-0.41076007796902675,-1.387306766427164,0.05660377358490566,0.4707846230416818,1.0,14/46,15.75%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;FGF2;PLCH1;PPIP5K2;PPIP5K1;PLCG1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5645424190747677,1.387262115378544,0.1157495256166983,0.5951738109537313,1.0,3/16,2.25%,PHLDB2;ARHGAP6;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5645424190747677,1.387262115378544,0.1157495256166983,0.5951738109537313,1.0,3/16,2.25%,PHLDB2;ARHGAP6;DLC1
prerank,cardiocyte differentiation (GO:0035051),0.6227364672166761,1.3872052376840782,0.1266294227188082,0.5934773678978602,1.0,3/10,3.95%,AKAP13;GATA6;BMP2
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4588807057537201,-1.387071799536647,0.08747044917257683,0.4696720562629768,1.0,10/25,14.81%,PDE4D;PDE4B;PLCG2;RPS3;MALT1;CD80;CD86;RUNX1;PNP;PTPRC
prerank,hippo signaling (GO:0035329),0.4972983078002169,1.3867033786726122,0.10301953818827708,0.5933120119058366,1.0,12/26,17.61%,TEAD1;AMOTL1;LATS2;DCHS1;TEAD2;STK3;YAP1;TJP1;STK4;WWTR1;YWHAE;CASP3
prerank,skeletal muscle contraction (GO:0003009),0.5306983300425783,1.3866329138628501,0.0916030534351145,0.5917284174277933,1.0,1/19,0.28%,TNNC1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5525109688541512,-1.3853808613337237,0.112,0.4728114441997606,1.0,5/12,15.48%,INSR;SETX;SMCR8;ADRB2;IRGM
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3940689713008485,1.3853420889903894,0.05812220566318927,0.5941584121749142,1.0,19/86,10.73%,BMP6;TEC;VTN;EPHA7;GHR;OSM;IL11;NRP1;ITGA5;ANGPT1;IL6;PRKCZ;HAX1;TNFRSF14;RIPK2;IGF2;RAP2C;PTPN6;ENPP2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5460898028301105,1.3853077131251412,0.09026548672566372,0.5924768955674619,1.0,2/18,1.49%,ATP1A2;STK39
prerank,regulation of innate immune response (GO:0045088),0.42419188972273836,1.385135018677342,0.07401315789473684,0.5912245430111165,1.0,18/57,17.00%,USP18;FPR2;PARP9;IFI35;PTPN22;APPL2;GBP5;BIRC3;ERAP1;APPL1;PTPN6;POLR3F;IRAK3;TRIM21;PTPN1;MUL1;IFNAR2;RNF135
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5171576335476328,1.3841008909130845,0.09566787003610108,0.5928553180723447,1.0,8/21,21.06%,SAMD4A;TUT4;PAN3;CNOT3;CNOT9;TUT7;PARN;PAN2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5132616958820531,1.3837459305892055,0.10326086956521739,0.5922101376629275,1.0,3/23,4.73%,ZBTB20;PRKAA2;ARNT
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5951466408360168,1.3831306875909724,0.1276595744680851,0.5925324263931465,1.0,2/11,8.56%,PDK1;STK24
prerank,positive regulation of protein modification process (GO:0031401),-0.3089645006851383,-1.3823874128119777,0.00851063829787234,0.47915630954140737,1.0,50/203,13.77%,TEK;PECAM1;LIMCH1;ERBB4;LIMK2;PPP1R16B;EFNA5;PDE8A;TNIK;INSR;TFRC;KDR;VEGFC;NOS1AP;PAK1;TBX1;CSNK1D;NTRK2;CAMTA1;CALM1;GAS6;SEMA4D;CALM2;PTBP1;RAB3GAP1;PIK3R3;MAPK3;NPTN;CALM3;BMP4;AKT1;ACE;SYMPK;PINK1;ACVR2A;VEGFA;CCND1;FAS;CD74;LYN;RACK1;CD40;FGF2;EGFR;HSP90AA1;CSF1R;HRAS;RAC1;KRAS;PLAUR
prerank,neuropeptide signaling pathway (GO:0007218),-0.38011399067816287,-1.3819918771352047,0.042134831460674156,0.47869636343658556,1.0,17/58,20.75%,CPE;SORCS1;SORCS3;GLRA3;OPRM1;SORL1;RAPGEF2;CYSLTR2;NXPH2;CYSLTR1;PPY;SORT1;GPR37;GLRA2;GLRA1;GRP;PENK
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.37329591120193284,1.381606043504747,0.046413502109704644,0.5956903738672745,1.0,22/121,8.99%,BMP6;TEC;PARP14;VTN;GHR;IL31RA;IL6ST;OSM;IL11;NRP1;PARP9;ITGA5;IL34;ANGPT1;KIT;IL6;HAX1;IL18;TNFRSF14;RIPK2;EPHA4;IGF2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.42088858259693823,1.3794375883090255,0.06436420722135008,0.6009481449509908,1.0,20/62,17.39%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;POLR2C;IWS1;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;AFF4;GTF2H2;CDK13
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5995013803986529,1.3793999702495152,0.11363636363636363,0.5992345765610996,1.0,3/10,5.68%,PID1;ENPP1;APPL2
prerank,regulation of neuron migration (GO:2001222),-0.4637696594923863,-1.3791520368523231,0.0995260663507109,0.4850558857833517,1.0,15/26,23.89%,CTNNA2;SEMA6A;ADGRG1;DAB2IP;ARHGEF2;NEXMIF;RAPGEF2;SHTN1;CAMK2A;SEMA3A;SRGAP2;NTNG1;NTNG2;PLAA;NSMF
prerank,regulation of fatty acid oxidation (GO:0046320),0.5469332103897155,1.3790227340041843,0.0962962962962963,0.5987264194765973,1.0,4/16,9.14%,PRKAG2;APPL2;PPARA;SIRT4
prerank,phosphatidylserine metabolic process (GO:0006658),0.4751472804441964,1.3785264626066802,0.11262798634812286,0.598542556235343,1.0,4/32,5.16%,PLA1A;PLA2G4A;OSBPL8;MBOAT2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4088241877824194,1.3784693368857055,0.061933534743202415,0.5969358908190352,1.0,10/72,4.19%,ROBO1;LPAR1;AKAP13;KANK2;COL3A1;HEG1;DLC1;KANK1;NRP1;F2RL3
prerank,regulation of lipid metabolic process (GO:0019216),0.4023004994868699,1.3776271544171637,0.03281027104136947,0.5980939100917335,1.0,11/88,6.90%,RORA;CHD9;PRKAG2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PANK2;PPARA;CREBBP;LACTB
prerank,protein kinase B signaling (GO:0043491),-0.4624755539614209,-1.376863152672732,0.10337078651685393,0.48984678863604075,1.0,6/23,11.27%,KDR;SETX;GAS6;PIK3R3;AKT1;PAX2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4040105447642002,1.376411236578908,0.06470588235294118,0.6002581956076192,1.0,15/76,11.12%,UACA;SASH1;EIF2AK2;NFAT5;PPM1A;IFI35;TLR4;BMP7;PTPN22;CPNE1;LGALS9;PHB2;DLG1;PPM1B;TLR2
prerank,intracellular sterol transport (GO:0032366),0.5730763067966098,1.376374627449318,0.13533834586466165,0.5985971937081632,1.0,8/13,29.74%,NPC1;STAR;ABCA1;SERAC1;VPS4A;OSBPL2;ABCG1;STARD4
prerank,positive regulation of immune system process (GO:0002684),0.5690123600961037,1.3762498188796568,0.12248628884826325,0.5971963133366924,1.0,5/16,10.70%,RSAD2;ANXA1;MIA3;LGALS9;HCAR2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.42490033880878825,-1.3760376283620865,0.06481481481481481,0.4904352140025273,1.0,16/33,28.08%,MEF2C;THBS1;NOTCH1;ACVRL1;HMGB1;FGF2;KLF4;RGCC;DLL4;CARD10;VASH1;ANGPT2;ANGPT4;HDAC5;CSNK2B;PDCD10
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.4414675516018876,1.3755066816526338,0.07272727272727272,0.598030116019804,1.0,6/46,7.65%,TCF7L2;SMAD3;NEDD4;ZIC1;TPR;GSK3B
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.44642651845168385,1.3753967102322797,0.08401976935749589,0.5965933137518511,1.0,9/41,13.10%,AFDN;PLPP3;FSTL3;BMP7;CD47;TJP1;PTPRU;ADAM19;JAK1
prerank,stabilization of membrane potential (GO:0030322),0.5426532690248835,1.3753157207089253,0.11648745519713262,0.5951249553421668,1.0,1/16,0.04%,KCNK2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.40870855693607366,1.3750935324525515,0.06696428571428571,0.5940974426405863,1.0,10/75,3.88%,SULF1;COL4A3;WNT4;ROCK2;CXCL10;FOXC1;THBS2;HSPG2;ADAMTS1;DCN
prerank,cellular amino acid catabolic process (GO:0009063),0.39414914575017695,1.374834022829485,0.05743740795287187,0.5932176811632562,1.0,30/87,22.45%,HAL;DDO;SHMT1;HYKK;PHYKPL;NOS2;ALDH4A1;ASPA;ACADSB;HGD;GLUL;AMT;HNMT;BCKDHA;ABAT;BLMH;ACAT1;SARDH;ALDH6A1;HIBADH;ACAD8;MCCC1;CARNMT1;PRODH;DBT;ALDH7A1;HOGA1;HAAO;IVD;MCCC2
prerank,zinc ion transmembrane transport (GO:0071577),-0.47116717529866037,-1.3745054308268065,0.10208816705336426,0.49317115361709746,1.0,7/22,14.55%,SLC39A10;SLC39A6;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8
prerank,negative regulation of cell junction assembly (GO:1901889),0.5068369481201453,1.3743516771605495,0.09090909090909091,0.5929990305670362,1.0,4/25,2.25%,PHLDB2;ARHGAP6;ROCK2;DLC1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5978413608044664,-1.3727929835641994,0.1101871101871102,0.49635006477988663,1.0,4/10,8.95%,PTPRJ;SNCA;APOD;NDRG4
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4886746481887136,1.372641394309274,0.10434782608695652,0.5969320139413941,1.0,4/27,2.50%,FN1;PDGFRA;DDR2;S100A6
prerank,diol biosynthetic process (GO:0034312),-0.5086568200366146,-1.3721678247716398,0.11231101511879049,0.49629271863731605,1.0,3/15,10.31%,ACER3;ACER2;GCH1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5692510763989365,-1.371463639187117,0.13107822410147993,0.49652856285080577,1.0,4/12,9.05%,TGFB2;MBNL1;FBXW4;LRP6
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4108205029677635,-1.371174576511769,0.06467661691542288,0.4956245172487354,1.0,7/38,3.31%,KCNMB2;KCNMA1;AKAP6;KCNJ3;KCNJ2;NOS1AP;GABBR2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.45288126043290367,1.3710862459113222,0.1053484602917342,0.6002519904651934,1.0,7/38,10.31%,RORA;TLE1;PPM1A;STAT1;ZMYND11;NLRX1;PPM1B
prerank,regulation of lipid storage (GO:0010883),0.5072988630332462,1.3703622455280082,0.10301953818827708,0.6010411043338951,1.0,5/22,7.66%,IL6;IKBKE;PTPN2;CRP;FTO
prerank,protein import into nucleus (GO:0006606),0.4131669615861977,1.3701324192405582,0.07894736842105263,0.6002099794407897,1.0,13/66,12.15%,CBLB;PRICKLE1;TNPO1;RANBP2;APPL2;TPR;KPNA6;KPNA7;KPNA4;PHB2;APPL1;IPO7;EIF4ENIF1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.31250814154572915,1.3699984051433618,0.0,0.5989348163612586,1.0,347/1645,16.64%,TCF7L2;TCF4;CREB5;KMT2A;EFEMP1;RORA;ZBTB20;SOX5;TSHZ2;WNT4;ZKSCAN2;EBF1;FOXD1;SMAD3;PRICKLE1;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;ZMIZ1;NR2F2;SP100;ELF1;CREB3L2;TLE1;ARNT2;MLLT3;OSR1;IL31RA;TBL1XR1;TEAD1;SMURF2;FOXC1;NFIA;LBX1;STAT2;NFYC;NFAT5;TRIM56;PHIP;GATA6;SPIB;TCF24;WNT3A;KDM7A;MAF;HIF3A;RGMB;SAMD13;PPM1A;ZBTB4;ZNF395;DENND4A;SSBP2;NR6A1;FSTL3;ZIC2;SNX6;FOXC2;RBFOX2;GLI3;NFATC4;MYB;ZIC4;MBD2;ZMYND15;TRAK1;PARP9;TGFA;TCEAL7;FZD2;HIVEP2;IKZF2;TGFB1I1;PRRX2;EID2B;HIVEP1;CRY2;NUCKS1;HOXC6;PRDM11;ZBTB8A;HOXC4;PERM1;KIT;ZIC1;LITAF;BMP2;STAT5B;RFX3;CRY1;LOXL3;BRWD1;APBB1;CREB3L4;IL6;ZFP30;EPAS1;HLF;GLI1;BCOR;ARNT;BMP7;EN2;SIM2;ZNF276;UXT;MTDH;GLIS3;GZF1;NIF3L1;TGFBR1;NCOA6;SALL1;CBFA2T2;PRRX1;ZNF3;LBHD1;MGA;TCF12;KDM3B;KLF5;NSD3;BAZ2A;HDGFL3;SP9;ZNF35;CREB3L3;WWC2;NR1H3;FOXP3;ATP2B4;TESMIN;ANXA4;DTX3L;HDAC4;ZKSCAN4;CREBL2;PPARA;TCF7L1;TSHZ3;DKK3;PBXIP1;VGLL3;CREBBP;GLIS2;PCGF5;NSD1;ZBTB37;ZBTB7C;POU1F1;SFR1;KLF9;HOXA2;CREBRF;RNF20;DPF2;STAT1;WAC;ARHGEF11;NEK4;ZSCAN21;QRICH1;MEF2A;ZMYND11;NFXL1;RNF111;CRLF3;PIAS1;PHB2;ZNF25;TEAD2;ATF7;BAZ1B;CUX1;WNT5A;ZNF182;ZFP37;SP8;YAP1;ZEB1;CCNH;KAT6B;RLF;EPC1;IGF2;ZNF394;NAA16;ELF4;MNAT1;ZBTB3;USP47;SCMH1;SUMO1;CREM;SMAD6;TOX4;HDGFL2;SP110;E4F1;EBF4;JARID2;SOX21;NUPR2;BRD4;PBX1;RFXANK;TAF7;SUFU;MAFB;MSC;CDK16;MAPK14;PSPC1;WWP2;CUX2;GMNN;BAZ1A;ATF7IP;HEYL;ZNF292;UBE2V1;CIR1;POLR3F;ZNF235;TGFBRAP1;RRP8;NAA15;ELF2;RFXAP;TCF7;SMAD4;STAT4;SCML4;HIVEP3;BCL7A;EGR3;PPP3CB;ZNHIT3;FOXO3;NR4A1;ACTL6A;RBBP8;LHX9;ZNF219;VGLL4;ILF3;ZFAT;KDM5B;DVL3;EGR2;ZKSCAN7;OGG1;RPS6KA3;BTRC;SRCAP;THAP1;MAP2K1;HOXA10;FBXW11;BPTF;KDM2A;NFIC;MED12;CBX4;ARRB1;MZF1;BHLHE41;NR3C1;GMEB1;SERTAD3;MED20;PKNOX1;NRF1;NFE2L1;HIC1;ARID5B;POU2F1;ZNF205;KAT6A;BRWD3;ERCC6;PRDM5;KDM8;MDM4;NCOA2;SALL2;RBM15;DMTF1;RFX2;FUS;RUNX1T1;CARM1;VHL;NIBAN2;ZBTB21;ZNF569;ZBTB12;HDAC2;IFRD1;RARA;MAP3K2;PML;ZNF18;UIMC1;MAMSTR;ILK;SP3;ZFX;SETD5;ZNF383;HOXB4;TEF;SMARCA4;ACVR2B;SOX4;PHF20L1;IRF9;KDM2B;DNAJC2;VEZF1;LIN9;ERN2;POU5F1;ELK4;CTDSP1;ZNF260;JDP2;SMARCC1;URI1;DRGX;SMAD2;TRIM16;RING1;WWTR1;BCL11B;ZNF483;POU6F1;SPINDOC;NFATC2;TBL1X;PSRC1;CCAR1;ANKRD49;ZBTB5
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.45222388920183176,1.3699211004407392,0.09634551495016612,0.5975084671982641,1.0,9/41,10.99%,PTGS1;PLA2G4A;ACSL1;PLA2G4C;PTGR1;ALOXE3;SCP2;EPHX1;SCD5
prerank,lipid phosphorylation (GO:0046834),-0.5811480409865668,-1.3695970337850742,0.11482254697286012,0.49851007980152023,1.0,4/10,6.91%,DGKB;DGKI;DGKH;DGKZ
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4749326711540082,-1.3691945609682468,0.08409090909090909,0.4979345172224349,1.0,5/21,9.05%,FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC5
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6159246007704021,1.3690720142789585,0.13717693836978131,0.5986040614467125,1.0,3/10,10.73%,PLA2G4A;PLA2G6;ENPP2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.47158469550214194,-1.368042029515033,0.1074561403508772,0.49945181434792185,1.0,10/20,31.32%,GATM;OPLAH;GCLC;PLOD2;PTDSS1;GGT1;MTHFS;HAGH;MGST2;GCLM
prerank,regulation of ion transport (GO:0043269),-0.35789152329697943,-1.3678216634446256,0.05099150141643059,0.49836543627781493,1.0,23/76,14.85%,NKAIN2;SYT1;KCNJ3;KCNJ2;ANK3;SNCA;ATP1A1;NKAIN3;CA2;YWHAH;NKAIN1;SYT4;SYT7;SIK1;B2M;NEDD4L;NOS1;KCNJ6;KCNJ8;KCNJ15;SYT9;SYT2;KCNA2
prerank,anterograde axonal transport (GO:0008089),-0.4098192676066128,-1.36773039141101,0.07711442786069651,0.4968935695639103,1.0,13/37,17.02%,DLG2;KIF1B;KIF1C;RAB27B;AP3S2;KIF5C;MAPK8IP3;KIF3B;AP3B2;KIF5A;SOD1;SNAPIN;AP3D1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.48670553764065566,1.3674447570685522,0.11602209944751381,0.6022720853387692,1.0,9/26,18.62%,KANK2;CRY2;CRY1;STRN3;HEYL;SMARCA4;DAB2;CNOT9;CLOCK
prerank,protein export from nucleus (GO:0006611),0.48168520599824133,1.3670344745938932,0.11013986013986014,0.6019397683517196,1.0,10/27,21.85%,RANBP3L;TPR;DUSP16;EGR2;STRADB;RAN;RANBP17;STYX;XPO5;PKD1
prerank,positive regulation of histone methylation (GO:0031062),0.5189568883331052,1.3667713470148444,0.11538461538461539,0.6010294340438531,1.0,6/24,13.46%,KMT2A;AUTS2;MYB;JARID2;SMAD4;PAF1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.586022365103676,1.3660764515197594,0.13320825515947468,0.6015986254781163,1.0,4/12,14.75%,NR1H3;PPARA;CRP;ABCA1
prerank,cellular glucan metabolic process (GO:0006073),0.5949754399208553,1.365278613950649,0.12830188679245283,0.6025773069709283,1.0,3/11,9.08%,PRKAG2;GSK3B;PYGM
prerank,T-helper cell differentiation (GO:0042093),-0.5345399667828652,-1.3649964168503217,0.1134453781512605,0.5027594667536698,1.0,3/14,9.13%,LEF1;HMGB1;ZFPM1
prerank,somite development (GO:0061053),0.612181235580896,1.3645444575480161,0.12941176470588237,0.6032725555311756,1.0,5/11,19.05%,MTHFD1;LOXL3;IHH;PTCH1;MEOX2
prerank,calcium import into the mitochondrion (GO:0036444),0.6098156023985973,1.3636188473608792,0.14559386973180077,0.6045781486668492,1.0,2/10,1.57%,MCU;MICU1
prerank,regulation of cell killing (GO:0031341),0.553105712595612,1.3633665156348749,0.13786764705882354,0.6037191877694862,1.0,5/16,8.47%,CFH;CD55;IL11;NOXO1;WNT5A
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.580240517034581,-1.363194630008766,0.12655601659751037,0.5062858781196262,1.0,3/10,8.85%,CTNNB1;FZD3;VEGFA
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.49889541064325266,1.3629902089317172,0.11317254174397032,0.6032703798077155,1.0,9/26,19.50%,CBLB;SNX6;TGFA;ERRFI1;ADRA2A;SOCS4;APP;SHC1;HBEGF
prerank,embryonic organ development (GO:0048568),0.41626126279905784,1.3616467002601522,0.06346749226006192,0.6058427467988381,1.0,16/61,12.67%,KMT2A;RBPJ;TEAD1;BMPR1A;GLI3;RBP4;KIT;SALL1;RARB;TGFBR2;TEAD2;COL13A1;PBX1;NES;SH2B3;RARRES2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5045907442118523,-1.361584292354028,0.10633484162895927,0.5090769857080877,1.0,11/16,25.74%,ATP5F1A;ATP5MC1;ATP5PO;ATP5F1B;ATP5PD;ATP5F1D;ATP5F1E;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,development of primary male sexual characteristics (GO:0046546),0.4674254417924787,1.3605727264799996,0.09385665529010238,0.6077800830400916,1.0,5/34,3.83%,WNT4;GATA6;WNT2B;LHFPL2;KIT
prerank,negative regulation of phosphorylation (GO:0042326),0.3976990215422529,1.3601159875940427,0.060514372163388806,0.6075650832787278,1.0,13/85,9.29%,PTPN13;IGFBP3;PID1;PLPP3;NUPR1;DYNLL1;FBLN1;BMP7;HDAC4;PPARA;CDKN2B;MYADM;LRRK2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5586435712278744,-1.3594499205194153,0.1227364185110664,0.5134031704847106,1.0,5/11,13.77%,ANK3;PRKCQ;LYN;SYK;PLAUR
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3571258853805624,-1.3592274116315453,0.03978779840848806,0.5123021216426887,1.0,25/72,18.17%,SLIT2;SHANK3;SSH2;NAV3;KANK3;HSPA8;KANK4;SNCA;HIP1R;ARHGEF2;STMN2;EMILIN1;CYRIB;PFDN5;TUBB4A;FGF13;PFDN2;CLASP2;TWF1;MAP2;SSH3;SHANK1;PFDN4;MID1IP1;STMN1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3991013102560689,1.3579879645034139,0.07164179104477612,0.6126441496902257,1.0,14/72,13.74%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;POLR2D;KL;HNRNPH1;FGF18;FLRT1;POLR2C;NOG;SHOC2;POLR2F
prerank,positive regulation of cellular catabolic process (GO:0031331),0.37050361782855606,1.357954812193564,0.03299856527977044,0.611097450686182,1.0,27/132,12.92%,ZBTB20;RNF152;SH3D19;ZC3HAV1;PRKAA2;DACT1;DAPK1;DCN;RC3H1;NRDC;ARNT;MTDH;OPTN;TRIM5;DTX3L;PPARA;PIK3C2A;GSK3B;SNX9;MOV10;LRRK2;TPCN1;FOXO3;VGLL4;TRIM21;PTPN1;SUPV3L1
prerank,establishment of endothelial barrier (GO:0061028),-0.4307662608818104,-1.3578928409812792,0.08433734939759036,0.5144204281535459,1.0,13/29,18.44%,PDE4D;PECAM1;PPP1R16B;ROBO4;RAPGEF2;PDE2A;SOX18;RAPGEF6;F11R;TJP2;RAP1A;MARVELD2;RAB1B
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5736874093584221,1.3577893261959841,0.1222879684418146,0.6099685896458745,1.0,4/13,10.34%,PDPK1;FGFR1;IGF2;AKT3
prerank,intracellular pH reduction (GO:0051452),-0.4204627677908714,-1.3573221007828786,0.06744186046511629,0.5143950187758856,1.0,13/33,21.48%,ATP6V0A1;CLCN3;ATP6V1B2;ATP6V0C;RAB38;DMXL2;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4490144321522747,1.3571724256634115,0.11734693877551021,0.6102643697833104,1.0,9/40,12.67%,GBP6;GBP2;IL6;CRP;GBP4;TNFRSF14;GBP7;TLR2;RARRES2
prerank,regulation of lipid kinase activity (GO:0043550),-0.5674546077217986,-1.3571223885921555,0.12943632567849686,0.5132086737638667,1.0,6/11,23.09%,PIK3R1;PIK3R3;WDR81;RBL1;RBL2;PPP2R5A
prerank,granulocyte differentiation (GO:0030851),-0.49753294460067315,-1.3570491356631613,0.10580912863070539,0.5117108819982302,1.0,7/18,17.25%,LEF1;CBFA2T3;TAL1;CDK2;CDKN1A;CDK4;RXRA
prerank,regulation of Wnt signaling pathway (GO:0030111),0.37414165433358343,1.3568132030554043,0.05916305916305916,0.6097494019756383,1.0,23/108,13.86%,SULF1;WLS;DCDC2;TLE1;KANK1;PTK7;WWOX;APCDD1;DACT1;BMP2;TERT;SALL1;FOXP3;TCF7L1;CDC73;SKI;LRRK2;NKD1;TLR2;VGLL4;BTRC;HIC1;RNF43
prerank,regulation of fibroblast proliferation (GO:0048145),0.4335285138055276,1.355812895111,0.09060955518945635,0.6112862764305654,1.0,9/45,8.47%,FN1;PDGFRA;DDR2;S100A6;MORC3;PARP10;CDC73;SKI;WNT5A
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.5097896813003632,1.3554740020054858,0.11785714285714285,0.6107345093428354,1.0,2/20,4.06%,WNT4;CRY1
prerank,regulation of axon regeneration (GO:0048679),0.5737736369671232,1.3554723442757795,0.1381957773512476,0.6091023974300622,1.0,3/12,8.56%,PTN;EPHA4;STK24
prerank,oxoacid metabolic process (GO:0043436),0.4846635405075156,1.3554356972403303,0.12195121951219512,0.6076045812523436,1.0,11/27,21.00%,DDO;ENPP1;TPST1;LIPT1;THAP4;HAO1;SULT1A1;ABHD14B;GRHPR;SULT6B1;AGXT
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4371766166239228,-1.355108692942197,0.08775981524249422,0.5155005744432543,1.0,7/29,5.00%,DPP10;KCNAB1;FGF12;KCNIP4;HOMER1;KCNIP1;DPP6
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5266315264473357,1.3540629154676376,0.12730627306273062,0.6107353299220747,1.0,8/19,19.05%,NFAT5;NFATC4;PLCE1;NMUR1;PPP3CB;ADGRB2;NFATC2;NFATC3
prerank,membrane organization (GO:0061024),-0.2995911702695365,-1.3540567694369119,0.004524886877828055,0.5168125231128244,1.0,51/227,13.89%,DNM3;SGIP1;SGCZ;SYT1;RIMS1;HIP1;FNBP1L;HSPA8;TFRC;AMPH;CERT1;ACTB;SH3KBP1;REEP1;EPN2;CHRM2;ANK3;LPCAT2;ACTG1;HIP1R;ATP2C1;SH3GL2;SNX3;DYSF;FNBP1;GLTP;CCDC88A;ARPC3;ARPC4;ARPC2;NSFL1C;UBB;REPS2;LDLRAP1;VPS33B;CNTN2;M6PR;MFN2;SERP1;ARPC1A;CBL;ADRB2;SCARB2;NUP93;SYNGR2;EGFR;NAPA;FZD4;UBA52;SYT9;SYT2
prerank,prostanoid biosynthetic process (GO:0046457),0.5473428960827071,1.353607757902041,0.11517367458866545,0.6105577915824716,1.0,2/15,1.37%,PTGS1;PLA2G4A
prerank,negative regulation of anoikis (GO:2000811),0.5623142254043039,1.353293034784933,0.1275797373358349,0.6099737517978144,1.0,5/14,11.16%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5060743695569484,-1.353027079201106,0.1284796573875803,0.5181974104506969,1.0,6/15,13.20%,JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,cardiolipin metabolic process (GO:0032048),0.5709386877095659,1.351978217421035,0.13594040968342644,0.6127343163892429,1.0,5/13,19.80%,PLA2G4A;PLA2G6;PLA2G5;HADHA;SLC27A1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5641022943775198,1.3511430889598586,0.12429378531073447,0.6138952813661818,1.0,2/16,0.16%,RANBP3L;IGFBP3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5847781231442268,1.349782879035602,0.1749502982107356,0.616746857993178,1.0,2/11,2.08%,EFNB2;WNT3A
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5865957127502315,1.3497757666509056,0.15678776290630975,0.6119287152796448,1.0,5/12,13.47%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5865957127502315,1.3497757666509056,0.15678776290630975,0.6119287152796448,1.0,5/12,13.47%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5865957127502315,1.3497757666509056,0.15678776290630975,0.6119287152796448,1.0,5/12,13.47%,ANAPC11;ESPL1;CUL3;NSMCE2;CDC27
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.40320610905047466,-1.34949050111346,0.07894736842105263,0.5269640485946545,1.0,9/37,5.85%,CADM1;NLGN1;HMCN1;PTPRD;GRID2;TENM2;TENM3;IL1RAPL1;TENM4
prerank,negative regulation of protein polymerization (GO:0032272),-0.44323639184009406,-1.3490029416888802,0.10457516339869281,0.5266751716175093,1.0,14/27,20.11%,SLIT2;SSH2;KANK3;KANK4;SNCA;HIP1R;STMN2;CYRIB;TUBB4A;TWF1;MAP2;SSH3;STMN1;PFN2
prerank,regulation of stem cell differentiation (GO:2000736),0.38707821047673335,1.3484969803173268,0.0650887573964497,0.614327666713365,1.0,15/89,10.29%,KMT2A;PTN;PDGFRA;EIF2AK2;TACSTD2;BMPR1A;OSM;MYB;TCF12;SLC4A11;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,endocrine system development (GO:0035270),0.5020227783898001,1.348470284182086,0.14417744916820702,0.61282857810292,1.0,4/21,6.51%,WNT4;TGFBR1;SALL1;DKK3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5316105161206315,1.3480097823265458,0.16730038022813687,0.6127363950875402,1.0,6/17,12.68%,RBPJ;NOTCH2;BMPR1A;BMP2;HEYL;NOG
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.44456119157331914,-1.3479548105886476,0.09273182957393483,0.5278863199333016,1.0,12/26,18.17%,PLCG2;RYR2;HTR2C;RYR3;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;SLC8B1;HTR2A
prerank,lipid oxidation (GO:0034440),-0.5321439575580587,-1.347785901645208,0.12080536912751678,0.5266567431338258,1.0,1/12,0.45%,ADIPOR2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5268259926626991,1.347434797160979,0.13172541743970315,0.6129480630249836,1.0,7/18,13.10%,IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5285863238838773,1.3470294213162024,0.15037593984962405,0.6125837138334906,1.0,4/17,4.72%,EFNB2;ROBO1;NRP1;MIA3
prerank,positive regulation of signal transduction (GO:0009967),0.3387638622416686,1.3466609342106532,0.028534370946822308,0.6121432690822696,1.0,48/238,12.42%,SULF1;ROBO1;WLS;BMP6;TSPAN5;DCDC2;SASH1;RBPJ;ZMIZ1;VTN;FGF1;AXL;IL6ST;PHIP;GHRH;KANK1;BMP2K;NRP1;ITGA5;DACT1;BMP2;TERT;LOXL3;SORBS1;IL6;GLI1;ARNT;PRKCZ;AAK1;TGFBR1;SALL1;CREBBP;CDC73;LY96;SKI;BAX;YAP1;IGF2;LRRK2;CUX2;RAB34;TLR2;NLGN2;IHH;DSTYK;P2RY6;CCBE1;MAML2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6027171799446358,1.3466448270109685,0.12692307692307692,0.6106514398567181,1.0,6/10,24.66%,PRKCZ;IL18;LGALS9;RARA;SPHK2;GATA3
prerank,Rho protein signal transduction (GO:0007266),0.42714261003741943,1.3466109524030079,0.0998389694041868,0.6091922640527621,1.0,8/53,7.74%,ARHGAP29;PDPN;ARHGAP6;ROCK2;NTN1;CELSR1;NGFR;ARHGEF11
prerank,ATP transport (GO:0015867),0.612807391273625,1.3465421315510668,0.1460446247464503,0.6078303845177382,1.0,4/10,14.25%,SLC17A9;CD47;SLC25A24;SLC25A4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4949780819343965,1.3463917717682912,0.10369068541300527,0.6067916052177186,1.0,5/23,5.70%,UACA;PPM1A;IFI35;BMP7;CPNE1
prerank,axonal transport (GO:0098930),-0.4072310103655257,-1.345954355592868,0.0777479892761394,0.5304321913012566,1.0,16/36,26.45%,SYBU;KIF1B;DYNC1H1;AP3S2;TMEM108;KIF3B;AP3B2;SOD1;MAPT;SNAPIN;AP3D1;DCTN1;KIF4A;HAP1;NEFL;BLOC1S4
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5316257066594512,1.3446468350292342,0.16221374045801526,0.6107394090008603,1.0,7/16,12.97%,PDGFRA;NRP1;FER;PDGFRB;PIK3C2A;PTPN1;PLAT
prerank,polyol metabolic process (GO:0019751),-0.39312656450622235,-1.3445677065269175,0.07936507936507936,0.5326262645937104,1.0,13/46,15.75%,INPP4B;PLCB1;PLCB4;PLCG2;ITPKB;INPP5D;CALM1;IP6K2;IMPA1;PLCH1;PPIP5K2;PPIP5K1;PLCG1
prerank,intermediate filament organization (GO:0045109),0.5304850862338907,1.3444390926088157,0.1470019342359768,0.6098892474741074,1.0,7/17,19.31%,VIM;DES;KRT9;EPPK1;BFSP1;DNAJB6;DSP
prerank,histone modification (GO:0016570),0.3720867883897132,1.3430024773261136,0.058823529411764705,0.6127518463384913,1.0,25/109,15.58%,EYA2;EYA1;TBL1XR1;MIER3;UBE2U;NSD3;BAZ2A;MIER1;HDAC4;CREBBP;NSD1;BAZ1B;KAT6B;HLCS;HUWE1;EYA4;ATXN7;BRD8;KAT6A;PRDM5;USP36;CARM1;RBM14;HDAC2;PHF20L1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3754335883484016,1.3429585945733138,0.04978038067349927,0.6113463994827241,1.0,18/104,7.91%,PDPK1;SMAD3;SMURF2;PPM1A;BMPR1A;FSTL3;NBL1;SNX6;LDLRAD4;TGFB1I1;PMEPA1;BMP2;WFIKKN1;TGFBR1;BCL9L;PPARA;TGFBR2;SKI
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4756210717478037,1.3424796892865891,0.12289562289562289,0.611186972463894,1.0,6/26,10.16%,FBN1;FSTL3;TLR4;CARTPT;PTPN2;MAFB
prerank,cardiac muscle cell action potential (GO:0086001),-0.4347596121642736,-1.3420718962451348,0.11358024691358025,0.5382323610105605,1.0,12/30,12.24%,DMD;ATP1B1;FGF12;KCNJ2;SCN1A;ATP1A1;SLC8A1;HCN2;CACNA1G;KCND3;CACNA1D;KCNQ1
prerank,regulation of angiogenesis (GO:0045765),0.3454222618162246,1.3419941251429468,0.04177545691906005,0.6112490324590277,1.0,29/192,8.47%,SULF1;PDPK1;COL4A3;ROCK2;SASH1;CXCL10;SP100;FGF1;ECM1;FOXC1;GATA6;THBS2;CEMIP2;HSPG2;CDH5;ITGB8;VEGFD;ANXA3;ADAMTS1;DCN;IL6;MTDH;SERPINE1;EPHA1;ATP2B4;CTSH;STAT1;GLUL;WNT5A
prerank,mRNA modification (GO:0016556),-0.45192143379917316,-1.3418501047661782,0.10491071428571429,0.5372072675194742,1.0,12/22,28.51%,PUS7;PUS3;VIRMA;ZC3H13;CBLL1;TRMT6;TRUB1;METTL8;TRMT10C;RPUSD2;METTL14;TRMT61A
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5418187661522302,1.34171234095653,0.13670411985018727,0.6106063464379148,1.0,4/16,5.23%,FOXD1;FGF1;BMP2;SALL1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3601349206978267,1.3413611519155035,0.04395604395604396,0.6102108516037565,1.0,32/158,14.54%,WLS;LPAR1;AKAP13;ECM1;GJA1;PPM1A;TRAF5;LITAF;CFLAR;IKBKE;ROR1;MTDH;GOLT1B;MIER1;PELI2;TRIM5;BIRC3;BST2;JMJD8;LGALS9;VAPA;RIPK2;ANKRD17;BRD4;UBE2V1;RHOC;MAP3K7;TRIM21;TIFA;TICAM1;ZDHHC17;TBK1
prerank,negative regulation of hormone secretion (GO:0046888),0.6070881011443339,1.340676094425819,0.15625,0.6108516844781949,1.0,3/10,2.68%,GJA1;OSM;IL11
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5701807337671797,-1.3405098149578731,0.12981744421906694,0.5394113586958839,1.0,5/11,25.16%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,nuclear transport (GO:0051169),-0.5020736789427,-1.3397677920908304,0.1353211009174312,0.5397549418268041,1.0,7/16,23.65%,NPM1;AAAS;XPO1;ANP32A;NXT1;RBM15B;BANF1
prerank,glycerolipid catabolic process (GO:0046503),-0.4721798674681559,-1.3381099658090265,0.13111111111111112,0.5430261152263117,1.0,5/19,5.90%,GPCPD1;MGLL;ABHD2;GDPD1;ENPP6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30851853322686706,1.3378412936628998,0.0,0.618219057903238,1.0,226/1082,16.61%,TCF7L2;TCF4;CREB5;KMT2A;RORA;BMP6;WNT4;SMAD3;RBPJ;ZEB2;ZMIZ1;NR2F2;CXCL10;SP100;ELF1;ELOF1;RGMA;CREB3L2;FGF1;PID1;AUTS2;ARNT2;MLLT3;OSR1;IL31RA;TBL1XR1;TEAD1;FOXC1;NFIA;NFAT5;TRIM56;PHIP;GATA6;SPIB;WNT3A;RGMB;CSRP3;PPM1A;BMPR1A;ZNF395;SSBP2;OSM;FSTL3;ZIC2;FOXC2;IL11;GLI3;WWOX;MYB;NCOA3;PARP9;CDK8;FZD2;LDB2;TGFB1I1;HIVEP1;PRDM11;HOXC4;ZIC1;DCN;LITAF;BMP2;STAT5B;RFX3;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;EPAS1;HLF;TLR4;GLI1;ARNT;BMP7;GLIS3;NIF3L1;TGFBR1;NCOA6;SALL1;LBHD1;TCF12;SERPINE1;KLF5;HAX1;NSD3;MLLT10;CREB3L3;NR1H3;FOXP3;ARF4;BCL9L;DTX3L;HDAC4;CREBL2;PPARA;CREBBP;RARB;POGZ;GLIS2;PCGF5;NSD1;POU1F1;SFR1;CREBRF;RNF20;IL18;DPF2;STAT1;WAC;ARHGEF11;SKI;CDKN2B;NEK4;ZSCAN21;QRICH1;MEF2A;RIPK2;RNF111;CRLF3;TEAD2;WNT5A;YAP1;RHOQ;CRTC1;KAT6B;RLF;EPC1;GLYR1;IGF2;NAA16;ELF4;CDK7;E4F1;UTP15;BRD4;PBX1;RFXANK;TAF7;PFKM;MAFB;TCEA1;ATF7IP;HEYL;MYSM1;UBE2V1;CDH13;TLR2;NAA15;ELF2;RFXAP;SMAD4;MAP2K5;HIVEP3;PPP3CB;FOXO3;NR4A1;CRTC3;ILF3;DVL3;EGR2;MAML2;RPS6KA3;BTRC;SS18;SERTAD2;MAP2K1;HOXA10;FBXW11;BPTF;TET2;NFIC;MED12;ARRB1;MZF1;NR3C1;BRD8;SERTAD3;WASL;NRF1;SENP1;ZNF462;POU2F1;KAT6A;THOC5;ERCC6;KDM8;NCOA2;SALL2;NCK1;TBK1;VHL;NIBAN2;THAP3;RBM14;HDAC2;RARA;MAP3K2;PML;EIF2AK3;ILK;SP3;HOXB4;SMARCA4;KAT2B;SOX4;DNAJC2;TXK;DAB2;VEZF1;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9;SMARCC1;SMAD2;TRIM16;WWTR1;BCL11B;NFATC2;TBL1X;PSRC1;ANKRD49
prerank,actin polymerization or depolymerization (GO:0008154),0.4178984111986902,1.3367220387574075,0.0825242718446602,0.6202923617540376,1.0,4/50,0.81%,GAS7;ARHGAP6;MICAL3;DIAPH1
prerank,myoblast fusion (GO:0007520),-0.5374189687708409,-1.3366446311288331,0.13692946058091288,0.5454981612427735,1.0,4/12,10.30%,ADGRB3;JAM2;KCNH1;NOS1
prerank,membrane depolarization (GO:0051899),-0.41861020911578556,-1.3359995572115764,0.08899297423887588,0.5457703195379774,1.0,13/32,17.85%,CACNA1E;CACNB4;SCN1A;SCN2A;CACNA1G;YWHAH;SCN8A;SCN9A;CAV1;P2RX7;SCN3A;CHRNA4;CACNA1A
prerank,regulation of GTPase activity (GO:0043087),-0.3031469168129958,-1.3358595477172346,0.02,0.544428870674905,1.0,46/177,15.18%,CHN2;DOCK9;PRKG1;FGD5;ITGA6;PLXNA4;EFNA5;BCAR3;EPHA5;DOCK10;NET1;LRCH1;NTRK2;SEMA4D;ADAP1;TBC1D30;CPEB2;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;CCL14;FGD6;RAPGEF2;RGS7;RCC2;ARHGAP15;RGS6;TMED2;ARHGAP27;RACK1;CAV2;CD40;DOCK8;ALS2;ARHGEF7;VAV1;RGP1;RAPGEF6;F11R;HRAS;AGRN;EVI5;SOD1;SNX18;CCL19
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5692384693840771,1.3357734722344135,0.15674603174603174,0.6218046337089013,1.0,7/12,16.18%,PARP3;PARP10;PARP12;PARP11;TIPARP;PARP16;TNKS2
prerank,regulation of osteoblast proliferation (GO:0033688),0.5189544080963175,1.3354648931603608,0.12921348314606743,0.6213430509289128,1.0,3/17,3.95%,EIF2AK2;NELL1;BMP2
prerank,regulation of chemotaxis (GO:0050920),0.46070968036947374,1.3348369265316584,0.11652173913043479,0.6216890392796709,1.0,5/30,6.52%,EFNB2;PDGFRA;MYCBP2;PDGFRB;PTPN2
prerank,phagosome acidification (GO:0090383),-0.44321390931785754,-1.3342315637048623,0.09932279909706546,0.5475599708172838,1.0,11/26,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5343309529877565,-1.3340999311303265,0.15450643776824036,0.5462148632926458,1.0,5/13,9.50%,PLCG2;TGFB2;SEMA7A;TGFB3;CD74
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.5839369064643488,1.3334674709618808,0.15487571701720843,0.6245895968376713,1.0,4/11,13.10%,IL6ST;STAT1;STAT4;JAK1
prerank,positive regulation of inflammatory response (GO:0050729),0.38427425956647754,1.3330116952367266,0.07591240875912408,0.6245432140566624,1.0,16/86,11.68%,IL16;NUPR1;IL6ST;OSM;IFI35;IL6;TLR4;ZBP1;SERPINE1;CREB3L3;CD47;IL18;SETD4;WNT5A;TLR2;NFKBIZ
prerank,microvillus organization (GO:0032528),-0.5250960372657709,-1.332889685954316,0.1431451612903226,0.5481876151147819,1.0,7/13,20.81%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5282512932930236,-1.3327826888600585,0.13606911447084233,0.5467687009769789,1.0,10/13,39.14%,NLGN1;EPS8;HRAS;FAM98A;PFN1;CARMIL2;PLEKHM1;NDEL1;EPS8L2;P2RY12
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5268326677234335,-1.3318569262006654,0.13417190775681342,0.5478892589046311,1.0,5/13,4.08%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1
prerank,Golgi localization (GO:0051645),0.585705334084206,1.3314402294097771,0.1606425702811245,0.6279715101174382,1.0,3/11,11.69%,ARHGAP21;UVRAG;ARCN1
prerank,regulation of muscle contraction (GO:0006937),0.4827433040879523,1.3307287182797307,0.12937062937062938,0.6286884045252472,1.0,4/26,5.56%,TNNC1;ATP1A2;TPM1;PLCE1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5129688002277328,1.330470027690068,0.13494809688581316,0.6279722399081697,1.0,2/19,0.82%,MCU;CAMK1D
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3963276039913871,1.329794969102817,0.06656101426307448,0.6286951367691279,1.0,11/67,6.10%,EFEMP1;TEC;PDGFRA;FGFR1;DDR2;GHR;EPHA3;FER;KIT;EPHA1;PDGFRB
prerank,regulation of cellular metabolic process (GO:0031323),0.4263011089444582,1.3296604244585835,0.09230769230769231,0.6276988263652836,1.0,7/45,6.94%,PID1;TBC1D16;PANK2;ARF4;MPV17;PPARA;SSH1
prerank,protein phosphorylation (GO:0006468),0.31903279249790806,1.329577652951422,0.012687427912341407,0.6264456294904737,1.0,114/479,15.93%,IGFBP3;PDPK1;PDK1;EFEMP1;TGFBR3;TEC;ROCK2;CAMK1D;NRK;PDGFRA;PRKAG2;FGFR1;STK32B;GRK3;FAM20C;STK39;DDR2;PRKAA2;OXSR1;EIF2AK2;TSSK3;INSRR;BMPR1A;EPHA3;BMP2K;EPHA8;FAM20A;FER;CDK8;KIT;DAPK1;BMP2;TAOK3;CRY1;IKBKE;TLR4;PRKCZ;TOP1;LATS2;MAP3K1;AAK1;TGFBR1;MORC3;MAPK6;EPHA1;PDGFRB;TGFBR2;MAP4K1;FAM20B;GSK3B;CCL2;NEK4;WNK4;MAP2K6;EPHA4;BAZ1B;STK24;STK3;SIK3;CCNH;LRRK2;PPP4R1;COQ8B;TLK2;CDK7;CDK12;MUSK;CDK16;MAPK14;AKT3;HIPK3;GRK5;PTPN6;TLR2;PTK2;IRAK3;PPP3CB;MAP3K7;ILF3;RPS6KA3;MASTL;DAPK2;MAP2K1;MAP3K13;STRADB;JAK1;SRPK1;MAPK9;GTF2H4;ACVR1C;WNK1;TRIB1;ALK;MAPKAPK5;TBK1;FRK;NUAK2;ABI1;BIRC6;RARA;CSNK2A2;EIF2AK3;RYK;ILK;LIMK1;CDKL3;STK4;ACVR2B;TXK;PKN2;PRKD2;ERN2;APP;IGF1R
prerank,negative regulation of cellular protein localization (GO:1903828),0.45833349505505605,1.3288455395772127,0.1270358306188925,0.6272210761770037,1.0,6/34,7.65%,LEPROT;ROCK2;LATS2;ACTN2;CTNNA1;GSK3B
prerank,inorganic cation transmembrane transport (GO:0098662),-0.2912291671613032,-1.3285468899611104,0.009900990099009901,0.5560004460599332,1.0,63/268,14.85%,SLC6A6;SLC12A2;KCNB2;KCND2;SLC9A2;KCNQ5;KCNAB1;KCNK5;TRPC3;ATP1B1;SLC24A2;ABCC9;KCNH7;KCNJ2;KCNC2;KCNQ3;SLC6A1;SCN1A;SLC40A1;HCN1;FKBP1A;GAS6;TRPC5;ATP1A1;TRPC4;SLC25A27;RYR3;ATP2C1;SLC8A1;KCNK10;SLC9A8;SLC39A6;HCN2;SCN2A;ATP2A3;CACNA1G;TRPC6;UCP2;KCNH1;TMEM175;ATP6V0C;KCNH5;SLC30A1;SLC39A14;KCND3;ATP5PO;CACNA1D;KCNB1;SLC36A1;SCN8A;KCNJ8;TMCO1;ATP5F1B;SCN9A;KCNQ1;SLC6A5;SLC39A13;ATP2A2;KCNC1;SLC6A11;SLC39A8;SLC9A5;KCNA2
prerank,positive regulation of type 2 immune response (GO:0002830),0.5537074628290023,1.3284792242216583,0.1358695652173913,0.6268877236842368,1.0,4/14,7.50%,RSAD2;IL6;PRKCZ;IL18
prerank,lipid homeostasis (GO:0055088),0.4138299111888575,1.3283083234208772,0.09580838323353294,0.6259871933224369,1.0,20/57,24.83%,ZBTB20;RBP1;PRKAA2;ACOXL;NR1H3;DGAT2;ABCA1;ABHD5;ACOX1;ANGPTL3;RCN3;XBP1;FBXW7;NR1D2;CEBPA;PRKAA1;TM6SF2;ABHD8;THADA;IRS2
prerank,protein localization to membrane (GO:0072657),-0.2975242522411654,-1.3280836211639415,0.007782101167315175,0.5555848382478115,1.0,47/187,14.15%,DPP10;NRXN1;NLGN1;DLG2;BSG;KCNB2;SHANK3;LRRC7;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;RFTN1;CPE;CDH1;KCNIP4;ITGA4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;RAB38;RAB3C;TM9SF3;TMED2;LRP6;RAMP2;DVL1;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;CAV1;RAB40B;F11R;AGRN;EHD4;CLASP2;ABHD17A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.4718260162562708,-1.3279520245738003,0.1301518438177874,0.5542937579027126,1.0,8/20,7.24%,DMD;ATP1B1;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,negative regulation of bone mineralization (GO:0030502),0.5573663953316402,1.3277656153731974,0.158203125,0.6261370606158022,1.0,5/13,13.77%,ENPP1;ECM1;BCOR;RFLNA;SRGN
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5229019650530318,-1.327497294865114,0.1402439024390244,0.5539965371911749,1.0,5/12,11.06%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,response to iron ion (GO:0010039),0.5676264220511577,1.3269436300970447,0.1537037037037037,0.627159770451162,1.0,4/12,12.58%,BMP6;BCL2;ACO1;HFE
prerank,microvillus assembly (GO:0030033),-0.5132134280409584,-1.326693208644424,0.14198782961460446,0.554627350993086,1.0,7/14,20.81%,TNIK;FXYD5;RAPGEF2;MINK1;RAPGEF6;RAP1A;STK26
prerank,regulated exocytosis (GO:0045055),-0.3031658261749332,-1.3266036185689711,0.01680672268907563,0.553149987796557,1.0,33/173,10.13%,PCDH7;ABCC4;VWF;PECAM1;SYT1;RIMS1;RIMS2;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;PCLO;SCG3;CALM1;RAB11FIP1;GAS6;SNAP25;SNCA;STXBP1;CYRIB;CDC37L1;RAB27B;CPLX1;STEAP2;A2M;SYT4;SYT7;VEGFA;TGFB3;CHID1;LYN;FAM3C
prerank,calcium ion homeostasis (GO:0055074),-0.3259967254371551,-1.326043315187392,0.04950495049504951,0.553075009743121,1.0,27/95,18.17%,TMTC2;ATP1B1;SLC24A2;RYR2;TPT1;HTR2C;SNCA;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;SLC30A1;SELENON;GRIN1;CXCL12;CALR;SLC10A7;CD40;TMCO1;CAV1;ATP2A2;CCL19;ATP13A4;HTR2B;SLC8B1;HTR2A
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4059010720532284,-1.3257939775187673,0.0783289817232376,0.5522325339299924,1.0,16/36,25.32%,ELMO1;THBS1;XKR4;XKR6;RHOG;MEGF10;DOCK1;RAC1;RHOH;RHOBTB1;FCGR1A;ITGB2;AIF1;BIN2;MSR1;ADGRB1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5227669206720095,1.3257006427489293,0.1596330275229358,0.6296393863414551,1.0,6/19,5.16%,TGFBR3;RBPJ;BMPR1A;RBP4;GLI1;TGFBR1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5889352561318884,1.325684069723032,0.1738241308793456,0.6281774896397229,1.0,2/10,4.23%,ADGRV1;IFT88
prerank,negative regulation of histone acetylation (GO:0035067),-0.564720356356228,-1.3256556995349016,0.15208333333333332,0.5509812093126115,1.0,5/11,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3093333658421236,1.3252744165029693,0.0021119324181626186,0.6280223896407574,1.0,179/807,16.50%,TCF7L2;FHL2;BMP6;WNT4;FOXD1;SMAD3;PRICKLE1;RBPJ;ZEB2;ZHX2;MXI1;ARID4A;ATXN1;KANK2;NR2F2;SP100;KCNIP3;PRDM6;TLE1;OSR1;TBL1XR1;SMURF2;FOXC1;GATA6;SAMD13;PPM1A;ZBTB4;NR6A1;ZIC2;SNX6;FOXC2;RBFOX2;GLI3;WWOX;MYB;MBD2;ZMYND15;PARP9;TCEAL7;LDB2;EID2B;HIVEP1;CRY2;PRDM11;DACT1;BMP2;RFX3;CRY1;LOXL3;APBB1;MIER3;BCOR;BMP7;AEBP1;UXT;MTDH;GLIS3;GZF1;SALL1;OTP;CBFA2T2;ZNF3;MIER1;TPR;WWC2;NR1H3;FOXP3;HDAC4;PPARA;TSHZ3;DKK3;PBXIP1;CREBBP;RARB;GLIS2;NSD1;USP9X;DPF2;STAT1;CDC73;SKI;MEF2A;ZMYND11;PHB2;ZNF25;VPS72;CUX1;WNT5A;ZFP37;YAP1;ZEB1;SAP130;KAT6B;DLG1;EPC1;IGF2;USP47;SCMH1;SUMO1;GATAD2B;CREM;E4F1;JARID2;NUPR2;TAF7;SUFU;PSPC1;WWP2;CUX2;PPID;GMNN;ATF7IP;HEYL;CIR1;CBX7;FNIP1;SMAD4;MAP2K5;SCML4;BCL7A;RTF1;ATN1;FOXO3;LHX9;IFI27;ZNF219;VGLL4;ILF3;BTRC;THAP1;NOG;EFNA1;FBXW11;BPTF;KDM2A;NFIC;CBX4;MZF1;BHLHE41;NR3C1;PEX2;PAF1;HIC1;ARID5B;POU2F1;ZNF205;KAT6A;PRDM5;KDM8;MDM4;RBM15;TLE6;RUNX1T1;FRK;VHL;NIBAN2;ZBTB21;HDAC2;RARA;PML;UIMC1;SP3;SMARCA4;ACVR2B;PER3;KDM2B;DAB2;ERN2;POU5F1;ELK4;CPEB3;MUC1;JDP2;URI1;SMAD2;RING1;POU6F1;SPINDOC;TBL1X
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.34523557021088547,-1.325086557134916,0.05089820359281437,0.551009632719057,1.0,26/70,24.51%,PSMC3;NCF2;MFSD6;PSMD14;PSMD3;B2M;CALR;FCER1G;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;FCGR1A;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1;SEC22B;PSMD11;PSMD8
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.560341649032464,1.3248572799209934,0.15294117647058825,0.6279857040991045,1.0,2/13,1.19%,ZMIZ1;ELOF1
prerank,protein monoubiquitination (GO:0006513),0.4455623148075445,1.3239404213975035,0.12162162162162163,0.6294892810455727,1.0,12/36,15.01%,KLHL22;DTX3L;MGRN1;RNF20;CDC73;WAC;HUWE1;CUL3;TRIM21;PAF1;LEO1;UBE2R2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5480314342274561,-1.3235985603485712,0.1422680412371134,0.5538871212804352,1.0,8/11,33.47%,FOXO1;FAS;CAV1;ATP6V0A2;ATP6AP1;TMEM199;ATP6V1A;ATP6V1G1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5851202227047643,1.32352900304588,0.17913385826771652,0.6292380303613518,1.0,1/11,0.23%,ENPP3
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.48712117720824566,1.3234051562569977,0.1166077738515901,0.6281493425473825,1.0,2/24,1.34%,LEPR;PID1
prerank,negative regulation of cation channel activity (GO:2001258),-0.42700614819665106,-1.323020323353341,0.12098765432098765,0.5540084583777249,1.0,11/26,25.23%,KCNAB1;FKBP1A;CALM1;CALM2;CALM3;SRI;CASQ2;GSTO1;GPR35;EPO;CBARP
prerank,blood vessel endothelial cell migration (GO:0043534),0.4918757978487226,1.3228249008888207,0.14990859232175502,0.6284921695225005,1.0,5/22,4.72%,EFNB2;ROBO1;CDH5;NRP1;MIA3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5609627860658206,1.32219163395846,0.15229357798165138,0.6289930411405049,1.0,3/13,5.16%,BMP6;BMPR1A;TGFBR1
prerank,regulation of lamellipodium organization (GO:1902743),0.5573179320226247,1.3218595252691305,0.15947467166979362,0.628629240951027,1.0,4/14,12.29%,PDPN;FER;CAPZB;EPHA2
prerank,actin filament network formation (GO:0051639),-0.5482737733980781,-1.3217877488538736,0.1282051282051282,0.5558788390560169,1.0,7/11,30.95%,ACTN1;PLS3;LCP1;FHOD3;CARMIL1;SPIRE2;CARMIL2
prerank,phospholipid translocation (GO:0045332),-0.4267015228671552,-1.3217280672417064,0.12385321100917432,0.5543654742617523,1.0,11/28,18.34%,ATP8A1;ATP10A;ATP11B;ATP8A2;ATP11A;ATP8B2;ATP8B1;MFSD2A;TMEM30A;P2RX7;ABCB4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5030391385992753,1.3216598032069344,0.15716753022452504,0.6278335531953759,1.0,5/20,7.50%,RSAD2;CD55;IL6;PRKCZ;IL18
prerank,positive regulation of interferon-alpha production (GO:0032727),0.505876050681184,1.3207658044793624,0.15539305301645337,0.6293923859639569,1.0,7/19,19.58%,TLR4;STAT1;RIPK2;IFIH1;TBK1;DHX36;SETD2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5567540229194298,1.319848051075231,0.14760147601476015,0.6308513772405125,1.0,7/13,17.54%,ENTPD7;RHOQ;LRRK2;EFL1;OPA1;RAN;GNAI3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4405096349210656,1.3195149404205295,0.11464968152866242,0.6303964746249685,1.0,10/37,10.26%,IL17D;IL6;ADCY7;TLR4;APPL2;GBP5;PPARA;NOS2;APPL1;MAPK14
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5961453178575322,1.319259109453934,0.19961612284069097,0.6296872597109299,1.0,6/10,29.20%,SETD4;SETD7;SETD2;SETD6;SMYD2;EHMT1
prerank,peptidyl-asparagine modification (GO:0018196),-0.4155857188331365,-1.3190702307536568,0.10436893203883495,0.5606715040468285,1.0,11/31,22.34%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;HIF1AN;DDOST
prerank,iron ion transmembrane transport (GO:0034755),-0.5588316688187384,-1.3187777187302856,0.1565040650406504,0.559893546773788,1.0,5/10,16.61%,SLC40A1;SLC39A14;SLC39A8;ABCC5;SCARA5
prerank,amino sugar metabolic process (GO:0006040),-0.5621122595340963,-1.318143391492047,0.1402061855670103,0.5601351645707925,1.0,4/10,12.97%,CSGALNACT1;FN3K;GFPT2;GFPT1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.4936621754619054,-1.3177654957092246,0.16289592760180996,0.5594997083049936,1.0,9/17,19.56%,SMAD7;CALM1;CALM2;INPP5K;CALM3;SPRED2;DDIT4;SPRED3;SPRED1
prerank,actin nucleation (GO:0045010),-0.45246850894703705,-1.317691526677386,0.12694877505567928,0.5580553152697949,1.0,7/21,13.20%,LMOD1;JMY;ARPC3;ARPC4;ARPC2;ARPC1A;WASHC1
prerank,regulation of hydrolase activity (GO:0051336),-0.34504886564962606,-1.3176882571129385,0.061946902654867256,0.5564295990248137,1.0,21/71,12.95%,CHN2;PRKG1;FGD5;PLXNA4;EFNA5;EPHA5;NTRK2;ADAP1;DAB2IP;ARHGAP44;RASIP1;RAB3GAP1;FGD6;ARHGAP15;CAMK2A;ARHGAP27;NOS1;SCARB2;VAV1;RAPGEF6;CAV1
prerank,endocardial cushion development (GO:0003197),-0.455986514587959,-1.3175495576367937,0.13023255813953488,0.5551857886708988,1.0,9/21,14.62%,NOS3;TGFB2;BMPR2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,digestive tract development (GO:0048565),0.45843484820497815,1.317115261681799,0.14213197969543148,0.6350535554929441,1.0,8/33,7.17%,GATA6;GLI3;KIT;GLI1;SALL1;CLMP;RARB;DNAAF1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.41295927909230057,-1.317111701879081,0.10632911392405063,0.5547278339969747,1.0,7/33,10.02%,DNM3;NLGN1;SYT1;AMPH;SNCA;NLGN3;SNAP91
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.40277468350944173,1.3170941037014925,0.10047846889952153,0.6336943759230497,1.0,20/64,17.39%,ELOF1;MLLT3;POLR2D;CDC73;CCNH;MNAT1;CDK7;CDK12;TCEA1;POLR2C;IWS1;RTF1;PAF1;POLR2F;GTF2H4;LEO1;MLLT1;AFF4;GTF2H2;CDK13
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.328901098733771,-1.3170120749505752,0.05362776025236593,0.5534125579993744,1.0,28/94,21.19%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;MAPK3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;UBA52;PSMA8;NOD2;PSME1;TOLLIP;IRAK1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,lipid catabolic process (GO:0016042),0.5115455191042866,1.3167547643956183,0.16396396396396395,0.6332773443227715,1.0,1/18,0.18%,PLA1A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.42253618165100054,-1.3165235716676669,0.11557788944723618,0.553218431643158,1.0,11/30,13.29%,FGF12;RYR2;KCNJ2;SCN1A;ATP1A1;GJC1;CACNA1G;NEDD4L;CACNA1D;KCNQ1;KCNE4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31596946334806714,1.3164477151641998,0.012429378531073447,0.6328421546740812,1.0,80/509,11.16%,TCF7L2;PDPK1;WLS;LPAR1;ROCK2;SASH1;AKAP13;FN1;SELP;PDGFRA;FGFR1;FGF1;AXL;ECM1;EIF2AK2;KSR1;NUPR1;NFAT5;DDX60;FAM110C;GAB2;GJA1;PPM1A;OSM;IL11;EPHA8;OSBPL8;FRS2;TRAF5;TGFA;KL;NEDD4;ADGRV1;ANGPT1;KIT;DCN;LITAF;BMP2;CFLAR;IFI35;IL6;IKBKE;ROR1;GSDME;TLR4;BCL2;MTDH;TGFBR1;GOLT1B;HAX1;CPNE1;MIER1;PELI2;PDGFRB;TRIM5;BIRC3;BST2;OASL;JMJD8;IL18;LGALS9;VAPA;RIPK2;PHB2;BAX;WNT5A;IGF2;ANKRD17;PIK3R5;MST1R;BRD4;DNM1L;FGF18;PTPN6;BCL2L1;UBE2V1;CDH13;TLR2;FNIP1;PTK2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5481235489060038,-1.3162972593143216,0.17291666666666666,0.5523129079220015,1.0,4/10,17.52%,SORL1;HSP90AB1;HSP90AA1;NAB2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5175342405255854,-1.3162162369100303,0.14912280701754385,0.5509863070871502,1.0,7/13,19.47%,ABHD2;ESR1;NR3C2;BMP4;CALCOCO1;PLPP1;ESR2
prerank,peptidyl-lysine modification (GO:0018205),0.37234028021619275,1.3159998809633748,0.07692307692307693,0.6329225942032719,1.0,27/99,16.54%,EYA1;SENP7;LOXL3;LOXL1;LIPT1;RANBP2;TPR;HDAC4;METTL21C;ETFBKMT;PIAS1;SIRT4;SUMO1;ESCO1;LOXL4;SENP6;SENP3;NSMCE2;EGR2;SENP1;POM121;IFIH1;P3H4;KAT2B;P3H3;ATPSCKMT;NUP37
prerank,positive regulation of developmental process (GO:0051094),0.3492568751840707,1.3159923634031252,0.054775280898876406,0.6315051440203034,1.0,36/164,15.52%,PHLDB2;SOX5;PTN;MCU;FOXD1;CCN2;FGFR1;SMURF2;GJA1;BMPR1A;NCOA3;DAG1;DCN;BMP2;BMP1;BMP7;CLASP1;PHLDB1;RALBP1;ADGRL1;WNT5A;SYDE1;TAPT1;DNM1L;ENPP2;DVL3;RPS6KA3;MAP3K13;RTN4;TLE6;ALK;VHL;NIBAN2;MIEF1;SHLD2;MUL1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5772794459973302,1.3158063780206797,0.1702127659574468,0.6306939759117844,1.0,4/11,6.93%,TGFBR3;BMP2;TGFBR1;TGFBR2
prerank,mesonephros development (GO:0001823),0.5736923006931048,1.3151569043210767,0.17647058823529413,0.6312712241444306,1.0,3/11,4.74%,FGF1;OSR1;BMP7
prerank,negative regulation of transposition (GO:0010529),0.5273785697464228,1.3145232950628378,0.16448598130841122,0.6319428290276676,1.0,3/16,8.80%,TUT4;PIWIL4;MOV10
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5906458523258032,1.3141325859447415,0.1718146718146718,0.631720977056593,1.0,3/10,4.73%,VTN;ITGA5;ARNT
prerank,regulation of signal transduction (GO:0009966),0.3414056215579223,1.3140090292707975,0.049399198931909215,0.6306840695934455,1.0,24/190,6.74%,SULF1;IGFBP3;RORA;DCDC2;SP100;ELF1;GRK3;IGFBP5;MPIG6B;CD55;FBXL17;IGFBPL1;NUCKS1;ZIC1;IGFBP6;GLI1;PLCE1;DTX1;ZDHHC3;FOXP3;TRIM5;TCF7L1;PTPN2;CREBBP
prerank,transport along microtubule (GO:0010970),0.5548277104692709,1.3138207794913566,0.1607843137254902,0.6298312811816315,1.0,7/13,23.84%,ARHGAP21;SPG11;APP;BORCS5;BAG3;CLIP3;COPG1
prerank,photoreceptor cell development (GO:0042461),-0.5056154426311142,-1.3132619793045284,0.14465408805031446,0.5579618789738245,1.0,6/14,16.59%,RORB;RP1;AHI1;VEGFA;MFSD2A;CEP290
prerank,lung development (GO:0030324),0.452921885653658,1.3131946316497194,0.12588652482269502,0.6303668864312407,1.0,6/33,7.17%,PDPN;FGF1;RBP4;LOXL3;ERRFI1;DNAAF1
prerank,inositol lipid-mediated signaling (GO:0048017),0.4123409488251171,1.3130100000272127,0.11326860841423948,0.6295643626112093,1.0,10/50,6.62%,PDGFRA;FGFR1;GAB2;ADAP2;PLCD3;PI4KA;PLCE1;PDGFRB;PLCB3;PIK3C2A
prerank,regulation of blood coagulation (GO:0030193),0.46531687217066414,1.3125304523670653,0.12169312169312169,0.6296872597109299,1.0,5/27,8.66%,TFPI;VTN;GP1BA;SERPINE1;SERPINE2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5291992357784074,-1.312011797055679,0.15268817204301074,0.5584836251223021,1.0,3/12,5.13%,AKAP6;CAMTA1;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5291992357784074,-1.312011797055679,0.15268817204301074,0.5584836251223021,1.0,3/12,5.13%,AKAP6;CAMTA1;PTBP1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.350385840916734,1.3113228473328193,0.06793478260869565,0.6321069677607217,1.0,20/150,6.10%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;FAM110C;GAB2;OSM;OSBPL8;FRS2;TGFA;KL;ANGPT1;KIT;MTDH;TGFBR1;HAX1;CPNE1;PDGFRB
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.46640980978931895,1.31112327206214,0.1520572450805009,0.6312821104844928,1.0,12/29,21.81%,SMAD3;TUT4;SNIP1;ADAR;TARBP2;ZC3H7B;SMAD2;HNRNPA2B1;PUM2;TUT7;PUS10;SRRT
prerank,ether lipid metabolic process (GO:0046485),0.5497407717851321,1.3110487638302697,0.1614678899082569,0.630132607530083,1.0,2/14,8.09%,AGMO;PLA2G6
prerank,clathrin coat assembly (GO:0048268),-0.4987859237522823,-1.3103721686800553,0.15734989648033126,0.5616294121094858,1.0,3/15,4.85%,SGIP1;HIP1;HIP1R
prerank,regulation of catecholamine secretion (GO:0050433),-0.4132299079325747,-1.309209001258874,0.10046728971962617,0.5634178504392686,1.0,13/29,26.68%,SYT1;SNCA;SYT4;SYT7;KCNB1;SYT9;SYT2;KCNA2;CHRNA4;SYT6;SYT10;SYT5;SYT17
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.401410709267204,1.3088942001149917,0.10136157337367625,0.6356041059621322,1.0,14/59,15.76%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;WNK1;TBK1;CSNK2A2;PRKD2
prerank,second-messenger-mediated signaling (GO:0019932),0.3844415987026986,1.3085413141481637,0.0930576070901034,0.635344678421273,1.0,13/82,9.48%,PDPK1;RCAN2;MCU;FPR2;ACKR2;CCR9;DGKD;RCAN1;PLCE1;NOS2;ACKR3;LRRK2;NMUR1
prerank,positive regulation of protein binding (GO:0032092),0.4075189761366363,1.308407521968462,0.12006079027355623,0.6344534436172526,1.0,21/56,17.86%,TCF7L2;VTN;WNT3A;DACT1;BMP2;TERT;DTX3L;SPPL3;GSK3B;RIPK2;STK3;AMFR;LRRK2;TRIM21;HFE;BDNF;STK4;APP;RAN;PPP2CA;LRP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.523369132538984,1.3077942285297646,0.14535901926444833,0.6350775716682193,1.0,2/17,0.82%,MCU;CAMK1D
prerank,long-term synaptic potentiation (GO:0060291),-0.4618356037974596,-1.3077736804834474,0.13646532438478748,0.5662350946776141,1.0,6/21,6.63%,SLC24A2;PTK2B;GRIN2A;SHANK2;GRIN2B;NPTN
prerank,entry into host (GO:0044409),-0.5128470279506109,-1.3077169652961278,0.1511879049676026,0.5647793581508304,1.0,6/13,15.88%,CDH1;MET;CTNNB1;CBL;PPIA;CBLL1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5748552580327756,1.3076039555920371,0.1693548387096774,0.6343232567737963,1.0,1/10,0.14%,KMT2A
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4439306817402717,-1.3072218983662864,0.13194444444444445,0.56467161233785,1.0,11/24,23.78%,MTHFR;MSRA;TXN2;GCLC;MTRR;SMS;CTH;ADO;MPST;AHCY;NOX4
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.30518612865320116,1.3071855005133586,0.004232804232804233,0.6342074315213988,1.0,167/834,15.89%,TCF7L2;TCF4;KMT2A;RORA;BMP6;SMAD3;RBPJ;ZEB2;ZMIZ1;NR2F2;CXCL10;ELF1;RGMA;FGF1;PID1;AUTS2;ARNT2;OSR1;TBL1XR1;TEAD1;FOXC1;NFIA;NFAT5;PHIP;GATA6;SPIB;WNT3A;CSRP3;BMPR1A;ZNF395;SSBP2;OSM;FSTL3;FOXC2;IL11;GLI3;WWOX;MYB;NCOA3;CDK8;LDB2;HIVEP1;HOXC4;DCN;LITAF;BMP2;STAT5B;RFX3;TERT;GABPB2;GABPB1;APBB1;CREB3L4;IL6;KMT2C;EPAS1;HLF;TLR4;GLI1;ARNT;GLIS3;NCOA6;SALL1;TCF12;SERPINE1;KLF5;HAX1;MLLT10;CREB3L3;NR1H3;FOXP3;ARF4;BCL9L;HDAC4;PPARA;CREBBP;RARB;POGZ;GLIS2;PCGF5;POU1F1;CREBRF;IL18;NGFR;DPF2;STAT1;CDC73;SKI;CDKN2B;ZSCAN21;MEF2A;RIPK2;RNF111;CRLF3;WNT5A;YAP1;RHOQ;CRTC1;KAT6B;RLF;EPC1;GLYR1;IGF2;ELF4;CDK7;CDK12;E4F1;BRD4;PBX1;RFXANK;TAF7;PFKM;TCEA1;HEYL;MYSM1;CDH13;TLR2;RFXAP;SMAD4;MAP2K5;PPP3CB;FOXO3;NR4A1;CRTC3;DVL3;EGR2;MAML2;RPS6KA3;SS18;HOXA10;BPTF;TET2;NFIC;MED12;ARRB1;MZF1;NR3C1;BRD8;WASL;NRF1;SENP1;ZNF462;POU2F1;KAT6A;NCOA2;LEO1;SALL2;NCK1;TBK1;THAP3;RBM14;HDAC2;RARA;SP3;HOXB4;SMARCA4;KAT2B;SOX4;TXK;DAB2;VEZF1;PRKD2;PKD2;POU5F1;ELK4;APP;TAF9
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.4690586216029885,-1.3065068632099686,0.1390593047034765,0.5651502586242467,1.0,8/19,18.00%,TEK;PTPRJ;KDR;MYOC;VEGFA;RAC1;COL16A1;PPM1F
prerank,negative regulation of gene expression (GO:0010629),0.32758615480763753,1.3055520461415089,0.03333333333333333,0.6379609763060183,1.0,66/302,16.02%,ROBO1;WNT4;PARP14;LGR4;ROCK2;RBMS3;SAMD4A;NOTCH2;PRKAA2;EIF2AK2;IGFBP5;SHMT1;PTBP3;BMPR1A;ITGB8;TWSG1;PARP9;TNRC6B;SLC24A3;SUZ12;DAPK1;BMP2;TERT;STOX1;PTPN22;IGF2BP1;SNX12;CPNE1;FOXP3;ATP2B4;NANOS2;NOS2;PARP10;DCP2;OPRD1;LGALS9;ANXA7;MYADM;TNRC6A;YAP1;MOV10;EPC1;NOCT;JARID2;TIPARP;WWP2;IGF2BP2;LRP3;EIF4ENIF1;ILF3;SLFN14;MAP2K1;DDX6;PTBP2;ATP2B1;TASOR;METTL16;SRGN;FLOT2;VHL;GIGYF2;EIF2AK3;KAT2B;APP;CNOT9;CPEB3
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4900409115481671,-1.3052798466793292,0.15274949083503056,0.5673096251820046,1.0,5/16,9.05%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST6GALNAC4;ST6GALNAC5
prerank,positive regulation of protein kinase activity (GO:0045860),-0.3107632468138556,-1.3051158186463525,0.043137254901960784,0.5662631176807138,1.0,42/148,16.16%,TNIK;GRM5;TGFB2;INSR;PTK2B;PAK1;CALM1;GAS6;SNCA;CALM2;EMP2;MMD;DAB2IP;HSP90AB1;RAPGEF2;PAK5;CCDC88A;CALM3;RASSF2;ACE;STK11;LRP8;CLSPN;VEGFA;MINK1;LCP2;BORA;ADRB2;ALS2;PAK3;JTB;SRCIN1;TTBK1;HSP90AA1;CSF1R;RELN;PTPRC;PAK4;CCL19;CDKN1A;IRGM;RAP1A
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5167979599496517,-1.3049607972257091,0.15889830508474576,0.5650936516420971,1.0,13/14,48.12%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;ERN1;CPSF7;NCBP1;CPSF4;NCBP2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5328961777351502,1.3039613214452441,0.16698656429942418,0.6415963660566812,1.0,4/14,14.08%,STK39;OXSR1;WNT5A;WNK1
prerank,body fluid secretion (GO:0007589),-0.49247202921033784,-1.303561913572615,0.15106382978723404,0.5675177447978519,1.0,4/15,12.79%,ERBB4;VEGFA;NPR1;PRLR
prerank,oligosaccharide metabolic process (GO:0009311),-0.3722853422026271,-1.3031151441715774,0.0962962962962963,0.5673216920116138,1.0,9/46,9.65%,ST6GALNAC3;ST8SIA4;FUT8;ST3GAL6;FUT9;ST8SIA6;ST6GALNAC4;ST6GALNAC5;NEU1
prerank,negative regulation of cell growth (GO:0030308),-0.31120360141417513,-1.302901051662183,0.04067796610169491,0.5663207385601657,1.0,25/121,11.76%,APBB2;SLIT2;PTPRJ;DIP2B;SMARCA2;TGFB2;BMPR2;DCC;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;CCN3;CAPRIN2;NDRG3;STK11;ING1;IP6K2;CCAR2;SEMA3G;RACK1;NPR1;FGF13;ULK1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5868714641496855,1.3025915821717868,0.17009345794392525,0.6444070522092911,1.0,2/10,1.96%,FN1;GATA6
prerank,neurotransmitter transport (GO:0006836),-0.33906517394542934,-1.302497690537025,0.07964601769911504,0.565871506529936,1.0,18/73,11.31%,NRXN1;SYT1;RIMS1;PPFIA2;HSPA8;LIN7A;PTPRN2;GABRA2;SNAP25;SYN3;SLC1A1;STXBP1;CPLX1;SLC1A2;SYN1;SNPH;DVL1;GAD2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4423086661901678,-1.301304359536157,0.13707865168539327,0.5677504020952792,1.0,8/22,13.39%,CALM1;CALM2;MRE11;CALM3;RASSF2;ACE;VEGFA;NEK10
prerank,regulation of smooth muscle contraction (GO:0006940),-0.45451271033542595,-1.3007374320587288,0.1331877729257642,0.5679105083294769,1.0,5/20,12.95%,KCNB2;CHRM3;CHRM2;ADRB2;CAV1
prerank,embryonic organ morphogenesis (GO:0048562),0.4258676321454617,1.3002389906446536,0.12559618441971382,0.6506014100921246,1.0,6/42,6.97%,EFEMP1;FBN1;PDGFRA;RBP4;HOXC4;DYNC2I1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5499322585425,-1.2994933008198268,0.13305613305613306,0.5699364165165374,1.0,2/10,8.00%,HMGB1;TNFRSF1B
prerank,positive regulation of insulin secretion (GO:0032024),0.4335093556728194,1.2990346896515534,0.13659359190556492,0.6530495261201542,1.0,7/36,13.27%,TCF7L2;MCU;RBP4;PLA2G6;NLGN2;PPP3CB;BAIAP3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.34126883672539726,1.2989824451244087,0.06649282920469361,0.6518260667796308,1.0,32/182,10.31%,ROBO1;WNT4;PARP14;ROCK2;RBMS3;NOTCH2;PRKAA2;BMPR1A;ITGB8;PARP9;TNRC6B;SLC24A3;BMP2;TERT;STOX1;PTPN22;OPTN;SNX12;CPNE1;ATP2B4;NOS2;PARP10;OPRD1;LGALS9;ANXA7;MYADM;TNRC6A;YAP1;MOV10;NOCT;TIPARP;WWP2
prerank,regulation of cell growth (GO:0001558),-0.2888901540984362,-1.2988740633320481,0.03619909502262444,0.5700757153441992,1.0,48/204,15.68%,APBB2;SLIT2;NRG3;PTPRJ;AKAP6;SMARCA2;TGFB2;BMPR2;TFRC;NET1;ADAM15;PPP2R1A;RERG;ACVRL1;SOX17;H3-3A;PRKCQ;CCN3;FAM107A;CAPRIN2;PAK5;AKT1;CAMK2D;NDRG3;CEACAM1;SDCBP;STK11;DDX49;ING1;IP6K2;SPOCK1;CCAR2;RACK1;KIF26A;NPR1;EXOSC2;RPS6KA1;BCAR1;EGFR;CEP43;MFSD2A;DCUN1D5;JADE1;TAF9B;PAK4;LGI1;CDKN1A;ENO1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3467072953193685,1.2984058092187962,0.05737704918032787,0.652381964740309,1.0,25/150,10.68%,PTPN13;IGFBP3;PDPK1;DEPTOR;PRKAG2;PID1;ENPP1;PLPP3;PPM1E;LDLRAD4;FBLN1;PMEPA1;ERRFI1;PRKCZ;EPHA1;MVP;PPEF2;MYADM;DTNBP1;LRRK2;SMAD6;GPD1L;TAF7;DNAJC3;PTPN6
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.48558229643401585,1.298371858664946,0.15780730897009967,0.6511211787152809,1.0,4/23,5.14%,MCU;DPP4;CAMK1D;C5AR2
prerank,bicarbonate transport (GO:0015701),-0.43929984356783225,-1.2983486987192328,0.12359550561797752,0.5701500474191593,1.0,8/25,14.55%,SLC4A10;SLC26A7;CA4;CA2;CYB5R1;CYB5RL;SLC4A7;SLC39A8
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5369335887854492,1.297848946002922,0.18198529411764705,0.65131035889342,1.0,6/15,13.96%,IL17D;IL6;TLR4;GBP5;APPL1;TICAM1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.46892240038723826,1.2978191252900428,0.13419117647058823,0.6500238565589436,1.0,10/25,20.26%,LSM1;SF3B3;DDX23;SLU7;SRSF4;TXNL4A;SCAF11;PRPF3;SNRNP40;KHSRP
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5848788627492807,1.2975078458657756,0.19615384615384615,0.6495983933578859,1.0,3/10,6.01%,IFI35;PTPN22;NR1H3
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5895362477290094,1.2974673185380374,0.18548387096774194,0.6483625335478039,1.0,5/10,17.01%,PARP14;PTPN2;SH2B3;NF2;PPP2CA
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5006229583019102,-1.2971515993561638,0.16738197424892703,0.5721256338195119,1.0,5/13,15.87%,ELOVL5;ELOVL7;TECR;TECRL;HACD3
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4965849657859317,1.296419474337793,0.16518650088809947,0.6504443170779033,1.0,4/20,5.16%,TGFBR3;RBPJ;BMP2;TGFBR1
prerank,receptor clustering (GO:0043113),-0.43034749996543165,-1.2960106964785578,0.15058823529411763,0.5740739095695694,1.0,5/27,3.73%,NRXN1;NLGN1;DLG2;LRRC7;ITGA4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.36935267278145045,1.2955062511735747,0.08695652173913043,0.6521304955832611,1.0,17/87,13.74%,FLRT2;FGFR1;FGF1;RBFOX2;FRS2;POLR2D;KL;HNRNPH1;CCL2;FGF18;FLRT1;POLR2C;EGR3;DSTYK;NR4A1;SHOC2;POLR2F
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4133069552351746,1.295324628547876,0.12479201331114809,0.6513718584593305,1.0,10/46,5.98%,ATRNL1;LAMC1;FN1;RADIL;PARVA;NRP1;FER;ANTXR1;LAMC3;EPHA1
prerank,peptide cross-linking (GO:0018149),0.47151345280588036,1.2951571148920362,0.1694290976058932,0.6505340254547208,1.0,3/25,3.54%,COL3A1;FN1;ANXA1
prerank,brain development (GO:0007420),-0.30798118136163183,-1.2950576751862148,0.04529616724738676,0.5753276935237973,1.0,24/136,9.11%,ADGRL3;ADGRL2;CNTNAP2;CTNNA2;ROBO2;SHANK3;CDH2;MEIS2;COL4A1;CNTN4;ZFHX3;PBX3;SHROOM4;GRIN2A;ADGRG1;APOD;RAB3GAP1;GRIN2B;SCYL2;RAPGEF2;SOX6;NDRG4;BAG6;GRIN1
prerank,gas transport (GO:0015669),-0.5563350569309897,-1.2949388533464046,0.14845360824742268,0.5741222088994965,1.0,3/10,11.57%,CA2;CYGB;IPCEF1
prerank,JNK cascade (GO:0007254),-0.38470943069144137,-1.2941554155801438,0.11401425178147269,0.574774188865087,1.0,13/40,19.11%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAP3K11;UBB;MAP4K3;MINK1;UBA52;NOD2;GPS1;IRAK1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5686831474508757,1.2940237493171,0.18452380952380953,0.6528301270772322,1.0,2/11,1.19%,ZMIZ1;ELOF1
prerank,membrane assembly (GO:0071709),-0.39636225480267745,-1.2934706594413128,0.10643564356435643,0.57526335713726,1.0,9/34,8.74%,NRXN1;NLGN1;PTPRD;RFTN1;ANK3;IL1RAPL1;EMP2;NSFL1C;NLGN3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3065157946491838,1.2927843420860452,0.016968325791855202,0.6553832466847739,1.0,109/497,16.47%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ARID4A;ATXN1;NR2F2;TLE1;SAMD4A;ENPP1;SMURF2;EIF2AK2;IGFBP5;GATA6;SHMT1;SAMD13;ZBTB4;ZIC2;SNX6;RBFOX2;GLI3;MYB;MBD2;ZMYND15;TCEAL7;EID2B;CRY2;PRDM11;DAPK1;BMP2;RFX3;CRY1;LOXL3;BCOR;BMP7;GZF1;SALL1;CBFA2T2;IGF2BP1;CDAN1;FOXP3;HDAC4;TSHZ3;NANOS2;DKK3;PBXIP1;GLIS2;DPF2;GSK3B;ZMYND11;PHB2;WNT5A;ZEB1;KAT6B;EPC1;USP47;SCMH1;SUMO1;JARID2;TAF7;PSPC1;WWP2;GMNN;ATF7IP;IGF2BP2;HEYL;CIR1;SMAD4;SCML4;BCL7A;TSPYL2;LHX9;ZNF219;EIF4ENIF1;VGLL4;ILF3;BTRC;FBXW11;DDX6;CBX4;BHLHE41;NR3C1;ARID5B;POU2F1;KAT6A;PRDM5;KDM8;RBM15;RUNX1T1;NIBAN2;ZBTB21;HDAC2;GIGYF2;RARA;PML;PDS5A;UIMC1;EIF2AK3;SP3;SMARCA4;ERN2;CNOT9;CPEB3;SMAD2;RING1;S100A11;SPINDOC
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.38773574628011764,-1.2926001572789934,0.11616161616161616,0.5761855579695665,1.0,14/39,14.03%,EFNA5;THBS1;ACER2;NOTCH1;ADAM15;MYOC;NEXMIF;SEMA3E;RCC2;AP1AR;SPOCK1;PTPRO;FZD4;ACTN4
prerank,homeostasis of number of cells (GO:0048872),-0.5320012882112043,-1.292304539941176,0.17970401691331925,0.5755152420050238,1.0,3/12,4.39%,NOS3;NOTCH1;CCN3
prerank,endothelial cell differentiation (GO:0045446),-0.5155926922399534,-1.2918679118555971,0.17255717255717257,0.5752027673064428,1.0,6/12,9.94%,TIE1;BMPR2;KDR;ACVRL1;SCUBE1;SOX18
prerank,neutral amino acid transport (GO:0015804),-0.4141069982191053,-1.2918067495453345,0.1542056074766355,0.5738400165888989,1.0,8/28,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,positive regulation of cell population proliferation (GO:0008284),0.31185937860044294,1.2917859713323996,0.022067363530778164,0.657274793041476,1.0,64/423,11.72%,TCF7L2;EFNB2;TGFBR3;BMP6;PTN;DPP4;LAMC1;RBPJ;FN1;PDGFRA;FGFR1;FGF1;PID1;DDR2;OSR1;IL31RA;IL6ST;PHIP;GHRH;WNT3A;GAB2;GJA1;BMPR1A;OSM;S100A6;IL11;FER;VEGFD;TGFA;IL34;PTHLH;BMP2;TERT;GLP2R;IL6;GLI1;BCL2;STOX1;TGFBR1;EPHA1;PDGFRB;HDAC4;BST2;CD47;TGFBR2;STAMBP;CTSH;IL18;STAT1;WNT5A;YAP1;IGF2;IL13RA1;DNAJA2;MST1R;GRK5;FGF18;PTPN6;CDH13;TJP1;PTK2;NES;DISP3;CUL3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.47585725517075667,1.2917183651255129,0.1592128801431127,0.6561620160900045,1.0,7/25,11.84%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,positive regulation of secretion (GO:0051047),-0.5311354306897533,-1.291649111154762,0.1630901287553648,0.5728206021597259,1.0,2/11,10.66%,ACSL3;NPR1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5623923284800513,-1.2915913124549683,0.17699115044247787,0.5699779561408279,1.0,6/10,27.44%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5623923284800513,-1.2915913124549683,0.17699115044247787,0.5699779561408279,1.0,6/10,27.44%,VLDLR;AP2B1;AP2A2;AP2A1;CLTA;AP2M1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4638518576311733,1.2910657844448417,0.15780141843971632,0.6568822288269155,1.0,7/26,13.83%,RSAD2;IFI35;PTPN22;NR1H3;PJA2;TLR2;RTN4
prerank,retinal metabolic process (GO:0042574),0.5462621277285764,1.2907136637726258,0.1814814814814815,0.656629200217666,1.0,4/12,14.80%,ABCA4;RDH10;BCO2;ALDH8A1
prerank,protein import into peroxisome matrix (GO:0016558),-0.5123306079110717,-1.2905885117824258,0.17311608961303462,0.5713247746606673,1.0,4/12,15.68%,PEX5L;PEX26;PEX10;PEX16
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.43499342332575375,-1.2896680239707492,0.1383495145631068,0.5725331232730791,1.0,11/24,18.17%,PLCG2;RYR2;HTR2C;RYR3;FGF2;PTPRC;ERO1A;CCL19;HTR2B;IBTK;HTR2A
prerank,cellular response to organonitrogen compound (GO:0071417),-0.31990091628330813,-1.2888727017557164,0.04501607717041801,0.5735157798435172,1.0,29/99,20.04%,SLIT2;MEF2C;AKAP6;ACTB;HCN1;CDH1;GABRB3;RYR3;SLC5A5;CTNNB1;INPP5K;HCN2;RAPGEF2;PDE3A;GABRB1;PDE2A;RRAGB;KCNQ1;GABRB2;CPEB4;HRH1;SPAAR;RAP1A;RRAGC;BRCA1;P2RX7;GLRA2;GLRA1;LAMTOR2
prerank,regulation of synapse maturation (GO:0090128),-0.5416656293591973,-1.288637800556394,0.1857707509881423,0.5726758516517799,1.0,3/10,5.14%,NRXN1;ARHGEF15;DAB2IP
prerank,smooth muscle cell differentiation (GO:0051145),-0.5203571236315033,-1.2885277483754904,0.1723404255319149,0.57150751877915,1.0,6/12,14.62%,MEF2C;MRTFB;BMP4;TMEM204;APLNR;HEY1
prerank,cell-substrate junction assembly (GO:0007044),-0.39990650726812316,-1.2883049513993077,0.1358313817330211,0.5706399246107228,1.0,12/33,11.94%,ITGA6;ACTN1;PTPRK;THSD1;PEAK1;ITGB4;LAMA3;TESK2;RCC2;TRIP6;BCR;ARHGEF7
prerank,neural crest cell development (GO:0014032),-0.3774897578700642,-1.288220931180107,0.10891089108910891,0.5694669426746678,1.0,12/44,10.34%,SEMA6D;CDH2;ERBB4;PHACTR4;TBX1;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,response to thyroid hormone (GO:0097066),-0.5009908897351544,-1.2874579200821132,0.17197452229299362,0.5701939218660049,1.0,5/13,11.06%,THRB;LMO2;CTSB;CTSS;CTSL
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5128615740606025,1.2872243635660863,0.177007299270073,0.6663315574826363,1.0,4/16,10.86%,SLX4;TOP2B;FANCM;CENPX
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5542108266903671,-1.286677857600064,0.17598343685300208,0.5708776615316915,1.0,4/10,7.81%,PDE3B;ACER2;NEXMIF;JAM3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5279954291735911,1.2866402782311306,0.1900369003690037,0.6668135499540687,1.0,3/14,15.91%,MOXD1;SLC5A7;SLC22A2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5166691600246555,-1.2863355344224376,0.18333333333333332,0.5704278686237321,1.0,12/13,48.12%,CSTF2;CPSF2;CSTF2T;CPSF1;CPSF4L;CPSF6;TUT1;NUDT21;CPSF7;NCBP1;CPSF4;NCBP2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.42649290161245623,1.2862462776532724,0.13050847457627118,0.6667538229425949,1.0,6/41,6.93%,TNNC1;TGFBR3;RBPJ;BMPR1A;TPM1;TGFBR2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.49362443331112493,-1.2855904555962114,0.17634408602150536,0.5711258826713849,1.0,5/14,15.75%,THBS1;ITGA4;CD40;RGCC;PLCG1
prerank,B cell receptor signaling pathway (GO:0050853),-0.40964006497482364,-1.2854784525605898,0.15990453460620524,0.5699900849213898,1.0,12/32,14.87%,MEF2C;PRKCB;PLCG2;RFTN1;PLEKHA1;BMX;CD38;BCAR1;SYK;PIK3CD;PTPRC;LAT2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4069499069244282,-1.2843509761293521,0.12910798122065728,0.5718827679758656,1.0,12/28,24.85%,NAV3;PAK1;RPS3;MET;FES;RAC1;MAPT;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,negative regulation of GTPase activity (GO:0034260),-0.43775218153106044,-1.2839544813592192,0.12293144208037825,0.5716092783708763,1.0,7/22,13.61%,LRCH1;CPEB2;DAB2IP;RCC2;TMED2;F11R;HRAS
prerank,regulation of gene expression (GO:0010468),0.29778833963726503,1.2836898291533934,0.007407407407407408,0.6735349536652869,1.0,170/903,14.69%,ROBO1;EFEMP1;RORA;BMP6;WNT4;PARP14;FOXD1;ROCK2;SMAD3;RBPJ;ATXN1;RBMS3;FN1;AFDN;WNT6;FGF1;PID1;PRDM6;TLE1;NOTCH2;PRKAA2;ARNT2;OSR1;FOXC1;NFIA;NFYC;AFF3;TRIM10;WNT3A;GJA1;PTBP3;ZBTB4;BMPR1A;ZNF395;DENND4A;SSBP2;CDH5;ITGB8;NELL1;MYB;PARP9;GCGR;SLC26A9;TNRC6B;SLC24A3;PRRX2;PRDM11;AHNAK;PTHLH;PERM1;ANGPT1;RC3H1;BMP2;PKP3;RFX3;TERT;APBB1;IL6;TLR4;BMP7;TRIM17;GZF1;STOX1;PTPN22;TGFBR1;IGF2BP1;NSD3;SNX12;CPNE1;BAZ2A;ZNF35;WWC2;FOXP3;ATP2B4;TESMIN;TRIM5;HDAC4;CREBL2;TCF7L1;NOS2;CRP;CREBBP;POGZ;PARP10;NSD1;CTSH;CLK4;POU1F1;NOVA1;RNF20;OPRD1;HNRNPH1;PDCD5;GSK3B;LGALS9;ZSCAN21;ANXA7;NFXL1;TEAD2;ATF7;MYADM;TNRC6A;WNT5A;ZFP37;YAP1;DTNBP1;KAT6B;MOV10;IGF2;TAPBP;NOCT;CREM;MUSK;FUBP1;SOX21;TIPARP;RFXANK;SUFU;MAFB;MSC;MAPK14;PSPC1;WWP2;CUX2;TDRD7;FGF18;IGF2BP2;UBE2V1;TLR2;LRP3;TGFBRAP1;TCF7;IHH;NFKBIZ;ADAM19;ZNHIT3;HNRNPH3;CSF1;ZNF219;ZFAT;TRIM21;OGG1;HFE;CRNN;THAP1;NOG;MAP2K1;TRIM26;PTBP2;MZF1;NR3C1;SERTAD3;MAPK9;METTL16;RNF39;HIC1;ZNF462;ZNF205;TICAM1;AFF1;PRDM5;NCOA2;USP36;FLOT2;DMTF1;PABPN1;FUS;CARM1;VHL;ZC3H7B
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5098159486869407,-1.2835727669971595,0.1735357917570499,0.5713241919913135,1.0,6/13,10.95%,COL4A1;KDR;CTNNB1;SEMA3E;VEGFA;NOTCH4
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5480550338369633,1.2835364450173128,0.21414538310412573,0.6726825596842991,1.0,7/11,20.22%,TPR;RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48398085883550857,-1.283370087517497,0.15040650406504066,0.5704581501608944,1.0,9/16,37.54%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,protein polyglutamylation (GO:0018095),-0.52219504501615,-1.2822623353403395,0.16024340770791076,0.5721551163732925,1.0,2/11,5.77%,TTLL7;TTLL5
prerank,regulation of multicellular organism growth (GO:0040014),0.5162896479921953,1.2806302421910603,0.17870036101083034,0.6807074187437535,1.0,7/15,18.81%,GHR;GHRH;STAT5B;GDF15;APP;STAT5A;PTCH1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3987230740152212,1.279643367361239,0.14261744966442952,0.682480241746407,1.0,12/51,12.67%,PTN;CXCL10;FPR2;VEGFD;IL34;IL6;SERPINE1;LGALS9;PTK2;ANO6;CSF1;RARRES2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5587442068454003,1.2792118344945962,0.18714555765595464,0.6824791224558574,1.0,1/10,0.56%,DPP4
prerank,inhibitory synapse assembly (GO:1904862),-0.5298645217548585,-1.2788566611782446,0.2079002079002079,0.5806402086098053,1.0,7/11,24.44%,GABRA2;GABRB3;LGI2;FGF13;GABRB2;GABRA1;PLXNB1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4158052475121937,1.2787103959957073,0.15126050420168066,0.6827236018185949,1.0,20/44,23.49%,ROCK2;ZC3HAV1;TNRC6B;RC3H1;NANOS2;FTO;TNRC6A;MOV10;EIF4ENIF1;METTL16;GIGYF2;CPEB3;DHX36;NANOS1;ROCK1;KHSRP;ZC3H12A;PNPT1;ZFP36L2;YTHDF3
prerank,regulation of stem cell population maintenance (GO:2000036),0.49907854686660647,1.278676469058492,0.18164794007490637,0.6814586619476278,1.0,2/18,3.02%,PTN;NCOA3
prerank,regulation of protein targeting to membrane (GO:0090313),-0.41157315749436546,-1.2775425947382215,0.1318181818181818,0.5827888655468276,1.0,8/28,15.70%,ANK3;CEMIP;INPP5K;MTCL1;MFF;KCNB1;HRAS;C2CD5
prerank,pulmonary valve development (GO:0003177),-0.462544574855973,-1.2773982704017932,0.17598343685300208,0.5818081044210628,1.0,8/18,8.00%,SLIT2;ROBO2;NOS3;TGFB2;BMPR2;NOTCH1;BMP4;TNFRSF1B
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5272587068019818,1.277218947156893,0.18923933209647495,0.6847169251615223,1.0,7/13,15.69%,NUPR1;LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;FEZ2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.41766612325761154,1.2771644206680315,0.14285714285714285,0.6835145946769976,1.0,10/43,12.23%,IGFBP5;GJA1;BMPR1A;ADAMTS1;IL6;PDGFRB;IL18;STAT1;CDH13;P2RY6
prerank,DNA damage checkpoint signaling (GO:0000077),-0.4088158938761471,-1.2762063174760432,0.15668202764976957,0.5839585377073988,1.0,13/28,24.83%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;RAD1;CHEK1;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3385693178029388,1.2756348256754613,0.09504132231404959,0.6870704093649527,1.0,30/151,11.85%,PDPK1;SOX5;BMP6;WNT4;SMAD3;ADAMTS12;FOXC1;CLEC3B;BMPR1A;NRP1;WWOX;ANXA1;BMP2;STAT5B;BMP7;PLK5;TGFBR1;APPL2;TGFBR2;PDCD5;CCL2;ACAP2;WNT5A;APPL1;MAPK14;SMAD4;MAP2K5;EGR3;DSTYK;NR4A1
prerank,regulation of cartilage development (GO:0061035),0.4984564131584451,1.2752554971384524,0.20802919708029197,0.6869631805473341,1.0,5/18,5.16%,SOX5;PTHLH;BMP2;BMP1;MBOAT2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.40268563040996597,-1.2752250895029722,0.14420803782505912,0.5852746914798792,1.0,10/30,22.34%,FUT8;MGAT5;RPN2;ALG5;LMAN1;DPM2;OSTC;STT3B;UBE2J1;DDOST
prerank,eye photoreceptor cell development (GO:0042462),-0.49061508618136196,-1.2749978212104753,0.17623762376237623,0.5845290735487082,1.0,5/15,16.59%,RORB;RP1;VEGFA;RPGRIP1;CEP290
prerank,post-translational protein modification (GO:0043687),0.3120828286837322,1.2749407637480403,0.04935370152761457,0.6866058707304181,1.0,48/332,12.85%,IGFBP3;CP;TNC;FBN1;LAMC1;FSTL1;FN1;PRKCSH;LTBP1;FAM20C;SPSB1;IGFBP5;APOA2;HIF3A;FSTL3;SDC2;FBXO11;RCN1;ITIH2;IL6;EPAS1;MIA3;KLHL21;KLHL22;SPSB4;APLP2;CUL4A;FBXO9;FBXL3;NUB1;PSMB10;CHM;PSMA3;FBXL20;PSME4;FBXL7;DNAJC3;FBXO4;PSMA5;KEAP1;ESCO1;CUL3;KLHL13;CSF1;ANO8;BTRC;FBXW11;ASB5
prerank,smoothened signaling pathway (GO:0007224),0.445375474985512,1.2745156571959182,0.17128027681660898,0.6865452853813565,1.0,8/32,11.55%,EVC2;GLI3;ARL13B;GLI1;GPC2;CC2D2A;DISP3;IHH
prerank,positive regulation of binding (GO:0051099),0.36802865286211633,1.274288420056727,0.11866859623733719,0.6859544947654206,1.0,20/84,12.58%,TCF7L2;VTN;FOXC1;WNT3A;PARP9;DACT1;BMP2;TERT;DTX3L;CLN5;SPPL3;GSK3B;SKI;RIPK2;STK3;AMFR;LRRK2;GMNN;TRIM21;HFE
prerank,positive regulation of neutrophil migration (GO:1902624),0.5023547111380247,1.2737457996699073,0.1757469244288225,0.6862699488713945,1.0,2/18,0.82%,MCU;CAMK1D
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.47845669305631,1.2730009701184577,0.18018018018018017,0.687272922750187,1.0,6/22,12.10%,PPM1E;PPM1A;DUSP10;DUSP16;PPM1B;DUSP5
prerank,monocarboxylic acid metabolic process (GO:0032787),0.35553928954474495,1.272732535184814,0.10027855153203342,0.6867193689154601,1.0,23/117,10.97%,ALDH1A2;PCCA;ACOT11;LDHAL6B;PANK2;PPARA;ALDH4A1;ME2;NPC1;PTGR1;GLO1;AMACR;ACADSB;ECHDC3;NAAA;PCCB;SCP2;BTD;HLCS;ACOT1;ABAT;HACL1;SCPEP1
prerank,negative regulation of cell cycle (GO:0045786),0.3759460333110759,1.2724592610961565,0.11676646706586827,0.6861953060544765,1.0,18/73,13.22%,SMAD3;NR2F2;NUPR1;FOXC1;BMP2;BTG3;BMP7;PTPN3;LATS2;BTG4;NPPC;NUPR2;GMNN;IPO7;NR4A1;TSPYL2;NUDT6;HECA
prerank,sulfation (GO:0051923),0.5610025907649929,1.2721322263326234,0.2178988326848249,0.6858717266637255,1.0,1/11,0.28%,UST
prerank,alpha-amino acid catabolic process (GO:1901606),0.4526377307526851,1.2721196828153476,0.17198581560283688,0.6845594009629674,1.0,7/29,13.18%,DDO;ALDH4A1;ACADSB;HGD;BLMH;ACAT1;SARDH
prerank,cellular copper ion homeostasis (GO:0006878),-0.4924057737625539,-1.272116642089579,0.1752136752136752,0.5916073600612102,1.0,7/14,26.85%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6
prerank,gland development (GO:0048732),0.3861925460431576,1.271896766072832,0.13195548489666137,0.6839574832647717,1.0,7/59,6.51%,TGFBR3;WNT4;PRKCSH;ANXA1;TGFBR1;SALL1;DKK3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3991788082991244,-1.2718866024068645,0.12165450121654502,0.5908270663305133,1.0,12/33,20.33%,H3-3A;ESR1;PKN1;HDAC6;TRIM68;CALR;RUNX1;CBFB;KDM4C;PARK7;SAFB2;UFL1
prerank,osteoclast differentiation (GO:0030316),0.47254573626804813,1.2718595097686725,0.17989417989417988,0.6827218024210782,1.0,6/22,12.29%,GAB2;ANXA2;GLO1;MAPK14;CSF1;EPHA2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4229414738145515,1.2716205803299048,0.15034965034965034,0.6822397388202293,1.0,12/40,15.64%,ARHGAP6;LPAR1;PDGFRA;FGFR1;KIT;PDGFRB;PHB2;NMUR1;P2RY6;BDNF;NTRK3;TXK
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37467214210327504,-1.271607011719136,0.1,0.590217244292235,1.0,18/42,33.71%,LARS2;KARS1;CARS1;EEF1E1;EARS2;TARS3;IARS1;RARS2;VARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;PARS2;QARS1
prerank,peptidyl-threonine modification (GO:0018210),0.383758928504282,1.2714969061360963,0.12708018154311648,0.6813127525526329,1.0,16/66,15.76%,PDPK1;ROCK2;STK39;OXSR1;TGFBR1;GALNT2;GALNT1;TGFBR2;GSK3B;LRRK2;HIPK3;MAP2K1;WNK1;TBK1;CSNK2A2;PRKD2
prerank,regulation of microtubule polymerization (GO:0031113),-0.37733996732984454,-1.2708869969693635,0.1311881188118812,0.5910435883124086,1.0,18/40,24.85%,NAV3;PAK1;SNCA;RPS3;MET;STMN2;TUBB4A;FES;PRUNE1;RAC1;MAPT;MAP2;STMN1;CDK5RAP2;DCTN1;ARL2;MAPRE1;OCLN
prerank,cellular response to oxygen levels (GO:0071453),-0.5471094093277258,-1.270430850128877,0.16600790513833993,0.5909362269838225,1.0,10/10,45.33%,CPEB4;ATP6V0A2;ATP6AP1;TMEM199;PICK1;ATP6V1A;ATP6V1G1;NDUFS2;ATP6V0D1;CCDC115
prerank,maturation of 5.8S rRNA (GO:0000460),0.5082793037066876,1.27017966362341,0.18727272727272729,0.6841741552436768,1.0,6/17,17.85%,MPHOSPH6;NSA2;WDR12;EXOSC10;RPF1;C1D
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.3545824524718585,-1.2701138615172154,0.1,0.5904158122855132,1.0,20/53,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;BCKDK;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD11;PSMD8
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5469822689690995,-1.269866272479557,0.188,0.5897378959508872,1.0,8/10,23.91%,ATP5F1A;ATP5MC1;ATP5PO;ATP5PD;ATP5F1D;VPS9D1;ATP5MG;ATP5MC3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5808192235892944,1.2695869543451073,0.20773930753564154,0.6835124897340069,1.0,3/10,6.37%,NUPR1;HDAC4;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),0.5808192235892944,1.2695869543451073,0.20773930753564154,0.6835124897340069,1.0,3/10,6.37%,NUPR1;HDAC4;PPARA
prerank,regulation of myoblast differentiation (GO:0045661),0.4393032682043889,1.2695544684876965,0.15384615384615385,0.682274960515586,1.0,3/32,3.64%,RANBP3L;IGFBP3;EID2B
prerank,protein dephosphorylation (GO:0006470),0.3444786376550004,1.2694611739853017,0.0989010989010989,0.681263488761866,1.0,34/135,12.78%,PTPN13;EYA2;EYA1;PPP2R2B;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;DUSP16;PTPN9;SSH1;PTPN21;PPEF2;PPP4R2;CTDSP2;PPP4R1;PPM1B;PTPN6;PPP1CB;EYA4;PTPRU;PPP3CB;DUSP5;BTRC;PTPN1;PTPN18;FBXW11
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.32650335795549845,-1.2692410450302476,0.09166666666666666,0.5901059141569144,1.0,37/79,27.92%,ACTR10;SH3GL2;MFSD6;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,Notch signaling involved in heart development (GO:0061314),0.546816824817475,1.2689735772411546,0.2032854209445585,0.6815712496045264,1.0,2/11,1.51%,RBPJ;NOTCH2
prerank,cell part morphogenesis (GO:0032990),0.5343700400798941,1.2687277832702077,0.21482889733840305,0.681049514363294,1.0,5/13,13.48%,PID1;PACSIN2;DNM1L;SUPV3L1;WASF1
prerank,central nervous system myelination (GO:0022010),-0.5175157109117167,-1.2686802380632711,0.18218623481781376,0.5903203647282994,1.0,7/11,33.60%,PLP1;TENM4;B4GALT6;CLU;CNTNAP1;B4GALT5;ABCA2
prerank,regulation of cellular pH (GO:0030641),-0.40217500272791207,-1.2678535717286898,0.15056179775280898,0.5911419602055147,1.0,8/29,14.68%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC4A7;SLC9A5
prerank,metanephric mesenchyme development (GO:0072075),0.5716875165757673,1.2676547220012007,0.21484375,0.6831501990688573,1.0,3/10,7.58%,WNT4;OSR1;STAT1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.3936823892927648,-1.2676333323228643,0.1425,0.5902979455899844,1.0,12/30,7.81%,PECAM1;SLC12A2;CLDN5;ESAM;DMD;ACTB;JAM2;ACTG1;SLC1A1;MBP;LSR;JAM3
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3460539150648704,-1.2673275871616092,0.0906515580736544,0.5897816086137314,1.0,16/64,6.95%,LIMCH1;EFNA5;PEAK1;THBS1;ACER2;PTK2B;GPM6B;ADAM15;UTRN;MACF1;EMP2;ACTG1;CDK6;MYOC;NEXMIF;SEMA3E
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.47943723723760456,-1.2671633173816583,0.21551724137931033,0.5888980604233297,1.0,8/15,19.88%,RYR2;RAB3GAP1;SRP14;SPCS2;SPCS1;ZFAND2B;SEC61A1;SEC61G
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4749751374018808,1.2667112800583364,0.17017543859649123,0.6848945514141965,1.0,4/20,10.95%,MCU;MICU1;PHB2;PMPCB
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.37343598101128744,1.2666770409312809,0.1152,0.6836686884383053,1.0,12/73,9.62%,ROBO1;COL4A3;SMAD3;CASP12;DLC1;TNFSF15;CFLAR;CASP4;IFT57;NGFR;BAX;CASP8AP2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.40919453538644146,1.2664962753810165,0.16,0.6829150618687522,1.0,3/40,2.56%,SLC7A11;SLC13A3;SLC19A1
prerank,GTP metabolic process (GO:0046039),0.5137869054609642,1.2660883220309194,0.1956521739130435,0.6828360313808465,1.0,7/15,17.54%,ENTPD7;RHOQ;LRRK2;EFL1;OPA1;RAN;GNAI3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5029878456300131,-1.2659203750457388,0.18018018018018017,0.5912223673681422,1.0,9/13,28.25%,SHANK3;LGMN;ZDHHC2;RELN;ADCY8;AKAP5;CHRNA7;SHISA7;SQSTM1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4441013874929697,1.2656972834576403,0.16695957820738136,0.6828173968910835,1.0,6/32,6.44%,PHLDB2;ARHGAP6;DLC1;CASK;SERPINE1;RASA1
prerank,protein autoubiquitination (GO:0051865),0.38862080714442665,1.2656164958441112,0.14026402640264027,0.6817492275794643,1.0,13/61,15.97%,RNF220;RNF213;SH3RF1;TRIM17;DTX3L;AMFR;WWP2;CUL3;TRIM21;BFAR;RNF181;RNF146;RNF185
prerank,positive regulation of RNA splicing (GO:0033120),-0.4080312009824253,-1.265396106196562,0.16336633663366337,0.5911686455844024,1.0,9/29,27.91%,PIK3R1;CELF4;SETX;TRA2A;RBM3;HNRNPLL;SLC38A2;RBMXL1;RBM20
prerank,regulation of cell population proliferation (GO:0042127),0.29621911068897505,1.2649078207397852,0.014054054054054054,0.6827728588392465,1.0,138/691,16.57%,TCF7L2;ALDH1A2;IGFBP3;EFNB2;PDPN;PODN;BMP6;COL4A3;PTN;DPP4;KANK2;FN1;CXCL10;PDGFRA;FGFR1;FGF1;IL31RA;EIF2AK2;KSR1;TPTE;NUPR1;STAT2;IL6ST;PHIP;GHRH;LDOC1;WNT3A;GAB2;DLC1;PDS5B;BMPR1A;OSM;IL11;RBFOX2;FER;SMIM22;VEGFD;TGFA;ADAMTS1;IL34;TGFB1I1;PTHLH;PTPN14;KIT;BMP2;IGFBP6;STAT5B;IFI35;GLP2R;IL6;BTG3;GSDME;GLI1;BCL2;STOX1;BTG4;TGFBR1;EPHA1;FOXP3;PDGFRB;HDAC4;PTPN2;CD47;COL18A1;TGFBR2;STAMBP;CTSH;ZBTB7C;POU1F1;CLMN;STAT1;CDC73;PDCD5;SKI;CDKN2B;PIAS1;SETD4;YAP1;IGF2;IL13RA1;DNAJA2;MST1R;IFITM1;SMAD6;NUPR2;CGRRF1;GRK5;FGF18;IFNLR1;PTPN6;CDH13;TJP1;PTK2;STAT4;PTPRU;SH2B3;CUL3;CSF1;NUDT6;CADM4;SLURP1;MAP2K1;TRAPPC14;TCIRG1;RBM5;NPR3;MDM4;IFIT3;ALK;WDR6;FRK;ABI1;VHL;NIBAN2;BIRC6;HDAC2;RARA;PML;NTRK3;TNS2;RAB33B;PDF;MEAK7;ADRA2A;KAT2B;CCKBR;P3H3;SOX4;PKD2;APP;IGF1R;INHA;AXIN2;NF2;WWTR1;S100A11;NOX1;CCAR1
prerank,glucose transmembrane transport (GO:1904659),-0.4560868233809572,-1.2648438683950163,0.16559139784946236,0.591389241080463,1.0,9/18,32.84%,SLC2A1;PPARD;SLC2A9;SORT1;SLC2A4;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,positive regulation of growth (GO:0045927),-0.33905686063362583,-1.26469997837681,0.07923497267759563,0.5903979637244493,1.0,19/64,18.30%,PLCB1;AKAP6;TGFB2;INSR;RFTN1;H3-3A;AKT1;SDCBP;DDX49;EXOSC2;RPS6KA1;EGFR;CEP43;MFSD2A;TAF9B;LGI1;CDKN2AIP;PPM1F;EXOSC4
prerank,positive regulation of signaling (GO:0023056),-0.38693740958469447,-1.2646876213718232,0.15308641975308643,0.5890387550540526,1.0,8/37,7.01%,SYT1;RIMS1;RIMS2;GRIK2;NSF;HOMER1;SNCA;ECE1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4487445683782572,-1.2643236751425384,0.14888888888888888,0.5887525825265018,1.0,7/20,9.49%,SLC12A2;KCNMA1;ATP1B1;KCNJ2;ATP1A1;SLC8A1;NEDD4L
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3821481704875942,-1.264093202834336,0.14180929095354522,0.5879829662258519,1.0,9/35,7.63%,NLGN1;CDH11;CDH12;ATP2C1;CDH10;CDH8;CDH22;CDH7;CDH20
prerank,cardiac muscle contraction (GO:0060048),0.429701550114092,1.2638631805737919,0.1765704584040747,0.6849371417769867,1.0,5/34,8.05%,TNNC1;ATP1A2;CSRP3;TPM1;SCN3B
prerank,response to interleukin-4 (GO:0070670),-0.5305941701520587,-1.2638005332926148,0.19,0.5874466980665092,1.0,1/10,0.14%,LEF1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3939330677092186,-1.2635250925658932,0.16252821670428894,0.5868357385360636,1.0,12/31,10.34%,SLIT2;ROBO2;SEMA6D;THBS1;NOTCH1;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B
prerank,calcium-mediated signaling (GO:0019722),0.3616440531443345,1.2631513309967186,0.1262848751835536,0.685909802367472,1.0,15/93,9.48%,PDPK1;RCAN2;MCU;SELP;FPR2;ACKR2;CCR9;RCAN1;PLCE1;VCAM1;ADGRL1;ACKR3;CACNA1C;LRRK2;NMUR1
prerank,prostaglandin biosynthetic process (GO:0001516),0.4882149778766036,1.263012573893581,0.181651376146789,0.6851061430676523,1.0,2/18,1.37%,PTGS1;PLA2G4A
prerank,nerve growth factor signaling pathway (GO:0038180),-0.523719881908175,-1.2627540412886233,0.20164609053497942,0.5876910668627968,1.0,4/10,16.45%,RAPGEF2;NGF;RAP1A;NTF3
prerank,negative regulation of blood pressure (GO:0045776),-0.5026308032193799,-1.2626999940391734,0.185589519650655,0.5864412251851576,1.0,4/13,10.30%,NOS3;BMPR2;PRCP;NOS1
prerank,cellular response to virus (GO:0098586),0.4405591462245858,1.2622306395726757,0.17137809187279152,0.6862771516997092,1.0,13/30,22.66%,CXCL10;IL6;GSDME;LGALS9;BAX;MAPK14;IFIH1;GBF1;ARF1;HIF1A;ZC3H12A;RIOK3;LGALS8
prerank,cell differentiation in spinal cord (GO:0021515),-0.5391180462201285,-1.2620703143042742,0.2231237322515213,0.5868239224120018,1.0,2/10,7.13%,MDGA2;SOX6
prerank,cellular response to peptide (GO:1901653),0.3965186671353824,1.2619925186189196,0.13902053712480253,0.6857204365613485,1.0,13/56,8.24%,FPR2;LDOC1;GJA1;VIM;SNX6;TLR4;PTPN22;CASP4;VCAM1;NGFR;GSK3B;RIPK2;EPHA4
prerank,protein O-linked glycosylation (GO:0006493),0.3558403174684165,1.261962958429389,0.11011904761904762,0.6845111049197306,1.0,15/96,7.45%,TMTC4;GALNT18;GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;TRAK1;TMTC1;LARGE1;GALNT2;GALNT1;RXYLT1;POMT2;GCNT4
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4753377720748033,-1.2618273944459915,0.1885245901639344,0.5861674934138714,1.0,5/15,14.89%,LEF1;CTDP1;TFAP4;SMARCB1;TAF11
prerank,cellular response to interleukin-4 (GO:0071353),-0.5272619850449624,-1.260446610650338,0.20883534136546184,0.5888216481233605,1.0,1/10,0.14%,LEF1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.48635389607216506,-1.2603804483593366,0.18571428571428572,0.587656874661032,1.0,7/13,22.46%,SORL1;GCC2;INSIG1;BRSK2;TMEM30A;SAR1B;CD81
prerank,leukotriene metabolic process (GO:0006691),0.49195732076349097,1.260199391478914,0.21023765996343693,0.6885840666491347,1.0,3/19,6.86%,PLA2G4A;DPEP2;PTGR1
prerank,mRNA destabilization (GO:0061157),0.42251480146775683,1.2601136657722654,0.16233766233766234,0.6875728901687901,1.0,16/38,23.49%,ROCK2;TUT4;POLR2D;RC3H1;FTO;MOV10;METTL16;GIGYF2;CPEB3;TUT7;DHX36;ROCK1;KHSRP;ZC3H12A;ZFP36L2;YTHDF3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4933448811167207,-1.2601114245456422,0.16163793103448276,0.5869864481434167,1.0,6/14,16.15%,PRKAR1A;RAPGEF2;ADRB2;PRKAR2B;PKIG;PKIB
prerank,protein polyubiquitination (GO:0000209),0.31384512330607023,1.2598500247559266,0.05703883495145631,0.6871337863974557,1.0,66/297,15.52%,SASH1;RNF152;RNF213;SPSB1;SMURF2;TRIM56;HERC6;RNF217;TRAF5;FBXO11;FBXL17;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;BCL2;RNF19A;UBE2U;RNF216;DZIP3;SIAH2;PELI2;TRIM5;DTX3L;FBXO9;NPEPPS;ANAPC11;RNF20;FBXL3;PSMB10;ANAPC1;AMFR;UBE2C;PSMA3;FBXL20;PSME4;LONRF1;FBXL7;FBXO4;PSMA5;WWP2;FBXO38;BLMH;HUWE1;UBE2V1;HECTD1;CUL3;IFI27;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;CDC27;PRPF19;BFAR;LNPEP;FBXL4;DDA1;UBE2R2;FBXL13;FBXL12;RNF146;MUL1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.5199785724014526,-1.2597260674657869,0.21108742004264391,0.5867335441731113,1.0,5/11,18.56%,NOL11;DDX11;SMARCB1;PWP1;SIRT7
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.332690693220782,-1.2594712170546596,0.09226190476190477,0.5862549717454708,1.0,24/67,24.51%,PSMC3;NCF2;PSMD14;PSMD3;B2M;CALR;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CYBB;PSMA8;PSME1;FCGR1A;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1;SEC22B;PSMD11;PSMD8
prerank,positive regulation of cell communication (GO:0010647),-0.41452101002600367,-1.259102929516355,0.16159250585480095,0.5859789677915597,1.0,6/28,3.91%,SYT1;RIMS1;RIMS2;GRIK2;HOMER1;ANK3
prerank,nuclear membrane disassembly (GO:0051081),-0.4854354007379075,-1.2584469330541714,0.20464135021097046,0.5865180190865624,1.0,9/14,37.68%,PRKCB;NEK9;CTDNEP1;VRK1;DCTN1;PLK1;CDK1;CCNB2;CCNB1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5018927125451325,-1.2582186930230894,0.18619246861924685,0.5857545699709191,1.0,6/12,16.42%,DMD;ATP1B1;ANK3;NOS1;GLRX;FXYD1
prerank,nervous system development (GO:0007399),-0.26273287899094133,-1.258204119087578,0.0064516129032258064,0.5844514053957973,1.0,84/429,12.44%,RAPGEF5;DNM3;ADGRL3;NRXN1;NLGN1;NAV2;ROBO2;LSAMP;SHANK3;SLC2A1;MERTK;ST8SIA4;SPOCK2;CDH2;ERBB4;MEF2C;ADGRG6;NAV3;CHRM3;KIRREL3;EFNA5;GPM6A;FGF12;CNTN4;WWP1;MYT1L;MBNL1;MOG;GPM6B;CNTN6;NCKAP1;CDH1;RBFOX3;RBFOX1;CHRM2;TRPC5;SEMA6A;GRIK1;SERPINI1;MET;SHANK2;SNTG2;EPHB1;S100B;PCDH1;SH3GL2;ADAM22;AHI1;MAL;DCLK1;MOBP;NRCAM;APBA2;MBP;EIF2B2;SCN2A;ALDH5A1;ZIC3;ZBTB16;SOX6;NINJ2;MBD5;NLGN3;VEGFA;L1CAM;ADAM23;SPOCK1;DNER;CNTFR;DHX30;DVL1;SEMA6B;DBNL;PCDHB16;FGF13;FGF2;SCN8A;NRSN1;NFASC;GFRA2;IL1RAPL2;NGF;NPAS2;VLDLR
prerank,positive regulation of phosphatase activity (GO:0010922),-0.43283013320697256,-1.2581990998875163,0.1920374707259953,0.583135462796198,1.0,5/21,6.94%,MEF2C;CALM1;CALM2;HSP90AB1;CALM3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30168767067537466,1.2580405139546933,0.035509736540664374,0.6916378066036898,1.0,85/417,15.24%,TCF7L2;WNT4;FOXD1;PRICKLE1;RBPJ;ZHX2;ARID4A;ATXN1;NR2F2;TLE1;SMURF2;GATA6;SAMD13;ZBTB4;ZIC2;SNX6;RBFOX2;GLI3;MYB;MBD2;ZMYND15;TCEAL7;EID2B;CRY2;PRDM11;BMP2;RFX3;CRY1;LOXL3;BCOR;BMP7;GZF1;NIF3L1;SALL1;CBFA2T2;FOXP3;HDAC4;TSHZ3;DKK3;PBXIP1;GLIS2;DPF2;ZMYND11;PHB2;WNT5A;ZEB1;KAT6B;EPC1;USP47;SCMH1;SUMO1;JARID2;TAF7;PSPC1;WWP2;GMNN;ATF7IP;HEYL;CIR1;SMAD4;SCML4;BCL7A;LHX9;ZNF219;VGLL4;ILF3;BTRC;FBXW11;CBX4;BHLHE41;NR3C1;ARID5B;POU2F1;KAT6A;PRDM5;KDM8;RBM15;RUNX1T1;NIBAN2;ZBTB21;HDAC2;RARA;PML;UIMC1;SP3
prerank,respiratory tube development (GO:0030323),0.4469804430630419,1.2575079935951352,0.18231046931407943,0.6920703483735834,1.0,5/28,7.17%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.4320019327838761,-1.257270317268567,0.19474835886214442,0.5844265620031853,1.0,7/21,4.93%,HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5;XYLT1;EXT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.45320893201482,1.2570976650189611,0.18434782608695652,0.6921007762234044,1.0,12/27,23.55%,TNRC6B;IL6;EIF4ENIF1;MAP2K1;DDX6;WTIP;PUM2;DDX5;AJUBA;RIPK1;DHX9;TGFB1
prerank,heart looping (GO:0001947),-0.37205337883544964,-1.2568735696368731,0.13043478260869565,0.5842444656880119,1.0,14/40,23.49%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7
prerank,transcription by RNA polymerase II (GO:0006366),0.3117544265591451,1.2567579059107465,0.06491885143570537,0.6918408612690412,1.0,85/305,20.49%,RORA;SOX5;RBPJ;CCN2;ELOF1;NOTCH2;MLLT3;TBL1XR1;TEAD1;MAF;NR6A1;POLR2D;PCF11;PIR;GLIS3;PRRX1;DTX1;NR1H3;RPRD2;PPARA;CREBBP;RARB;CDC73;INTS9;TRIM24;TEAD2;YAP1;CCNH;MNAT1;NABP1;NOCT;CDK7;CDK12;TAF7;TCEA1;POLR2C;IWS1;INTS14;RTF1;NR4A1;MAML2;NFIC;NR3C1;MED20;PKNOX1;PAF1;POLR2F;POU2F1;INTS3;GTF2H4;ERCC6;LEO1;PABPN1;RARA;INTS8;MLLT1;CSTF3;SNAPC3;KAT2B;IRF9;TAF9;DDX21;WWTR1;TBL1X;AFF4;GTF2H2;CDK13;SLBP;INTS13;PMF1;NFYA;ESRRA;WDR33;PGR;E2F2;SNAPC5;RPRD1B;INTS6;SETD2;DDX5;NABP2;RNGTT;MED26;POLR2K;GMEB2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3724554261674396,1.2566388412989433,0.14488188976377953,0.690933302932053,1.0,13/68,9.91%,MMAB;ENPP1;PCCA;SHMT1;SLC19A1;AOX1;MTHFD1;PANK2;PCCB;LMBRD1;BTD;PDXK;HLCS
prerank,organonitrogen compound catabolic process (GO:1901565),0.38609754101019095,1.2559646671904743,0.14108527131782947,0.6916349030561147,1.0,13/57,14.01%,PLA2G4A;CPQ;ANPEP;GGACT;NPEPPS;CLN5;TRIM24;PLA2G6;ERAP1;ENPP2;CLPX;AMDHD2;LNPEP
prerank,negative regulation of neuron death (GO:1901215),-0.3153014818972496,-1.2557397148827252,0.08411214953271028,0.5860562625979804,1.0,27/93,17.94%,MEF2C;PTK2B;CD34;NTRK2;SIX1;SNCA;SORL1;FOXQ1;NDNF;LGMN;AKT1;TNFRSF1B;PINK1;TGFB3;NGF;ATF4;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;BTBD10;SET;NTF3;TOX3;ADAM8
prerank,icosanoid metabolic process (GO:0006690),0.40706169038676626,1.2552429222444161,0.17333333333333334,0.6926769691825384,1.0,8/40,12.95%,PTGS1;PLA2G4A;DPEP2;PLA2G4C;PTGR1;ALOXE3;EPHX1;PON3
prerank,striated muscle tissue development (GO:0014706),-0.40192806698610056,-1.2552360232050712,0.16161616161616163,0.5862208890541449,1.0,8/29,8.44%,SGCZ;PGM5;MEF2C;SGCD;BMPR2;SIX1;MYL6;TBX2
prerank,positive regulation of MAPK cascade (GO:0043410),0.3145451344389801,1.2550151892204007,0.06861499364675985,0.6920193120433975,1.0,38/245,9.47%,ROBO1;LPAR1;ROCK2;CCN2;PDGFRA;FGFR1;FGF1;NOTCH2;EIF2AK2;KSR1;FPR2;MTURN;OSM;IL11;GLIPR2;EPHA8;NRP1;IL34;ANGPT1;KIT;BMP2;TAOK3;IL6;ROR1;GSDME;PRKCZ;PTPN22;PELI2;PDGFRB;TRIM5;CCL2;ACKR3;LGALS9;PHB2;IGF2;LRRK2;PIK3R5;MST1R
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5860568545500997,1.2549480685055654,0.23387096774193547,0.6909065429461128,1.0,2/10,6.03%,TLR4;FOXP3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.308142912173755,1.2546522181055035,0.054696789536266346,0.690579503278526,1.0,62/348,13.32%,ROBO1;BMP6;FOXD1;ROCK2;SMAD3;RBPJ;RBMS3;FN1;AFDN;WNT6;FGF1;PID1;TLE1;OSR1;WNT3A;GJA1;ANXA2;CDH5;ITGB8;GCGR;SLC26A9;TNRC6B;SLC24A3;ANGPT1;BMP2;PKP3;IL6;TLR4;BMP7;STOX1;PTPN22;TGFBR1;DTX3L;CRP;CTSH;PDCD5;GSK3B;LGALS9;TNRC6A;WNT5A;YAP1;DTNBP1;MOV10;RESF1;MUSK;FUBP1;MAPK14;CUX2;FGF18;ATF7IP;TLR2;LRP3;MAP2K5;ADAM19;CSF1;HFE;PTPN1;NOG;MAP2K1;ARRB1;TASOR;MAPK9
prerank,regulation of cell junction assembly (GO:1901888),-0.40963575011737585,-1.2545926826419043,0.16279069767441862,0.5868444314653921,1.0,9/27,16.16%,PRKCH;CLDN5;MEF2C;RAPGEF2;RUNX1;CBFB;F11R;APLNR;RAP1A
prerank,regulation of neutrophil migration (GO:1902622),-0.5447495835333885,-1.2540822503605713,0.21875,0.5869374185164715,1.0,7/10,32.79%,JAM3;RHOG;RAC1;RHOH;BST1;MPP1;RAC2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.34616705789177005,1.25390155341941,0.11077844311377245,0.6916572783236881,1.0,15/108,8.35%,UACA;ROBO1;COL4A3;SMAD3;CASP12;DLC1;DAPK1;TNFSF15;CFLAR;CASP4;IFT57;NGFR;PDCD5;LGALS9;BAX
prerank,positive regulation of leukocyte migration (GO:0002687),0.44556942424335927,1.2538462745184344,0.18739352640545145,0.6905531098219011,1.0,3/27,4.72%,PTN;IL6;MIA3
prerank,regulation of neuron apoptotic process (GO:0043523),-0.30708197091572853,-1.2533777481378736,0.09779179810725552,0.587620964094063,1.0,28/96,17.94%,GRID2;MEF2C;TGFB2;PTK2B;TRIM2;NTRK2;SIX1;CTNNB1;FOXQ1;NDNF;LGMN;PINK1;SIGMAR1;TGFB3;KCNB1;NGF;ATF4;AKT1S1;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;SET;NTF3;TOX3;ADAM8
prerank,positive regulation of embryonic development (GO:0040019),0.4881155745996124,1.2529733364481161,0.19099099099099098,0.6920308977197254,1.0,3/19,2.08%,WNT4;OSR1;WNT3A
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.41229523168173654,-1.2527761729255797,0.15730337078651685,0.5879320686253381,1.0,11/26,29.72%,PDE8A;AKT1;PINK1;ATF4;PPIA;PARK7;GPR37;GPR37L1;PYCR1;VNN1;HSPB1
prerank,regulation of p38MAPK cascade (GO:1900744),0.42308649296325446,1.2527231328361916,0.17200674536256325,0.6916145991820534,1.0,8/35,8.89%,SASH1;RELL1;DUSP10;BMP2;PTPN22;LGALS9;PJA2;DLG1
prerank,negative regulation of translation (GO:0017148),0.36268062863698936,1.2522726066972305,0.13270142180094788,0.6917542993797519,1.0,20/87,16.02%,ROCK2;SAMD4A;EIF2AK2;IGFBP5;SHMT1;DAPK1;IGF2BP1;TPR;NANOS2;CPEB1;FTO;IGF2BP2;EIF4ENIF1;ILF3;DDX6;METTL16;GIGYF2;EIF2AK3;CNOT9;CPEB3
prerank,positive regulation of JNK cascade (GO:0046330),-0.3319918915994733,-1.2520214060701647,0.0953757225433526,0.5887248303049106,1.0,24/70,17.54%,PLCB1;PTK2B;TPD52L1;MAP3K5;DAB2IP;HMGB1;RASSF2;MAP3K11;SDCBP;MFHAS1;DUSP22;MAPK8IP1;MINK1;GADD45G;ANKRD6;SEMA3A;HRAS;SH3RF3;CCL19;NOD2;CD27;DUSP15;LTBR;PYCARD
prerank,triglyceride homeostasis (GO:0070328),0.4615875737251932,1.2517457330689588,0.17398648648648649,0.6920845243477164,1.0,4/26,12.04%,RORA;NR1H3;IL18;DGAT2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.518758314224591,1.2501174803974808,0.2159090909090909,0.6960526318512786,1.0,1/14,0.15%,SULF1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38688545239664995,1.25006639526084,0.15170278637770898,0.6949525172721884,1.0,15/56,13.47%,ADAMTS1;ANXA1;STOX1;CCND3;ANAPC11;KLHL18;ESPL1;PHB2;UBE2C;ANKRD17;BRD4;CUL3;NSMCE2;RAD51B;CDC27
prerank,sphingolipid catabolic process (GO:0030149),-0.4684498402745737,-1.2497581370685524,0.1939655172413793,0.5936165216857444,1.0,2/15,2.19%,ACER3;ACER2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.4784075708284756,1.248985034908469,0.2039355992844365,0.6969797635267193,1.0,6/19,14.67%,ROBO1;DCN;CCBE1;CADM4;SMOC2;MYO1C
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.46662810963669177,1.248979808507728,0.18356643356643357,0.6957348433561865,1.0,6/22,9.78%,BPIFB1;IFI35;PTPN22;APPL2;NR1H3;APPL1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47927764511321286,1.2483010161647226,0.22202486678507993,0.6966617295888016,1.0,3/19,4.44%,WNT4;VIM;IL6
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.48897527852583156,-1.247068713554242,0.189873417721519,0.5999725799023011,1.0,10/13,37.04%,TOX;BMP4;SOD1;CAMK4;ADAM8;ZC3H8;CLPTM1;VNN1;FOXJ1;TESPA1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.42959145310740604,-1.2464534875499373,0.18162393162393162,0.6005379370471646,1.0,6/19,20.27%,SLCO1C1;KLF2;MAPK8;KLF4;EGF;CHRNA7
prerank,regulation of adaptive immune response (GO:0002819),0.49429346408833086,1.2463642107077335,0.21172022684310018,0.701571208820434,1.0,2/18,4.55%,IL6ST;ADCY7
prerank,protein localization to cell surface (GO:0034394),-0.41474209596992884,-1.246236778074458,0.17391304347826086,0.599877748826771,1.0,8/26,10.57%,PTPRK;EMP2;FBLN5;CTNNB1;RIC3;JAM3;PIGU;PIGK
prerank,amino acid import (GO:0043090),-0.4326790024461172,-1.2462288443960974,0.16404494382022472,0.59859329816154,1.0,6/21,5.64%,SLC6A6;SLC47A1;SLC7A5;SLC6A1;SLC7A1;SLC1A1
prerank,regulation of epithelial cell migration (GO:0010632),0.39426071533445833,1.2461133358186234,0.16390728476821192,0.7011656255458424,1.0,13/51,11.16%,PTN;MCC;SASH1;DOCK5;TACSTD2;GLIPR2;DUSP10;CLASP1;CTSH;GLUL;INSL3;ENPP2;PTK2
prerank,negative regulation of defense response (GO:0031348),0.36546124081968606,1.2454997214282433,0.13846153846153847,0.7018296279019755,1.0,8/77,6.52%,ENPP3;RORA;FPR2;CDH5;TNFAIP8L2;NR1H3;PPARA;PTPN2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.41489838829471776,1.2454356274047955,0.18461538461538463,0.700771610684944,1.0,6/36,5.67%,AFDN;SPTBN1;VAMP5;TRARG1;RAB10;OPTN
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.46902214383483626,-1.2453831313143082,0.19148936170212766,0.5998289329248471,1.0,7/16,7.24%,DMD;RYR2;CALM1;CALM2;SLC8A1;CALM3;CAMK2D
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3529526772482226,-1.244913424254346,0.12129380053908356,0.599936557225143,1.0,19/50,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;PSMD11;PSMD8
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.43031686818156106,-1.2443112363485145,0.20412844036697247,0.6003586136552097,1.0,6/21,13.22%,MTUS1;THBS1;PTK2B;MAPK3;CMKLR1;CSF1R
prerank,secondary palate development (GO:0062009),0.5158256826446449,1.2434587483343005,0.23897058823529413,0.7057752943453222,1.0,6/14,11.50%,TGFBR3;WNT3A;LRRC32;TGFBR2;WNT5A;SMAD4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3865242633260487,-1.2433688854988878,0.15704387990762125,0.6017192347900769,1.0,11/33,17.14%,CHRM3;AKAP6;KCNJ3;KCNJ2;NEDD4L;KCNJ6;KCNJ8;KCNQ1;KCNJ15;CASQ2;P2RX7
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5360834981697608,1.2433169083442062,0.2255772646536412,0.7049292833349459,1.0,6/13,24.30%,IDH1;D2HGDH;IDH2;PHYH;ADHFE1;OGDH
prerank,regulation of viral entry into host cell (GO:0046596),-0.39633303481941046,-1.2432233100615144,0.15841584158415842,0.600841137563745,1.0,10/30,18.15%,LY6E;HS3ST5;SNX3;MID2;CD74;TRIM68;TRIM62;IFITM3;IFITM2;LGALS1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.46627325163556366,1.2431618193137115,0.20408163265306123,0.704098523579205,1.0,4/23,8.09%,PLA2G4A;MBOAT2;PLA2G4C;PLA2G6
prerank,nitric oxide biosynthetic process (GO:0006809),-0.479341107875772,-1.2425646425088144,0.2033898305084746,0.6013925650023971,1.0,4/13,10.31%,NOS3;AKT1;NOS1;GCH1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3851044044589439,1.2423714475585654,0.14772727272727273,0.705304227329158,1.0,14/51,15.53%,FBN1;FSTL1;SMURF2;BMPR1A;FSTL3;NBL1;BMP2;SKI;SMAD6;SMAD4;NOG;CHRDL1;GREM2;ACVR2B
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.44676554996733425,-1.242177794143411,0.1943231441048035,0.6012102222881968,1.0,6/17,12.61%,SLC7A5;PRKCQ;HAVCR2;FCER1G;CD86;SYK
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3619567996611937,-1.2420790625823024,0.12020460358056266,0.6002476886357596,1.0,18/48,15.75%,PDE4D;UBASH3B;DMD;AKAP6;PTK2B;FKBP1A;CALM1;SNCA;CALM2;CEMIP;CALM3;CAMK2D;SELENON;NOS1;SRI;APLNR;CASQ2;PLCG1
prerank,aortic valve development (GO:0003176),-0.3823547256612168,-1.2418534352928254,0.14446952595936793,0.5996201158648493,1.0,10/34,8.00%,SLIT2;ROBO2;NOS3;TIE1;BMPR2;NOTCH1;ELN;EMILIN1;BMP4;TNFRSF1B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.48045108332446207,1.2418332654561262,0.21530249110320285,0.705823209513823,1.0,5/20,7.70%,TLR4;MTDH;PTPN22;IL18;CCL2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4279685311094338,1.2418226292833414,0.18106312292358803,0.7045990697277729,1.0,6/35,7.70%,SULF1;COL4A3;NR2F2;NGFR;STAT1;CCL2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4748105753539593,-1.2416870493584202,0.21794871794871795,0.5987493284575013,1.0,5/14,15.11%,DMD;ATP1B1;ANK3;ACTN4;GLRX
prerank,regulation of hemopoiesis (GO:1903706),0.5717030303049876,1.2413926758227174,0.2403846153846154,0.7045987800939837,1.0,5/10,10.81%,PTN;IL17D;CREBBP;MAFB;MYSM1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4641859252447017,-1.240896553155375,0.16632443531827515,0.5996508272503758,1.0,9/17,37.54%,CADM1;RAET1E;LAMP1;RASGRP1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5256105939645206,1.2406521388026501,0.2274436090225564,0.705691163405228,1.0,4/13,4.69%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,regulation of cell migration (GO:0030334),0.2991696499053396,1.2403791905070274,0.05357142857142857,0.7052844548276264,1.0,72/382,12.68%,PLXNA2;SULF1;ROBO1;DPYSL3;SEMA3D;PDPN;PODN;ROCK2;SASH1;AFDN;PDGFRA;FGF1;SYNE2;CXCL16;IGFBP5;FAM110C;LMO4;DLC1;KANK1;CDH5;LDLRAD4;FER;DAG1;NUMB;SMIM22;LDB2;ANXA1;DUSP10;KIT;BMP2;WNT5B;MIA3;AMOTL1;TPM1;VCL;TGFBR1;FAM83H;SERPINE1;APPL2;MMP14;EPHA1;PDGFRB;SEMA4B;MGAT3;BST2;CTSH;CLIC4;CLDN1;RNF20;NGFR;EPHA4;MYADM;STK24;SERPINE2;PLAU;RAP2C;IFITM1;APPL1;FGF18;NKD1;ENPP2;CDH13;TJP1;PTK2;PTPRU;FOXO3;RHOC;CSF1;EPPK1;SLURP1;ARSB;NOG
prerank,regulation of protein kinase B signaling (GO:0051896),0.32256396497615625,1.2403021506819893,0.10649350649350649,0.7042545342449832,1.0,23/193,6.37%,TCF7L2;PDPK1;PDGFRA;FGFR1;FGF1;AXL;TPTE;FAM110C;GAB2;OSM;OSBPL8;FRS2;DAG1;TGFA;KL;ANGPT1;KIT;MTDH;TGFBR1;HAX1;CPNE1;PDGFRB;PPARA
prerank,regulation of mononuclear cell migration (GO:0071675),-0.41386555599825414,-1.239361243452176,0.2,0.60245881996177,1.0,7/23,13.22%,SLIT2;THBS1;STK10;MAPK3;LYN;CMKLR1;CSF1R
prerank,presynaptic endocytosis (GO:0140238),-0.41416707251831714,-1.239345612561593,0.18518518518518517,0.6012111370887234,1.0,5/24,8.74%,NLGN1;SYT1;AMPH;SNCA;NLGN3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4315309119144224,-1.239305378371543,0.1712962962962963,0.600039064274367,1.0,5/20,7.09%,MEIS2;PTK2B;CDK6;HOXB8;ZBTB16
prerank,androgen metabolic process (GO:0008209),-0.43823117172434584,-1.2393046741370757,0.17841409691629956,0.5987645772860026,1.0,4/18,17.90%,SRD5A3;SPP1;HSD17B7;HSD17B10
prerank,ERBB2 signaling pathway (GO:0038128),-0.39131900568380273,-1.239209094135797,0.1939655172413793,0.5978060871076138,1.0,9/31,18.67%,ERBB4;PIK3R1;GAB1;MYOC;EGFR;HSP90AA1;EGF;ERBIN;NRG2
prerank,thymus development (GO:0048538),-0.4846500845830685,-1.239166029296301,0.21237113402061855,0.5966792341763671,1.0,8/13,29.54%,TBX1;SIX1;SOD1;EPHB3;HES1;FOXE1;FADD;FGF10
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.4880993601531433,1.2391244803658314,0.1976284584980237,0.7068661710723626,1.0,5/19,11.81%,BMP6;AFDN;TJP1;PTPRU;ADAM19
prerank,muscle cell differentiation (GO:0042692),-0.3858631545554858,-1.2390243876969471,0.15935334872979215,0.5958250362435668,1.0,6/32,3.45%,SYNE1;SGCZ;MEF2C;DMD;MRTFB;TBX1
prerank,O-glycan processing (GO:0016266),0.3867041955085926,1.2384590480448505,0.16666666666666666,0.7077044438059973,1.0,9/54,9.82%,GALNT14;GALNT15;MUC2;GXYLT2;GALNT12;GALNT2;GALNT1;GCNT4;C1GALT1C1
prerank,regulation of mitochondrial fission (GO:0090140),0.4561613877080813,1.238194564265843,0.22066549912434325,0.7073331029400348,1.0,11/24,21.44%,MCU;STAT2;DCN;RALBP1;LRRK2;DNM1L;MIEF1;MUL1;MYO19;SPIRE1;VPS35
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3981286685306659,1.2377617154157516,0.18076285240464346,0.7075062280521438,1.0,12/43,15.07%,PID1;ENPP1;KANK1;NUCKS1;SORBS1;PRKCZ;PTPN2;IGF2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5103827425977575,-1.2375695614158464,0.21166306695464362,0.5987235143713836,1.0,7/11,36.51%,UQCRH;UQCR11;UQCC3;UQCR10;UQCRQ;CYCS;UQCRB
prerank,regulation of endothelial cell migration (GO:0010594),0.35688844378577417,1.2371102715245668,0.13925925925925925,0.7083167492938361,1.0,12/85,3.88%,PTN;RIN2;ROCK2;SASH1;NR2F2;SP100;FGF1;FOXC2;NRP1;ANXA3;ANGPT1;DCN
prerank,long-term memory (GO:0007616),0.48545934192178664,1.236898057534835,0.20669291338582677,0.7077704141422991,1.0,3/19,8.78%,RASGRF1;NFATC4;PJA2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5493706914192302,1.236500904340103,0.23679060665362034,0.7077952855622212,1.0,3/10,3.40%,STK39;OSR1;NEDD4
prerank,regulation of striated muscle contraction (GO:0006942),-0.3995944691675392,-1.23628093488144,0.1783132530120482,0.6012042228819006,1.0,8/27,12.86%,DMD;RYR2;SMAD7;CALM1;CALM2;CALM3;NOS1;SRI
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.4055069068652872,-1.2361659725902214,0.1592505854800937,0.6003112743801992,1.0,15/28,23.71%,NOTCH3;BEND6;GATA2;AKT1;LFNG;YTHDF2;EGFL7;EGFR;HEY1;EGF;DLL4;DLL1;HIF1AN;RITA1;TCIM
prerank,regulation of receptor internalization (GO:0002090),-0.3840217281022903,-1.2361391737213472,0.18719211822660098,0.5991218707688771,1.0,14/35,19.10%,INSR;ANKRD13A;ATXN2;AHI1;SCYL2;SDCBP;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5;RIN3;MTMR2
prerank,pancreas development (GO:0031016),0.5351980788231364,1.2360956508694623,0.2309197651663405,0.7077911443685652,1.0,2/12,7.17%,TCF7L2;DNAAF1
prerank,activin receptor signaling pathway (GO:0032924),0.5041004458122968,1.236071657578476,0.22426470588235295,0.7066302835581519,1.0,5/15,16.33%,SMAD3;TGFBR1;ACVR1C;ACVR2B;SMAD2
prerank,blood vessel morphogenesis (GO:0048514),0.3787475965051499,1.23599933632208,0.15640599001663893,0.7055836629776748,1.0,10/54,8.55%,EFNB2;TGFBR3;RBPJ;CCM2;ITGB8;NRP1;TGFBR1;RASA1;TGFBR2;ADM
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5302819987919183,-1.2359959494387116,0.2251655629139073,0.5982477907772844,1.0,3/10,5.29%,CSGALNACT1;XYLT1;B3GAT2
prerank,negative regulation of cellular component movement (GO:0051271),0.5042931894568123,1.2359895299972548,0.23454545454545456,0.7044001694857823,1.0,5/15,6.81%,TGFBR3;SP100;TACSTD2;FBLN1;SPINT2
prerank,cell chemotaxis (GO:0060326),0.3735245737032352,1.2359307618319437,0.1617873651771957,0.7033728443039375,1.0,15/60,15.74%,LPAR1;PDGFRA;PARVA;ACKR2;CCR9;NRP1;KIT;PDGFRB;ACKR3;EGR3;NR4A1;EPHA2;CCL25;CCRL2;CXCR4
prerank,transition metal ion transport (GO:0000041),-0.3837959450105811,-1.2357339698199445,0.17761557177615572,0.59768705951845,1.0,10/35,7.54%,TRPC3;TFRC;ATOX1;TRPC5;FTH1;TRPC4;ATP2C1;SLC31A1;TRPC6;SLC30A1
prerank,neuron projection regeneration (GO:0031102),0.5684793191731856,1.2354321810778937,0.23772102161100198,0.7037171108705542,1.0,2/10,5.80%,PTN;NREP
prerank,regulation of insulin secretion (GO:0050796),0.3469176025253985,1.2353887252543192,0.1287988422575977,0.7026372429848264,1.0,15/101,11.81%,TCF7L2;MCU;DPP4;RAPGEF4;ITPR1;RBP4;RFX3;IL6;ADCY5;NOS2;CACNA1C;SIRT4;CDK16;NLGN2;PPP3CB
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.4439512476756866,-1.234957986044151,0.20137299771167047,0.5985301383320517,1.0,10/18,31.22%,GINS3;POLA1;POLD2;POLE;LIG3;RFC4;POLE3;GINS4;PCNA;GINS2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.38074862871480597,-1.2344901649505926,0.17411764705882352,0.598620100580755,1.0,9/33,11.27%,NET1;SETX;MAP3K5;RPS3;PLEKHA1;RHOB;HDAC6;SIGMAR1;PAX2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4470638997679167,1.2339825052218643,0.19965870307167236,0.7058780746245348,1.0,6/26,7.65%,FHL2;RCAN1;ATP2B4;EFHB;SPPL3;GSK3B
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4992055696211741,-1.2332522869013878,0.211864406779661,0.6009859165678734,1.0,4/12,7.21%,SLIT2;PLCB1;CCN3;AKT1
prerank,negative regulation of protein modification process (GO:0031400),0.360511231456339,1.2330365895773474,0.16124260355029585,0.7075772820723236,1.0,12/79,10.16%,PTPN13;IGFBP3;PID1;PLPP3;PRKAA2;FBLN1;SNTA1;ATP2B4;GSK3B;MYADM;LRRK2;XRCC1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5137208208018129,1.2330226739411378,0.23191094619666047,0.7064109105950768,1.0,4/13,8.99%,SORBS1;PRKCZ;ECHDC3;IGF2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.43087292060852933,1.2309621522755814,0.20136518771331058,0.7119583939815658,1.0,6/31,6.97%,PDGFRA;OSR1;HOXC4;TGFBR1;TGFBR2;DYNC2I1
prerank,male gonad development (GO:0008584),0.4221702523176627,1.2307758698242277,0.1879310344827586,0.7113177887548175,1.0,4/34,3.83%,WNT4;GATA6;WNT2B;KIT
prerank,positive regulation of phosphorylation (GO:0042327),0.31121853515133274,1.2307216944089454,0.09261576971214018,0.7102743456340527,1.0,57/240,15.93%,ZBTB20;LEPR;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;PRKAA2;FPR2;WNT3A;INSRR;LMO4;EPHA3;EPHA8;FAM20A;NRP1;VEGFD;IL34;ANGPT1;KIT;BMP2;SLCO3A1;ROR1;ARNT;CCND3;RAD50;EPHA1;PELI2;PDGFRB;RALBP1;FBH1;EPHA4;IGF2;LRRK2;MST1R;MUSK;FGF18;FNIP1;PTK2;DSTYK;EPHA2;DVL3;RARRES2;EFNA1;ARRB1;KCTD20;ALK;P2RY1;NTRK3;RYK;ILK;STK4;DAB2;APP;IGF1R
prerank,regulation of phospholipase C activity (GO:1900274),0.4951293651374253,1.2306390694078548,0.20348837209302326,0.7093060000517739,1.0,4/15,6.10%,PDGFRA;FGFR1;KIT;PDGFRB
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4601568486028874,-1.2296523379038595,0.19772727272727272,0.6100370381070664,1.0,7/16,16.37%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;HTR2B
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3699579927434947,1.2294036685612768,0.16018662519440124,0.7118441847073125,1.0,18/68,17.54%,AMPD3;ENPP1;ACOT11;PTHLH;TPST1;ENTPD7;RHOQ;LRRK2;ACOT9;ACOT1;ACAT1;EPHA2;EFL1;OPA1;SULT1A1;ABHD14B;RAN;GNAI3
prerank,histone monoubiquitination (GO:0010390),0.45318294258836894,1.2294009094592215,0.21390374331550802,0.7106559101778626,1.0,10/24,16.98%,BCOR;DTX3L;RNF20;CDC73;WAC;PAF1;LEO1;KDM2B;RING1;RNF2
prerank,nitric oxide metabolic process (GO:0046209),-0.4693777237393012,-1.2293977528047562,0.22338204592901878,0.6094066582844504,1.0,4/14,10.31%,NOS3;AKT1;NOS1;GCH1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.44048002152141336,1.2291160901367946,0.20418848167539266,0.7103291904903724,1.0,5/29,8.09%,PLA2G4A;MBOAT2;NR1H3;PLA2G4C;PLA2G6
prerank,RNA metabolic process (GO:0016070),0.32856151650357807,1.2288665709353994,0.14086471408647142,0.7099325096086027,1.0,37/127,20.84%,CELF2;ATXN1;RBMS1;RBFOX2;POLR2D;RBMS2;PAPOLG;LSM1;NOVA1;HNRNPH1;FTO;HNRNPC;RBM39;SND1;POLR2C;HNRNPH3;ADAR;SUPV3L1;DHX8;RBM5;POLR2F;RBM6;TENT2;PABPN1;ALKBH1;HNRNPR;HNRNPA2B1;NUFIP1;RNASEH1;PCBP2;DHX36;RNASE3;SNRNP40;RNASEL;RNGTT;POLR2K;PARN
prerank,cellular metal ion homeostasis (GO:0006875),-0.3019566099376613,-1.2287417758431987,0.08754208754208755,0.6100809401982725,1.0,26/102,15.34%,SLC12A2;KCNMA1;ATP1B1;SLC24A2;RYR2;TPT1;KCNJ2;HTR2C;ATP1A1;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;SLC30A1;CXCL12;NEDD4L;CALR;SLC10A7;CD40;TMCO1;CAV1;ATP2A2;CCL19;ATP13A4;ATP1A3
prerank,bile acid and bile salt transport (GO:0015721),-0.4174331235945312,-1.2281925368005653,0.1822429906542056,0.6103984554846722,1.0,8/24,23.42%,ABCC4;SLCO1C1;CEACAM1;ATP8B1;RXRA;STARD5;SLC10A3;SLCO1B1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.393597073885727,-1.2280794795576948,0.1674641148325359,0.6094433361587873,1.0,10/29,22.46%,MEF2C;TFRC;CD38;CD74;CD40;PTPRC;CLCF1;CD320;MIF;CD81
prerank,negative regulation of synaptic transmission (GO:0050805),-0.4224975944906805,-1.227763255485773,0.19187358916478556,0.609072662873901,1.0,8/23,19.34%,SLC24A2;SHANK2;STXBP1;SLC30A1;ATAD1;GRIK3;MTMR2;TMEM25
prerank,respiratory system development (GO:0060541),0.41982202379661937,1.2276144930136241,0.20862068965517241,0.7127379472157668,1.0,5/32,7.17%,PDPN;FGF1;RBP4;LOXL3;DNAAF1
prerank,cellular glucose homeostasis (GO:0001678),0.39668299698536025,1.22757497141755,0.2039151712887439,0.711668173318437,1.0,7/41,9.01%,ZBTB20;PRKAA2;NUCKS1;UNC13B;CARTPT;NGFR;HKDC1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.48901091617044395,1.2274485548576965,0.25457875457875456,0.7108716672359546,1.0,2/16,2.51%,WNT4;VIM
prerank,neuron projection extension (GO:1990138),0.42499673727914467,1.2271725923024461,0.200339558573854,0.7105686670444205,1.0,11/32,15.71%,ALCAM;AUTS2;NRP1;CPNE1;USP9X;FLRT1;PPP3CB;SPG11;CDKL3;IQGAP1;FLRT3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.348850627984493,-1.2268949047961357,0.136,0.6102835359160153,1.0,21/47,25.74%,ATP5F1A;ATP5MC1;ATP5PO;GHITM;SAMM50;TIMM8B;ATP5F1B;ATP5PD;MAIP1;ATP5F1D;MTX3;MTX1;TIMM22;UQCC3;NDUFA13;ATP5F1E;TIMM10;ATP5ME;ATP5MG;ATP5MC3;ATP5MF
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5363299746219574,1.2266644833842903,0.2549019607843137,0.7109500750372356,1.0,4/11,17.30%,GRK3;ADM;ARRB1;GTF2H2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5131149452887754,1.2265419202710448,0.21821631878557876,0.7101538573622964,1.0,6/15,14.82%,WNT6;FOXC1;BMP2;EDA;ANKRD11;HDAC2
prerank,cellular response to interleukin-6 (GO:0071354),0.43990573277724354,1.2261254516792763,0.20214669051878353,0.7102455795678773,1.0,8/26,13.10%,PID1;IL6ST;FER;IL6;STAT1;YAP1;SMAD4;JAK1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4767163904970244,1.225322850389258,0.25668449197860965,0.7116317227890668,1.0,2/17,2.51%,WNT4;VIM
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.31705312555705056,-1.225303579006317,0.143646408839779,0.6122519768993007,1.0,36/78,27.92%,ACTR10;SH3GL2;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.31705312555705056,-1.225303579006317,0.143646408839779,0.6122519768993007,1.0,36/78,27.92%,ACTR10;SH3GL2;CTSD;OSBPL1A;LGMN;AP1S1;CTSS;AP1S2;DYNC1H1;CD74;KIF26A;FCER1G;KIF18A;CTSL;KIF15;KIF3B;DYNC1I2;KIF5A;DYNLL2;AP1B1;ACTR1B;CAPZA2;SAR1B;AP2B1;KIF23;AP1S3;DCTN1;KIF22;KIF4A;RACGAP1;DCTN6;AP2A2;AP2A1;CLTA;AP2M1;KLC2
prerank,regulation of lymphocyte activation (GO:0051249),-0.4928942390775615,-1.2249224714559008,0.2384937238493724,0.6120209911650865,1.0,8/12,37.58%,KAT2A;PAG1;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4309707904364133,1.2244503332347358,0.20623916811091855,0.7130816260718316,1.0,8/33,11.84%,MTURN;STAT5B;ARNT;BRD1;STAT1;FAM210B;MAPK14;FOXO3
prerank,cell-cell junction maintenance (GO:0045217),0.5395667608924498,1.2241885596331439,0.22690763052208834,0.7126723354338873,1.0,4/11,11.27%,PARD6A;MYADM;TJP1;NLGN2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.37861627715194623,-1.2239157217711658,0.1872037914691943,0.6136256236578905,1.0,17/32,32.16%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;TOPBP1;PLK1;CDK1;TICRR
prerank,aerobic respiration (GO:0009060),-0.41848135004437415,-1.2237020130147087,0.19866071428571427,0.6129089833170124,1.0,8/20,24.28%,SDHC;ME3;NDUFS7;UQCRH;ATP5F1D;MTFR1L;MDH2;UQCR10
prerank,immunoglobulin mediated immune response (GO:0016064),-0.5211280817256179,-1.2220679960966279,0.221505376344086,0.6162056553916031,1.0,7/10,41.12%,CD74;FCER1G;CD27;CD81;TLR8;FCGR2B;CARD9
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3671229563892394,1.221539795171713,0.16666666666666666,0.7197994112158805,1.0,14/66,12.35%,ROBO1;SASH1;FGFR1;FGF1;IL34;KIT;TAOK3;PDGFRB;LRRK2;PIK3R5;MST1R;FGF18;MAP3K7;DVL3
prerank,regulation of focal adhesion assembly (GO:0051893),0.37642052780087576,1.2212854629180045,0.17298187808896212,0.7193900727199354,1.0,10/54,6.00%,PHLDB2;ARHGAP6;ROCK2;DLC1;EPHA3;NRP1;S100A10;CLASP1;VCL;PTPRA
prerank,actin crosslink formation (GO:0051764),0.5213464776786139,1.2210466722198436,0.23809523809523808,0.7188462458109218,1.0,2/12,4.72%,DPYSL3;BAIAP2L1
prerank,regulation of anoikis (GO:2000209),0.4664153471228834,1.2208087692799627,0.213768115942029,0.7183736369220508,1.0,5/19,11.16%,TLE1;ITGA5;BCL2;MCL1;PTK2
prerank,mitochondrion morphogenesis (GO:0070584),0.531551608172688,1.2207933459419233,0.2414448669201521,0.7172433453241492,1.0,7/11,24.57%,PID1;DNM1L;SUPV3L1;WASF1;PNPT1;SLIRP;MTM1
prerank,cellular response to alkaloid (GO:0071312),-0.45230328907645184,-1.2205184691188051,0.21568627450980393,0.619480726532481,1.0,6/17,16.12%,RYR2;RYR3;CASP7;SLC8A1;CASQ2;RAD51
prerank,positive regulation of cell adhesion (GO:0045785),-0.31849265806730537,-1.2202297377132645,0.12759643916913946,0.6190758417219593,1.0,17/74,13.66%,FRMD5;PTPRJ;TGFB2;ZFHX3;SMAD7;STX3;VIT;ADGRG1;NDNF;VEGFA;CXCL12;ATM;RET;MEGF10;SYK;EPB41L4B;RAC1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3877767878465753,-1.2198463092861231,0.18055555555555555,0.6188918581612184,1.0,8/29,14.75%,SMAD7;RPS2;PINK1;FEM1A;DCUN1D2;DCUN1D5;DCUN1D1;PARK7
prerank,neuron differentiation (GO:0030182),-0.28047001974635744,-1.2191179573397353,0.05725190839694656,0.6196892440295341,1.0,29/165,11.12%,PTPRD;MEF2C;TENM2;TGFB2;TENM3;EPHA5;ACSL3;MYT1L;RORB;PBX3;FUT9;NTRK2;IL1RAPL1;ATP8A2;VSX1;MET;LHX6;CTNNB1;TENM4;FZD3;MYEF2;THOC2;VEGFA;LRP6;SPOCK1;SNPH;DDIT4;MANF;RUNX1
prerank,visual perception (GO:0007601),0.3563803073016022,1.2188570822383566,0.15963855421686746,0.7221190223885077,1.0,16/84,15.15%,EFEMP1;RDH10;ZIC2;ADGRV1;MYO9A;TULP2;COL18A1;CRYBB3;IMPG2;EYA4;ATXN7;CRYBA1;OPA1;EML2;PDE6C;CEP250
prerank,C4-dicarboxylate transport (GO:0015740),-0.4634917147744585,-1.2188529921742532,0.2374727668845316,0.6192142589108636,1.0,7/14,30.59%,SLC1A1;SLC1A2;SLC25A30;SLC25A13;SLC25A12;LRRC8E;SLC13A5
prerank,cytoskeleton organization (GO:0007010),0.3400386498335838,1.218770955931263,0.14410480349344978,0.7211855036677787,1.0,22/114,11.96%,MICAL3;DIAPH1;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;BRWD1;DES;TPM1;PLCE1;RHOBTB2;RHOF;PACSIN2;CAPZB;CCL2;FMNL2;CNN2;CECR2;SPRYD3;ZMYM6;RHOC
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.424582562451637,1.2187368203225772,0.2061328790459966,0.7200834276731811,1.0,6/29,9.14%,ZBTB20;SORBS1;NR1H3;CREBL2;PPARA;SIRT4
prerank,regulation of embryonic development (GO:0045995),0.41741625601720794,1.2186537158884414,0.19210977701543738,0.7191723090531877,1.0,5/34,5.18%,PHLDB2;DAG1;TRIP12;CLASP1;PHLDB1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4278995133571559,-1.218583249678789,0.21615720524017468,0.618788463621193,1.0,5/18,14.81%,NAV3;CD34;HDAC7;HAVCR2;PTPRC
prerank,cellular protein modification process (GO:0006464),0.2813456331006302,1.2184549932564104,0.02,0.718644650199183,1.0,194/983,15.91%,PTPN13;IGFBP3;CP;PDPK1;PDK1;UST;TNC;FBN1;TEC;PARP14;LAMC1;ROCK2;FSTL1;NRK;ZC3HAV1;COL3A1;FN1;PRKCSH;PRKAG2;FGFR1;LTBP1;GRK3;FAM20C;SPSB1;STK39;GALNTL5;PRKAA2;OXSR1;EIF2AK2;TPTE;IGFBP5;TSSK3;APOA2;HIF3A;PPM1E;PPM1A;BMPR1A;FSTL3;SDC2;BMP2K;FAM20A;FER;MAN2A1;FBXO11;PARP9;CDK8;RCN1;ANXA1;DUSP10;ITIH2;PTPN14;DAPK1;BMP2;TAOK3;PTPN4;LARGE1;IL6;IKBKE;LOXL1;EPAS1;MIA3;PTPN3;PRKCZ;ARAF;LATS2;MAP3K1;AAK1;PTPN22;TGFBR1;LIPT1;MORC3;KLHL21;KLHL22;SPSB4;PARP3;APLP2;CUL4A;MAPK6;PTPRA;ARF4;MTMR3;DUSP16;PTPN9;FBXO9;NPC1;PARP10;TGFBR2;SSH1;PTPN21;MAP4K1;FAM20B;GSK3B;FBXL3;CCL2;NUB1;NEK4;WNK4;PPEF2;PSMB10;PPP4R2;FUT4;MANBA;CHM;CTDSP2;STK24;STK3;SIK3;PSMA3;SIRT4;FBXL20;PSME4;LRRK2;PPP4R1;COQ8B;TLK2;TRIOBP;CDK7;CDK12;HLCS;FUT10;TIPARP;FBXL7;DNAJC3;CDK16;FBXO4;PSMA5;WWP2;PPM1B;AKT3;HIPK3;GRK5;KEAP1;PTPN6;PPP1CB;IRAK3;PTPRU;CUL3;KLHL13;PPP3CB;CSF1;DUSP5;ANO8;FNTB;ILF3;PARP16;BTRC;PTPN1;PTPN18;DAPK2;MAP2K1;FBXW11;ASB5;MAP3K13;PORCN;PLAT;STRADB;JAK1;SRPK1;WDR45B;MAPK9;PPM1M;ALG1;ACVR1C;FBXL4;WNK1;DDA1;TRIB1;CHRDL1;TBK1;FRK;NUAK2;VHL;BIRC6;RARA;PTPRR;FBXL13;EIF2AK3;RYK;PDF;ILK;FBXL12;LIMK1;ASB3;CDKL3;STK4;ACVR2B;SOCS6;TXK;PKN2;PRKD2;ERN2;IGFBP4;APP;CTDSP1
prerank,phosphorylation (GO:0016310),0.29436642825661385,1.2183157280194055,0.06993006993006994,0.7178984570418985,1.0,89/385,15.86%,IGFBP3;PDPK1;PDK1;TEC;ROCK2;NRK;EPHA7;PRKAG2;FGFR1;GRK3;FAM20C;STK39;PRKAA2;OXSR1;EIF2AK2;TSSK3;BMPR1A;BMP2K;FAM20A;FER;DGKD;CDK8;DAPK1;BMP2;TAOK3;IKBKE;PI4KA;PRKCZ;TOP1;LATS2;MAP3K1;AAK1;TGFBR1;MORC3;PANK2;MAPK6;TGFBR2;MAP4K1;FAM20B;GSK3B;CCL2;NEK4;WNK4;STK24;STK3;SIK3;GK5;LRRK2;PPP4R1;COQ8B;TLK2;CDK7;CDK12;CDK16;AKT3;HIPK3;GRK5;IRAK3;XYLB;PPP3CB;ILF3;DAPK2;MAP2K1;MAP3K13;STRADB;JAK1;SRPK1;MAPK9;ACVR1C;WNK1;TRIB1;ALK;TBK1;FRK;NUAK2;BIRC6;RARA;EIF2AK3;RYK;ILK;LIMK1;CDKL3;STK4;ACVR2B;TXK;PKN2;PRKD2;ERN2;APP
prerank,organic acid transport (GO:0015849),0.3407191294977884,1.2180381637890223,0.16879432624113475,0.7175705869032829,1.0,9/94,5.61%,SLC7A11;PDPN;SLC7A2;SLC13A3;SLC6A13;SLC19A1;SLC6A12;SLC7A14;ACSL1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.4871831902731087,-1.217335631480207,0.24380165289256198,0.6211429770222632,1.0,7/13,17.72%,MGAT5;DOT1L;PTPRT;PIGU;PTPRC;EGF;HES1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.49701263189421646,1.217334838348918,0.24493554327808473,0.7186835172529795,1.0,6/15,13.10%,PDPK1;FGF1;ITGA5;JMJD8;TJP1;JAK1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5035654434096962,1.2163921718419455,0.2375886524822695,0.7205250331129062,1.0,3/15,8.07%,SH3D19;NRDC;SNX9
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3977034107960543,1.2161060175315803,0.178125,0.7202325571799424,1.0,10/44,12.52%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;LBR;CH25H
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.42715124710008423,-1.2159807481338645,0.1704781704781705,0.6238424448343796,1.0,6/19,14.20%,PTPRD;IL1RAPL1;CAPRIN2;LRP8;DBNL;RELN
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.41788531277224983,-1.21564411265952,0.19817767653758542,0.623530597570084,1.0,7/23,15.32%,PDE4B;RYR2;SNCA;MAPK3;KCNQ1;ATF4;NR4A3
prerank,positive regulation of cellular component organization (GO:0051130),-0.2980642437615346,-1.2147383703679449,0.10197368421052631,0.6248315536554646,1.0,30/107,18.34%,ATP10A;NRXN1;SHANK3;TGFB2;INSR;TFRC;SNCA;RPS3;DAB2IP;SLF1;VEGFA;TGFB3;NEDD4L;GNL3L;TAL1;RACK1;RUNX1;LMAN1;SYK;TMEM30A;RELN;MPP7;PARK7;BMF;CCL19;CBLL1;ADD1;MMP1;TPPP;ABCB4
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4698166985157574,1.2147355718578075,0.24118738404452691,0.7234207780954742,1.0,4/17,6.37%,PRKAG2;PRKAA2;PANK2;PPARA
prerank,retinol metabolic process (GO:0042572),0.5090802289054124,1.2145244082988351,0.258252427184466,0.7229238345915843,1.0,2/14,3.35%,RDH10;RBP4
prerank,photoperiodism (GO:0009648),0.43346020005792973,1.2144215597312336,0.20783645655877342,0.7220687016955257,1.0,11/28,19.62%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;PML;FBXL12;PER3;CLOCK;BHLHE40
prerank,androgen receptor signaling pathway (GO:0030521),0.545965901861844,1.2141577029980022,0.2361111111111111,0.7216858206218392,1.0,2/11,3.82%,ZMIZ1;PMEPA1
prerank,organic substance transport (GO:0071702),-0.2922319428543212,-1.213872946132292,0.09407665505226481,0.6261558706187756,1.0,36/121,23.42%,ATP8A1;ABCG2;SLC47A1;LRP1B;SLCO2A1;ABCA3;SPNS2;SCAMP5;LMAN2L;RAB38;SCAMP1;SCAMP2;VPS33B;RAMP2;SLC22A6;MFSD2A;ABCD2;SLC22A5;GM2A;SLC50A1;CHMP1A;CHMP1B;CEP290;MFSD12;PEX19;CHMP2B;CD320;SLC35F3;DISP1;SLC19A2;CHKA;SLC18A2;CENPF;ABCA13;CHMP2A;SLCO1B1
prerank,regulation of MAPK cascade (GO:0043408),0.3228822730625497,1.2138630651621607,0.13648648648648648,0.7214504562290192,1.0,21/157,6.19%,TGFBR3;LPAR1;ROCK2;NRK;FN1;EPHA7;FGFR1;KSR1;OSM;IL11;EPHA8;DAG1;PRDM11;KIT;BMP2;TAOK3;IL6;ROR1;GSDME;PELI2;TRIM5
prerank,negative regulation of cellular process (GO:0048523),0.2893117071618406,1.2138197875843004,0.048478015783540024,0.7204212057391165,1.0,119/521,17.78%,ALDH1A2;PLXNA2;IGFBP3;PDPN;TGFBR3;PODN;COL4A3;SMAD3;KANK2;CCN2;SP100;ENPP1;EIF2AK2;TPTE;NUPR1;LDOC1;GJA1;DLC1;PDS5B;OSM;CASK;FBLN1;PIWIL4;ADAMTS1;TGFB1I1;PRDM11;PTHLH;SUZ12;PTPN14;ANGPT1;BMP2;IGFBP6;IFI35;APBB1;IL6;BTG3;GSDME;MIA3;BMP7;BCL2;BTG4;APPL2;NR1H3;FOXP3;RASA1;BST2;PTPN2;COL18A1;ZBTB7C;POU1F1;CLMN;CDC73;PDCD5;SKI;CDKN2B;CRLF3;IFITM1;SMAD6;SUSD2;DCBLD2;NUPR2;CGRRF1;GMNN;IFNLR1;PTPN6;CDH13;TLR2;SMAD4;PTPRU;SH2B3;NR4A1;TSPYL2;VGLL4;NUDT6;PARP16;SERTAD2;SLURP1;NDUFS3;MAP2K1;DACT2;RBM5;SERTAD3;RTN4;MDM4;IFIT3;LRPAP1;WDR6;NCK1;FRK;ABI1;VHL;NIBAN2;PML;TNS2;EIF2AK3;CHMP4B;SMARCA4;KAT2B;MUL1;P3H3;SOX4;PKD2;APP;INHA;AXIN2;NF2;S100A11;PSRC1;PPP2CA;CDKN3;GAS8;PODXL;DLG5;OSGIN2;TXNIP;DNAJB2;OSGIN1;PPP2R5C;TENM1
prerank,primary neural tube formation (GO:0014020),0.42750972264851994,1.2136330865425256,0.2071917808219178,0.7198060495297703,1.0,6/30,7.91%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,regulation of JNK cascade (GO:0046328),-0.30171532782387767,-1.213383463374597,0.10472972972972973,0.6263066136447779,1.0,33/101,17.54%,MECOM;PLCB1;PTK2B;TPD52L1;PHLPP1;MAP3K5;EPHB1;DAB2IP;HMGB1;RASSF2;MAP3K11;SDCBP;MFHAS1;PINK1;DUSP22;MAPK8IP1;MINK1;GADD45G;ANKRD6;EGFR;SEMA3A;MAPK8IP3;HRAS;SH3RF3;CCL19;CYLD;NOD2;COPS5;MEN1;CD27;DUSP15;LTBR;PYCARD
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3550099095050906,1.2130942461147627,0.16815476190476192,0.7204029258395771,1.0,11/84,3.83%,PDPK1;RIN2;ROCK2;SASH1;FGFR1;FGF1;PLPP3;FOXC2;NRP1;ANXA3;ANGPT1
prerank,skin development (GO:0043588),0.3650853460800516,1.2130004695212881,0.17073170731707318,0.7195443869958118,1.0,23/65,21.85%,COL5A2;COL3A1;GATA6;ANXA1;ERRFI1;COL5A1;CLIC4;CLDN1;ALOXE3;WNT5A;KRT9;EPHA2;DACT2;OPN3;COL1A2;TXNIP;CASP3;DSP;WNT10A;COL1A1;PIP5K1A;TGM1;PKD1
prerank,negative regulation of receptor binding (GO:1900121),-0.5135202831958049,-1.2129088564467265,0.24180327868852458,0.626385786243495,1.0,4/10,13.61%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3939755596880441,1.2128519789132912,0.20292207792207792,0.7188383869715953,1.0,7/42,7.89%,SELP;IL6;TLR4;SERPINE1;OPTN;NOS2;TNFRSF14
prerank,magnesium ion transport (GO:0015693),-0.48506187029802994,-1.2127388019568066,0.24158415841584158,0.6256510283865573,1.0,5/12,10.29%,CNNM4;NIPAL3;NIPAL4;NIPA2;NIPA1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3959587630515116,1.212540255228191,0.2144,0.7186066895439482,1.0,13/45,16.12%,BMP6;BMPR1A;TWSG1;BMP2;BMP7;TGFBR1;BMP8B;SMAD4;HFE;GDF11;GDF15;DAB2;INHA
prerank,lymphocyte chemotaxis (GO:0048247),0.41170200059369266,1.2123548857747108,0.20632279534109818,0.7180381944963248,1.0,6/34,7.70%,CXCL10;CXCL16;CYP7B1;CKLF;MSMP;CCL2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4372077980394017,1.2122122240731064,0.20618556701030927,0.7173379471587306,1.0,9/27,15.60%,FBXL17;CRY2;CRY1;FBXL3;CRTC1;PPP1CB;PML;FBXL12;PER3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4249123694358642,1.212156567880972,0.2167577413479053,0.7163701274966405,1.0,6/27,6.10%,PDGFRA;FPR2;AMBRA1;EPHA8;KIT;PDGFRB
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42417381317983577,1.212025127421324,0.23450586264656617,0.7156623508839841,1.0,7/30,14.94%,LEPROT;NPEPPS;PDCD5;HUWE1;RHOU;USP36;CSNK2A2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.48956360639831065,-1.2119738844829666,0.22317596566523606,0.6266785373373919,1.0,7/12,31.32%,OPLAH;GCLC;GGT1;HAGH;MGST2;BDH2;GCLM
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5239346009557719,-1.2116998226812963,0.22540983606557377,0.6262121953135474,1.0,5/10,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3248882497673685,1.2112226050474524,0.13397790055248618,0.7170078597588949,1.0,40/138,15.93%,STYK1;PTN;EPHA7;PDGFRA;FGFR1;AXL;DDR2;IL31RA;IL6ST;INSRR;EPHA3;EPHA8;FRS2;FER;KIT;EFS;ROR1;EPHA1;PDGFRB;BDKRB2;NPPC;EPHA4;MTSS1;MST1R;POLR1G;MUSK;PTK2;PTPRU;CSF1;EPHA2;BDNF;SHC2;ALK;FRK;ABI1;GUCY2C;NTRK3;RYK;ACVR2B;IGF1R
prerank,positive regulation of neuron death (GO:1901216),0.39096612422076216,1.2110280210055644,0.2078740157480315,0.7164942088376759,1.0,7/46,8.47%,EFNB2;EPHA7;NUPR1;TLR4;GSK3B;BAX;WNT5A
prerank,7-methylguanosine RNA capping (GO:0009452),0.42425614824322944,1.210893804445473,0.2027729636048527,0.7146364352491785,1.0,15/31,27.64%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;RNGTT;POLR2K;POLR2H;CMTR1;GTF2F1;ERCC2;ERCC3
prerank,7-methylguanosine mRNA capping (GO:0006370),0.42425614824322944,1.210893804445473,0.2027729636048527,0.7146364352491785,1.0,15/31,27.64%,POLR2D;CCNH;MNAT1;CDK7;POLR2C;POLR2F;GTF2H4;GTF2H2;RNGTT;POLR2K;POLR2H;CMTR1;GTF2F1;ERCC2;ERCC3
prerank,positive regulation of cyclase activity (GO:0031281),-0.46654065308143,-1.2107303092449406,0.20815450643776823,0.6278382154716178,1.0,5/14,10.30%,NOS3;MAPK8;MAPK3;CACNA1D;NOS1
prerank,primary miRNA processing (GO:0031053),0.5441322448926179,1.2103179534122819,0.2647058823529412,0.715294691750527,1.0,5/10,21.81%,SMAD3;SMAD2;HNRNPA2B1;PUS10;SRRT
prerank,tube closure (GO:0060606),0.4227674768795075,1.210247249919411,0.2117039586919105,0.7143744307368799,1.0,6/31,7.91%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,striated muscle contraction (GO:0006941),0.37140551163647906,1.2096270998468424,0.19286871961102106,0.7151963974869766,1.0,7/53,10.19%,TNNC1;ATP1A2;CSRP3;TPM1;ARHGEF11;SCN3B;RCSD1
prerank,apical protein localization (GO:0045176),-0.5151632018340402,-1.2096154679190776,0.2405857740585774,0.6297932570269269,1.0,8/10,17.16%,ACTB;GOPC;MAL;JAM3;ATP8B1;SHROOM3;INSC;VANGL2
prerank,myelination in peripheral nervous system (GO:0022011),-0.4753470149963512,-1.2096048423658903,0.2245762711864407,0.6285880207242113,1.0,5/13,18.02%,ADGRG6;MYOC;SOD1;NCMAP;DICER1
prerank,regulation of feeding behavior (GO:0060259),0.5244681610916809,1.2093866961032913,0.2795275590551181,0.7148631381906579,1.0,2/11,5.27%,LEPR;UCN
prerank,cellular response to cAMP (GO:0071320),-0.3882202980886869,-1.209360478560458,0.19014084507042253,0.6280955885024021,1.0,8/30,12.24%,AKAP6;HCN1;SLC5A5;INPP5K;HCN2;RAPGEF2;PDE2A;KCNQ1
prerank,leukotriene biosynthetic process (GO:0019370),0.5080547151662413,1.2092758228587475,0.27071823204419887,0.7141233863417787,1.0,2/14,2.95%,PLA2G4A;GGTA1
prerank,embryonic digestive tract development (GO:0048566),0.4881868890166356,1.208896041447195,0.21955719557195572,0.7141265840445827,1.0,4/18,6.77%,PDGFRA;GLI3;SALL1;RARB
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.41197377491103837,1.2081224006868096,0.2286212914485166,0.7153211774643989,1.0,9/34,13.47%,PHIP;TGFA;PDGFRB;ANAPC11;ESPL1;IGF2;CUL3;NSMCE2;CDC27
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4849927762181748,1.2080970709216878,0.263254113345521,0.7142970262999172,1.0,4/17,18.72%,PLA2G4A;SERAC1;LPGAT1;PLA2G5
prerank,lipid transport (GO:0006869),-0.30362455687248113,-1.2080518500132345,0.125,0.6305877946539492,1.0,16/97,8.59%,ATP8A1;ABCC4;SLCO1C1;SLCO2A1;CERT1;PITPNC1;PITPNA;ABCA3;SPNS2;PPARD;GLTP;SCARB1;CEACAM1;PRELID2;PRELID1;ATP8B1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4257825521968497,-1.2079393694798006,0.21524663677130046,0.6296988624348052,1.0,5/20,14.61%,FUT8;ST3GAL6;FUT9;ST6GALNAC5;ST3GAL4
prerank,positive regulation of calcium ion transport (GO:0051928),-0.36950930957920886,-1.2075502505550015,0.18622448979591838,0.6295651151719052,1.0,9/36,12.95%,CACNB2;TRPC3;TRPC6;CAMK2A;MYLK;GRIN1;CXCL12;CACNA1D;CAV1
prerank,negative regulation of immune response (GO:0050777),0.3222143814810618,1.2073507056513906,0.1396957123098202,0.7154118076638291,1.0,23/154,12.33%,ENPP3;COL3A1;GHRH;ADORA2A;FER;PTHLH;RC3H1;GLP2R;IL6;ADCY5;ADCY7;MC2R;FOXP3;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;PPM1B;GPR39;IRAK3;TRIM21
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3439766938879463,1.2073288591511409,0.15373563218390804,0.7143770562294961,1.0,16/101,8.47%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;MTDH;PTPN22;SERPINE1;NR1H3;IL18;CDC73;CCL2;LY96;CD274;WNT5A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.42393171545389097,1.2072104912049342,0.22552447552447552,0.7136267696013023,1.0,10/28,15.07%,PID1;ENPP1;KANK1;PRKCZ;APPL2;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,positive regulation of hydrolase activity (GO:0051345),-0.28620890292318474,-1.2068391855407252,0.09965635738831616,0.6303449520638353,1.0,34/137,15.18%,DOCK9;ITGA6;BCAR3;DOCK10;NET1;CALM1;SEMA4D;CALM2;MAPK8;RPS3;TBC1D30;RAB3GAP1;CCL14;RAPGEF2;CALM3;RGS7;MTCL1;RGS6;PINK1;ARHGAP27;RACK1;CAV2;CD40;DOCK8;ALS2;ARHGEF7;RGP1;RAPGEF6;F11R;HRAS;AGRN;EVI5;SNX18;CCL19
prerank,apoptotic cell clearance (GO:0043277),-0.38321560107929115,-1.2062029118474733,0.20572916666666666,0.630905848060029,1.0,11/30,17.36%,THBS1;XKR4;GAS6;HMGB1;SCARB1;XKR6;RHOG;MEGF10;RAC1;RHOH;RHOBTB1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4388368685369659,1.2056884303284336,0.2556390977443609,0.7171244974769192,1.0,3/25,4.19%,PDPK1;CXCL10;F2RL3
prerank,carbohydrate derivative transport (GO:1901264),-0.44234478022186763,-1.2056633549028177,0.21651785714285715,0.6312174268587539,1.0,6/18,15.72%,SLC15A2;SCARB1;SLC10A7;VLDLR;MFSD2A;SLC25A19
prerank,negative regulation of peptidase activity (GO:0010466),0.3877245885182883,1.2052113499825465,0.21337579617834396,0.7174366014298192,1.0,11/47,12.45%,VTN;ECM1;TIMP3;SERPING1;CSTB;SERPINB7;SERPINE1;TIMP2;SERPINE2;SERPINB8;SERPINE3
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4349636111859764,1.2049690769743748,0.22956521739130434,0.717112548754603,1.0,6/28,7.40%,ARHGAP18;ARHGAP28;HAX1;RASA1;PLEKHG2;DBN1
prerank,response to metal ion (GO:0010038),-0.3254491473941065,-1.2042490154957237,0.1424581005586592,0.6338605177240689,1.0,18/67,17.19%,TRPC3;KCNMA1;THBS1;MT1A;MT1X;HOMER1;CALM1;SNCA;CALM2;GPHN;CALM3;NEDD4L;PPP1CA;MT2A;CAV1;MAPT;ATP5F1D;SLC25A13
prerank,regulation of establishment of cell polarity (GO:2000114),0.49653663527736636,1.204199636961833,0.263254113345521,0.7184742339907022,1.0,3/16,2.79%,ROCK2;KANK1;CDH5
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.40537830257415003,-1.2037593900672308,0.19457013574660634,0.6340844957642296,1.0,8/24,20.39%,ANK3;CEMIP;MTCL1;MFF;KCNB1;HRAS;C2CD5;ITGB2
prerank,regulation of protein neddylation (GO:2000434),-0.5152973844004208,-1.2033320202713274,0.25,0.6340992237875009,1.0,6/10,14.48%,RPL5;RPL11;DCUN1D2;COPS9;DCUN1D5;DCUN1D1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.37659087141414205,1.2029668802627602,0.19236883942766295,0.7211117432708519,1.0,17/56,16.12%,BMP6;BMPR1A;LDLRAD4;TWSG1;PMEPA1;BMP2;BMP7;TGFBR1;BMP8B;SMAD6;SMAD4;HFE;NOG;GDF11;GDF15;DAB2;INHA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.483014736307108,1.2028925999339701,0.2407766990291262,0.7202381739437094,1.0,3/17,7.50%,CD55;TLR4;IL18
prerank,regulation of sensory perception of pain (GO:0051930),-0.49909478271640145,-1.2024837368170995,0.23709369024856597,0.635322639935934,1.0,2/11,4.39%,MGLL;CCN3
prerank,heart trabecula morphogenesis (GO:0061384),0.47614065466151007,1.202017313795239,0.26958105646630237,0.7217907934548905,1.0,6/18,5.16%,TGFBR3;RBPJ;BMPR1A;RBP4;BMP7;TGFBR1
prerank,negative regulation of axonogenesis (GO:0050771),-0.38492353265436285,-1.2019094410059257,0.2039911308203991,0.6356914080980416,1.0,11/27,20.76%,DIP2B;DCC;SEMA3G;FGF13;ULK1;MCF2;ARHGDIA;MAP2;EFNB3;OMG;TRIM46
prerank,embryonic digit morphogenesis (GO:0042733),0.4716226460755943,1.2017672255440686,0.2313167259786477,0.7214969222742605,1.0,6/18,14.82%,OSR1;GLI3;SALL1;CREBBP;NOG;HDAC2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3166789235072862,-1.2015812161300765,0.1468354430379747,0.6354195570716832,1.0,18/65,15.98%,PTPRJ;HIP1;BCAR3;SH3KBP1;HIP1R;DAB2IP;SH3GL2;CCDC88A;AKT1;CEACAM1;MVB12B;CBL;ARHGEF7;EGFR;PLAUR;RNF126;RHBDF2;EGF
prerank,glycogen metabolic process (GO:0005977),0.43538977153924996,1.2015343834413046,0.23488773747841105,0.7211010378612405,1.0,6/27,11.43%,PRKAG2;PYGB;GYG1;GSK3B;PYGM;STBD1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.34871747132226344,-1.201468645256883,0.17804878048780487,0.6345029223466183,1.0,14/43,23.49%,MEF2C;NOTCH1;SOX17;AHI1;ZIC3;TBX2;NDRG4;SOX18;APLNR;VANGL2;DLL1;SRF;TBX6;BBS7
prerank,sphingolipid biosynthetic process (GO:0030148),-0.31594879731937753,-1.2009565576489871,0.14076246334310852,0.6346004588051541,1.0,10/71,4.60%,SGMS1;ACER3;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;SPNS2
prerank,mRNA methylation (GO:0080009),-0.44990493635541096,-1.200676890611376,0.2168421052631579,0.6341883685361198,1.0,8/15,28.51%,VIRMA;ZC3H13;CBLL1;TRMT6;METTL8;TRMT10C;METTL14;TRMT61A
prerank,positive regulation of bone resorption (GO:0045780),-0.49857735901563766,-1.2005512578526236,0.2611218568665377,0.6333238528822456,1.0,5/11,22.10%,SPP1;SYK;ADAM8;ATP6AP1;TNFRSF11A
prerank,negative regulation of interleukin-6 production (GO:0032715),0.4316632021473094,1.2001273262987444,0.24179620034542315,0.7245528778027827,1.0,6/27,13.07%,TLR4;C5AR2;PTPN22;PTPN6;IRAK3;ARRB1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3917385612349747,1.1999330899721803,0.22330097087378642,0.724077720264223,1.0,16/47,22.01%,MEDAG;BMP2;BMP7;TMEM64;CREBL2;NOCT;AAMDC;RARRES2;CARM1;NAPEPLD;ASXL2;CEBPB;PTGS2;XBP1;CDS1;ZC3H12A
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.38276879947369963,-1.1995425079736368,0.18899521531100477,0.6350457823573529,1.0,7/29,6.43%,SLIT2;SHANK3;SSH2;KANK3;KANK4;HIP1R;CYRIB
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.31369070528529247,1.1994763516866886,0.1595744680851064,0.7244101685695146,1.0,36/190,12.71%,UACA;RORA;CGNL1;DEPTOR;ITPR1;TLE1;PRKAA2;PPM1A;DGKD;DAG1;ARHGAP12;IFI35;BMP7;BCL2;MCL1;CPNE1;WWC2;ATP2B4;PPARA;MGRN1;STAMBP;STAT1;ZMYND11;PPEF2;MYADM;GPD1L;NLRX1;MAPK14;PPM1B;PLEK;BCL2L1;FNIP1;SH2B3;VGLL4;EPHA2;NDUFS3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.40804435530630573,1.1988709719612538,0.22259136212624583,0.7251759521847974,1.0,6/34,13.96%,LGR4;BPIFB1;TLR4;LY96;IRAK3;TICAM1
prerank,supramolecular fiber organization (GO:0097435),0.29417071428813024,1.1985111453295778,0.09523809523809523,0.7251874996421721,1.0,46/334,10.07%,COL4A3;CGNL1;TNXB;COL23A1;TSPAN5;COL4A6;COL4A4;COL5A2;COL3A1;TMOD3;COL4A5;DDR2;SHROOM2;HSPG2;VIM;MYO1B;ARHGAP12;CENPJ;LOXL3;DES;BMP1;EFEMP2;LOXL1;TPM1;CLIP4;TGFBR1;COL20A1;NCKAP5L;KATNAL1;RHOBTB2;HDGFL3;COL5A1;SIAH2;RHOF;FAT1;COL18A1;DBN1;USP9X;CCDC13;DLG1;COL13A1;TUBGCP4;TRIOBP;SERF1A;FIGN;TPM4
prerank,amino acid import across plasma membrane (GO:0089718),0.4389979241592399,1.1978724720323812,0.23185840707964603,0.7260901978812114,1.0,5/24,3.87%,SLC7A2;SLC1A3;SLC6A13;SLC6A9;SLC16A2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5012246910047266,1.197866538016509,0.22201834862385322,0.7250156988816164,1.0,5/14,5.63%,IGFBP3;IGFBP5;BMPR1A;TPM1;SERPINE1
prerank,positive regulation of cell migration (GO:0030335),0.30055569306369706,1.197371489222014,0.1092964824120603,0.7254149576702527,1.0,36/253,9.05%,SEMA3D;PDPN;ROCK2;VTN;DOCK5;FN1;PDGFRA;FGF1;DDR2;SYNE2;SMURF2;CXCL16;FAM110C;CDH5;GLIPR2;NRP1;FER;NUMB;SMIM22;KIT;BMP2;WNT5B;MIA3;CLASP1;TGFBR1;FAM83H;MMP14;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1;MYADM;INSL3;PLAU;SYDE1
prerank,skeletal system morphogenesis (GO:0048705),0.3947330347026009,1.1971882893033643,0.228099173553719,0.7248655290446575,1.0,12/42,15.85%,PDGFRA;FGFR1;WWOX;HOXC4;TGFBR1;DYNC2I1;SKI;RFLNA;ANKRD11;RAB33B;HOXB4;SPEF2
prerank,cellular response to amyloid-beta (GO:1904646),0.4153683070332891,1.1967518320691757,0.22885572139303484,0.7250772458197399,1.0,13/35,15.95%,FPR2;GJA1;SNX6;TLR4;CASP4;VCAM1;NGFR;GSK3B;EPHA4;CACNA2D1;APP;IGF1R;ICAM1
prerank,nucleoside catabolic process (GO:0009164),0.5217795728717007,1.1964609452300963,0.27041742286751363,0.724864410716265,1.0,4/11,9.75%,DPYD;UPP1;NT5C;DERA
prerank,response to cholesterol (GO:0070723),0.474300346007333,1.1964350071487895,0.22968197879858657,0.7238393348027823,1.0,3/17,6.93%,GRAMD1C;TGFBR1;TGFBR2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.28323603328115826,-1.196319206155638,0.10752688172043011,0.6429287994521936,1.0,46/132,24.95%,RPS15;RPL24;CELF4;RPL5;RPS27;RPS19;RPL38;SETX;LUC7L3;RPL6;RPL11;RPLP0;RPS28;PUF60;HSP90AB1;RRP7A;SRSF1;SART3;TRAF7;HSP90AA1;EIF3A;XAB2;RPS5;PPAN;RPS14;SART1;SNRPB;NLE1;LUC7L;DICER1;SNRPF;SRSF9;GCFC2;PRMT5;MDN1;LSM4;RPL3;SNRPD1;SNRPD2;SRSF6;CELF6;RPL23A;ABT1;GEMIN8;EIF6;SRPK2
prerank,cholesterol efflux (GO:0033344),0.46611893148904865,1.1962603680230854,0.2543859649122807,0.7232472854004669,1.0,5/20,17.50%,APOA2;NPC1;SOAT1;ABCA1;ABCA7
prerank,regulation of Rac protein signal transduction (GO:0035020),0.48353333893351147,1.19607409277522,0.25512104283054005,0.7227592224228576,1.0,2/16,1.46%,RASGRF1;AUTS2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4864434868736679,1.195794122800933,0.25,0.7225379877923446,1.0,4/15,6.93%,PDGFRA;MTHFD1;TGFBR1;TGFBR2
prerank,cGMP-mediated signaling (GO:0019934),-0.4703709872217509,-1.1957365572748502,0.21748878923766815,0.6434051248394552,1.0,5/13,9.24%,KCNC2;HTR2C;GUCY1B1;PDE3A;PDE2A
prerank,negative regulation of protein binding (GO:0032091),-0.3116175058724363,-1.1947757330846556,0.15625,0.6449464351368274,1.0,22/71,15.98%,ACTB;ADAM15;ITGA4;MAPK8;SORL1;ATP2A3;AKT1;SYMPK;DDX11;B2M;ZFPM1;GNL3L;DVL1;RACK1;PPP1CA;ADRB2;TTBK1;CAV1;ATP2A2;PARK7;CDKN1A;MAP2
prerank,positive regulation of cell killing (GO:0031343),0.5061261148112104,1.1944394459646492,0.2463768115942029,0.7254083446042726,1.0,4/13,8.47%,PRF1;NOS2;NOXO1;WNT5A
prerank,regulation of kinase activity (GO:0043549),0.34423073400148213,1.1943851402799381,0.18479880774962743,0.7244671256617564,1.0,22/89,12.29%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;LDB2;KIT;ROR1;PLCE1;RAD50;EPHA1;PDGFRB;EPHA4;MST1R;MUSK;DSTYK;TSPYL2;EPHA2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.4634930031801303,1.1938644331035413,0.2460456942003515,0.7250282094108512,1.0,3/19,5.90%,ZMIZ1;AXL;MMP14
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4888736491349472,1.1936283622145052,0.2644927536231884,0.7246628776299472,1.0,5/14,14.34%,DPYD;UPP1;NT5C;UMPS;ERH
prerank,ceramide transport (GO:0035627),-0.48361695256951437,-1.193219229336751,0.23504273504273504,0.6481521924046639,1.0,8/12,37.41%,CERT1;GLTP;SGPP1;ABCB4;ABCA13;ABCA2;PLEKHA3;CPTP
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.42600195811459407,-1.1930761073768654,0.2420814479638009,0.6473576606586011,1.0,8/20,22.51%,ACSL3;FAR2;ACACA;ACLY;SCD;HSD17B8;FASN;GCDH
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3756628233813631,-1.1930197318929552,0.1966019417475728,0.6462922615523657,1.0,8/32,7.58%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;HSP90AB1;CALM3;SYMPK
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.38549704457990325,1.1928731720931602,0.20101351351351351,0.7258993538289081,1.0,6/45,6.62%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A
prerank,muscle contraction (GO:0006936),0.3238094147773647,1.1928410405884609,0.15760111576011157,0.7249066089364867,1.0,17/126,10.07%,TNNC1;ROCK2;MYOF;TMOD3;CALD1;VIM;DES;SORBS1;TPM1;VCL;SNTA1;ACTN2;BDKRB2;ARHGEF11;SSPN;NMUR1;TPM4
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.47843306107468325,-1.1928227782163354,0.24798387096774194,0.645672321293758,1.0,8/12,37.68%,PRKCB;NEK9;CTDNEP1;VRK1;PLK1;CDK1;CCNB2;CCNB1
prerank,neutrophil activation (GO:0042119),-0.4843980880898078,-1.1926517297841108,0.2546583850931677,0.6449478436553407,1.0,3/12,12.61%,PREX1;FCER1G;SYK
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4208441607067811,-1.1926089152380825,0.2444933920704846,0.6439118490070594,1.0,7/18,23.07%,PPP1R16B;INPP5K;MFHAS1;PPP1R26;SH3RF2;PPP1R15A;PPP1R8
prerank,response to progesterone (GO:0032570),-0.43300942761387673,-1.192057344347345,0.22075055187637968,0.6442481816730524,1.0,5/18,12.95%,TGFB2;THBS1;ABHD2;TGFB3;CAV1
prerank,motor neuron axon guidance (GO:0008045),-0.45905392829655667,-1.1918225419489896,0.23636363636363636,0.6437655822311025,1.0,8/15,22.31%,SLIT2;TMEFF1;RHOG;SEMA3A;RAC1;RHOH;CHN1;LHX1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.49865741196162217,-1.1917507502610376,0.2713178294573643,0.6427923917334082,1.0,4/11,28.64%,PINK1;PARK7;STK26;MMP3
prerank,mRNA polyadenylation (GO:0006378),0.43851789442598227,1.1914577071273806,0.2363013698630137,0.7269903969015747,1.0,15/26,24.45%,PCF11;PAPOLG;CDC73;PAF1;LEO1;TENT2;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,RNA polyadenylation (GO:0043631),0.43851789442598227,1.1914577071273806,0.2363013698630137,0.7269903969015747,1.0,15/26,24.45%,PCF11;PAPOLG;CDC73;PAF1;LEO1;TENT2;CSTF3;APP;PAPOLB;GRSF1;WDR33;TENT4B;PNPT1;CLP1;PAPOLA
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.45865779339580076,-1.1914006409633908,0.25303643724696356,0.6426110018483244,1.0,7/14,28.08%,THBS1;NOTCH1;KLF4;DLL4;CARD10;HDAC5;PDCD10
prerank,modulation by host of symbiont process (GO:0051851),-0.3741667052635207,-1.1913066043859761,0.20601851851851852,0.6417321692431288,1.0,6/31,9.20%,LEF1;INPP5K;CTDP1;TFAP4;SMARCB1;HDAC1
prerank,regulation of tissue remodeling (GO:0034103),0.4678176259360607,1.1910753205439313,0.2571428571428571,0.7270608217412752,1.0,3/18,7.50%,LEPR;DDR2;IL18
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43914462912124524,1.1909723540443002,0.25432525951557095,0.7263322425223696,1.0,5/23,10.49%,NUPR1;CRY1;HDAC4;PPARA;PLEK
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3093140579752274,-1.190938590084368,0.13432835820895522,0.6416795637182807,1.0,17/79,15.86%,CSGALNACT1;ST8SIA4;ST3GAL6;BMPR2;XYLT1;FUT9;ST8SIA6;CHST9;ALG5;B3GNT2;SERP1;NUS1;GCNT1;BMPR1B;B3GNT9;ST3GAL4;B3GALNT2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5010227586314919,1.1907716900190863,0.2849364791288566,0.7258496783446852,1.0,6/14,14.88%,MYB;ANXA1;PRKCZ;IL18;NFKBIZ;RARA
prerank,response to interferon-alpha (GO:0035455),0.47660272862392294,1.1897161513128505,0.25919117647058826,0.7279398264720314,1.0,6/16,12.14%,AXL;EIF2AK2;TPR;BST2;IFITM1;ADAR
prerank,diol metabolic process (GO:0034311),-0.4269326413006437,-1.1895382797473357,0.2562358276643991,0.6444244265671538,1.0,8/19,16.98%,NOS3;DEGS2;CALM1;AKT1;GCH1;HSP90AA1;PLPP1;SGPP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4339501601473921,-1.1893667109698591,0.24330357142857142,0.643719728041126,1.0,4/16,8.42%,CELF4;PUF60;SRSF1;DDX17
prerank,retina homeostasis (GO:0001895),-0.4072304703086641,-1.189320064581922,0.2317596566523605,0.6426560926180646,1.0,6/23,16.32%,ACTB;POTEF;ACTG1;B2M;SOD1;CDH3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3711041510784678,1.189196296182158,0.22056384742951907,0.7284261236645624,1.0,15/52,21.06%,SAMD4A;TUT4;POLR2D;RC3H1;LSM1;DCP2;PAN3;DDX6;DIS3;CNOT3;CNOT9;TUT7;PATL1;PARN;PAN2
prerank,anion transport (GO:0006820),0.4088887224731676,1.1890826607488663,0.2345679012345679,0.7276912360037834,1.0,5/33,3.74%,SLC13A3;SLC13A4;SLC19A1;SLC26A9;VDAC2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.400257618491634,1.1888323172728057,0.23240589198036007,0.7273250279213026,1.0,14/38,23.74%,LEPROT;HAX1;NPEPPS;LRRK2;HUWE1;RHOU;USP36;CSNK2A2;ATP5IF1;SREBF1;FBXW7;ATG13;HPS4;RNF31
prerank,inflammatory response (GO:0006954),0.3062064828032028,1.1885631018525542,0.1363040629095675,0.7271065721807569,1.0,27/195,8.78%,CXCL10;FPR2;HSPG2;ADORA2A;NFATC4;ANXA1;KIT;BMP2;LOXL3;IL17D;IL6;TPST1;TLR4;C5AR2;HDAC4;PLA2G4C;NOS2;CRP;ADCY1;BDKRB2;IL18;CCL2;LGALS9;SIGLEC1;RIPK2;ADM;PJA2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.46421100762820133,1.1882188184831834,0.26126126126126126,0.7270764644917577,1.0,6/18,15.52%,MCU;DCN;RALBP1;DNM1L;MIEF1;MUL1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35141116011365425,1.188049992972895,0.19530102790014683,0.7264983225514112,1.0,16/77,14.94%,TCF7L2;PHIP;SH3RF1;CFLAR;BCL2;TGFBR1;MCL1;SIAH2;ZMYND11;BCL2L1;NDUFS3;OPA1;TMEM14A;BDNF;BIRC6;CSNK2A2
prerank,blood vessel diameter maintenance (GO:0097746),-0.36230227457405956,-1.1876248889850716,0.2,0.6463003691814171,1.0,12/34,17.08%,EDNRA;NOS3;KCNMB2;KLF2;ECE1;ACE;NOS1;ACE2;NPR1;GCLC;HTR2B;PER2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4639581646440835,1.1873670165763681,0.2459016393442623,0.727417789719478,1.0,6/18,17.64%,DDX60;BIRC3;OASL;ANKRD17;PUM2;USP15
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3992340264980799,1.1872515310488079,0.2306368330464716,0.7267133966852374,1.0,11/35,19.62%,ZMIZ1;RBFOX2;NEDD4;PMEPA1;YAP1;NR3C1;TMF1;PPARGC1B;PGR;UBR5;DDX5
prerank,epidermal cell differentiation (GO:0009913),0.3883815288853019,1.1871901205966737,0.22950819672131148,0.725837136143105,1.0,13/41,21.25%,GATA6;ANXA1;GLI1;CLIC4;WNT5A;EPHA2;HDAC2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,determination of bilateral symmetry (GO:0009855),-0.39866732609565125,-1.1870272502253751,0.23349056603773585,0.6468035772618326,1.0,10/25,26.43%,NOTCH1;TBX1;ZIC3;DNAH11;KIF3B;DLL1;ODAD2;BBS7;ODAD3;STIL
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.3104448206644919,-1.1860427165632292,0.166189111747851,0.6483481854145473,1.0,21/69,19.16%,MEF2C;PTK2B;NTRK2;SIX1;FOXQ1;NDNF;LGMN;PINK1;TGFB3;NGF;GRN;SIX4;PARK7;SOD1;CPEB4;CLCF1;SET;NTF3;TOX3;ADAM8;NONO
prerank,blood circulation (GO:0008015),0.37065180948287835,1.1857445735824075,0.21617161716171618,0.7291409443432081,1.0,8/49,7.58%,COL4A3;ROCK2;CXCL10;MYOF;ADORA2A;SERPING1;BDKRB2;STAT1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.428119795987929,1.1852092695929697,0.23801065719360567,0.7296523382226928,1.0,5/26,6.17%,ROCK2;ALMS1;SYNPO2;SYNPO;ASAP3
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4346598883180039,1.1852038921048713,0.24285714285714285,0.7286081097241811,1.0,4/24,4.74%,ROCK2;FOXC1;NCOA3;ERRFI1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.40951106635892087,1.18476702047111,0.22972972972972974,0.7288404665704554,1.0,7/34,8.47%,RBP4;IL6;LACC1;PTPN22;TNFRSF14;PHB2;WNT5A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.354667863728316,1.1847520750206497,0.1946624803767661,0.7278270696422382,1.0,12/67,12.03%,PLEKHA2;DOCK5;FN1;ECM2;NRP1;S100A10;EPHA1;GSK3B;MYADM;TRIOBP;CDH13;CSF1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.31824327166583233,1.1840393753358545,0.16690042075736325,0.7289429473740804,1.0,17/142,8.78%,ATP1A2;LPAR1;SMAD3;PDGFRA;FPR2;ACKR2;CCR9;CD55;ADCY5;C5AR2;PLCE1;ATP2B4;BDKRB2;SPPL3;ACKR3;WNT5A;CACNA1C
prerank,negative regulation of neurogenesis (GO:0050768),0.4016436604111018,1.1837816998352595,0.21176470588235294,0.7286741388161969,1.0,6/34,7.53%,PTN;WNT3A;IL6;APPL2;LRP4;NGFR
prerank,vasculogenesis (GO:0001570),0.407772303107151,1.182569918742319,0.22702702702702704,0.7312741579847241,1.0,7/32,8.55%,TGFBR3;CCM2;ITGB8;PDGFRB;RASA1;TGFBR2;ADM
prerank,regulation of autophagosome assembly (GO:2000785),0.3999731433290659,1.18244762776022,0.24914675767918087,0.7305812905949535,1.0,13/33,16.32%,NUPR1;IFT88;MTMR3;LRRK2;TMEM39A;IFT20;SCFD1;NPRL3;PIP4K2B;CHMP4A;CHMP4B;FEZ2;RAB5A
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.507918014882027,1.1817959462755792,0.2796296296296296,0.7315377599131468,1.0,4/12,11.45%,ELF1;RC3H1;PTPN22;ELF2
prerank,neuron projection morphogenesis (GO:0048812),-0.27819427901112437,-1.181560482657815,0.13818181818181818,0.6599286805645465,1.0,34/137,12.25%,CNTNAP2;NLGN1;CTNND2;CTNNA2;SHANK3;TNIK;GPM6A;CNTN4;DOCK10;DCC;ACTB;NCKAP1;TRIO;PAK1;KLF7;ANK3;NYAP2;EPHB1;S100B;DAB2IP;CTNNB1;DCLK1;NRCAM;MAP1B;SHTN1;UBB;MINK1;DVL1;DBNL;NEFH;PAX2;ALS2;PAK3;NGF
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5207609826443305,1.181257227065637,0.2765957446808511,0.7320545063557135,1.0,5/11,18.49%,CDC73;ZC3H3;PAF1;LEO1;DHX36
prerank,extracellular matrix disassembly (GO:0022617),-0.3272352654724704,-1.1810690961642585,0.20485175202156333,0.6601614535423098,1.0,16/53,17.94%,BSG;TLL1;ADAM15;MMP16;SCUBE1;A2M;CTSS;MMP15;HTRA1;CTSL;CAPN1;WASHC1;CAPNS1;MMP1;LCP1;ADAM8
prerank,diacylglycerol metabolic process (GO:0046339),-0.3931321806316841,-1.180800337629999,0.22843822843822845,0.6597041322567765,1.0,5/23,7.28%,DGKB;DGKI;DGKH;DGKZ;LIPE
prerank,regulation of DNA repair (GO:0006282),0.38632908973777413,1.1807314082763587,0.21951219512195122,0.7326225952113581,1.0,4/44,3.37%,EYA2;EYA1;POLH;TRIP12
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.30183633677757843,-1.1807148138435843,0.1513353115727003,0.6587527830922797,1.0,39/87,33.09%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;SAMM50;COX20;NDUFB2;NDUFA12;NDUFA11;NDUFAF4;NDUFB7;IMMP2L;NDUFB10;UQCC3;NDUFC2;NDUFA13;COX19;NDUFA9;NDUFAF8;FOXRED1;NDUFAF7;OMA1;BCS1L;PET100;NDUFAF3;NDUFA10;TIMM21;SDHAF2;COA5;NDUFS6;NDUFV3;NDUFS1;NDUFA2;SCO2;TMEM126B;NUBPL;COA3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.44431081739665756,1.1805458672519054,0.24514991181657847,0.7321121573456114,1.0,2/21,1.57%,MCU;MICU1
prerank,positive regulation of dendrite development (GO:1900006),0.5325345609007575,1.180408186450002,0.30538922155688625,0.7315158593531761,1.0,2/10,4.74%,PTN;BMP7
prerank,vascular transport (GO:0010232),0.33651519352020437,1.1796188103926921,0.19701492537313434,0.7329541259063774,1.0,12/81,4.01%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC13A3;SLC6A13;SLC19A1;SLC6A9;SLC24A3;SLC16A2;SLC16A12;SLCO3A1
prerank,cellular component disassembly (GO:0022411),-0.3280135203557612,-1.1791867033140748,0.19834710743801653,0.6619421785561723,1.0,16/53,17.94%,BSG;TLL1;ADAM15;MMP16;SCUBE1;A2M;CTSS;MMP15;HTRA1;CTSL;CAPN1;WASHC1;CAPNS1;MMP1;LCP1;ADAM8
prerank,protein polymerization (GO:0051258),0.36481504985348334,1.1789651943890518,0.23857868020304568,0.7338839372252028,1.0,11/56,15.26%,GAS7;ARHGAP6;DIAPH1;CENPJ;HDGFL3;UBE2C;WASL;WASF1;CHMP3;CHMP4A;CHMP4B
prerank,peroxisome organization (GO:0007031),-0.3929507813914704,-1.1788820833582534,0.23529411764705882,0.6616684157914868,1.0,12/25,27.46%,ABCD4;TMEM135;MFF;PEX10;ABCD2;PEX16;PLAAT3;PEX19;PEX11A;PEX3;LONP2;PEX11B
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.32181289441297145,1.1787440239552598,0.17612809315866085,0.733468436523517,1.0,29/138,16.50%,RORA;RBPJ;CCN2;NOTCH2;TBL1XR1;TEAD1;NR6A1;POLR2D;NR1H3;PPARA;CREBBP;RARB;TEAD2;YAP1;CCNH;MNAT1;CDK7;TAF7;POLR2C;NR4A1;MAML2;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;TAF9;WWTR1;TBL1X
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4384250039803883,1.1785385475503787,0.268630849220104,0.7330871783456985,1.0,10/22,23.91%,CDC73;CDK12;BRD4;THOC5;ERCC6;LEO1;CDK13;EAPP;ELL;DDX39B
prerank,fatty acid elongation (GO:0030497),-0.45621501339980436,-1.178398798992357,0.26304347826086955,0.6619824652831975,1.0,3/13,6.50%,ELOVL5;ELOVL7;TECR
prerank,histone mRNA catabolic process (GO:0071044),0.4745679532988685,1.1781445321429764,0.2771317829457364,0.73329732494608,1.0,9/15,21.39%,TUT4;LSM1;DCP2;XRN1;TENT2;SSB;EXOSC10;TUT7;TENT4B
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5167534250062112,1.1781269621178874,0.28346456692913385,0.7323196300398244,1.0,3/11,6.03%,ANXA1;RC3H1;FOXP3
prerank,aortic valve morphogenesis (GO:0003180),-0.37709084747622545,-1.1779192352693058,0.2328159645232816,0.662201742464958,1.0,8/30,7.09%,SLIT2;ROBO2;NOS3;TIE1;NOTCH1;ELN;EMILIN1;BMP4
prerank,replicative senescence (GO:0090399),0.5143128455603789,1.1777060953015412,0.2729044834307992,0.7325412413227013,1.0,3/12,5.63%,PLA2R1;TERT;SERPINE1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28717994896422566,1.1775588843481541,0.08823529411764706,0.7319674669930581,1.0,89/390,16.11%,SULF1;FLRT2;EFNB2;STYK1;COL4A6;ROCK2;EPHA7;PDGFRA;FGFR1;FGF1;AXL;DDR2;GHR;IL31RA;FOXC1;PHIP;INSRR;EPHA3;SDC2;FOXC2;RBFOX2;EPHA8;NFATC4;FRS2;NRP1;FER;VEGFD;POLR2D;KL;SHB;ANGPT1;KIT;SORBS1;EFS;ROR1;EPHA1;PDGFRB;RASA1;PTPN2;PIK3C2A;BDKRB2;MVP;NGFR;HNRNPH1;GSK3B;EPHA4;RHOQ;IGF2;ZNF106;DNM1;MTSS1;MST1R;POLR1G;APPL1;MUSK;NGEF;MAPK14;FGF18;FLRT1;PTK2;POLR2C;CSF1;EPHA2;RARRES2;EFNA1;EFNB1;SHOC2;PLAT;TCIRG1;WASL;BDNF;ATP6V0B;POLR2F;SHC2;ALK;NCK1;FRK;ABI1;GIGYF2;NTRK3;EIF2AK3;RYK;GDF15;BAIAP2;ATP6V1E1;FLRT3;PRKD2;IGF1R;ATP6V1C1
prerank,positive regulation of myelination (GO:0031643),-0.4962941298078044,-1.1774027971795384,0.28512396694214875,0.6624862294623561,1.0,5/11,18.02%,TENM4;TNFRSF1B;TPPP;NCMAP;DICER1
prerank,urogenital system development (GO:0001655),0.524534132864444,1.1773026410523464,0.29423076923076924,0.7317127589439307,1.0,2/11,3.54%,OSR1;ANXA1
prerank,positive regulation of vascular permeability (GO:0043117),0.5020681773330924,1.1772777625471824,0.28413284132841327,0.7307782669734963,1.0,2/12,3.83%,BMP6;ANGPT1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4352172755217487,1.1771480015847722,0.2521891418563923,0.7301288436953475,1.0,8/22,21.01%,ROCK2;IL6ST;MEF2A;SMAD4;P2RX4;ROCK1;SLC9A1;AGT
prerank,negative regulation of centrosome duplication (GO:0010826),-0.48715738282789267,-1.1766977630088338,0.25840336134453784,0.6633149874889771,1.0,6/11,20.07%,NPM1;CCNF;BRCA1;TRIM37;KAT2A;CDK5RAP2
prerank,glial cell differentiation (GO:0010001),-0.38936073697062523,-1.1764316179444483,0.22748815165876776,0.6629261443715871,1.0,13/28,29.97%,CDH2;ADGRG6;PAX2;NFIB;RELN;TPPP;SOX2;PTPRZ1;CDK5;SOX11;PICK1;FGF10;SLC8A3
prerank,cell-matrix adhesion (GO:0007160),0.33357019901528684,1.176296681166912,0.20268256333830104,0.7315524579022114,1.0,18/95,9.10%,VTN;COL3A1;FN1;ADAMTS12;ECM2;DLC1;NID2;ITGB8;ITGBL1;ITGA10;SORBS1;VCL;VCAM1;THBS3;ACTN2;SIGLEC1;ITGA11;COL13A1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4456688168226555,-1.176259511941096,0.24288840262582057,0.6622305354305669,1.0,5/15,13.38%,NLGN1;SYN3;STXBP1;CNTNAP4;USP46
prerank,mitochondrial genome maintenance (GO:0000002),0.5148966712964167,1.1758874474911778,0.30060120240480964,0.7317624008136365,1.0,6/11,19.97%,MPV17;MEF2A;AKT3;OPA1;SLC25A4;LONP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4085518883771001,1.1754684083660316,0.24210526315789474,0.7319377889204723,1.0,17/30,27.67%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,regulation of protein kinase C signaling (GO:0090036),0.48922411988995707,1.1753971134116565,0.2701688555347092,0.7311438064380588,1.0,5/14,9.73%,DGKD;ADGRV1;MYADM;WNT5A;GPD1L
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.47996409212166863,1.1752881821014436,0.25842696629213485,0.7304360396165858,1.0,3/15,4.92%,UST;DCN;DSE
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.342520390174568,-1.1752803537490573,0.1926829268292683,0.6638871407408518,1.0,12/39,11.23%,DMD;FGF14;FGF12;HECW1;FXYD5;NETO1;UTRN;ANK3;YWHAH;CAMK2D;NEDD4L;FGF13
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.29268349247152514,1.1752113766874182,0.1276073619631902,0.7296449773711422,1.0,74/327,17.01%,EFEMP1;RORA;ATXN1;ZMIZ1;ARNT2;FOXC1;NFIA;NFYC;ZBTB4;ZNF395;DENND4A;SSBP2;MYB;PRRX2;PERM1;BMP2;RFX3;APBB1;GZF1;NIF3L1;TGFBR1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBL2;TCF7L1;CREBBP;NSD1;POU1F1;RNF20;ZSCAN21;NFXL1;TEAD2;ATF7;ZFP37;KAT6B;IGF2;CREM;SOX21;SUFU;MAFB;MSC;PSPC1;UBE2V1;TGFBRAP1;TCF7;ZNHIT3;ZNF219;ZFAT;OGG1;THAP1;MZF1;NR3C1;SERTAD3;HIC1;ZNF205;NCOA2;DMTF1;FUS;CARM1;VHL;PML;SP3;ACVR2B;SOX4;POU5F1;WWTR1;NFATC2;CCAR1;WTIP;PPP2CA
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5070993272113823,-1.1746386568119926,0.26104417670682734,0.664589483200123,1.0,7/10,33.35%,DLGAP1;DLGAP2;BEGAIN;NPTX2;CACNG5;NPTXR;NPTX1
prerank,regulation of defense response (GO:0031347),0.34732902644527264,1.174503025561684,0.22590361445783133,0.730750703807108,1.0,15/76,11.10%,USP18;CASP12;ADAMTS12;ANXA1;LACC1;PTPN22;ZBP1;CASP4;APPL2;BIRC3;WNT5A;ERAP1;APPL1;BRD4;NLRP6
prerank,cellular response to calcium ion (GO:0071277),-0.30676242769691403,-1.1737534590186693,0.1977077363896848,0.665938656052203,1.0,19/67,18.71%,NLGN1;SYT1;MEF2C;PLCG2;ITPKB;RYR3;KCNH1;LGMN;CAMK2D;SYT4;SYT7;CPNE4;SYT9;SYT2;ADD1;ADCY8;HPCA;ECT2;CPNE7
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4359476862511447,1.1737034256801988,0.25528169014084506,0.7321502685793033,1.0,4/22,8.78%,SASH1;RELL1;BMP2;PJA2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.43357075232314735,1.1735896854036552,0.26373626373626374,0.7314760105908162,1.0,4/23,7.09%,CBLB;SNX6;ERRFI1;MVP
prerank,ion transport (GO:0006811),-0.28775516102280246,-1.1727486030687433,0.1540880503144654,0.667717608856203,1.0,21/111,9.21%,SLC12A7;PIEZO2;SLC26A7;SLC12A2;SLC9A2;SLC26A2;SLC24A2;ANO1;ATP11B;SLC5A5;AQP11;SLC15A2;SLC8A1;SLC1A1;SLC9A8;TRPC6;TMEM63C;SLC1A2;SLC12A5;GRIN1;GABRB1
prerank,canonical glycolysis (GO:0061621),-0.38997458231722737,-1.1726963933586099,0.2088607594936709,0.6655809099306621,1.0,8/24,19.92%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.38997458231722737,-1.1726963933586099,0.2088607594936709,0.6655809099306621,1.0,8/24,19.92%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,protein localization to cell periphery (GO:1990778),-0.2741685093052491,-1.17192640415342,0.1033210332103321,0.66666136980826,1.0,34/133,14.01%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;LIN7A;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;RAB3C;TMED2;LRP6;RAMP2;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;CAV1;RAB40B;F11R;EHD4;CLASP2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.49495987298560934,1.171755148527567,0.2839285714285714,0.7359875567261609,1.0,4/13,12.43%,DCTPP1;NTHL1;NT5C;OGG1
prerank,response to unfolded protein (GO:0006986),-0.3320096144347711,-1.1715621136821661,0.1918158567774936,0.6666054000908922,1.0,14/48,18.94%,HSPA8;TM7SF3;DAB2IP;HSPA14;HSP90AB1;HSPE1;HSPA4;HSP90AA1;DNAJB4;TOR1B;HSPA5;HSPA4L;PACRG;STT3B
prerank,outflow tract septum morphogenesis (GO:0003148),0.4317568917811187,1.1714468169761592,0.26071428571428573,0.7358474531381356,1.0,8/24,11.50%,ROBO1;PARVA;GATA6;BMPR1A;NRP1;TGFBR2;SMAD6;SMAD4
prerank,aorta morphogenesis (GO:0035909),0.46770607631047006,1.1713577266432964,0.27425373134328357,0.7350756099654493,1.0,4/17,6.10%,RBPJ;BMPR1A;EFEMP2;PDGFRB
prerank,intraciliary retrograde transport (GO:0035721),0.5084576164525999,1.1710783864507648,0.2808349146110057,0.7349197162071861,1.0,4/12,17.88%,DYNC2I1;DYNC2LI1;WDR19;TTC21B
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3967842880181548,1.170741585808638,0.25728987993138935,0.7348592765887372,1.0,6/33,3.88%,MCC;NR2F2;SP100;TACSTD2;DUSP10;DCN
prerank,activation of protein kinase B activity (GO:0032148),0.41645104071090155,1.1703665401293397,0.26252158894645944,0.7349339975660569,1.0,10/29,17.88%,PDPK1;FGF1;OSBPL8;IL18;WNT5A;ADRA2C;NTRK3;ADRA2A;RICTOR;MAPKAP1
prerank,regulation of phagocytosis (GO:0050764),-0.32446731329832484,-1.1701032562754443,0.1878453038674033,0.669661701478036,1.0,13/53,10.46%,MERTK;RAB27A;GAS6;DOCK2;GATA2;SNX3;DYSF;SCARB1;SYT7;CALR;TUB;RACK1;FCER1G
prerank,inositol phosphate catabolic process (GO:0071545),-0.4673725802188343,-1.1700945672947778,0.2708333333333333,0.668522155069211,1.0,7/12,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;NUDT3;INPP5B;SYNJ1
prerank,zinc ion transport (GO:0006829),-0.40868280798220646,-1.1700596689475633,0.22716627634660422,0.6674545286656911,1.0,11/21,31.63%,SLC39A6;SLC30A1;SLC39A14;SLC39A13;SLC39A8;TRPM2;SLC30A5;SLC30A10;SLC30A9;SLC30A3;MT3
prerank,regulation of plasminogen activation (GO:0010755),0.4856018102473295,1.169613822811932,0.2896678966789668,0.7362645287806124,1.0,4/12,11.00%,CLEC3B;SERPINE1;SERPINE2;PLGRKT
prerank,actin filament depolymerization (GO:0030042),0.5175952630258294,1.1691852056251002,0.27755905511811024,0.7365157465150372,1.0,2/11,7.61%,MICAL3;DSTN
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.40313065177460605,1.1690918313044012,0.2354948805460751,0.7357665995925137,1.0,7/31,12.68%,RANBP3L;TMEM64;SKI;NOCT;SMAD6;SUFU;NOG
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.400439972254863,-1.1686445354596087,0.23777777777777778,0.6703988412155366,1.0,6/21,11.66%,PRKCH;SLC39A10;PRKCB;LYN;RUNX1;CBFB
prerank,striated muscle cell differentiation (GO:0051146),0.4681876184345619,1.1686369603368778,0.2722117202268431,0.7361347917730994,1.0,4/16,7.91%,AKAP13;BMP2;POPDC2;SKI
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.5294113329119516,1.1685840811882033,0.2730844793713163,0.7352846480789672,1.0,3/10,7.85%,CD55;TGFBR2;LGALS9
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4976129873782913,1.1684655259192929,0.2772808586762075,0.7346171065083151,1.0,2/13,2.97%,PLXNA2;NRP1
prerank,regulation of filopodium assembly (GO:0051489),-0.35701098040469914,-1.1680580427455693,0.2524271844660194,0.6709856531654216,1.0,7/38,2.31%,MYO10;NLGN1;PPP1R16B;FNBP1L;TENM2;GPM6A;PIK3R1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.41674772544363387,1.1675249931184113,0.2625,0.7363807797911035,1.0,3/26,3.98%,PDPK1;FOXC1;STAT5B
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.28695599319242876,1.1673950572808531,0.12649164677804295,0.7357902451960008,1.0,82/366,16.76%,EFEMP1;RORA;ATXN1;ARNT2;FOXC1;NFIA;NFYC;ZBTB4;ZNF395;DENND4A;SSBP2;ORC5;MYB;PRRX2;NUCKS1;PERM1;BMP2;PKP3;RFX3;APBB1;GZF1;TGFBR1;NSD3;BAZ2A;ZNF35;WWC2;FOXP3;TESMIN;CREBL2;TCF7L1;CREBBP;NSD1;POU1F1;RNF20;ZSCAN21;NFXL1;TEAD2;ATF7;ZFP37;KAT6B;IGF2;ANKRD17;CREM;SOX21;SUFU;MAFB;MSC;PSPC1;GMNN;UBE2V1;TGFBRAP1;ESCO1;TCF7;ZNHIT3;FOXO3;ZNF219;ZFAT;OGG1;THAP1;MZF1;NR3C1;SERTAD3;HIC1;ZNF205;NCOA2;GEMIN5;DMTF1;FUS;MAPKAPK5;ORC3;CARM1;VHL;PML;SP3;ACVR2B;SOX4;POU5F1;APP;WWTR1;NFATC2;CCAR1;WTIP
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4484272555800175,-1.16716925838558,0.26373626373626374,0.6723853298794605,1.0,7/15,15.27%,TMSB4X;THBS1;NOTCH1;MET;LGMN;FGF2;PRKD1
prerank,odontogenesis (GO:0042476),0.39888633757295694,1.1668139126908976,0.2663316582914573,0.7364596026525981,1.0,6/35,6.91%,WNT6;OSR1;FOXC1;BMP2;BCOR;EDA
prerank,protein neddylation (GO:0045116),-0.4611172789067325,-1.1664784658902108,0.257847533632287,0.6731638484481761,1.0,8/13,36.94%,DCUN1D2;DCUN1D5;DCUN1D1;UBE2F;DCUN1D3;NEDD8;UBE2M;RBX1
prerank,transport across blood-brain barrier (GO:0150104),0.3339055209355639,1.1662975915349398,0.21139430284857572,0.7370678200186561,1.0,12/83,4.01%,SLC7A2;LEPR;ATP1A2;SLC1A3;SLC13A3;SLC6A13;SLC19A1;SLC6A9;SLC24A3;SLC16A2;SLC16A12;SLCO3A1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2730604124508588,-1.1661626693352818,0.1357142857142857,0.6729556083343369,1.0,45/133,23.64%,TRPC3;ATP1B1;SLC24A2;RYR2;TPT1;HTR2C;SLC35G1;MCUB;TRPC5;TRPC4;ATP2C1;SLC8A1;CCL14;NPTN;ATP2A3;TRPC6;CAMK2D;SLC30A1;CXCL12;CALR;SMDT1;SLC10A7;CAV2;CD40;TMCO1;CAV1;ATP2A2;CCDC47;CCL19;ATP13A4;MAIP1;ADCY8;HTR2B;TMEM178A;SLC8B1;HTR2A;TRPC7;CHRNA7;PTH1R;SLC24A5;ATP2B3;CLN3;CALB2;ATP13A1;STC1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4173990866438584,-1.1660868505444388,0.265625,0.6720135054831035,1.0,4/19,2.23%,PTPRJ;GRM5;RYR2;KDR
prerank,cellular response to purine-containing compound (GO:0071415),-0.4988571086918604,-1.1656085377256538,0.2962962962962963,0.6722214384105692,1.0,5/10,21.52%,RYR2;RYR3;SLC8A1;CASQ2;TRPM2
prerank,regulation of transport (GO:0051049),-0.3469126046504208,-1.1654410888040858,0.22627737226277372,0.6715607680855253,1.0,9/36,8.21%,EPB41;ICA1;ACTB;SNCA;ACTG1;MBTPS1;WWC1;REEP5;PINK1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4897032662394168,-1.1651229254634934,0.2884990253411306,0.6712756865573869,1.0,2/10,7.57%,PRKG1;CEACAM1
prerank,protein autophosphorylation (GO:0046777),0.30856431046341865,1.1648890632582445,0.18347338935574228,0.7403172192479344,1.0,26/157,11.16%,PDPK1;TEC;PDGFRA;FGFR1;STK39;DDR2;OXSR1;EIF2AK2;INSRR;EPHA8;FER;KIT;DAPK1;TAOK3;AAK1;EPHA1;PDGFRB;MAP4K1;GSK3B;EPHA4;STK24;LRRK2;CDK12;MUSK;GRK5;PTK2
prerank,polyol biosynthetic process (GO:0046173),-0.43604794745470277,-1.1647004579457898,0.2771855010660981,0.6714064626784473,1.0,6/16,15.55%,ACER3;ITPKB;IP6K2;FGF2;PPIP5K2;PPIP5K1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4733320282335388,1.1645530599145701,0.26881720430107525,0.7403281678088078,1.0,7/16,20.12%,CREBBP;NAA16;NAA30;NAA15;KAT2B;NAA35;NAA40
prerank,positive regulation of neurogenesis (GO:0050769),-0.3093361220330793,-1.1644341986474482,0.19943019943019943,0.6710015209564224,1.0,14/68,8.85%,SLIT2;PTPRD;ROBO2;SHANK3;PLXNA4;TIAM1;NTRK2;IL1RAPL1;OPRM1;CAPRIN2;CTNNB1;NPTN;FZD3;VEGFA
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3508013110820859,1.1641057231426963,0.24180967238689546,0.7406069931783902,1.0,14/66,10.68%,KANK2;ADAMTS1;ANXA1;DACT1;PLK5;CCND3;APPL2;CDC73;CCL2;CDKN2B;DLG1;ANKRD17;APPL1;PTPN6
prerank,gene silencing by miRNA (GO:0035195),0.40203597519671475,1.1630970306054753,0.2646048109965636,0.7426831447664621,1.0,12/32,21.46%,TNRC6B;SNIP1;TNRC6A;MOV10;ADAR;TARBP2;ZC3H7B;WTIP;RAN;PUM2;AJUBA;XPO5
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4281571033743233,1.1630690065164249,0.2762237762237762,0.7417688184137562,1.0,5/24,5.63%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1
prerank,V(D)J recombination (GO:0033151),-0.47359717328762235,-1.1625508445949781,0.2633587786259542,0.6752109893484384,1.0,4/11,18.32%,HMGB1;TCF3;DCAF1;LIG3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.37065203644520683,-1.1621562071804903,0.22350230414746544,0.6751385264841291,1.0,10/29,23.52%,RPS19;RPS8;RPS16;RPS21;RPS14;UTP6;BMS1;HEATR1;WDR46;ABT1
prerank,pyruvate metabolic process (GO:0006090),-0.3280330677014495,-1.161743537424531,0.20051413881748073,0.6751518665573473,1.0,14/52,15.68%,BSG;ME1;PGK1;PKM;ME3;SLC16A1;ALDOC;GPI;TPI1;PGAM1;PGAM4;VDAC1;NR4A3;ENO1
prerank,SNARE complex assembly (GO:0035493),-0.4897581540639525,-1.1616425096692342,0.2815734989648033,0.6742901187943753,1.0,3/10,8.18%,SNCA;STXBP1;STXBP6
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5019818330065599,-1.1612191373997112,0.2833333333333333,0.674299626415421,1.0,2/10,2.16%,SLC2A1;ACSL3
prerank,negative regulation of receptor internalization (GO:0002091),-0.4728404593883271,-1.1612017488947328,0.28602620087336245,0.673211170102422,1.0,6/12,22.20%,ANKRD13A;ATXN2;SDCBP;RIN3;MTMR2;ANKRD13B
prerank,response to purine-containing compound (GO:0014074),-0.4243953872200441,-1.1610012400492702,0.2658486707566462,0.6726432028063815,1.0,3/17,2.18%,TRPC3;ABCC9;RYR2
prerank,response to muramyl dipeptide (GO:0032495),0.5014113552681363,1.1604804496763912,0.29215686274509806,0.7484446365575496,1.0,4/12,8.04%,LDOC1;VIM;PTPN22;RIPK2
prerank,ion homeostasis (GO:0050801),-0.3692303922954506,-1.1600013336199784,0.24541284403669725,0.6743798993640049,1.0,6/30,9.49%,SLC4A10;KLHL3;UNC80;CAMK2D;SLC12A5;NEDD4L
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.47217070907553443,1.1597034250392484,0.29401408450704225,0.7497600570272691,1.0,7/15,13.46%,GLI1;CDC73;KLHL18;PHB2;CUL3;CRNN;PAF1
prerank,regulation of peptidase activity (GO:0052547),0.44719094866602727,1.1597026518549554,0.30085470085470084,0.7487616814618185,1.0,5/19,8.88%,ECM1;CSTB;NRDC;CTSH;PSMA3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3912483781630042,-1.159393232101455,0.28868360277136257,0.674971693499102,1.0,9/23,24.82%,UBB;COPS6;UBA52;COPS5;COPS2;GPS1;COPS4;DDB2;RAD23B
prerank,regulation of histone modification (GO:0031056),-0.4611436736754496,-1.1593184271754537,0.2842323651452282,0.6740654148945884,1.0,5/13,17.30%,MTHFR;PARG;PARK7;HPF1;NNMT
prerank,triglyceride metabolic process (GO:0006641),0.3690765830847151,1.1590194473072652,0.2445141065830721,0.7497370610737829,1.0,5/48,12.04%,AGMO;APOA2;MOGAT3;GK5;DGAT2
prerank,cellular response to hexose stimulus (GO:0071331),0.4300477060694685,1.1587402127925588,0.26654740608228983,0.7496273803603586,1.0,7/23,17.32%,ZBTB20;PRKAA2;UNC13B;SLC26A6;SOX4;IGF1R;PCK2
prerank,cholesterol homeostasis (GO:0042632),0.3538590805963111,1.1583010994889238,0.25773195876288657,0.7499454650499158,1.0,10/64,12.04%,RORA;APOA2;CYP7B1;NR1H3;NPC1;IL18;LIMA1;SOAT1;DISP3;DGAT2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3490793250518713,-1.1581489931506397,0.25888324873096447,0.6762130842537186,1.0,8/36,5.86%,SLIT2;MEF2C;THBS1;NOTCH1;ACVRL1;PTPRM;DAB2IP;HMGB1
prerank,non-motile cilium assembly (GO:1905515),0.4064894741944548,1.158016564216957,0.24956063268892795,0.7497916808053453,1.0,9/30,15.31%,ARL13B;IFT88;IFT57;TMEM107;CCDC13;C2CD3;RPGRIP1L;CEP250;TOGARAM1
prerank,lipid modification (GO:0030258),-0.3394558333975175,-1.1579578336527467,0.2743142144638404,0.6755880919005933,1.0,13/37,18.89%,DGKB;DGKI;DGKH;PLPPR1;PLPP5;DGKZ;MBOAT1;DGKG;PLPP1;PLPPR2;MBOAT7;SGPP1;PLPPR5
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.30825586171324,1.1578248839259373,0.1917808219178082,0.749329886532886,1.0,20/152,8.86%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;FPR2;AKAP12;ADORA2A;GCGR;PTHLH;GLP2R;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADGRL1;ADM;INSL3
prerank,bile acid metabolic process (GO:0008206),0.4144495943098916,1.1576077504438567,0.27304347826086955,0.748974140681889,1.0,9/27,17.99%,CYP7B1;CYP27A1;NPC1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9;GBA2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.41049913181275366,-1.1574935160413609,0.2698072805139186,0.6757927605822777,1.0,9/20,12.74%,SEMA6D;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3272493208705407,-1.1573900315693102,0.19834710743801653,0.674927143911109,1.0,19/54,15.75%,MEF2C;NOS3;TMSB4X;THBS1;KDR;ACVRL1;GATA2;HMGB1;PRCP;ATP5F1A;AKT1;VEGFA;CD40;NUS1;FGF2;ATP5F1B;RGCC;PRKD1;PLCG1
prerank,positive regulation of defense response (GO:0031349),0.33212463467956993,1.1570892434391724,0.21656976744186046,0.7495447272961703,1.0,16/89,11.68%,IL16;FPR2;OSM;IFI35;TLR4;ZBP1;SERPINE1;OPTN;GBP5;CD47;IL18;SETD4;WNT5A;POLR3F;TLR2;NFKBIZ
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.43258425430535485,1.1570701507072947,0.297951582867784,0.7486178376573688,1.0,5/20,11.93%,GRK3;CRY1;MGRN1;PLEK;RPGRIP1L
prerank,sprouting angiogenesis (GO:0002040),0.36107609426092147,1.1570158721716872,0.24281150159744408,0.7477965137819651,1.0,8/51,4.72%,EFNB2;ROBO1;RNF213;PARVA;NRP1;VEGFD;ANGPT1;MIA3
prerank,regulation of cell development (GO:0060284),-0.350227321206976,-1.1568228398248703,0.23173803526448364,0.6754231450960408,1.0,14/36,20.22%,FOXO1;RPS19;CTNNB1;HDAC9;AKT1;YTHDF2;PRUNE1;GRN;HEY1;PER2;HES6;HES1;FBXO22;DLL1
prerank,motile cilium assembly (GO:0044458),0.5044317412815957,1.1560682657214576,0.30721649484536084,0.7495301583490787,1.0,3/12,8.27%,SPATA6;DNAAF1;RSPH9
prerank,actin filament organization (GO:0007015),0.3059150489817131,1.155532152628755,0.20454545454545456,0.7501741544406684,1.0,29/151,14.67%,DPYSL3;CGNL1;MCU;TMOD3;SHROOM2;MYO1B;ARHGAP12;EFS;BAIAP2L1;NEBL;TPM1;RHOBTB2;RHOF;FAT1;VILL;DBN1;DSTN;DLG1;TRIOBP;RFLNA;TPM4;MYO1A;RHOC;WASL;TLE6;MYO15A;ABI1;MYO1C;MYO1E
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3557823479252209,-1.1554095114023517,0.23842592592592593,0.6782272905766885,1.0,11/34,11.16%,KDR;NOTCH1;MT1G;VEGFC;FLT1;GAB1;SEMA6A;DAB2IP;VEGFA;RAMP2;NUS1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.42249908327888175,1.1548655974021023,0.2757417102966841,0.7511772550122451,1.0,4/24,7.58%,PARP9;PTPN22;DTX3L;STAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.4406821816556087,1.1546964588948239,0.27181208053691275,0.7497141005424892,1.0,11/20,24.02%,ACADSB;BCKDHA;ACAT1;ALDH6A1;HIBADH;ACAD8;MCCC1;DBT;IVD;MCCC2;ECHS1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.4406821816556087,1.1546964588948239,0.27181208053691275,0.7497141005424892,1.0,11/20,24.02%,ACADSB;BCKDHA;ACAT1;ALDH6A1;HIBADH;ACAD8;MCCC1;DBT;IVD;MCCC2;ECHS1
prerank,receptor-mediated endocytosis (GO:0006898),-0.27601676609278875,-1.1545427794963137,0.16428571428571428,0.6795860393112088,1.0,30/132,13.37%,DNM3;LRP1B;SGIP1;FNBP1L;INSR;TFRC;SNCA;SORL1;STAB1;HIP1R;SCARB1;AP1S1;NLGN3;LDLRAP1;ARHGAP27;LRP6;RAMP2;M6PR;CALR;SNAP91;FCER1G;CAV2;CTSL;ADRB2;SCARB2;VLDLR;SYK;HSP90AA1;CAV1;TMEM108
prerank,negative regulation of inflammatory response (GO:0050728),0.3026312185057086,1.1545346719092555,0.18592297476759628,0.7491740347000901,1.0,21/182,8.86%,ENPP3;RORA;GHRH;FPR2;ADORA2A;CDH5;TNFAIP8L2;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;NR1H3;PPARA;RXFP2;PTPN2;ADCY1;RAMP1;ADM;INSL3
prerank,negative regulation of developmental process (GO:0051093),-0.30703180063539837,-1.154499717818753,0.21705426356589147,0.6785887620577855,1.0,15/69,8.44%,NOS3;GRIN3A;CST3;TFRC;NOTCH1;DCC;TBX1;KLF7;GAS6;ARHGEF15;CDK6;BMP4;BCL11A;PINK1;TBX2
prerank,regulation of interleukin-8 production (GO:0032677),0.3449049831457161,1.1544790067852677,0.23711340206185566,0.7483773719620687,1.0,15/69,13.07%,APOA2;ANXA1;IL17D;IL6;TLR4;C5AR2;PTPN22;SERPINE1;ANXA4;NOS2;CRP;LGALS9;TLR2;MAP2K5;ARRB1
prerank,mitochondrion distribution (GO:0048311),0.49746174613821303,1.1540888236331044,0.29961832061068705,0.7485254527932685,1.0,5/12,11.89%,TRAK1;MEF2A;LRRK2;DNM1L;ATCAY
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.4278186644360694,1.1537451913908376,0.281767955801105,0.7485750549161537,1.0,4/23,10.26%,EFNB2;WNT3A;MMP14;MAPK14
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3351369558074275,-1.1537058733594392,0.22493224932249323,0.679791132960479,1.0,21/46,32.11%,PIEZO2;CRADD;TMEM150C;MAPK8;MAPK3;FAS;PDE2A;CD40;F11R;LTBR;CHEK1;CASP1;BAD;TNFRSF10B;TLR7;TNFRSF1A;MYD88;FADD;TLR5;MAP3K14;BCL10
prerank,multivesicular body organization (GO:0036257),-0.3604680145655675,-1.1530543375379392,0.25820568927789933,0.680499061214796,1.0,13/31,27.50%,RAB27A;VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP7;CHMP2B;VPS28;SNF8;CHMP2A;HGS;CHMP6;CHMP4C
prerank,folic acid-containing compound metabolic process (GO:0006760),0.44385551254113487,1.1528365858610348,0.28835489833641403,0.7503459222049422,1.0,3/19,3.93%,SHMT1;SLC19A1;MTHFD1
prerank,translational elongation (GO:0006414),-0.2802733909302692,-1.1521731960797517,0.15737704918032788,0.6818536062209269,1.0,49/101,36.96%,EEF1G;EEF1A1;GTPBP1;MRPL4;EEF2;GFM1;MRPS18A;RACK1;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;LTN1;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;EEF1D;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;EEF1B2;MRPL37;ERAL1;EEF2K;MRPL45;MRPL30;GTPBP2;MRPS24
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4744901737258921,-1.1516896395002056,0.32854209445585214,0.6820771022961476,1.0,6/12,10.75%,PTPRJ;F3;SNCA;APOD;NDRG4;CBL
prerank,negative regulation of protein processing (GO:0010955),0.5073958628522638,1.1514031167143672,0.3346228239845261,0.7536331305894743,1.0,4/12,9.29%,SERPINE1;SNX12;SERPINE2;LRRK2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3565411205346106,-1.1511648750688563,0.24047619047619048,0.6824940798112165,1.0,13/34,15.58%,TEK;PTK2B;PIK3R1;FLT1;DAB2IP;PIK3R3;WDR81;PIK3IP1;FGF2;WASHC1;CCL19;PRKD1;NOD2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.35682855154270343,1.1507297201846882,0.25660964230171074,0.7545527795695154,1.0,11/63,9.45%,LEPR;NUPR1;TIMP3;NELL1;PTPN3;BCL2;PTPN22;MCL1;KLHL22;TIMP2;TLK2
prerank,negative regulation of complement activation (GO:0045916),0.5109498525201961,1.1502567414142864,0.29750479846449135,0.7550087359487111,1.0,2/10,2.94%,CD55;SERPING1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.49435081289439975,1.1501759594442653,0.3019230769230769,0.7542611015063544,1.0,2/12,10.28%,NINL;NIN
prerank,response to glucagon (GO:0033762),0.44706389961693604,1.1500839531645022,0.30740037950664134,0.7535571129372283,1.0,5/19,7.01%,GCGR;CRY1;ADCY5;ADCY7;ADCY1
prerank,sterol homeostasis (GO:0055092),0.3504374679056559,1.1497082294552632,0.25882352941176473,0.7536565839081945,1.0,10/65,12.04%,RORA;APOA2;CYP7B1;NR1H3;NPC1;IL18;LIMA1;SOAT1;DISP3;DGAT2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.29296214954790134,-1.1495197156600125,0.1908831908831909,0.6861486045136612,1.0,29/88,15.23%,PTPRB;UBASH3B;ADARB1;SNCA;SORL1;DAB2IP;SLC8A1;INPP5K;AKT1;CEACAM1;SMCR8;NPM1;LRP6;SH3BP5L;PTPRT;DVL1;CEP85;PTPRO;SRCIN1;AKT1S1;LRP5;CEP43;CAV1;PRKRIP1;PPIA;PARK7;PTPRC;GNAQ;CDKN1A
prerank,response to UV-B (GO:0010224),-0.456797206154447,-1.14898964507382,0.2886178861788618,0.6864868679658898,1.0,8/12,37.31%,STK11;CDKN1A;MFAP4;HYAL3;RELA;HYAL2;CRIP1;IL12A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.31980244431337546,1.148762431791118,0.21915820029027577,0.7554604038378517,1.0,16/110,8.55%,LPAR1;ADGRD1;LGR4;CXCL10;GHRH;ADORA2A;GCGR;PTHLH;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADGRL1;ADM
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4810090983749956,1.148472416229038,0.29056603773584905,0.7553808840181617,1.0,2/13,3.64%,PRICKLE1;EID2B
prerank,platelet degranulation (GO:0002576),-0.27194831030148375,-1.1482763029355276,0.17006802721088435,0.6873920551151281,1.0,23/118,10.88%,PCDH7;ABCC4;VWF;PECAM1;ACTN1;TMSB4X;TGFB2;THBS1;VEGFC;SCG3;CALM1;GAS6;STXBP1;CYRIB;CDC37L1;RAB27B;A2M;VEGFA;TGFB3;CHID1;LYN;FAM3C;MANF
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4683796226736217,1.1481359111406086,0.30467289719626167,0.7553921130561408,1.0,4/16,4.69%,TGFBR3;RBPJ;BMPR1A;GLI1
prerank,cellular amide metabolic process (GO:0043603),0.3237865052806854,1.1479656657666375,0.22270742358078602,0.7548921427175388,1.0,15/102,9.97%,SMPD3;PLPP3;PCCA;SHMT1;ACOT11;SLC19A1;MTHFD1;AEBP1;PANK2;NAAA;PCCB;BTD;ACOT9;HLCS;ACOT1
prerank,peptidyl-amino acid modification (GO:0018193),0.5185715411197169,1.1477271400089342,0.33270676691729323,0.7546129633469477,1.0,4/10,21.67%,APOA2;PDF;TTLL4;METAP2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.38202457338797846,-1.1476819767895619,0.26651480637813213,0.6879352408973889,1.0,7/25,16.03%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,maturation of SSU-rRNA (GO:0030490),-0.347645974482749,-1.1471040863990019,0.24047619047619048,0.6884883858449136,1.0,11/34,22.29%,RPS19;RPS8;RPS16;RPS28;NOL11;RPS14;SNU13;UTP6;BMS1;HEATR1;WDR46
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5268552776148632,1.1462285711347957,0.30115830115830117,0.7582091959992602,1.0,5/10,23.88%,PCGF5;IGF2;DNMT3A;PCGF3;MECP2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.32922645658898975,1.1462109353510024,0.23711340206185566,0.7572921664435694,1.0,11/86,6.99%,RASGRF1;AKAP13;KANK2;NOTCH2;DLC1;KANK1;DENND4A;PLCE1;SYNGAP1;STAMBP;DENND1A
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3116681411912328,-1.1458721945724224,0.2154696132596685,0.6909512534490635,1.0,25/60,30.49%,PRKCQ;NEK7;PARM1;CTNNB1;MAPK3;HSP90AB1;ATM;NVL;FGF2;KLF4;HSP90AA1;RGCC;PNKP;PKIB;CCT5;RFC4;WRAP53;ATR;FGFR4;RFC5;RFC2;MAP3K4;CHTF18;MYC;PCNA
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3488954889941628,1.1452707921610061,0.24920127795527156,0.759072718061705,1.0,25/61,23.88%,EYA2;EYA1;WRN;RAD50;PARP3;PDGFRB;USP9X;EYA4;SMOC2;ERCC6;PML;UIMC1;PRKD2;DHX36;BRCC3;STPG4;USP7;ERCC8;EYA3;RTEL1;SMCHD1;DHX9;CEBPG;ZCWPW1;MECP2
prerank,regulation of astrocyte differentiation (GO:0048710),0.4965258821118357,1.1452221856264735,0.2923076923076923,0.7582442820555009,1.0,5/12,12.68%,BMP2;IL6;EPHA4;SERPINE2;NOG
prerank,pyroptosis (GO:0070269),0.468426457366676,1.1450397581240115,0.30337078651685395,0.7578379758869331,1.0,3/15,5.50%,GSDME;ZBP1;CASP4
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.3826586773788607,-1.1449227126793113,0.2768878718535469,0.6924778071595696,1.0,9/25,21.87%,ITGA6;THBS1;SNCA;SDCBP;EGFR;EGF;BTBD10;PTH1R;MIF
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4261642191413073,1.1444575634125724,0.31047619047619046,0.7586239408191465,1.0,4/21,4.69%,ROCK2;ENPP1;ECM1;BCOR
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4878454359012677,1.1440821351311037,0.31898238747553814,0.7586930796777361,1.0,5/13,18.79%,ENPP1;TPST1;SULT1A1;ABHD14B;SULT6B1
prerank,negative regulation of programmed cell death (GO:0043069),0.2821021443971411,1.1436847716338518,0.16666666666666666,0.7589122769854806,1.0,73/355,16.51%,PDPN;FHL2;FSTL1;ARHGAP10;KANK2;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;IL6ST;PHIP;GATA6;PRAP1;SH3RF1;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;MCL1;HAX1;SIAH2;ARF4;ANXA4;BIRC3;RASA1;CTSH;GLO1;NGFR;GSK3B;ANXA5;RIPK2;PHB2;WNT5A;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;GRK5;BCL2L1;TJP1;PTK2;NAA15;EGR3;DSTYK;RPS6KA3;API5;SUPV3L1;OPA1;CBX4;TMEM14A;BFAR;ERCC5;IFIT3;NUAK2;VHL;NIBAN2;BIRC6;HDAC2;FIGNL1;DAB2;TAF9;IGF1R;HSPA9;MGMT;OPN3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4551345063546105,-1.1430447351333666,0.2908704883227176,0.6967849065712375,1.0,5/13,27.01%,PIK3AP1;IRAK1;PIK3C3;TLR7;MYD88
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3801076476077286,-1.1429782836583462,0.2938496583143508,0.6958473062552444,1.0,12/25,27.95%,CSGALNACT1;NDST3;FUT9;EXT1;B3GNT2;B3GNT9;NDST4;B3GNT3;HAS1;HAS3;B3GNT6;B4GAT1
prerank,regulation of RNA metabolic process (GO:0051252),0.34807043034046564,1.142653240205547,0.27917981072555204,0.7610170028813192,1.0,19/59,18.89%,PTBP3;AHNAK;RC3H1;IGF2BP1;RASA1;OASL;CLK4;NOVA1;HNRNPH1;IGF2BP2;OAS2;HNRNPH3;PTBP2;USP36;FUS;MBNL2;AFF2;PCBP2;GRSF1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.37387360367334055,1.1421967354271014,0.27463651050080773,0.7613800802548273,1.0,10/36,16.38%,LEPROT;GHR;KIT;CENPJ;IL6;CRLF3;SH2B3;VHL;OCIAD1;NF2
prerank,positive regulation of nervous system process (GO:0031646),-0.41515209836451605,-1.1421776180196208,0.26153846153846155,0.6970295836704703,1.0,7/18,18.02%,RIMS1;RIMS2;TENM4;TNFRSF1B;TPPP;NCMAP;DICER1
prerank,ether lipid biosynthetic process (GO:0008611),0.5127449169047837,1.142155768788954,0.3026315789473684,0.7605214254971072,1.0,2/10,6.29%,PLA2G4A;PLA2G4C
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.486381625307867,-1.1417722622665571,0.3173277661795407,0.6970352078921214,1.0,3/10,9.75%,MAPK3;FAS;LYN
prerank,cardiac muscle cell development (GO:0055013),0.43709529066729036,1.1416547931076317,0.3062015503875969,0.7609830382971033,1.0,4/20,6.10%,CXADR;PDGFRA;CSRP3;PDGFRB
prerank,histone H4-K16 acetylation (GO:0043984),0.44589419708533523,1.1416119065644628,0.3094812164579606,0.7601430888731583,1.0,1/19,0.14%,KMT2A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.297133327810979,-1.1414954840881713,0.2215568862275449,0.6967277851364548,1.0,28/75,21.15%,CTNNA2;MEF2C;CNTN4;DCC;ACTB;KLF7;ANK3;S100B;NRCAM;UNK;MAP1B;SHTN1;MINK1;DVL1;NEFH;PAX2;PAK3;MFSD2A;BRSK2;SLITRK2;MAP2;SLITRK1;CELSR2;CCK;ABITRAM;NTNG1;NTNG2;DSCAML1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5080088117864524,1.141190978689328,0.29981378026070765,0.7603920735188349,1.0,2/11,6.95%,LEPROT;ACTN2
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.490327950846057,-1.1404503743709757,0.2959830866807611,0.6976446559370694,1.0,4/10,13.20%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.490327950846057,-1.1404503743709757,0.2959830866807611,0.6976446559370694,1.0,4/10,13.20%,CDC42EP3;CDC42EP1;CDC42EP5;WASHC1
prerank,negative regulation of angiogenesis (GO:0016525),0.33470979715686033,1.1404463966783471,0.24444444444444444,0.76149451702056,1.0,11/84,6.07%,SULF1;COL4A3;ROCK2;CXCL10;FOXC1;THBS2;HSPG2;ADAMTS1;DCN;SERPINE1;ATP2B4
prerank,regulation of actin filament-based process (GO:0032970),0.3449718645115501,1.140284953870848,0.2546583850931677,0.7610061619738758,1.0,14/70,9.49%,ROCK2;ARHGAP18;DLC1;EPHA3;SMIM22;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;RHOQ;ABRACL;IQGAP2;CNN2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.40029233292315775,1.1402010762114625,0.28546712802768165,0.76025878500369,1.0,9/27,15.07%,PID1;ENPP1;KANK1;PRKCZ;PTPN2;PTPN1;PIP4K2B;NCK1;TNS2
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2774061595887822,-1.1401795278427433,0.1821561338289963,0.6972371881508306,1.0,32/124,16.98%,FRY;CNTNAP2;NLGN1;GPM6A;CNTN4;PLP1;GPM6B;STX3;PTPRM;PLEKHA1;SH3GL2;HMGB1;MYOC;STMN2;RAPGEF2;RAB35;L1CAM;LYN;MANF;MICALL2;ZFYVE27;ULK1;CSF1R;TMEM108;RAC1;BICDL1;LGI1;MAPT;MAP2;STMN4;MNS1;SNAPIN
prerank,sarcomere organization (GO:0045214),0.4031743201694944,1.140040747634888,0.3045045045045045,0.7598001754040912,1.0,4/27,6.95%,CSRP3;TPM1;CSRP1;ACTN2
prerank,muscle tissue morphogenesis (GO:0060415),0.45486259522194533,1.1395021497005657,0.3055028462998102,0.7604582417455055,1.0,3/16,4.57%,TGFBR3;BMP2;EFEMP2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.38786438655955796,1.139440169732037,0.304421768707483,0.7596727710643245,1.0,8/33,15.46%,SMAD3;TEAD1;TERT;KLF5;NGFR;FOXO3;NR3C1;SMARCA4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4686884175616808,1.1388807402045236,0.29791271347248577,0.7603391249652535,1.0,9/16,24.79%,PARP9;PARP3;DTX3L;SHLD2;KMT5C;RIF1;KMT5B;SMCHD1;SHLD1
prerank,bone morphogenesis (GO:0060349),-0.4428232730253824,-1.1385735970911566,0.29867256637168144,0.7008892062784654,1.0,5/14,13.13%,BMPR2;LRP6;SFRP4;LRP5;BMPR1B
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.47680346299021087,-1.1385447919875784,0.30995475113122173,0.6998452969996163,1.0,3/10,7.21%,LRCH1;APOD;AKT1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.37347280811722916,-1.1385220315531628,0.2825112107623318,0.698806352686214,1.0,5/24,8.21%,PTK2B;CTSC;PSMD14;UBB;PINK1
prerank,regulation of interferon-alpha production (GO:0032647),0.4172081540970893,1.13837117108403,0.29858657243816256,0.7609452605508623,1.0,7/23,19.58%,TLR4;STAT1;RIPK2;IFIH1;TBK1;DHX36;SETD2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3990126450683417,-1.138330291940639,0.3023255813953488,0.6983177389337436,1.0,5/22,7.57%,PDE3B;APOD;ASXL3;CCDC3;CEACAM1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3354833358739395,1.138323578752276,0.23655913978494625,0.7601292208209616,1.0,11/70,5.98%,ATRNL1;LAMC1;FN1;RADIL;PARVA;NRP1;FER;ARL13B;ANTXR1;LAMC3;EPHA1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3873025163166148,-1.1379381589703825,0.2857142857142857,0.6983212381184768,1.0,11/23,37.54%,CADM1;PIK3R6;RAET1E;LAMP1;RASGRP1;LILRB1;SLAMF6;NECTIN2;CD226;IL12A;CRTAM
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.45053140610772385,1.137759266922272,0.3058608058608059,0.760816858487221,1.0,4/18,6.37%,TNFAIP8L2;MIA3;PTPN22;PPARA
prerank,cellular response to osmotic stress (GO:0071470),0.438064267907642,1.1377313180596758,0.2943327239488117,0.7599592519196928,1.0,4/21,10.19%,STK39;OXSR1;SLC4A11;RCSD1
prerank,negative regulation of axon extension (GO:0030517),-0.36321580207056947,-1.1374085068406974,0.24768518518518517,0.6987377776782302,1.0,10/30,12.74%,SEMA6D;DIP2B;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,glutathione biosynthetic process (GO:0006750),-0.4713208572423993,-1.1369869204019647,0.3060796645702306,0.698848183233108,1.0,6/11,31.32%,OPLAH;GCLC;GGT1;HAGH;MGST2;GCLM
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.39049141223278466,-1.1369751969036583,0.28378378378378377,0.6977750793340337,1.0,12/21,31.63%,HDAC6;PINK1;SIRT5;PAX2;ABCD2;PARK7;BRCA1;SLC18A2;SLC30A10;MMP3;TFAP2A;MT3
prerank,regulation of catabolic process (GO:0009894),-0.4091451340173551,-1.1369058467609716,0.28018223234624146,0.6968759739851563,1.0,11/18,33.35%,FAP;NEDD4L;ZDHHC2;ZDHHC7;HPGD;SNF8;HGS;CHMP6;FAM83D;MDM2;FURIN
prerank,serine family amino acid metabolic process (GO:0009069),0.46281966667052565,1.1366565807886102,0.3151969981238274,0.7622307144150451,1.0,4/16,10.71%,SHMT1;MTHFD1;SEPSECS;SEPHS2
prerank,microtubule anchoring at centrosome (GO:0034454),0.5147179285201031,1.1358267038657313,0.3163064833005894,0.763673347987533,1.0,2/10,10.28%,NINL;NIN
prerank,response to retinoic acid (GO:0032526),0.3509618730828315,1.1356660973167703,0.26324237560192615,0.7631859165556699,1.0,11/59,8.47%,WNT6;WNT10B;GATA6;WNT3A;EPHA3;PTK7;RBP4;WNT5B;ZNF35;CTSH;WNT5A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2622433848678886,-1.1353823664704596,0.20077220077220076,0.700149089345718,1.0,34/163,14.87%,PDE4D;PTPRJ;MEF2C;PDE4B;PRKCB;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;PLEKHA1;BMX;EIF2B2;CD38;PSMD14;PSMD3;LCP2;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;BCAR1;PAK3;PSMB8;SYK;PIK3CD;TNFRSF21;PSMA8;PTPRC;LAT2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4916505496648093,-1.135277745667706,0.31315240083507306,0.6993138698308196,1.0,7/10,37.07%,RNF125;GPATCH3;C1QBP;UFD1;SEC14L1;TSPAN6;TKFC
prerank,protein localization to cilium (GO:0061512),0.3859606937788561,1.1352579700266698,0.28477905073649756,0.7635341576713427,1.0,10/32,20.38%,INVS;ARL3;ODAD4;TMEM107;TULP2;WDR19;IFT20;TTC21B;ARL6;TULP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.41208795822454075,1.1352362739643072,0.2864406779661017,0.7626591641984137,1.0,3/24,5.80%,PDPN;ITGA5;COL5A1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3163708342913889,-1.1351109068568213,0.23670212765957446,0.6986591687001784,1.0,17/50,21.65%,SMAD7;IVNS1ABP;RPS3;AKT1;GNL3L;CAV1;CAMLG;PARK7;PER2;N4BP1;SIRT7;MINAR1;VPS28;UFL1;PRMT3;PRR7;SH3RF2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.36801078332224585,1.1348529953720126,0.31270903010033446,0.7629070655929606,1.0,11/43,15.81%,SMAD3;TEAD1;NFATC4;TERT;KLF5;PPARA;NGFR;FOXO3;NR3C1;SMARCA4;POU5F1
prerank,regulation of actin filament polymerization (GO:0030833),-0.302370975661516,-1.1348112483564257,0.22160664819944598,0.6983988924595645,1.0,26/69,21.33%,SLIT2;SSH2;ESAM;KANK3;KANK4;PTK2B;NCKAP1;HIP1R;LMOD1;CYRIB;CDC42EP3;VASP;CDC42EP1;DBNL;CDC42EP5;PAK3;EVL;TWF1;SSH3;PYCARD;ARF6;PFN2;ABITRAM;CARMIL1;HCLS1;PRKCE
prerank,negative regulation of innate immune response (GO:0045824),0.3782171971161098,1.1334555954514212,0.2874354561101549,0.7660497433425132,1.0,9/34,17.64%,USP18;STAT2;SERPING1;PTPN2;IRAK3;TRIM21;MUL1;FAM3A;USP15
prerank,acidic amino acid transport (GO:0015800),0.46113404511429573,1.1327278083236818,0.3301707779886148,0.767208669380169,1.0,3/17,2.23%,SLC1A3;SLC6A13;GJA1
prerank,cardiac muscle cell differentiation (GO:0055007),0.42517680330049523,1.1327203385676714,0.3094812164579606,0.7662841817569611,1.0,3/21,3.95%,AKAP13;CXADR;BMP2
prerank,hemidesmosome assembly (GO:0031581),-0.47235251942236134,-1.132695421526543,0.3305613305613306,0.7035369923260206,1.0,3/11,4.11%,ITGA6;ITGB4;LAMA3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3389032499727526,1.1322248498189755,0.27769347496206376,0.7667497059779701,1.0,15/72,11.16%,FN1;SELP;PDGFRA;FGFR1;OSM;NEDD4;KIT;DCN;ROR1;HAX1;PDGFRB;IL18;PIK3R5;PTPN6;PTK2
prerank,positive regulation of heart rate (GO:0010460),-0.4182486841033419,-1.1321224443628446,0.297008547008547,0.7041326833840991,1.0,5/17,13.61%,PDE4D;RYR2;ADRA1B;KCNQ1;ATP2A2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3394508909277517,1.1320975502042205,0.262015503875969,0.766199736307974,1.0,14/72,13.10%,USP18;ELF1;AXL;CFLAR;ZBP1;BIRC3;PTPN2;STAT1;PIAS1;SUMO1;PTPN6;IRAK3;PTPN1;JAK1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2943874833176247,-1.131935809647874,0.20797720797720798,0.7035565144810211,1.0,25/75,23.01%,PTPRJ;SORL1;DAB2IP;RASIP1;SLC8A1;PRKAR1A;INPP5K;BMP4;AKT1;PAQR3;TFAP4;LRP6;HHEX;LYN;PRKAR2B;LRP5;PKIG;MEN1;PKIB;PYCARD;CDKN1C;HEXIM2;DUSP7;SPRY4;TESK1
prerank,glucose metabolic process (GO:0006006),-0.3100975195636785,-1.1316236343778499,0.25132275132275134,0.7033897193981246,1.0,18/58,21.55%,PPARD;PGK1;APOD;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;LRP5;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,positive regulation of neuron differentiation (GO:0045666),0.37521048410257407,1.1314234906071536,0.27350427350427353,0.7672773602375639,1.0,6/40,5.70%,TCF4;FGFR1;NBL1;KCTD11;BMP2;CPNE1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.41815289937042655,1.1314110598388374,0.29724770642201837,0.7663740543023574,1.0,6/23,12.53%,ENPP1;GLI3;MGRN1;GLIS2;SUFU;BTRC
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.483698924403954,1.1311324865137855,0.33984375,0.7662231672898968,1.0,1/11,1.09%,SP100
prerank,positive regulation of neuron projection development (GO:0010976),-0.28655403954683023,-1.1307459829145794,0.2154696132596685,0.7048656425529494,1.0,25/85,12.44%,ITGA6;LRRC7;TENM3;PTK2B;RIT2;FUT9;NTRK2;SETX;SERPINI1;TOX;DAB2IP;CAPRIN2;SNX3;STMN2;NDNF;NPTN;RAPGEF2;LRP8;NDRG4;LYN;DBNL;RET;SCARB2;FES;VLDLR
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2861936455712732,-1.1307038850236362,0.17964071856287425,0.7039150999043889,1.0,27/93,15.48%,PDE4D;DMD;BCAR3;TFRC;SMAD7;PAK1;GAS6;SNCA;CAPRIN2;INPP5K;HSP90AB1;AKT1;PAQR3;RASSF2;HDAC6;PINK1;VEGFA;NOS1;RACK1;DDIT4;EGFR;NGF;HSP90AA1;CAV1;PARK7;PRKD1;IRGM
prerank,negative chemotaxis (GO:0050919),0.3869148764477682,1.1306951391740259,0.3081081081081081,0.7666179178106909,1.0,5/33,6.27%,ROBO1;SEMA3D;EPHA7;NTN1;SEMA4B
prerank,endothelial cell migration (GO:0043542),0.3769600684593797,1.130465923163884,0.2989864864864865,0.7663801074802647,1.0,8/37,11.85%,DPP4;FSTL1;CDH5;NRP1;STAT1;CDH13;EGR3;NR4A1
prerank,response to lipopolysaccharide (GO:0032496),0.3075252222313007,1.1303285393003852,0.2452316076294278,0.7658560262645563,1.0,27/138,14.45%,SELP;CXCL10;AXL;LDOC1;VIM;FER;IL6;TLR4;PTPN22;SERPINE1;NR1H3;NOS2;CDC73;CCL2;LY96;LGALS9;CD274;WNT5A;NOCT;SMAD6;MAPK14;IRAK3;RPS6KA3;PAF1;TICAM1;TRIB1;PABPN1
prerank,regulation of neuron differentiation (GO:0045664),-0.2928564331116315,-1.1302547694890774,0.22741433021806853,0.704174971164494,1.0,16/76,7.53%,NLGN1;BRINP3;MEF2C;BRINP1;CNTN4;ZFHX3;TIAM1;BEND6;SIX1;BRINP2;MMD;NRCAM;ARHGEF2;YWHAH;TCF3;VWC2
prerank,organophosphate ester transport (GO:0015748),-0.3811388138235684,-1.1302471188802192,0.27640449438202247,0.7031104323173195,1.0,6/24,8.19%,PITPNC1;PITPNA;ABCA3;SCARB1;PRELID2;PRELID1
prerank,protein targeting (GO:0006605),-0.27290897451409313,-1.12984385460257,0.18685121107266436,0.7032131121253362,1.0,39/118,23.10%,NLGN1;AKAP6;RASSF9;SORL1;AQP11;RPL11;VPS37B;GABARAP;SRP14;SDCBP;MFF;SPCS2;ZDHHC14;ZDHHC20;MFN2;ZDHHC2;GDAP1;SPCS1;TIMM8B;ZDHHC24;NACA;RABGEF1;ZFAND2B;VPS37A;PEX16;ZDHHC7;AP4S1;AIP;PEX19;SEC61A1;TOMM20;YIF1B;TIMM22;SEC61G;AP1S3;ZDHHC23;ZDHHC9;TIMM10;HAP1
prerank,regulation of protein phosphorylation (GO:0001932),0.28612121447463923,1.129629678192006,0.2088050314465409,0.7669606867332768,1.0,43/256,13.07%,PTPN13;IGFBP3;LEPR;ROCK2;FN1;EPHA7;FGF1;PID1;PLPP3;STAT2;PHIP;FPR2;WNT3A;CDH5;FAM20A;FER;FBLN1;VEGFD;IL34;ANGPT1;BMP2;SLCO3A1;BMP7;CCND3;PLCE1;PELI2;RALBP1;NSD1;FBH1;MYADM;IGF2;LRRK2;MUSK;BRD4;FGF18;FNIP1;PTK2;TSPYL2;DVL3;CADM4;RARRES2;EFNA1;ARRB1
prerank,regulation of neuron death (GO:1901214),-0.29038772183351724,-1.1294224945136893,0.21341463414634146,0.7032979874012691,1.0,15/82,10.51%,GRID2;MEF2C;DCC;CD34;TRIM2;MAP3K5;SNCA;SORL1;EPHB1;GRIN2B;AKT1;TNFRSF1B;UBB;SIGMAR1;DDIT4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4203181918578336,1.129197296529251,0.3083778966131907,0.7673086936979068,1.0,6/20,10.73%,BCL2;MCL1;GSK3B;BAX;APPL1;BCL2L1
prerank,acylglycerol catabolic process (GO:0046464),-0.35233969940597176,-1.1290747359720683,0.23980815347721823,0.7031619616990137,1.0,10/30,28.38%,MGLL;ABHD2;LIPE;ABHD6;LPL;PNPLA3;FAAH;LIPH;FABP3;LIPC
prerank,carboxylic acid transport (GO:0046942),0.3531720951503842,1.1284792684731193,0.2706270627062706,0.7684705831659863,1.0,9/55,7.18%,SLC13A3;SLC6A13;SLC16A11;SLC6A9;SLC16A2;SLC16A12;SLC6A12;SLC16A5;SLC38A6
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.30227163967491616,1.1283502762925341,0.23636363636363636,0.7678707021210576,1.0,22/136,13.07%,TCF7L2;SP100;NUPR1;MTURN;TCEAL7;BMP7;FOXP3;ANXA4;HDAC4;GLIS2;PARP10;PHB2;SUMO1;SUFU;WWP2;KEAP1;HEYL;IRAK3;MAP2K5;TRIM21;BTRC;ARRB1
prerank,positive regulation of interferon-beta production (GO:0032728),0.3898494968596572,1.127994690873939,0.3106457242582897,0.7679974819030446,1.0,13/33,24.27%,TRIM56;TLR4;RIPK2;POLR3F;TLR2;OAS2;IFIH1;TBK1;RNF135;RIOK3;DHX9;TOMM70;POLR3B
prerank,icosanoid biosynthetic process (GO:0046456),0.5086646662305231,1.1279819178125732,0.33941605839416056,0.7671065789914675,1.0,1/10,1.37%,PLA2G4A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.44486064571318007,1.1277487948363445,0.2935606060606061,0.7668397890048793,1.0,1/16,0.36%,LEPROT
prerank,negative regulation of response to external stimulus (GO:0032102),0.3121343756686795,1.127487791139787,0.2664756446991404,0.7666054688006204,1.0,16/105,12.41%,ENPP3;RORA;FPR2;CASK;CDH5;TNFAIP8L2;SERPINE1;NR1H3;PPARA;PTPN2;EPHA4;PPM1B;IRAK3;EPPK1;TRIM21;CD109
prerank,cellular response to chemical stress (GO:0062197),-0.28139903590399795,-1.1274227601620916,0.1761194029850746,0.70680473685673,1.0,22/96,15.29%,FOXO1;PRR5L;SETX;SNCA;CPEB2;MSRA;NCF2;CHCHD2;PINK1;NUDT2;FAS;ATM;ATF4;CAV1;PYROXD1;CYBB;PPIA;PARK7;SOD1;ERO1A;PRKD1;PYCR2
prerank,sensory perception of light stimulus (GO:0050953),0.3258902801052304,1.1271405426126202,0.2654600301659125,0.7666813572045869,1.0,14/87,13.05%,EFEMP1;RDH10;ZIC2;ADGRV1;MYO9A;TULP2;COL18A1;CRYBB3;IMPG2;EYA4;ATXN7;CRYBA1;OPA1;EML2
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.46183746378679363,-1.1271256165101842,0.32854209445585214,0.706587784386855,1.0,3/12,17.72%,NOTCH1;YTHDF2;HES1
prerank,relaxation of cardiac muscle (GO:0055119),-0.4402700075798038,-1.1270150442109377,0.32127659574468087,0.705827966998743,1.0,5/13,7.24%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,folic acid metabolic process (GO:0046655),0.4449408678776824,1.126715372048511,0.30857142857142855,0.7669616769242072,1.0,3/18,3.93%,SHMT1;SLC19A1;MTHFD1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.49773863979878763,1.1266923347450284,0.34210526315789475,0.766134916970086,1.0,4/10,17.59%,GHR;STAT5B;PTPN1;STAT5A
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.47843162465591277,1.1266567033411297,0.33586337760910817,0.7653113127747746,1.0,3/12,7.50%,NUPR1;IL6;IL18
prerank,regulation of endopeptidase activity (GO:0052548),0.34636175457107665,1.126518173777017,0.26595744680851063,0.7647673779986208,1.0,12/59,12.45%,VTN;TIMP3;SERPING1;SERPINB7;NRDC;SERPINE1;BIRC3;TIMP2;SERPINE2;PSMA3;SERPINB8;SERPINE3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.46802496431034024,-1.1264977661475095,0.3292433537832311,0.7062268653632754,1.0,2/11,2.33%,FOXO1;NOTCH1
prerank,neurotrophin signaling pathway (GO:0038179),-0.38260232877429945,-1.1263109531460733,0.2980132450331126,0.7056542216506125,1.0,9/21,16.45%,NTRK2;RAPGEF2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1;RAP1A;NTF3
prerank,heterotypic cell-cell adhesion (GO:0034113),0.41071325596566954,1.1263095644920325,0.30335097001763667,0.7644506152043216,1.0,5/25,9.38%,CXADR;PARVA;ITGA5;VCAM1;DSC2
prerank,protein-containing complex assembly (GO:0065003),0.2804424645601047,1.1262852682314126,0.19852941176470587,0.7635969078144746,1.0,53/259,16.53%,TCF7L2;KMT2A;MCU;LAMC1;FN1;AFDN;TLE1;TEAD1;TGFA;TERT;TLE3;SEC23A;ST13;BCL9L;TCF7L1;CREBBP;SEC24D;CLDN1;CDC73;GSK3B;SNX9;RSPH9;TEAD2;YAP1;TAPBP;MNAT1;LRRK2;TUBGCP4;FBXL7;PPID;DNM1L;PPP6R3;ANO6;TCF7;CUL3;WDR19;SEC24C;HFE;SCFD1;OPA1;TUBGCP2;WASL;WASF1;MDM4;LEO1;GEMIN5;PML;SEC24B;SMARCA4;GOLGA2;PYGO1;AXIN2;SH3PXD2B
prerank,neural tube closure (GO:0001843),0.38158737764637896,1.12628328979499,0.2998324958123953,0.7626891968848842,1.0,6/34,7.91%,PRICKLE1;LMO4;DLC1;MTHFD1;CELSR1;SKI
prerank,cholesterol biosynthetic process (GO:0006695),-0.350587637117573,-1.1256054849315615,0.28536585365853656,0.7065916354357652,1.0,14/31,32.03%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;SC5D;HSD17B7;DHCR7;LSS;MVD;MSMO1;DHCR24;IDI1;PLPP6
prerank,artery morphogenesis (GO:0048844),-0.3596440541335323,-1.1254995667874952,0.29086538461538464,0.705814459666708,1.0,8/30,8.85%,TGFB2;BMPR2;NOTCH1;SMAD7;TBX1;BMP4;TBX2;VEGFA
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.46560869909680835,-1.125496123059053,0.33755274261603374,0.7047527046869183,1.0,8/12,24.04%,ACTB;LAMA3;ACTG1;AHI1;ZDHHC7;VANGL2;TRAF3IP1;LAMA5
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.45655179374165833,1.125409651276157,0.33840304182509506,0.7642896627828739,1.0,6/15,19.93%,LARGE1;MGAT3;AMDHD2;EXTL2;NAGK;CHST3
prerank,pulmonary valve morphogenesis (GO:0003184),-0.41874869297269224,-1.12539628386327,0.3022774327122153,0.7039525046730449,1.0,5/17,2.33%,SLIT2;ROBO2;NOS3;TGFB2;NOTCH1
prerank,cellular response to inorganic substance (GO:0071241),-0.39695345333809534,-1.1253093326192025,0.2794759825327511,0.7031766186446515,1.0,4/21,8.49%,FOXO1;KCNC2;DDX11;GUCY1B1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3551345040125345,1.1252417271988044,0.291866028708134,0.7639213989780826,1.0,7/50,8.25%,SASH1;EIF2AK2;NFAT5;IFI35;TLR4;LGALS9;PHB2
prerank,tyrosine metabolic process (GO:0006570),0.4897335120173929,1.1251393346355267,0.351931330472103,0.763314359480213,1.0,2/11,12.98%,HGD;THAP4
prerank,mitotic cytokinesis (GO:0000281),0.3540030269714648,1.1247185644169733,0.27967479674796747,0.7635732712719024,1.0,9/47,8.97%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;KLHDC8B;SNX9;ESPL1;USP8
prerank,positive regulation of gene expression (GO:0010628),0.27026228532433755,1.124672544998721,0.18317972350230416,0.7628090831904296,1.0,56/442,11.14%,ROBO1;BMP6;FOXD1;ROCK2;SMAD3;RBPJ;RBMS3;FN1;PLD1;AFDN;WNT6;FGF1;PID1;TLE1;SAMD4A;OSR1;EIF2AK2;WNT3A;GJA1;VIM;CDH5;ITGB8;GCGR;PLA2R1;SLC26A9;TNRC6B;SLC24A3;ANGPT1;BMP2;PKP3;IL6;TLR4;BMP7;STOX1;PTPN22;TGFBR1;CRP;CTSH;POLR1C;PDCD5;GSK3B;LGALS9;BAZ1B;TNRC6A;WNT5A;YAP1;DTNBP1;MOV10;POLR1G;MUSK;FUBP1;MAPK14;CUX2;FGF18;TLR2;LRP3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.34180910838314865,1.1245749079799194,0.28,0.7621823348957542,1.0,8/59,12.52%,ALDH1A2;CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;ABCD3;CH25H
prerank,positive regulation of multicellular organismal process (GO:0051240),0.27909545011153475,1.1244765978649207,0.21253071253071254,0.7615246502392916,1.0,30/308,6.13%,PDPN;SOX5;LEPR;PTN;FOXD1;SMAD3;GHR;SMURF2;EIF2AK2;FOXC1;GHRH;GJA1;BMPR1A;GLIPR2;NCOA3;PLA2R1;ALMS1;TGFB1I1;BMP2;RFX3;TERT;IL6;BMP1;EPAS1;TGFBR1;UCN;ACSL1;SERPINE1;APPL2;BCL9L
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4837324317004801,1.1242469825578087,0.3163064833005894,0.7604103095067841,1.0,3/12,3.11%,TACSTD2;KANK1;FBLN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4837324317004801,1.1242469825578087,0.3163064833005894,0.7604103095067841,1.0,3/12,3.11%,TACSTD2;KANK1;FBLN1
prerank,relaxation of muscle (GO:0090075),-0.43895317781127513,-1.1241798750904148,0.315450643776824,0.7051830082140429,1.0,5/13,7.24%,ATP1B1;KCNJ2;ATP1A1;SLC8A1;CAMK2D
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.42853752554938657,1.1237933307215737,0.31066176470588236,0.7607342704032884,1.0,6/20,17.11%,SULF1;DSTYK;NOG;SMOC2;PRKD2;GPC1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.44984211438066724,1.1236767214636,0.31150442477876106,0.7601609052119939,1.0,3/17,5.01%,ROCK2;CDH5;VCL
prerank,response to amyloid-beta (GO:1904645),0.368487427787513,1.123676015991995,0.2940226171243942,0.7592689003421899,1.0,9/44,8.24%,FPR2;GJA1;SNX6;TLR4;CASP4;VCAM1;NGFR;GSK3B;EPHA4
prerank,cell-cell junction organization (GO:0045216),0.3339167838174402,1.1232571785747085,0.2534992223950233,0.7595459233138586,1.0,16/79,11.27%,SDK1;SDK2;SMAD3;CXADR;AFDN;CDH5;PKP3;PARD6A;CTNNA1;CTNND1;CLDN1;DCHS1;MYADM;CDH13;TJP1;NLGN2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4481603788036829,1.123185140665947,0.3314500941619586,0.7588829565082247,1.0,4/17,11.40%,CXCL10;FPR2;SERPINE1;ANO6
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.31628483348123326,-1.1230897344174284,0.26912181303116145,0.7072238484554193,1.0,19/53,26.35%,PSMC3;DAB2IP;HSP90AB1;RAD23A;PSMD14;UBB;PINK1;XPO1;TMTC3;GNA12;FOXF2;PSME1;UBQLN4;PSMC6;UFL1;PSMC5;RAD23B;TREM2;F8A1
prerank,cell junction maintenance (GO:0034331),0.4623566656987004,1.1228043672326256,0.321011673151751,0.7590898159846949,1.0,4/14,11.27%,PARD6A;CLDN1;MYADM;NLGN2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3727781989823424,1.1226956734276488,0.3058252427184466,0.7585515201573301,1.0,10/40,13.39%,PID1;BCL2;STOX1;SLC4A11;OPRD1;BAX;HEBP2;LRRK2;BCL2L1;BCO2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.44576568963045027,1.1226862951877865,0.3382899628252788,0.7577020875454452,1.0,6/17,15.74%,PTN;IL34;BMP2;SERPINE2;EGR2;CXCR4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3750354909809239,1.122533405211085,0.3135593220338983,0.7572809676690387,1.0,6/37,4.91%,IGFBP5;GJA1;BMPR1A;ADAMTS1;EFEMP2;TPM1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.43904562351468257,-1.1224662716818898,0.3057324840764331,0.7078906559555911,1.0,10/14,37.58%,RPS3;CD81;CARD11;RELA;BCL10;NECTIN2;IKBKG;CD226;TESPA1;LCK
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4860037224714847,1.1220966242884645,0.3416030534351145,0.7576862341460062,1.0,4/11,16.38%,LEPROT;SH2B3;VHL;NF2
prerank,cyclooxygenase pathway (GO:0019371),0.4944976699017061,1.1219587369000026,0.352112676056338,0.7571919944585277,1.0,4/10,22.63%,PTGS1;PTGES2;PTGS2;PTGES3
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4320379353433119,1.1217625716301411,0.30127041742286753,0.7568663354130128,1.0,6/21,16.40%,BMP6;BMPR1A;TGFBR1;SMAD4;DAB2;WWTR1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.36039280928265327,-1.1216873341836033,0.27315914489311166,0.709041796253038,1.0,16/28,30.58%,STMN2;MAP1B;PRUNE1;CLASP2;MAPT;MAP2;SKA2;STMN4;STMN1;FKBP4;GAS2L1;ARL2;MAPRE1;SKA3;STMN3;CAMSAP1
prerank,DNA biosynthetic process (GO:0071897),0.4506587570167404,1.1213274750569726,0.31899641577060933,0.757230852389923,1.0,3/16,4.22%,POLH;TERT;WRN
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3645797350747272,-1.1212120397119616,0.27710843373493976,0.7092166941114403,1.0,9/26,16.37%,NOS1AP;SCARB1;AKT1;GCH1;NUS1;S100A1;PARK7;CDH3;HTR2B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.491396984034294,1.1206650157517097,0.3258003766478343,0.7582445052638204,1.0,4/12,15.52%,COLEC12;IFIT1;IFIH1;MUL1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2980926647968266,1.1201555307572713,0.24717514124293785,0.7588960065164939,1.0,33/166,16.50%,RORA;RBPJ;CCN2;NOTCH2;TBL1XR1;TEAD1;NR6A1;POLR2D;NCOA6;NR1H3;PPARA;CREBBP;RARB;POLR1C;TEAD2;YAP1;CCNH;MNAT1;POLR1G;CDK7;TAF7;POLR2C;NR4A1;MAML2;NR3C1;POLR2F;GTF2H4;RARA;KAT2B;TAF9;POLR3H;WWTR1;TBL1X
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4505971440315425,-1.1194761999065184,0.3061630218687873,0.7131059096063297,1.0,2/12,8.51%,STARD3NL;FDXR
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4321221178603446,1.119312490224385,0.3357271095152603,0.760293106094162,1.0,3/18,4.44%,PTN;CAMK1D;IL6
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3890596187483125,-1.1193001078567024,0.29295154185022027,0.712536348536002,1.0,6/21,4.28%,LIMCH1;EFNA5;PEAK1;GPM6B;MACF1;ACTG1
prerank,positive regulation of peptidase activity (GO:0010952),-0.3900159403280389,-1.1191448872352705,0.28604118993135014,0.7119453278344808,1.0,6/20,21.03%,PRELID1;PINK1;GRN;PSENEN;PSME1;NDUFA13
prerank,regulation of nuclear division (GO:0051783),-0.3907797685361072,-1.1191118855058857,0.2926267281105991,0.7109350600843574,1.0,12/20,39.63%,BORA;CAV2;CCDC8;L3MBTL1;PRMT5;MKI67;KIF20B;CUL9;DAPK3;PIN1;PDXP;CDC25C
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.39828774220295093,1.118827176603171,0.3169491525423729,0.7608524019387355,1.0,6/25,11.72%,FBXL17;ZYG11B;POMT2;KLHL15;UGGT2;CUL3
prerank,acute-phase response (GO:0006953),0.4734804610718292,1.1187411713877566,0.3282442748091603,0.7602091992015882,1.0,4/12,18.84%,IL6;CRP;IL22;CEBPB
prerank,steroid biosynthetic process (GO:0006694),0.3463984790074981,1.1182410401058254,0.2911392405063291,0.760762781170234,1.0,12/56,15.36%,PRKAG2;CYP7B1;HSD17B1;CYP27A1;AMACR;INSIG2;SCP2;SLC27A2;LBR;CH25H;STAR;OSBPL9
prerank,regulation of protein binding (GO:0043393),0.31198272475518884,1.1177758363600938,0.2621776504297994,0.7611740274625873,1.0,33/114,18.40%,TCF7L2;VTN;CFHR2;WNT3A;IFIT2;DACT1;BMP2;TERT;DTX3L;HDAC4;EFHB;SPPL3;GSK3B;RIPK2;BAX;STK3;AMFR;LRRK2;NES;TRIM21;IFIT1;HFE;LRPAP1;STK4;DAB2;APP;GOLGA2;RAN;PPP2CA;GAS8;DNAJB2;LRP1;KDM1A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4417086479734788,1.117738002955837,0.3592592592592593,0.7595223911296408,1.0,7/17,19.42%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7R;IL7
prerank,cellular response to interleukin-7 (GO:0098761),0.4417086479734788,1.117738002955837,0.3592592592592593,0.7595223911296408,1.0,7/17,19.42%,STAT5B;BRWD1;JAK1;SMARCA4;STAT5A;IL7R;IL7
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4540610780297163,1.117704251148909,0.3537037037037037,0.7587393431342517,1.0,2/17,4.00%,GJA1;TERT
prerank,cellular response to oxygen-containing compound (GO:1901701),0.27828667810156804,1.117615268354553,0.2318125770653514,0.7581355725216349,1.0,35/291,8.47%,RORA;ROCK2;CXCL10;PDGFRA;WNT6;PID1;AXL;IGFBP5;WNT10B;LDOC1;WNT3A;SHMT1;EPHA3;PTK7;VIM;FER;NCOA3;DAPK1;IL6;WNT5B;TLR4;TPM1;SERPINE1;ZNF35;NR1H3;ATP2B4;MPV17;CPEB1;SSH1;CDC73;CCL2;LY96;CD274;FAM210B;WNT5A
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3185946598367411,-1.1176036111012295,0.27889447236180903,0.7140269732186322,1.0,6/48,9.13%,PDE4D;PDE4B;SLC7A5;IL1R1;CYRIB;ZFPM1
prerank,lamellipodium assembly (GO:0030032),-0.3653057881616403,-1.117330393496609,0.30295566502463056,0.7137746420408518,1.0,8/26,13.66%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4087106208915897,1.117299290130685,0.29285714285714287,0.7581278460592885,1.0,7/26,13.47%,ANAPC11;ESPL1;UBE2C;CUL3;NSMCE2;HECW2;CDC27
prerank,response to chemokine (GO:1990868),0.46447807396205504,1.1170607501815522,0.333955223880597,0.7579441852687175,1.0,3/13,1.80%,STK39;OXSR1;FOXC1
prerank,regulation of axon guidance (GO:1902667),0.4963655178770435,1.1169301325897323,0.3512476007677543,0.7574251153703682,1.0,2/10,4.84%,NRP1;MYCBP2
prerank,regulation of intracellular pH (GO:0051453),-0.3496723945517852,-1.11585779353642,0.27764127764127766,0.7170235246881822,1.0,8/34,14.68%,SLC4A10;SLC9A2;CA2;SLC9A8;SLC9B1;ATP5F1B;SLC4A7;SLC9A5
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4081526771857941,-1.1158276677178738,0.3187066974595843,0.7160546377519783,1.0,8/18,14.62%,NOS3;TGFB2;NOTCH1;ACVRL1;BMP4;TBX2;ACVR1;HEY1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.44302903182861586,-1.1156476165399802,0.3275488069414317,0.7154866193255536,1.0,10/13,54.86%,ADRA1B;CAV1;SMTNL2;ADRA1A;ADRA1D;TRPM4;OXTR;SMTNL1;AVPR1A;F2R
prerank,neuron migration (GO:0001764),-0.31672035738913706,-1.1156388818411955,0.26700251889168763,0.7144571640663248,1.0,19/48,14.20%,ADGRL3;MEF2C;GPM6A;NTRK2;NRCAM;NDNF;RAPGEF2;ASTN1;ASTN2;MAP1B;VEGFA;SPOCK1;DNER;DDIT4;FGF13;MARK1;SEMA3A;RAC1;RELN
prerank,prostanoid metabolic process (GO:0006692),0.47286128078524226,1.115426212958146,0.3404669260700389,0.7607458474952113,1.0,2/13,6.86%,PTGS1;PTGR1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.395512836241219,-1.1152106617011615,0.3080459770114943,0.7146517128145143,1.0,4/19,10.88%,CTNNB1;VEGFA;LRP6;MANF
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3675839041165629,-1.115205530509634,0.29978118161925604,0.713608251135333,1.0,8/25,19.92%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;ENO1;GAPDHS
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3371996692623628,1.115204291702445,0.2962962962962963,0.760498398941257,1.0,11/70,10.29%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,positive regulation of kinase activity (GO:0033674),0.3107020586506622,1.1151110564890223,0.26666666666666666,0.7598755568258154,1.0,24/107,12.63%,EPHA7;PDGFRA;PRKAG2;FGFR1;AXL;DDR2;INSRR;LMO4;EPHA3;EPHA8;KIT;ROR1;RAD50;EPHA1;PDGFRB;SNX9;EPHA4;MST1R;MUSK;PTK2;DSTYK;CSF1;EPHA2;EEF1A2
prerank,positive regulation of angiogenesis (GO:0045766),0.310756880421556,1.1148916821994777,0.2725947521865889,0.7596508354513867,1.0,20/108,11.06%,PDPK1;SASH1;FGF1;ECM1;GATA6;FOXC2;CDH5;ITGB8;ITGA5;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;JMJD8;WNT5A;ADAM12;FGF18;TJP1
prerank,mitotic chromosome condensation (GO:0007076),-0.3758263916588895,-1.1147736195378335,0.30444444444444446,0.7138186959143437,1.0,12/26,31.16%,MCPH1;SMC2;CHMP1A;SET;NCAPH2;NCAPH;TENT4A;TTN;CSNK2B;NCAPD2;PLK1;CDK1
prerank,axon extension (GO:0048675),0.4111520773809964,1.1147218799674405,0.3188405797101449,0.759254100524242,1.0,6/23,11.84%,ALCAM;AUTS2;NRP1;USP9X;PPP3CB;SPG11
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.33400096487423714,-1.1142450427319313,0.29411764705882354,0.7142351636365771,1.0,12/37,22.20%,ANKRD13A;ATXN2;SDCBP;PINK1;SIRT5;AP1AR;PAX2;BRCA1;RIN3;MTMR2;EDNRB;ANKRD13B
prerank,membrane fusion (GO:0061025),-0.34114894486942055,-1.1138339141340852,0.3103448275862069,0.7143378611636332,1.0,6/33,9.06%,DNM3;RIMS1;NSF;DYSF;NSFL1C;VPS33B
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.38332896058938115,1.1136175592880364,0.3151618398637138,0.7616155282780422,1.0,12/34,15.07%,PTPN13;DUSP10;PTPN22;PTPN2;DUSP16;PTPN9;PTPN6;DUSP5;PTPN1;PTPN18;PTPRQ;TNS2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3229093008128304,1.1135349220169692,0.27699530516431925,0.7609920249517567,1.0,16/88,11.96%,SMAD3;SMPD3;CDH5;SYNPO2;SYNPO;BMP7;SLX4;TPR;SPIDR;GSK3B;BAX;SUMO1;SLF2;PLEK;FNIP1;RHOC
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4907630278230425,1.1134118354610418,0.3595959595959596,0.7604708797367249,1.0,1/10,1.09%,SP100
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.28407858655587215,1.1127606213530215,0.25353925353925355,0.7614389877242558,1.0,42/214,15.95%,TGFBR3;CCN2;FN1;EPHA7;PDGFRA;NOTCH2;FPR2;MTURN;TIMP3;GLIPR2;NRP1;FBLN1;DUSP10;ANGPT1;BMP2;ROR1;TLR4;PRKCZ;PTPN22;PDGFRB;PTPN2;CCL2;ACKR3;LGALS9;PHB2;DLG1;PTPN6;SMAD4;DSTYK;P2RY6;EPHA2;PTPN1;MAP2K1;ARRB1;ZDHHC17;P2RY1;CCL25;PTPRR;NTRK3;PRKD2;APP;ICAM1
prerank,regulation of MAP kinase activity (GO:0043405),0.3182174784092756,1.1125739595283102,0.2948905109489051,0.7611088800581052,1.0,17/92,12.68%,ROBO1;FGFR1;FGF1;KSR1;IL34;KIT;BMP7;PDGFRB;PPEF2;LRRK2;PIK3R5;MST1R;CDK12;FGF18;IRAK3;SH2B3;PTPN1
prerank,RNA biosynthetic process (GO:0032774),0.3819505442767931,1.1125675986417403,0.31732418524871353,0.7602588196811507,1.0,5/31,10.12%,TERT;NCOA6;POLA2;PRIM2;TAF7
prerank,protein heterooligomerization (GO:0051291),-0.4083008266403096,-1.1125554221667386,0.3230088495575221,0.7168126999887159,1.0,7/17,24.16%,KCNC2;GRIN2B;GRIN1;TMEM120B;FARSB;HSD17B8;MAT2A
prerank,negative regulation of response to wounding (GO:1903035),0.4302013055766999,1.1124494432638703,0.32142857142857145,0.7597154566089265,1.0,5/19,12.41%,CASK;SERPINE1;EPHA4;EPPK1;CD109
prerank,regulation of cytoplasmic translation (GO:2000765),-0.426631995574022,-1.112300141502621,0.32426778242677823,0.7165104333992806,1.0,6/14,20.10%,CPEB2;PKM;UNK;CNBP;CPEB4;RBM24
prerank,polarized epithelial cell differentiation (GO:0030859),0.462860050746176,1.1122845148084957,0.3333333333333333,0.759329948219363,1.0,2/13,5.76%,RAB10;MYO9A
prerank,sensory perception of smell (GO:0007608),0.48814959953999143,1.1119374108555555,0.33992094861660077,0.7594455173874635,1.0,1/11,2.31%,BEST2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4214249124325039,1.1119318383042318,0.3246753246753247,0.7586143593720945,1.0,6/20,18.04%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4188696694949806,1.1114976320762884,0.30868761552680224,0.7589888099348445,1.0,7/20,19.13%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;CSK
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.32166504920745453,1.1114903193904573,0.28550074738415543,0.7581523436623584,1.0,16/79,12.68%,SULF1;ADAMTS12;SMURF2;BMPR1A;FSTL3;NBL1;CASK;NEDD4;BMP2;ATP2B4;SKI;SMAD6;SMAD4;CADM4;PTPN1;NOG
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4003021990837122,1.1114421573735271,0.30866425992779783,0.7574329212701053,1.0,5/25,9.23%,AMPD3;SHMT1;MTHFD1;PAICS;PRPSAP1
prerank,positive regulation of autophagy (GO:0010508),0.3214386401580757,1.1113386997744985,0.2916053019145803,0.7568761653244999,1.0,19/81,14.54%,RNF152;PRKAA2;DAPK1;DCN;MTDH;OPTN;TRIM5;PIK3C2A;GSK3B;WAC;PHB2;LRRK2;TPCN1;SESN1;FOXO3;MAP3K7;TRIM21;TICAM1;TBK1
prerank,regulation of cellular localization (GO:0060341),-0.32313250397530985,-1.1104913429405352,0.28688524590163933,0.720566925009339,1.0,19/46,20.76%,EFNA5;EPHA5;HSP90AB1;CAMK2D;WWC1;REEP5;PINK1;DYNC1H1;LYN;DVL1;FES;HSP90AA1;LRP5;BRSK2;MAP2;PPM1F;MAD1L1;SPAG5;TRIM46
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.39390525275946586,-1.1101724522879344,0.2903225806451613,0.7204817692989602,1.0,6/17,29.72%,AKT1;PPIA;SOD1;TREM2;VNN1;HSPB1
prerank,oogenesis (GO:0048477),0.4588701179984828,1.1096248289784816,0.35940409683426444,0.7608218730713866,1.0,2/15,6.48%,PTN;NANOS2
prerank,regulation of phosphorylation (GO:0042325),0.30534610389894096,1.1089322578189273,0.28733997155049784,0.7619296518101042,1.0,26/120,17.01%,FN1;PRKAG2;STAT2;PHIP;DYNLL1;CDH5;NRP1;FER;LDB2;BMP7;RANBP2;TPR;JMJD8;CDKN2B;FNIP1;PTK2;CADM4;POM121;KCTD20;PML;ILK;APP;INHA;NUP37;NDUFS4;PPP2CA
prerank,regulation of axon extension (GO:0030516),-0.3421796841140084,-1.108906845270839,0.2868020304568528,0.7231801552211696,1.0,12/37,15.98%,DIP2B;MACF1;NRCAM;SEMA7A;SHTN1;L1CAM;SEMA3G;DBNL;ZFYVE27;SEMA3A;MAPT;MAP2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.47753113384482443,-1.108173141165046,0.36147186147186144,0.7242329024395942,1.0,4/10,25.23%,CALM1;CALM3;GPR35;CBARP
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.38164749666751824,1.107883123977447,0.32318104906937395,0.7640002374247511,1.0,4/33,4.91%,IGFBP3;IGFBP5;EFEMP2;TPM1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.3520904797502588,-1.107749487938444,0.29411764705882354,0.7244386139290604,1.0,7/30,16.03%,HSPA8;HSPA14;BAG1;HSPE1;DNAJB4;ERO1A;HSPA5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4598773987591911,1.1072346285861028,0.33266932270916333,0.7649765691625252,1.0,2/13,4.44%,NFAT5;IL6
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4175290786656878,1.1068467909842334,0.3125,0.7652000517815585,1.0,3/20,6.40%,NUPR1;CFLAR;BIRC3
prerank,vacuolar acidification (GO:0007035),-0.3906629321598667,-1.1066262943346157,0.31839622641509435,0.7265796247276645,1.0,9/21,24.53%,ATP6V0A1;DMXL2;GRN;ATP6AP2;ATP6V0A2;ATP6V0E2;ATP6V0D2;CLN3;TMEM199
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4505961162973998,1.1064377609643068,0.3458498023715415,0.7654883353028366,1.0,5/15,18.00%,CD55;GLI3;IHH;IL23R;HSPH1
prerank,presynapse organization (GO:0099172),-0.46436659362299704,-1.1063823262526888,0.3217391304347826,0.7261958617624455,1.0,4/10,10.23%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.4126849204300672,1.1063465005378739,0.33562822719449226,0.7648910851801097,1.0,2/23,0.81%,ATP1A2;DIAPH1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4721527229055276,-1.105959699781418,0.35236220472440943,0.7263081176954852,1.0,6/10,28.28%,PDE8A;PARK7;GPR37;STK26;GPR37L1;PYCR1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3229518669481754,1.105881072073101,0.2886435331230284,0.7653712734514528,1.0,15/78,10.73%,PDPK1;PID1;SPTBN1;EPHA3;NUMB;SORBS1;MMP14;ATP2B4;PTPN9;KIF5B;RHOQ;DLG1;STX8;APPL1;BCL2L1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.26574293398512994,-1.105637459062484,0.23322683706070288,0.7261960961309412,1.0,27/119,13.42%,PIP5K1B;INPP4B;EFR3B;PLCG2;ITPKB;INPP5D;PIK3R1;PIK3R6;MTMR6;PLEKHA1;PIK3C2B;BMX;PIK3R3;INPP5K;MPPE1;MTMR12;IP6K2;PIGM;PIGU;PI4K2A;IMPA1;FGF2;PIGQ;PIGH;DPM2;PIK3CD;CDIPT
prerank,sterol metabolic process (GO:0016125),0.34137993217569174,1.1051957285263547,0.30851063829787234,0.7665012060542998,1.0,10/60,12.77%,PRKAG2;APOA2;CYP7B1;APOF;CYP27A1;INSIG2;SOAT1;LBR;CH25H;OSBPL5
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4646905710837034,1.1051780621109388,0.3357142857142857,0.7657162928620099,1.0,3/14,8.39%,ACOXL;AMACR;SCP2
prerank,heart morphogenesis (GO:0003007),0.35047457181430985,1.1050007618617508,0.325,0.765406073442777,1.0,6/50,5.16%,FLRT2;TGFBR3;DLC1;BMPR1A;BMP2;TGFBR1
prerank,organophosphate catabolic process (GO:0046434),0.4894935514091129,1.1049940594464676,0.3505747126436782,0.7645841047700931,1.0,2/11,10.73%,APOA2;ENPP2
prerank,regulation of interferon-beta production (GO:0032648),0.35097446602381355,1.1041508599996313,0.32669983416252074,0.7661083980162718,1.0,10/46,14.54%,TRIM56;TLR4;RNF216;RIPK2;PPM1B;POLR3F;TLR2;OAS2;IFIH1;TBK1
prerank,cell cycle G2/M phase transition (GO:0044839),0.3010837474810238,1.1040452312114644,0.27698863636363635,0.7655646939832383,1.0,41/130,21.55%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CENPJ;CLASP1;OPTN;CEP152;HAUS8;FBXL3;CDKN2B;CCNH;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;BTRC;MASTL;FBXW11;KDM8;ACTR1A;CEP250;FBXL12;YWHAE;PPP2R2A;CCNY;CEP131;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4137071451027625,1.1039982396700243,0.3404634581105169,0.7648681029983891,1.0,5/23,7.89%,AXL;TLR4;FOXP3;LGALS9;CD274
prerank,protein O-linked mannosylation (GO:0035269),0.43682086404463294,1.1035034053711767,0.3500931098696462,0.765430196782551,1.0,5/18,7.25%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.43093094670647575,-1.1029802044459096,0.3392857142857143,0.7329184710722598,1.0,6/13,35.26%,TMSB4X;HEY1;PER2;SOX11;HEY2;DDIT3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4751625211336782,1.1028152325666323,0.34122287968441817,0.7665845358358402,1.0,4/12,11.99%,NEDD4;PTPN14;TPR;IFI27
prerank,positive regulation of axonogenesis (GO:0050772),0.3573329256028115,1.102737613101268,0.30528052805280526,0.7659739626153199,1.0,7/43,7.53%,PLXNA2;ROBO1;TIAM2;NTN1;MAP6;DBN1;NGFR
prerank,regulation of macromolecule metabolic process (GO:0060255),0.28670002483565077,1.102630744204125,0.2874493927125506,0.7654709344139098,1.0,40/170,18.36%,ROCK2;PRDM6;AFF3;TRIM10;NELL1;TBC1D16;PRDM11;PTHLH;TRIM17;STOX1;IGF2BP1;MTMR3;TRIM5;RASA1;POGZ;NOVA1;TAPBP;FUBP1;RFXANK;IGF2BP2;IHH;NFKBIZ;TRIM21;CRNN;TRIM26;RNF39;ZNF462;AFF1;PRDM5;HNRNPDL;TXK;POU5F1;APP;AFF2;ARF1;AFF4;GDNF;C1D;BMI1;PCBP2
prerank,negative regulation of TOR signaling (GO:0032007),0.36966730556467003,1.1024626729779918,0.32558139534883723,0.7651608269162578,1.0,8/36,14.52%,DEPTOR;RNF152;PRKAA2;FNIP1;SESN1;NPRL3;TBC1D7;MAPKAPK5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4593557407005812,-1.102240143635721,0.3564154786150713,0.7340105104620338,1.0,5/11,20.91%,ST18;FAS;PLAUR;PARK7;PRR7
prerank,response to peptide (GO:1901652),0.37377488022933514,1.1021008957922636,0.33807829181494664,0.7652785038909931,1.0,6/33,11.52%,STAT2;ANXA1;STAT5B;STAT1;EIF2B3;STAT4
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3814276359909163,1.1018192644081368,0.3380530973451327,0.7652248402927974,1.0,3/32,4.19%,PDPK1;CXCL10;F2RL3
prerank,renal filtration (GO:0097205),0.4984955694939892,1.1016005601557302,0.35236220472440943,0.7649630136531604,1.0,1/10,0.15%,SULF1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.44017051008352004,1.1010721944808743,0.3651685393258427,0.7655723801778849,1.0,4/17,18.72%,PLA2G4A;PLA2G4C;LPGAT1;PLA2G5
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.30084177766153003,1.1010516977846154,0.2758132956152758,0.7647863832847357,1.0,41/129,21.55%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CENPJ;CLASP1;OPTN;CEP152;HAUS8;FBXL3;CDKN2B;CCNH;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;BTRC;MASTL;FBXW11;KDM8;ACTR1A;CEP250;FBXL12;YWHAE;PPP2R2A;CCNY;CEP131;KHDRBS1;AJUBA;CEP63;CEP78;PKMYT1;OFD1;CHEK2;CUL1
prerank,positive regulation of cell projection organization (GO:0031346),0.3025212274007638,1.100999790511234,0.29027576197387517,0.7640925893770313,1.0,12/115,5.28%,PLXNA2;ROBO1;DPYSL3;PTN;TIAM2;CAMK1D;EPHA3;PTK7;ROR1;MAP6;PLK5;CBFA2T2
prerank,positive regulation of vasculature development (GO:1904018),0.31242852939314675,1.1008611779905664,0.2887218045112782,0.7636512802100682,1.0,15/94,9.37%,PDPK1;SASH1;FGF1;ECM1;GATA6;CDH5;ITGB8;VEGFD;ANXA3;MTDH;SERPINE1;EPHA1;CTSH;WNT5A;ADAM12
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.34572895734315373,-1.1001058997180115,0.3308270676691729,0.7391338972457824,1.0,8/30,18.29%,DACH1;BMPR2;ACVRL1;TERF1;GNL3L;CDKN1A;MEN1;TINF2
prerank,calcium ion import (GO:0070509),-0.3516389986626921,-1.099496297584125,0.3120567375886525,0.7397447604053311,1.0,11/28,17.85%,CACNA1E;CACNB2;MCUB;TRPC4;SLC8A1;CACNA1G;CACNA1D;SMDT1;ATP2A2;MAIP1;CACNA1A
prerank,positive regulation of viral genome replication (GO:0045070),0.3896185084971135,1.0993546102453986,0.3402061855670103,0.7669629907606054,1.0,10/29,15.71%,TOP2B;PPARA;STAU1;PPID;TMEM39A;ADAR;IFIT1;SRPK1;TARBP2;PKN2
prerank,cellular response to chemokine (GO:1990869),0.34677886777051703,1.098917256880638,0.33014354066985646,0.76728143340204,1.0,6/46,7.76%,CXCL10;STK39;OXSR1;FOXC1;CCL2;ACKR3
prerank,modulation by symbiont of host process (GO:0044003),-0.48036775918773944,-1.0987198996663938,0.3445378151260504,0.7409512217089873,1.0,5/10,15.68%,PGK1;UBB;B2M;UBA52;ENO1
prerank,regulation of receptor binding (GO:1900120),-0.46996208470808803,-1.0984977527661657,0.3433734939759036,0.7405378996763149,1.0,4/10,13.61%,ADAM15;ATP2A3;B2M;ATP2A2
prerank,sodium ion transport (GO:0006814),-0.28204997589962777,-1.0984570685898427,0.25449101796407186,0.7396084567454737,1.0,18/85,12.37%,SLC6A6;SLC12A2;SLC9B2;ATP1B1;SLC24A2;SLC6A1;SCN1A;HCN1;SLC5A5;SLC8A1;SLC5A6;HCN2;SCN2A;NEDD4L;FGF13;SCN8A;SCN9A;SLC6A5
prerank,B cell activation (GO:0042113),-0.29367383805068265,-1.097722658143795,0.26857142857142857,0.740719897927954,1.0,19/68,17.66%,PTPRJ;MEF2C;PRKCB;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;MALT1;CD86;CD40;PIK3CD;DCAF1;PTPRC;LAT2;CLCF1;RABL3;CHRNA4
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3480652965843919,-1.0972734227578416,0.3054945054945055,0.7409763079603866,1.0,12/32,19.25%,THBS1;KDR;NOTCH1;GATA2;HDAC7;HDAC9;VEGFA;FGF2;KLF4;SRPX2;DLL4;CARD10
prerank,protein sumoylation (GO:0016925),0.34667974122309614,1.09723703628443,0.3223787167449139,0.7711258166216453,1.0,10/49,16.54%,EYA1;RANBP2;TPR;PIAS1;SUMO1;NSMCE2;EGR2;POM121;IFIH1;NUP37
prerank,prostaglandin metabolic process (GO:0006693),0.3992990101335673,1.0971260626293935,0.335676625659051,0.7706068039585277,1.0,3/26,6.86%,PTGS1;PLA2G4A;PTGR1
prerank,regulation of cellular response to heat (GO:1900034),-0.28203791657774724,-1.0970128542342388,0.27514792899408286,0.7407051220383924,1.0,27/77,26.61%,HSPA8;CD34;MAPK3;HSP90AB1;CAMK2D;BAG1;CAMK2A;HSBP1;CCAR2;ATM;AAAS;NUP93;AKT1S1;HSP90AA1;RAE1;MAPT;FKBP4;MLST8;BAG4;NUP62;ATR;NUP188;NUP54;CAMK2G;NUP210;NUP42;NUP153
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3377135130048628,-1.09693525210993,0.30641330166270786,0.739854223382183,1.0,18/32,37.14%,HINT1;JMY;STK11;BAG6;PPP1R13B;DDIT4;PYCARD;BCL3;MYBBP1A;HIPK2;CDIP1;PMAIP1;TP53;TMEM109;POU4F1;BOK;AEN;PDK2
prerank,cAMP biosynthetic process (GO:0006171),0.4828412022189458,1.09666258907057,0.34930139720558884,0.7709816218100758,1.0,3/10,7.01%,ADCY5;ADCY7;ADCY1
prerank,regulation of cell adhesion (GO:0030155),-0.2630736298041798,-1.096581123382471,0.24444444444444444,0.7398701020279749,1.0,28/129,12.92%,FRMD5;PTPRJ;PLXNA4;EFNA5;PDE3B;PTK2B;ZFHX3;CYTH1;STX3;PPP2R1A;ACVRL1;SEMA4D;TGFBI;ADGRG1;ADAM22;YTHDF2;ARHGDIB;VEGFA;CXCL12;LYN;PRKX;MINK1;ATM;ZDHHC2;RET;FES;ARHGDIA;EPB41L4B
prerank,synaptic vesicle localization (GO:0097479),-0.43406377933310636,-1.0961501999613752,0.33954451345755693,0.740029545193729,1.0,6/13,16.98%,NLGN1;RAB27A;SYNDIG1;KIF5C;KIF5A;SNAPIN
prerank,protein localization to plasma membrane (GO:0072659),-0.2607590818183664,-1.0960245453290447,0.22794117647058823,0.739357367648661,1.0,33/129,14.01%,DPP10;BSG;KCNB2;EFR3B;CACNB2;TNIK;ATP1B1;CDH1;KCNIP4;GAS6;ANK3;MAP7;EMP2;TSPAN14;DPP6;STXBP1;INPP5K;RAPGEF2;CCDC88A;RAB3C;TMED2;LRP6;RAMP2;ZDHHC2;KCNB1;FGF13;ZFYVE27;RAB12;RAPGEF6;RAB40B;F11R;EHD4;CLASP2
prerank,protein localization to kinetochore (GO:0034501),-0.4122066866935103,-1.0958455091264871,0.34444444444444444,0.7388186092978768,1.0,11/14,42.54%,RCC2;ZWILCH;CENPT;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.46508500128376584,-1.0956686073477837,0.3595959595959596,0.738284295530928,1.0,5/10,8.00%,CST3;NOTCH1;FAP;EMILIN1;TNFRSF1B
prerank,cognition (GO:0050890),-0.3196914899443736,-1.0956144333077062,0.30073349633251834,0.7374236425636028,1.0,13/42,22.52%,GRM5;PTCHD1;SHROOM4;FAM107A;DOP1B;SLC1A4;MFSD2A;ST3GAL4;CHMP2B;CHRNA4;CHRNA7;TTC8;LHCGR
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.47440854192328513,-1.0955485920034624,0.36767676767676766,0.7365901567736329,1.0,9/10,43.97%,RCC2;ECT2;KNSTRN;SPAG5;RACGAP1;CCNB1;CDC42;NEK2;APC
prerank,synaptic vesicle recycling (GO:0036465),-0.3487168459803217,-1.0944332708877382,0.34074074074074073,0.7386519528456017,1.0,6/31,8.74%,NLGN1;SYT1;AMPH;SNCA;SYT7;NLGN3
prerank,stress granule assembly (GO:0034063),-0.3727455521647142,-1.0943772602827544,0.3470715835140998,0.7377871638259832,1.0,4/20,8.39%,RPS23;ATXN2;YTHDF2;DYNC1H1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.46857010015348044,-1.0931095835406366,0.37894736842105264,0.7405021826316543,1.0,5/10,20.95%,ESR1;PSMC3;HMGB1;PSMC6;PSMC5
prerank,bile acid biosynthetic process (GO:0006699),0.40346045452430324,1.0929949299667951,0.34519572953736655,0.7805551768284457,1.0,7/24,15.36%,CYP7B1;CYP27A1;AMACR;SCP2;SLC27A2;CH25H;OSBPL9
prerank,regulation of cholesterol esterification (GO:0010872),0.49711451027945386,1.0929069838462682,0.3492647058823529,0.7799516810004471,1.0,1/10,2.03%,APOA2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.4805021398455943,1.0927847277564113,0.3625254582484725,0.7794665122176152,1.0,3/12,4.44%,DOCK11;NOTCH2;IL6
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2984057783477089,1.0926173979441283,0.28751753155680226,0.7791245641391604,1.0,19/124,12.35%,TCF7L2;WNT4;PRICKLE1;SMURF2;FZD2;TNRC6B;PARD6A;PLCB3;CELSR1;PSMB10;TNRC6A;WNT5A;MOV10;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;DVL3
prerank,actin filament-based transport (GO:0099515),0.39683079865169457,1.0919506303585906,0.3479020979020979,0.780180440189201,1.0,10/21,19.11%,SYNE2;MYO1B;MYO1A;WASL;MYO15A;MYO1C;MYO1E;MYO5A;MYO19;MYO5B
prerank,regulation of RNA export from nucleus (GO:0046831),0.47753350684313767,1.0917277979743425,0.38445807770961143,0.7800076538952864,1.0,5/11,23.45%,TPR;IWS1;SETD2;KHDRBS1;DHX9
prerank,metal ion export (GO:0070839),0.3794555397345993,1.0917228825748446,0.33783783783783783,0.7791822832498321,1.0,2/31,0.51%,ATP1A2;KCNT2
prerank,protein destabilization (GO:0031648),0.3764880330133248,1.0916791116964137,0.34395973154362414,0.7784677406504383,1.0,12/32,15.52%,CREBBP;CTSH;CDC73;FBXL3;SERF1A;CUL3;TRIM21;BTRC;FBXW11;PEX2;KDM8;MUL1
prerank,transferrin transport (GO:0033572),-0.3358126225543929,-1.091153215380168,0.3309692671394799,0.7452192936080702,1.0,12/33,21.84%,ATP6V0A1;TFRC;ATP6V1B2;ATP6V0C;ATP6V1D;ARHGAP1;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.44722927260478523,-1.0910693875099893,0.3658051689860835,0.7444283992759235,1.0,5/11,15.58%,MERTK;GAS6;CXCL12;CCL19;NOD2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4259175563706885,1.0908772341991864,0.3629764065335753,0.779959756051421,1.0,7/19,15.89%,ELF1;PARP9;WNT5A;MAP2K5;SH2B3;IFIH1;TAF9
prerank,regulation of intracellular signal transduction (GO:1902531),0.2643579907754804,1.090687234706584,0.24041811846689895,0.779679119494009,1.0,60/420,10.43%,ARHGAP29;PTPN13;PDPK1;ARHGAP6;TIAM2;AKAP13;ARHGAP21;ARHGAP10;NRK;PRKAG2;ARHGAP20;ARHGAP18;FGF1;PRKAA2;ZFAND6;TPTE;AKAP12;DLC1;ARHGAP28;ARHGAP32;TRIP10;FGD4;ARHGAP12;TRAF5;PRDM11;TAOK3;WRN;NEK8;ARAF;PTPN22;RAD50;OPTN;CPNE1;MYO9A;WWC2;RHOF;BIRC3;FAM13B;TAGAP;FBXO9;RALBP1;PLEKHG2;ARHGEF11;MAP2K6;WNT5A;STK3;ARHGAP26;RHOQ;PJA2;DLG1;SYDE1;GMIP;LRRK2;ARHGEF12;SOS2;RPA3;NGEF;TAF7;MAPK14;TTC5
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.35767959133798766,1.089896459561485,0.34317343173431736,0.7811018452028121,1.0,7/43,7.09%,CBLB;SNX6;TGFA;ERRFI1;PTPN3;PTPN2;MVP
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3063288078243608,1.0893836322503543,0.3098995695839311,0.7817102176616404,1.0,14/100,7.50%,PTPN13;FN1;SELP;PDGFRA;FGFR1;OSM;NEDD4;KIT;DCN;ROR1;HAX1;PDGFRB;STAMBP;IL18
prerank,cellular response to alcohol (GO:0097306),0.3528665257039847,1.0892136341588536,0.34551495016611294,0.781339953063956,1.0,8/42,7.28%,GRAMD1C;ADCY5;ADCY7;CTNNA1;ADCY1;SPIDR;MAP4K1;KLF9
prerank,T cell migration (GO:0072678),0.45771114278174674,1.0891997503572373,0.3597678916827853,0.7805484908505027,1.0,2/13,1.76%,CXCL10;CXCL16
prerank,histone lysine methylation (GO:0034968),0.3789800590288861,1.0891412440619603,0.3277310924369748,0.7798867350476414,1.0,2/33,4.06%,KMT2A;WDR5B
prerank,regulation of RNA splicing (GO:0043484),-0.29047174733352915,-1.0890704745836335,0.2796610169491525,0.7492350103113539,1.0,12/69,9.53%,QKI;PIK3R1;MBNL1;KHDRBS2;SETX;PTBP1;KHDRBS3;RPS13;HNRNPK;HNRNPH2;AHNAK2;RPS26
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.35855755254332633,-1.0887593557410777,0.345679012345679,0.7491438275688567,1.0,8/25,22.20%,ANKRD13A;ATXN2;SDCBP;RAC1;ARF6;RIN3;MTMR2;ANKRD13B
prerank,cilium assembly (GO:0060271),0.27089679722311727,1.0886172667339882,0.2826362484157161,0.780502130549864,1.0,78/297,21.92%,DCDC2;TNPO1;NINL;PARVA;SPATA6;CYS1;ASAP1;DYNLL1;ALMS1;ARL13B;SDCCAG8;CENPJ;RFX3;IFT88;ARL3;CLASP1;TTC39C;HYLS1;IFT57;ARF4;TMEM107;CEP152;EXOC2;DYNC2I1;DNAAF1;NPHP1;CCDC13;HAUS8;C2CD3;RSPH9;NUDCD3;IFT81;DYNC2LI1;CC2D2A;NEDD1;CDC14A;CCDC57;RPGRIP1L;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;ACTR1A;CEP250;TOGARAM1;CPLANE1;GBF1;AVIL;TTBK2;GAS8;EXOC7;EXOC1;YWHAE;TTC21B;RPGR;IFT52;ARL6;CCDC39;WDR11;KIF3C;CEP131;CEP63;SSX2IP;CEP78;B9D2;OFD1;RP2;ACTR3;TRIP11;DZIP1L;PKD1;LZTFL1
prerank,regulation of leukocyte activation (GO:0002694),-0.4142530685932836,-1.0885874139047291,0.3419354838709677,0.7485651468271559,1.0,5/14,21.87%,MFHAS1;CD74;LYN;MYO18A;MIF
prerank,melanosome transport (GO:0032402),-0.3915754947922264,-1.0883368947462013,0.3333333333333333,0.7471930981344985,1.0,12/18,41.99%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,pigment granule transport (GO:0051904),-0.3915754947922264,-1.0883368947462013,0.3333333333333333,0.7471930981344985,1.0,12/18,41.99%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,regulation of intracellular transport (GO:0032386),-0.3245586124020154,-1.0882391492348753,0.3254156769596199,0.7464146553182424,1.0,13/38,23.10%,WWC1;REEP5;DYNC1H1;AAAS;NEFH;CAPN10;MLC1;LAMP1;MAP2;LCP1;SPAG5;ATP9A;HAP1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.4752409158583257,1.088120351484694,0.3723608445297505,0.7810455931106062,1.0,2/11,6.95%,STK39;ACTN2
prerank,regulation of cellular senescence (GO:2000772),-0.3568252033104017,-1.087890234197203,0.32941176470588235,0.746403855624482,1.0,7/28,10.92%,YPEL3;CDK6;YBX1;RBL1;B2M;ABI3;EEF1E1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.33532704870371344,-1.0875323102447805,0.30339805825242716,0.7463845129639101,1.0,11/36,19.63%,AQP11;RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;CAMLG;PARK7;N4BP1;EIF3H
prerank,regulation of immune response (GO:0050776),0.2932011480039077,1.0872198293053095,0.2851123595505618,0.7827675651907787,1.0,14/135,9.78%,CXADR;RSAD2;COL3A1;COLEC12;ICAM4;ADCY7;PTPN22;APPL2;FOXP3;VCAM1;BIRC3;IFITM1;ERAP1;APPL1
prerank,cGMP metabolic process (GO:0046068),-0.45039247723407977,-1.086694434970409,0.35807860262008734,0.7478063340510716,1.0,4/12,10.66%,GUCY1B1;PDE2A;GUCY1A1;NPR1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3713385596395049,-1.0866819871454048,0.31519274376417233,0.7468090703432841,1.0,10/24,12.74%,SEMA6D;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;VEGFA;SEMA3G;SEMA6B;SEMA3A
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3436591339928459,1.0865219276674303,0.3355155482815057,0.7838847639140295,1.0,8/49,9.65%,PPM1A;LDLRAD4;DACT1;PMEPA1;PRKCZ;OPRD1;GSK3B;SMAD6
prerank,endodermal cell fate commitment (GO:0001711),0.48411572896696115,1.086044199588302,0.3629764065335753,0.7843846146337143,1.0,5/10,15.81%,CDC73;RTF1;PAF1;LEO1;POU5F1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.32163445167632365,1.0858840372759024,0.3400309119010819,0.7840084487909706,1.0,10/69,6.62%,PDGFRA;FGFR1;TPTE;GAB2;PLCD3;PI4KA;PLCE1;PDGFRB;PLCB3;PIK3C2A
prerank,neuromuscular junction development (GO:0007528),0.4035542010374714,1.085824804144234,0.3628158844765343,0.7833468977924812,1.0,6/24,9.85%,PDZRN3;NEDD4;UNC13B;LRP4;LRRK2;MUSK
prerank,hexose transmembrane transport (GO:0008645),-0.3811575769425517,-1.0856985056164625,0.3486238532110092,0.7485636046895117,1.0,10/21,32.84%,SLC2A1;PPARD;SLC2A9;SLC50A1;SLC2A4;SLC45A3;SLC2A2;SLC2A10;SLC5A3;SLC2A3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.48670968545221105,1.0854865295229752,0.3980952380952381,0.7834793564979503,1.0,1/10,0.45%,ATP1A2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3057286280307328,1.0849406924434652,0.30994152046783624,0.7841940295798935,1.0,16/95,9.68%,UST;GPC6;CHST15;HSPG2;SDC2;ANGPT1;DCN;NDST1;OMD;DSE;CHSY1;NDST2;B4GALT1;GLCE;PRELP;GPC2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3739276439567787,-1.0848549347942478,0.3466666666666667,0.749830180164911,1.0,9/19,22.69%,AKT1;TAF3;PINK1;TAF8;HSPA5;BCL3;ARL2;SKP1;CHCHD10
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.4513729142589527,1.0848095260548416,0.3672316384180791,0.783732108683031,1.0,1/15,0.80%,MOXD1
prerank,protein secretion (GO:0009306),0.339298619350211,1.0847804660333915,0.3472,0.7829944136864119,1.0,7/56,5.70%,WLS;ARFGAP3;STEAP3;ANXA1;RAB10;MIA3;FAM3B
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.39460182914050235,-1.0847179258082016,0.3744394618834081,0.7492273072751008,1.0,6/17,16.31%,COX6C;COX4I1;COX8A;NDUFA4;COX6A1;COX7B
prerank,organophosphate biosynthetic process (GO:0090407),-0.32458443768912504,-1.084546856840275,0.32019704433497537,0.748716782733762,1.0,10/37,15.55%,ITPKB;GPHN;MBOAT1;PCYT2;IP6K2;FGF2;TKT;TPI1;PPIP5K2;PPIP5K1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.49226173871976003,1.0843604341295918,0.39341085271317827,0.7833373672992691,1.0,6/10,24.62%,NCK1;VHL;CITED2;SIRT2;BAG3;DNAJB1
prerank,activation of GTPase activity (GO:0090630),0.31398543822963126,1.0834511859046736,0.3230994152046784,0.7850912239911016,1.0,16/89,13.71%,ARHGAP29;RASGRF1;TIAM2;ARHGAP42;TBC1D16;EPHA1;GRTP1;SYDE1;GMIP;DOCK7;NGEF;SIPA1L2;EPHA2;RAP1GAP;GPR65;TBC1D7
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3329421554559531,-1.0828943071121986,0.33249370277078083,0.7524302656134764,1.0,11/35,15.18%,SGIP1;HIP1;HIP1R;HNRNPK;B2M;LDLRAP1;SNAP91;CBL;TNK2;RAC1;CCL19
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4146458989240001,-1.0822671409185578,0.35853131749460043,0.7532267297039738,1.0,5/15,9.49%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,digestive tract morphogenesis (GO:0048546),0.4449571082942828,1.0818008717798069,0.35650623885918004,0.7888617543485195,1.0,2/14,4.69%,PDGFRA;GLI1
prerank,gluconeogenesis (GO:0006094),-0.3244468883843165,-1.0812719638270176,0.32587064676616917,0.7550554250595662,1.0,15/39,21.55%,PGK1;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,sulfur compound transport (GO:0072348),-0.35596554801596253,-1.0812065425460227,0.34186046511627904,0.7542226344965871,1.0,3/27,0.51%,ABCG2;SLC6A6;SLC26A7
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3974446663715526,-1.0808910563715974,0.3525773195876289,0.7540282412355372,1.0,2/17,3.12%,CTNNA2;NCKAP1
prerank,positive regulation of B cell activation (GO:0050871),-0.3057105068501647,-1.0808553348508572,0.3037974683544304,0.7531176093899518,1.0,13/50,17.70%,MEF2C;TFRC;SH3KBP1;CD38;CD74;CD40;SYK;HMCES;PTPRC;CLCF1;NOD2;CD27;CD320
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.36947031511690864,1.080845031874542,0.3656462585034014,0.7906481572184433,1.0,9/33,13.46%,ADAMTS1;ANXA1;GLI1;CCND3;CDC73;PHB2;ANKRD17;CRNN;PAF1
prerank,negative regulation of kinase activity (GO:0033673),0.3291392437054569,1.0808330331184932,0.33746130030959753,0.789852845203693,1.0,4/62,2.16%,PDPK1;DEPTOR;PRKAG2;PPM1E
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.36065301954110324,-1.0806034954944752,0.36065573770491804,0.7528115666090609,1.0,9/25,13.61%,CTNNA3;RYR2;NOS1AP;CALM1;CALM3;CAMK2D;FGF13;CAV1;ATP2A2
prerank,regulation of mitochondrion organization (GO:0010821),0.3530478142170922,1.080555005375846,0.34846029173419774,0.7898443552593556,1.0,16/47,21.76%,PID1;STAT2;STOX1;HAX1;GSK3B;LRRK2;DNM1L;USP36;CSNK2A2;MUL1;RHOT1;MYO19;RHOT2;SREBF1;VPS35;FBXW7
prerank,cellular component assembly (GO:0022607),0.2727197627601356,1.0802372590103413,0.29120198265179675,0.789931883035456,1.0,50/253,15.31%,KMT2A;DPYSL3;PAWR;LAMC1;SPTBN1;PARVA;CALD1;TEAD1;QRICH2;WNT3A;SHROOM2;MYO1B;FLNC;BAIAP2L1;CDAN1;MYO9A;ST13;CREBBP;FBLIM1;SNX9;RSPH9;TEAD2;SYCP2;WNT5A;YAP1;RHOQ;TAPBP;MNAT1;LIMA1;TUBGCP4;PPID;DNM1L;NLGN2;WDR19;EPPK1;HFE;TEX12;TUBGCP2;GORASP2;WASL;WASF1;RTN4;RHOU;MDM4;GEMIN5;P3H4;PML;ILK;BAIAP2;TOGARAM1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.33630278071589315,-1.0795909643889907,0.33251833740831294,0.7546410011537759,1.0,18/32,42.95%,CDK17;CDK14;CDK15;POLA1;HINFP;CDC45;E2F7;CDK5;PCNA;CCNE1;CDC6;KLF11;E2F1;RRM2;CDK18;TYMS;BACH1;CDT1
prerank,dendritic cell migration (GO:0036336),-0.40110413916094534,-1.0795106990726027,0.34801762114537443,0.7538550225327408,1.0,12/16,45.18%,EPS8;HMGB1;CCL19;TRPM2;ALOX5;CCL5;CCR1;PIK3CG;CCR5;CCR6;CXCR2;TRPM4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4552062138642571,1.0794877251345694,0.3784786641929499,0.7911577844347759,1.0,3/12,8.99%,SORBS1;PRKCZ;IGF2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3096907493939761,1.0791724348449203,0.3323615160349854,0.7911775170277724,1.0,14/92,8.86%,RIN2;ROCK2;SASH1;DOCK5;FGF1;FOXC2;GLIPR2;NRP1;ANXA3;ANGPT1;CLASP1;CTSH;WNT5A;INSL3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.39011707894686837,1.0790675365074385,0.34452296819787986,0.7906494770021315,1.0,5/23,8.20%,GHR;KIT;CENPJ;IL6;CRLF3
prerank,cellular response to ketone (GO:1901655),0.36242443465903956,1.0789644557197544,0.3555166374781086,0.7901398242842025,1.0,9/35,17.32%,ROCK2;ADCY5;ADCY1;MAP4K1;KLF9;NR3C1;ADCY6;GNG2;PCK2
prerank,positive regulation of viral process (GO:0048524),0.335313606517582,1.0783278575502386,0.347068145800317,0.7910596894458604,1.0,14/60,15.71%,AXL;POLR2D;PPARA;KPNA6;STAU1;PPID;POLR2C;TMEM39A;ADAR;IFIT1;SRPK1;POLR2F;TARBP2;PKN2
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3670654839763932,-1.0781622267508661,0.3657505285412262,0.7567026652547794,1.0,13/23,31.77%,HSPA4;SAMM50;TIMM8B;HSP90AA1;BMF;MAIP1;TIMM22;BAD;NDUFA13;TIMM10;PMAIP1;TIMM13;TOMM22
prerank,t-circle formation (GO:0090656),0.48119248872855047,1.077975366440633,0.37995824634655534,0.7896249164824866,1.0,5/10,19.42%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.48119248872855047,1.077975366440633,0.37995824634655534,0.7896249164824866,1.0,5/10,19.42%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.48119248872855047,1.077975366440633,0.37995824634655534,0.7896249164824866,1.0,5/10,19.42%,WRN;SLX4;ERCC1;SMARCAL1;DNA2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.26972737509924516,-1.0778946894691228,0.279874213836478,0.7564925328763541,1.0,20/88,10.31%,EXOC6;HSPA8;SORCS1;FTH1;SORL1;FTL;SH3GL2;DOP1B;CLINT1;GOPC;EXOC4;CLVS1;SCAMP1;AP1S1;STEAP2;STXBP6;AP1S2;SCAMP2;CORO7;KLHL20
prerank,peroxisomal membrane transport (GO:0015919),-0.3429753584956497,-1.0774033249413653,0.3380281690140845,0.7569409459695194,1.0,15/27,34.74%,ABCD4;ATAD1;PEX26;GDAP1;PEX10;ABCD2;PEX16;PEX19;PXMP4;RAB8B;PEX3;PEX11B;ALDH3A2;PEX1;PEX13
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.44535372358012615,-1.077312468114759,0.358,0.7561547157132484,1.0,2/11,4.39%,SLIT2;CCN3
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3299549854231266,-1.0771602998443652,0.3611111111111111,0.7556069510667498,1.0,8/37,7.96%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;CALM3;SYMPK;MFHAS1
prerank,activation of protein kinase activity (GO:0032147),0.30307861336381176,1.077020547706491,0.31470588235294117,0.791474362323728,1.0,16/106,8.57%,PDPK1;NRK;FGF1;GHR;OSBPL8;ANGPT1;TNFSF15;TAOK3;ADCY5;ADCY7;TGFBR2;ADCY1;IL18;PHB2;WNT5A;STK3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4975684836582503,1.0769545871140418,0.392578125,0.7908275362435753,1.0,3/10,10.34%,DUSP10;PTPN22;HIPK3
prerank,regulation of B cell proliferation (GO:0030888),-0.3126020559273254,-1.0769505192065127,0.3128205128205128,0.7551828405262981,1.0,11/44,17.70%,MEF2C;TFRC;CD38;CD74;LYN;ATM;CD40;TNFRSF21;PTPRC;CLCF1;CD320
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.35657104451209876,-1.0767532219955207,0.3579676674364896,0.7547529390334445,1.0,7/26,16.20%,EFNA5;ANO1;EPHA5;KLF7;LRP5;BRSK2;ADCY8
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.4067665444404139,-1.076156993568926,0.37209302325581395,0.7553945277884548,1.0,13/16,49.61%,SLC39A14;PRMT5;ACP3;GRP;C3;MRAP2;PDE6G;NECAB2;MRAP;PDE6H;CHGA;F2;PRKCA
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.3260877800001799,-1.076143864295482,0.3302325581395349,0.7544262075250108,1.0,14/36,24.83%,INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CDC45;RAD1;CHEK1;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4730887849888964,1.075765958840037,0.40229885057471265,0.7933080241284634,1.0,4/12,12.53%,ADAMTS12;DCN;ATP2B4;CADM4
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.34189777322168763,1.0756829223750601,0.3333333333333333,0.7927383067871548,1.0,4/47,6.07%,WNT4;ROCK2;CRY1;ATP2B4
prerank,insulin receptor signaling pathway (GO:0008286),-0.2877316126803902,-1.0752500750109792,0.3231707317073171,0.7560455992181769,1.0,17/69,12.91%,GRB14;BCAR3;ATP6V0A1;FOXO1;INSR;PIK3R1;GAB1;ATP6V1B2;PIK3R3;NAMPT;ATP6V0C;AKT1;SLC39A14;CAV2;ATP6V1D;BCAR1;FOXO4
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4385930742371879,-1.0751524935054368,0.37422037422037424,0.75535343871106,1.0,8/13,21.71%,RPL26;SPRED2;ATM;EEF1E1;SPRED3;SPRED1;MSX1;ATR
prerank,erythrocyte differentiation (GO:0030218),0.34440874186472037,1.0745576077201087,0.3564516129032258,0.7951613375213975,1.0,13/44,18.98%,TGFBR3;MPIG6B;KIT;UBA5;PTPN2;ACIN1;SH2B3;ALAS2;INHA;HSPA9;CASP3;ATP5IF1;DMTN
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4752812189351965,1.074523964265168,0.38330170777988615,0.79443788758186,1.0,5/11,26.26%,TAF7;HDAC2;XBP1;TMEM106A;JAK2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.274471706209666,1.0736323107953714,0.2981770833333333,0.7961231690467206,1.0,44/234,14.46%,SMAD3;CAMK1D;DDR2;PLPP3;EIF2AK2;ZIC2;FER;TRAF5;ANXA3;FZD2;KIT;SLCO3A1;CFLAR;IL6;IKBKE;ROR1;TLR4;PRKCZ;MTDH;TRIM5;HDAC4;EDA;ADCY1;IL18;OPRD1;LGALS9;RIPK2;PHB2;WNT5A;STK3;CRTC1;UBE2V1;TLR2;IRAK3;CRTC3;MAP3K7;TRIM21;CRNN;TRIM26;MAP3K13;ARID5B;TICAM1;FLOT2;ALK
prerank,activation of phospholipase C activity (GO:0007202),0.38001939827467307,1.0733129619411532,0.34929078014184395,0.7962108485736519,1.0,7/29,15.64%,ARHGAP6;LPAR1;PHB2;NMUR1;P2RY6;BDNF;TXK
prerank,cell differentiation in hindbrain (GO:0021533),-0.44664521844687854,-1.073228376359386,0.4069529652351738,0.759957261163213,1.0,1/11,0.38%,GRID2
prerank,protein K48-linked ubiquitination (GO:0070936),0.33295744609399364,1.0731766055735075,0.364951768488746,0.79575446767788,1.0,14/54,15.51%,RNF152;TTC3;RNF216;DTX3L;AMFR;UBE2C;FBXO38;CUL3;IFI27;UBE2E3;UBE2Q2;BFAR;UBE2R2;RNF146
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.42674124249479495,1.0729379897676714,0.3808630393996248,0.7955746934112982,1.0,7/17,15.46%,RBPJ;CREBBP;STAT1;PBX1;HEYL;MAML2;KAT2B
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.277178833376413,-1.072909541587297,0.3256578947368421,0.7598201415569937,1.0,27/88,16.67%,TEK;PPP1R16B;TIE1;NRP2;THBS1;BMPR2;KDR;VEGFC;F3;ACVRL1;PTPRM;ATP5F1A;BMP4;AKT1;VEGFA;EGFL7;SCG2;CAV2;FGF2;PIK3CD;CAV1;RGCC;PRKD1;KRIT1;EGF;HTR2B;EMC10
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3368021908576981,-1.0728346840791598,0.32798165137614677,0.7590089632645676,1.0,3/31,1.99%,DLG2;LRRC7;LIN7A
prerank,homotypic cell-cell adhesion (GO:0034109),0.35759034642345205,1.0725742942442127,0.3627287853577371,0.7957417769190447,1.0,8/39,10.49%,FN1;PDGFRA;PLPP3;GP1BA;VCL;CSRP1;DSC2;PLEK
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.30840256538924704,1.0723959122668059,0.3208955223880597,0.7954153257068801,1.0,27/84,22.76%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;RTN1;DAPK1;IGF2BP1;NANOS2;IGF2BP2;EIF4ENIF1;ILF3;DDX6;RTN4;GIGYF2;EIF2AK3;CNOT9;CPEB3;ABCA7;FXR2;DHX36;NANOS1;ROCK1;RNF139;GGA3;EPRS1;NCL;GAPDH
prerank,regulation of JUN kinase activity (GO:0043506),0.37268152008988914,1.0721950370074842,0.36260162601626017,0.7951714897178451,1.0,8/33,12.35%,SASH1;DUSP10;TAOK3;PTPN22;PPEF2;HIPK3;MAP3K7;DVL3
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3470161562268596,-1.072183106293369,0.3402777777777778,0.7599228556964192,1.0,7/27,15.23%,DACH1;BMPR2;ACVRL1;ATM;FGF2;RGCC;CDKN1A
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.34700616467142964,-1.0719488844178584,0.3542600896860987,0.7595918002401516,1.0,19/29,44.10%,CADM1;CYRIB;RAET1E;LAMP1;STX7;RASGRP1;FADD;TYROBP;SLAMF6;NECTIN2;CD226;IL12A;CRTAM;IL12RB1;STAP1;IL23A;ITGAM;KLRD1;CD160
prerank,endothelial tube morphogenesis (GO:0061154),0.46915878701927843,1.0713313451439452,0.38910505836575876,0.7967890756377572,1.0,2/10,2.43%,RBPJ;CCM2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3971396309437921,1.0712825036048852,0.3645833333333333,0.7961224648666001,1.0,5/24,11.84%,EPHA7;NUPR1;MCL1;BAX;FOXO3
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.44157652975534417,-1.0712332298858083,0.3516260162601626,0.7597042753854353,1.0,6/11,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.44157652975534417,-1.0712332298858083,0.3516260162601626,0.7597042753854353,1.0,6/11,25.18%,INPP5K;IMPA1;IMPA2;INPP5J;INPP5B;SYNJ1
prerank,negative regulation of cell death (GO:0060548),-0.27098689550440624,-1.0711525639094177,0.3130434782608696,0.7589040805057325,1.0,39/88,32.04%,MECOM;PDE8A;CD34;SNCA;TM7SF3;CCN3;SORL1;CCN5;BMP4;AKT1;TNFRSF1B;PINK1;FGF2;PAX2;NPAS2;PARK7;PRKD1;BTBD10;HTR2B;PACRG;BNIP3L;SRGAP2;PSMC5;NUP62;SRSF6;CHMP2A;ADNP2;CDK5;EIF4G1;SOX11;WNT16;AMIGO2;CLU;RAD18;TRAF2;DCPS;GPNMB;MT3;TMEM109
prerank,lamellipodium organization (GO:0097581),-0.3424928573520037,-1.0709771552663145,0.3712121212121212,0.7584017022847792,1.0,8/29,13.66%,PARVB;SPATA13;ARHGEF6;CCDC88A;S1PR1;PTPRO;ARHGEF7;RAC1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.25396844323641554,1.0708692703765426,0.2984409799554566,0.7964595062934502,1.0,97/532,16.17%,RORA;LEPR;TEC;RSAD2;FN1;CXCL10;SP100;IL16;GHR;IL31RA;GBP2;FOXC1;STAT2;IL6ST;GAB2;OSM;VIM;IL11;ANXA2;FER;TRAF5;IFIT2;IL34;ANXA1;KIT;TNFSF15;STAT5B;BRWD1;IFI35;IL6;BCL2;MCL1;APPL2;PELI2;TRIM5;VCAM1;TNFRSF12A;BIRC3;BST2;NOS2;SNRPA1;EDA;OASL;IL18;OPRD1;STAT1;CCL2;ACKR3;TNFRSF14;RIPK2;PSMB10;YAP1;ZEB1;PSMA3;IL13RA1;PSME4;CNN2;IFITM1;APPL1;PSMA5;IFNLR1;PTPN6;BCL2L1;UBE2V1;OAS2;IRAK3;SMAD4;STAT4;SH2B3;FOXO3;IFI27;CSF1;ADAR;MAP3K7;TRIM21;IFIT1;BTRC;FBXW11;TRIM26;JAK1;IL22;POU2F1;RHOU;IFIT3;GREM2;CCL25;PML;ILK;SMARCA4;IL23R;SOCS6;HNRNPDL;IRF9;ICAM1;IFNAR2;MUC1;HSPA9
prerank,regulation of protein modification process (GO:0031399),0.3487988288143109,1.070798591310608,0.3851132686084142,0.7958433569209814,1.0,17/50,18.71%,FN1;STAT2;PHIP;CDH5;FER;IGF2;PPP1R16A;FNIP1;PTK2;CADM4;PML;KAT2B;NDUFS4;PPP2CA;ATG10;PLXNB2;FKTN
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.370155625136548,1.070704381230457,0.36923076923076925,0.7952891116725371,1.0,10/30,18.98%,PARP14;PRKCZ;PTPN2;MVP;PTPN6;SH2B3;CADM4;NF2;PPP2CA;DMTN
prerank,signal transduction in response to DNA damage (GO:0042770),-0.30293338999942043,-1.0706703936375643,0.3155216284987277,0.7583374911100352,1.0,17/49,24.83%,ACER2;INTS7;CLSPN;DOT1L;MAP3K20;ATM;HINFP;CASP9;RAD1;BCL3;CHEK1;E2F7;ATRIP;ATR;DONSON;FBXO6;RHNO1
prerank,organic hydroxy compound transport (GO:0015850),-0.3259727196463049,-1.0705096014014013,0.33578431372549017,0.7578154406858467,1.0,5/36,8.59%,ABCC4;SLCO1C1;CEACAM1;SLC16A1;ATP8B1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3636628612491275,1.0703394052126718,0.34056761268781305,0.7954740004488348,1.0,7/33,8.89%,KANK2;DACT1;PLK5;CDC73;CCL2;CDKN2B;DLG1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.42290850508573286,1.070275262929103,0.3853211009174312,0.794859732994239,1.0,3/18,2.33%,HEG1;DLC1;KANK1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3987446733145633,-1.069871099010544,0.3851203501094092,0.7585774007466234,1.0,2/16,7.92%,CLDN5;CLDN14
prerank,positive regulation of dephosphorylation (GO:0035306),-0.35249117438811967,-1.0698688609410354,0.34523809523809523,0.7575846945863942,1.0,7/27,7.58%,PPP1R16B;CAMTA1;CALM1;CALM2;PTBP1;CALM3;SYMPK
prerank,cellular response to organic cyclic compound (GO:0071407),0.2885420229849598,1.0698328156943337,0.34045584045584043,0.7952944820560689,1.0,28/141,16.82%,RORA;TFPI;ATP1A2;ROCK2;DIAPH1;IGFBP5;NCOA3;ADCY5;SSH1;CTNNA1;ADCY1;SPIDR;IL18;CCL2;FAM210B;LRRK2;TIPARP;P2RY6;NR3C1;CIB2;SLC26A6;P2RY1;ADCY6;PKD2;GNG2;URI1;P2RX4;RAPGEF3
prerank,neural crest cell migration (GO:0001755),0.35615183395683986,1.0688288593246527,0.34440559440559443,0.7972573219682041,1.0,5/36,6.27%,SEMA3D;FN1;RADIL;NRP1;SEMA4B
prerank,ERBB signaling pathway (GO:0038127),0.3192255216544424,1.0687446890405874,0.3536977491961415,0.7966915886337989,1.0,7/64,7.09%,PDPK1;EFEMP1;DGKD;TGFA;PLCE1;PIK3C2A;MVP
prerank,membrane raft organization (GO:0031579),0.4327242653279807,1.0685537711661044,0.38783269961977185,0.7964126069520363,1.0,6/15,17.50%,ANXA2;S100A10;NPC1;MYADM;FLOT2;ABCA7
prerank,negative regulation of response to stimulus (GO:0048585),0.3290399926000349,1.0685183641418001,0.33914421553090335,0.795719535592042,1.0,8/60,6.03%,IGFBP3;COL3A1;MPIG6B;CASK;TERT;APPL2;NR1H3;FOXP3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.43085541928777565,1.068355126207507,0.3799212598425197,0.7953622081424618,1.0,3/15,9.44%,CMPK2;ENTPD7;AK5
prerank,DNA replication initiation (GO:0006270),0.356458380084237,1.0682056218259015,0.36482084690553745,0.7949977181464417,1.0,10/37,17.14%,ORC5;POLA2;PRIM2;RPA3;MCM4;GMNN;MCM6;ORC3;ORC4;LRWD1
prerank,phospholipid metabolic process (GO:0006644),0.3186423558530838,1.0682023547845994,0.34970238095238093,0.7942057959586828,1.0,9/71,11.22%,SMPD3;PLA2G4A;PLPP3;APOA2;AGPAT4;PLA2G4C;PLPPR3;ENPP2;AGPAT3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.46550593988202443,1.067999830497267,0.38333333333333336,0.7939956122418202,1.0,3/12,9.94%,KDELR3;INSIG2;TAPT1
prerank,mesenchyme morphogenesis (GO:0072132),-0.4019935877427852,-1.0677960970806983,0.34813084112149534,0.7624683817476897,1.0,7/17,14.62%,NOS3;TGFB2;NOTCH1;ACVRL1;TBX2;ACVR1;HEY1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.437615990995618,-1.0673602275071725,0.3724279835390947,0.7625885269252377,1.0,5/12,19.92%,MAOA;OAZ2;DDC;SMS;SRM
prerank,positive regulation of transferase activity (GO:0051347),-0.2521564346242776,-1.0672352078134961,0.2851851851851852,0.761910406678757,1.0,35/142,14.70%,TEK;MERTK;ERBB4;TIE1;SERINC1;INSR;EPHA5;KDR;NTRK2;FLT1;PRKCQ;MET;NEK7;SORL1;EPHB1;PARM1;CTNNB1;SERINC5;MRE11;MAPK3;HSP90AB1;RPS2;PINK1;EPHA6;CD74;RET;DCUN1D2;NVL;EGFR;KLF4;HSP90AA1;CSF1R;DCUN1D5;DCUN1D1;PNKP
prerank,endochondral bone morphogenesis (GO:0060350),-0.4186301742052392,-1.0671976304182005,0.3855932203389831,0.7610048331392972,1.0,4/11,13.13%,MEF2C;BMPR2;BMP4;BMPR1B
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3764218749197826,1.0668744440020725,0.38380281690140844,0.7963388799572703,1.0,5/27,11.66%,CTPS1;RRM1;NUDT13;AK5;RRM2B
prerank,neutrophil activation involved in immune response (GO:0002283),-0.22524715485289087,-1.0667812689398197,0.19708029197080293,0.7612301115891268,1.0,88/428,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;SYK;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,response to steroid hormone (GO:0048545),0.3703263137537324,1.0661607788494267,0.3808724832214765,0.7974556950199463,1.0,5/31,9.42%,TFPI;ATP1A2;NR1H3;YAP1;CATSPER4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3957759234240096,-1.0660838969565951,0.38660907127429806,0.7622684555581242,1.0,2/17,1.17%,PRKG1;MEF2C
prerank,cellular response to retinoic acid (GO:0071300),0.35116506392543284,1.0660072952779653,0.3912310286677909,0.7970889727566155,1.0,8/42,8.47%,WNT6;WNT10B;WNT3A;EPHA3;PTK7;WNT5B;ZNF35;WNT5A
prerank,sodium ion transmembrane transport (GO:0035725),-0.272363203299664,-1.0658768407229267,0.3211267605633803,0.761891120547081,1.0,12/84,6.69%,SLC6A6;SLC12A2;SLC9A2;ATP1B1;SLC24A2;SLC6A1;SCN1A;HCN1;ATP1A1;SLC8A1;HCN2;SCN2A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3954498650027864,1.0658741274257388,0.3826086956521739,0.7958616884133266,1.0,6/23,11.50%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3954498650027864,1.0658741274257388,0.3826086956521739,0.7958616884133266,1.0,6/23,11.50%,ZEB2;TGFB1I1;CREBBP;CDKN2B;RNF111;SMAD4
prerank,modification-dependent protein catabolic process (GO:0019941),0.2775065381728972,1.065553309368746,0.3150326797385621,0.7959589930438317,1.0,37/193,15.97%,RNF213;SPSB1;SMURF2;RNF217;FBXO11;TRIP12;NEDD4;TTC3;RC3H1;RNF19A;SPSB4;SIAH2;DTX3L;ANAPC11;NTAN1;RNF20;KLHL15;NUB1;RNF111;ANAPC1;AMFR;UBR4;UBE2C;FBXL7;KEAP1;CUL3;BTRC;ARRB1;CDC27;BFAR;RNF43;FBXL4;RCHY1;BIRC6;UBE2R2;RNF146;RNF185
prerank,positive regulation of receptor internalization (GO:0002092),-0.36721216222269126,-1.0653300036723519,0.36343115124153497,0.7624295892532567,1.0,9/22,18.68%,INSR;AHI1;SCYL2;VEGFA;ATAD1;SFRP4;EGF;NTF3;TBC1D5
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3072370799788427,1.0649571789211214,0.3455098934550989,0.7968645875590179,1.0,20/88,16.02%,SAMD4A;EIF2AK2;IGFBP5;SHMT1;NELL1;CSTB;DAPK1;IGF2BP1;NANOS2;SERPINE2;DNAJC1;IGF2BP2;EIF4ENIF1;ILF3;DDX6;PLAT;GIGYF2;EIF2AK3;CNOT9;CPEB3
prerank,cellular response to UV (GO:0034644),-0.2706895843135626,-1.0647390988415397,0.32063492063492066,0.7631957352008623,1.0,30/76,32.70%,PTPRK;RPL26;STK11;NPM1;YY1;ATF4;COPS9;CASP9;BMF;CDKN1A;MFAP4;MMP1;N4BP1;CHEK1;NOC2L;POLD1;ATR;POLK;DDB2;TIMP1;RHNO1;HYAL3;MMP2;MMP3;MYC;PCNA;TMEM161A;TP53;HYAL2;RUVBL2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.30574426947961064,1.0646717986313101,0.3367198838896952,0.7969119254344184,1.0,18/95,14.45%,CXCL10;AXL;LDOC1;VIM;IL6;TLR4;SERPINE1;NR1H3;CDC73;CCL2;LY96;CD274;WNT5A;MAPK14;TLR2;PAF1;TICAM1;PABPN1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40016474773744026,-1.0644008731422165,0.37579617834394907,0.7631370852602749,1.0,7/15,15.27%,TMSB4X;KDR;MET;LGMN;VEGFA;FGF2;PRKD1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3372243258351021,-1.0641314608560566,0.36666666666666664,0.7629008781135233,1.0,7/30,14.75%,H3-3A;PKN1;HDAC6;HDAC1;TRIM68;KDM4C;PARK7
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.47720478047279685,1.0640704807001662,0.38140417457305503,0.7977543487706648,1.0,4/10,12.73%,ANXA2;NELL1;EPHA4;EFNA1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3969291312140188,-1.063983465671878,0.3640256959314775,0.7623129934565541,1.0,15/16,51.13%,CYRIB;CEACAM1;PTPRC;STX7;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL12B;RIPK3;XCL1;KLRC1;AGER
prerank,peptidyl-serine phosphorylation (GO:0018105),0.28371679311600145,1.063854668148535,0.3254847645429363,0.7976089245803959,1.0,38/153,18.59%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;PRKCZ;TOP1;LATS2;TGFBR1;MORC3;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;MAPK14;AKT3;HIPK3;RPS6KA3;MASTL;MAP3K13;MAPK9;WNK1;MAPKAPK5;TBK1;CSNK2A2;EIF2AK3;STK4;PKN2;PRKD2;TTBK2;MKNK2;RICTOR;SMG1;DMPK;MAPKAPK3;RPS6KB2
prerank,necroptotic process (GO:0070266),0.4235864873822851,1.0635142797733421,0.37595419847328243,0.7977030362265481,1.0,6/16,21.65%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,glycolipid metabolic process (GO:0006664),-0.304998085699065,-1.0633182818876417,0.3377659574468085,0.7631659495393963,1.0,10/47,14.61%,ST6GALNAC3;ST3GAL6;ST8SIA6;HEXB;GLTP;ST6GALNAC4;NEU1;CERK;GM2A;ST3GAL4
prerank,regulation of melanin biosynthetic process (GO:0048021),0.48068411653370585,1.0628514631017447,0.40076335877862596,0.7986606972368656,1.0,3/10,16.51%,ZEB2;APPL1;OPN3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3169574499698241,1.0624709928341514,0.3691376701966717,0.7989263487314706,1.0,22/72,20.64%,POLR2D;CUL4A;RFC1;CCNH;MNAT1;CDK7;RPA3;XRCC1;TCEA1;POLR2C;PRPF19;POLR2F;GTF2H4;ERCC5;ERCC6;ERCC1;GTF2H2;UVSSA;USP7;ERCC8;POLR2K;POLD3
prerank,protein targeting to mitochondrion (GO:0006626),-0.298226480253092,-1.062061234142329,0.35543766578249336,0.7657775902320194,1.0,16/52,22.68%,MFF;HSPA4;MFN2;GDAP1;SAMM50;TIMM8B;HSP90AA1;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22;IMMP2L;NDUFA13;TIMM10
prerank,substrate-dependent cell migration (GO:0006929),0.432110493048399,1.0615822487363866,0.405607476635514,0.8006032928490496,1.0,4/14,8.06%,EPHA8;NRP1;NTN1;ITGA11
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4017344117401668,1.0611717892815156,0.4181494661921708,0.8001440192483847,1.0,6/21,17.30%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4017344117401668,1.0611717892815156,0.4181494661921708,0.8001440192483847,1.0,6/21,17.30%,CUL4A;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,regulation of cellular component size (GO:0032535),-0.34237082461871426,-1.0609453115623018,0.37303370786516854,0.7679451632899732,1.0,12/30,27.46%,EPS8;RAP1GAP2;PPP1CA;VAV1;RAC1;RIN3;PEX11A;PPP1R15A;RAB3B;LAMTOR4;AP2M1;PEX11B
prerank,neutrophil mediated immunity (GO:0002446),-0.22291023902419266,-1.0608779701122,0.22695035460992907,0.7671267973409673,1.0,88/432,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;ACE;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4220139191235217,-1.0607969135198319,0.3655913978494624,0.7663900884273342,1.0,3/12,9.11%,PLCG2;RAB27A;GRIN1
prerank,cellular response to acid chemical (GO:0071229),-0.34312538017604166,-1.0606609357661145,0.36046511627906974,0.765790335492653,1.0,11/27,26.20%,KLF2;VEGFA;RRAGB;CPEB4;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4526815323056479,1.0600422476588347,0.4066147859922179,0.8024509312228477,1.0,4/13,15.47%,AXL;IL18;TICAM1;IL23R
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.34002434867247916,1.0599273667878026,0.35909822866344604,0.8019968177949305,1.0,11/45,13.22%,SMAD3;FOXC1;BTG3;BMP7;PTPN3;BTG4;PRCC;ZWINT;NABP1;TOM1L2;HECA
prerank,embryonic hemopoiesis (GO:0035162),0.4481286362730248,1.0598462151400692,0.3799621928166352,0.8014326394644891,1.0,5/12,13.95%,KMT2A;KIT;TGFBR2;SH2B3;THOC5
prerank,carnitine metabolic process (GO:0009437),0.45668575493448094,1.0590307039362934,0.38476190476190475,0.8028369418588758,1.0,2/12,9.64%,SHMT1;TMLHE
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4412431435309781,1.0589767531883882,0.40655105973025046,0.8021998610965573,1.0,6/13,25.86%,UBA5;SENP6;ATG10;ATG7;DESI1;DESI2
prerank,regulation of protein polymerization (GO:0032271),0.3561143497617713,1.058707497686269,0.3546218487394958,0.8021624148964288,1.0,6/35,7.40%,ARHGAP18;ARHGAP28;HAX1;RASA1;PLEKHG2;DBN1
prerank,neutrophil degranulation (GO:0043312),-0.2235543192061965,-1.0584914540411652,0.2318840579710145,0.7709182819078321,1.0,87/425,15.28%,PTPRB;ATP8A1;PECAM1;PTPRJ;LRRC7;CST3;ATP6V0A1;HSPA8;RAB27A;PTPRN2;ACTR10;CD93;ATP11B;CTSC;CTSB;STK10;SNAP25;FTH1;STOM;DOCK2;TSPAN14;HEXB;FTL;PSMC3;ATP11A;EEF1A1;HMGB1;PKM;PRG2;PRCP;SRP14;CTSD;HSP90AB1;KPNB1;ATP6V0C;EEF2;SCAMP1;CEACAM1;SDCBP;TNFRSF1B;CTSS;PSMD14;DYNC1H1;PSMD3;B2M;ALDOC;MLEC;NEU1;ARL8A;CD53;QPCT;RHOG;GDI2;HMOX2;FCER1G;DBNL;PSMD6;ATP6V1D;NBEAL2;CAPN1;FRMPD3;NFASC;GPI;GUSB;HRNR;HSP90AA1;ACLY;PGLYRP1;GRN;LAIR1;CYBB;TMBIM1;RAC1;TNFAIP6;RAB5C;PLAUR;PNP;ATP6AP2;TMEM30A;GM2A;TUBB4B;ARHGAP45;PGAM1;PPIA;PTPRC;QSOX1;CFP
prerank,glutamate metabolic process (GO:0006536),-0.38008872745812317,-1.057852323774317,0.4023529411764706,0.7717274567135586,1.0,6/19,21.91%,ALDH5A1;GCLC;GLS;GLS2;GGT1;MTHFS
prerank,positive regulation of immune response (GO:0050778),0.32037739493923556,1.0578492383288869,0.3701923076923077,0.8036512427630518,1.0,7/64,7.85%,RSAD2;IL6ST;FPR2;MYB;IFI35;GBP5;LGALS9
prerank,regulation of chromatin binding (GO:0035561),0.46193191918780385,1.0575160573368845,0.391812865497076,0.8037929521108287,1.0,3/10,10.50%,PARP9;DTX3L;GMNN
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.4280342890242689,-1.0574845004928324,0.41163793103448276,0.7717602757461508,1.0,5/12,15.41%,LY6E;SNX3;MID2;IFITM3;IFITM2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.37168155847349865,1.0574088978108616,0.39182282793867124,0.8033348842470996,1.0,9/29,19.03%,CUL4A;CCNH;MNAT1;CDK7;RPA3;GTF2H4;ERCC5;GTF2H2;XPC
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.44751774141959566,1.0571109967539343,0.4149908592321755,0.8033242625982823,1.0,3/13,10.13%,SP100;TPR;SUFU
prerank,regulation of sequestering of triglyceride (GO:0010889),0.43976355858099686,1.057085823679824,0.39501779359430605,0.802600456950977,1.0,4/15,18.20%,OSBPL8;PPARA;PLIN3;ABHD5
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.4618859013147013,1.0570685378373332,0.3985102420856611,0.8018551131030385,1.0,5/11,23.45%,WTIP;PUM2;AJUBA;XPO5;DHX9
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4186830710422991,1.0568726962953194,0.40754039497307004,0.8015899065014551,1.0,5/17,13.07%,ANXA1;PTPN22;ANXA4;MAP2K5;ARRB1
prerank,response to tumor necrosis factor (GO:0034612),0.3006538698151848,1.056752364741506,0.35015290519877673,0.8010980416302698,1.0,9/91,7.87%,PID1;ADAMTS12;ZFAND6;GBP2;CXCL16;AFF3;GSDME;CCL2;NUB1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.36223139510041613,1.0566779882587236,0.36904761904761907,0.8005041478821856,1.0,8/35,11.84%,STAT5B;ARNT;BRD1;STAT1;FAM210B;MAFB;MAPK14;FOXO3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.47079678869277775,1.056554169113011,0.39410681399631675,0.8000390672805061,1.0,3/10,8.90%,DPYD;UPP1;NT5C
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3905489699798858,1.056482137739317,0.4068965517241379,0.7994511660359268,1.0,5/24,8.99%,ENPP1;SORBS1;EPM2AIP1;GSK3B;IGF2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3323649253111114,-1.056313934970593,0.38480392156862747,0.7740417535810779,1.0,13/30,32.03%,HMGCS1;NSDHL;SQLE;INSIG1;ACLY;HSD17B7;DHCR7;LSS;MVD;MSMO1;DHCR24;IDI1;PLPP6
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.28900254747313053,1.0562962314923106,0.3521739130434783,0.7991648632474184,1.0,19/118,9.29%,PHLDB2;SH3D19;SP100;PID1;STAT2;PHIP;SDC2;DAG1;NEDD4;RC3H1;IL6;CLASP1;PHLDB1;BCL9L;GSK3B;CAPZB;EPHA4;FMNL2;LRRK2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4384161732939249,1.056218804729679,0.39114391143911437,0.7986140980953392,1.0,3/13,10.49%,BMP2;DKK3;PLEK
prerank,arachidonic acid metabolic process (GO:0019369),0.35778220350872036,1.0560723375429024,0.39451114922813035,0.7982333171270557,1.0,5/35,10.27%,PTGS1;PLA2G4A;PLA2G4C;ALOXE3;EPHX1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.36376915114702796,-1.0558506356958999,0.3978021978021978,0.7743965067919788,1.0,4/20,21.43%,STARD3NL;FDXR;HSD17B10;CYP46A1
prerank,negative regulation of apoptotic process (GO:0043066),0.25486680307130544,1.055690975091119,0.33138173302107726,0.7984922567624553,1.0,83/444,16.27%,PDPN;FHL2;FSTL1;ARHGAP10;RNF213;TLE1;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;IL6ST;PHIP;GATA6;PRAP1;SNX6;NFATC4;SH3RF1;ITGA5;ANXA1;ANGPT1;CFLAR;IL6;BCL2;ARAF;MTDH;MCL1;HAX1;SIAH2;ARF4;ANXA4;BIRC3;RASA1;CTSH;GLO1;NGFR;GSK3B;CCL2;ANXA5;RIPK2;PHB2;WNT5A;YAP1;UBE2Z;NAA16;USP47;SMAD6;DNAJC3;HIPK3;GRK5;BCL2L1;TJP1;FNIP1;PTK2;NAA15;MAP2K5;EGR3;DSTYK;RPS6KA3;API5;SUPV3L1;OPA1;CBX4;TMEM14A;BDNF;BFAR;ERCC5;IFIT3;NUAK2;VHL;NIBAN2;BIRC6;HDAC2;CSNK2A2;FIGNL1;KDM2B;DAB2;TAF9;IGF1R;HSPA9;MGMT
prerank,activation of adenylate cyclase activity (GO:0007190),0.3548190533612565,1.055374446623463,0.37970540098199673,0.7985423269632866,1.0,6/35,8.73%,LGR4;ADCY5;ADCY7;RXFP2;ADCY1;ACR
prerank,aorta development (GO:0035904),0.4279867427886513,1.0551902319821556,0.4116541353383459,0.7983084367945037,1.0,3/14,6.10%,ROBO1;EFEMP2;PDGFRB
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3608127621838801,-1.0550458847560327,0.39635535307517084,0.7756872404243295,1.0,3/22,3.31%,GRM3;CAP2;GABBR2
prerank,regulation of axonogenesis (GO:0050770),0.333559943168417,1.0542682863951804,0.3902053712480253,0.799968429531697,1.0,8/51,8.24%,PLXNA2;ROBO1;TIAM2;MAP6;LRP4;NGFR;GSK3B;EPHA4
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.440203772994148,1.054039284291663,0.41523809523809524,0.7998101095326532,1.0,5/15,13.47%,TPR;ANAPC1;UBE2C;HECW2;CDC27
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.3811491826082257,-1.0539157523642608,0.3973509933774834,0.7779956789902801,1.0,6/17,5.50%,ATP1B1;RYR2;ATP1A1;GJC1;GJD3;SLC8A1
prerank,toxin transport (GO:1901998),0.4641344484055912,1.0538517061988923,0.42613636363636365,0.7994945346533208,1.0,4/10,21.35%,ANTXR1;SLC22A2;ANTXR2;SLC22A3
prerank,response to ATP (GO:0033198),-0.38482563392380775,-1.053804072328497,0.3769063180827887,0.7773453238687478,1.0,3/18,4.62%,TRPC3;ABCC9;RYR3
prerank,renal absorption (GO:0070293),-0.4581109588202295,-1.053653334373429,0.4017094017094017,0.7768026501569169,1.0,3/10,12.24%,KLHL3;SLC15A2;KCNQ1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4087530212253537,1.053010868696933,0.3890977443609023,0.8010581007640786,1.0,7/19,20.82%,RFX3;ODAD4;DNAAF1;NPHP3;SPEF2;CCDC39;OFD1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.42435836279078487,1.0526467554787087,0.37725631768953066,0.8012928022832037,1.0,6/15,17.11%,BMP2K;DGKD;AAK1;WASL;DAB2;NEU3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3738539026044347,1.0524274448551167,0.3927927927927928,0.8011197064795018,1.0,2/27,4.19%,LPAR1;F2RL3
prerank,double-strand break repair (GO:0006302),0.2781847496888313,1.0520782469848085,0.3524590163934426,0.8012984468053796,1.0,46/158,21.52%,EYA1;PARP9;NHEJ1;NUCKS1;WRN;APBB1;TONSL;SLX4;RAD50;PARP3;DTX3L;SPIDR;SFR1;FBH1;AP5Z1;BAZ1B;XRCC4;SUMO1;NABP1;RPA3;XRCC1;DCLRE1A;RFWD3;RBBP8;NSMCE2;KDM2A;RAD51B;PRPF19;ERCC5;UIMC1;ERCC1;SMARCAL1;ACTR8;TDP2;BRCC3;DNA2;CYREN;RIF1;SMC6;NABP2;UBXN1;EYA3;INO80;CHEK2;PALB2;NSMCE1
prerank,regulation of mast cell activation (GO:0033003),-0.44658510240280724,-1.051913701116988,0.41420118343195267,0.780918079988723,1.0,8/10,48.77%,LYN;CD84;TSLP;NECTIN2;CD226;MILR1;PLSCR1;CD300LF
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.29677818741509765,-1.0518636741277816,0.3567567567567568,0.7800549739748992,1.0,15/51,12.25%,CNTNAP2;TNIK;GPM6A;NCKAP1;TRIO;PAK1;NYAP2;DAB2IP;DCLK1;SHTN1;UBB;MINK1;DBNL;ALS2;NGF
prerank,cell junction organization (GO:0034330),0.3131674475996406,1.051816736006385,0.3528481012658228,0.8012590083188187,1.0,9/71,7.36%,SDK1;SDK2;SMAD3;CXADR;FLNC;MYO9A;LRP4;FBLIM1;CLDN1
prerank,DNA dealkylation (GO:0035510),0.4760228978690091,1.0516786911037663,0.4091816367265469,0.8000857686616526,1.0,4/10,16.27%,ASCC3;FTO;ALKBH1;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4760228978690091,1.0516786911037663,0.4091816367265469,0.8000857686616526,1.0,4/10,16.27%,ASCC3;FTO;ALKBH1;MGMT
prerank,epiboly involved in wound healing (GO:0090505),0.42231585791003134,1.0512215980672075,0.4014732965009208,0.800605609816628,1.0,1/16,0.30%,PDPN
prerank,regulation of protein sumoylation (GO:0033233),0.41654016956495665,1.0510795872456602,0.41012216404886565,0.8002339975868132,1.0,3/17,8.23%,ZMIZ1;HDAC4;PIAS1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.39941288165681355,1.0510492962856524,0.36363636363636365,0.7995463122032725,1.0,7/20,17.45%,STK39;OSR1;NEDD4;ACTN2;HECW2;ADRA2A;YWHAE
prerank,potassium ion export across plasma membrane (GO:0097623),0.44914858283971776,1.050863186196275,0.42366412213740456,0.7993211235208426,1.0,1/13,0.51%,KCNT2
prerank,sensory perception of sound (GO:0007605),0.3011919576639842,1.0507742495992027,0.37821482602118,0.7988072328996069,1.0,8/88,6.54%,COL4A3;EYA1;DCDC2;ADGRV1;KIT;ROR1;GSDME;CCDC50
prerank,protein homotetramerization (GO:0051289),0.33206063602352054,1.0507248604315427,0.3891625615763547,0.7981731879918358,1.0,4/49,6.32%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,response to axon injury (GO:0048678),0.4194170367684591,1.0507112302924642,0.4121863799283154,0.7974556371300614,1.0,2/18,5.80%,DPYSL3;NREP
prerank,regulation of apoptotic process (GO:0042981),0.24705691856288464,1.0506581974574076,0.321701199563795,0.7968305925703512,1.0,116/676,14.82%,IGFBP3;PDPN;FHL2;PAWR;TIAM2;AKAP13;FSTL1;ARHGAP10;PHLDA1;CXCL10;AXL;NOTCH2;PRKAA2;OSR1;IL31RA;ZFAND6;NUPR1;WNT10B;IL6ST;PHIP;GATA6;PRAP1;FGD4;PNMA3;STEAP3;FBXO11;SH3RF1;IFIT2;ADAMTSL4;ANXA1;ANGPT1;DAPK1;BMP2;CFLAR;WRN;APBB1;IL6;PLK5;BCL2;ARAF;LATS2;MTDH;UNC13B;ZBP1;MCL1;HAX1;IFT57;SIAH2;ARF4;ANXA4;TNFRSF12A;BIRC3;RASA1;CREBBP;ACTN2;USP27X;CTSH;GLO1;PLEKHG2;ANP32E;NGFR;STAT1;PDCD5;GSK3B;ARHGEF11;TRIM24;ANXA5;QRICH1;RIPK2;PHB2;CHM;BAX;WNT5A;STK3;UBE2Z;NAA16;CALHM2;USP47;ARHGEF12;SMAD6;SOS2;NGEF;DNAJC3;HIPK3;PPID;GRK5;DNM1L;PTPN6;BCL2L1;TJP1;PTK2;NAA15;ANO6;EGR3;DSTYK;FOXO3;RPS6KA3;API5;DAPK2;SUPV3L1;OPA1;CBX4;TMEM14A;RBM5;BFAR;RTN4;ERCC5;ACVR1C;IFIT3;USP36;ALK;NUAK2;VHL;NIBAN2;BIRC6;HDAC2
prerank,ureteric bud development (GO:0001657),0.4175142676581253,1.0506188607723774,0.4,0.7961723570518248,1.0,5/17,5.23%,OSR1;FOXC1;BMP2;BMP7;SALL1
prerank,positive regulation of cell motility (GO:2000147),0.26931883607241985,1.0505078602102855,0.34478203434610305,0.7957084480251428,1.0,24/205,7.36%,SEMA3D;PDPN;ROCK2;PDGFRA;FGF1;SYNE2;CXCL16;FAM110C;CDH5;FER;NUMB;SMIM22;KIT;BMP2;NTN1;WNT5B;TGFBR1;FAM83H;MMP14;EPHA1;PDGFRB;SEMA4B;CTSH;CLDN1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2868957299355583,-1.0496297971907085,0.3387096774193548,0.785542046697143,1.0,20/57,21.03%,NOD1;MAP3K5;GRIN2A;PERP;GRIN2B;HMGB1;CTSD;LGMN;SOX7;GRIN1;MALT1;AIM2;SYK;TTBK1;FOXL2;PYCARD;PPM1F;CASP1;BAD;NDUFA13
prerank,regulation of cellular respiration (GO:0043457),-0.38097771847190365,-1.0493007565957764,0.38095238095238093,0.7854801459002119,1.0,4/17,8.19%,PRDM16;CBFA2T3;IFNAR1;PRELID1
prerank,regulation of trophoblast cell migration (GO:1901163),0.4326774978008878,1.0490559712015814,0.41379310344827586,0.7989196868879598,1.0,4/14,14.05%,SMURF2;GJA1;SYDE1;ACVR1C
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4327089855431263,-1.049034218899755,0.4073319755600815,0.7852610128465601,1.0,5/11,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,peptidyl-lysine methylation (GO:0018022),0.3859721458700764,1.0489254546838611,0.39198606271777003,0.7985133507744696,1.0,11/26,26.95%,METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;SMYD3;EHMT2;SUV39H1;SETD6;SMYD2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3122359783206587,-1.0481994684770266,0.3816793893129771,0.786657203483696,1.0,9/39,9.86%,CHRM3;FGF12;FXYD5;HOMER1;UTRN;YWHAH;TRPC6;NEDD4L;CACNA1D
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4352806527612328,-1.0481551023721198,0.4230769230769231,0.7857715452415152,1.0,3/12,2.25%,UBASH3B;RYR2;PTK2B
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4522502821713398,1.0477858224493113,0.4043824701195219,0.8007384025376282,1.0,5/11,15.66%,MLLT3;WNT5B;PLEKHA4;NKD1;DAB2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.32831602253284703,-1.0477426764568791,0.38902147971360385,0.7860284398174754,1.0,8/32,17.26%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;PKIB;CCT5
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4172774186616614,1.0476955304721651,0.41767764298093585,0.8002090488519207,1.0,4/18,10.13%,LATS2;CTNNA1;GSK3B;SUFU
prerank,synaptic membrane adhesion (GO:0099560),-0.4006407227923416,-1.047521897501145,0.3975659229208925,0.7856557098402901,1.0,7/14,20.67%,PTPRD;LRRC4C;LRRC4B;SLITRK2;SLITRK1;LRFN5;NTNG1
prerank,keratinocyte differentiation (GO:0030216),0.3631743227839411,1.0469347611148527,0.37846655791190864,0.8014887169976702,1.0,10/29,21.25%,ANXA1;CLIC4;WNT5A;EPHA2;OPN3;TXNIP;CASP3;DSP;PIP5K1A;TGM1
prerank,protein mannosylation (GO:0035268),0.392250521806389,1.0469123050567346,0.40852575488454707,0.8007972057606428,1.0,5/22,7.25%,TMTC4;TMTC1;LARGE1;RXYLT1;POMT2
prerank,phosphatidic acid metabolic process (GO:0046473),0.3305171249457239,1.0469094560868835,0.3784219001610306,0.8000498257962257,1.0,7/48,11.22%,PLD1;PLA2G4A;AGPAT4;DGKD;PLA2G6;GPD1L;AGPAT3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.37855415193206776,1.0468217172223342,0.3922942206654991,0.7995129803771401,1.0,5/24,8.20%,GHR;KIT;CENPJ;IL6;CRLF3
prerank,DNA metabolic process (GO:0006259),0.2621629059887091,1.045995443949006,0.36545682102628285,0.8009541596470285,1.0,67/270,20.64%,TCF7L2;SP100;PDS5B;DCTPP1;ORC5;POLH;TERT;WRN;TOP1;SLX4;UBE2U;RAD50;PARP3;POLA2;TOP2B;PRIM2;RFC1;POLG;NTHL1;DDX23;MNAT1;PSME4;SUMO1;NABP1;UVRAG;RPA3;XRCC1;MCM4;GMNN;ADPRS;RBBP8;OGG1;SUPV3L1;MCM6;RAD51B;INTS3;GTF2H4;ERCC5;ORC3;RAD9A;DNASE1L1;PDS5A;ALKBH1;ERCC1;ORC4;USP45;MGMT;DDX21;AXIN2;KMT5C;RAN;LRWD1;SMARCAL1;FANCC;RNASEH1;PARP4;XPC;DFFB;DNA2;NSMCE3;USP7;LONP1;RIF1;CTC1;NABP2;KMT5B;POLD3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4420266299348392,1.045830110218664,0.38783269961977185,0.8006179315566525,1.0,7/12,26.82%,PCGF5;RBM15;LRIF1;PCGF3;RLIM;SMCHD1;YTHDC1
prerank,secretory granule organization (GO:0033363),0.4665700078102101,1.045653831315442,0.42147117296222664,0.8003346990378436,1.0,4/10,14.75%,F2RL3;DTNBP1;SRGN;ABCA1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.468358896229159,1.0454945194139822,0.3969171483622351,0.80001620341435,1.0,1/10,0.35%,SOX5
prerank,positive regulation of telomere capping (GO:1904355),-0.38060103253627164,-1.0447666891503398,0.4026548672566372,0.7926024568586508,1.0,5/17,16.15%,PRKCQ;NEK7;MAPK3;PNKP;PKIB
prerank,aggrephagy (GO:0035973),0.37200983748043925,1.0443402290690091,0.411864406779661,0.8022024882954297,1.0,4/27,4.23%,DYNLL1;VIM;ARL13B;IFT88
prerank,regulation of protein secretion (GO:0050708),0.2909814232606651,1.04431440294894,0.36731843575418993,0.8015237333927204,1.0,14/119,10.57%,BMP6;DPP4;RAPGEF4;RSAD2;ITPR1;RFX3;APBB1;IL6;UNC13B;NOS2;CACNA1C;DNAJC1;PPID;DNM1L
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.29738227499092695,-1.0442894663653688,0.4030612244897959,0.7930034489209334,1.0,8/44,10.04%,PTPRJ;SORL1;DAB2IP;INPP5K;BMP4;PAQR3;LYN;MAPK8IP1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.41660931487921143,1.0437397409913425,0.4157303370786517,0.8023838380295535,1.0,3/16,8.03%,ROCK2;IL6ST;MEF2A
prerank,positive regulation of endocytosis (GO:0045807),-0.298273121894113,-1.0437240610368121,0.3848101265822785,0.7936355177912704,1.0,9/45,10.75%,NLGN1;SGIP1;HIP1;SNCA;HNRNPK;B2M;LDLRAP1;NEDD4L;CBL
prerank,phospholipid biosynthetic process (GO:0008654),-0.3227123241535027,-1.0435105921542212,0.38642297650130547,0.7932950620815491,1.0,15/36,28.12%,SGMS1;SRD5A3;MBOAT1;PCYT2;NUS1;SGMS2;DOLPP1;CPNE7;AGPAT5;CLN3;DHDDS;FADS1;HDHD5;MVD;SAMD8
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.28875002550687207,-1.0434297806856203,0.36486486486486486,0.7925014571359993,1.0,14/54,14.02%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1;B3GAT2;CHST9;HS3ST2;GUSB;SGSH;AGRN;NAGLU
prerank,membrane depolarization during action potential (GO:0086010),-0.34908642256678435,-1.0431467900741616,0.40589569160997735,0.7923508034394563,1.0,10/26,11.70%,KCNJ2;SCN1A;SLC8A1;HCN2;SCN2A;CACNA1G;YWHAH;CACNA1D;SCN8A;SCN9A
prerank,oligodendrocyte development (GO:0014003),-0.39790668308624877,-1.0431015021751984,0.42376681614349776,0.7914936394925257,1.0,7/15,33.42%,PLP1;EIF2B2;TPPP;B4GALT6;CNTNAP1;PRDM8;B4GALT5
prerank,response to hydrogen peroxide (GO:0042542),-0.29775594354745333,-1.042992950268993,0.3616504854368932,0.790866682413963,1.0,13/45,21.52%,NET1;SETX;MAP3K5;RPS3;PLEKHA1;RHOB;HDAC6;PAX2;PARK7;SOD1;ECT2;STK26;TRPM2
prerank,regulation of autophagy (GO:0010506),0.26694066178570686,1.0429155966124155,0.3710292249047014,0.8038686829506133,1.0,59/216,22.08%,LEPR;ITPR1;RNF152;PRKAG2;PRKAA2;NUPR1;SNX6;NEDD4;DAPK1;DCN;BCL2;MTDH;PTPN22;MCL1;KLHL22;HAX1;OPTN;MTMR3;TRIM5;PIK3C2A;GSK3B;LRRK2;TLK2;TPCN1;DNM1L;KEAP1;FOXO3;SLC38A9;TRIM21;EEF1A2;DAPK2;PIP4K2B;ATP6V0B;TICAM1;USP36;WDR6;CSNK2A2;ATP6V1E1;ATP6V1C1;GOLGA2;EXOC7;EXOC1;CASP3;ABL2;USP10;PIP4K2C;PLEKHF1;VPS26B;ROCK1;TRIM8;SREBF1;SIRT2;MTMR4;TRIM65;VPS35;FBXW7;ATG13;ZC3H12A;RRAGD
prerank,response to cAMP (GO:0051591),-0.32207499248356547,-1.0428123069180883,0.3645833333333333,0.7904063676969139,1.0,8/37,12.24%,AKAP6;HCN1;SLC5A5;INPP5K;HCN2;RAPGEF2;PDE2A;KCNQ1
prerank,ventricular septum development (GO:0003281),0.34917264816883997,1.042790994490311,0.3962900505902192,0.8034752927043967,1.0,11/37,14.11%,ROBO1;TGFBR3;BMPR1A;TGFBR1;SALL1;TGFBR2;HEYL;SMAD4;HECTD1;NOG;MDM4
prerank,heart contraction (GO:0060047),0.3428930460489904,1.042553960143437,0.3779264214046823,0.803410285159382,1.0,4/41,4.91%,TNNC1;ATP1A2;CSRP3;TPM1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.39801857213966774,1.0425501798581653,0.40569395017793597,0.8026706519294036,1.0,2/20,3.95%,WNT4;BMP2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.44954002068354526,1.042459813594478,0.4187380497131931,0.8021555839569484,1.0,3/12,15.47%,IL17D;IL18;IL23R
prerank,B cell mediated immunity (GO:0019724),-0.4393756554188303,-1.0422508021993244,0.4245689655172414,0.7909939907454259,1.0,7/10,43.96%,CD74;FCER1G;CD27;TLR8;FCGR2B;CARD9;SLA2
prerank,organelle transport along microtubule (GO:0072384),0.3602785243418802,1.0422130760399184,0.4350758853288364,0.8020273666842079,1.0,9/31,21.23%,ARHGAP21;TRAK1;UXT;KIF5B;FBXW11;RHOT1;RHOT2;BORCS5;PEX14
prerank,cellular response to light stimulus (GO:0071482),-0.2757509940493419,-1.0417004624657589,0.3628048780487805,0.7916107947948517,1.0,26/66,32.70%,PTPRK;RPL26;NPM1;YY1;ATF4;COPS9;CASP9;BMF;PDE6A;GPR88;N4BP1;NOC2L;POLD1;ATR;POLK;SAG;RHNO1;MYC;PDE6G;PCNA;TMEM161A;RRH;TP53;OPN1MW3;OPN1MW;RUVBL2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3313074397774453,1.0414960332026224,0.39384116693679094,0.8031841972996894,1.0,4/46,3.03%,PLD1;PLA2G4A;AGPAT4;DGKD
prerank,amino sugar biosynthetic process (GO:0046349),-0.4194383096976976,-1.0414167162930068,0.39293139293139295,0.791449612369459,1.0,5/12,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.43704525101964015,1.0413682070041317,0.4056603773584906,0.802751846247458,1.0,6/15,20.73%,GGACT;ALDH4A1;SARDH;PRODH;DPEP1;HOGA1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2565211442888709,1.0411589893012128,0.3802647412755716,0.802601650495112,1.0,72/348,16.12%,LEPR;BMP6;TEC;ROCK2;VTN;PRKAG2;FGF1;DDR2;GHR;FPR2;WNT3A;BMPR1A;OSM;IL11;FAM20A;NRP1;TWSG1;ITGA5;VEGFD;IL34;ANGPT1;BMP2;SLCO3A1;IL6;BMP7;ARAF;STOX1;TGFBR1;CCND3;RAD50;HAX1;PELI2;ATP2B4;CREBL2;RALBP1;BMP8B;OPRD1;FBH1;TNFRSF14;RIPK2;SNX9;IGF2;LRRK2;RAP2C;DOCK7;MUSK;FGF18;ENPP2;FNIP1;PTK2;SMAD4;CSF1;DVL3;HFE;RARRES2;EFNA1;ARRB1;MTCP1;BDNF;TBK1;P2RY1;GDF11;NTRK3;GDF15;ILK;IQGAP1;STK4;DAB2;PRKD2;APP;CNOT9;INHA
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3307258284963874,-1.0409273175531706,0.3829787234042553,0.7918847791216024,1.0,5/31,8.06%,HSPA8;TM7SF3;DAB2IP;HSPA14;HDAC6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.29211531523906,-1.0406984119358893,0.3697916666666667,0.7915799399919533,1.0,10/52,8.42%,NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;PUF60;KHDRBS3;DDX17
prerank,response to ketone (GO:1901654),-0.3503255079139226,-1.0401664468839875,0.41705069124423966,0.7920202241763887,1.0,4/24,2.48%,SLIT2;TGFB2;THBS1;ABHD2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3551089499062615,-1.040142876265901,0.42289719626168226,0.7910905028051763,1.0,10/22,33.18%,ESR1;PSMC3;MED30;PSMC6;PSMC5;SRF;MED13;TP53;PAXIP1;SUB1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4590576649565975,1.0397769085671449,0.4288354898336414,0.8054811839286689,1.0,3/11,7.89%,TWSG1;LGALS9;CD274
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4570239555446829,1.039728045092212,0.42574257425742573,0.8048658190761925,1.0,5/11,21.65%,NUPR1;BIRC3;SLC25A4;PELI1;RIPK1
prerank,innate immune response (GO:0045087),0.2643501590967482,1.039672213719706,0.376425855513308,0.8042724093923637,1.0,40/217,15.86%,STYK1;CXCL10;SP100;COLEC12;CXCL16;TRIM56;TRIM10;FER;BPIFB1;TLR4;TRIM17;TRIM5;BST2;NOS2;CRP;NUB1;RIPK2;PHB2;PJA2;ANKRD17;IFITM1;IFNLR1;TLR2;PTK2;IFI27;ADAR;TRIM21;IFIT1;RARRES2;TRIM26;SRPK1;ANKHD1;RNF39;TIFA;IFIH1;TBK1;FRK;PML;IL23R;APP
prerank,T cell mediated immunity (GO:0002456),-0.41810616882872875,-1.0393997748155703,0.41188524590163933,0.7922094895863222,1.0,3/13,11.29%,CADM1;EMP2;CD46
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2982900847460192,-1.0391135262116156,0.3925729442970822,0.7920373695467682,1.0,13/50,14.75%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;RFFL;VEGFA;PAX2;RPS6KA1;NGF;KLF4;PLAUR;PARK7
prerank,pore complex assembly (GO:0046931),0.3945750783412379,1.039024484388504,0.4067796610169492,0.8052959656344444,1.0,5/19,13.83%,AFDN;TPR;ANO6;AHCTF1;RTN4
prerank,regulation of myotube differentiation (GO:0010830),-0.3488509605016876,-1.038973036282002,0.4212860310421286,0.7914321115786155,1.0,6/24,9.20%,NOTCH1;CCN3;ATP11A;HDAC9;SIK1;HDAC1
prerank,TOR signaling (GO:0031929),-0.34775391286419166,-1.0388847120771312,0.41435185185185186,0.7907033520435122,1.0,5/26,8.21%,PRR5L;RPS6;CCDC88A;AKT1;PINK1
prerank,regulation of protein localization to membrane (GO:1905475),0.3712027506637012,1.0382437617956897,0.3992673992673993,0.806658213709968,1.0,6/28,9.78%,GPC6;SPTBN1;MMP14;GPC2;STX8;APPL1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.33197138396389897,1.0378195736311984,0.38688524590163936,0.8070088781856308,1.0,7/49,8.80%,KMT2A;MTURN;TNRC6B;GP1BA;KMT2C;TNRC6A;MOV10
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3980929545906239,-1.0377898776196623,0.4276729559748428,0.7929004729776196,1.0,3/15,2.61%,STOX2;TGFB2;CELF4
prerank,macrophage activation involved in immune response (GO:0002281),-0.41102125166152603,-1.0377747483618525,0.4057649667405765,0.7919777543682276,1.0,4/13,13.26%,PLCG2;DYSF;SYK;GRN
prerank,dephosphorylation (GO:0016311),0.28063663440725123,1.0377656870084395,0.3872752420470263,0.8064084671341631,1.0,33/147,12.78%,PTPN13;PLPP3;TPTE;PPM1E;PPM1A;DUSP10;PTPN14;PTPN4;DUSP28;PTPN3;PTPN22;PTPRA;MTMR3;DUSP16;PTPN9;SSH1;PTPN21;PPEF2;PPP4R2;CTDSP2;PLPPR3;NT5C;PPP4R1;PPM1B;PTPN6;PPP1CB;PTPRU;PPP3CB;DUSP5;BTRC;PTPN1;PTPN18;FBXW11
prerank,proteoglycan metabolic process (GO:0006029),0.3686813426378057,1.0372323267540648,0.41421143847487,0.8070307891285022,1.0,2/26,1.66%,SULF1;ADAMTS12
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3486858774832845,1.0371704113141422,0.4195205479452055,0.8064413634712312,1.0,9/36,12.25%,TCF7L2;FZD2;TNRC6B;PLCB3;TNRC6A;WNT5A;MOV10;PPP3CB;MAP3K7
prerank,vasculature development (GO:0001944),0.4143102731295115,1.0371018075216931,0.40384615384615385,0.8058773010406833,1.0,4/16,6.10%,PDGFRA;CDH5;ERRFI1;PDGFRB
prerank,anterior/posterior pattern specification (GO:0009952),0.33166811374887384,1.0370356519526822,0.4,0.8052998997651702,1.0,12/53,16.33%,WLS;HOXC6;HOXC4;BMP2;TGFBR1;TIFAB;SKI;HEYL;BHLHE41;HOXB4;ACVR2B;SMAD2
prerank,protein modification process (GO:0036211),-0.2734263424513835,-1.0368924016090708,0.3888888888888889,0.7935994053535206,1.0,17/76,16.64%,ST8SIA4;CHRM3;ST3GAL6;CPE;MSRA;RPN2;FBXL2;MMP15;SERP1;QPCT;PIGH;UBA52;PHEX;SEPHS1;PLOD2;ERO1A;UBE2D3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.366765316972074,-1.0365680419497794,0.40274599542334094,0.7935436871683319,1.0,9/19,35.36%,BAG6;DDIT4;PYCARD;BCL3;HIPK2;CDIP1;TP53;TMEM109;AEN
prerank,negative regulation of DNA replication (GO:0008156),0.4424717907497254,1.036529170699589,0.41282565130260523,0.8058662015027171,1.0,5/13,16.44%,CDAN1;GMNN;TSPYL2;PDS5A;S100A11
prerank,B cell homeostasis (GO:0001782),-0.44306148297731285,-1.0364974597083898,0.4087912087912088,0.7927816598978797,1.0,4/10,14.09%,MEF2C;DOCK10;LYN;CAMLG
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.40184771504323324,-1.0364397180590779,0.4282608695652174,0.7919863954275903,1.0,3/14,8.54%,GAS6;CCDC3;RFFL
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3077053296280832,1.0360671561627515,0.42338072669826227,0.8063821424106263,1.0,11/73,10.29%,KMT2A;EIF2AK2;FOXC1;OSM;MYB;TCF12;PSMB10;YAP1;PSMA3;PSME4;PSMA5
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.31923609842896217,1.035929023145762,0.38854489164086686,0.8060271659963358,1.0,10/60,13.36%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10;ATF7IP;MED12;MED20
prerank,glycolytic process (GO:0006096),-0.3392575274615029,-1.035714279574158,0.4067415730337079,0.7930731728808655,1.0,8/28,15.68%,PGK1;PKM;ALDOC;GPI;TPI1;PGAM1;PGAM4;ENO1
prerank,positive regulation of lyase activity (GO:0051349),-0.39748438380059636,-1.03512045564403,0.42526315789473684,0.7937509916309641,1.0,5/14,18.69%,NOS3;CACNA1D;NOS1;PARK7;AKAP5
prerank,copper ion homeostasis (GO:0055070),-0.3756155663950023,-1.0351173938103297,0.41914893617021276,0.7928001075413362,1.0,9/17,34.86%,ATOX1;SLC31A1;SLC31A2;MT2A;CCDC22;COX19;ABCB6;XIAP;ANKRD9
prerank,regulation of mast cell degranulation (GO:0043304),0.42374225314009795,1.0350351599017487,0.41929499072356213,0.8076707812318791,1.0,3/14,7.85%,GAB2;FER;LGALS9
prerank,positive regulation of exocytosis (GO:0045921),-0.3175380516861922,-1.0350032433828609,0.39294117647058824,0.7921633235775644,1.0,15/35,27.65%,RAB27A;CADPS;SNCA;RAB27B;SDCBP;CLASP2;EXPH5;RAB15;SYTL4;ATP6AP1;SNF8;CHMP2A;SDC4;HGS;UNC13D
prerank,skeletal muscle organ development (GO:0060538),0.3696839454161487,1.034444801131813,0.4074074074074074,0.8085771573233566,1.0,6/26,10.19%,CSRP3;CFLAR;LARGE1;IGSF8;POPDC2;MSC
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2562292727355483,-1.0336336830387325,0.36507936507936506,0.7952153009288311,1.0,21/98,13.06%,SLCO1C1;THBS1;INSR;NSF;SNCA;PPARD;AHI1;SCYL2;CHCHD2;ECE1;AKT1;IFNAR1;PRELID1;VEGFA;ATAD1;GHITM;ACE2;SFRP4;ACACA;KLF4;ACLY
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3976793405394377,1.0333150633150634,0.4209558823529412,0.8107470745014241,1.0,6/20,13.26%,ROCK2;RHOQ;FMNL2;DLG1;PLEK;LLGL2
prerank,positive regulation of cartilage development (GO:0061036),0.4185267185388127,1.0331819959560582,0.42752293577981654,0.8103465621313688,1.0,3/17,4.47%,SOX5;BMP2;BMP1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32311093878597347,1.0330443648597167,0.40327868852459015,0.8099788873279073,1.0,8/57,8.86%,LPAR1;FPR2;AKAP12;HRH3;ADCY5;ADCY7;ADCY1;INSL3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2481576545021864,-1.0328616453580253,0.3713355048859935,0.7964334524134433,1.0,36/114,25.30%,ST18;TMSB4X;PTK2B;PSMC3;COMMD7;TNFRSF1B;PSMD14;PSMD3;PSMD4;PSMD6;CD40;PSMA6;AIM2;EIF5A;PSMA4;PSMB8;ACTN4;PSMA8;CD27;LTBR;PSME1;PYCARD;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;BAG4;PSMB1;TRAF1;TNFRSF11A;TNFRSF9;PSMD11;TNFSF13;PSMD8;TXNDC17
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.38546811387356916,1.0328163025941144,0.43233743409490333,0.8098898926944438,1.0,8/24,15.76%,VTN;ITGA5;NEDD4;ARNT;CADM4;PTPN1;NIBAN2;PRKD2
prerank,detection of mechanical stimulus (GO:0050982),-0.3672855989851258,-1.032767812504204,0.4243119266055046,0.7957312134920365,1.0,3/19,5.47%,PIEZO2;CDH2;CTNNB1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3078415343690969,-1.0325501724423185,0.3969849246231156,0.795399297295385,1.0,15/40,16.45%,SGIP1;HIP1;INSR;AHI1;SCYL2;HNRNPK;B2M;LDLRAP1;VEGFA;ATAD1;CBL;SFRP4;CCL19;EGF;NTF3
prerank,muscle cell migration (GO:0014812),-0.44490479048000475,-1.0323844636241066,0.4375,0.7949528890605673,1.0,7/10,34.45%,SIX1;CCN3;MEGF10;THBS4;DDR1;ITGB1BP1;AAMP
prerank,positive regulation of GTPase activity (GO:0043547),-0.2341247687539659,-1.032244978241603,0.3168724279835391,0.7943564939120596,1.0,49/188,16.45%,DOCK9;ITGA6;RALGAPA2;BCAR3;ABR;TBC1D8;DOCK10;NET1;TIAM1;SEMA4D;ARHGEF15;TBC1D30;RAP1GAP2;RAB3GAP1;CCL14;RAPGEF2;RGS7;RGS6;CCDC125;SGSM1;ARHGAP27;BCR;RHOG;RACK1;ARHGEF26;CAV2;CD40;TBC1D22B;DOCK8;ALS2;TBC1D8B;TBC1D14;ARHGEF7;RALGAPA1;RGP1;RUNDC1;RAPGEF6;SIPA1L3;F11R;HRAS;AGRN;ARHGAP45;EVI5;SNX18;ARHGAP24;CCL19;TBC1D12;RAP1A;NTF3
prerank,response to UV-A (GO:0070141),-0.394269919141452,-1.0320915367760088,0.41739130434782606,0.7938443902798612,1.0,7/14,28.64%,AKT1;CCND1;EGFR;MMP1;TIMP1;MMP2;MMP3
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.27455354839274737,-1.0316747603416978,0.39106145251396646,0.7940771216747818,1.0,16/62,12.39%,MEF2C;MEIS2;PRKCB;THBS1;PTK2B;H3-3A;PRKCQ;CDK6;HOXB8;ZBTB16;ZFPM1;HDAC1;LYN;RUNX1;CBFB;FES
prerank,GPI anchor biosynthetic process (GO:0006506),-0.33307513461081806,-1.0316514435639206,0.41570438799076215,0.7931890522678643,1.0,8/30,15.91%,MPPE1;PIGM;PIGU;PIGK;PIGQ;PIGH;DPM2;PIGO
prerank,response to molecule of bacterial origin (GO:0002237),0.3085816832372494,1.0316130058522588,0.39509954058192953,0.8123240238472802,1.0,14/69,15.47%,SELP;FER;IL6;TLR4;PTPN22;NOS2;LY96;LGALS9;NOCT;SMAD6;IRAK3;RPS6KA3;TRIB1;IL23R
prerank,regulation of cytokine production (GO:0001817),0.28181512942837483,1.031606752447378,0.3938953488372093,0.8116033362426784,1.0,25/126,15.64%,LGR4;EIF2AK2;TRIM56;TWSG1;PLA2R1;ANXA1;IL6;DTX4;C5AR2;IGF2BP1;ZBP1;FOXP3;NOS2;CD47;CRP;LGALS9;MAPK14;IGF2BP2;TRIM21;ATP2B1;SRGN;IFIH1;TBK1;ADRA2A;TXK
prerank,monoacylglycerol metabolic process (GO:0046462),0.4348681560630196,1.0315896800214739,0.41681901279707495,0.8109150598806593,1.0,3/13,12.04%,PLA2G4A;MOGAT3;DGAT2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4453736327670216,-1.0315496385399991,0.43870967741935485,0.792547097368064,1.0,3/10,6.57%,IL33;KDR;NAMPT
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.31481336757908873,1.0314762110300117,0.3903225806451613,0.8104837262039689,1.0,10/56,11.96%,ROCK2;SPTBN1;ARL3;RASA1;STAMBP;SNX9;ESPL1;USP8;CECR2;RHOC
prerank,vasoconstriction (GO:0042310),-0.4262849283191362,-1.031369797781604,0.42917547568710357,0.7920568340315361,1.0,3/11,6.29%,EDNRA;SLC8A1;ACTA2
prerank,ncRNA metabolic process (GO:0034660),0.3399460904600173,1.031350288195906,0.4172297297297297,0.8100611578163146,1.0,11/37,21.46%,TUT4;PIWIL4;EXD1;DTD2;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,macromolecule catabolic process (GO:0009057),0.37181954022500835,1.0313100931170514,0.4144620811287478,0.8094248905749222,1.0,5/26,12.19%,NEDD4;CLN5;TRIM24;UVRAG;CLPX
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.279524400261279,1.0310393090637837,0.3806818181818182,0.8093555547658132,1.0,28/140,18.10%,LPAR1;PDGFRA;FPR2;ACKR2;CCR9;CD55;F2RL3;ADCY5;C5AR2;PLCE1;BDKRB2;SPPL3;ACKR3;CACNA1C;JPH1;GPR65;JPH3;CIB2;P2RY1;CCRL2;CACNA2D1;CCKBR;CXCR4;JPH4;P2RX4;TAC4;ABL2;GPR157
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.35710657082435593,1.031005715059415,0.39718804920913886,0.8087237299171435,1.0,3/32,4.19%,PDPK1;CXCL10;F2RL3
prerank,positive regulation of T cell activation (GO:0050870),0.31635088093616254,1.030998769225654,0.4142194744976816,0.8080064327303067,1.0,9/62,7.89%,ZMIZ1;IL6ST;ANXA1;IL6;VCAM1;CD47;CCL2;LGALS9;CD274
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.38678907390728084,-1.0304079857225623,0.42038216560509556,0.7938260226219396,1.0,6/15,9.68%,KDR;VEGFC;F3;VEGFA;CXCL12;SCG2
prerank,phagosome maturation (GO:0090382),-0.31665526808267563,-1.0303182810374178,0.419953596287703,0.793129122103739,1.0,12/35,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;RAB38;ATP6V1D;RAB39A;ATP6V0A2;ATP6V1G2;ATP6V0E2;ATP6V1F;RAB32;ATP6V0D2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.43642286617984727,-1.0300589647169878,0.4245689655172414,0.7928410471519066,1.0,4/10,16.37%,DGKH;GAP43;PLPP1;HTR2B
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3297791380154763,-1.0299343587271734,0.4340909090909091,0.7923049932013253,1.0,5/27,5.42%,CSGALNACT1;CSPG4;XYLT1;B3GAT2;CHST9
prerank,cellular protein localization (GO:0034613),-0.22298857436755493,-1.0298218481645358,0.328042328042328,0.7916625452964771,1.0,53/285,12.57%,CNTNAP2;GRID2;ESAM;PTPRK;DMD;TBC1D8;NSF;CPE;SYNDIG1;STX3;REEP1;ID1;EMP2;ARF5;TBC1D30;FBLN5;CTNNB1;AHI1;ARHGEF2;STXBP1;RAB6B;CEP68;YWHAH;STX16;RIC3;RAB38;HERC2;AMOT;TM9SF3;ARL1;SCG5;JAM3;CNTLN;HDAC6;NPM1;SGSM1;TMED2;VPS33B;CNTN2;RRAGB;CD74;ATG9A;HHEX;MFN2;PIGU;PIGK;TBC1D22B;TBC1D8B;TBC1D14;CPLANE2;EGFR;NAPA;RUNDC1
prerank,regulation of chemokine production (GO:0032642),0.3470429637191824,1.0296834384480174,0.4095394736842105,0.8108066043688552,1.0,7/36,11.12%,EIF2AK2;IL6;TLR4;IL18;LGALS9;WNT5A;TLR2
prerank,negative regulation of insulin secretion (GO:0046676),-0.3809369171305812,-1.02944907843116,0.4307692307692308,0.7918477206444793,1.0,4/17,13.96%,KLF7;CCN3;KCNB1;INHBB
prerank,sodium ion homeostasis (GO:0055078),-0.3585248072009683,-1.0293401377847513,0.39737991266375544,0.7912171016570617,1.0,5/21,9.49%,SLC12A2;ATP1B1;ATP1A1;SLC8A1;NEDD4L
prerank,cellular respiration (GO:0045333),-0.30044672749510803,-1.0290256595565124,0.4068627450980392,0.7912109596953301,1.0,17/41,36.51%,SDHC;ME3;NDUFS7;UQCRH;NR4A3;ATP5F1D;SLC25A13;COQ10B;MTFR1L;MDH2;UQCR10;COX4I2;NDUFS1;MTLN;CYCS;BLOC1S1;UQCRB
prerank,base-excision repair (GO:0006284),0.3323427321856644,1.0288316969918523,0.42338072669826227,0.8123798502056373,1.0,12/48,14.05%,WRN;RFC1;POLG;NTHL1;USP47;RPA3;XRCC1;HUWE1;ADPRS;OGG1;ERCC5;ERCC6
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3721647869876845,-1.0285380757003468,0.4090909090909091,0.7916359003730605,1.0,7/17,20.73%,AHI1;BMP4;SFRP4;FGF2;NKX6-1;BTG1;BAD
prerank,T cell receptor signaling pathway (GO:0050852),-0.24184778073289273,-1.0284179247328429,0.3829787234042553,0.7910418205946639,1.0,38/138,21.19%,PDE4D;PTPRJ;PDE4B;PLCG2;INPP5D;RFTN1;PIK3R1;MOG;PAK1;PRKCQ;PSMC3;EIF2B2;PSMD14;PSMD3;LCP2;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;BCAR1;PAK3;PSMB8;PIK3CD;TNFRSF21;PSMA8;PTPRC;PLCG1;PSME1;PRAM1;PSMD7;PSMC6;IKBKB;CD276;PSMB5;CD247;PSMC5;PSMB1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.442348898569085,1.0283974211827016,0.4384920634920635,0.8128176288634742,1.0,1/12,0.31%,SDK2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.40683804075309904,-1.0280040852172794,0.43506493506493504,0.7912606514624408,1.0,3/13,6.57%,IL33;KDR;NAMPT
prerank,mammary gland epithelium development (GO:0061180),0.4233763527260325,1.0279387997254266,0.4206773618538324,0.8133215475267732,1.0,1/14,0.44%,WNT4
prerank,peptidyl-serine modification (GO:0018209),0.26939011444315286,1.0278108526727014,0.3997326203208556,0.8129385602034118,1.0,37/166,17.19%,PDPK1;ROCK2;CAMK1D;STK32B;STK39;IKBKE;PRKCZ;TOP1;LATS2;TGFBR1;MORC3;GALNT2;GALNT1;TGFBR2;MAP4K1;GSK3B;LRRK2;TLK2;MAPK14;AKT3;HIPK3;RPS6KA3;MASTL;MAP3K13;MAPK9;WNK1;MAPKAPK5;TBK1;CSNK2A2;EIF2AK3;STK4;PKN2;PRKD2;TTBK2;MKNK2;RICTOR;SMG1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.31437185827071923,1.0276310876005283,0.42857142857142855,0.8127013043801632,1.0,10/55,12.60%,GPC6;CEMIP2;HSPG2;SDC2;DCN;OMD;PRELP;GPC2;LYVE1;ARSB
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.43095273276734497,1.0272017942715033,0.424901185770751,0.8130265616563543,1.0,3/13,8.80%,ZC3HAV1;RC3H1;MOV10
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.34918761638725243,1.027119665608556,0.4478632478632479,0.8125062285423533,1.0,3/35,2.97%,PLXNA2;SEMA3D;NRP1
prerank,regulation of activated T cell proliferation (GO:0046006),0.35334309165286915,1.0270832345470156,0.41361256544502617,0.8118825021456061,1.0,6/30,8.99%,RC3H1;FOXP3;IL18;LGALS9;CD274;IGF2
prerank,fatty acid biosynthetic process (GO:0006633),-0.28308927657297944,-1.0269344742496256,0.39570552147239263,0.7933694497955085,1.0,34/63,43.98%,ELOVL5;ABHD2;ELOVL7;TECR;ACACA;TECRL;ACLY;SCD;ACSBG1;HACD3;LPL;HSD17B8;HPGD;MCAT;FADS1;LIPH;LIPC;ELOVL2;ALOX5;LIAS;CYP2E1;ACOT7;OLAH;GSTM4;GPX4;CBR4;ABCD1;DEGS1;CYP1A1;LTC4S;ACSM3;ELOVL4;ELOVL6;ALOX12
prerank,secondary alcohol metabolic process (GO:1902652),0.33743129748278605,1.0268162585739349,0.42996742671009774,0.8118607615582852,1.0,9/42,14.75%,APOA2;APOF;CYP27A1;IDH1;SOAT1;CH25H;OSBPL5;IDH2;ABCA1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.42091038882353904,-1.0267232559697395,0.4053497942386831,0.7930275183423824,1.0,2/13,1.72%,PLCB1;IL33
prerank,aminoglycan catabolic process (GO:0006026),0.3654638415633236,1.0265224437119773,0.4236706689536878,0.8119029435431836,1.0,3/28,2.57%,GPC6;HSPG2;SDC2
prerank,negative regulation of catabolic process (GO:0009895),0.3287361526851788,1.0265038660559593,0.41318327974276525,0.8112315912631939,1.0,12/47,15.39%,NUPR1;APOA2;SNX12;HDAC4;PPARA;AZIN2;SF3B3;HCAR2;IRAK3;MDM4;ALK;ADRA2A
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35731792264202716,1.0264012995804395,0.4418212478920742,0.8107693442011548,1.0,10/33,13.10%,PDPK1;FGF1;CEMIP2;ITGA5;JMJD8;GLUL;FGF18;TJP1;EPN1;JAK1
prerank,negative regulation of viral life cycle (GO:1903901),-0.38891347719215225,-1.0263947644576172,0.4336283185840708,0.7930435033253598,1.0,6/15,15.41%,LY6E;SNX3;MID2;IFITM3;PPIA;IFITM2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.35862004228821454,-1.0259833526779045,0.41755888650963596,0.7931924552118305,1.0,7/20,21.34%,ENTPD1;HSP90AB1;PSTPIP1;P2RX7;PYCARD;CASP1;C3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3965936401057565,1.0258644477722798,0.40601503759398494,0.8114407862999453,1.0,5/18,9.78%,SPTBN1;MMP14;MISP;STX8;APPL1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4076616599542009,1.0258253063874765,0.4227005870841487,0.810813496939,1.0,2/18,4.24%,ENPP3;IFI35
prerank,negative regulation of heart contraction (GO:0045822),0.44564104290741996,1.025667561661356,0.4296875,0.8104774418589957,1.0,1/11,0.45%,ATP1A2
prerank,autonomic nervous system development (GO:0048483),0.4139513348975198,1.025563830553826,0.4307116104868914,0.8099940086744409,1.0,2/17,2.97%,FN1;NRP1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3508088313537497,-1.0249084188131694,0.4172661870503597,0.7951526283302986,1.0,7/20,25.72%,FKBP1A;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,positive chemotaxis (GO:0050918),0.40333243574431943,1.024607377530296,0.4296160877513711,0.8117525841128682,1.0,3/17,3.83%,FPR2;NRP1;ANGPT1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2910529248706583,-1.0241602178361637,0.40992167101827676,0.796347035916987,1.0,14/47,15.73%,TGFB2;FOXO1;MID1;PHLPP1;EPHB1;DAB2IP;MAPK3;FAS;MAPK8IP1;EGFR;MAPK8IP3;PPIA;NOD2;COPS5
prerank,recombinational repair (GO:0000725),0.30047076809398604,1.023950574248016,0.39908256880733944,0.8127790277245458,1.0,17/77,14.03%,NUCKS1;WRN;TONSL;SLX4;RAD50;SPIDR;SFR1;FBH1;AP5Z1;NABP1;RPA3;XRCC1;RFWD3;RBBP8;NSMCE2;RAD51B;ERCC5
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3343841838005222,1.0238517033746157,0.4205933682373473,0.8123087292699965,1.0,17/42,19.51%,MBD2;ANP32E;HNRNPC;VPS72;GATAD2B;CECR2;ACTL6A;SRCAP;ERCC6;HDAC2;SMARCA4;SMARCC1;CHD8;CHD4;ARID1B;ACTR8;NASP
prerank,regulation of microtubule depolymerization (GO:0031114),-0.34314154308955613,-1.023080337266539,0.428246013667426,0.7983917106884113,1.0,7/25,17.33%,NAV3;ARHGEF2;STMN2;MAP1B;FGF13;CLASP2;MID1IP1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3213835832732791,1.0228621632221886,0.420545746388443,0.8141889449815625,1.0,18/53,23.52%,EYA2;EYA1;PLA2R1;FBH1;EYA4;HIC1;ERCC6;UIMC1;FXR2;BRCC3;DDX5;ERCC8;EYA3;NSMCE1;NACC2;SMCHD1;DHX9;CEBPG
prerank,amide transport (GO:0042886),-0.3389408997220074,-1.0228155920166309,0.4040632054176072,0.798238865785196,1.0,6/26,6.82%,ABCG2;CERT1;SLC38A5;AQP11;SLC5A6;GLTP
prerank,microtubule-based transport (GO:0099111),-0.40866251284317057,-1.0225306829349354,0.4331896551724138,0.7981476834919049,1.0,7/13,34.13%,DYNC1I2;ADCY10;SPAG17;HTT;CABYR;DNAAF2;CCDC40
prerank,positive regulation of type I interferon production (GO:0032481),0.2965680174401269,1.0225160223548406,0.4166666666666667,0.8143898400235432,1.0,29/73,27.24%,TRIM56;TLR4;PTPN22;ZBP1;CREBBP;POLR1C;STAT1;RIPK2;POLR3F;TLR2;OAS2;POLR2F;IFIH1;TBK1;POLR3H;RNF135;DHX36;SETD2;POLR2K;RIOK3;GAPDH;DHX9;TOMM70;POLR3B;POLR2H;STAT6;ISG15;CRCP;CGAS
prerank,mitochondrial translation (GO:0032543),-0.24668779623880585,-1.0225076035717997,0.3853211009174312,0.7972978867078683,1.0,45/104,35.83%,MRPL4;LARS2;GFM1;MRPS18A;EARS2;MRPL1;MRPS30;MRPS23;FASTKD2;MRPL57;RARS2;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;HARS1;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MTIF2;MRPL45;MRPL30
prerank,I-kappaB phosphorylation (GO:0007252),0.47192982819063256,1.0222721366401395,0.437984496124031,0.8143271685136475,1.0,3/10,12.25%,TLR4;TLR2;MAP3K7
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.39039057039833425,-1.0222192216900652,0.42947368421052634,0.7972104107046238,1.0,6/14,20.46%,PCYT2;ETNK1;SELENOI;LPIN3;CEPT1;CHKA
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3503020775394878,-1.022044634592745,0.4367816091954023,0.7967362217885675,1.0,4/21,8.85%,TOX;CTNNB1;FZD3;VEGFA
prerank,serine family amino acid catabolic process (GO:0009071),0.4631911459847734,1.0219830489649462,0.42052313883299797,0.8143701451572531,1.0,2/10,8.48%,SHMT1;AMT
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2897714204337216,1.021784963008666,0.42731277533039647,0.8141658572479287,1.0,20/95,14.03%,NUCKS1;WRN;TONSL;SLX4;RAD50;SPIDR;SFR1;FBH1;AP5Z1;NABP1;RPA3;XRCC1;MCM4;FANCM;RFWD3;RBBP8;NSMCE2;MCM6;RAD51B;ERCC5
prerank,regulation of blood circulation (GO:1903522),0.3449385062183991,1.0216413893120313,0.4266666666666667,0.8138565789213301,1.0,4/34,7.03%,CELF2;DES;TPM1;BDKRB2
prerank,cilium organization (GO:0044782),0.2618083749452967,1.0215903864087124,0.42533333333333334,0.8132683080765051,1.0,55/210,22.19%,DCDC2;PARVA;CYS1;ASAP1;DYNLL1;ARL13B;CENPJ;RFX3;IFT88;ARL3;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;DYNC2I1;DNAAF1;NUDCD3;IFT81;CC2D2A;CDC14A;CCDC57;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;CEP250;CPLANE1;PKD2;GBF1;AVIL;TTBK2;EXOC7;EXOC1;RPGR;IFT52;ARL6;WDR11;CEP131;SSX2IP;CEP78;B9D2;OFD1;RP2;ACTR3;DZIP1L;PKD1;LZTFL1;CFAP410
prerank,peptidyl-proline modification (GO:0018208),-0.32919258253191036,-1.021355027980615,0.4117647058823529,0.7976821740492382,1.0,8/25,25.72%,FKBP1A;FKBP7;PPIA;PPIB;FKBP4;NKTR;PPIL6;PPIL3
prerank,monocarboxylic acid transport (GO:0015718),-0.28825582861705284,-1.021229730416669,0.4140625,0.7970711010775318,1.0,9/51,8.59%,ABCG2;ABCC4;SLCO1C1;SLCO2A1;SLC16A9;SLC5A6;CEACAM1;SLC16A1;ATP8B1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.45802472411844086,1.0211753263886618,0.45714285714285713,0.8136542847031513,1.0,2/10,3.93%,SHMT1;MTHFD1
prerank,L-amino acid transport (GO:0015807),0.36257456504526275,1.0211379683590265,0.4150268336314848,0.8130284712558974,1.0,2/28,0.80%,SLC7A2;SLC1A3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3416769287228153,-1.02100820071765,0.4253393665158371,0.796758680367677,1.0,5/24,5.63%,DACH1;BMPR2;ACVRL1;RPS3;MSH3
prerank,regulation of calcium ion transport (GO:0051924),-0.28413980221570706,-1.0209592446692404,0.45938375350140054,0.7959640860993267,1.0,12/54,12.86%,EPB41;CACNB2;HOMER1;CTNNB1;INPP5K;TRPC6;CAMK2A;MYLK;CACNA1D;NOS1;CD84;SRI
prerank,nuclear export (GO:0051168),0.2975899667786499,1.0204666987149875,0.425,0.8140602117092413,1.0,16/80,17.92%,RANBP3L;ATXN1;WASHC4;TPR;SLU7;SRSF4;EGR2;MAGOHB;STRADB;DDX39A;THOC5;POM121;SRSF5;RAN;LSG1;RANBP17
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.23393790059806133,-1.0204452771011037,0.4222222222222222,0.7964730474931234,1.0,35/151,20.68%,SGMS1;ACER3;DMD;ELOVL5;ACER2;CERS4;CERT1;PPM1L;DEGS2;ELOVL7;PCYT1B;LPCAT2;GPHN;SPNS2;SLC44A5;ALAS1;GCH1;SGMS2;GCNT1;GSTM5;MFSD2A;PLPP1;ST3GAL4;PRKD1;HACD3;SPTSSA;STARD7;SGPP1;GSTO2;LPIN3;CEPT1;GSTO1;TYW5;CHKA;PCSK5
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.33382535835580696,-1.0198879314212699,0.4073170731707317,0.797093843936352,1.0,10/26,17.54%,GRIN2B;MBP;PRELID1;GRIN1;LYN;AIM2;TTBK1;PSENEN;PSME1;PYCARD
prerank,muscle organ development (GO:0007517),-0.28567383740571434,-1.019854505091684,0.381201044386423,0.7962826011597508,1.0,9/54,7.13%,MEF2C;DMD;SGCD;COL6A3;TEAD4;TBX1;UTRN;MKX;SOX6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.4580199824087896,1.019754062020345,0.4448669201520912,0.8145420217324598,1.0,2/10,8.09%,SMPD3;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.4580199824087896,1.019754062020345,0.4448669201520912,0.8145420217324598,1.0,2/10,8.09%,SMPD3;PLA2G6
prerank,import into nucleus (GO:0051170),0.30262698725445114,1.0197257767372094,0.4391371340523883,0.8139107595599829,1.0,11/73,14.28%,PRICKLE1;TNPO1;GEMIN4;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;GEMIN5
prerank,negative regulation of endopeptidase activity (GO:0010951),0.328030720341503,1.0196982652077078,0.44246353322528365,0.8132685991957401,1.0,12/47,16.67%,VTN;TIMP3;SERPING1;SERPINB7;SERPINE1;TIMP2;SERPINE2;SERPINB8;SERPINE3;RECK;ANXA8;ANXA8L1
prerank,error-free translesion synthesis (GO:0070987),0.38800337344011426,1.0196706377908278,0.43345323741007197,0.8126267067279853,1.0,6/22,14.52%,POLH;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,arachidonic acid secretion (GO:0050482),0.460268927488356,1.0194045710649842,0.42714570858283435,0.8119021877586721,1.0,2/10,7.03%,ANXA1;BDKRB2
prerank,arachidonate transport (GO:1903963),0.460268927488356,1.0194045710649842,0.42714570858283435,0.8119021877586721,1.0,2/10,7.03%,ANXA1;BDKRB2
prerank,negative regulation of cell adhesion (GO:0007162),-0.26869923715877303,-1.019238235670511,0.3960674157303371,0.7970968288602572,1.0,20/72,16.83%,PLXNA4;PDE3B;ACER2;NOTCH1;CDH1;ACVRL1;SEMA4D;SEMA6A;TGFBI;ADAM22;NEXMIF;JAM3;ARHGDIB;SPOCK1;PTPRO;ARHGDIA;FZD4;PTPRC;CBLL1;PLXND1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4551979537122594,1.0192013676320102,0.4696969696969697,0.8117126284916978,1.0,5/11,21.65%,COLEC12;SCARA3;TICAM1;UNC93B1;RIPK1
prerank,positive regulation of macrophage activation (GO:0043032),-0.3691159903099018,-1.018770076807694,0.4166666666666667,0.7974907091445159,1.0,4/17,12.72%,IL33;THBS1;KARS1;TTBK1
prerank,extracellular matrix assembly (GO:0085029),-0.35007343849217365,-1.0187058902239354,0.4195804195804196,0.7967350927490201,1.0,13/23,24.93%,NTN4;GPM6B;GAS6;MYH11;FBLN5;EMILIN1;RAMP2;QSOX1;MFAP4;NTNG1;NTNG2;HAS1;HAS3
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.39764568654340826,1.0183070757975898,0.44652908067542213,0.8132983198785332,1.0,5/18,13.46%,MORC3;PARP10;CDC73;SKI;PEX2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.35247481620112636,1.017883712346368,0.4101694915254237,0.8136844971881563,1.0,7/31,9.71%,KANK2;DACT1;CDC73;CCL2;CDKN2B;DLG1;SUSD2
prerank,RNA processing (GO:0006396),0.266153984595995,1.0177880570927704,0.41426611796982166,0.8132313877670686,1.0,43/176,18.57%,CELF2;ATXN1;RBMS1;TUT4;RBMS2;FASTKD5;SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPH1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RBM39;RNPC3;SRSF4;DHX16;HNRNPH3;ADAR;MAGOHB;USB1;DHX8;RBM5;SRPK1;ZMAT5;RBM6;TENT2;PABPN1;FUS;SRSF5;CSTF3;HNRNPR;HNRNPA2B1;PPP2CA;NUFIP1;WBP4;SCAF11;TUT7;USP39;PRPF3
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4359220936179977,-1.0177346418800743,0.4560669456066946,0.7984898350997126,1.0,3/10,14.27%,SNCA;HDAC6;AOC3
prerank,negative regulation of calcium ion transport (GO:0051926),0.41723457334221864,1.017551116160179,0.4613899613899614,0.8131401065314382,1.0,1/15,0.45%,ATP1A2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3334911714952565,1.0173054875454235,0.42857142857142855,0.8130421779035967,1.0,5/41,7.19%,PRKAG2;LACC1;RANBP2;TPR;JMJD8
prerank,regulation of lymphocyte migration (GO:2000401),-0.42726600660295866,-1.0169224774950405,0.43568464730290457,0.7998814075804427,1.0,3/10,7.21%,STK10;JAM2;AKT1
prerank,microtubule nucleation (GO:0007020),0.38954023132068266,1.0164829093853327,0.4452423698384201,0.8144404698060437,1.0,8/20,16.23%,CENPJ;CLASP1;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.30494128302468343,1.01638238025294,0.4265402843601896,0.8139865788738344,1.0,8/65,7.57%,RORA;GATA6;TERT;EPAS1;BMP7;CPEB1;NPEPPS;OPRD1
prerank,regulation of cell motility (GO:2000145),0.27578517275190445,1.0160451778493083,0.4218289085545723,0.8141045522087454,1.0,13/121,6.81%,PLXNA2;ROCK2;DIAPH1;ARHGAP18;FGF1;LMO4;TACSTD2;FBLN1;LDB2;NTN1;AMOTL1;MGAT3;SPINT2
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3121151679302659,1.0156249855483879,0.446875,0.8144554712643046,1.0,11/64,10.80%,PLA2G4A;AIG1;ACSL1;PLA2G4C;ALOXE3;SCP2;SLC27A2;ACOT1;EPHX1;SLC27A3;HACL1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3887705338571519,-1.0156035660586957,0.4504310344827586,0.8026587056197988,1.0,4/15,13.06%,HMGCS1;HMGCS2;ACACA;ACLY
prerank,regulation of supramolecular fiber organization (GO:1902903),0.378323665140036,1.015381883663831,0.42962962962962964,0.8143661456587474,1.0,3/22,4.96%,AKAP13;EFEMP2;AEBP1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.3016057271125586,-1.0153456722271321,0.42710997442455245,0.8024027586060788,1.0,7/38,13.98%,PTPRJ;PHLPP1;PLEKHA1;INPP5K;AKT1;RACK1;PPP2R5B
prerank,regulation of cellular component organization (GO:0051128),-0.2426988885235123,-1.0152923095436284,0.40892193308550184,0.8016505556408552,1.0,30/135,16.16%,NRG3;HIP1;HSPA8;TFRC;NET1;RIT2;SEMA4D;PRKCQ;HIP1R;DAB2IP;FAM107A;RAPGEF2;PAK5;CAMK2D;ERMN;CEACAM1;STK11;PINK1;SSRP1;SPOCK1;ANKRA2;BCAR1;HSP90AA1;DCUN1D5;RAB5C;PARK7;PAK4;IRGM;SLITRK2;RAP1A
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.38631968616720846,1.0151623435687585,0.4358974358974359,0.8142583548512414,1.0,4/21,6.98%,CGNL1;ARHGAP12;SYNGAP1;STAMBP
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.2995044833475897,1.0151350883155468,0.42989214175654855,0.8136323849943365,1.0,23/73,17.78%,WNT3A;OSM;IL11;IL6;ARAF;STOX1;HAX1;ATP2B4;CREBL2;OPRD1;RIPK2;DOCK7;FNIP1;MTCP1;BDNF;TBK1;NTRK3;STK4;PRKD2;APP;CNOT9;RAPGEF3;TENM1
prerank,embryonic limb morphogenesis (GO:0030326),0.35015588230673217,1.014949552716073,0.44966442953020136,0.8133800928713951,1.0,7/34,8.78%,OSR1;AFF3;GLI3;SALL1;CREBBP;SKI;CACNA1C
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.40535879904406413,-1.0148181534467375,0.43983402489626555,0.8020584342428636,1.0,4/12,19.84%,GNL3L;GNL3;CCT5;WRAP53
prerank,regulation of vasculogenesis (GO:2001212),-0.39546145767790897,-1.014400063715052,0.4245472837022133,0.8022727378903973,1.0,7/14,16.16%,KDR;CD34;EMP2;RAPGEF2;CEACAM1;HEY1;RAP1A
prerank,negative regulation of protein localization to membrane (GO:1905476),0.36781708388565915,1.0143346915848,0.40515653775322286,0.8142391523725423,1.0,9/24,23.55%,PID1;NUMB;RHOQ;BCL2L1;DAB2;PPFIA1;DMTN;LZTFL1;TGFB1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.43800210611345236,1.013851471967067,0.4600760456273764,0.8147610441764225,1.0,1/12,0.67%,ROCK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4431591397583983,1.0138296446051047,0.45935727788279773,0.812705608173955,1.0,7/11,31.09%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,coenzyme A biosynthetic process (GO:0015937),0.4431591397583983,1.0138296446051047,0.45935727788279773,0.812705608173955,1.0,7/11,31.09%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4431591397583983,1.0138296446051047,0.45935727788279773,0.812705608173955,1.0,7/11,31.09%,PANK2;ACAT1;PANK3;PPCS;PPCDC;DCAKD;COASY
prerank,protein-containing complex subunit organization (GO:0043933),0.28259638577374624,1.013678060090437,0.43156424581005587,0.8123873293770253,1.0,22/109,14.99%,KMT2A;LAMC1;TEAD1;TPR;ST13;CREBBP;SNX9;TEAD2;YAP1;TAPBP;MNAT1;TUBGCP4;PPID;DNM1L;WDR19;HFE;TUBGCP2;WASL;WASF1;MDM4;GEMIN5;PML
prerank,microtubule depolymerization (GO:0007019),-0.3727362010435112,-1.013525567368621,0.46021505376344085,0.8038053711779789,1.0,8/17,28.05%,STMN2;KIF18A;NCKAP5;STMN4;STMN1;KIF14;STMN3;KIF19
prerank,negative regulation of organelle assembly (GO:1902116),0.3406841396772518,1.0133900123230686,0.43154246100519933,0.8124340761193529,1.0,13/35,16.15%,NUPR1;YAP1;LRRK2;SMAD4;TMEM39A;SCFD1;TBC1D7;RBM14;CHMP4A;CHMP4B;KAT2B;FEZ2;ODF2L
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.36026385835771596,1.01265289480997,0.445578231292517,0.8135631732031618,1.0,9/27,20.27%,TLR4;MAP3K1;LY96;TLR2;IRAK3;MAP3K7;TAB1;TNIP1;CD36
prerank,lymphocyte differentiation (GO:0030098),0.30250731658389735,1.0124232443925052,0.4406779661016949,0.8134252282565351,1.0,9/68,6.52%,LEPR;AXL;IL11;NHEJ1;KIT;PTPN22;VCAM1;HDAC4;PTPN2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.3190920828112248,1.0122086516747624,0.42096774193548386,0.8132598768483479,1.0,6/48,7.19%,PRKAG2;GCGR;RANBP2;TPR;NOS2;JMJD8
prerank,regulation of macrophage activation (GO:0043030),0.35659442176777134,1.012182823735827,0.43986254295532645,0.8126319804764335,1.0,6/30,8.78%,IL31RA;IL6;TLR4;NR1H3;WNT5A;PJA2
prerank,cellular response to unfolded protein (GO:0034620),-0.3367650862340319,-1.0120336409082837,0.437219730941704,0.8070784392678065,1.0,4/26,5.60%,HSPA8;TM7SF3;DAB2IP;HSPA14
prerank,negative regulation of macroautophagy (GO:0016242),0.36233169222206674,1.0118194462318402,0.4465195246179966,0.8128664689080977,1.0,9/26,17.19%,NUPR1;LRRK2;TMEM39A;SCFD1;USP36;CHMP4A;CHMP4B;FEZ2;SMG1
prerank,regulation of neuroinflammatory response (GO:0150077),0.3878694043326315,1.0112509044575642,0.44107142857142856,0.8135968501570631,1.0,3/19,7.50%,NUPR1;IL6;IL18
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.32694987045783247,1.0108587949481882,0.43666666666666665,0.813963682806934,1.0,7/42,7.65%,PLEKHA2;RIN2;NRP1;S100A10;EFEMP2;EPHA1;GSK3B
prerank,cellular response to glucose stimulus (GO:0071333),0.3545526382943241,1.0107779322287802,0.4444444444444444,0.8134799563089699,1.0,3/30,5.34%,ZBTB20;PRKAA2;UNC13B
prerank,negative regulation of secretion by cell (GO:1903531),0.33840743224317166,1.0106132258043226,0.44612794612794615,0.8131962306419086,1.0,5/38,4.41%,RSAD2;OSM;IL11;ANXA1;HRH3
prerank,cellular response to interleukin-1 (GO:0071347),-0.23283058940610246,-1.0104798789928,0.42803030303030304,0.8104225027060534,1.0,35/143,21.19%,PLCB1;ST18;RPS6KA5;IL1R1;NOD1;IL1RAP;PSMC3;DAB2IP;CCL14;MAPK3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;CD40;PSMA6;PSMA4;PSMB8;PTGIS;UBA52;PSMA8;CCL19;NOD2;PSME1;PYCARD;TOLLIP;IRAK1;PSMD7;PSMC6;IKBKB;PSMB5;UPF1;PSMC5;PSMB1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3802130888567586,1.0101632740631323,0.45898778359511344,0.8136424036183625,1.0,3/20,5.16%,ZMIZ1;EPAS1;TGFBR1
prerank,cellular response to fatty acid (GO:0071398),0.42658269307088165,1.0099002877202763,0.44216417910447764,0.8136235850760555,1.0,2/12,12.04%,PID1;DGAT2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.31699407444089683,1.0097706488244527,0.45585874799357945,0.8132764541939651,1.0,9/52,8.89%,PDPK1;SPTBN1;EPHA3;SORBS1;EPB41L2;ATP2B4;PTPN9;KIF5B;DLG1
prerank,negative regulation of platelet activation (GO:0010544),-0.37383736835420417,-1.0095860085725548,0.42769857433808556,0.8120377208449403,1.0,3/16,7.57%,PRKG1;NOS3;CEACAM1
prerank,Ras protein signal transduction (GO:0007265),0.27525364588702433,1.0095579589386579,0.42105263157894735,0.8130744276354709,1.0,37/137,20.41%,ARHGAP29;PDPN;ARHGAP6;ROCK2;PLD1;KSR1;RRAS2;NTN1;PLCE1;CELSR1;NGFR;ARHGEF11;USP8;RAP2C;RALGDS;CDC42EP4;MAPK14;CDH13;SHOC2;WASF1;SHC2;BRAP;MAPKAPK5;LIMK1;ADRA2A;RIT1;RAPGEF3;COL1A2;RAP2B;SOS1;SHC1;FARP2;NRAS;SETDB1;RASSF1;ROCK1;CRKL
prerank,positive regulation of cellular component movement (GO:0051272),0.3691018014578975,1.0092427511738533,0.4293193717277487,0.8131855939702929,1.0,3/24,5.16%,PDPN;NTN1;TGFBR1
prerank,regulation of microtubule-based movement (GO:0060632),-0.41067431949586686,-1.009205717139566,0.4619771863117871,0.8122009510952377,1.0,6/11,26.74%,HDAC6;NEFH;LAMP1;MAP2;HAP1;CCDC65
prerank,catecholamine biosynthetic process (GO:0042423),-0.4224303295950252,-1.0091954452331011,0.43434343434343436,0.8113044648480882,1.0,4/11,10.31%,TGFB2;SNCA;DDC;GCH1
prerank,selective autophagy (GO:0061912),0.31109698105701145,1.0089349487935513,0.44251968503937006,0.813294084473346,1.0,9/56,11.43%,DYNLL1;VIM;AMBRA1;ARL13B;IFT88;UBA5;PHB2;UBE2V1;STBD1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.27667573040943205,-1.008757363922924,0.42618384401114207,0.8115672110188161,1.0,26/57,32.58%,FOXN3;MRE11;CLSPN;CCND1;BABAM1;ATM;MDC1;CDK2;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;PLK1;CDK1;TP53;PRKDC;FBXO31;NEK11;TICRR;MUS81
prerank,mitochondrion localization (GO:0051646),0.3843952269289354,1.0087515623039032,0.4357142857142857,0.8130519628135581,1.0,6/19,15.52%,TRAK1;MEF2A;LRRK2;ATCAY;TLE6;MUL1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.41281657543971095,-1.008565337565767,0.44142259414225943,0.8111716780401665,1.0,4/12,13.74%,SIX1;VEGFA;PAX2;SIX4
prerank,calcium ion transmembrane transport (GO:0070588),0.2897329012095898,1.008539467263895,0.4287833827893175,0.8128905411439802,1.0,13/86,11.40%,TRPM3;MCU;TRPM6;MICU1;NALCN;SLC24A3;ATP2B4;PHB2;CACNA1C;TMEM165;TRPC1;PMPCB;ANO6
prerank,endoderm formation (GO:0001706),-0.31497897125603136,-1.008483199786174,0.4572192513368984,0.8104631005189854,1.0,9/35,9.60%,COL8A1;ITGA4;SOX17;LAMA3;MMP15;COL12A1;SOX7;COL6A1;ITGA7
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2936426513333209,-1.0083625537017247,0.457286432160804,0.809926849465989,1.0,19/43,32.16%,FOXN3;MRE11;CLSPN;BABAM1;ATM;CDKN1A;BRCA1;CHEK1;DTL;DONSON;TAOK2;CDC14B;BLM;HUS1B;TOPBP1;PLK1;CDK1;CDC6;TICRR
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30237753305606346,1.008024102327061,0.44375,0.8134762053894449,1.0,6/67,3.67%,SULF1;ROCK2;AXL;NRP1;VEGFD;SHB
prerank,regulation of keratinocyte proliferation (GO:0010837),0.378610958727735,1.0077897292784586,0.45486725663716815,0.8134072478161178,1.0,5/22,12.62%,NOTCH2;CASK;KLF9;EPPK1;CRNN
prerank,protein homooligomerization (GO:0051260),0.27403720838139767,1.0077754530009793,0.4453900709219858,0.8127530281425442,1.0,8/114,6.32%,ALDH1A2;RNF213;MICU1;SHMT1;PRF1;CLYBL;APPL2;GBP5
prerank,tricarboxylic acid metabolic process (GO:0072350),0.43245599359186015,1.007634336931357,0.4592445328031809,0.8124315389756583,1.0,6/12,20.78%,IDH1;SIRT4;ACO1;IDH2;IREB2;ASS1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.31195350743777517,1.007287814631227,0.4440944881889764,0.8126496499946301,1.0,7/59,8.80%,TCF7L2;CDK8;TNRC6B;IL6;BAX;TNRC6A;MOV10
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.39450307156487274,1.0071496590434619,0.4351851851851852,0.8123287890739409,1.0,6/18,18.46%,BCL2;HEBP2;BCL2L1;SLC25A4;MUL1;SLC25A31
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.39550475659290735,-1.0070023983835417,0.44863731656184486,0.812786294843679,1.0,5/13,16.80%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4723200854685362,1.0068818440158853,0.45436507936507936,0.8122931781270338,1.0,5/10,24.69%,MYB;JARID2;KDM1A;RIF1;ATRX
prerank,positive regulation of DNA repair (GO:0045739),0.3207088847750457,1.0067002988187232,0.4437194127243067,0.8120882598997952,1.0,17/46,23.81%,EYA2;EYA1;SPIDR;SLF2;XRCC1;EYA4;ERCC6;UIMC1;MGMT;BRCC3;ERCC8;EYA3;SPIRE1;SMCHD1;DHX9;CEBPG;ZCWPW1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.29294963437204413,1.006700052644673,0.4594594594594595,0.8114072272575109,1.0,14/87,9.48%,ROCK2;PDGFRA;ARHGAP18;NOTCH2;DLC1;EPHA3;SMIM22;RHOBTB2;PDGFRB;RHOF;BST2;CELSR1;RHOQ;IQGAP2
prerank,response to lipid (GO:0033993),0.2810203197081093,1.0065243517368998,0.4392655367231638,0.8111951881896104,1.0,19/105,12.46%,SELP;GATA6;FER;RBP4;ANXA1;STAT5B;TLR4;PTPN22;PPARA;NOS2;CTSH;LY96;LGALS9;STRN3;NOCT;SMAD6;IRAK3;FOXO3;RPS6KA3
prerank,copper ion transport (GO:0006825),-0.4051516125994141,-1.0064090684057394,0.46220302375809935,0.8134897196204391,1.0,4/11,10.91%,ATOX1;SLC31A1;STEAP2;SLC31A2
prerank,regulation of fibrinolysis (GO:0051917),-0.39748984546546223,-1.0063191204680266,0.4583333333333333,0.8128465424746724,1.0,3/13,12.50%,THBS1;FAP;USF1
prerank,response to exogenous dsRNA (GO:0043330),0.39168564776797876,1.0056058156371819,0.44366197183098594,0.812809053984191,1.0,6/18,15.52%,COLEC12;IRAK3;IFIT1;TICAM1;IFIH1;MUL1
prerank,Notch signaling pathway (GO:0007219),0.31290465965640335,1.005435822956348,0.4405705229793978,0.8125306427356105,1.0,12/59,12.42%,RBPJ;NOTCH2;GMDS;BMP2;DTX4;DTX1;DTX3L;CREBBP;STAT1;PBX1;HEYL;MAML2
prerank,sulfur amino acid catabolic process (GO:0000098),-0.42805853958658746,-1.005236363601011,0.4537987679671458,0.8149461739991732,1.0,5/10,23.02%,TXN2;MTRR;CTH;ADO;MPST
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.43482414407627185,1.0051473698378486,0.4790874524714829,0.8125769147225498,1.0,4/12,12.03%,IL34;BST2;PTK2;CSF1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.41002909315378977,1.0048904359851512,0.4485294117647059,0.8125208535896044,1.0,4/15,12.72%,RBPJ;FER;CDH13;PTPN18
prerank,positive regulation of protein sumoylation (GO:0033235),0.44975039375691683,1.0045656408951589,0.45886654478976235,0.8126545142312416,1.0,3/10,15.52%,HDAC4;PIAS1;MUL1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.4589720861405828,1.0045626641116727,0.48185483870967744,0.8119867884081858,1.0,2/10,3.83%,FPR2;KIT
prerank,positive regulation of cytokine production (GO:0001819),0.24840753301316282,1.004381185414166,0.44074074074074077,0.8117559199172515,1.0,31/292,8.47%,SULF1;RORA;ROCK2;IL16;SPTBN1;EIF2AK2;IL6ST;APOA2;OSM;PLA2R1;ANXA1;IL17D;IL6;TLR4;ARNT;LACC1;PRKCZ;PTPN22;ZBP1;SERPINE1;GBP5;NOS2;CREBBP;POLR1C;IL18;LGALS9;CD274;TNFRSF14;RIPK2;SETD4;WNT5A
prerank,apical junction assembly (GO:0043297),0.31319626303542814,1.004172444340329,0.4525660964230171,0.8116110447143212,1.0,13/53,16.05%,AFDN;CDH5;PARD6G;PARD6A;VCL;CTNNA1;CLDN1;DLG1;RHOC;FBF1;CLDN11;PKN2;PATJ
prerank,positive regulation of transport (GO:0051050),0.2886208732414229,1.0041348578171145,0.46607669616519176,0.8110330221564507,1.0,10/85,8.35%,KMT2A;CAMK1D;FPR2;APOA2;ANXA2;ANXA1;NR1H3;CD47;GSK3B;BAX
prerank,response to estradiol (GO:0032355),0.34601128594415387,1.0039566495421277,0.4454225352112676,0.8107644531585612,1.0,5/31,8.58%,NCOA3;ANXA1;STAT5B;FAM210B;STRN3
prerank,platelet aggregation (GO:0070527),0.346326270411113,1.0036577398024749,0.45454545454545453,0.810841977167474,1.0,5/33,5.47%,FN1;PDGFRA;GP1BA;VCL;CSRP1
prerank,negative regulation of mRNA processing (GO:0050686),-0.3764309167725864,-1.0036166615346598,0.475,0.8184916648222151,1.0,6/15,21.65%,PTBP1;BARD1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,negative regulation of double-strand break repair (GO:2000780),0.3571293116498837,1.0033846602670309,0.4578313253012048,0.810841361799155,1.0,15/30,27.81%,TRIP12;KLHL15;FBH1;OGG1;ERCC6;SHLD2;UBR5;CYREN;RIF1;SMCHD1;SHLD1;TFIP11;FANCB;CGAS;HMGA2
prerank,amino acid transmembrane transport (GO:0003333),0.32290427834595387,1.0033176894402442,0.46485623003194887,0.8103276038691108,1.0,3/45,3.87%,SLC7A11;SLC6A13;SLC16A2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4119394460959533,-1.0030860563134458,0.46555323590814196,0.8191001821296854,1.0,7/12,31.46%,PFDN5;PFDN2;PFDN4;VBP1;TREM2;CLU;LDLR
prerank,histone H4-K5 acetylation (GO:0043981),-0.38433929762700725,-1.0030707486388004,0.44713656387665196,0.8173204363692803,1.0,6/15,24.15%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),-0.38433929762700725,-1.0030707486388004,0.44713656387665196,0.8173204363692803,1.0,6/15,24.15%,JADE3;PHF20;JADE1;KAT7;ING4;MCRS1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.25420801118066993,-1.0030302064200805,0.46407185628742514,0.8165462188835706,1.0,13/84,8.46%,QKI;NOVA2;MBNL1;CELF4;KHDRBS2;RBFOX3;RBFOX1;PTBP1;PUF60;KHDRBS3;HNRNPK;DDX17;TRA2A
prerank,myeloid cell differentiation (GO:0030099),0.3207289540919682,1.0029710004771317,0.4437194127243067,0.8105342880476804,1.0,15/47,17.68%,MPIG6B;IL11;KIT;UBA5;NCOA6;PTPN2;CDKN2B;ACIN1;TET2;KAT6A;ALAS2;INHA;HSPA9;CASP3;ATP5IF1
prerank,response to organophosphorus (GO:0046683),-0.38308622031753,-1.0029422251859759,0.46120689655172414,0.8158966141821242,1.0,2/16,2.03%,TRPC3;ABCC9
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.408995633805751,1.0028704311788097,0.45018450184501846,0.8101278232035146,1.0,8/16,21.52%,MIA3;VAPA;LRRK2;TAPT1;GBF1;ANK2;SEC16A;BCAP31
prerank,regulation of organelle assembly (GO:1902115),0.2978765860081329,1.002691097093131,0.44038155802861684,0.8098815854857756,1.0,13/73,16.32%,DCDC2;TBC1D16;ALMS1;SDCCAG8;CENPJ;IFT88;MTMR3;DYNC2LI1;SENP6;IFT20;NPRL3;SPICE1;RAB5A
prerank,nucleic acid-templated transcription (GO:0097659),0.32753350217038935,1.0024863210438306,0.44089456869009586,0.809738529826533,1.0,11/42,13.74%,POLR2D;TERT;BAZ2A;DTX1;CREBL2;MEF2A;EPC1;POLR2C;THAP1;MED20;POLR2F
prerank,inorganic anion transport (GO:0015698),0.31981578716816533,1.0024390822064981,0.4541139240506329,0.8091801000189733,1.0,10/53,12.18%,ENPP3;SLC13A4;ENPP1;SLC26A9;SLC4A11;CLIC4;ANO10;NMUR1;ANO6;ANO8
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29304976418099976,1.0024341006512907,0.4523449319213313,0.8085224112313527,1.0,16/76,15.52%,PRICKLE1;ANGPT1;CRY1;MYCBP2;HDAC4;BIRC3;RIPK2;PIAS1;LRRK2;FBXO4;HUWE1;CENPX;CUL3;TBC1D7;RCHY1;MUL1
prerank,positive regulation of heart contraction (GO:0045823),0.3900041748042643,1.0020676292177009,0.45072992700729925,0.808718260200695,1.0,3/19,8.55%,ATP1A2;SCN3B;ADM
prerank,cytoplasmic sequestering of protein (GO:0051220),0.41705326907227097,1.001864681439805,0.46494464944649444,0.8085209812315703,1.0,7/13,21.85%,DBN1;SUFU;KEAP1;PKD2;NFKBIE;GET4;PKD1
prerank,superoxide anion generation (GO:0042554),-0.4024251797793233,-1.001304141828832,0.47478991596638653,0.8195733756732531,1.0,9/13,43.98%,NCF2;CYBB;TAFA4;NOX4;NCF1;NOX3;NCF4;DUOX1;ALOX12
prerank,plasma membrane organization (GO:0007009),0.30318770754651175,1.000954871996055,0.45625,0.810133310381546,1.0,11/61,11.40%,MYOF;SPTBN1;A4GALT;COL5A1;PACSIN2;SNX9;MICALL1;PLSCR4;STX2;PLSCR2;ANO6
prerank,positive regulation of protein catabolic process (GO:0045732),0.2863677772426544,1.0008938449661269,0.4374057315233786,0.8096283899374396,1.0,15/84,12.85%,SH3D19;SMURF2;NEDD4;DACT1;NRDC;GSK3B;SNX9;WNT5A;TIPARP;WWP2;HUWE1;NKD1;VGLL4;HECW2;ASB5
prerank,cellular response to superoxide (GO:0071451),-0.42262288240391627,-1.0008635149628795,0.4837310195227766,0.8199050460243125,1.0,3/10,21.77%,NOS3;SOD1;PRDX2
prerank,cellular response to glucagon stimulus (GO:0071377),0.4032810383395129,1.0006589085945414,0.4444444444444444,0.8095772848187397,1.0,4/17,7.01%,GCGR;ADCY5;ADCY7;ADCY1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2807479846857326,1.000615191492195,0.44970414201183434,0.8090334545303339,1.0,15/94,12.29%,PDK1;ITPR1;IKBKE;BCL2;MCL1;CASP4;CUL4A;FHIT;QRICH1;BAX;STK24;BCL2L1;RRP8;CUL3;EPHA2
prerank,N-glycan processing (GO:0006491),0.40198400876561025,1.000596062115104,0.4685185185185185,0.8084134033046602,1.0,3/18,3.00%,MAN1C1;PRKCSH;MAN2A1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.38370545808152434,1.000594888738699,0.4581818181818182,0.8077502257793897,1.0,4/21,11.81%,DAG1;SPPL3;ERAP1;ADAM19
prerank,neutrophil migration (GO:1990266),-0.27234785839861214,-1.000299423566624,0.453781512605042,0.8205312975231727,1.0,10/58,15.18%,BSG;PECAM1;PDE4B;TGFB2;CCL14;FCER1G;SYK;PIK3CD;PPIA;CCL19
prerank,positive regulation of protein import (GO:1904591),0.3556911413098738,1.00012648675439,0.4572425828970332,0.8082670066768816,1.0,4/30,7.63%,SMAD3;ZIC1;TPR;PDCD5
prerank,negative regulation of autophagy (GO:0010507),0.31482670844305405,0.9998649968035915,0.4628751974723539,0.80823245044,1.0,8/54,9.45%,LEPR;NUPR1;BCL2;PTPN22;MCL1;KLHL22;LRRK2;TLK2
prerank,lysine metabolic process (GO:0006553),0.4351552062378618,0.9998579232534176,0.4824399260628466,0.806928329036716,1.0,2/12,6.12%,HYKK;PHYKPL
prerank,lysine catabolic process (GO:0006554),0.4351552062378618,0.9998579232534176,0.4824399260628466,0.806928329036716,1.0,2/12,6.12%,HYKK;PHYKPL
prerank,negative regulation of transferase activity (GO:0051348),-0.3189085265287593,-0.9997439416308029,0.4519906323185012,0.8211984637251375,1.0,8/28,19.80%,SMAD7;INPP5K;TERF1;PARK7;MAPT;MEN1;CDKN1C;EIF4A2
prerank,negative regulation of protein transport (GO:0051224),0.3706499159696706,0.9995597994405137,0.46842105263157896,0.8070084563976502,1.0,3/25,10.31%,RSAD2;SNX12;WWP2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3725311683253289,0.9992511362695651,0.4525043177892919,0.8071156080567174,1.0,5/22,14.68%,ROCK2;CRY2;GSK3B;MASTL;BOD1L1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.38195800802647634,-0.9986486583423768,0.4700665188470067,0.8233785833716276,1.0,3/16,7.35%,BMPR2;PRCP;ACE
prerank,nucleoside salvage (GO:0043174),-0.43076523769376407,-0.9983008278759056,0.45124282982791586,0.8234227827529738,1.0,5/10,22.06%,UCK2;UPP2;UCKL1;UCK1;HPRT1
prerank,positive regulation of protein metabolic process (GO:0051247),0.27687763950533817,0.9982172989602741,0.4502840909090909,0.80905725243524,1.0,19/110,12.85%,ROCK2;SMURF2;SLC6A9;NEDD4;DACT1;IL17D;NR1H3;IL18;GSK3B;WNT5A;TIPARP;SLC25A37;WWP2;HUWE1;NKD1;MAP2K5;CSF1;HECW2;ASB5
prerank,regulation of dendrite development (GO:0050773),0.3352908903484311,0.9981477626825875,0.4563758389261745,0.8085541601806848,1.0,7/37,7.65%,PTN;CAMK1D;SDC2;NEDD4;BMP7;DBN1;GSK3B
prerank,regulation of integrin activation (GO:0033623),0.41562015917475376,0.9979368196984861,0.4653846153846154,0.8084550320562413,1.0,3/15,10.49%,SELP;FBLIM1;PLEK
prerank,release of cytochrome c from mitochondria (GO:0001836),0.38710115210808427,0.9977073716091553,0.48154981549815495,0.808358453488402,1.0,4/17,10.73%,BCL2;BAX;DNM1L;BCL2L1
prerank,ubiquinone metabolic process (GO:0006743),-0.3774204504753722,-0.9974739688634487,0.45045045045045046,0.8247944943046318,1.0,7/15,23.86%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5;AIFM2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.42900452262379046,0.9974581436709365,0.4723320158102767,0.8083256666216009,1.0,5/12,9.50%,DOCK5;IGFBP5;ADAMTS1;TPM1;DOCK7
prerank,cellular response to hormone stimulus (GO:0032870),0.29999596764857983,0.9974324397245224,0.4490106544901065,0.8077262498100699,1.0,10/69,7.82%,TFPI;ATP1A2;GHR;NCOA3;STAT5B;CTSH;SFR1;KLF9;RAMP1;TRIM24
prerank,mesenchyme development (GO:0060485),0.4035985448069988,0.9972820975295676,0.48363636363636364,0.8074383155982757,1.0,3/15,5.16%,BMP2;BMP7;TGFBR1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.26199706448120336,-0.9970109862662266,0.45294117647058824,0.825119334864537,1.0,25/72,24.51%,PSMC3;AKT1;PSMD14;PSMD3;MALT1;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;DICER1;IRAK1;CARD10;PSMD7;PSMC6;PSMB5;PSMC5;TNFRSF10B;PSMB1;NFKB2;SKP1;PSMD11;PSMD8
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4452603538184518,0.996752766937557,0.4857142857142857,0.8080847954886214,1.0,1/11,2.03%,APOA2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2906654746680584,0.9964446774243859,0.4659606656580938,0.8081958434009726,1.0,20/80,20.80%,ROCK2;PLD1;SMPD3;SAMD4A;VIM;IL6;PLA2G6;EPHA4;ZCCHC4;EFNA1;SOX4;CPEB3;UPF3A;CASP3;FXR2;PLXNB2;SIRT3;ERBB2;ELAVL1;SPHK2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3534987213977662,-0.9960702365182955,0.4579646017699115,0.8268636509410274,1.0,8/17,26.80%,ALG14;SRD5A3;NUS1;DOLPP1;ALG6;DHDDS;ALG13;MVD
prerank,regulation of mitochondrial fusion (GO:0010635),0.4447086663890039,0.9959700002968807,0.4539877300613497,0.8086869736736658,1.0,3/11,15.52%,PID1;HUWE1;MUL1
prerank,ephrin receptor signaling pathway (GO:0048013),0.2905367098167887,0.9957214730579294,0.4434654919236417,0.8086849514797181,1.0,16/82,13.45%,EFNB2;ROCK2;EPHA7;EPHA3;SDC2;EPHA8;EPHA1;RASA1;EPHA4;DNM1;NGEF;PTK2;EPHA2;EFNA1;EFNB1;WASL
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.39376775083863125,0.9955040106253639,0.45729537366548045,0.8085579652922248,1.0,3/18,2.79%,ROCK2;KANK1;CDH5
prerank,regulation of viral life cycle (GO:1903900),0.3764171006934191,0.99548601129906,0.4537205081669691,0.8079506860072371,1.0,4/21,12.33%,AXL;TRIM5;KPNA6;TRIM21
prerank,negative regulation of viral release from host cell (GO:1902187),0.41932369185248175,0.9952989101808334,0.4625984251968504,0.8077534284503438,1.0,7/13,24.18%,TRIM5;TRIM21;TRIM26;CHMP3;PML;TRIM8;TRIM32
prerank,import into cell (GO:0098657),0.3260059226028998,0.994726150756782,0.45645161290322583,0.808527770823571,1.0,5/41,3.87%,ATP1A2;SLC1A3;SLC6A13;SLC19A1;SLC16A2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3126215731656143,0.9946110450756093,0.45339652448657186,0.8081190795862382,1.0,8/51,10.22%,IL16;IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,response to histamine (GO:0034776),0.4477170060548192,0.9942452131899489,0.4811715481171548,0.8083341550859692,1.0,1/10,0.81%,DIAPH1
prerank,regulation of macrophage differentiation (GO:0045649),0.4173615388612222,0.9941924275359147,0.4657534246575342,0.8078027002740167,1.0,4/15,16.12%,IL34;PTPN2;CSF1;INHA
prerank,positive regulation of glucose import (GO:0046326),0.3767366545140151,0.9938644635404014,0.47451669595782076,0.8079516198745632,1.0,5/21,9.78%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,negative regulation of developmental growth (GO:0048640),-0.31511798243652767,-0.993675365583343,0.46788990825688076,0.8325556039459976,1.0,9/30,17.38%,DIP2B;DCC;WWC1;SEMA3G;FGF13;ULK1;CDKN1A;MAP2;BBS2
prerank,superoxide metabolic process (GO:0006801),-0.31899861449994443,-0.9935737672144951,0.47368421052631576,0.8319064484563811,1.0,9/29,23.78%,NOS3;SH3PXD2A;NCF2;PREX1;CYBB;SOD1;PRDX2;TAFA4;NOX4
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4262301323466548,0.9935719754463547,0.47410358565737054,0.8080822257025764,1.0,7/12,20.91%,RESF1;ATF7IP;TASOR;PPHLN1;SETDB1;MPHOSPH8;TET1
prerank,myotube cell development (GO:0014904),-0.4228263357999575,-0.9932785459853853,0.4824742268041237,0.8317845775781869,1.0,3/10,10.78%,SIX1;SELENON;CAV2
prerank,"transcription, DNA-templated (GO:0006351)",0.25368959494212096,0.9930807308935765,0.4476067270375162,0.8086711898170057,1.0,46/207,18.56%,SOX5;MLLT3;MAF;POLR2D;PIR;GLIS3;NCOA6;BAZ2A;DTX1;CREBL2;POLR1C;CDC73;TRIM24;MEF2A;CCNH;EPC1;MNAT1;NOCT;CDK7;TAF7;HIPK3;TCEA1;POLR2C;IWS1;RTF1;FOXO3;THAP1;NFIC;MED20;PKNOX1;PAF1;POLR2F;GTF2H4;ERCC6;LEO1;MLLT1;SNAPC3;IRF9;TAF9;POLR3H;DDX21;AFF4;GTF2H2;TTF1;PMF1;NFYA
prerank,tRNA aminoacylation (GO:0043039),-0.2995252710103055,-0.992964229259163,0.46987951807228917,0.8317569359971736,1.0,14/37,33.71%,LARS2;KARS1;CARS1;EEF1E1;IARS1;RARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;QARS1
prerank,negative regulation of telomere maintenance (GO:0032205),0.4042761854522705,0.9929046903799292,0.46108949416342415,0.8084487285068244,1.0,5/15,16.18%,SLX4;RAD50;SMG6;ERCC1;TNKS2
prerank,positive regulation of innate immune response (GO:0045089),0.3438053723237612,0.9928894142905137,0.4690265486725664,0.8078362112822731,1.0,6/30,11.02%,FPR2;IFI35;ZBP1;GBP5;WNT5A;POLR3F
prerank,phosphate ion homeostasis (GO:0055062),0.4442343516746146,0.992472587921663,0.4774951076320939,0.8082077578073028,1.0,1/10,1.45%,ENPP1
prerank,positive regulation of locomotion (GO:0040017),-0.32172694773698873,-0.9924052478540124,0.44339622641509435,0.8324994455558099,1.0,3/27,3.24%,SPOCK2;THBS1;STX3
prerank,regulation of cell division (GO:0051302),0.2936140978527899,0.9922889113008184,0.456973293768546,0.8080394251817697,1.0,18/72,18.07%,FGF1;MLLT3;NCOA3;PLK5;KLHL21;UVRAG;SUSD2;BCL2L1;KLHL13;AHCTF1;ENTR1;FSD1;TLE6;BIRC6;POU5F1;TXNIP;NLRP5;MYO19
prerank,protein localization to cell-cell junction (GO:0150105),0.40381193313562663,0.9920345345236358,0.466789667896679,0.8080340344560113,1.0,2/15,2.79%,CGNL1;CDH5
prerank,sodium ion export across plasma membrane (GO:0036376),0.42345023722699493,0.9914828997347953,0.46037735849056605,0.8087413402334966,1.0,1/13,0.45%,ATP1A2
prerank,multivesicular body assembly (GO:0036258),-0.3143579226577431,-0.9914597904224157,0.4747252747252747,0.8343394111132731,1.0,12/30,27.50%,VPS37B;VPS37A;CHMP1A;CHMP1B;CHMP7;CHMP2B;VPS28;SNF8;CHMP2A;HGS;CHMP6;CHMP4C
prerank,negative regulation of cytokine production (GO:0001818),0.2642322929821936,0.9910851394552387,0.4816272965879265,0.8090508541955778,1.0,31/163,15.47%,LGR4;FN1;AXL;APOA2;TWSG1;ANXA1;IL6;IKBKE;ADCY7;TLR4;C5AR2;PTPN22;APPL2;RNF216;FOXP3;ANXA4;PPARA;LGALS9;CD274;NLRX1;PTPN6;IRAK3;MAP2K5;HOMER3;ARRB1;ATP2B1;SRGN;IFIH1;TBK1;RARA;IL23R
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.40735109220743804,0.9909318737627067,0.4675834970530452,0.8087903214482588,1.0,2/14,9.44%,CMPK2;AK5
prerank,glucan catabolic process (GO:0009251),0.3992645453821508,0.9908302456316593,0.4620811287477954,0.8084109269286588,1.0,4/15,11.43%,PYGB;MGAM;PYGM;STBD1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3767924601630198,-0.9907710364220265,0.4656319290465632,0.8353144182094999,1.0,7/15,23.92%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5;NDUFA9
prerank,regulation of protein localization to nucleus (GO:1900180),0.31760336986219717,0.9898777094942554,0.45241809672386896,0.8100418721959557,1.0,9/43,8.62%,PARP9;LATS2;TPR;DTX3L;CTNNA1;NGFR;GSK3B;GLUL;YAP1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3768787394096439,0.9897993665460645,0.4638447971781305,0.809580359163761,1.0,5/20,17.13%,TERT;SNIP1;TARBP2;ZC3H7B;PUM2
prerank,GPI anchor metabolic process (GO:0006505),-0.33113505159530343,-0.9895633391128422,0.4713656387665198,0.8377683160806234,1.0,7/26,15.91%,MPPE1;PIGM;PIGU;PIGQ;PIGH;DPM2;PIGO
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.32136227734780204,0.9894589838817741,0.4801980198019802,0.8097503179835602,1.0,13/45,15.95%,SP100;GBP2;TRIM5;VCAM1;OASL;STAT1;OAS2;TRIM21;TRIM26;JAK1;PML;IRF9;ICAM1
prerank,response to interleukin-1 (GO:0070555),0.28985901095716066,0.9894023744260453,0.4864457831325301,0.8092478056674549,1.0,14/73,16.20%,ADAMTS12;GBP2;ANXA1;RC3H1;HDAC4;CD47;CCL2;LGALS9;IRAK3;ADAMTS7;CCL25;APP;TAF9;GBP3
prerank,negative regulation of macrophage activation (GO:0043031),0.40029230365685575,0.9892338964781303,0.4944852941176471,0.8089961221855365,1.0,2/16,6.01%,IL31RA;NR1H3
prerank,programmed necrotic cell death (GO:0097300),0.3837991105226274,0.9891196881725377,0.45179584120982985,0.8086175937907905,1.0,6/18,21.65%,TLR4;LY96;DNM1L;TICAM1;TRPM7;RIPK1
prerank,regulation of interleukin-17 production (GO:0032660),0.3428876651434637,0.9885952109806753,0.4865831842576029,0.8092157224303742,1.0,5/31,7.50%,OSM;IL6;TLR4;FOXP3;IL18
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4116609632161057,0.9878588107908439,0.46139705882352944,0.8103652293584905,1.0,1/15,2.03%,APOA2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.2933852229361109,-0.9877320874382362,0.4937655860349127,0.8419619634665889,1.0,12/39,16.16%,TIE1;HSPA8;NOTCH1;DAB2IP;RAPGEF2;PINK1;ANKRA2;HSP90AA1;SPTY2D1;CCL19;IRGM;RAP1A
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.40866621209753495,-0.9869636015742934,0.5030181086519114,0.8431863746313306,1.0,8/11,35.94%,ARL6IP1;VCPIP1;ATL2;STX18;BNIP1;TRDN;LPCAT3;MOSPD3
prerank,apoptotic process (GO:0006915),-0.22311143300466338,-0.9867169619836301,0.4890829694323144,0.8429622687276824,1.0,42/203,15.09%,HIP1;EFNA5;FOXO1;ELMO1;PTK2B;DCC;CIT;ADAM15;NCKAP1;PPP2R1A;TBX1;PLAGL1;TRPC5;SEMA6A;ARHGEF6;CASP7;PPARD;MAL;FAP;PRUNE2;SCN2A;PAK5;ZBTB16;AKT1;STK11;RHOB;RFK;NUDT2;BAG6;FAS;TRAF7;DDIT4;MRPS30;FASTKD2;TNFRSF21;CASP9;JADE1;PPIA;PAK4;AKAP1;BMF;VDAC1
prerank,oligodendrocyte differentiation (GO:0048709),-0.35703529286817703,-0.9866616338865845,0.48337028824833705,0.8421910173961136,1.0,8/19,34.59%,EIF2B2;SOX6;TPPP;PTPRZ1;CDK5;SLC8A3;PRDM8;SOX8
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2597508246977066,-0.9864162733081095,0.4764705882352941,0.8419729662128298,1.0,15/71,14.25%,CTSC;CTSB;OTUD7A;FAP;LGMN;CTSS;HDAC6;UBB;BAG6;MALT1;ZRANB1;CTSL;PSMA6;UBA52;PSMA8
prerank,protein N-linked glycosylation (GO:0006487),-0.261834888551837,-0.9860474272944413,0.4903581267217631,0.8421461854998856,1.0,21/66,20.57%,FUT8;MGAT5;ALG14;RPN2;SRD5A3;ALG5;GFPT2;LMAN1;MGAT4A;DPM2;DOLPP1;PGM3;GFPT1;SLC39A8;GAL3ST1;OSTC;ALG6;PMM2;STT3B;MOGS;UBE2J1
prerank,regulation of cell-cell adhesion (GO:0022407),0.32160745432630483,0.9857119977291658,0.4664429530201342,0.8150293681530819,1.0,7/39,8.22%,DPP4;EPHA7;AFDN;FSTL3;CD47;SPINT2;FUT4
prerank,response to growth factor (GO:0070848),0.32485169636668565,0.9852200654884636,0.4723618090452261,0.8155660965168009,1.0,16/41,20.47%,GATA6;BMPR1A;STAT5B;PLK5;TGFBR1;TGFBR2;MAP2K5;EPHA2;TBC1D7;ACVR1C;ACVR2B;URI1;SHC1;EMD;ERBB2;MAPK7
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.351367397792795,0.9849513696774725,0.4750889679715303,0.8155749175967077,1.0,3/27,2.87%,SLC7A2;SLC1A3;SLC6A9
prerank,female gonad development (GO:0008585),0.3766464497086742,0.9847057793103078,0.47909407665505227,0.8155312148549653,1.0,2/19,3.83%,NR2F2;KIT
prerank,neuron projection organization (GO:0106027),-0.3768696276231545,-0.9841123080241424,0.4824561403508772,0.8465616689856894,1.0,6/15,21.20%,INSR;LGMN;ABCD2;ATP1A3;CHRNA7;DCTN1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4132518884200756,0.9839997806284496,0.4682080924855491,0.8165840180770862,1.0,4/13,16.02%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.39514093596655014,0.9837895289195159,0.48141263940520446,0.8164478415254387,1.0,1/16,1.78%,NUPR1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2653181988653003,-0.9836046648149644,0.49142857142857144,0.8471016070505208,1.0,22/61,24.51%,PSMC3;OAZ1;PSMD14;OAZ2;SIRT5;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;CAV1;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;FGFR4;PSMD11;PSMD8
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.40779670396138834,-0.9834710117006066,0.5072463768115942,0.8465510409924852,1.0,3/12,11.68%,PROM1;PTPRO;BASP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3080030807054357,-0.9834651327288577,0.4835680751173709,0.8456515839093187,1.0,11/32,18.90%,NAV3;SNCA;ARHGEF2;STMN2;TUBB4A;FGF13;CLASP2;MAP2;MID1IP1;STMN1;FKBP4
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.30007896003085344,-0.9832306898043736,0.4900990099009901,0.8454490252843877,1.0,13/37,19.63%,RPL5;RPS7;RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;RPL23;CAMLG;PARK7;N4BP1;EIF3H
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3431015890999031,-0.9830038968558469,0.47544642857142855,0.8451590162464372,1.0,9/20,22.69%,SYNE1;TAF3;TAF8;BARD1;PARK7;BCL3;ARL2;SKP1;CHCHD10
prerank,membrane repolarization (GO:0086009),-0.3775720344131791,-0.9827845690335142,0.4650112866817156,0.8448863024773353,1.0,6/15,13.29%,ATP1B1;KCNJ2;ATP1A1;KCND3;KCNQ1;KCNE4
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.30556841358849884,-0.9825268782640956,0.5167037861915368,0.8446885536547062,1.0,11/33,23.10%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR;EGF;AFAP1L2;NUP62;HAP1
prerank,peptide catabolic process (GO:0043171),0.36215215756512126,0.9823682711090732,0.49636363636363634,0.8192924806786096,1.0,5/23,9.69%,CPQ;ANPEP;NPEPPS;CTSH;ERAP1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3868607414570774,-0.9820583837004001,0.4722838137472284,0.8451066770119176,1.0,3/13,6.94%,GRIN2A;PERP;LGMN
prerank,purine nucleotide metabolic process (GO:0006163),0.3591543804147184,0.9817806845939158,0.48223350253807107,0.8200734977697505,1.0,9/24,21.76%,MTHFD1;FHIT;NT5C;PRPSAP1;ITPA;PRPSAP2;NT5C1A;XDH;ADSL
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.43819213391861633,0.9813052336544427,0.5,0.8205279283691529,1.0,1/10,0.40%,BMP6
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.31488197757518877,-0.9810902815156017,0.4745762711864407,0.8469185208528524,1.0,7/27,10.30%,FGF12;FXYD5;UTRN;YWHAH;CAMK2D;NEDD4L;NOS1
prerank,cobalamin metabolic process (GO:0009235),0.3811637030513797,0.9806387063189894,0.48188405797101447,0.8214781378511683,1.0,2/17,8.51%,MMAB;LMBRD1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2783725451804433,0.9805644776781327,0.4971014492753623,0.8210199501874245,1.0,14/102,9.79%,PDPK1;ENPP1;FER;GCGR;TRARG1;RAB10;SORBS1;ADCY5;ADCY7;CPEB1;ADCY1;INSIG2;RHOQ;OTOP1
prerank,chemical homeostasis (GO:0048878),0.2995676939771497,0.9801476821871108,0.48861911987860396,0.8214326665459972,1.0,6/61,7.95%,ZBTB20;RBP1;ACOXL;SLC4A11;NR1H3;WNK4
prerank,telomere maintenance via recombination (GO:0000722),0.4414301900782705,0.9800643174057342,0.49619771863117873,0.8209829002584487,1.0,5/11,21.67%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,peptide hormone secretion (GO:0030072),0.3508905215859745,0.9797495863938565,0.4851657940663176,0.8211122871828971,1.0,5/26,10.25%,GHRH;ANXA1;IL6;FAM3B;CDK16
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3674957704338674,-0.979741095212826,0.46770601336302897,0.8496814081208797,1.0,3/15,9.94%,AKT1;PRELID1;GHITM
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.39762001668385366,-0.9788954006754662,0.4909456740442656,0.8511517471104547,1.0,6/12,18.17%,SNCA;STMN2;TUBB4A;ARHGEF7;MAP2;STMN1
prerank,cell projection organization (GO:0030030),0.3465495872793497,0.9788734816206837,0.47923875432525953,0.8226217724372719,1.0,8/30,14.00%,PARVA;QRICH2;PACSIN2;NPHP1;RHOQ;PLEK;ATP1B2;RHOU
prerank,regulation of ERAD pathway (GO:1904292),-0.4163819400443684,-0.9787387154592713,0.5066079295154186,0.8506711989137197,1.0,6/11,28.13%,AQP11;BAG6;USP13;ATXN3;TMEM259;HERPUD1
prerank,response to organic cyclic compound (GO:0014070),0.30924668478227185,0.9785472066891466,0.5048701298701299,0.8227542654223987,1.0,9/52,10.07%,IGFBP5;ANXA1;STAT5B;IL18;CCL2;STRN3;LRRK2;HLCS;TIPARP
prerank,organelle disassembly (GO:1903008),0.3358431169783363,0.9781586029221059,0.4755244755244755,0.8230363662748116,1.0,10/33,21.38%,UBA5;PLK5;KIF5B;KLC1;ATG2A;GBF1;GOLGA2;MCTS1;MRRF;ZFAND1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.24599408144582274,-0.9780310123995669,0.5032051282051282,0.8517104779146907,1.0,19/91,14.81%,SYT1;RIMS2;HIP1;RIT2;NSF;HIP1R;STXBP5L;MAPK3;MBTPS1;SCARB1;RAB3C;CPLX1;SYT7;CPLANE2;FES;RAB12;SYK;RAB5C;PTPRC
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.40553125159200776,-0.9778191902777792,0.5085106382978724,0.8514110546842223,1.0,6/12,31.60%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2940452986692016,-0.97780840648272,0.49622166246851385,0.8505289429736386,1.0,4/39,2.04%,MYO1D;PPFIA2;FNBP1L;TANC2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.34700936346148586,0.9777079619016573,0.5,0.8234684883897773,1.0,4/27,7.70%,NFAT5;IL6;CD47;CCL2
prerank,small GTPase mediated signal transduction (GO:0007264),0.2709254873508686,0.9774755285783479,0.5043103448275862,0.8233916656671606,1.0,16/103,10.26%,RIN2;TIAM2;PLD1;ARHGAP18;KSR1;RRAS2;ARHGAP32;NTN1;ARL3;PLCE1;SIAH2;RALBP1;RRAD;USP8;RALGDS;MAPK14
prerank,limb development (GO:0060173),0.3501721076458025,0.97740978518538,0.4696707105719237,0.8229123234227306,1.0,9/28,20.75%,GLI3;SALL1;LRP4;NOG;IQCE;KAT2B;RSPO2;PTCH1;MEGF8
prerank,positive regulation of intracellular transport (GO:0032388),-0.28969662143625197,-0.977281711035102,0.4925373134328358,0.8510977823034409,1.0,19/38,34.18%,PRR5L;SORL1;OAZ1;STK11;OAZ2;DYNC1H1;PCNT;CAPN10;MLC1;CEP290;SPAG5;B3GAT3;STX18;PDCD10;VAMP2;PGAP1;KIF20B;PLA2G4E;BCAS3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3586894141014702,0.9772095996738162,0.46819787985865724,0.8227537596198738,1.0,9/24,21.39%,SLX4;DCP2;HNRNPC;XRN1;TNKS2;EXOSC10;TEN1;CTC1;TENT4B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.38731489415291714,-0.9771706486626018,0.49583333333333335,0.8505012397501328,1.0,4/13,9.73%,EPN2;DAB2IP;EMILIN1;HHEX
prerank,intracellular protein transmembrane transport (GO:0065002),-0.28962254548683414,-0.9768813981987039,0.49746192893401014,0.850376624986922,1.0,15/42,27.56%,PEX26;PEX10;ZFAND2B;PEX16;C2CD5;DNLZ;HSPA5;GRPEL2;TOMM40L;SEC61A1;TOMM20;SEC61G;RTN2;TIMM21;SEC61B
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3892893328150967,0.9768745916934297,0.4742857142857143,0.8229578630595821,1.0,3/17,8.00%,CPEB1;RNF20;ZC3H3
prerank,regulation of interferon-gamma production (GO:0032649),-0.2562311491806982,-0.9766669003701528,0.46956521739130436,0.8500484312846769,1.0,9/71,9.14%,PDE4D;PDE4B;SLC7A5;IL1R1;GAS6;HMGB1;CYRIB;ZFPM1;HAVCR2
prerank,protein targeting to membrane (GO:0006612),-0.24883040887164132,-0.9766201162393324,0.4925373134328358,0.8492797423124324,1.0,29/83,24.06%,ARL6IP1;AQP11;VPS37B;SRP14;SDCBP;ZDHHC14;ZDHHC20;ATAD1;PEX26;ZDHHC2;GDAP1;TRAM1;ZDHHC24;NACA;RABGEF1;ABCD2;SSR2;VPS37A;PEX16;ZDHHC7;PEX19;SEC61A1;PXMP4;YIF1B;ZDHHC23;SGTB;ZDHHC9;TAOK2;RAB8B
prerank,positive regulation of lipid catabolic process (GO:0050996),0.38101477973523534,0.9760445907789573,0.4750889679715303,0.8243241445119787,1.0,7/19,27.13%,APOA2;PPARA;ABHD5;ANGPTL3;DAGLB;IRS2;PRKCD
prerank,neural crest cell differentiation (GO:0014033),-0.3534587601294283,-0.9755395665594438,0.5011037527593819,0.8514391832451883,1.0,2/18,1.17%,CDH2;MEF2C
prerank,macrophage chemotaxis (GO:0048246),0.4528749757565902,0.9753595097501752,0.49504950495049505,0.8254556802438471,1.0,2/10,7.70%,CKLF;CCL2
prerank,regulation of cell communication (GO:0010646),0.3301635229357835,0.9753333690851538,0.4847972972972973,0.8248877214565222,1.0,4/35,3.54%,CXADR;GRK3;IGFBPL1;ANXA1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2807106964686275,0.975329205166157,0.49127906976744184,0.8242561268024302,1.0,9/93,4.00%,SASH1;CCN2;EIF2AK2;MTURN;RELL1;TRAF5;SH3RF1;BMP2;TAOK3
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.37535997908291896,-0.9752976494946292,0.48717948717948717,0.8512146895412933,1.0,5/14,28.10%,THBS1;CMKLR1;C1QBP;JAK3;LILRB1
prerank,protein transport (GO:0015031),-0.20967049368042018,-0.9751947668765901,0.625,0.850584710798172,1.0,83/332,19.55%,LRP1B;PRKCB;ATP6V0A1;TBC1D8;TFRC;NSF;SYNDIG1;STX3;ANK3;MACF1;SCAMP5;ARF5;TBC1D30;ATP6V1B2;SEL1L;LMAN2L;ARHGEF2;STXBP1;RAB6B;TVP23B;YWHAH;STX16;TANGO6;ATP6V0C;RAB38;SCAMP1;HERC2;RAB3C;ARL1;SCG5;HDAC6;GCC2;NPM1;SCAMP2;SGSM1;TMED2;VMP1;VPS33B;RAMP2;CD74;SCG2;SLC10A7;ATP6V1D;TBC1D22B;ARHGAP1;TBC1D8B;TBC1D14;NAPA;VLDLR;RUNDC1;RAB12;KIF3B;RAB5C;PPY;SNX8;MIA2;EVI5;CHMP1A;TBC1D12;VIPAS39;ATP6V0A2;DNAJC27;CHMP1B;CEP290;TMED7;RABL3;AP3D1;ATP6V1G2;TVP23A;BBS2;CHMP2B;NECAB3;BBS1;LRSAM1;RAB1B;RAB15;ARF6;TBC1D5;ARL4D;SAR1B;ATP6V0E2;IFT22;TBC1D1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.319665948272083,-0.9751456696754192,0.49889135254988914,0.8498197981816085,1.0,12/27,28.37%,CD74;SPRED2;ATM;EEF1E1;PTTG1IP;SPRED3;SPRED1;MSX1;ATR;MIF;YJU2;PMAIP1
prerank,transcription by RNA polymerase I (GO:0006360),0.329861255627336,0.9750668148226531,0.48257839721254353,0.8242489460749924,1.0,18/34,27.67%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;TTF1;POLR2K;UBTF;TAF1;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,camera-type eye morphogenesis (GO:0048593),-0.42089416403813407,-0.9747543514060034,0.5194274028629857,0.8499984746802929,1.0,4/10,9.05%,TENM3;TBX2;VEGFA;LRP6
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3624784057860424,0.9747156284842132,0.49633699633699635,0.8244259337563046,1.0,4/24,5.63%,CXCL10;FPR2;NBL1;SERPINE1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.37470382627420484,0.9745714275044873,0.4846153846153846,0.8241717651931862,1.0,5/20,19.69%,TNRC6B;TNRC6A;MOV10;WTIP;AJUBA
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.32466769475712776,0.9745045049935916,0.484375,0.8236947701567833,1.0,11/39,17.19%,BMP6;BMP2;MIA3;PPARA;SPINT2;MYADM;PTK2;MAP2K5;WNK1;NF2;PODXL
prerank,positive regulation of chromatin organization (GO:1905269),-0.39369522327335327,-0.9744146410241468,0.4989648033126294,0.8500484092965228,1.0,4/12,18.29%,H3-3A;TERF1;TAL1;TINF2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.43534469623821415,0.9742838026999376,0.49101796407185627,0.8235776560216352,1.0,4/10,21.76%,TGFA;ADRA2A;HBEGF;FBXW7
prerank,cellular response to fluid shear stress (GO:0071498),-0.38827545716922085,-0.9737397544814305,0.490280777537797,0.8510012758719224,1.0,2/12,3.29%,MEF2C;KLF2
prerank,calcium ion transport (GO:0006816),-0.24017632463344524,-0.9733084068801428,0.525,0.8513626847722322,1.0,25/113,13.61%,CACNA1E;CACNB2;GRIN3A;TRPC3;SLC24A2;RYR2;TPT1;FKBP1A;GAS6;TRPC5;TRPC4;RYR3;ATP2C1;SLC8A1;ATP2A3;CACNA1G;TRPC6;CAMK2A;RAMP2;CACNA1D;CRACR2B;TMCO1;CAV1;SLC3A2;ATP2A2
prerank,microtubule anchoring (GO:0034453),0.4197475731544806,0.9729345987335768,0.4980769230769231,0.8262281487859449,1.0,2/12,4.98%,DAG1;CLASP1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.35319938805138573,-0.9728691882447156,0.5078651685393258,0.8517211640122402,1.0,8/18,25.75%,SLC2A1;PRKCB;INPP5K;NR4A3;C2CD5;C3;OCLN;RTN2
prerank,insulin secretion (GO:0030073),-0.3511497279787881,-0.972785186635319,0.49776785714285715,0.8510757910959903,1.0,9/19,27.02%,RIMS2;PTPRN2;SNX19;PARK7;RAB11FIP5;PTPRN;SELENOT;CAMK2G;MAFA
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.35427788586791065,-0.9725717368914412,0.4977973568281938,0.8507964489772835,1.0,7/17,20.22%,KLF7;APOLD1;CEACAM1;PRKX;CAV1;MAFF;DLL1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4161667008996362,0.9724394255677734,0.501937984496124,0.8268053015641017,1.0,5/13,19.42%,AXL;WNT5A;IFIH1;TAF9;IL7
prerank,microtubule polymerization (GO:0046785),0.3453879631654497,0.9724118351842581,0.47304347826086957,0.8262394889794187,1.0,9/29,16.23%,CENPJ;CLASP1;HDGFL3;TUBGCP4;SLAIN2;CCDC57;TUBGCP2;TUBGCP5;GOLGA2
prerank,positive regulation of apoptotic process (GO:0043065),0.24173470931777274,0.9723725046181129,0.5161691542288557,0.8256851008834252,1.0,38/293,10.57%,IGFBP3;PAWR;TIAM2;AKAP13;EPHA7;PHLDA1;NUPR1;WNT10B;DLC1;FGD4;PNMA3;IFIT2;ADAMTSL4;PRDM11;DAPK1;BMP2;APBB1;IL6;LATS2;TGFBR1;UNC13B;ZBP1;TNFRSF12A;USP27X;PLEKHG2;NGFR;PDCD5;ARHGEF11;QRICH1;BAX;STK3;UBE2Z;CALHM2;ARHGEF12;SOS2;NGEF;PPID;DNM1L
prerank,regulation of Notch signaling pathway (GO:0008593),0.2849713684649366,0.97236275599687,0.4915514592933948,0.8250811031794727,1.0,10/76,6.74%,TSPAN5;RBPJ;ZMIZ1;IL6ST;BMP2K;AAK1;DLK1;DTX1;MMP14;CREBBP
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3888012447191386,0.9722676863728443,0.4894837476099426,0.8246759690973928,1.0,7/16,21.48%,SLX4;SMG5;SMG6;TNKS2;HNRNPA2B1;DHX36;RTEL1
prerank,thyroid hormone generation (GO:0006590),0.4367555023945032,0.972263067577045,0.4806949806949807,0.8240518668753429,1.0,2/10,10.14%,CPQ;DIO2
prerank,hemopoiesis (GO:0030097),0.279951337806293,0.9720821314041141,0.49777777777777776,0.8238653135720004,1.0,15/87,11.59%,KMT2A;TGFBR3;NOTCH2;WNT10B;WNT2B;FSTL3;KIT;NCOA6;SBDS;TGFBR2;WNT5A;FUT10;PLEK;SH2B3;MFAP5
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.289398907459376,0.9718794019548752,0.5007849293563579,0.823730856607427,1.0,14/75,11.85%,PDPK1;FGFR1;ECM1;NRP1;VEGFD;BMP2;ARNT;TGFBR1;WNT5A;IGF2;AKT3;CDH13;EGR3;NR4A1
prerank,mesoderm development (GO:0007498),-0.34886355120783763,-0.9714587847871705,0.5170212765957447,0.8529218061585947,1.0,12/18,36.94%,TIE1;TBX1;BMX;VEGFA;IKZF1;TBX6;MEST;TCF15;MESD;IKZF3;HES7;BTK
prerank,sensory perception (GO:0007600),-0.2812879392956332,-0.9714504489453165,0.5111111111111111,0.852052594762298,1.0,13/45,20.93%,PCDH15;TMEM150C;GNAS;OPRM1;SCN9A;KCNA2;NTSR2;GNAL;P2RX7;CHRNA4;CHRNA7;PENK;TTC8
prerank,ventricular septum morphogenesis (GO:0060412),0.3472402473838624,0.9709584509731016,0.5050335570469798,0.8253312848188579,1.0,8/27,12.68%,ROBO1;TGFBR3;BMPR1A;TGFBR1;TGFBR2;HEYL;SMAD4;NOG
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.24990372296552946,-0.9709177294540697,0.526813880126183,0.8526479510669975,1.0,26/84,24.51%,PSMC3;CDC26;PSMD14;UBB;PSMD3;PTTG1;PSMD4;PSMD6;PSMA6;UBE2E1;PSMA4;PSMB8;UBA52;PSMA8;CDK2;BUB1B;UBE2D1;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;ECRG4;PSMD11;PSMD8
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.31242868068095,0.9705852403667593,0.49759229534510435,0.8256217508061501,1.0,9/46,14.97%,TIMP3;FBLN1;DUSP10;TLR4;PTPN2;DLG1;SMAD4;PTPN1;PTPRR
prerank,negative regulation of leukocyte activation (GO:0002695),0.38984907841246497,0.970425449451675,0.5149812734082397,0.8253626489324499,1.0,2/15,6.01%,IL31RA;NR1H3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.39286964159978677,-0.9704064960352927,0.5246252676659529,0.8531008970589808,1.0,6/13,31.60%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,positive regulation of nuclear division (GO:0051785),0.3551003781003543,0.9700263033600223,0.4915254237288136,0.8257057950211957,1.0,4/25,8.99%,PHIP;TGFA;PDGFRB;IGF2
prerank,actomyosin structure organization (GO:0031032),0.28301842657703374,0.9697219923923434,0.5166666666666667,0.8257724047209762,1.0,9/75,6.95%,ROCK2;TMOD3;CSRP3;SORBS1;EPB41L5;TPM1;EPB41L2;CSRP1;ACTN2
prerank,atrial septum morphogenesis (GO:0060413),-0.41287424878786494,-0.9694249494239104,0.5137420718816068,0.8548726460531273,1.0,4/10,12.80%,TGFB2;BMPR2;ZFPM1;ACVR1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2842054787867487,0.969236716751865,0.5059523809523809,0.826300075577462,1.0,17/78,15.97%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;SGTA;LRRK2;SUMO1;KEAP1;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.37872141756284367,0.9690141989956045,0.5027624309392266,0.8262018213485447,1.0,5/18,15.52%,GSK3B;BAX;TMEM14A;ZNF205;MUL1
prerank,nucleic acid metabolic process (GO:0090304),0.28802682014675046,0.9689875291865183,0.5046153846153846,0.8256417650365251,1.0,15/69,16.84%,ENPP1;RBFOX2;POLR2D;WRN;RAD50;LSM1;POLG;HNRNPH1;HNRNPC;POLR2C;POLR2F;DNASE1L1;HNRNPR;HNRNPA2B1;RAN
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.370424191717542,0.968961681214565,0.5027124773960217,0.8250780881566615,1.0,5/19,12.67%,CAMK1D;IL34;PTK2;CSF1;RARRES2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.40738219126315145,-0.9688667682525449,0.5258620689655172,0.8555330916721248,1.0,6/10,29.30%,INSIG1;YOD1;UBE2J1;UBAC2;SVIP;UBE2G2
prerank,positive regulation of blood coagulation (GO:0030194),-0.35442357912283085,-0.9688380458940802,0.5053304904051172,0.8547247714722191,1.0,4/17,14.61%,THBS1;F3;USF1;ST3GAL4
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4357724419743455,0.968739708938934,0.5119705340699816,0.8249586345842025,1.0,3/11,7.85%,GATA6;BMPR1A;LGALS9
prerank,positive regulation of exosomal secretion (GO:1903543),0.3961076183895089,0.9686615088707496,0.4896030245746692,0.8245110014310197,1.0,1/15,1.31%,SMPD3
prerank,regulation of protein autophosphorylation (GO:0031952),0.3236664280412901,0.9685905776265312,0.4914965986394558,0.8240558648968289,1.0,6/36,9.46%,EPHA7;ENPP1;ERRFI1;RAD50;MVP;RAP2C
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2651558028222669,-0.9683457025435661,0.4973958333333333,0.8552380530685914,1.0,18/55,24.51%,PSMC3;PSMD14;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;PSMD8
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.34523288881878916,0.9681442615075995,0.4809688581314879,0.82453370896971,1.0,12/28,26.14%,PARP9;PARP3;DTX3L;ERCC6;SHLD2;KMT5C;CYREN;RIF1;KMT5B;SMCHD1;SHLD1;TFIP11
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3343714149069413,0.9678351501964495,0.511265164644714,0.8246676133265046,1.0,8/33,12.73%,DPP4;FOXC2;EPHA8;SERPINE1;PLAU;PTK2;EPHA2;EFNA1
prerank,negative regulation of T cell proliferation (GO:0042130),0.3454466679554691,0.9678094163580406,0.49663299663299665,0.8241087262636877,1.0,5/28,7.89%,RC3H1;FOXP3;LGALS9;CD274;TNFRSF14
prerank,positive regulation of immune effector process (GO:0002699),0.3359139896013249,0.9677569936561374,0.5095320623916811,0.8236092857712479,1.0,5/27,9.25%,DDX60;MYB;APPL2;LGALS9;ANKRD17
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3251827031137962,0.9675785408781237,0.4918032786885246,0.8234167172749458,1.0,6/39,7.70%,PDPK1;IL11;CDH5;ANGPT1;SERPINE1;CCL2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.271597945996573,0.967188603400281,0.5186246418338109,0.8237251116885116,1.0,12/109,6.62%,PTPN13;PLEKHA2;PLA2G4A;TPTE;PI4KA;PDGFRB;MTMR11;MTMR3;PLCB3;PLEKHA4;PLA2G4C;PIK3C2A
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3592101985974635,0.9671249327116672,0.514336917562724,0.823273719653883,1.0,8/23,22.97%,PLK5;PRCC;ZWINT;NABP1;INTS3;NABP2;CDK5RAP3;WEE1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3268021114012088,0.9670451336315096,0.5017482517482518,0.8228459350683749,1.0,5/34,9.65%,DOCK5;NRP1;S100A10;MYADM;TRIOBP
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.28599896051313145,0.9669361909118821,0.5227272727272727,0.8224838251564516,1.0,27/76,24.21%,PRICKLE1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;PTK2;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180;DNAJB2;RNF139;SIRT2;PTEN;FBXW7;CDK5RAP3;CEBPA;RNF14;TAF1;COP1
prerank,regulation of vacuole organization (GO:0044088),0.3684281535143168,0.9664088737926088,0.5111524163568774,0.8230888303292995,1.0,10/20,25.01%,ANXA2;IFT88;MTMR3;IFT20;NPRL3;RAB5A;ADPRH;UBQLN2;MTM1;NPRL2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.35648187429517064,-0.9664066442322793,0.49134199134199136,0.8596619479005726,1.0,9/17,32.17%,STX3;SNAP25;SYNGR2;AP3D1;SNAP29;STX1B;TOR1A;SYNGR1;STX19
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3117242698718679,0.9662390237810435,0.49748743718592964,0.8228960499932846,1.0,7/43,11.49%,TLR4;C5AR2;PTPN22;LGALS9;CD274;PTPN6;IRAK3
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2638456833574328,-0.9659937628790883,0.5289256198347108,0.8599195167944853,1.0,11/56,15.58%,PLCG2;NOD1;CTSB;HMGB1;LGMN;CTSS;UBB;CTSL;S100A1;UBA52;NOD2
prerank,peripheral nervous system development (GO:0007422),-0.32735496775602096,-0.9658912371245784,0.4988662131519274,0.8592565563873976,1.0,6/23,16.45%,ADGRG6;SERPINI1;SCN8A;NFASC;NGF;NTF3
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2797693369765813,-0.9655072713178872,0.4948717948717949,0.8594413431559927,1.0,12/46,19.74%,AKT1;MFF;PINK1;MFN2;GDAP1;TIMM8B;DNLZ;GRPEL2;AIP;TOMM40L;TOMM20;TIMM22
prerank,cellular response to DNA damage stimulus (GO:0006974),0.23652645294063548,0.9654547768854098,0.5656324582338902,0.8241567574748758,1.0,83/336,20.39%,PRAP1;PDS5B;ZBTB4;POLH;TRIP12;TAOK3;SPATA18;CRY1;WRN;APBB1;IKBKE;PLK5;BCL2;SLX4;NCOA6;MCL1;UBE2U;RAD50;PARP3;CUL4A;DTX3L;SUSD6;SPIDR;CCDC13;WAC;FBH1;NEK4;MAP2K6;BAX;BAZ1B;YAP1;MNAT1;SIRT4;PSME4;USP47;SUMO1;SLF2;NABP1;TLK2;UVRAG;NUPR2;MAPK14;SETD7;BCL2L1;RFWD3;ADPRS;RBBP8;EPHA2;OGG1;MASTL;RAD51B;HIC1;INTS3;GTF2H4;BOD1L1;RAD9A;PML;PDS5A;ALKBH1;ERCC1;TAF9;USP45;MGMT;NFATC2;MACROD1;KMT5C;NIPBL;SMARCAL1;FANCC;SHPRH;ATF2;PARP4;USP10;XPC;UBR5;NSMCE3;RIF1;SMC6;CEP63;NABP2;ERCC8;BLK;KMT5B
prerank,endodermal cell differentiation (GO:0035987),0.33486032096269525,0.9650490099588961,0.49413735343383586,0.8244445507027665,1.0,8/31,14.19%,VTN;FN1;ITGA5;MMP14;CDC73;RTF1;PAF1;LEO1
prerank,positive regulation of programmed cell death (GO:0043068),0.24074707506622764,0.964924465842511,0.5354919053549191,0.8241260348670975,1.0,36/272,10.57%,IGFBP3;PAWR;TIAM2;AKAP13;PHLDA1;WNT10B;PRF1;FGD4;PNMA3;IFIT2;ADAMTSL4;DAPK1;BMP2;APBB1;IL6;LATS2;UNC13B;ZBP1;TNFRSF12A;NOS2;USP27X;PLEKHG2;NGFR;PDCD5;ARHGEF11;QRICH1;BAX;STK3;UBE2Z;CALHM2;LRRK2;ARHGEF12;SOS2;NGEF;PPID;DNM1L
prerank,response to ionizing radiation (GO:0010212),0.28839851083421525,0.9646651082138903,0.5197472353870458,0.8241169610360621,1.0,14/70,15.16%,EYA1;XRRA1;NHEJ1;ANXA1;IKBIP;SPIDR;XRCC4;NABP1;MAPK14;RFWD3;INTS3;RAD9A;UIMC1;FIGNL1
prerank,transepithelial transport (GO:0070633),0.39831366856797557,0.9644655716920273,0.5237154150197628,0.8239572107550737,1.0,2/15,0.80%,CXADR;SLC1A3
prerank,regulation of protein kinase activity (GO:0045859),0.2693986539516892,0.9640697329178151,0.5314787701317716,0.8242861572872784,1.0,15/106,12.03%,PDPK1;DEPTOR;PRKAG2;DDR2;PPM1E;PLCE1;EPHA1;SNX9;DTNBP1;RAP2C;UVRAG;TAF7;PTK2;TSPYL2;CSF1
prerank,negative regulation of nervous system development (GO:0051961),-0.3511525212386475,-0.9629852357609091,0.5110132158590308,0.8656061271757505,1.0,4/17,8.76%,ROBO2;NOTCH1;SORL1;B2M
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.29707235040572894,-0.9627274758169869,0.5125628140703518,0.865446963692639,1.0,18/35,30.46%,FAR2;HMGCS2;GGT5;ACACA;ACLY;SCD;GGT7;GGT1;HSD17B8;HPGD;FASN;HMGCLL1;GCDH;BDH1;HMGCL;ALOX5AP;ALOX5;BDH2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3085720861951064,-0.9624271750430465,0.5254237288135594,0.8653595069000699,1.0,7/25,12.81%,INSR;NOS1AP;KLF2;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3592385400617835,0.9622777742731058,0.49645390070921985,0.827866834435251,1.0,3/20,10.74%,NR2F2;LATS2;IPO7
prerank,positive regulation of catabolic process (GO:0009896),0.2873389426784131,0.9622195030016999,0.5176651305683564,0.8273716595088487,1.0,12/65,12.85%,SMURF2;APOA2;NEDD4;DACT1;GSK3B;WNT5A;TIPARP;WWP2;HUWE1;NKD1;HECW2;ASB5
prerank,positive regulation of viral life cycle (GO:1903902),0.36271674449292923,0.9618892670156604,0.5238095238095238,0.8275016326079943,1.0,3/22,7.85%,AXL;KPNA6;LGALS9
prerank,L-glutamate transmembrane transport (GO:0015813),0.43179402135003364,0.9617591422984251,0.4789272030651341,0.8271993408266273,1.0,1/10,0.80%,SLC1A3
prerank,cAMP metabolic process (GO:0046058),0.39694828316139813,0.9615397497527499,0.4815533980582524,0.8270797131704956,1.0,6/13,15.73%,PTHLH;ADCY5;ADCY7;ADCY1;EPHA2;ADCY6
prerank,Golgi ribbon formation (GO:0090161),-0.3772700650058325,-0.9615352862713632,0.5150905432595574,0.866962236414986,1.0,7/13,28.15%,STX16;GCC2;VTI1A;MYO18A;PRMT5;TMED5;GOLPH3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.24644894980891477,-0.9613100520471884,0.5438066465256798,0.8667001050535168,1.0,18/80,13.78%,NLGN1;FNBP1L;TENM2;GPM6A;EPS8;PIK3R1;NCKAP1;CCDC88A;CDC42EP3;ARPC2;TGFB3;CDC42EP1;CDC42EP5;ANLN;WASHC1;HRAS;RAC1;AGRN
prerank,response to insulin (GO:0032868),0.2808349052824656,0.9611390300253676,0.4858420268256334,0.8274011947577788,1.0,11/80,9.79%,PDPK1;ENPP1;FER;TRARG1;RAB10;SORBS1;EPM2AIP1;CPEB1;INSIG2;RHOQ;OTOP1
prerank,contractile actin filament bundle assembly (GO:0030038),0.3964371315607549,0.9609811551946447,0.5209125475285171,0.8265211139510379,1.0,3/15,13.07%,SORBS1;CUL3;ARRB1
prerank,stress fiber assembly (GO:0043149),0.3964371315607549,0.9609811551946447,0.5209125475285171,0.8265211139510379,1.0,3/15,13.07%,SORBS1;CUL3;ARRB1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3268358932500805,-0.9606634104714528,0.5275938189845475,0.866678229176013,1.0,9/22,28.90%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3268358932500805,-0.9606634104714528,0.5275938189845475,0.866678229176013,1.0,9/22,28.90%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC4;GOLGA7B
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.27974807239833804,-0.9605050278953504,0.5142857142857142,0.8662423228595127,1.0,14/44,21.33%,PTK2B;NCKAP1;LMOD1;ARPC4;CDC42EP3;VASP;CDC42EP1;CDC42EP5;EVL;PYCARD;ARF6;PFN2;CARMIL1;PRKCE
prerank,pinocytosis (GO:0006907),-0.4112191282431798,-0.9604069367526308,0.5167364016736402,0.8656072056911986,1.0,5/10,27.58%,DOCK2;PYCARD;CARMIL1;SNX33;AHSG
prerank,inorganic ion transmembrane transport (GO:0098660),-0.39348578965619685,-0.9602042173046983,0.5330578512396694,0.8652970425636737,1.0,2/12,11.40%,ABCC9;KCNJ8
prerank,piRNA metabolic process (GO:0034587),0.3707124029691401,0.9599546871031235,0.5183823529411765,0.8282970994423868,1.0,2/19,8.17%,PIWIL4;EXD1
prerank,response to laminar fluid shear stress (GO:0034616),-0.3998448251029359,-0.9598030173502639,0.501039501039501,0.8655369448645311,1.0,3/10,12.59%,SMAD7;KLF2;KLF4
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4213088924414381,0.9596774221309784,0.5029013539651838,0.8283353029915349,1.0,4/11,23.55%,IL34;CSF1;RIPK1;TGFB1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.30580641409954684,-0.9589870500055845,0.5244755244755245,0.866912086508612,1.0,6/30,11.92%,TPT1;RPS3;CXCL12;CD74;CCAR2;PTTG1IP
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3903132348866324,-0.9589821051253586,0.5235042735042735,0.8660332015049644,1.0,5/12,17.57%,HMGB1;MBP;CD74;KLF4;LPL
prerank,amide biosynthetic process (GO:0043604),-0.27528968370063917,-0.9589274312914509,0.5088161209068011,0.8652888363557538,1.0,4/47,3.39%,SGMS1;DMD;CERS4;DEGS2
prerank,endoderm development (GO:0007492),0.41164296537063166,0.9589087674456335,0.5101663585951941,0.8295681987322662,1.0,1/13,0.60%,LAMC1
prerank,positive regulation of cellular process (GO:0048522),0.22717347195612123,0.9586575619922971,0.6141124586549063,0.8295362431403294,1.0,58/565,9.47%,EFNB2;PDPN;BMP6;PTN;DPP4;CAMK1D;CCN2;FN1;PDGFRA;FGFR1;COLEC12;FGF1;PRKAA2;IL31RA;CXCL16;NUPR1;IL6ST;PHIP;GHRH;FPR2;APOA2;WNT3A;GAB2;OSM;IL11;FER;VEGFD;TGFA;IL34;PTHLH;GLP2R;IL6;TLR4;GLI1;BCL2;TPM1;STOX1;TGFBR1;KLHL22;MMP14;EPHA1;PDGFRB;HDAC4;CD47;TGFBR2;STAMBP;CTSH;NOXO1;RIPK2;ECHDC3;EPHA4;WNT5A;IGF2;IL13RA1;DNAJA2;ANKRD17;USP47;MST1R
prerank,calcium ion transport into cytosol (GO:0060402),-0.3373478798209356,-0.9585750892567285,0.5169300225733634,0.8653352000498852,1.0,5/21,9.11%,RYR2;GRIN2A;SLC8A1;GRIN2B;GRIN1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3737045820698538,0.9584673759552412,0.5218978102189781,0.8293552135027675,1.0,4/18,17.32%,ANXA1;KLF9;NR3C1;PCK2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.39423459857288423,0.9583170449302023,0.5267034990791897,0.8291163023080986,1.0,4/14,12.68%,GHR;STAT5B;PTK2;PTPN1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.2855054418766477,-0.9582928199245172,0.5389755011135857,0.8652038156787368,1.0,10/39,15.98%,PTPRJ;SH3KBP1;DAB2IP;SH3GL2;LGMN;CBL;ARHGEF7;EGFR;RNF126;EGF
prerank,atrioventricular valve morphogenesis (GO:0003181),0.366939298728226,0.9569108805849766,0.5107913669064749,0.8318303268747523,1.0,9/19,15.56%,BMPR1A;BMP2;TGFBR2;SMAD6;HEYL;SMAD4;EFNA1;MDM4;SOX4
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3331083349968025,0.9567060171795777,0.5242369838420108,0.831703885138898,1.0,5/29,6.10%,PDGFRA;AMBRA1;EPHA8;KIT;PDGFRB
prerank,iron ion transport (GO:0006826),-0.2731944013071443,-0.9563566784678725,0.5298701298701298,0.8696712283145472,1.0,17/47,21.84%,ATP6V0A1;TFRC;SLC40A1;FTH1;ATP6V1B2;ATP6V0C;SLC39A14;ATP6V1D;ARHGAP1;TTYH1;ATP6V0A2;SCARA5;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V0D2;ATP6AP1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3878198548149521,0.9562354923869938,0.5054545454545455,0.83154795246818,1.0,6/15,22.79%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3878198548149521,0.9562354923869938,0.5054545454545455,0.83154795246818,1.0,6/15,22.79%,TNRC6B;NANOS2;CPEB3;DHX36;NANOS1;ZFP36L2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.34508655637083857,-0.9560746442794846,0.5491071428571429,0.8695262544554047,1.0,13/17,44.93%,ZWILCH;SPDL1;CENPA;CTCF;ZW10;CDK1;MIS12;BUB3;KNL1;BOD1;AURKB;CHAMP1;HASPIN
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3347229228024015,0.9555619450922961,0.5182608695652174,0.832460491364835,1.0,2/30,1.51%,RASGRF1;NOTCH2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2867705619629258,0.9554278321159861,0.522508038585209,0.8321740296385043,1.0,10/70,11.99%,PDPK1;SMAD3;BCL2;MCL1;GSK3B;BAX;CASP8AP2;APPL1;BCL2L1;IFI27
prerank,limb morphogenesis (GO:0035108),-0.3397861605407694,-0.955427707903766,0.5331858407079646,0.8703583075223028,1.0,5/20,13.13%,TGFB2;MBNL1;FBXW4;LRP6;BMPR1B
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3418364977643504,-0.9554194574024782,0.5264270613107822,0.8694905479373106,1.0,7/18,29.72%,AKT1;PINK1;PPIA;PARK7;NONO;VNN1;HSPB1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.2915873196818572,-0.9553101567827084,0.5285359801488834,0.8689058887280205,1.0,5/33,9.94%,TFRC;AKT1;PRELID1;PINK1;GHITM
prerank,regulation of receptor recycling (GO:0001919),0.386192826583679,0.9551841759414732,0.5197841726618705,0.832142530009789,1.0,3/16,5.67%,ANXA2;TBC1D16;OPTN
prerank,lipid droplet formation (GO:0140042),0.43246367607773784,0.9547802515934498,0.5241779497098646,0.8324196216028785,1.0,2/10,6.29%,SMIM22;PLA2G4C
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.3673893949823779,0.9546883410370739,0.519927536231884,0.8320392352196453,1.0,4/22,8.47%,APOA2;LACC1;TNFRSF14;WNT5A
prerank,myeloid dendritic cell activation (GO:0001773),-0.39965620960994075,-0.9543130658133037,0.54375,0.8707265164429877,1.0,4/12,17.73%,DOCK2;HMGB1;PYCARD;CAMK4
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.32098223653305724,-0.9542341385048696,0.5172413793103449,0.870077077300405,1.0,11/24,26.05%,UBB;UBA52;POLD2;POLE;LIG3;RFC4;POLD1;POLB;POLK;RFC5;RFC2
prerank,vitamin transport (GO:0051180),0.3351707723620967,0.9535953294347757,0.5823008849557522,0.8339343666684687,1.0,2/29,2.56%,PDPN;SLC19A1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.33965966795955144,0.9534191028053279,0.5185185185185185,0.8337336720778051,1.0,8/29,17.71%,TENT5A;PKP3;DHX34;NOCT;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,regulation of centrosome cycle (GO:0046605),-0.32764031616248285,-0.9529113394530561,0.5409090909090909,0.8728573242647404,1.0,11/21,35.00%,NPM1;CHMP1A;CHMP1B;CHMP2B;GEN1;CHMP2A;CHMP4C;FBXW5;AURKA;PKHD1;VPS4B
prerank,negative regulation of cellular senescence (GO:2000773),-0.3749166190219714,-0.9529109641248856,0.5088495575221239,0.8719768419949947,1.0,3/13,7.60%,CDK6;YBX1;RBL1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.32215547122159693,-0.9527509187896329,0.5187793427230047,0.87153726560013,1.0,6/24,13.57%,PECAM1;ITGA4;SEMA4D;SYK;GFUS;F11R
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2512791792176337,-0.9526261955939886,0.55,0.8709873460370284,1.0,24/75,22.65%,GPCPD1;PLCB1;DGKH;SERINC1;GDPD1;ABCA3;SERINC5;ENPP6;PIGM;PIGQ;PIGH;DPM2;CSF1R;PGP;GDE1;PLCG1;ABHD6;PNPLA6;CPNE7;PNPLA3;PIGB;PLA2G7;CLN3;PLA2G4F
prerank,histone H3 acetylation (GO:0043966),-0.2807310859462042,-0.9524415444970171,0.5297029702970297,0.8706483096868648,1.0,12/40,23.62%,LEF1;TADA2A;JADE3;JADE1;BRCA2;TAF5L;KAT7;KAT2A;SGF29;BRPF1;POLE3;ING4
prerank,regulation of interleukin-6 production (GO:0032675),0.2665863634156624,0.9523611081501954,0.5448079658605974,0.8355995486646034,1.0,14/96,11.49%,IL16;IL17D;IL6;TLR4;C5AR2;PTPN22;NOS2;CD47;LGALS9;SETD4;WNT5A;PTPN6;TLR2;IRAK3
prerank,metanephros development (GO:0001656),0.34514117505924025,0.9522866525899152,0.5129087779690189,0.8351718665568362,1.0,4/26,7.04%,FOXD1;OSR1;BMP7;CTSH
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.28924407909326394,-0.9522330491043327,0.5343137254901961,0.8703234429332377,1.0,7/36,9.77%,SGMS1;CRADD;TPD52L1;RPS3;DAB2IP;FAS;TRAF7
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.381097553951365,0.9521206516996238,0.5148148148148148,0.8349505615702787,1.0,3/18,12.73%,ROCK2;EPHA4;EFNA1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.35483092637599595,0.952003328352788,0.5163043478260869,0.8346289399036891,1.0,9/24,20.88%,SUZ12;EPC1;JARID2;TASOR;DNMT3A;PPHLN1;BMI1;MPHOSPH8;PHF1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.27764284074697687,0.9519992179257846,0.553680981595092,0.8340254817820347,1.0,15/80,14.52%,PRICKLE1;ANGPT1;CRY1;MYCBP2;SPSB4;BIRC3;RIPK2;LRRK2;FBXO4;FANCM;HUWE1;CENPX;CUL3;TBC1D7;RCHY1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3641925657650291,-0.9517745375173396,0.5289079229122056,0.8706967257778212,1.0,8/14,42.98%,TNFRSF1B;GRN;PTPRC;TREM2;LDLR;IL4;CST7;TAFA3
prerank,regulation of metal ion transport (GO:0010959),0.3776334926326289,0.9508485135529537,0.503448275862069,0.8360910304846585,1.0,5/16,15.11%,IL16;BCL2;DLG1;GRIN3B;CACNA2D1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3790987084638917,0.950690228139895,0.522140221402214,0.8358445954784121,1.0,5/16,18.55%,PDS5B;POGZ;PDS5A;NIPBL;DSCC1
prerank,mRNA catabolic process (GO:0006402),0.3045960092384956,0.9506457321855021,0.5264900662251656,0.8353404864881926,1.0,12/44,19.62%,TUT4;RC3H1;DHX34;NANOS2;DCP2;XRN1;SLFN14;SUPV3L1;METTL16;EXOSC10;TUT7;DDX5
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.34388577621793975,0.9502792769628108,0.5130890052356021,0.8356135190237008,1.0,9/25,23.09%,CDC73;ZMYND11;CDK12;BRD4;LEO1;CDK13;EAPP;ELL;HEXIM1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3913276137950856,0.950126998850046,0.5418181818181819,0.8353307569535464,1.0,7/16,22.79%,RC3H1;MOV10;CPEB3;DHX36;KHSRP;ZC3H12A;ZFP36L2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3028189671767344,0.9500113216744567,0.5453100158982512,0.834990477709459,1.0,7/49,7.85%,APOA2;IL17D;IL6;TLR4;SERPINE1;NOS2;LGALS9
prerank,positive regulation of protein import into nucleus (GO:0042307),0.34073223110598205,0.9496250820618677,0.5218150087260035,0.8352217167465703,1.0,3/28,5.82%,SMAD3;ZIC1;TPR
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.27780750555195455,-0.9495299093330849,0.558974358974359,0.8757552819406279,1.0,10/44,12.59%,THBS1;GAS6;SNCA;ARL6IP1;AKT1;VEGFA;PAX2;RPS6KA1;NGF;KLF4
prerank,ESCRT III complex disassembly (GO:1904903),-0.40817263913725943,-0.9492791699536804,0.5420944558521561,0.8747000978701077,1.0,5/10,23.37%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),-0.40817263913725943,-0.9492791699536804,0.5420944558521561,0.8747000978701077,1.0,5/10,23.37%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A
prerank,positive regulation of cell death (GO:0010942),0.2931152517990302,0.9491561659507401,0.545727136431784,0.835681859758448,1.0,7/59,9.29%,EFNB2;SLC6A13;GSK3B;RIPK2;WNT5A;HEBP2;LRRK2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4283226013524526,0.9491124082700667,0.5217391304347826,0.8351729393606929,1.0,2/10,3.02%,FOXC1;NCOA3
prerank,cellular response to oxidative stress (GO:0034599),-0.23062749345641914,-0.9488200799362752,0.597972972972973,0.8750726603864348,1.0,26/118,15.43%,PTPRK;FOXO1;PRR5L;SETX;SNCA;MAPK8;RPS3;CPEB2;MSRA;NCF2;MAPK3;CHCHD2;AKT1;PINK1;NUDT2;EGFR;ATF4;PYROXD1;CYBB;PPIA;PARK7;SOD1;ERO1A;PRKD1;PYCR2;MAPT
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.39017862269113457,0.9488084324523905,0.5094339622641509,0.8352666232206167,1.0,6/14,23.54%,LRRK2;BCL2L1;OPA1;XBP1;TXNDC12;SYVN1
prerank,regulation of nervous system process (GO:0031644),-0.3409297805153455,-0.948738997396393,0.5305676855895196,0.8743895482258497,1.0,4/18,4.33%,NOS3;HTR2C;DLGAP1;DLGAP2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.31649213279304406,-0.9487218950276768,0.5142118863049095,0.8735697582040086,1.0,12/26,31.97%,PLCG2;RAB27A;SNCA;GRIN1;ABCD2;PARK7;SLC18A2;ADGRB1;SLC30A10;TLR6;ALOX5;SLC5A3
prerank,protein localization to cell junction (GO:1902414),0.3567616968748761,0.9487214883224369,0.5185185185185185,0.8348513829826851,1.0,5/22,13.10%,CGNL1;HEG1;TJP1;NLGN2;JAK1
prerank,cell cycle checkpoint signaling (GO:0000075),0.4100434329242796,0.9485259349610295,0.5313725490196078,0.8346966523905383,1.0,3/12,9.40%,PRCC;ZWINT;NABP1
prerank,striated muscle cell development (GO:0055002),-0.3576207785837907,-0.9479333777974309,0.5311827956989247,0.8748140239116768,1.0,2/14,6.20%,PGM5;LMOD1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3081198010915216,-0.9477629594157633,0.5220588235294118,0.8743923022383377,1.0,5/27,8.26%,CSNK1D;SORL1;PAQR3;ARL1;GCC2
prerank,artery development (GO:0060840),0.3513766321332922,0.9477000458759712,0.5346358792184724,0.8360157694554108,1.0,4/23,5.16%,ROBO1;NRP1;EFEMP2;TGFBR1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3714493998309577,-0.9474267094348765,0.5454545454545454,0.8744500493622435,1.0,3/13,6.85%,STX3;HSP90AB1;RIC3
prerank,negative regulation of phagocytosis (GO:0050765),-0.3455727168368472,-0.9472888980002108,0.5294117647058824,0.8739238445259118,1.0,4/17,10.38%,SNX3;HMGB1;DYSF;RACK1
prerank,peptidyl-arginine modification (GO:0018195),-0.3627011324716985,-0.9471204087431122,0.5496828752642706,0.8734909417657523,1.0,3/15,19.69%,ART3;PARK7;PRMT5
prerank,morphogenesis of an epithelium (GO:0002009),-0.31327747761259905,-0.9461270900476121,0.5290023201856149,0.8752482876102567,1.0,6/25,9.91%,ACTB;LAMA3;ACTG1;AHI1;LRP6;PRKX
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.30822853230402736,0.9461147884107746,0.5481727574750831,0.8390550938202614,1.0,9/48,10.62%,PDPK1;FGFR1;FOXC2;ANXA1;ANGPT1;PIK3C2A;MAPK14;AKT3;FGF18
prerank,regulation of ruffle assembly (GO:1900027),-0.32304882693966247,-0.9460296728309245,0.5198135198135199,0.8746297630317581,1.0,9/23,20.74%,NLGN1;EPS8;ABI3;CAV1;HRAS;EVL;ARHGAP24;PFN2;FAM98A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23288467655472336,0.9459033974736732,0.5903614457831325,0.83894383118163,1.0,57/341,15.01%,RNF213;SPSB1;TBL1XR1;SMURF2;RNF217;FBXO11;FBXL17;TRIP12;NEDD4;TGFB1I1;TTC3;NHLRC3;RC3H1;RNF19A;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;DTX3L;ANAPC11;NTAN1;USP9X;RNF20;KLHL15;NUB1;PSMB10;RNF111;ANAPC1;AMFR;UBR4;UBE2C;PSMA3;PSME4;FBXL7;PSMA5;WWP2;KEAP1;UBXN2A;HUWE1;SPOPL;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;CDC27;BFAR;RNF43;FBXL4;RCHY1;BIRC6;KCTD5;PML;UBE2R2
prerank,regulation of aerobic respiration (GO:1903715),-0.3569567355251059,-0.9459020923741219,0.5527426160337553,0.8741126220484797,1.0,2/15,8.21%,CBFA2T3;PINK1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.24745132735177242,-0.9456913879128288,0.5658263305322129,0.8738272500482636,1.0,10/75,8.05%,PLCB1;RGS5;RGS3;MGLL;CALM1;RGS12;RGS4;RGS6;SLC39A14;CAMK2A
prerank,regulation of multicellular organismal development (GO:2000026),0.34587285226316516,0.9451264015929665,0.5295169946332737,0.8400894338026329,1.0,4/25,11.24%,PTN;TRIP12;MYSM1;OAS2
prerank,sodium-independent organic anion transport (GO:0043252),-0.39940913118512444,-0.944674363368334,0.5598377281947262,0.8756313620657626,1.0,2/10,1.10%,SLCO1C1;SLCO2A1
prerank,transition metal ion homeostasis (GO:0055076),0.33609281901528815,0.9446573351484728,0.524701873935264,0.840585613052504,1.0,1/28,0.17%,CP
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.38340481962389994,0.9443368023400587,0.5338491295938105,0.8407046084623392,1.0,3/14,3.31%,FOXC1;NRP1;VEGFD
prerank,negative regulation of cilium assembly (GO:1902018),-0.37824566412282923,-0.9439578700241537,0.5238095238095238,0.8767369668539471,1.0,2/12,4.90%,LIMK2;TBC1D30
prerank,glutathione metabolic process (GO:0006749),-0.28184261328491755,-0.9435818001348084,0.548926014319809,0.8768957158998552,1.0,21/38,43.27%,OPLAH;GGT5;GSTM5;GCLC;PARK7;SOD1;GGT7;GGT1;HAGH;ETHE1;MGST2;GCLM;GSTA4;GSR;HPGDS;NAT8;GSTM4;GPX1;GLRX2;GSTP1;GGCT
prerank,positive regulation of protein transport (GO:0051222),-0.25031865877520565,-0.9435316938735518,0.56,0.8761612612808636,1.0,27/67,28.16%,TGFB2;PRR5L;ACSL3;FRMD4A;ATP2C1;OAZ1;OAZ2;TGFB3;PCNT;RACK1;PPIA;MYOM1;MYO18A;CEP290;EXPH5;ADAM8;ARF6;SYTL4;VPS28;TTN;CLN3;B3GAT3;APBB3;TREM2;PDCD10;GOLPH3;VAMP2
prerank,regulation of protein localization to centrosome (GO:1904779),0.42235392175054304,0.9434611882892666,0.5434343434343434,0.8421772981561104,1.0,3/10,15.15%,PARD6A;GSK3B;CEP250
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3024652115938784,-0.9434095117490642,0.571072319201995,0.8756192550848927,1.0,7/26,12.81%,INSR;NOS1AP;KLF2;HSP90AB1;AKT1;KLF4;HSP90AA1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3763765656953472,-0.9432231448905739,0.5521064301552107,0.875242739658159,1.0,3/13,4.82%,CACNB2;KCNJ3;GJC1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3591541719448939,0.9427216975592754,0.5355871886120996,0.8432988386686623,1.0,8/21,23.54%,LRRK2;BCL2L1;OPA1;NCK1;EIF2AK3;XBP1;TXNDC12;SYVN1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.43019353423056,0.9425471418947731,0.5440613026819924,0.8430732154563356,1.0,4/10,19.29%,WNT3A;WNT5A;RYK;WNT2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.30172770887298056,0.9415607897902117,0.5584,0.8447827695208824,1.0,11/45,17.13%,PARP9;RC3H1;PKP3;TDRD7;FOXO3;METTL16;GEMIN5;MAPKAPK5;ZC3H7B;APP;PUM2
prerank,mitochondrion organization (GO:0007005),0.24774971231299467,0.9415273702543451,0.5956284153005464,0.8442568812900171,1.0,33/165,15.52%,CXADR;PID1;TRAK1;IFIT2;TERT;SPATA18;GABPB1;HAX1;MPV17;TIMM17A;MEF2A;PHB2;BAX;SIRT4;NIPSNAP2;LRRK2;DNM1;MTFP1;AFG1L;TMEM70;AKT3;DNM1L;BCL2L1;ATCAY;SUPV3L1;OPA1;MTFR1;WASF1;NRF1;TIMM9;SLC25A4;MIEF1;MUL1
prerank,neuron apoptotic process (GO:0051402),-0.33086972723356367,-0.9413851935956521,0.5379464285714286,0.8792320478780273,1.0,5/19,13.40%,CIT;TRPC5;SCN2A;FAS;TNFRSF21
prerank,negative regulation of endocytosis (GO:0045806),-0.3142147947653651,-0.9411925543180885,0.5490196078431373,0.878927679490675,1.0,11/24,28.10%,MCTP1;SCAMP5;CAV1;RAC1;PRKD1;LRSAM1;ARF6;MTMR2;SNX33;NR1H2;LILRB1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.377280502688069,-0.9411695349352185,0.5213675213675214,0.8781280465283225,1.0,2/12,3.81%,STX3;SNAP25
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3872951926681237,-0.9405922425214719,0.5464362850971922,0.8787928584670562,1.0,3/11,7.21%,PLCB1;PIK3R1;AKT1
prerank,DNA geometric change (GO:0032392),0.3396667689827515,0.9401323190021548,0.5472370766488414,0.8468744365094184,1.0,11/24,24.40%,ANXA1;WRN;ASCC3;RAD50;SUPV3L1;HNRNPA2B1;DHX36;DNA2;RTEL1;DHX9;ZRANB3
prerank,steroid catabolic process (GO:0006706),-0.3979050760465327,-0.9400316168276864,0.5441478439425051,0.8793806183424461,1.0,3/10,15.92%,YWHAH;SPP1;HSD11B1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3037585282233989,-0.9399072078569085,0.5633187772925764,0.8788603638222005,1.0,8/28,17.40%,CRADD;DAB2IP;GABARAP;DDX47;DEDD;NGF;SORT1;DEDD2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3826505896378629,-0.939786669589814,0.5595744680851064,0.8783280233649489,1.0,4/11,12.62%,MEF2C;RAPGEF2;LYN;PIK3CD
prerank,receptor internalization (GO:0031623),-0.2705604327526034,-0.9395637216355891,0.5529100529100529,0.8780676115800449,1.0,10/44,12.95%,DNM3;TFRC;SNCA;SCYL2;CEACAM1;LDLRAP1;RAMP2;FCER1G;SYK;CAV1
prerank,actin filament capping (GO:0051693),0.36742434446034106,0.939484144754881,0.5464684014869888,0.847187285226913,1.0,8/18,22.16%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2
prerank,barbed-end actin filament capping (GO:0051016),0.36742434446034106,0.939484144754881,0.5464684014869888,0.847187285226913,1.0,8/18,22.16%,ADD3;VILL;CAPZB;TRIOBP;AVIL;CAPZA1;CAPG;TWF2
prerank,regulation of cellular protein localization (GO:1903827),0.30202936862196894,0.9393389123755839,0.547077922077922,0.8469225050649353,1.0,14/45,19.58%,GPC6;PRKAA2;SPIDR;GPC2;DVL3;HFE;PTPN1;CCDC66;BDNF;GBF1;GPC1;KDM1A;GPC4;SETD2
prerank,sympathetic nervous system development (GO:0048485),-0.35379718055874865,-0.9389709578005002,0.5322245322245323,0.8788147493521955,1.0,4/15,12.74%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.28629137666576754,-0.9389588042637635,0.5441176470588235,0.8779824954441231,1.0,9/35,10.15%,TGFB2;MET;DAB2IP;ARHGAP44;RASIP1;MYOC;CCDC125;MFN2;ITGA3
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.3485676962740302,-0.9387801638013417,0.5557986870897156,0.8776197622651987,1.0,12/18,50.23%,PRELID1;XRCC6;PRKDC;IKZF3;CRTAM;PRDM1;CCR2;TBX21;ABL1;SLAMF8;NCKAP1L;CD2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3380491788477411,0.9378949933530126,0.5495798319327732,0.8496530838719477,1.0,10/27,23.42%,PCF11;NYNRIN;XRN1;SLFN14;ZC3H12B;CSTF3;RNASEH1;PARN;ZC3H12A;KHNYN
prerank,vesicle transport along actin filament (GO:0030050),-0.3357047835811865,-0.937326325542414,0.5365296803652968,0.880600051842267,1.0,2/19,1.44%,MYO1D;FNBP1L
prerank,regulation of peptide hormone secretion (GO:0090276),0.28620349567921327,0.9370607522970533,0.5678627145085804,0.8509863673803995,1.0,16/67,19.78%,DPP4;RAPGEF4;ITPR1;RFX3;IL6;NOS2;CACNA1C;PPP3CB;HFE;ADRA2C;ADRA2A;RAPGEF3;CLOCK;ITPR2;UQCC2;KCNS3
prerank,regulation of interleukin-10 production (GO:0032653),0.2979455910083396,0.9369749225984245,0.552755905511811,0.8505676105973379,1.0,7/44,7.89%,IL6;TLR4;PRKCZ;FOXP3;CD47;LGALS9;CD274
prerank,cellular response to nutrient levels (GO:0031669),0.2827257451863566,0.936811199000663,0.5642540620384048,0.8503552455693162,1.0,11/62,11.13%,PRKAA2;GCGR;WRN;LAMP2;CARTPT;PPARA;CDKN2B;STK24;LRRK2;NUPR2;FNIP1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.352664943405828,-0.9366241231253462,0.5384615384615384,0.881602370297159,1.0,3/16,2.33%,TGFB2;BMPR2;NOTCH1
prerank,Golgi to endosome transport (GO:0006895),-0.3489569805761559,-0.9365237401427849,0.5221238938053098,0.8810349452004264,1.0,6/16,15.36%,DOP1B;AP1AR;CORO7;KLHL20;KIF16B;SORT1
prerank,epidermis development (GO:0008544),0.2901840757639486,0.9364703872219609,0.5844155844155844,0.8505720173461346,1.0,5/56,6.60%,CCN2;GATA6;PTHLH;GLI1;SVEP1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3460452317436692,-0.9362449488644621,0.5517241379310345,0.8809317026971442,1.0,5/17,13.29%,RYR2;NEDD4L;KCNJ8;KCNQ1;KCNE4
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3169326717726332,-0.9362191824306975,0.5530474040632054,0.8801521990870919,1.0,8/22,20.22%,CNTN4;B2M;CALR;HEY1;HES1;NEPRO;SOX2;DLL1
prerank,telomere maintenance (GO:0000723),0.29698301294480695,0.9361372687270757,0.5488372093023256,0.8507400852044132,1.0,16/50,22.63%,SP100;TERT;WRN;RAD50;PARP3;RPA3;NSMCE2;TEN1;DNA2;RIF1;SMC6;CTC1;POLD3;RTEL1;TEP1;PTGES3
prerank,axonal transport of mitochondrion (GO:0019896),-0.3892105026499579,-0.9360439922649053,0.5334728033472803,0.8797565306018766,1.0,2/11,2.69%,SYBU;ACTR10
prerank,stress-activated MAPK cascade (GO:0051403),-0.25426607345865754,-0.9359202787514093,0.5950413223140496,0.8792339776344272,1.0,11/61,10.09%,NOD1;MAP3K5;MAPK8;ARHGEF6;MAPK10;MAPK3;MAP3K11;UBB;MAP4K3;MAP3K20;MINK1
prerank,glycine metabolic process (GO:0006544),0.4053131396483365,0.9357532433750325,0.5447470817120622,0.8510354665005354,1.0,2/12,8.48%,SHMT1;AMT
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2699695765752008,0.9357503781453337,0.5814648729446936,0.8504311810417484,1.0,7/85,6.54%,COL4A3;EYA1;DCDC2;ADGRV1;ROR1;GSDME;CCDC50
prerank,tetrapyrrole metabolic process (GO:0033013),0.36285527255574956,0.9356715699021065,0.5384615384615384,0.8499964226639914,1.0,2/18,8.51%,MMAB;LMBRD1
prerank,amyloid fibril formation (GO:1990000),-0.267462267145452,-0.9356531744981664,0.5782493368700266,0.8790511792304138,1.0,9/51,8.76%,CST3;FKBP1A;H3-3A;SNCA;TGFBI;SORL1;TSPAN14;UBB;B2M
prerank,tRNA 5'-end processing (GO:0099116),-0.3515461150806424,-0.9355645672798589,0.5599128540305011,0.878446708735317,1.0,6/15,26.42%,PRORP;RPP30;HSD17B10;RPP25L;TRMT10C;POP7
prerank,response to amino acid (GO:0043200),-0.2891420435490658,-0.9355213800567824,0.5491606714628298,0.8777111523668194,1.0,11/31,26.20%,GLRA3;GRIN1;RRAGB;CPEB4;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2;NSMF;LAMTOR4
prerank,response to interferon-beta (GO:0035456),0.35410220112130114,0.9350954726495361,0.5635673624288425,0.8507434786544791,1.0,9/22,23.67%,IKBKE;BST2;STAT1;IFITM1;IFNAR2;SHFL;UBE2K;PNPT1;XAF1
prerank,tight junction assembly (GO:0120192),-0.26763457389550216,-0.934962251555188,0.5703324808184144,0.8783151555226301,1.0,10/49,14.33%,PECAM1;CLDN5;ESAM;ACTG1;LSR;CLDN14;RAMP2;MICALL2;F11R;MPP7
prerank,intracellular protein transport (GO:0006886),0.23256161574490442,0.9340424894713123,0.6423267326732673,0.8525957389884492,1.0,79/304,22.03%,RANBP3L;WLS;PRICKLE1;TNPO1;COPZ2;ARFGAP3;SNX6;TRAK1;TBC1D16;TRARG1;RAB22A;LAMP2;RAB43;APPL2;TPR;ARF4;GRTP1;SIL1;SRPRA;NGFR;SNX9;PHB2;SCFD2;SLU7;AP4E1;ARF3;STX8;APPL1;STX2;FUT10;STX11;IPO7;KIF13B;COX18;ARCN1;HOMER3;SNX27;EIF4ENIF1;EGR2;SCFD1;STRADB;POM121;TMED9;VPS26C;ARL4A;MYO1C;COPZ1;SAR1A;RAB5A;TRIM23;AP4M1;ARF1;RAN;SEC31A;RPGR;RANBP17;AP3B1;RAB19;ARL6;USP6NL;WDR11;SEC16A;NUP85;ARFIP2;TBC1D25;VPS26B;VPS33A;FAM91A1;SNX15;HIKESHI;UNC93B1;GGA3;RAB14;VPS35;XPO5;MYO6;PKD1;OXA1L;NAPG
prerank,homocysteine metabolic process (GO:0050667),-0.3906785143401682,-0.9339344541643517,0.5359342915811088,0.8801476603117772,1.0,5/11,23.78%,MTHFR;MTRR;CTH;MPST;NOX4
prerank,intracellular lipid transport (GO:0032365),0.3606982193268884,0.9338822401419995,0.5332167832167832,0.8523803455950287,1.0,2/21,1.61%,PRKAG2;PRKAA2
prerank,T cell homeostasis (GO:0043029),-0.39839099122641625,-0.9336443543476939,0.551440329218107,0.8800699623525303,1.0,6/10,28.37%,AKT1;FAS;ZC3H8;JAK3;FADD;PMAIP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.28537841824971727,-0.9336404928188953,0.5547619047619048,0.8792425618263444,1.0,8/35,17.26%,PRKCQ;NEK7;CTNNB1;MAPK3;ATM;PNKP;PKIB;CCT5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4046001052171995,0.933455311206049,0.5499092558983666,0.852759128141766,1.0,4/12,14.08%,MIA3;PPARA;FUT4;WNK1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.38643503196297324,-0.9328137252420505,0.5529661016949152,0.8805364867668218,1.0,4/11,11.12%,MECOM;CD34;YTHDF2;RUNX1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.29703674149087866,-0.9327384678489407,0.5532879818594104,0.8798792868286495,1.0,10/30,19.63%,RPL11;HSP90AB1;SDCBP;RYBP;BAG6;CCAR2;CAMLG;PARK7;N4BP1;EIF3H
prerank,positive regulation of proteolysis (GO:0045862),0.28890064369902335,0.932610113193223,0.5786163522012578,0.8540390450971819,1.0,16/55,22.01%,SH3D19;NRDC;CTSH;SNX9;CCBE1;BTRC;FBXW11;HDAC2;ADRA2A;CYFIP2;ATP5IF1;ASPH;TNIP1;IST1;RCN3;ZC3H12A
prerank,tRNA processing (GO:0008033),-0.2496568254139413,-0.9325687684441202,0.5936599423631124,0.8795018808381603,1.0,26/61,34.91%,CSTF2;KARS1;THUMPD1;QTRT2;RPP30;PUS3;ELP5;DTWD2;WDR4;TSEN54;TYW5;CDKAL1;TRMT6;TRMT9B;TRUB1;TRMT10C;CPSF1;ADAT2;POP7;CTU2;TRMT61A;TSEN34;ADAT1;TRMT10A;DDX1;THG1L
prerank,regulation of mitotic cell cycle (GO:0007346),-0.21450030824300817,-0.9324973201389078,0.6397058823529411,0.8788301559480455,1.0,45/171,21.28%,BRINP3;MEIS2;BRINP1;NEK7;BRINP2;PSMC3;CDC26;LGMN;SDCBP;PSMD14;SIK1;PSMD3;TFAP4;TTC28;TAL1;PSMD4;BORA;CAV2;CCDC8;PSMD6;PSMA6;UBE2E1;ANGEL2;PSMA4;PSMB8;DYNLT3;PSMA8;CYLD;BUB1B;BTG1;ASNS;UBE2D1;PSME1;L3MBTL1;MAEA;CDKN1C;PRMT5;PSMD7;PSMC6;PSMB5;USP2;MKI67;PSMC5;PSMB1;AFAP1L2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.29342774989609366,0.9323454691789567,0.596694214876033,0.8539931163129152,1.0,10/57,15.52%,MCU;DCN;RALBP1;PDCD5;GSK3B;BAX;DNM1L;ZNF205;MIEF1;MUL1
prerank,membrane protein proteolysis (GO:0033619),0.31229252675183344,0.931908290719461,0.5341098169717138,0.8544061528059043,1.0,6/37,11.81%,DAG1;CTSH;SPPL3;NGFR;ERAP1;ADAM19
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3049801229610733,0.9316967334690683,0.5415335463258786,0.8542876585338539,1.0,15/42,23.12%,SPIDR;KLHL15;FBH1;PPP4R2;ERCC6;FUS;FIGNL1;SHLD2;KDM1A;SETD2;RIF1;RTEL1;PPP4C;SMCHD1;ARID2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3811595186651201,0.9312893441701368,0.5412844036697247,0.8545935072479415,1.0,3/15,4.50%,RNF213;DACT1;WNT5B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.3022528953167167,-0.9311183281530475,0.569377990430622,0.8815509303556176,1.0,10/27,23.84%,MAP3K5;MAPK8;MAPK3;UBB;MAP3K20;UBA52;KAT7;IKBKB;SKP1;TAOK2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3223216276802598,0.931075551952868,0.557347670250896,0.854467404610671,1.0,17/32,27.67%,POLR1C;CCNH;MNAT1;POLR1G;CDK7;POLR2F;GTF2H4;GTF2H2;CAVIN1;POLR2K;UBTF;TAF1;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,mitochondrial fission (GO:0000266),-0.34492477328948756,-0.9309984561109693,0.5505376344086022,0.8810242924657354,1.0,3/16,10.98%,DNM3;MFF;GDAP1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3325118388569376,0.9308051264480485,0.5502555366269165,0.8544748021363626,1.0,10/27,21.01%,NR1H3;PPARA;CRP;IL18;CSF1;MAPK9;ABCA1;PLA2G5;CD36;AGT
prerank,regulation of organelle organization (GO:0033043),0.2757848708601689,0.9307853068226828,0.5575757575757576,0.8539111188435675,1.0,19/80,19.72%,ZEB2;DIAPH1;STOX1;CLIC4;SYDE1;ARMH3;DNM1L;TJP1;PTK2;TMEM33;TMED9;RAB33B;MUL1;SAR1A;MYO5A;RHOT1;USP6NL;RHOT2;TBC1D25
prerank,cellular polysaccharide catabolic process (GO:0044247),0.36884044644729,0.9307155798058678,0.5443262411347518,0.8534709657753191,1.0,4/16,11.43%,PYGB;MGAM;PYGM;STBD1
prerank,RNA destabilization (GO:0050779),0.36244321090727366,0.9299869819321791,0.5400763358778626,0.8545544430233886,1.0,4/18,14.87%,ROCK2;FTO;METTL16;GIGYF2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.26156014271767175,0.9295271133467352,0.5886627906976745,0.8550512956867624,1.0,26/101,19.80%,ROBO1;FGFR1;FGF1;IL34;KIT;CCND3;ATP2B4;PDGFRB;WNT5A;LRRK2;PIK3R5;MST1R;FGF18;PARP16;MAP2K1;MTCP1;ADRA2A;PKD2;PSRC1;PPP2CA;TENM1;MAPRE3;DIRAS1;CCNY;ERBB2;SLC27A1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3969840114037278,-0.9294186699067092,0.5616161616161616,0.8841854642923935,1.0,3/10,18.62%,IQSEC1;EPB41L4B;ARF6
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.29916613006204473,0.92855245891595,0.5782312925170068,0.8566593701875281,1.0,11/48,16.30%,ZMIZ1;ELOF1;POLR1C;BAZ1B;POLR1G;SERTAD2;POLR2F;ERCC6;MYO1C;KAT2B;DDX21
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2343919886090264,-0.9284801336733899,0.630718954248366,0.8857786228027754,1.0,17/90,13.10%,ADIPOR2;EBF2;GATM;PRDM16;KSR2;GNAS;UCP2;DYNC1H1;VEGFA;MFN2;ADRB2;CMKLR1;GADD45G;SYK;PRLR;CAV1;SCD
prerank,positive regulation of filopodium assembly (GO:0051491),0.3447342886584709,0.9282352122290797,0.5693693693693693,0.8567958687908099,1.0,3/24,2.97%,DPYSL3;DOCK11;NRP1
prerank,lymphocyte mediated immunity (GO:0002449),0.3946619484406707,0.9281127370887187,0.5703703703703704,0.856505168486131,1.0,1/12,2.46%,CD55
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.38815400100804026,-0.9274940603425678,0.5390781563126252,0.887564173545625,1.0,4/10,17.25%,TBX1;RXRB;ACTN4;RXRA
prerank,positive regulation of protein processing (GO:0010954),0.3547437355797272,0.927439035050504,0.5373134328358209,0.857450112838442,1.0,3/19,12.37%,CLEC3B;PLGRKT;CCBE1
prerank,antibacterial humoral response (GO:0019731),-0.34365366209692816,-0.9272180867768185,0.5617021276595745,0.8874478491414213,1.0,3/16,14.16%,RPL39;DEFA6;RNASE7
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3310783683376051,-0.9271779399192414,0.5607476635514018,0.8867152065549069,1.0,5/20,10.30%,RPS6KA5;DIP2B;TADA2A;MAPK3;NOS1
prerank,positive regulation of metabolic process (GO:0009893),-0.22980204615718278,-0.9266890090468548,0.6345514950166113,0.887164942348017,1.0,20/103,13.10%,ADIPOR2;EBF2;INSR;GATM;PRDM16;KSR2;GNAS;UCP2;DYNC1H1;VEGFA;MFN2;ADRB2;CMKLR1;GADD45G;ACACA;SYK;PRLR;CAV1;ACLY;SCD
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.32351244450240774,0.9264908780345132,0.5454545454545454,0.859054719367841,1.0,4/30,5.67%,SPTBN1;VAMP5;RAB10;OPTN
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.31629636028905017,0.9263349315292164,0.5594294770206022,0.8587851053946586,1.0,5/38,6.63%,ROCK2;SMAD3;TLR4;ATP2B4;CD47
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2807601331449606,-0.9262159964940925,0.6173708920187794,0.8875130561229634,1.0,6/35,8.46%,FKBP1A;CALM1;CALM2;HSP90AB1;CALM3;PPP1R11
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.32125019447171554,-0.925804714532208,0.5594713656387665,0.8877608145266124,1.0,8/21,22.06%,PDE4D;HINT1;PDE2A;PNP;NT5C2;NUDT18;NUDT3;HPRT1
prerank,cellular response to dsRNA (GO:0071359),0.38986814943465603,0.9257975333073981,0.5563636363636364,0.8594301769062304,1.0,4/15,15.52%,COLEC12;IFIT1;IFIH1;MUL1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.37327872983242577,-0.9256145883163513,0.5686695278969958,0.8874056189792595,1.0,3/12,11.10%,PIK3R1;DAB2IP;ATF6
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3407575633319345,0.9254672195006761,0.5628318584070796,0.8595792966399314,1.0,12/24,21.88%,SEC23A;SEC24D;TAPBP;ERAP1;SEC24C;HFE;SEC24B;SEC31A;TAP2;ABCB9;BCAP31;PDIA3
prerank,histone deacetylation (GO:0016575),0.30398841661957426,0.925279555627716,0.5688225538971807,0.8594227199850941,1.0,11/43,17.36%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;PRDM5;RBM14;HDAC2;ELK4;TBL1X;MIDEAS
prerank,regulation of protein catabolic process (GO:0042176),-0.22660425360049843,-0.9244597936454982,0.6698412698412698,0.8896148389205348,1.0,15/99,12.13%,FMN2;FOXO1;WWP1;HECW1;NSF;SORL1;EEF1A1;DAB2IP;SNX3;OAZ1;OAZ2;NEDD4L;ZDHHC2;BARD1;EGFR
prerank,sulfur compound biosynthetic process (GO:0044272),0.25783559129415035,0.9240411401133781,0.6008771929824561,0.861665223603205,1.0,12/104,9.21%,UST;CHST15;GGTA1;ANGPT1;DCN;OMD;DSE;CHSY1;B4GALT1;GLCE;GSTK1;PRELP
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3684117061657326,-0.9239131948620813,0.5608108108108109,0.8901981009314223,1.0,4/12,15.96%,PPP1R3B;INPP5K;AKT1;PPP1R3C
prerank,negative regulation of catalytic activity (GO:0043086),-0.3123739913883374,-0.9236539322297124,0.5798687089715536,0.8900392709682744,1.0,12/24,31.64%,NOTCH1;CAMK2A;HDAC6;CCAR2;NOS1;TMBIM1;APBA3;CLN3;TIMP1;PLN;MT3;TP53
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.361709346541762,0.9234953659355252,0.5490909090909091,0.8622995898945188,1.0,3/16,6.37%,ADCY7;APPL2;PPARA
prerank,cellular response to reactive oxygen species (GO:0034614),0.2851157407161613,0.9234857326750245,0.56957928802589,0.8617226173405645,1.0,7/59,6.19%,PDGFRA;OSER1;FER;ANXA1;IL6;TPM1;MPV17
prerank,cellular response to hypoxia (GO:0071456),0.25347938745617465,0.9233437819387115,0.6077032810271041,0.8614641197136705,1.0,16/126,10.29%,RORA;GATA6;HIF3A;TERT;EPAS1;ARNT;BMP7;STOX1;CPEB1;NPEPPS;CREBBP;OPRD1;PSMB10;PSMA3;PSME4;PSMA5
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3253483934090081,-0.9229078539150711,0.5578231292517006,0.8911482803490363,1.0,6/20,15.75%,THBS1;ITGA4;SFRP4;CD40;RGCC;PLCG1
prerank,generation of neurons (GO:0048699),0.24068910380977973,0.9229011344191913,0.6348167539267016,0.8618586967563165,1.0,17/190,5.23%,WNT4;DCDC2;WNT6;FGFR1;AUTS2;WNT10B;WNT3A;WNT2B;NRP1;SH3RF1;FZD2;SDCCAG8;WNT5B;EN2;BTG4;NIF3L1;OTP
prerank,regulation of transposition (GO:0010528),0.38761578483580295,0.9227515314440903,0.558766859344894,0.8615970401666369,1.0,1/13,3.26%,PIWIL4
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22478197035849995,-0.9224753217820318,0.613013698630137,0.8913853756837168,1.0,34/109,21.19%,PLCG2;PIK3R1;PAK1;CALM1;MAPK8;PRKCQ;PSMC3;MAPK10;MAPK3;PSMD14;PSMD3;LYN;LCP2;MALT1;FCER1G;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;VAV1;SYK;RAC1;PSMA8;LAT2;NR4A3;PLCG1;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,positive regulation of double-strand break repair (GO:2000781),0.30765525969069735,0.922436244549239,0.575,0.8617506553574843,1.0,17/39,24.79%,PARP9;PARP3;DTX3L;SPIDR;SLF2;ERCC6;FUS;SHLD2;MGMT;KMT5C;RIF1;KMT5B;SPIRE1;SMCHD1;ARID2;ZCWPW1;SHLD1
prerank,response to alcohol (GO:0097305),-0.3053989692374477,-0.9223621329469675,0.5822784810126582,0.8908297275112831,1.0,7/27,15.18%,SLIT2;GRIN3A;GRIN2A;GRIN2B;GRIN1;SOD1;CCL19
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.28687641151708715,-0.9218084535648989,0.5654205607476636,0.8913702980076983,1.0,7/32,15.49%,RPS19;RPL39;RPL30;DEFA6;PGLYRP1;RNASE7;HMGN2
prerank,carbohydrate transport (GO:0008643),-0.3873826037935939,-0.9212755295858338,0.5787321063394683,0.8918517039457132,1.0,5/11,29.52%,AQP11;SLC50A1;SLC2A2;SLC23A1;SLC23A2
prerank,regulation of interleukin-1 production (GO:0032652),0.3753013012849503,0.9212531342854404,0.5711711711711712,0.863918977209698,1.0,2/15,4.67%,ANXA1;TLR4
prerank,dopamine metabolic process (GO:0042417),-0.3360923849867935,-0.9210727209839348,0.5720250521920668,0.8915101912617567,1.0,4/18,10.31%,TGFB2;SNCA;MAOA;GCH1
prerank,steroid metabolic process (GO:0008202),0.2697110056957341,0.9207941157964241,0.5746606334841629,0.8643592789364959,1.0,7/72,8.39%,CYP7B1;HSD17B1;CYP27A1;RDH5;NPC1;AMACR;SCP2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4047432297281748,0.9204738599506707,0.5770020533880903,0.86445256896381,1.0,4/11,10.70%,IGF2BP1;RASA1;NOVA1;IGF2BP2
prerank,cellular response to glucose starvation (GO:0042149),0.3003352621127959,0.9204130571417959,0.5853658536585366,0.8639776795176257,1.0,8/41,15.08%,PRKAG2;PRKAA2;MTMR3;RRP8;SESN1;FOXO3;NUAK2;EIF2AK3
prerank,regulation of immunoglobulin production (GO:0002637),0.34212930949969644,0.9199387655217421,0.5765765765765766,0.8644756948603849,1.0,3/23,8.25%,RBP4;IL6;PHB2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.32165113200793405,-0.9198164263513047,0.5739910313901345,0.8938787410058028,1.0,4/21,8.46%,PPP1R16B;FKBP1A;MFHAS1;PPP1R11
prerank,dendritic cell chemotaxis (GO:0002407),-0.3521335080316087,-0.91956433618995,0.5627615062761506,0.8936954231116411,1.0,11/14,47.91%,HMGB1;CCL19;TRPM2;CCL5;CCR1;PIK3CG;CCR5;CCR6;CXCR2;TRPM4;CCR2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.39586855839498547,0.9193467253419288,0.5551401869158878,0.8652027826908423,1.0,3/12,11.00%,PLK5;WAC;RFWD3
prerank,dendrite morphogenesis (GO:0048813),0.3115774591441193,0.9192487533732168,0.5740740740740741,0.8648401002478969,1.0,6/35,8.03%,PTN;DCDC2;SDC2;MAP6;LRP4;MEF2A
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.30434785822640714,0.9189266637918809,0.5495798319327732,0.8649769863918458,1.0,7/37,10.73%,NUPR1;GSDME;BCL2;FBH1;BAX;DNM1L;BCL2L1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.24297589547348242,-0.9188144256542493,0.6561604584527221,0.8948380690629153,1.0,15/73,17.94%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;CD86;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL;ADAM8
prerank,RNA modification (GO:0009451),-0.25700861360180505,-0.9185271231662541,0.5989159891598916,0.8947159298310104,1.0,16/54,23.06%,ADARB1;PUS7;FTSJ3;THUMPD1;QTRT2;PUS3;ELP5;DTWD2;WDR4;TYW5;RBM15B;CDKAL1;TRMT6;TRMT9B;TFB1M;TRUB1
prerank,protein localization to nucleus (GO:0034504),0.25670123385323557,0.9182136410921867,0.6083815028901735,0.8660294703549621,1.0,21/102,18.28%,PRICKLE1;TNPO1;GBP2;WRN;BMP7;MORC3;APPL2;TPR;PHB2;APPL1;TOR1AIP1;IPO7;EIF4ENIF1;PAF1;POM121;PML;RAN;YWHAE;ABCA7;RANBP17;INTS13
prerank,regulation of superoxide anion generation (GO:0032928),0.37356095443876297,0.9179831940008922,0.5767716535433071,0.8659260132487261,1.0,2/14,6.64%,FPR2;CRP
prerank,regulation of chromatin organization (GO:1902275),0.3803061937741794,0.9179443161556433,0.5549019607843138,0.8654123225445014,1.0,4/14,15.33%,MLLT3;IGF2;TLK2;SETD5
prerank,regulation of primary metabolic process (GO:0080090),0.2536612939212513,0.9178536223255505,0.6070460704607046,0.8650331001403765,1.0,13/126,10.29%,CHD9;ROCK2;C1QTNF2;TBL1XR1;NFYC;NCOA6;PPARA;CREBBP;LACTB;PSMB10;PSMA3;PSME4;PSMA5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.342727684779817,0.9176989379275112,0.5798611111111112,0.8647962081655959,1.0,4/23,8.04%,PRKAG2;BMP7;STOX1;RIPK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3450273968624915,-0.9175086319346665,0.5764462809917356,0.8964153846056016,1.0,4/16,9.99%,TPT1;RPS3;CXCL12;CCAR2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3182264242823342,-0.9174857935594561,0.5506607929515418,0.8956353803065183,1.0,6/20,13.86%,HSP90AB1;AKT1;CCND1;EGFR;TTBK1;RGCC
prerank,clathrin-dependent endocytosis (GO:0072583),-0.29683770157521255,-0.9170706949299497,0.5603644646924829,0.8958908598845995,1.0,10/26,27.44%,SGIP1;FNBP1L;SNAP91;AP2B1;DLL1;ITSN2;AP2A2;AP2A1;CLTA;AP2M1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.36709868846669397,-0.9169753065835138,0.5765407554671969,0.8953030758490006,1.0,3/13,3.09%,RYR2;NOTCH1;CPE
prerank,positive regulation of response to stimulus (GO:0048584),-0.27737488134451815,-0.9169313234231303,0.6164021164021164,0.8945790941105186,1.0,8/40,10.92%,TGFB2;HOMER1;YPEL3;SELENON;B2M;ABI3;CD80;EEF1E1
prerank,mitotic DNA replication (GO:1902969),-0.3943983637694228,-0.9169066297146281,0.5849056603773585,0.8938046638220821,1.0,3/10,16.39%,GINS3;POLA1;CDC45
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.272329914669648,-0.9161890116299863,0.6108490566037735,0.8948045417990715,1.0,8/39,12.62%,EFR3B;ITPKB;PIK3R1;PIK3C2B;PIK3R3;IP6K2;PI4K2A;PIK3CD
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3819402939788813,-0.9161638658548162,0.5792811839323467,0.8940418730255631,1.0,6/11,37.90%,SORL1;MTMR2;MSN;PTPN23;EIPR1;EZR
prerank,negative regulation of nuclear division (GO:0051784),0.40006769447305174,0.9160085474596518,0.5386064030131826,0.8680195808637319,1.0,5/11,22.28%,BMP7;NANOS2;TOM1L2;TOM1L1;NME6
prerank,mitochondrial translational elongation (GO:0070125),-0.22729078685108614,-0.9146696976490443,0.6614906832298136,0.8970311635002314,1.0,38/88,35.83%,MRPL4;GFM1;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;TUFM;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MRPL45;MRPL30
prerank,regulation of actin filament-based movement (GO:1903115),0.4057160435399148,0.9141600142296421,0.5464895635673624,0.8716260479495849,1.0,1/10,0.30%,PDPN
prerank,purine-containing compound catabolic process (GO:0072523),0.39067173673182076,0.9140857796146246,0.572744014732965,0.8711887315289415,1.0,5/13,20.56%,DPYD;NT5C;ITPA;NT5C1A;XDH
prerank,positive regulation of histone modification (GO:0031058),-0.28383907035778055,-0.9138293625238639,0.6009852216748769,0.8983692961840029,1.0,8/33,17.04%,RPS6KA5;TADA2A;MAPK3;SART3;NOS1;CTBP1;APLNR;BRCA1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2402761508408859,0.9131127531884671,0.6369593709043251,0.8727859197751526,1.0,41/166,20.78%,SMAD3;ZEB2;PLD1;SAMD4A;VIM;SLC6A9;SORBS1;IL6;TLR4;GLI1;ARNT;NR1H3;EPM2AIP1;PDGFRB;PTPN2;IGF2;APPL1;SLC25A37;ZCCHC4;SMOC2;ZNF205;STAR;SOX4;PRKD2;PKD2;CPEB3;OPN3;LPGAT1;P2RX4;UPF3A;FXR2;PLXNB2;DNA2;ERBB2;SLC27A1;CTC1;CD36;PTGS2;SREBF1;ELAVL1;ASS1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.34381323503378397,0.91307128478047,0.5642857142857143,0.8722807916524286,1.0,3/21,7.53%,EPHA7;BIRC3;NGFR
prerank,mesonephric tubule development (GO:0072164),0.3741327480675555,0.912976991156593,0.5695732838589982,0.8719013618031918,1.0,4/15,5.23%,OSR1;FOXC1;BMP7;SALL1
prerank,quinone biosynthetic process (GO:1901663),-0.35351730541474113,-0.9128619097732243,0.5906040268456376,0.9000076056177265,1.0,6/14,23.50%,COQ9;FDXR;COQ10B;COQ8A;COQ3;COQ5
prerank,negative regulation of cyclase activity (GO:0031280),-0.35405167416544536,-0.9127498431601585,0.5739514348785872,0.8994690111131003,1.0,2/14,3.31%,GRM3;GABBR2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.30674039399325115,-0.9124003665796967,0.5920177383592018,0.8995070176758638,1.0,3/24,8.69%,ABCG2;SUCLA2;ALAS1
prerank,nucleotide-excision repair (GO:0006289),0.258750749057135,0.91234903068983,0.6230440967283073,0.8727020519364217,1.0,28/101,20.64%,POLR2D;SLX4;CUL4A;RFC1;RNF111;CCNH;MNAT1;CDK7;RPA3;XRCC1;TCEA1;POLR2C;OGG1;PRPF19;POLR2F;GTF2H4;ERCC5;ERCC6;ERCC1;USP45;GTF2H2;FANCC;UVSSA;XPC;USP7;ERCC8;POLR2K;POLD3
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3488454690257774,-0.9122686766095585,0.58004158004158,0.8989984445845874,1.0,5/16,18.02%,HMGB1;KPNB1;H1-0;FOXL2;DICER1
prerank,negative regulation of locomotion (GO:0040013),0.3945359555005459,0.912058589343841,0.5804066543438078,0.872774935306993,1.0,4/12,6.81%,TACSTD2;FBLN1;PTPN2;SPINT2
prerank,chromatin remodeling (GO:0006338),0.2559578390200413,0.9115375916892893,0.624103299856528,0.8733648923837499,1.0,28/100,19.06%,MYB;MBD2;TOP1;BAZ2A;FOXP3;HDAC4;HNRNPC;BAZ1B;GATAD2B;JARID2;CECR2;BAZ1A;MYSM1;ACTL6A;KDM5B;SRCAP;BPTF;ERCC6;HDAC2;SMARCA4;KAT2B;SMARCC1;CHD8;INO80C;CHD4;HCFC2;ARID1B;ACTR8
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3013688236933697,-0.911402456825843,0.5982532751091703,0.9003076558474431,1.0,7/25,13.77%,HIP1;BCAR3;HIP1R;CCDC88A;AKT1;CBL;PLAUR
prerank,translational termination (GO:0006415),-0.22510005722390386,-0.9110526075512451,0.6634615384615384,0.9003808968805161,1.0,38/95,34.01%,MRPL4;MRPS18A;MRPL1;MRPS30;GSPT2;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;GSPT1;MRPS31;MRPL49;MRPS12;MRPL11;N6AMT1;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1
prerank,mammary gland development (GO:0030879),0.33798012163149566,0.9110160289870716,0.5651408450704225,0.8738927194593864,1.0,1/21,0.44%,WNT4
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3341449879037338,-0.9107575238430837,0.6121593291404612,0.9002622090747188,1.0,6/18,11.24%,KDR;GATA2;HDAC7;HDAC9;VEGFA;FGF2
prerank,regulation of cellular response to stress (GO:0080135),-0.22000092951444847,-0.9105298602247784,0.7312925170068028,0.9000156788290425,1.0,42/115,26.67%,HSPA8;OPRM1;MAPK3;CHCHD2;HSP90AB1;CAMK2D;BAG1;CAMK2A;PINK1;NPM1;HSBP1;CCAR2;ATM;AAAS;MANF;NUP93;ATF4;NPAS2;AKT1S1;HSP90AA1;CASP9;RAE1;MAPT;ARMT1;ADCY8;FKBP4;VASH1;MLST8;BAG4;NUP62;ATR;NUP188;CLN3;SLC38A2;AIFM2;NUP54;CAMK2G;NUP210;MBTPS2;NUP42;NUP153;EIF4G1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.32286653585040753,0.9104977023560972,0.5949367088607594,0.8744716682364491,1.0,6/26,11.66%,LARGE1;RRM1;GBGT1;GK5;ALG11;RRM2B
prerank,protein-DNA complex assembly (GO:0065004),0.255726974189786,0.910226750758968,0.652046783625731,0.8744731534120648,1.0,19/116,15.43%,TCF4;ORC5;CUL4A;PSMB10;CCNH;KAT6B;PSMA3;MNAT1;PSME4;CDK7;RPA3;MCM4;PSMA5;GMNN;MCM6;GTF2H4;ERCC5;ORC3;ORC4
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.368759216405589,-0.9096630700382968,0.5835095137420718,0.9013655752143607,1.0,8/12,48.13%,CLSPN;HUS1B;TOPBP1;CDC6;TICRR;RAD17;SETMAR;HUS1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.33543543351446375,-0.9096620960271051,0.5851528384279476,0.9005399547768745,1.0,3/18,9.81%,IL33;THBS1;KARS1
prerank,histone H3-K36 demethylation (GO:0070544),0.4123969175851951,0.909297810968497,0.5899419729206963,0.8759640648695501,1.0,4/10,15.61%,KDM7A;KDM2A;KDM8;KDM2B
prerank,establishment of spindle localization (GO:0051293),0.38307924057399123,0.9092717533691943,0.553030303030303,0.8754188863681962,1.0,6/14,18.02%,CLASP1;ESPL1;LLGL2;MAP4;TLE6;NLRP5
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3804701420942773,0.9092700018966747,0.5682730923694779,0.8748214073210638,1.0,2/13,6.64%,FPR2;CRP
prerank,cellular response to insulin stimulus (GO:0032869),0.24858335710339582,0.90911216937517,0.6396648044692738,0.8745783883336617,1.0,30/124,17.32%,PDPK1;ENPP1;PHIP;FOXC2;FER;TRARG1;RAB10;SORBS1;PTPN2;PIK3C2A;CPEB1;GSK3B;INSIG2;RHOQ;IGF2;ZNF106;APPL1;OTOP1;RARRES2;TCIRG1;ATP6V0B;DENND4C;BAIAP2;KAT2B;ATP6V1E1;IGF1R;ATP6V1C1;MYO5A;LPIN2;PCK2
prerank,regulation of cilium assembly (GO:1902017),0.27866034829857,0.9090516543390106,0.6220472440944882,0.8741083742959268,1.0,11/62,14.43%,DCDC2;TBC1D16;SDCCAG8;IFT88;YAP1;TAPT1;DYNC2LI1;ENTR1;IFT20;TBC1D7;CROCC
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3189536774924746,-0.9088797474388454,0.5807174887892377,0.9016872873472109,1.0,2/19,0.90%,DLG2;LRRC7
prerank,chromatin assembly (GO:0031497),-0.27266583946662476,-0.9088304634439625,0.631578947368421,0.9009895326109348,1.0,11/38,23.29%,H3-3A;LIN54;NPM1;SART3;ASF1A;H1-0;ANP32B;SPTY2D1;NOC2L;NAP1L2;POLE3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.37163734275181504,-0.9074367180189926,0.5759493670886076,0.9036149381365632,1.0,6/11,33.67%,MFHAS1;LYN;TREM2;TLR6;TLR1;TIRAP
prerank,aminoglycan biosynthetic process (GO:0006023),-0.2589679894131772,-0.9074351095879097,0.6185567010309279,0.902790282093608,1.0,7/49,4.93%,GPC5;HS3ST1;HS6ST2;HS3ST5;XYLT1;SDC3;EXT1
prerank,regulation of developmental growth (GO:0048638),-0.2830336075583785,-0.9074316394283191,0.6157760814249363,0.9019699626026336,1.0,9/29,16.05%,PLCB1;INSR;SIX1;NRCAM;MBD5;MFSD2A;SIX4;SOD1;SPAAR
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.37171880890894166,-0.9073129351722361,0.5835051546391753,0.9014411751042187,1.0,4/12,15.10%,UCK2;UPP2;UCKL1;UCK1
prerank,ovarian follicle development (GO:0001541),-0.3548047844904212,-0.9072457371405606,0.5867237687366167,0.9007788185388926,1.0,6/13,22.52%,EIF2B2;VEGFA;INHBB;SOD1;FOXL2;LHCGR
prerank,establishment of spindle orientation (GO:0051294),0.3226884490548537,0.9071932473440054,0.5735785953177257,0.8777033140627927,1.0,6/28,13.66%,GJA1;CLASP1;MISP;FBXW11;LLGL2;MAP4
prerank,negative regulation of T cell differentiation (GO:0045581),0.40929627985118383,0.9065544621663811,0.569672131147541,0.8784807327999209,1.0,2/10,11.55%,GLI3;IHH
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3610695696310773,0.9064925522033729,0.5844402277039848,0.8780297595068944,1.0,2/18,3.51%,PTN;IL34
prerank,regulation of transferase activity (GO:0051338),0.3543234089902235,0.9063874358468798,0.6,0.877686402903457,1.0,6/17,20.14%,LDB2;JMJD8;SMG6;HMBOX1;PARP4;NABP2
prerank,nucleus organization (GO:0006997),-0.2582544347009462,-0.9062046662761548,0.6157760814249363,0.9025624676532772,1.0,17/47,30.84%,SYNE1;RPS19;NUP93;CTDNEP1;CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A;CEP55;NUP54;CHMP6;CHMP4C;REEP4;NDC1;PITPNB;TOR1A
prerank,sterol transport (GO:0015918),0.36130832891190867,0.9056608288095691,0.588034188034188,0.8787302261580671,1.0,3/19,12.77%,APOA2;NPC1;OSBPL5
prerank,protein processing (GO:0016485),-0.21887179149854075,-0.9054795564813471,0.6745562130177515,0.9034573047385074,1.0,23/102,22.59%,F3;CPE;PCSK2;MMP16;LGMN;ECE1;FAM111A;CTSS;CPD;SPCS2;SEC11C;CTSL;SPCS1;PCSK7;PHEX;PSENEN;ADAMTS3;CPXM1;CASP1;GGT1;PCSK5;CPZ;CLN3
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2533337962082432,-0.9054677832443743,0.6349206349206349,0.9026673220301925,1.0,17/48,28.40%,FMN2;SNX3;HSP90AB1;PFDN5;CD84;EGFR;PFDN2;INHBB;EIF2AK1;PFDN4;EDNRB;VBP1;TREM2;ADGRB1;EDN1;AZIN1;CLU
prerank,regulation of type I interferon production (GO:0032479),0.25956015411484556,0.9053942058108149,0.6341829085457271,0.8787174400675932,1.0,32/84,27.24%,TRIM56;IKBKE;DTX4;PTPN22;ZBP1;RNF216;CREBBP;POLR1C;NLRX1;POLR3F;TRIM21;POLR2F;IFIH1;TBK1;POLR3H;RNF135;PCBP2;DHX36;POLR2K;NLRP4;OTUD5;GAPDH;TAX1BP1;DHX9;TRIM32;POLR3B;POLR2H;UBE2L6;STAT6;ISG15;CRCP;CGAS
prerank,histone H4 acetylation (GO:0043967),0.28981510824024553,0.9053229395729654,0.6196513470681458,0.8782835529795099,1.0,10/47,17.72%,KMT2A;APBB1;EPC1;JADE2;ACTL6A;BRD8;ZZZ3;TRIM16;KANSL1;ATF2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3597738285959689,-0.9052963007117601,0.5650224215246636,0.902265914571488,1.0,2/13,3.31%,GRM3;GABBR2
prerank,sulfate transport (GO:0008272),-0.3536096287345667,-0.905058056227929,0.6078028747433265,0.9020263195952675,1.0,2/14,1.62%,SLC26A7;SLC26A2
prerank,protein import into peroxisome membrane (GO:0045046),-0.30224414754398526,-0.9049962832299447,0.604494382022472,0.901348327607633,1.0,10/22,27.46%,ATAD1;PEX26;GDAP1;ABCD2;PEX16;PEX19;PXMP4;RAB8B;PEX3;PEX11B
prerank,regulation of amyloid fibril formation (GO:1905906),-0.34822042099153816,-0.9046919609106234,0.6203090507726269,0.9012904218032245,1.0,8/15,31.46%,PFDN5;PFDN2;PFDN4;CHRNA7;VBP1;TREM2;CLU;LDLR
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.37438886789923276,-0.9045277013895434,0.6163522012578616,0.9008599630469641,1.0,3/11,14.89%,C1QTNF3;SIK1;PGP
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4078917307027087,0.904475915342518,0.5807050092764379,0.8795802678809493,1.0,2/10,11.54%,EMC2;EMC9
prerank,regulation of lipid catabolic process (GO:0050994),0.36228656343645016,0.9042752764843314,0.5872420262664165,0.8794009769980176,1.0,5/19,15.39%,APOA2;HCAR2;RARRES2;ALK;ADRA2A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.33472682444379354,0.9041434705922364,0.6261343012704175,0.8790887262743183,1.0,6/25,12.25%,CD55;KIT;LACC1;TNFRSF14;WNT5A;MAP3K7
prerank,negative regulation of protein depolymerization (GO:1901880),0.3312581932017038,0.903846979167682,0.5776614310645725,0.8791416308922279,1.0,5/24,11.20%,PLEKHH2;CLASP1;HDGFL3;LIMA1;ATXN7
prerank,regulation of histone acetylation (GO:0035065),0.3126973972263717,0.9035745955708951,0.6024955436720143,0.8791771706116622,1.0,8/33,16.82%,KMT2A;FOXP3;GLYR1;TAF7;IWS1;ARRB1;SETD5;RAPGEF3
prerank,protein deacetylation (GO:0006476),0.29939986195910956,0.90350659079042,0.6113902847571189,0.8787374284825821,1.0,12/41,18.56%,TBL1XR1;MIER3;BAZ2A;MIER1;HDAC4;SIRT4;PRDM5;RBM14;HDAC2;TBL1X;MIDEAS;SIRT3
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3828041758510728,0.9034161018503628,0.5654648956356736,0.8783573982108358,1.0,5/13,19.93%,LARGE1;MGAT3;EXTL2;NAGK;CHST3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2321703719863266,-0.9029773179493337,0.6906906906906907,0.9038931437329126,1.0,17/83,16.39%,USP29;CDK17;CDK14;CDK6;MAX;CAMK2A;CCND1;CDK15;POLA1;BCAT1;ACVR1;HINFP;USP37;CDK2;CDKN1A;CDK4;CDC45
prerank,N-terminal protein amino acid modification (GO:0031365),0.37268292630050115,0.9022995326973651,0.5729537366548043,0.8802326779154984,1.0,6/14,21.67%,NAA16;NAA15;PDF;NAA35;NAA40;METAP2
prerank,carbohydrate catabolic process (GO:0016052),-0.2712773550015451,-0.9022131410111858,0.6244131455399061,0.904963959131836,1.0,9/38,15.68%,PGK1;PKM;ALDOC;NEU1;GPI;TPI1;PGAM1;PGAM4;ENO1
prerank,T cell activation involved in immune response (GO:0002286),-0.3512700630549473,-0.9018049281275782,0.5959183673469388,0.9051349238045777,1.0,3/12,17.58%,CD74;FCER1G;LCP1
prerank,cellular iron ion homeostasis (GO:0006879),0.2800995993311618,0.9017652267980336,0.6260162601626016,0.8807827737962264,1.0,2/55,0.40%,CP;BMP6
prerank,homologous chromosome segregation (GO:0045143),-0.3105526313990522,-0.9015890421631457,0.5910112359550562,0.9048244568092672,1.0,4/20,18.56%,FMN2;PTTG1;MEI4;SIRT7
prerank,regulation of acrosome reaction (GO:0060046),-0.38295918323010475,-0.9010406781937542,0.6012396694214877,0.9053820210723621,1.0,1/10,0.97%,PLCB1
prerank,positive regulation of isotype switching (GO:0045830),-0.34702694930609235,-0.9006101578686346,0.6053811659192825,0.9056255315014131,1.0,4/15,15.24%,TFRC;CD40;HMCES;CLCF1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.27909000361129477,-0.9003935367941209,0.635,0.905355369481096,1.0,11/35,13.61%,TEK;ESAM;PTK2B;SEMA3E;ARHGDIB;ABI3;FES;ARHGDIA;CSF1R;F11R;HRAS
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3901742981038222,0.9003356596324211,0.5970149253731343,0.8834486396859728,1.0,3/12,8.99%,SORBS1;EPM2AIP1;IGF2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.39914774239113227,0.9002917789440117,0.5795246800731262,0.8829392657348392,1.0,4/11,19.29%,WNT3A;WNT5A;RYK;WNT2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3571745840206524,-0.8999901850571241,0.5648535564853556,0.9055548845751398,1.0,3/12,19.78%,KLF2;CALR;ASXL1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.3148953581627218,-0.8999813708498134,0.6081081081081081,0.9047720349588544,1.0,6/21,17.33%,NAV3;ARHGEF2;STMN2;FGF13;CLASP2;MID1IP1
prerank,fatty acid catabolic process (GO:0009062),0.27017747489954597,0.8999238456752808,0.629742033383915,0.883148812106442,1.0,22/67,23.00%,PCCA;AIG1;PCCB;SCP2;SLC27A2;HACL1;ACAT1;ABCD3;PEX2;PECR;HAO1;PHYH;ACADS;LPIN2;ABHD3;ACOX1;HADHA;ACBD5;NUDT19;HADH;MMUT;LPIN1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2824956520358508,-0.899828826911123,0.6311881188118812,0.9043228782689029,1.0,8/30,15.87%,ELOVL5;ELOVL7;ABCD4;TECR;TECRL;ABCD2;ACSBG1;HACD3
prerank,regulation of biosynthetic process (GO:0009889),-0.37441191549716024,-0.8996256642514404,0.6075949367088608,0.9040095425447269,1.0,10/11,53.07%,SNCA;MID1IP1;ALOX5;THRSP;GSTP1;CCN6;SLC25A33;PIKFYVE;UCP1;PCK1
prerank,estrogen metabolic process (GO:0008210),0.3668115146214633,0.8995154591184774,0.6026365348399246,0.8834606101770598,1.0,3/15,16.54%,HSD17B1;HSD17B14;SULT1A1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.23796732696690903,0.899448363587131,0.6685314685314685,0.8830216729556457,1.0,17/151,8.25%,CCN2;PDGFRA;NOTCH2;FPR2;MTURN;GLIPR2;NRP1;ANGPT1;BMP2;ROR1;PRKCZ;PTPN22;PDGFRB;CCL2;ACKR3;LGALS9;PHB2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3339057642979568,-0.8991428602885156,0.6105032822757112,0.9043619970326483,1.0,6/17,9.86%,CACNB2;KCNJ2;SLC8A1;HCN2;CACNA1G;CACNA1D
prerank,regulation of heart contraction (GO:0008016),0.25866191057689003,0.8990822497847097,0.6537313432835821,0.8832452729250396,1.0,9/90,7.73%,CELF2;ATP1A2;ITPR1;TMEM65;DES;TPM1;ATP2B4;CORIN;NPPC
prerank,positive regulation of chemotaxis (GO:0050921),-0.26425687278776233,-0.8990061043771062,0.6231155778894473,0.9038876452669312,1.0,11/43,15.27%,TMSB4X;THBS1;KDR;F3;STX3;MET;LGMN;VEGFA;FGF2;CCL19;PRKD1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.2857954273644693,0.8989395940991834,0.6146341463414634,0.8829542929284239,1.0,6/47,6.93%,PID1;FPR2;TLR4;PDGFRB;CRP;TGFBR2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.29948385920849757,-0.8987213288237869,0.6153846153846154,0.9037978086996616,1.0,7/25,15.08%,SLIT2;LIMK2;TBC1D30;ARHGAP44;ABI3;EVL;ARHGAP24
prerank,regulation of neuroblast proliferation (GO:1902692),0.36390379086547286,0.8986173584438251,0.5840867992766727,0.8830885729270068,1.0,1/15,0.48%,PTN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2208641244585072,-0.8984616922060493,0.7046979865771812,0.9028149113503482,1.0,27/104,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,cellular response to lectin (GO:1990858),-0.2208641244585072,-0.8984616922060493,0.7046979865771812,0.9028149113503482,1.0,27/104,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3112753966553102,-0.8984388124912746,0.6194895591647331,0.902065854415279,1.0,7/23,18.19%,RPS6KA5;TADA2A;MAPK3;SMARCB1;NOS1;BRCA1;KAT7
prerank,histone mRNA metabolic process (GO:0008334),0.32030375239757397,0.8982722259433789,0.6048951048951049,0.8832371762845296,1.0,9/27,18.21%,TUT4;LSM1;DCP2;XRN1;TENT2;SSB;EXOSC10;TUT7;SLBP
prerank,positive regulation of DNA replication (GO:0045740),-0.3340223158911162,-0.8979565424944089,0.5876068376068376,0.9024062095495354,1.0,5/16,18.19%,BCAR3;EGFR;ATAD5;EGF;KAT7
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.339220038399053,0.8978793529769005,0.6189624329159212,0.8835199836238,1.0,5/22,14.28%,BMP7;MYADM;MAP2K5;WNK1;FLOT2
prerank,regulation of mRNA processing (GO:0050684),-0.27803872878254393,-0.8974066000064896,0.6195899772209568,0.9029424450356254,1.0,5/32,11.59%,QKI;KHDRBS2;KHDRBS3;HNRNPK;PTCD2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2497448961126267,0.8972789168405141,0.6526772793053546,0.8842725081931891,1.0,15/116,10.90%,GHRH;ADORA2A;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;GPR39
prerank,negative regulation of secretion (GO:0051048),0.40534489697916054,0.8967521732778918,0.5643939393939394,0.8848068946192721,1.0,5/10,23.20%,NR1H3;TIFAB;ERBB3;PTGER3;NRG1
prerank,muscle cell development (GO:0055001),0.3183381142967833,0.8967147171254191,0.6052173913043478,0.884286565571905,1.0,4/30,4.79%,CXADR;MYOF;EFEMP2;NEBL
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.23253343625132294,0.896581456118853,0.6853055916775033,0.8840139951835427,1.0,44/173,21.58%,SPTBN1;COPZ2;DYNLL1;CD55;ARFGAP3;TGFA;KDELR3;MIA3;SEC23A;ARF4;SEC24D;CAPZB;VAPA;DCTN5;PROS1;ERGIC1;COPE;GOSR1;ARCN1;CUL3;SEC24C;SCFD1;COG2;LMAN1L;TMED9;ACTR1A;COPZ1;SEC24B;GBF1;SPTBN2;GOLGA2;SAR1A;SEC31A;CAPZA1;ANK2;SEC16A;F5;COG4;COG1;DCTN4;VAMP7;IER3IP1;BCAP31;TRIP11
prerank,negative regulation of cell aging (GO:0090344),-0.3340159027125703,-0.8964989456637569,0.5877192982456141,0.9043216839880467,1.0,3/16,7.60%,CDK6;YBX1;RBL1
prerank,regulation of fibroblast migration (GO:0010762),-0.31871233059453297,-0.8963644295289068,0.6072234762979684,0.9038351632468292,1.0,10/20,22.74%,THBS1;PRR5L;RFFL;FGF2;ARHGEF7;RAC1;GNA12;PRKCE;CLN3;HAS1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.25595600742568014,0.8961008366797221,0.6340740740740741,0.8844883822064027,1.0,25/95,20.82%,NINL;DYNLL1;ALMS1;SDCCAG8;CENPJ;CLASP1;CEP152;NPHP1;HAUS8;C2CD3;CC2D2A;NEDD1;RPGRIP1L;RAB3IP;IQCB1;FBF1;ACTR1A;CEP250;TTBK2;YWHAE;CEP131;CEP63;CEP78;B9D2;OFD1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.31569547912398155,0.8956974646118947,0.6027874564459931,0.8848525487564907,1.0,6/31,11.12%,IL16;TLR4;LGALS9;RIPK2;MAPK14;TLR2
prerank,regulation of cell size (GO:0008361),0.33526833282671686,0.895452338206392,0.5978456014362658,0.8847801516418927,1.0,1/23,0.53%,DEPTOR
prerank,telomere organization (GO:0032200),0.29508632419014397,0.8951463135759371,0.6239737274220033,0.8848782329991219,1.0,5/43,5.63%,SP100;TERT;WRN;RAD50;PARP3
prerank,membrane lipid metabolic process (GO:0006643),0.34248480149030824,0.8949699215742675,0.6076642335766423,0.8846808345248098,1.0,1/22,0.19%,AGMO
prerank,cholesterol transport (GO:0030301),0.2918168565981629,0.8945642965329867,0.6173228346456693,0.8849666744492445,1.0,9/45,17.50%,APOA2;NPC1;LIMA1;SOAT1;OSBPL5;STAR;ABCA1;SERAC1;ABCA7
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3265868668183112,0.8945638948505502,0.5904255319148937,0.884375773184866,1.0,3/22,10.74%,NR2F2;LATS2;IPO7
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3602293283052866,-0.8943947441940352,0.6099585062240664,0.9077220481188017,1.0,8/12,33.81%,EPHB1;HSP90AB1;HSP90AA1;B4GALT6;EPHB6;SPTBN4;B4GALT5;EPHB2
prerank,mitotic cell cycle phase transition (GO:0044772),0.2299892787642619,0.8941369112807622,0.6950444726810674,0.8847679656815057,1.0,38/204,15.27%,PHLDA1;NINL;DYNLL1;FBXL17;ALMS1;SDCCAG8;CENPJ;CLASP1;LATS2;CCND3;OPTN;CUL4A;CEP152;HAUS8;FBXL3;CDKN2B;CRLF3;ANAPC1;CCNH;UBE2C;MNAT1;CDK7;PPP1R12B;FBXL7;PPP1CB;NEDD1;NES;CCDC57;CUL3;BTRC;MASTL;FBXW11;CDC27;KDM8;ACTR1A;CEP250;CHMP4B;FBXL12
prerank,cellular response to radiation (GO:0071478),-0.26520638678958103,-0.8938838182927388,0.6240963855421687,0.9081674866982488,1.0,17/40,31.96%,NET1;INTS7;RHOB;KDM4D;CDKN1A;RAD51;RAD1;GPR88;ECT2;RHNO1;RAD51AP1;BLM;EEF1D;RRH;TP53;OPN1MW3;OPN1MW
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3585362950654315,-0.8938439237732491,0.6016597510373444,0.907450326049077,1.0,10/13,48.65%,CYRIB;MR1;STX7;FADD;NECTIN2;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,regulation of defense response to virus (GO:0050688),0.37026124227413926,0.8938388410668893,0.5932203389830508,0.8848337246189423,1.0,3/14,10.65%,RNF216;PPM1B;IFNLR1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.20891154504588447,-0.8936718930919556,0.7481751824817519,0.9070403857325657,1.0,49/146,24.51%,PPP2R1A;CSNK1D;PSMC3;KCNH5;RCC2;PSMD14;DYNC1H1;PSMD3;CCND1;PCNT;PSMD4;TUBA1A;PSMD6;TUBB4A;PSMA6;PSMA4;PRKAR2B;PSMB8;HSP90AA1;CEP43;DYNC1I2;NDE1;TUBB4B;PSMA8;CEP135;PLK4;CDK2;CDK4;CEP290;PSME1;SSNA1;TUBG1;PSMD7;PSMC6;CDK5RAP2;PSMB5;CEP41;PSMC5;PSMB1;DCTN1;CENPF;SKP1;DTL;HMMR;CEP70;PSMD11;KIF14;MAPRE1;PSMD8
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.33993547068331753,0.8935980267113794,0.5934819897084048,0.8847649415928273,1.0,4/21,12.35%,WNT3A;FZD2;GSK3B;DVL3
prerank,chromosome condensation (GO:0030261),-0.2790708848572268,-0.8925091472033689,0.6509433962264151,0.9089889966444266,1.0,18/36,37.96%,MCPH1;SMC2;H1-0;CHMP1A;SET;NCAPH2;NCAPH;TENT4A;TTN;BANF1;CSNK2B;NCAPD2;PLK1;CDK1;NCAPD3;INCENP;CCNB1;BANF2
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.23374652054061343,-0.8924311334205006,0.6818181818181818,0.9083678259645336,1.0,24/76,21.62%,TEK;PTK2B;NCKAP1;LMOD1;CDC42EP3;DYNC1H1;VASP;CDC42EP1;CDC42EP5;PFDN2;FES;HRAS;EVL;PLK4;NTF3;P2RX7;PYCARD;ARF6;PFN2;SPAG5;CARMIL1;HCLS1;PRKCE;NUP62
prerank,regulation of sodium ion transport (GO:0002028),0.30526797926302024,0.8923864389395701,0.6159052453468697,0.8868904370825387,1.0,10/34,14.08%,NKAIN4;NEDD4;SNTA1;ATP2B4;WNK4;SCN3B;DLG1;GPD1L;SLMAP;WNK1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3413971814197072,0.8918678750972695,0.5846153846153846,0.8874369979032815,1.0,2/20,3.95%,RBPJ;BMP2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.21948277775696165,-0.8918406393269597,0.7027027027027027,0.9090256866913117,1.0,27/105,21.19%,PLCG2;RPS6KA5;PAK1;PSMC3;PSMD14;PSMD3;LYN;MALT1;FCER1G;PSMD4;PSMD6;ICAM2;PSMA6;PSMA4;PAK3;PSMB8;SYK;HRAS;KRAS;PSMA8;PSME1;PSMD7;PSMC6;IKBKB;PSMB5;PSMC5;PSMB1
prerank,negative regulation of JNK cascade (GO:0046329),0.3103516358502505,0.8916933985103794,0.6041666666666666,0.8872291764454815,1.0,6/31,10.34%,DUSP10;DACT1;TAOK3;PTPN22;ZMYND11;HIPK3
prerank,vesicle transport along microtubule (GO:0047496),-0.3066417463545267,-0.8916759475365497,0.6129807692307693,0.9086476551129915,1.0,9/23,23.43%,KIF1C;DYNC1H1;KIF3B;NDE1;BICDL1;KIF5A;CLN3;HAP1;HTT
prerank,cardiac cell development (GO:0055006),-0.37334553682842364,-0.8914719609983238,0.6318897637795275,0.9083257550681987,1.0,4/11,8.85%,NOTCH1;MYH11;SLC8A1;VEGFA
prerank,endomembrane system organization (GO:0010256),0.2329993024335257,0.8910698096006109,0.7184466019417476,0.8879948068420508,1.0,43/178,19.30%,ARHGAP21;MYOF;SPTBN1;A4GALT;RAB22A;MIA3;WASHC4;CLASP1;RAB43;OPTN;VAPA;GOLGA5;GOLGA8B;FAM174B;USP8;LRRK2;DNM1;DNM1L;UBXN2A;HUWE1;TMCC1;GORASP2;TJAP1;SRGN;COG2;LMAN1L;TMED9;EIF2AK3;GBF1;ATL1;GOLGA2;ANXA8;ANXA8L1;SEC31A;HOOK1;DMPK;DNAJC28;LYSMD3;PLEKHF1;USP6NL;SEC16A;ARFGEF2;PLEKHM2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2767350320785273,0.8907618096889263,0.6210191082802548,0.8880588084577811,1.0,10/59,14.54%,ROCK2;TLR4;BIRC3;LY96;RIPK2;TLR2;MAP3K7;TIFA;TICAM1;TBK1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3595007411771931,-0.8905282380334968,0.6070038910505836,0.9097659029263887,1.0,4/12,15.27%,VEGFA;CTBP1;APLNR;PRKD1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.31644228610204533,0.8903070743923173,0.6330434782608696,0.888490024928962,1.0,5/29,11.40%,CXCL10;FPR2;SERPINE1;LGALS9;ANO6
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3833938578207678,-0.8902533101592605,0.6290630975143403,0.9096242066887811,1.0,4/10,7.57%,KDR;CD34;RAPGEF2;CEACAM1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.2891782790369093,0.8896429752662529,0.6246006389776357,0.8893039661685521,1.0,6/42,9.92%,POLH;WRN;PARP10;RFC1;REV1;RPA3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3988765668543471,0.8894467643393035,0.6053130929791272,0.8891326012247281,1.0,3/10,15.08%,CCL2;QRICH1;EIF2AK3
prerank,neuron projection fasciculation (GO:0106030),-0.3739210840620488,-0.8884290507351517,0.5991735537190083,0.9132117203949665,1.0,4/10,19.95%,CNTN4;NRCAM;EPHB3;AMIGO1
prerank,AMP metabolic process (GO:0046033),0.37916372847236435,0.8883177245569703,0.5973025048169557,0.8910317685680942,1.0,1/13,1.05%,AMPD3
prerank,organelle organization (GO:0006996),0.21548536003307361,0.8880836246655592,0.7491166077738516,0.8909567405151767,1.0,90/388,19.97%,MICAL3;CXADR;DIAPH1;ARHGAP21;ARHGAP10;SH3D19;SYNE3;PHIP;FGD4;TERT;BRWD1;DES;GABPB1;MIA3;TPM1;CLASP1;RAB43;PLCE1;HAX1;OPTN;PACSIN2;CAPZB;CCL2;VAPA;GOLGA5;GOLGA8B;PHB2;FMNL2;FAM174B;SIRT4;NIPSNAP2;LRRK2;CNN2;AFG1L;CECR2;ZFYVE16;SPRYD3;PPID;GEM;DNM1L;UBXN2A;HUWE1;RAB34;ATXN7;TMCC1;ZMYM6;ABCD3;OPA1;MTFR1;GORASP2;TJAP1;WASL;PEX2;NRF1;COG2;LMAN1L;CHMP3;RHOU;BRWD3;TMED9;EIF2AK3;FAF2;CHMP4A;CHMP4B;PDZD8;PKD2;GBF1;ZMYM3;ATL1;GOLGA2;SAR1A;WTIP;PYROXD2;SEC31A;RHOT1;DNAJC28;PLD2;SIRT3;ESRRA;LYSMD3;PLEKHF1;USP6NL;DMTN;SEC16A;RHOT2;PLEKHM2;AJUBA;CHMP5;COG4;LONP1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.26707469067796913,0.8880502629018487,0.6194968553459119,0.8904353841251414,1.0,8/66,8.62%,SMAD3;PARP9;ZIC1;TERT;TPR;DTX3L;NGFR;YAP1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.30197264757580206,-0.8876642255377023,0.6339285714285714,0.9142351422434426,1.0,10/22,30.64%,NOL11;DDX11;SMARCB1;PWP1;ATF4;HEATR1;RASL11A;LYAR;WDR75;PIH1D1
prerank,cellular senescence (GO:0090398),0.3228154340711626,0.8875390049891404,0.6219312602291326,0.8909578514465134,1.0,8/27,14.99%,CDKN2B;MAPK14;NSMCE2;MAP2K1;OPA1;KAT6A;MAPKAPK5;PML
prerank,negative regulation of protein secretion (GO:0050709),-0.26608316157238554,-0.8874626172521944,0.6228287841191067,0.9138925467662898,1.0,8/38,14.87%,RAB11FIP1;CCN3;OPRM1;RAB11FIP3;KCNB1;INHBB;RHBDF2;RAB11FIP5
prerank,positive regulation of phagocytosis (GO:0050766),0.2809770088661904,0.8874270321445229,0.629570747217806,0.8906131893430712,1.0,7/47,8.08%,CAMK1D;FPR2;APOA2;APPL2;CD47;CCL2;C2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2782854556729881,0.8873320879411006,0.631578947368421,0.8902327703854376,1.0,8/52,8.89%,PDPK1;SPTBN1;EPHA3;SORBS1;ATP2B4;PTPN9;KIF5B;DLG1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2200044719063338,-0.8872671558596079,0.7087378640776699,0.9135487439418749,1.0,30/98,23.39%,DPP10;PRKCH;PIK3R1;STX3;ANK3;MAPK8;CEMIP;YWHAH;AKT1;MTCL1;MFF;PPP1R13B;ITGA3;RHOG;KCNB1;EGFR;HRAS;STAC;STAC3;C2CD5;YWHAQ;ARF6;AKAP5;ITGB2;BAD;PRKCE;NKD2;CD81;YWHAZ;CNPY4
prerank,protein localization to condensed chromosome (GO:1903083),-0.35201394287000815,-0.8870510821470237,0.6091703056768559,0.9132380762721973,1.0,9/12,42.54%,ZWILCH;SPDL1;ZW10;CDK1;MIS12;BUB3;KNL1;AURKB;CHAMP1
prerank,regulation of cell differentiation (GO:0045595),0.23699667846898492,0.8870509238711803,0.6938775510204082,0.8902644985679803,1.0,14/148,6.74%,PHLDB2;CCN2;FGFR1;EIF2AK2;EPHA3;DAG1;PTHLH;SUZ12;CLASP1;TGFBR1;MBOAT2;PHLDB1;NREP;CREBBP
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.3011495913459203,-0.8868442587944074,0.6181818181818182,0.9129180215369326,1.0,8/23,15.98%,SIX1;BMP4;VEGFA;FGF2;PAX2;PIK3CD;SIX4;EGF
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.33782896485952074,-0.8868310618977441,0.6361607142857143,0.9121456812311151,1.0,6/16,22.59%,INSR;HDAC6;MTRF1;UPF1;GSPT1;CLN3
prerank,cranial nerve development (GO:0021545),0.38901775283730355,0.8866071396966669,0.597165991902834,0.89066816412125,1.0,2/11,7.71%,SALL1;TIFAB
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.27599564889316747,-0.8862240581683518,0.6466165413533834,0.9127689951188275,1.0,10/33,19.39%,PIK3R1;NYAP2;PLEKHA1;PIK3C2B;AKT1;PIK3CD;MYO16;HTR2B;HTR2A;C1QBP
prerank,mRNA splice site selection (GO:0006376),0.3103400368626046,0.8861313919455539,0.6230088495575221,0.8910977573588228,1.0,1/30,0.13%,CELF2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3092485533972935,-0.8861134924341637,0.6187363834422658,0.9122331675927143,1.0,4/21,11.52%,RPL5;RPS7;RPL11;RPL23
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3338719292863507,-0.8854524792658446,0.6299376299376299,0.9129632827512009,1.0,5/15,13.74%,SIX1;BMP4;VEGFA;PAX2;SIX4
prerank,cytosolic calcium ion transport (GO:0060401),0.3130080697948084,0.8852828455871072,0.6412859560067682,0.8923594093888254,1.0,8/28,16.74%,MCU;MICU1;CACNA1C;JPH1;ATP2B1;JPH3;CACNA2D1;JPH4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3385445293650533,0.8850492134448509,0.6196911196911197,0.8922659049784349,1.0,2/19,4.00%,AMPD3;TERT
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2818436498203754,0.8846812231653957,0.6499162479061976,0.8925003689188719,1.0,8/48,11.27%,AMPD3;ADCY5;ADCY7;PANK2;ADCY1;NPPC;AK5;ACAT1
prerank,iron ion homeostasis (GO:0055072),0.272938118907032,0.884501092278688,0.6537842190016103,0.8923135622210454,1.0,2/58,0.40%,CP;BMP6
prerank,regulation of protein localization (GO:0032880),0.26886709033588946,0.8839779660345123,0.6618357487922706,0.8928963279155642,1.0,11/58,12.35%,AFDN;TRIM17;AAK1;TPR;TRIM5;DLG1;USP8;SUMO1;ATCAY;TRIM21;DVL3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.31042885510599705,0.8838458063890013,0.6153846153846154,0.8926124396346694,1.0,5/28,8.35%,ITPR1;BCL2;CASP4;QRICH1;BAX
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.25568998025032513,0.8837014382437641,0.650381679389313,0.8923481963076418,1.0,16/80,15.80%,PLPP3;COPZ2;ARFGAP3;KDELR3;ARF4;TAPBP;ERGIC1;ARF3;COPE;UVRAG;ARCN1;SCFD1;KLC1;TMED9;COPZ1;GBF1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.31260929578619245,-0.883634717114506,0.625,0.9163637591367465,1.0,5/19,13.57%,PRKCH;CLDN5;RUNX1;CBFB;F11R
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.25502861320521664,0.8833232941374194,0.6779911373707533,0.8925946766836128,1.0,18/85,15.97%,PRICKLE1;NUPR1;RNF217;ZYG11B;RNF19A;GSK3B;NUB1;PIAS1;LRRK2;SUMO1;KEAP1;HECTD1;DDA1;TRIB1;RCHY1;DAB2;RNF180;RNF185
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.3773834991609485,-0.883074028190621,0.6178861788617886,0.9168833233074096,1.0,4/10,24.43%,SORL1;DNAJA4;SACS;HSPA2
prerank,replication fork processing (GO:0031297),0.292162528534289,0.8829601410689797,0.6178451178451179,0.892806830989726,1.0,7/38,11.00%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,neuron fate commitment (GO:0048663),-0.3449930963920754,-0.8829171235217677,0.6294736842105263,0.916479486864606,1.0,7/14,35.39%,MYT1L;POU3F2;DLL4;DLL1;POU4F1;PAX6;ASCL1
prerank,fatty acid transmembrane transport (GO:1902001),0.35161834290553906,0.8826743553108661,0.6097122302158273,0.892805206903056,1.0,2/19,1.61%,PRKAG2;PRKAA2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.329110609793919,-0.8826108685288733,0.6363636363636364,0.9164134704882043,1.0,3/16,16.84%,CELF4;TRA2A;RBM3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2931888709167725,-0.8824594162384948,0.6321585903083701,0.9151683643190911,1.0,10/23,33.93%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53;E2F1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2931888709167725,-0.8824594162384948,0.6321585903083701,0.9151683643190911,1.0,10/23,33.93%,MAPK8;YWHAH;PPP1R13B;YWHAQ;BAD;YWHAZ;PPP3CC;PMAIP1;TP53;E2F1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.35042465445631255,-0.8823626616230733,0.5995717344753747,0.9146010876614793,1.0,5/13,14.47%,PTK2B;NEDD4L;NOS1;CAV1;CASQ2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3704909054023886,-0.8823014339135891,0.6289308176100629,0.913949914627215,1.0,5/10,33.14%,RPUSD2;RPUSD3;RPUSD1;NOP10;NHP2
prerank,cGMP biosynthetic process (GO:0006182),-0.377977099611301,-0.8822892794141725,0.6069246435845214,0.9131882822152899,1.0,3/10,10.66%,GUCY1B1;GUCY1A1;NPR1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3876374625316872,0.8822250715055124,0.6065259117082533,0.8931880183185025,1.0,3/11,11.06%,AFDN;RAP2C;TJP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.323066641276211,-0.8819806713761147,0.639344262295082,0.9131361614751001,1.0,4/16,17.04%,CEACAM1;ERLIN1;ACADVL;BRCA1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.25869823818725113,0.881943547472275,0.6439393939393939,0.8932232844617551,1.0,10/74,10.29%,RBPJ;HIF3A;EPAS1;ARNT;STOX1;CREBBP;PSMB10;PSMA3;PSME4;PSMA5
prerank,cellular response to pH (GO:0071467),0.3478130456675407,0.8816779613277809,0.6339754816112084,0.8932092333920517,1.0,2/17,10.21%,INSRR;PKD1L3
prerank,negative regulation of protein catabolic process (GO:0042177),0.28847564452337804,0.8813955527985223,0.6347402597402597,0.8932348475801088,1.0,8/40,11.49%,TIMP3;NELL1;PTPN3;SNX12;TIMP2;AZIN2;SF3B3;IRAK3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.26893554946641524,0.8813135300005732,0.6475155279503105,0.8928290707084795,1.0,6/67,4.23%,DCDC2;PLD1;FER;TBC1D16;SDCCAG8;IFT88
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.32486015412615205,-0.8810664223677158,0.608421052631579,0.914395025720721,1.0,6/17,33.22%,RFFL;CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.35901853149164026,-0.8806653560035123,0.640495867768595,0.9144452371742873,1.0,3/12,9.20%,NOTCH1;CCN3;HDAC1
prerank,regulation of extracellular matrix organization (GO:1903053),0.35871621169478984,0.8805689910992237,0.5948905109489051,0.8938747935703706,1.0,3/15,4.96%,DDR2;EFEMP2;AEBP1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.30448063550671745,-0.8801338629066403,0.6275862068965518,0.9148743399470751,1.0,2/23,7.57%,GAS6;CEACAM1
prerank,establishment of protein localization to organelle (GO:0072594),0.2627987277404201,0.8801013835720268,0.6661490683229814,0.8942854050790888,1.0,13/72,17.92%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;APPL1;IPO7;EIF4ENIF1;POM121;RAN;HK1;RANBP17
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.32531492134247664,-0.8797765616255917,0.6352459016393442,0.9148982744811561,1.0,6/15,15.36%,NTRK2;DDIT4;ZFYVE27;BCAR1;NGF;SORT1
prerank,vesicle coating (GO:0006901),-0.23191562608934854,-0.8791672639996708,0.6976127320954907,0.9139095082149218,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,COPII vesicle coating (GO:0048208),-0.23191562608934854,-0.8791672639996708,0.6976127320954907,0.9139095082149218,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.23191562608934854,-0.8791672639996708,0.6976127320954907,0.9139095082149218,1.0,17/61,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,MAPK cascade (GO:0000165),0.21925031773262707,0.8789424687328294,0.7533577533577533,0.8961439216934481,1.0,48/295,13.10%,RASGRF1;NRK;PDGFRA;FGFR1;FGF1;SPTBN1;IL31RA;KSR1;CCM2;FRS2;TGFA;KL;ANGPT1;KIT;TAOK3;PTPN3;ARAF;PTPRA;PDGFRB;SYNGAP1;RASA1;ACTN2;CTSH;IL18;CCL2;LGALS9;MEF2A;PSMB10;PSMA3;DLG1;RGL3;PSME4;LRRK2;RALGDS;PSMA5;FGF18;BCL2L1;PPP1CB;PTK2;CUL3;DUSP5;MAP3K7;FNTB;BTRC;MAP2K1;FBXW11;SHOC2;JAK1
prerank,smooth muscle contraction (GO:0006939),0.36929673782693967,0.8787326847187219,0.61,0.896003733161875,1.0,4/14,9.48%,ROCK2;PIK3C2A;BDKRB2;NMUR1
prerank,regulation of establishment of planar polarity (GO:0090175),0.2514515320359244,0.8783285158098962,0.6695778748180495,0.8963070569368065,1.0,11/88,10.29%,PRICKLE1;SMURF2;FZD2;DACT1;PARD6A;CELSR1;PSMB10;WNT5A;PSMA3;PSME4;PSMA5
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.22267826482348735,-0.8778230847317482,0.722397476340694,0.9161708227532606,1.0,24/86,21.74%,NAV3;PTK2B;NCKAP1;PAK1;RPS3;MET;LMOD1;STMN2;CDC42EP3;VASP;CDC42EP1;CDC42EP5;FES;RAC1;EVL;MAPT;PYCARD;ARF6;CDK5RAP2;PFN2;CARMIL1;DCTN1;PRKCE;ARL2
prerank,pre-miRNA processing (GO:0031054),0.36954769288221834,0.877306233773162,0.6146245059288538,0.8979187402924661,1.0,4/14,18.15%,TUT4;ADAR;TARBP2;TUT7
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.32803836300434996,-0.8768698727186112,0.6326530612244898,0.9175848143326114,1.0,4/16,12.30%,PIGM;PIGQ;PIGH;DPM2
prerank,autophagosome maturation (GO:0097352),-0.2724737319370939,-0.876661818058408,0.6595238095238095,0.9172985715000033,1.0,12/32,26.99%,CALM1;GABARAP;GABARAPL1;VMP1;VPS33B;TECPR1;ATP2A2;VIPAS39;LIX1;CLN3;SNAP29;MAP1LC3B
prerank,vesicle organization (GO:0016050),-0.25479664437528793,-0.8757506174633496,0.7121951219512195,0.9185792936504151,1.0,20/46,29.48%,FNBP1L;CD34;ALS2CL;VPS33B;PI4K2A;CAV2;ALS2;CAV1;SORT1;CHMP2B;SAR1B;DNAJC13;SNX33;VPS18;LAPTM4B;PHETA2;PI4K2B;SNX10;SQSTM1;SNX11
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3600131355194141,0.8754459466749679,0.5828677839851024,0.9013088829981201,1.0,3/14,15.47%,IL17D;IL18;IL23R
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3057427886463758,0.8753127265568174,0.6335616438356164,0.900996599554901,1.0,5/30,7.89%,IL6;TLR4;PRKCZ;LGALS9;CD274
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.33320895693799707,-0.8751407676310887,0.6822033898305084,0.9191825102757363,1.0,1/15,0.19%,PRKCH
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24250814929397188,0.8751161102898997,0.6970128022759602,0.9008492678961988,1.0,15/117,10.90%,GHRH;ADORA2A;PTHLH;GLP2R;IL6;ADCY5;ADCY7;MC2R;RXFP2;ADCY1;RAMP1;ADM;INSL3;MAPK14;GPR39
prerank,atrioventricular valve development (GO:0003171),-0.3429945006523204,-0.8750533270592238,0.6230248306997742,0.9185975176823261,1.0,6/14,14.08%,TGFB2;BMPR2;NOTCH1;ZFPM1;ACVR1;APLNR
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.320431389060461,0.8748638989015122,0.62,0.9008005371582647,1.0,7/25,14.99%,QRICH2;EPHA4;SGTA;HFE;EFNA1;CSNK2A2;PML
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3148980034090426,0.874823317463325,0.6254480286738351,0.9002944026345105,1.0,4/29,8.62%,KANK2;UBA5;STRN3;YAP1
prerank,pre-replicative complex assembly (GO:0036388),-0.23522020771632224,-0.8745477323586417,0.7412790697674418,0.9189317870884955,1.0,18/64,21.19%,PSMC3;PSMD14;UBB;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;ORC6;UBA52;PSMA8;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2833132247103468,-0.8740021261213488,0.6950354609929078,0.9193993204110245,1.0,3/27,5.90%,GPCPD1;GDPD1;ENPP6
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.27584900282627506,0.8739759204582898,0.6584158415841584,0.9015243966744738,1.0,11/49,16.18%,NUPR1;GSDME;BCL2;MCL1;BAX;DNM1L;BCL2L1;NDUFS3;DAPK2;EIF2AK3;URI1
prerank,protein depolymerization (GO:0051261),0.3147066987256022,0.8737871938922402,0.6749555950266429,0.9013416194749144,1.0,3/27,7.61%,MICAL3;NCKAP5L;DSTN
prerank,DNA-dependent DNA replication (GO:0006261),-0.21089045673024373,-0.8737851835963089,0.7972972972972973,0.9190804441885121,1.0,46/128,27.76%,REV3L;PSMC3;GINS3;PSMD14;UBB;PSMD3;PSMD4;POLA1;MGME1;PSMD6;PSMA6;PSMA4;PSMB8;ORC6;UBA52;PSMA8;TWNK;PNKP;POLD2;CDK2;RAD51;CDC45;PSME1;POLE;RFC4;SIRT7;PSMD7;PSMC6;POLD1;PSMB5;PSMC5;PSMB1;POLB;POLE3;PSMD11;WRNIP1;MCM10;PSMD8;SRPK2;RFC5;RFC2;RECQL;CDC34;GINS4;BLM;CDK2AP1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.2768549048099177,-0.8737291424929969,0.6570048309178744,0.9184113939343816,1.0,5/30,6.60%,CSGALNACT1;CSPG4;HEXB;CHST9;NDNF
prerank,DNA double-strand break processing (GO:0000729),-0.31902474334664077,-0.8731737862151249,0.643956043956044,0.9189238438296541,1.0,6/18,17.04%,UBE2V2;MRE11;ATM;BARD1;EXD2;BRCA1
prerank,long-chain fatty acid transport (GO:0015909),0.3148932137471605,0.8730698885502097,0.6267605633802817,0.9022622135598849,1.0,5/30,12.51%,PRKAG2;PRKAA2;ACSL1;SLC27A2;ABCD3
prerank,cellular lipid catabolic process (GO:0044242),0.3142347375448636,0.8728024631893159,0.6684210526315789,0.9022677842603348,1.0,9/27,23.00%,APOA2;ENPP2;LPIN2;ACOX1;ANGPTL3;SIRT2;ACBD5;NUDT19;LPIN1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.37671108387502217,0.8725000395351312,0.6228239845261122,0.9023365916463219,1.0,3/13,12.47%,PARP9;PARP10;PARP16
prerank,response to glucocorticoid (GO:0051384),-0.2897087733970114,-0.8719638307674212,0.6699029126213593,0.9208087012191163,1.0,2/26,5.15%,SLIT2;FAM107A
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.25982380193807475,-0.8719547808460404,0.6860759493670886,0.9200460762085764,1.0,11/37,16.48%,SMAD7;CALM1;CALM2;CEMIP;INPP5K;CALM3;SPRED2;DDIT4;IRGM;EGF;SPRED3
prerank,regulation of myoblast fusion (GO:1901739),0.38304188703201264,0.8717460258827363,0.6288461538461538,0.9033489314054036,1.0,2/11,10.26%,CFLAR;MAPK14
prerank,protein deacylation (GO:0035601),-0.28718674605358463,-0.8713773777118498,0.6570155902004454,0.9205277966959071,1.0,6/23,18.56%,HDAC7;HDAC6;SIRT5;HDAC1;ABHD17A;SIRT7
prerank,pharyngeal system development (GO:0060037),-0.32922639213387966,-0.8712462414116138,0.6373873873873874,0.9200327849363868,1.0,4/15,7.09%,TGFB2;BMPR2;TBX1;BMP4
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3719361188936026,-0.8712273935355134,0.6311300639658849,0.9192928746333221,1.0,4/10,19.50%,ELOVL5;ABCD2;MID1IP1;SLC45A3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.24629896666400997,0.8711428201065581,0.6959654178674352,0.9040302572369099,1.0,22/100,15.97%,PRICKLE1;RNF217;ZYG11B;ARAF;RNF19A;FHIT;GSK3B;WAC;NUB1;PIAS1;LRRK2;SUMO1;TLK2;KEAP1;HECTD1;HFE;DDA1;TRIB1;RCHY1;DAB2;TAF9;RNF180
prerank,regulation of DNA binding (GO:0051101),-0.2549076316818566,-0.8711274002901164,0.699228791773779,0.9187473235701503,1.0,11/44,17.85%,LEF1;MAPK8;HMGB1;MDFI;DOT1L;TFAP4;NGF;PLAUR;EGF;HES1;BCL3
prerank,positive regulation of cell cycle (GO:0045787),-0.23292514868422087,-0.8709276887012969,0.7146666666666667,0.9184261937920318,1.0,15/62,18.55%,MEIS2;TGFB2;RPS15A;LGMN;AKT1;RAD23A;CCND1;LRP6;CALR;TAL1;EGFR;RGCC;CDK4;ASNS;CHEK1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.22636571660184931,0.8708743461765617,0.7602108036890646,0.9040359353176178,1.0,28/198,12.10%,ENPP3;EPHA7;PLA2G4A;ENPP1;PLPP3;TPTE;PPM1A;ACYP2;DUSP10;PLCD3;PI4KA;DUSP28;TOP1;PLCE1;PANK2;PLCB3;PLA2G4C;DUSP16;PLPPR3;NT5C;HKDC1;GK5;LRRK2;PFKM;INPP1;XYLB;PPP3CB;DUSP5
prerank,mitochondrial gene expression (GO:0140053),-0.25093060779653986,-0.8704207255463984,0.6979695431472082,0.918788614393602,1.0,14/42,24.77%,LARS2;MRPS18A;FASTKD2;TWNK;MRPL57;RARS2;MRPL47;HARS1;MRPS2;TFB2M;MRPL23;MRPS12;POLRMT;MRPS16
prerank,negative regulation of biosynthetic process (GO:0009890),-0.31914768611261296,-0.8700532953300636,0.6457399103139013,0.9188105147405051,1.0,5/16,14.75%,ASXL3;EMILIN1;CEACAM1;ABCD2;PARK7
prerank,establishment of protein localization to membrane (GO:0090150),0.2570885238600581,0.8695164613212216,0.691131498470948,0.9063080985979503,1.0,13/66,14.71%,SYNE3;AFDN;RAB10;ZDHHC3;NPC1;CHM;MICALL1;COX18;GRIN3B;RAB3IP;GORASP2;MYO1C;SEC63
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3822035420983041,0.8694256674940858,0.628731343283582,0.9059201920228944,1.0,7/11,26.52%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,snRNA metabolic process (GO:0016073),-0.31946306643232364,-0.8690435408828747,0.6494623655913978,0.920266618161128,1.0,9/17,31.32%,INTS7;INTS10;INTS12;ZCCHC8;INTS11;INTS1;INTS5;INTS2;RBM7
prerank,T cell proliferation (GO:0042098),-0.35078640359563934,-0.8690208958615696,0.6551020408163265,0.9195450513413628,1.0,1/13,0.07%,CADM1
prerank,regulation of response to oxidative stress (GO:1902882),-0.3578567278832987,-0.8688352552369041,0.6326963906581741,0.9191785278035266,1.0,7/11,29.93%,MCTP1;PINK1;SELENON;GGT7;AIFM2;ACOX2;ALOX5
prerank,regulation of centriole replication (GO:0046599),0.33058850512235793,0.8687791795690718,0.631768953068592,0.9066592168764,1.0,5/18,15.58%,ALMS1;CENPJ;RBM14;KAT2B;SPICE1
prerank,positive regulation of axon extension (GO:0045773),-0.29983712951244346,-0.8686811911870308,0.6306695464362851,0.9187379212885975,1.0,8/22,15.43%,MACF1;SEMA7A;SHTN1;VEGFA;L1CAM;DBNL;ZFYVE27;MAPT
prerank,sphingoid metabolic process (GO:0046519),0.37414859814634416,0.86792467790373,0.6215139442231076,0.907924257476661,1.0,2/12,8.10%,PLPP3;NAAA
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.281584815005506,0.8677604996754826,0.6526845637583892,0.9077071983101753,1.0,7/41,14.88%,TLR4;C5AR2;PTPN22;LGALS9;PTPN6;IRAK3;RARA
prerank,skeletal muscle tissue development (GO:0007519),0.30135383160055496,0.8676693060755843,0.6504347826086957,0.9073181321983005,1.0,7/32,12.36%,CSRP3;CFLAR;IGSF8;POPDC2;SKI;MSC;EGR2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.37498670217695806,-0.8676476600917786,0.6435845213849287,0.9201805001787556,1.0,5/10,37.14%,SIRT7;ZNF692;DGKQ;GNMT;PDK2
prerank,reverse cholesterol transport (GO:0043691),0.3686254913639179,0.8672408093675965,0.620253164556962,0.9076364899392816,1.0,1/13,2.03%,APOA2
prerank,phospholipid dephosphorylation (GO:0046839),-0.26537337904552233,-0.8669359023138801,0.6810126582278481,0.9209789560321436,1.0,18/37,25.38%,MTMR6;PLPPR1;PLPP5;INPP5K;MTMR12;PLPP1;PLPPR2;SGPP1;PIP4P1;MTMR7;PLPPR5;MTMR2;INPP5J;INPP5B;PLPPR4;MTMR1;SYNJ1;MTMR9
prerank,genitalia development (GO:0048806),0.375178463905223,0.8669287803252179,0.6309751434034416,0.9077132971256031,1.0,2/12,8.47%,TIFAB;WNT5A
prerank,chromosome organization (GO:0051276),0.2475754634524469,0.8666730803308079,0.7225352112676057,0.9076500574807324,1.0,10/99,11.00%,TCF7L2;NUCKS1;BRWD1;CDAN1;CUL4A;TOP2B;TCF7L1;SETD7;GEM;RFWD3
prerank,regulation of translation (GO:0006417),0.22673697100532236,0.8664056959150975,0.7418478260869565,0.9076176301713191,1.0,38/173,19.46%,PLD1;SAMD4A;EIF2AK2;IGFBP5;SHMT1;VIM;DAPK1;PKP3;IL6;IGF2BP1;NANOS2;IGF2BP2;CTIF;TRAP1;FOXO3;ZCCHC4;EIF4ENIF1;ILF3;RPS6KA3;DDX6;GEMIN5;MAPKAPK5;GIGYF2;EIF2AK3;ALKBH1;SOX4;APP;CNOT9;CPEB3;UPF3A;OGFOD1;FXR2;SHFL;PLXNB2;DHX36;EIF4H;NANOS1;ERBB2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.25955740014698936,0.8658776354021351,0.6973478939157566,0.908167510744799,1.0,21/73,20.88%,SUZ12;HDAC4;POLR1C;BAZ1B;EPC1;IGF2;POLR1G;JARID2;TASOR;POLR2F;ERCC6;MYO1C;KAT2B;DDX21;DNMT3A;PPHLN1;BMI1;MPHOSPH8;POLR2K;SPHK2;PHF1
prerank,positive regulation of TOR signaling (GO:0032008),-0.2526552629739134,-0.8658092788108659,0.680306905370844,0.9227542630363021,1.0,16/40,32.05%,GPR137C;GAS6;SMCR8;RRAGB;RRAGC;PIP4P1;LAMTOR2;MLST8;TREM2;MIOS;LAMTOR4;HTR6;GOLPH3;WDR24;PIH1D1;SEC13
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3843090755602747,0.8657707357466745,0.6228239845261122,0.9078140945342662,1.0,3/10,13.95%,CRY1;RFWD3;THOC5
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.37162558478145086,-0.8656965215259348,0.6339468302658486,0.9222480711346814,1.0,4/10,18.37%,GALNT13;GALNT3;GALNT4;POGLUT3
prerank,regulation of mRNA catabolic process (GO:0061013),0.23634895478096865,0.8655702813722754,0.7339055793991416,0.907632644899408,1.0,15/121,11.12%,TNPO1;ZC3HAV1;SAMD4A;VIM;RC3H1;PKP3;IGF2BP1;DCP2;PSMB10;MOV10;PSMA3;PSME4;PSMA5;IGF2BP2;XRN1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2949591208778859,-0.8652847611701097,0.6884057971014492,0.9223456136283182,1.0,11/23,36.75%,SEL1L;LMAN1;TECPR2;PREB;RANGRF;SEC61B;HERPUD1;UFD1;SEC13;AUP1;DERL1
prerank,establishment of vesicle localization (GO:0051650),-0.3122091838461354,-0.8647910091478388,0.6425531914893617,0.9226676960952954,1.0,9/18,26.35%,LIMK2;RAB27A;KIF5C;KIF5A;SNAPIN;TESK1;CDK5;SYNJ1;F8A1
prerank,nitrogen compound transport (GO:0071705),0.22974333497180863,0.8646188210246689,0.7412398921832885,0.9089834348537632,1.0,7/141,4.72%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC6A12;SLC7A14;MIA3
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2433991678059467,-0.8644467152040711,0.7344173441734417,0.922642966959656,1.0,11/49,13.61%,CST3;LRCH1;CPEB2;DAB2IP;RCC2;SLC39A14;CAMK2A;TMED2;NOS1;F11R;HRAS
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3136128795921022,0.8643656540190304,0.658578856152513,0.9089671385977265,1.0,6/26,11.56%,STK39;NEDD4;ACTN2;DLG1;WWP2;ATP1B2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.3290924440023578,-0.8640164044170139,0.6709129511677282,0.9227727199281105,1.0,2/15,2.99%,PIEZO2;SCN1A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36282834644002554,0.8639481405806021,0.6374745417515275,0.9092788650975173,1.0,4/13,19.24%,VDAC2;BAX;RHOT1;RHOT2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3067486204521217,0.8637994028635012,0.6347826086956522,0.9090151518142434,1.0,6/29,14.54%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3079363966043862,0.8636795063298482,0.6542372881355932,0.9086756507171789,1.0,5/26,9.78%,OSBPL8;SORBS1;CREBL2;RHOQ;APPL1
prerank,respiratory electron transport chain (GO:0022904),-0.32887803493878925,-0.863417602610562,0.6625,0.9233832936419368,1.0,3/14,21.32%,GPD2;SLC25A13;SLC25A12
prerank,spliceosomal complex assembly (GO:0000245),0.2742432159937099,0.8632832801635537,0.6566164154103853,0.9089202448612528,1.0,10/46,18.42%,CELF2;ZRSR2;DDX23;RBM5;SRPK1;PRPF19;SRSF5;TXNL4A;SCAF11;USP39
prerank,ear morphogenesis (GO:0042471),0.3296902685827452,0.8630558172905631,0.6431226765799256,0.9087924926339703,1.0,4/20,12.68%,OSR1;ZIC1;TIFAB;NOG
prerank,myeloid leukocyte differentiation (GO:0002573),0.26293503489813147,0.8627478810061222,0.6782884310618067,0.9088455084250465,1.0,13/65,14.99%,IL31RA;GAB2;KIT;PIR;TGFBR2;GLO1;LGALS9;MAPK14;CSF1;EPHA2;THOC5;RARA;PML
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.34793271652773916,0.8625282980732625,0.6146616541353384,0.9087378824668144,1.0,4/15,16.02%,TNRC6B;TNRC6A;EIF4ENIF1;CPEB3
prerank,mitochondrial translational termination (GO:0070126),-0.21481258483170923,-0.8622398535109271,0.765625,0.9251780698466439,1.0,37/88,35.83%,MRPL4;MRPS18A;MRPL1;MRPS30;MRPS23;MRPL57;MRPL28;MRPL47;AURKAIP1;MTRF1;MRPL35;MRPS5;MRPL34;MRPS2;MRPL52;MRPL23;MRPL9;MRPS31;MRPL49;MRPS12;MRPL11;MRPL50;MRPS16;MRPS22;MRPS25;MRPL44;CHCHD1;MRPL51;MRPL32;MRPL54;MRPL43;MRPL2;MRPL24;MRPL37;ERAL1;MRPL45;MRPL30
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3190425008108617,-0.8619603330626714,0.6751152073732719,0.9250144852086122,1.0,6/18,21.32%,MTHFR;MSRA;SMS;ASNS;SLC25A13;SLC25A12
prerank,spindle assembly (GO:0051225),0.2585792605762063,0.8619137681322686,0.6832298136645962,0.9094420842184725,1.0,22/67,23.81%,MAP9;STAG1;CLASP1;HAUS8;GOLGA8B;MISP;TUBGCP4;TUBGCP2;TUBGCP5;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;MAPRE3;CEP63;OFD1;INO80;CHEK2;STAG2;MAPRE2;NEK6
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.21486712116082943,0.8618325435460035,0.8179519595448799,0.9090389606617476,1.0,73/260,22.55%,DCDC2;PARVA;CYS1;ASAP1;DYNLL1;FGD4;NRP1;ARL13B;KIT;CENPJ;RFX3;IFT88;NTN1;ARL3;VCL;TTC39C;HYLS1;ARF4;TMEM107;EXOC2;ACTN2;DYNC2I1;DNAAF1;PMP22;MTSS1;RAP2C;NUDCD3;IFT81;CC2D2A;CDH13;ANO6;CDC14A;CCDC57;WDR19;RAB3IP;CFAP221;IQCB1;IFT20;TRAPPC14;FBF1;CCDC66;RFX2;NPHP3;CEP250;CPLANE1;GBF1;AVIL;TTBK2;RAP2B;EXOC7;EXOC1;RPGR;IFT52;ARL6;WDR11;DMTN;CEP131;ARFIP2;SSX2IP;B9D2;PIP5K1A;OFD1;RP2;ACTR3;DZIP1L;FGD1;PKD1;LZTFL1;CFAP410;FSCN1;CYFIP1;RAP2A;RHOD
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.292847606477011,-0.8616184464618968,0.6652631578947369,0.9250068185194781,1.0,3/22,4.35%,SLC7A5;RFTN1;PRKCQ
prerank,macrophage differentiation (GO:0030225),0.35927559020195626,0.8614621363803264,0.6579925650557621,0.909235181486334,1.0,2/13,12.03%,IL31RA;CSF1
prerank,regulation of cardiac conduction (GO:1903779),0.27111550252771716,0.8613887383099437,0.6948051948051948,0.9087973151138143,1.0,9/54,13.14%,ATP1A2;ITPR1;TMEM65;ATP2B4;CORIN;NPPC;TRPC1;ATP1B2;ATP2B1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.29595748794005355,-0.8610124524308818,0.6712328767123288,0.9255481928555536,1.0,6/21,23.30%,NOS1AP;CACNA1D;KCNQ1;KCNE4;GJA5;SCN1B
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3471089723116306,-0.8609462556458389,0.6639175257731958,0.9249022412302527,1.0,1/12,0.98%,TMEFF2
prerank,response to UV (GO:0009411),-0.21318433932373526,-0.8608886106815209,0.7792642140468228,0.9242539342213363,1.0,26/95,23.75%,PTPRK;RPL26;MAPK8;AKT1;NPM1;MAP4K3;YY1;CCND1;CCAR2;EGFR;ATF4;USF1;COPS9;CASP9;BMF;MEN1;MFAP4;BCL3;N4BP1;NOC2L;POLD1;ATR;DCUN1D3;DTL;POLK;DDB2
prerank,protein localization to organelle (GO:0033365),-0.20162566837769563,-0.860863754373014,0.8228782287822878,0.923540712714748,1.0,40/133,22.18%,CSNK1D;SCG3;SIX1;SORL1;RPL11;YBX1;CEP68;BMP4;PAQR3;ARL1;CNTLN;GCC2;RAB35;CALR;HHEX;TUB;SERP1;DVL1;TRAM1;ATP6V1D;SIX4;DCP1A;TMEM30A;LAMP5;CCDC47;TOR1B;CTDNEP1;LAMP1;WDR83OS;BBS2;BBS1;TOLLIP;ARF6;SEC61G;MSX1;MTCH2;UBAC2;CYB5A;PPP1R15A;CD68
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3078241465456598,-0.8605804065493666,0.6703539823008849,0.9233519020693851,1.0,2/19,2.90%,CYTH3;CYTH1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3342605669159673,0.8604613190249647,0.6596491228070176,0.9101573251571446,1.0,8/18,24.03%,TERT;IL6;MAP2K1;DDX5;RIPK1;ZC3H12A;TGFB1;ZC3H10
prerank,Golgi to plasma membrane transport (GO:0006893),0.2769220360515986,0.860369971947653,0.6622734761120264,0.9097690305363458,1.0,7/47,7.15%,SPTBN1;VAMP5;RAB10;ARL3;OPTN;EXOC2;VPS35L
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.29886680441201696,0.8601995265668707,0.671304347826087,0.9095683535449958,1.0,5/30,10.49%,MLLT3;FSTL3;KIT;SBDS;PLEK
prerank,protein deubiquitination (GO:0016579),-0.19017627815704885,-0.860120757387339,0.9432989690721649,0.9235732523195713,1.0,72/242,25.03%,USP29;IL33;SMAD7;ACTB;ESR1;PSMC3;OTUD7A;SNX3;USP31;NFRKB;CLSPN;RAD23A;PSMD14;UBB;MBD5;PSMD3;YY1;BABAM1;EIF3F;USP13;PSMD4;SMAD1;ZRANB1;PSMD6;BARD1;ADRB2;PSMA6;PSMA4;PSMB8;USP3;FOXO4;TFPT;USP46;USP37;UBA52;PSMA8;TAF9B;VCPIP1;OTUD1;MINDY2;CYLD;COPS5;YOD1;USP38;SUDS3;BRCA1;UBE2D1;PSME1;TOMM20;KAT2A;PSMD7;PSMC6;ASXL1;MINDY1;USP42;PSMB5;USP2;PSMC5;PSMB1;POLB;ATXN3;OTUB2;SHMT2;USP22;KDM1B;PSMD11;DDB2;MCRS1;PSMD8;USP11;RAD23B;JOSD2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.37990507146051655,0.8594668636948978,0.6082677165354331,0.9104868786582244,1.0,2/10,14.33%,TERT;TARBP2
prerank,muscle tissue development (GO:0060537),0.3614685330585002,0.8591790639066506,0.6093457943925233,0.9105199222594759,1.0,2/13,5.47%,CSRP3;CSRP1
prerank,B cell differentiation (GO:0030183),-0.24963661360374992,-0.8591455504607018,0.7116883116883117,0.9249064873376308,1.0,11/46,16.86%,PTPRJ;PLCG2;TPD52;ITGA4;HDAC9;TCF3;HHEX;DCAF1;PTPRC;CLCF1;RABL3
prerank,sphingosine metabolic process (GO:0006670),-0.30892349517449547,-0.8591208804946107,0.6557734204793029,0.9241814229264159,1.0,2/17,2.19%,ACER3;ACER2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.26642285115422704,-0.8590407072369227,0.676605504587156,0.9235693690165845,1.0,14/30,33.90%,ACER2;HINT1;JMY;STK11;PPP1R13B;PYCARD;BCL3;E2F7;MYBBP1A;PMAIP1;TP53;POU4F1;PAXIP1;BOK
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3735317931995417,0.858768147051132,0.6609848484848485,0.9108318436220458,1.0,5/12,20.16%,CLN5;LRRK2;TMEM165;TMEM9;VPS33A
prerank,positive regulation of protein acetylation (GO:1901985),0.3635037807625567,0.858373995637314,0.6302681992337165,0.9109975096362951,1.0,1/12,1.61%,PRKAA2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.33675463269779454,-0.8581255695475302,0.6710526315789473,0.9247219142926586,1.0,3/13,11.77%,RPS15;NPM1;XPO1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.37987440232477754,0.8581061131941111,0.6146435452793835,0.9109733430152017,1.0,2/10,11.40%,APPL2;ANO6
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.25567134172714473,-0.8580825844013134,0.7030878859857482,0.924038850058619,1.0,12/41,20.28%,GRM5;NTRK2;GAS6;DOCK3;ACE;LRP8;SRCIN1;CSF1R;RELN;EGF;FCGR1A;DLG3
prerank,regulation of intracellular protein transport (GO:0033157),-0.2710613811390355,-0.8580126852085785,0.6725,0.9234343911841587,1.0,10/32,20.44%,PRR5L;OAZ1;BMP4;GCC2;OAZ2;PCNT;CEP290;LCP1;SIRT7;UHMK1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28728987833386654,-0.8578545043912468,0.6919431279620853,0.9229985155691056,1.0,8/23,22.71%,OTUD7A;USP37;VCPIP1;MINDY2;YOD1;MINDY1;ATXN3;OTUB2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.37304844205441845,-0.8578484049316804,0.6606060606060606,0.9222539653044961,1.0,3/10,11.68%,BMP4;PAX2;BASP1
prerank,sensory perception of taste (GO:0050909),0.3881740003766243,0.857734086695138,0.6411764705882353,0.9111985865144271,1.0,10/10,61.21%,PKD1L3;CD36;ASIC2;TAS1R3;GNAT3;TAS1R2;ASIC1;PKD2L1;TAS1R1;ASIC3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3088747987064023,-0.8576700422836793,0.7170212765957447,0.9218775327229476,1.0,4/20,11.45%,PDE4D;ADRA1B;RAPGEF2;ADRB2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2585459367303817,-0.857621357175455,0.7031630170316302,0.9212225364920413,1.0,10/38,14.81%,GRM5;GAS6;ACE;LRP8;SH3BP5L;SRCIN1;CAV1;CSF1R;RELN;PTPRC
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.22640036166768873,0.8575301325811668,0.7603748326639893,0.9110194849239821,1.0,18/172,9.73%,PTPN13;PLEKHA2;PLD1;PLA2G4A;APOA2;AGPAT4;DGKD;PI4KA;CPNE1;MTMR3;PLEKHA4;PLA2G4C;PIK3C2A;ETNK2;STARD10;PIK3R5;ARF3;GPD1L
prerank,granulocyte chemotaxis (GO:0071621),0.26619734637718123,0.8574578321483773,0.6850152905198776,0.9106001746737186,1.0,5/55,7.70%,CXADR;CXCL10;ANXA1;CKLF;CCL2
prerank,regulation of cell death (GO:0010941),-0.21385021464194245,-0.857349758304625,0.7699680511182109,0.9210476732218918,1.0,23/94,21.65%,ACER3;PDE8A;ACER2;DCC;SNCA;CCN3;EPHB1;CCN5;BMP4;TNFRSF1B;UBB;FGF2;NPAS2;PARK7;PRKD1;HTR2B;PACRG;BNIP3L;SRGAP2;CHRNA7;PRR7;SNCG;SRSF6
prerank,negative regulation of cell activation (GO:0050866),0.35020972916303506,0.8572821438462462,0.625,0.9103730027827823,1.0,1/14,1.10%,PDGFRA
prerank,negative regulation of binding (GO:0051100),0.2512733030386071,0.8572529387396868,0.6990881458966566,0.9098622687828345,1.0,11/81,9.33%,SP100;CFHR2;ARHGAP28;IFIT2;DACT1;CPNE1;EFHB;GSK3B;BAX;LRRK2;SUMO1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3834075116669947,0.8568922894742744,0.6500956022944551,0.9100518133174429,1.0,1/10,1.62%,MLLT3
prerank,leukocyte tethering or rolling (GO:0050901),0.3408759085188051,0.8568579150599801,0.6829710144927537,0.9095505325032995,1.0,2/17,6.20%,SELP;VCAM1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2560199569811369,0.8566713788430786,0.6992366412213741,0.9093848178094627,1.0,16/70,19.80%,PLA2G4A;APOA2;MBOAT2;NR1H3;PLA2G4C;PLA2G6;STARD10;ENPP2;CSNK2A2;PCYT1A;LPIN2;ABHD3;PEMT;PLA2G5;SLC44A2;SLC27A1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.30788133491165676,0.8566475195994658,0.627177700348432,0.9088587896467236,1.0,1/25,0.36%,LEPROT
prerank,snRNA 3'-end processing (GO:0034472),-0.2989328975215898,-0.8566473210292032,0.6442105263157895,0.92178636545307,1.0,9/19,30.93%,INTS7;INTS6L;EXOSC2;INTS12;EXOSC4;TOE1;INTS1;INTS5;INTS2
prerank,DNA catabolic process (GO:0006308),0.3720960217375753,0.8566000797367543,0.6227544910179641,0.9083855937337733,1.0,3/11,19.28%,FBH1;DNASE1L1;DFFB
prerank,stem cell development (GO:0048864),-0.32432136259571365,-0.8563276923164418,0.6536796536796536,0.9216951288814804,1.0,9/16,42.24%,CDH2;PTPRC;SOX11;KBTBD8;SOX8;CYP26C1;NOLC1;KLHL12;SNAI2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.38117585890113875,0.8561234506555675,0.6539196940726577,0.9088128581115612,1.0,3/10,11.68%,RC3H1;FOXP3;NFKBIZ
prerank,regulation of synapse organization (GO:0050807),-0.2788644266914296,-0.8560552450296751,0.7208237986270023,0.9215270746715657,1.0,3/26,3.96%,CTNNA2;MEF2C;IL1RAPL1
prerank,protein insertion into membrane (GO:0051205),-0.26631932011046033,-0.8558464248056101,0.6889952153110048,0.9212164738921957,1.0,14/32,28.16%,REEP1;SERP1;TRAM1;EGFR;CCDC47;MAIP1;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;GET1;SEC61B;VAMP2
prerank,mononuclear cell differentiation (GO:1903131),0.31814720645640143,0.8556439820217758,0.645655877342419,0.9092077099319573,1.0,3/24,4.88%,AXL;IL31RA;PIR
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3526653336724315,0.8554471739555104,0.6588021778584392,0.9090317012513538,1.0,2/15,8.09%,SMPD3;PLA2G6
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.22999560912437936,-0.8540423914004054,0.7869318181818182,0.9243405962413442,1.0,13/69,17.57%,PTPRJ;PLCG2;IL33;THBS1;HMGB1;ARHGEF2;HAVCR2;SYK;PTPRC;CCL19;NOD2;PYCARD;LPL
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3501053695993676,-0.8535890702601254,0.6731601731601732,0.9245108066765924,1.0,6/12,20.13%,SERINC3;SERINC5;PSPH;SEPHS1;CTH;GGT1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3016499481566342,0.8531068426116175,0.6807017543859649,0.9132696566674475,1.0,7/29,15.14%,COPZ2;GOLGA5;COPE;GOSR1;COG2;RAB33B;COPZ1
prerank,regulation of water loss via skin (GO:0033561),-0.3303661756763939,-0.8530041892739698,0.6774193548387096,0.924222850465135,1.0,6/15,24.09%,MET;LSR;HRNR;STMN1;UGCG;FA2H
prerank,establishment of skin barrier (GO:0061436),-0.3303661756763939,-0.8530041892739698,0.6774193548387096,0.924222850465135,1.0,6/15,24.09%,MET;LSR;HRNR;STMN1;UGCG;FA2H
prerank,negative regulation of lyase activity (GO:0051350),-0.3193073810493223,-0.8528462085029286,0.6695652173913044,0.9238044264837455,1.0,2/16,3.31%,GRM3;GABBR2
prerank,modulation by host of viral genome replication (GO:0044827),0.3597083293639926,0.8527608424069881,0.6368613138686131,0.9134003230681164,1.0,3/13,11.99%,NUCKS1;VAPA;IFI27
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.320482640361961,0.8525555826567273,0.6559139784946236,0.9132477065727346,1.0,4/22,10.49%,DYNLL1;BMP7;CDKN2B;PLEK
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.33184530981928845,0.85241515869105,0.6557377049180327,0.9129700037128565,1.0,5/18,13.61%,FRS2;BMP2;HDAC4;BHLHE41;BDNF
prerank,positive regulation of chemokine production (GO:0032722),0.27743878798012717,0.8518070255766585,0.7075163398692811,0.9136154544278531,1.0,7/44,11.12%,EIF2AK2;IL6;TLR4;IL18;LGALS9;WNT5A;TLR2
prerank,rRNA 3'-end processing (GO:0031125),-0.36192704442359935,-0.8517520108158304,0.6525911708253359,0.925357903045879,1.0,3/10,17.35%,RPS21;EXOSC2;ERI1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.3572588683532674,-0.8514232326038457,0.6490066225165563,0.9253308049663428,1.0,1/11,0.95%,AGBL4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.26405659023289324,0.8511227899924761,0.6933115823817292,0.9144560205652289,1.0,9/55,10.73%,NUPR1;WWOX;GSDME;BCL2;TGFBR1;TNFRSF12A;BAX;DNM1L;BCL2L1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.358442672268208,0.8508638810698456,0.644404332129964,0.9143964510512637,1.0,3/13,8.99%,SORBS1;EPM2AIP1;IGF2
prerank,regulation of telomere capping (GO:1904353),-0.2848984564411904,-0.8508345214516025,0.6822429906542056,0.9258150627626937,1.0,6/23,16.15%,PRKCQ;NEK7;MAPK3;ATM;PNKP;PKIB
prerank,nuclear pore complex assembly (GO:0051292),0.3826636378877136,0.8505147632571155,0.6376237623762376,0.9145381186145477,1.0,3/10,13.83%,TPR;AHCTF1;RTN4
prerank,modulation by symbiont of entry into host (GO:0052372),-0.31744134643724553,-0.8502630820706344,0.6550976138828634,0.9262985318655653,1.0,5/16,16.46%,HS3ST5;TRIM68;TRIM62;CAV1;FUCA2
prerank,protein glycosylation (GO:0006486),0.23303217471628804,0.8501635401064592,0.7725321888412017,0.9147234725019291,1.0,22/125,13.87%,MAN1C1;GALNT18;GALNTL5;TRAK1;LARGE1;GALNT2;ALG9;MGAT3;NPC1;GALNT1;POMT2;B4GALT1;GCNT4;FUT4;C1GALT1C1;FUT10;TMEM165;ALG11;TET2;TUSC3;MGAT4C;ALG1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3522191168351558,-0.8500983693086539,0.6507276507276507,0.9258709007737874,1.0,3/11,19.84%,TERF1;CCT5;WRAP53
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.2891384549797994,-0.8498727628035982,0.6845794392523364,0.9255955605728113,1.0,8/25,15.11%,DMD;ATP1B1;ANK3;TRPC6;CTSS;NDUFA4;STAC;GLRX
prerank,histone methylation (GO:0016571),0.30885042508416327,0.8495008289375843,0.6638078902229846,0.9154912419245328,1.0,10/26,26.95%,NSD3;CREBBP;NSD1;CARM1;SMYD3;PRMT1;EHMT2;SUV39H1;SETD6;SMYD2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.34349543726650833,-0.8490677973449123,0.69375,0.9265449999368833,1.0,2/12,13.08%,ACSL3;MFSD2A
prerank,positive regulation of secretion by cell (GO:1903532),-0.22402681061477078,-0.848467652616771,0.7846153846153846,0.9270806588690704,1.0,18/70,18.93%,SLC12A2;TGFB2;RAB27A;CADPS;FRMD4A;SNCA;RAB27B;TGFB3;KCNB1;RGCC;CLASP2;PPIA;MYOM1;MYO18A;EXPH5;ADAM8;ARF6;SYTL4
prerank,keratan sulfate metabolic process (GO:0042339),-0.2642051490134408,-0.8483883491846205,0.6870229007633588,0.9264950344651857,1.0,13/31,29.51%,ST3GAL6;HEXB;B3GNT2;B4GALT4;ST3GAL4;LUM;B3GNT3;B4GALT6;CHST5;B4GALT2;B4GAT1;GALNS;ST3GAL2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.3605053421158248,0.848371310937503,0.6460348162475822,0.9172857235645325,1.0,2/12,4.44%,TERT;IL6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3051967721549212,0.8480723367388657,0.6949740034662045,0.9172975487660939,1.0,3/26,6.01%,PRKAG2;PRKAA2;NR1H3
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2115764287042298,-0.848062795616299,0.813953488372093,0.9264229445921583,1.0,26/91,24.51%,PSMC3;CDC26;PSMD14;PSMD3;TFAP4;PSMD4;PSMD6;PSMA6;UBE2E1;PSMA4;PSMB8;NEK10;PSMA8;CDKN1A;BUB1B;UBE2D1;PSME1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;TCIM;PSMD8
prerank,myelin assembly (GO:0032288),-0.3588672732320935,-0.8477542561481691,0.6432865731462926,0.9262733951755169,1.0,7/10,35.54%,TENM4;TPPP;NCMAP;DICER1;CNTNAP1;ABCA2;CD9
prerank,protein import (GO:0017038),0.24663134851985555,0.8475637228140432,0.7161961367013373,0.9177499354462663,1.0,13/84,14.16%,PRICKLE1;TNPO1;LAMP2;APPL2;TPR;PHB2;PXMP2;APPL1;IPO7;EIF4ENIF1;ABCD3;PEX2;POM121
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.27311636722876376,0.8471052961662239,0.7017543859649122,0.9181355632724719,1.0,7/45,10.22%,IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3252858195262458,-0.8468866027610711,0.6757322175732218,0.9272717879960094,1.0,5/14,21.65%,PTBP1;RNPS1;SRSF9;C1QBP;SRSF6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.29985502756070714,0.8464061377936751,0.7068965517241379,0.9183819223076839,1.0,4/29,11.27%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.29985502756070714,0.8464061377936751,0.7068965517241379,0.9183819223076839,1.0,4/29,11.27%,ACOT11;ACOT9;ACOT1;ACAT1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24892935438148073,-0.8461262476712278,0.72544080604534,0.9280195579152642,1.0,12/40,20.33%,PTK2B;RPL5;RPS7;RPL11;RAD23A;RPL23;XPO1;GNA12;FOXF2;UBQLN4;CCDC22;UFL1
prerank,rRNA catabolic process (GO:0016075),0.33379688023312604,0.8458415544641145,0.6730401529636711,0.9189149571659715,1.0,6/16,16.37%,XRN1;DIS3L;SLFN14;DIS3;ERN2;EXOSC10
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2988601059652574,0.8457210480425849,0.6672443674176777,0.9186040445808081,1.0,6/30,14.54%,IKBKE;TLR4;BIRC3;LY96;TICAM1;TBK1
prerank,regulation of DNA metabolic process (GO:0051052),0.27465959033713877,0.8452676835207353,0.6985413290113452,0.9189201420001678,1.0,12/44,21.26%,POLH;NUCKS1;STOX1;MPV17;UBE2V1;SMG5;SMG6;SMG1;IL7R;MPHOSPH8;WDR70;TOM1L1
prerank,epithelial cell-cell adhesion (GO:0090136),0.3734199001448813,0.8451752133656216,0.655310621242485,0.9185539451910857,1.0,3/11,11.08%,KIT;VCL;SERPINB8
prerank,regulation of microtubule nucleation (GO:0010968),-0.35694361762098603,-0.8447580662872443,0.6713709677419355,0.9300709031958758,1.0,4/10,27.41%,PAK1;ARHGEF7;DCTN1;RANGRF
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.29117239888397806,-0.8446377735509631,0.7016317016317016,0.9295680159160141,1.0,5/23,7.34%,PAK1;MAP3K5;RPS3;DAB2IP;MAP3K11
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3617377862379562,0.8443103674878868,0.6438631790744467,0.9197573627954837,1.0,3/13,11.55%,GLI3;TGFBR2;IHH
prerank,mucosal immune response (GO:0002385),0.34734379672622145,0.8440772238047184,0.6415094339622641,0.9196582076367896,1.0,3/15,10.65%,BPIFB1;NOS2;IFNLR1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.30459537913352724,-0.8431063822262117,0.7037861915367484,0.9319022571986858,1.0,3/17,7.57%,PTPRJ;DGKZ;CEACAM1
prerank,regulation of necroptotic process (GO:0060544),0.310634928308471,0.8424417819734987,0.691743119266055,0.9223602490105819,1.0,5/23,14.28%,CFLAR;ZBP1;BIRC3;SLC25A4;FLOT2
prerank,regulation of presynapse organization (GO:0099174),0.32976306232683794,0.8423229614002095,0.6836158192090396,0.9214618021215115,1.0,2/18,2.08%,GPC6;WNT3A
prerank,regulation of presynapse assembly (GO:1905606),0.32976306232683794,0.8423229614002095,0.6836158192090396,0.9214618021215115,1.0,2/18,2.08%,GPC6;WNT3A
prerank,organelle assembly (GO:0070925),0.20394452959486603,0.8421056429872232,0.8772136953955135,0.9213461677421689,1.0,80/385,18.95%,DCDC2;TMOD3;PARVA;CYS1;ASAP1;DYNLL1;AMBRA1;SMIM22;ARL13B;CENPJ;RC3H1;RFX3;SYNPO;IFT88;ARL3;RAB43;TTC39C;HYLS1;ARF4;TMEM107;PLA2G4C;EXOC2;POGZ;DYNC2I1;DNAAF1;HAUS8;GOLGA8B;HPS1;TUBGCP4;NUDCD3;IFT81;CC2D2A;UBXN2A;ATG12;CDC14A;CCDC57;WDR19;UBAP2L;EIF4ENIF1;RAB3IP;CFAP221;IQCB1;DDX6;IFT20;TRAPPC14;WDR45B;TUBGCP2;FBF1;CCDC66;GORASP2;CHMP3;RFX2;RBM14;NPHP3;TUBGCP5;CEP250;CHMP4A;CHMP4B;CPLANE1;ATG2A;GBF1;AVIL;GOLGA2;TTBK2;SH3PXD2B;CENPC;EXOC7;EXOC1;CCDC61;OGFOD1;WIPI2;RPGR;PATL1;RAB19;MAPRE3;IFT52;PRRC2C;ARL6;FARP2;WDR11
prerank,neurogenesis (GO:0022008),0.27449415899355545,0.8420298057182585,0.7121464226289518,0.9209246298749029,1.0,5/43,7.98%,LPAR1;TRAK1;ANXA1;CLN5;DCHS1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.3308864743939636,-0.8417972915399425,0.6597938144329897,0.9338052244682491,1.0,2/14,5.50%,SLC24A2;SLC8A1
prerank,proteasomal protein catabolic process (GO:0010498),0.21836367432964962,0.8415387689101287,0.8192612137203166,0.92135314825566,1.0,51/201,22.39%,SPSB1;TBL1XR1;SMURF2;FBXL17;NEDD4;NHLRC3;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;PSMB10;PSMA3;PSME4;PSMA5;WWP2;ERLEC1;UBXN2A;HUWE1;SPOPL;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;PRPF19;BFAR;KCTD5;PML;SOCS6;RNF185;TBL1X;UBE4B;PPP2R5C;TRIM3;PCBP2;CLOCK;PSMC2;ERCC8;RNF139;UBE2K;SIRT2;RCN3;UBXN1;PELI1;RMND5B;FBXW7;PSMD1;RMND5A
prerank,heterocycle biosynthetic process (GO:0018130),-0.3271719110508976,-0.8414264093070365,0.6781115879828327,0.9337816275197657,1.0,7/14,33.05%,GPHN;GCH1;PYCR2;PYCR1;ALOX5;LIAS;MOCS2
prerank,lipid biosynthetic process (GO:0008610),0.24585293612897136,0.8414110083809929,0.7450381679389313,0.9210416360896038,1.0,11/77,16.00%,PRKAA2;AGPAT4;HSD17B1;PAM;ACSL1;SCP2;SCD5;AGPAT3;ABCD3;STAR;PDSS1
prerank,negative regulation of viral transcription (GO:0032897),-0.33468346202169696,-0.8413451894493975,0.6764705882352942,0.9332011250254464,1.0,3/13,13.64%,MID2;TRIM62;IFITM3
prerank,mitochondrial fusion (GO:0008053),-0.30145781966237173,-0.8408546992954332,0.6666666666666666,0.9335026741803708,1.0,4/18,11.20%,MFF;MFN2;GDAP1;MFN1
prerank,proteolysis (GO:0006508),0.21080927029277546,0.840422117016317,0.8457648546144121,0.922456958860832,1.0,37/252,14.01%,DPP4;ADAMTS12;CPQ;ADGRV1;PRSS57;ANPEP;BMP1;AEBP1;CASP4;CPNE1;MMP14;DPP8;NPEPPS;LACTB;CTSH;SPPL3;PLAU;CPB2;ERAP1;SUFU;CTSW;CAPN15;NLN;ADAM19;SENP6;ENDOU;CLPX;DPP7;CELA1;PLAT;SENP1;FBXO3;SRGN;RNPEP;ADAMTS7;CPXM2;LNPEP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3429835790167397,-0.8403327197881579,0.6878850102669405,0.933802911465373,1.0,2/12,2.18%,CTNNA3;RYR2
prerank,receptor metabolic process (GO:0043112),-0.2337032421337752,-0.8399735924495365,0.7601078167115903,0.9337488009136004,1.0,10/53,14.30%,DNM3;TFRC;SNCA;LGMN;LDLRAP1;RAMP2;FCER1G;SYK;CAV1;KIF16B
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3105669775561748,-0.8397304753183156,0.6794354838709677,0.9334692446130178,1.0,3/16,8.42%,ESR1;DDX54;DDX17
prerank,snRNA processing (GO:0016180),-0.31269550246427463,-0.839587098999956,0.6750524109014675,0.9330217415536263,1.0,9/16,30.93%,INTS7;INTS10;INTS6L;INTS12;TOE1;INTS11;INTS1;INTS5;INTS2
prerank,negative regulation of DNA recombination (GO:0045910),0.2748329000040818,0.8394795207864564,0.6888519134775375,0.9237178959366575,1.0,18/43,27.24%,POLR2D;PARP3;KLHL15;FBH1;POLR2C;POLR2F;SHLD2;RIF1;POLR2K;RTEL1;MSH2;SMCHD1;ZRANB3;ATRX;SHLD1;POLR2H;FANCB;CGAS
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3357989493520542,0.8392870680045774,0.672316384180791,0.9235328337226834,1.0,2/16,6.37%,PID1;PPARA
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2634063671693272,-0.8391233459337495,0.7301587301587301,0.9332347979823116,1.0,12/31,27.38%,DIS3L2;EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EXOSC1;EDC3;LSM2;POLR2G;LSM3
prerank,macrophage migration (GO:1905517),0.3630947340873483,0.8388878638018264,0.6647940074906367,0.9237513564532575,1.0,3/13,16.77%,CKLF;CCL2;P2RX4
prerank,regulation of protein processing (GO:0070613),0.31444926840828247,0.8385066465860945,0.6678260869565218,0.9239654121537667,1.0,6/21,20.29%,SNX12;SERPINE2;LRRK2;CCBE1;GAS1;RNF139
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.35371789183767854,0.8384967583058943,0.6273764258555133,0.923417841356563,1.0,6/12,24.03%,TERT;POU5F1;ELAVL1;ZC3H12A;TGFB1;ZC3H10
prerank,purine-containing compound salvage (GO:0043101),0.35536217574831025,0.8384862848168115,0.676056338028169,0.9228757342489541,1.0,1/12,1.05%,AMPD3
prerank,cellular response to leucine starvation (GO:1990253),-0.3588421202887299,-0.8383316093103473,0.6955645161290323,0.9340631489351942,1.0,2/10,9.32%,SESN3;RRAGB
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.3468275434321191,-0.8381464682067642,0.6713995943204868,0.9337208268767868,1.0,5/10,15.18%,GAS6;RAPGEF2;CXCL12;LYN;CCL19
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.34803181429558927,0.8375914187273141,0.6466165413533834,0.9240844824324632,1.0,2/13,6.01%,NUPR1;NR1H3
prerank,icosanoid secretion (GO:0032309),0.36102653285132646,0.8375743281855849,0.6517509727626459,0.9235516067115384,1.0,3/12,7.03%,ANXA1;NOS2;BDKRB2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.2151631425644958,-0.8375287106274636,0.8113207547169812,0.9341944734841464,1.0,28/86,25.14%,KLF2;PSMC3;PSMD14;UBB;PSMD3;ELOB;VEGFA;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;ATF4;UBA52;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;HIGD1A;PSMB1;HIF1AN;PSMD11;EPO;PSMD8;HMOX1
prerank,cellular response to misfolded protein (GO:0071218),0.3150400860665372,0.837153691154849,0.6666666666666666,0.9237782870427951,1.0,5/20,15.97%,POMT2;KLHL15;UGGT2;CUL3;RNF185
prerank,DNA duplex unwinding (GO:0032508),0.26347513417006907,0.8370974939674064,0.7220447284345048,0.9233329113053917,1.0,9/50,14.02%,ANXA1;WRN;ASCC3;RAD50;CUL4A;MCM4;SUPV3L1;MCM6;GTF2H4
prerank,monocyte differentiation (GO:0030224),0.38068430744939014,0.8369431231319415,0.6685714285714286,0.923069659600352,1.0,2/10,4.88%,IL31RA;PIR
prerank,innate immune response in mucosa (GO:0002227),0.3786967757645647,0.8361537687906567,0.6771037181996086,0.9240549284745758,1.0,2/10,6.49%,BPIFB1;NOS2
prerank,regulation of programmed cell death (GO:0043067),0.2208023845321943,0.8358406672871384,0.823841059602649,0.9241047594093867,1.0,18/161,8.35%,IGFBP3;KANK2;CXCL10;STEAP3;FBXO11;DAPK1;WRN;PLK5;HAX1;IFT57;BIRC3;CREBBP;ACTN2;ANP32E;STAT1;TRIM24;CHM;BAX
prerank,spermatid development (GO:0007286),0.288733292080284,0.8358341868773151,0.7129798903107861,0.9235553371352818,1.0,2/32,3.09%,GALNTL5;ZMYND15
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3188984666594647,0.8353821926961432,0.6735459662288931,0.9238628181061659,1.0,6/21,15.73%,ADCY5;ADCY7;ADCY1;NPPC;GUCY2C;ADCY6
prerank,positive regulation of T cell differentiation (GO:0045582),0.27962623929431424,0.8351651261439818,0.7003484320557491,0.9237227150543295,1.0,3/36,3.59%,ZMIZ1;GLI3;DUSP10
prerank,regulation of protein kinase A signaling (GO:0010738),0.31782857371805334,0.8350543070236347,0.6872791519434629,0.9233905575722746,1.0,4/20,9.29%,AKAP12;ADGRV1;PJA2;LRRK2
prerank,regulation of protein metabolic process (GO:0051246),-0.24461861657035822,-0.8349850982672486,0.7335164835164835,0.9384600369803788,1.0,10/44,13.77%,KLF2;FKBP1A;MAPK8;HSP90AB1;ACE;SPOP;NEDD4L;ZDHHC2;KLF4;PLAUR
prerank,protein targeting to lysosome (GO:0006622),-0.2959613713730508,-0.834789193232402,0.7032967032967034,0.9380764163814641,1.0,5/20,11.75%,HSPA8;SORL1;GCC2;M6PR;SCARB2
prerank,glycoprotein catabolic process (GO:0006516),0.3360789424751722,0.8342247646862334,0.6703703703703704,0.9244547095573439,1.0,2/17,8.24%,ADAMTS12;MANBA
prerank,bicellular tight junction assembly (GO:0070830),0.26968843060353903,0.8339433909847647,0.7119476268412439,0.9244535919401929,1.0,6/46,8.89%,AFDN;CDH5;PARD6G;PARD6A;CLDN1;DLG1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.280089678262262,0.8338881824628116,0.6979332273449921,0.923995659359435,1.0,6/36,8.89%,DUSP10;DACT1;TAOK3;PTPN22;ZMYND11;DLG1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.31837170860699854,0.8338317637633139,0.6875,0.9235424382748765,1.0,1/20,1.80%,FOXC1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3374795000611259,-0.8337987971219889,0.6954732510288066,0.9393203523499154,1.0,3/11,14.81%,SMAD7;CEACAM1;PTPRC
prerank,histone H2A acetylation (GO:0043968),0.33529978147172756,0.8334465075799766,0.7115044247787611,0.9237815767714896,1.0,9/16,30.29%,EPC1;ACTL6A;BRD8;NAA40;SPHK2;EP400;ING3;RUVBL1;MORF4L1
prerank,regulation of DNA replication (GO:0006275),0.26022641716621164,0.8332817427914059,0.7301587301587301,0.9235430931207684,1.0,15/49,20.09%,ORC5;NUCKS1;GLI1;CDAN1;ANKRD17;GMNN;ESCO1;TSPYL2;ORC3;PDS5A;S100A11;PPP2CA;DSCC1;DNA2;CTC1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.33356265713249883,-0.8326173290258768,0.6896551724137931,0.9408731659065056,1.0,1/12,1.77%,IL1R1
prerank,negative regulation by host of viral process (GO:0044793),0.3699393404128949,0.8325586853033287,0.6686507936507936,0.9243751343371667,1.0,2/10,7.86%,CRP;VAPA
prerank,Fc receptor signaling pathway (GO:0038093),0.22918522696906818,0.8322465244547594,0.8025387870239774,0.9244190793013154,1.0,15/110,13.32%,PDPK1;TEC;GAB2;FER;KIT;MAP3K1;PSMB10;PSMA3;PSME4;PSMA5;PPP3CB;MAP3K7;BTRC;FBXW11;MAPK9
prerank,regulation of cell cycle (GO:0051726),0.20820740437808133,0.8321550966524957,0.8768844221105527,0.9240243856399811,1.0,50/271,16.38%,TCF7L2;SMAD3;NOTCH2;NUPR1;GATA6;SMIM22;FBXL17;PRDM11;BMP2;APBB1;BMP7;BTG4;TGFBR1;PRCC;BIRC3;RNF20;FBXL3;CDKN2B;MAP2K6;CRLF3;ANKRD17;CDK7;E4F1;NUPR2;SND1;GMNN;GRK5;RRP8;CDC14A;NR4A1;TSPYL2;TRIM21;NUDT6;MASTL;THAP1;MAP2K1;WDR6;RARA;CSNK2A2;PML;FIGNL1;FBXL12;IQGAP1;KAT2B;WDR12;LIN9;PKD2;GBF1;INHA;NF2
prerank,hexose biosynthetic process (GO:0019319),-0.2422771978070331,-0.8321526727924022,0.7586206896551724,0.9410573117949337,1.0,15/42,21.55%,PGK1;SLC39A14;ALDOC;GPI;TPI1;ATF4;MDH1;PGAM1;ENO1;PER2;SLC25A13;CRTC2;GAPDHS;SLC25A12;MDH2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.270389393208188,-0.8321227685731778,0.7286995515695067,0.9403633011043536,1.0,8/25,18.17%,STMN2;KIF18A;FGF13;NCKAP5;MAPT;STMN4;TPPP;STMN1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2739044010687729,0.832035922126646,0.7030716723549488,0.9236922794006209,1.0,4/41,7.19%,PRKAG2;RANBP2;TPR;JMJD8
prerank,regulation of secretion (GO:0051046),-0.3301147543026087,-0.8320131998601102,0.6952191235059761,0.9398225878352192,1.0,7/13,32.56%,ACSL3;KCNQ1;EGF;SGK1;POFUT2;FGF10;SCIN
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3638835737436576,0.83166480156797,0.6698473282442748,0.9238240501623863,1.0,3/11,8.47%,TGFBR2;STAT1;WNT5A
prerank,DNA repair (GO:0006281),0.20880436186165668,0.8313749443357212,0.8686493184634448,0.9238144579627943,1.0,69/284,21.52%,EYA1;PDS5B;PARP9;POLH;NUCKS1;WRN;APBB1;SLX4;ASCC3;UBE2U;RAD50;PARP3;DTX3L;FTO;FBH1;BAZ1B;XRCC4;MNAT1;PSME4;USP47;SUMO1;NABP1;UVRAG;RPA3;XRCC1;FANCM;HUWE1;DCLRE1A;CENPX;UBE2V1;RFWD3;ADPRS;RBBP8;FANCE;OGG1;RAD51B;INTS3;GTF2H4;ERCC5;ERCC6;RAD9A;PDS5A;UIMC1;ALKBH1;ERCC1;USP45;MGMT;KMT5C;SMARCAL1;GTF2H2;FANCC;PARP4;WDR33;XPC;ACTR8;TDP2;BRCC3;DNA2;SETD2;NSMCE3;NABP2;ERCC8;KMT5B;POLD3;UBXN1;EYA3;INO80;CHEK2;NSMCE1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2239632660395416,0.8308299029976175,0.8169209431345353,0.9243256581209759,1.0,26/149,14.46%,EIF2AK2;FER;TRAF5;SLCO3A1;CFLAR;IL6;ROR1;TLR4;PRKCZ;MTDH;TRIM5;EDA;IL18;LGALS9;RIPK2;WNT5A;UBE2V1;TLR2;IRAK3;MAP3K7;TRIM21;CRNN;MAP3K13;TICAM1;FLOT2;ALK
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.32821351828080464,-0.8305872514506566,0.7146067415730337,0.9418696286404833,1.0,9/14,32.11%,PLCG2;SEMA7A;CD74;NR4A3;CAMK4;LILRB1;LAPTM5;GPRC5B;BCL10
prerank,midbody abscission (GO:0061952),-0.30194529712925655,-0.8299152365127247,0.7239915074309978,0.9424314671177425,1.0,9/17,30.19%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.33571008526559,0.8297863033525794,0.7,0.9257615157269565,1.0,1/17,0.72%,AKAP13
prerank,positive regulation of cellular protein localization (GO:1903829),0.2469300760461595,0.8296963340771263,0.7454545454545455,0.9253768762263037,1.0,18/69,17.50%,PRKAA2;PARP9;PARD6A;DTX3L;NGFR;GSK3B;YAP1;GPD1L;ENTR1;RTN4;CROCC;EIF2AK3;CEP250;MEAK7;TM9SF4;WWTR1;GAS8;ABCA7
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3152999536062094,0.8294811638389571,0.6831858407079646,0.9252378852688652,1.0,3/22,12.73%,ROCK2;EPHA4;EFNA1
prerank,regulation of mRNA stability (GO:0043488),0.22182874741409164,0.8283406256513083,0.8219749652294854,0.9269038571698387,1.0,21/145,14.96%,ROCK2;TNPO1;SAMD4A;TENT5A;VIM;RC3H1;IGF2BP1;DCP2;FTO;PSMB10;PSMA3;PSME4;NOCT;PSMA5;IGF2BP2;XRN1;EIF4ENIF1;METTL16;FUS;GIGYF2;DIS3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.32873580076058684,0.8277848175377078,0.6782449725776966,0.9274051851184354,1.0,5/18,11.86%,CAMK1D;ADCY1;OPRD1;CRTC1;CRTC3
prerank,mRNA 3'-end processing (GO:0031124),0.24466912972905058,0.8277252732286265,0.7821482602118003,0.9269475302264069,1.0,29/78,24.63%,POLR2D;PCF11;RPRD2;PAPOLG;CDC73;SLU7;SRSF4;MAGOHB;PAF1;DDX39A;THOC5;LEO1;TENT2;PABPN1;SRSF5;CSTF3;APP;PAPOLB;SLBP;GRSF1;WDR33;RPRD1B;TENT4B;SRSF3;SRSF11;CLP1;DDX39B;PAPOLA;SRSF7
prerank,regulation of interleukin-12 production (GO:0032655),0.2692348799181576,0.8274343635433382,0.7529215358931552,0.926914352142668,1.0,8/47,11.49%,IL16;TLR4;CD47;LGALS9;RIPK2;MAPK14;TLR2;IRAK3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.246989288183788,0.8270063556557355,0.7692307692307693,0.9271861873331911,1.0,8/68,8.47%,IL16;IL17D;IL6;TLR4;NOS2;LGALS9;SETD4;WNT5A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.3539804114746901,0.8265953301400518,0.6641221374045801,0.9273919225479768,1.0,3/13,6.49%,PID1;PPARA;NOS2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.29305244226406113,0.8263773910528897,0.7024647887323944,0.9272446765888404,1.0,4/28,8.24%,PTN;ADCY1;GSK3B;EPHA4
prerank,protein complex oligomerization (GO:0051259),0.23615981298379057,0.8263097826409206,0.7791411042944786,0.9268330683912807,1.0,23/85,23.12%,MCU;RNF213;MICU1;PRF1;CLDN1;DNM1L;CUTC;OPA1;TIFA;FUS;PKD2;ATL1;RNF135;IKZF4;JMJD6;ELAVL1;SLC9A1;NACC2;OXA1L;ZC3H12A;PNPT1;SPAST;PRMT1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.2715411527584535,0.8262106391239724,0.7275747508305648,0.9264752984584712,1.0,2/42,1.76%,PDPN;ECM2
prerank,cellular response to leucine (GO:0071233),0.3743039380913015,0.8261716943463829,0.6843177189409368,0.9254395996377,1.0,4/10,22.08%,KLHL22;SESN1;LARS1;RRAGD
prerank,response to leucine (GO:0043201),0.3743039380913015,0.8261716943463829,0.6843177189409368,0.9254395996377,1.0,4/10,22.08%,KLHL22;SESN1;LARS1;RRAGD
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3196834568521544,0.8258882301734988,0.6767317939609236,0.9254215259473828,1.0,19/19,68.07%,ZC3H12A;CARD16;CD33;MEFV;GHSR;FFAR1;GHRL;NLRP2B;IGF1;TNFAIP3;CX3CL1;FFAR4;PYDC1;APOA1;GSTP1;GIT1;CPTP;CX3CR1;NLRP3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.19482731111491172,-0.8258081757112767,0.8888888888888888,0.9497473576530773,1.0,48/125,30.94%,RPS27;KPNB1;EFHC2;RCC2;DYNC1H1;PCNT;KIF18A;XPO1;KIF3B;DYNC1I2;NDE1;CLASP2;PPP1CC;NEK9;CENPU;SKA2;BUB1B;DYNLL2;ZWILCH;CENPT;CENPQ;CENPL;STMN1;TUBG1;MAD1L1;NSL1;CENPN;CENPF;KIF4A;DSN1;KNTC1;SPDL1;TUBG2;DCTN6;CENPA;BCCIP;MAPRE1;SGO1;STIL;BIRC5;ITGB3BP;CLIP1;TBCE;PLK1;ZW10;DLGAP5;NUF2;AURKA
prerank,positive regulation of lymphocyte migration (GO:2000403),0.35455520165643456,0.8254411552369544,0.6549707602339181,0.9256795030010667,1.0,2/12,7.89%,CXCL10;TNFRSF14
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.33861314068830667,-0.8253892949940497,0.6885245901639344,0.949837142401484,1.0,1/11,1.55%,PLCG2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.31760631829744074,-0.8251997573471328,0.712742980561555,0.9494663012603697,1.0,8/14,34.38%,PHACTR4;EMP2;PRKD1;LIMS2;TIMP1;BST1;SLC2A10;ITGB1BP1
prerank,renal water homeostasis (GO:0003091),0.30387033850230144,0.8251836199260212,0.7093235831809872,0.925645527222731,1.0,7/23,21.44%,ADCY5;ADCY7;ADCY1;ADCY6;MYO5B;RAB11FIP2;PRKAR1B
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.32134299967478197,-0.825079203118558,0.7016460905349794,0.9489217709629363,1.0,4/14,19.85%,TMSB4X;MDFI;NFKBIB;CCDC22
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3307496169286535,0.8248944647923441,0.6954022988505747,0.9256507273300596,1.0,2/16,9.13%,AMPD3;PAICS
prerank,activation of protein kinase A activity (GO:0034199),0.3342874441555811,0.8247817428467382,0.675146771037182,0.925316756263207,1.0,3/16,7.01%,ADCY5;ADCY7;ADCY1
prerank,gastrulation (GO:0007369),0.33465575093754174,0.8245103863899087,0.7068645640074211,0.9252923921730652,1.0,5/15,20.75%,LMBRD1;TASOR;NPHP3;SMAD2;MEGF8
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.3197452528099416,-0.8244943221860128,0.6991525423728814,0.9493163293735615,1.0,8/14,37.29%,ENTPD1;ADPRM;NUDT18;NUDT16;NUDT1;ENTPD2;NUDT15;ENTPD3
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3363470835687826,0.8244278999809755,0.68762278978389,0.924890814117772,1.0,14/14,66.39%,MYO9A;PATJ;FSCN1;RAP2A;SH3BP1;SCRIB;CAMSAP3;RHOA;OPHN1;CDC42;EZR;SYNE4;FOXJ1;MSN
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.33931918821321283,0.8244243567067593,0.6856617647058824,0.9243463658737066,1.0,8/16,27.24%,KLHL15;FBH1;SHLD2;RIF1;SMCHD1;SHLD1;FANCB;CGAS
prerank,negative regulation of hippo signaling (GO:0035331),-0.32941217456326743,-0.8243636384605696,0.7084233261339092,0.9488183098086426,1.0,3/12,7.27%,CIT;SHANK2;WWC1
prerank,cortical cytoskeleton organization (GO:0030865),0.272498130789885,0.8236440242688167,0.7416666666666667,0.9252928526523002,1.0,9/41,13.26%,ROCK2;RHOBTB2;RHOF;RHOQ;FMNL2;DLG1;PLEK;RHOC;LLGL2
prerank,histone H2A monoubiquitination (GO:0035518),0.33093840287310133,0.8235785262083208,0.6958174904942965,0.9248553234658428,1.0,8/17,21.94%,BCOR;PCGF5;KDM2B;RING1;RNF2;BMI1;PCGF3;PCGF2
prerank,mitotic nuclear division (GO:0140014),0.24322669316989062,0.8235114421959311,0.7850609756097561,0.9244369282344566,1.0,22/71,23.03%,MAP9;STAG1;CLASP1;KLHL22;KLHDC8B;ESPL1;MISP;UBE2C;ZWINT;CHMP4B;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;RAN;CCDC61;OFD1;INO80;CHEK2;STAG2;SPAST;UBE2S
prerank,regulation of mitochondrial depolarization (GO:0051900),0.36633453060747023,0.823349250407479,0.6963946869070209,0.9241765713673027,1.0,3/10,9.29%,DCN;BCL2;LRRK2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.23871147708954513,0.8232759491957796,0.7987711213517665,0.9237770867141102,1.0,11/80,12.46%,UACA;EPHA7;SH3RF1;DAPK1;SIAH2;NGFR;PDCD5;USP47;FNIP1;MAP2K5;RPS6KA3
prerank,positive regulation of calcium ion import (GO:0090280),0.35375005009678817,0.8227147928874534,0.683495145631068,0.9242844594718962,1.0,2/12,7.70%,PDGFRB;CCL2
prerank,in utero embryonic development (GO:0001701),0.29842131814776907,0.8226890081059782,0.7013888888888888,0.9237919566858331,1.0,4/25,8.99%,ARNT2;BMP2;TGFBR1;IGF2
prerank,cardiac ventricle development (GO:0003231),0.3136224252374629,0.822376286777492,0.7027522935779816,0.9238225766228583,1.0,5/20,14.11%,TMEM65;SALL1;HEYL;HECTD1;MDM4
prerank,regulation of interleukin-13 production (GO:0032656),-0.31973665248521776,-0.8223516205015473,0.7056277056277056,0.9519145181955463,1.0,1/13,0.14%,LEF1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3211348693151875,0.8223091027942879,0.6971428571428572,0.9233958474017351,1.0,6/19,18.88%,ENPP1;TPST1;SULT1A1;ABHD14B;SULT6B1;PAPSS1
prerank,regulation of protein ubiquitination (GO:0031396),0.2283478641784254,0.8221135674592509,0.7926657263751763,0.9232036475861214,1.0,17/108,14.52%,SASH1;PRICKLE1;ANGPT1;CRY1;MYCBP2;TGFBR1;BIRC3;RIPK2;LRRK2;FBXO4;HUWE1;SPOPL;CENPX;CUL3;ARRB1;TBC1D7;RCHY1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.34317734141904876,-0.8220764131674223,0.7022132796780685,0.9517115446956734,1.0,3/10,11.66%,HMGB1;RUNX1;CBFB
prerank,cellular response to amino acid starvation (GO:0034198),-0.21603624963363383,-0.8220474957738472,0.8233532934131736,0.9510254364084821,1.0,25/71,27.31%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;FAS;RRAGB;ATP6V1D;ATF4;CDKN1A;PRKD1;RRAGC;ATP6V1G2;ATP6V0E2;LAMTOR2;ATP6V1F;MLST8;ATP6V0D2;DEPDC5;SH3GLB1;MIOS;LAMTOR4;ITFG2
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.25888033622589696,-0.8218442835080779,0.7465940054495913,0.9506403027251661,1.0,7/33,18.39%,SETX;CSTF2;CPSF2;SYMPK;SNRPB;CSTF2T;SNRPF
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.2832840056159279,-0.8215773002180969,0.7402298850574712,0.9503813075069044,1.0,11/23,41.52%,CALM1;PDE6A;SAG;NMT2;PDE6G;GUCA1B;PDE6B;GUCY2D;GUCY2F;FNTA;GRK4
prerank,regulation of spindle organization (GO:0090224),0.3157453336254641,0.8214087094605854,0.6868131868131868,0.9239813742929337,1.0,5/18,16.55%,MAP9;PARP3;SENP6;FSD1;PSRC1
prerank,cellular protein catabolic process (GO:0044257),-0.22477623887145373,-0.8206039941424503,0.7967479674796748,0.9514871206447479,1.0,11/59,12.58%,CTSC;CTSB;DAB2IP;FAP;LGMN;CTSS;MALT1;CTSL;PSMA6;VLDLR;RAB12
prerank,establishment of protein localization to extracellular region (GO:0035592),0.27270484967000913,0.8205258453703425,0.725752508361204,0.9250897089067746,1.0,4/39,4.72%,ARFGAP3;STEAP3;RAB10;MIA3
prerank,negative regulation of defense response to virus (GO:0050687),0.3706756792500669,0.8204310971552753,0.6856581532416502,0.9247141247703181,1.0,4/10,18.36%,PPM1B;TARBP2;MUL1;PCBP2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.32584029546929266,-0.8193782495639639,0.7207207207207207,0.9530003586834851,1.0,8/13,35.54%,FCER1G;SYK;LPL;ITGB2;CD81;LDLR;PPARG;CD9
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.34116845534980045,0.819322307052781,0.6955684007707129,0.9262165780455243,1.0,1/13,2.18%,GAB2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.34308129935068676,-0.8190062485487702,0.7103174603174603,0.9529631254564352,1.0,5/11,30.44%,TIMM8B;TIMM22;NDUFA13;TIMM10;TIMM13
prerank,RNA stabilization (GO:0043489),0.28156201771207695,0.8190061514784612,0.7182608695652174,0.9262508381747184,1.0,10/33,20.84%,TENT5A;NOCT;EIF4ENIF1;TENT2;FUS;AXIN2;GDNF;DHX36;ELAVL1;PARN
prerank,regulation of T cell cytokine production (GO:0002724),0.3313467518303486,0.8188028721369286,0.6994328922495274,0.9260524393984364,1.0,4/15,12.58%,CD55;FOXP3;MAP3K7;HFE
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.3766290859357708,0.8188026560386609,0.6758747697974218,0.9255069947896752,1.0,3/10,13.96%,TLR4;MIA3;TICAM1
prerank,histone H2A ubiquitination (GO:0033522),0.3229672822865685,0.8187281516929191,0.7210626185958254,0.9251201640963977,1.0,5/17,16.98%,BCOR;DTX3L;KDM2B;RING1;RNF2
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2775418449637336,-0.8187257382039274,0.724373576309795,0.9527160393557529,1.0,8/22,32.98%,MMS19;NDOR1;HSCB;CIAO3;IBA57;ISCU;GLRX5;NUBPL
prerank,positive regulation of reproductive process (GO:2000243),0.2821816301070586,0.8184518989518035,0.6993243243243243,0.9250679834420841,1.0,3/31,3.58%,SMURF2;LHFPL2;FAM170B
prerank,miRNA metabolic process (GO:0010586),0.30989079668052844,0.8179735189885159,0.7279411764705882,0.9254172373198339,1.0,9/20,21.46%,TUT4;SND1;TARBP2;RAN;TUT7;KHSRP;PARN;TENT4B;XPO5
prerank,heterochromatin assembly (GO:0031507),0.312263207721122,0.8175623683817084,0.6937716262975778,0.9256147187147707,1.0,10/20,27.81%,MBD2;BAZ2A;RRP8;ZNFX1;SIRT2;SMCHD1;EZH1;CENPV;SUV39H1;HMGA2
prerank,lipoprotein transport (GO:0042953),-0.3555228312868937,-0.8174162708464101,0.6975717439293598,0.9544022381702594,1.0,2/10,8.69%,PRKCB;VMP1
prerank,regulation of mitotic spindle organization (GO:0060236),0.2771208495724081,0.8173602056592938,0.7184801381692574,0.9254340739757353,1.0,8/35,16.64%,MAP9;PARP3;TPR;FSD1;CHMP3;CHMP4B;PSRC1;EML3
prerank,positive regulation of cell cycle process (GO:0090068),-0.20422505431603405,-0.8171782534988917,0.8654434250764526,0.9540778343730919,1.0,36/91,33.33%,INSR;CIT;RCC2;NSFL1C;DDX11;DYNC1H1;MAP3K20;RANBP1;LRP5;RGCC;PLK4;EGF;ECT2;GEN1;KIF23;SPAG5;E2F7;PRKCE;WIZ;NUP62;RACGAP1;KIF14;CDC14B;RHNO1;EDN1;UBXN2B;RAD21;NUDT16;AURKA;CDC6;FEN1;E2F8;KIF20B;OPN1MW;DBF4;DRD3
prerank,protein stabilization (GO:0050821),0.21565212875498327,0.8170791074584891,0.8428571428571429,0.9254031007136018,1.0,35/168,16.58%,PLPP3;PARVA;WNT10B;APOA2;LAMP2;AAK1;MORC3;CREBL2;USP27X;CTNND1;USP9X;EPHA4;PHB2;STK3;CCNH;NAA16;SUMO1;CDK7;ATF7IP;NAA15;ATP1B2;DVL3;EFNA1;RTN4;MDM4;USP36;FLOT2;VHL;STK4;MUL1;SOX4;PER3;TAF9;TBL1X;CCT6A
prerank,glycogen catabolic process (GO:0005980),0.3330352229412839,0.8170116332625941,0.6731107205623902,0.9249769040130125,1.0,5/15,20.04%,PYGB;PYGM;STBD1;PHKB;PHKA2
prerank,organelle fission (GO:0048285),-0.27370081632361154,-0.8169843146961214,0.7583148558758315,0.9536854739922106,1.0,6/24,21.13%,DNM3;MFF;GDAP1;PEX19;PEX11A;MTFR1L
prerank,regulation of amyloid-beta formation (GO:1902003),0.28151499168913585,0.8167524353701522,0.7325383304940375,0.9249209719874747,1.0,9/34,21.01%,ROCK2;RTN1;EPHA4;EFNA1;RTN4;ABCA7;CASP3;ROCK1;GGA3
prerank,cochlea morphogenesis (GO:0090103),-0.3514607153196514,-0.8167503982933115,0.7151515151515152,0.9533854770577951,1.0,2/10,11.27%,TBX1;PAX2
prerank,sensory organ development (GO:0007423),-0.22904740714193234,-0.8166452389255533,0.7931937172774869,0.9528430802103816,1.0,10/51,13.74%,MEIS2;TGFB2;PBX3;AHI1;ECE1;FREM2;ATF6;BMPR1B;SIPA1L3;SIX4
prerank,regulation of macroautophagy (GO:0016241),-0.20098582653125655,-0.8164384016817036,0.8819672131147541,0.9524718868725112,1.0,29/105,22.76%,ATP6V0A1;KDR;MAPK8;SCOC;ATP6V1B2;EXOC4;SESN3;ATP6V0C;AKT1;SMCR8;HDAC6;PINK1;RRAGB;EPM2A;ATP6V1D;CAPN1;ULK1;CAPNS1;QSOX1;ATP6V0A2;RRAGC;ATP6V1G2;BNIP3L;ATP6V0E2;LAMTOR2;MLST8;ATP6V0D2;CLN3;PAFAH1B2
prerank,stem cell differentiation (GO:0048863),0.27652424114565716,0.8162035362947208,0.7459546925566343,0.9253482718088062,1.0,6/39,9.96%,MLLT3;OSR1;FBXL17;KIT;JARID2;SOX21
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.27238710279179146,0.8161909645740392,0.7372742200328407,0.9248339649460952,1.0,6/40,11.00%,POLH;CRY1;MCL1;NEK4;UBE2V1;RFWD3
prerank,epithelial cell differentiation (GO:0030855),0.23394949841031712,0.8160998695968599,0.7873303167420814,0.9244664162926626,1.0,9/88,8.12%,FSTL1;GATA6;MAF;ANXA1;RAB10;GLI1;ANXA4;GSTK1;ANXA7
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.303658093511079,0.8160381655447099,0.7114337568058077,0.924047743887926,1.0,8/22,23.93%,MAN1C1;AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;EDEM1
prerank,regulation of cholesterol transport (GO:0032374),0.31438219833313086,0.8157416057019902,0.6725043782837128,0.9240348833414747,1.0,2/20,6.01%,APOA2;NR1H3
prerank,regulation of platelet aggregation (GO:0090330),0.32251923966190443,0.8156910675190256,0.6896551724137931,0.9235854845134055,1.0,1/17,0.30%,PDPN
prerank,response to interleukin-6 (GO:0070741),0.3597099646250945,0.8153803908014661,0.6795366795366795,0.9236215138151743,1.0,1/10,1.34%,PID1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.23407971492952434,0.8153381117669676,0.8014598540145985,0.9231625947033876,1.0,10/85,10.29%,PRICKLE1;SMURF2;FZD2;PARD6A;CELSR1;PSMB10;WNT5A;PSMA3;PSME4;PSMA5
prerank,cellular response to interferon-beta (GO:0035458),-0.3183833359965371,-0.8150521756766977,0.7372881355932204,0.9542338967960431,1.0,6/14,29.30%,AIM2;IFITM2;IRGM;NDUFA13;CDC34;UBE2G2
prerank,exit from mitosis (GO:0010458),-0.3239533942073477,-0.8149239837205925,0.7015590200445434,0.9537225946534911,1.0,6/12,23.37%,EPS8;CTDP1;CLASP2;CHMP7;SIRT7;CHMP2A
prerank,cellular response to heat (GO:0034605),0.2802494660552263,0.8141952274512466,0.7475083056478405,0.9246432715735203,1.0,5/35,9.33%,FGF1;POLR2D;TPR;SLU7;SUMO1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3552692546189734,0.8141695288182159,0.6867469879518072,0.924146046991217,1.0,3/10,15.46%,CREBBP;ESCO1;KAT2B
prerank,response to organonitrogen compound (GO:0010243),-0.24021064745206955,-0.8137853437686475,0.7655502392344498,0.9550335423013157,1.0,11/38,21.52%,GLRA3;SEL1L;BRSK2;CCDC47;RRAGC;KAT7;GLRA2;GLRA1;UBXN6;KYNU;TRPM2
prerank,regulation of exosomal secretion (GO:1903541),0.3170459295230581,0.8136297160731882,0.7182835820895522,0.9245713071197107,1.0,1/19,1.31%,SMPD3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3234591229886283,0.8136061580377812,0.7018867924528301,0.9240741338373368,1.0,1/15,0.46%,TEC
prerank,embryonic axis specification (GO:0000578),0.33227962518844034,0.813374783151209,0.6735849056603773,0.9239359571859256,1.0,4/15,18.81%,SMAD6;TASOR;SMAD2;PTCH1
prerank,glycolipid biosynthetic process (GO:0009247),-0.24643783960668292,-0.8131149522097748,0.740909090909091,0.9555277600159832,1.0,13/38,22.26%,ST8SIA6;MPPE1;ST6GALNAC5;PIGM;PIGU;PIGQ;PIGH;DPM2;ST3GAL4;PIGO;ST8SIA5;B4GALT6;PIGB
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.31102412281016145,-0.8131100702669797,0.7008733624454149,0.9547941191590742,1.0,5/15,19.50%,ELOVL5;PPARD;NR4A3;MID1IP1;SLC45A3
prerank,calcium ion import into cytosol (GO:1902656),-0.31328705237503673,-0.8125376873688691,0.7265135699373695,0.9550366090386299,1.0,2/15,5.50%,SLC24A2;SLC8A1
prerank,response to amino acid starvation (GO:1990928),-0.21310810504029026,-0.8119102972220777,0.8323353293413174,0.9554257770353101,1.0,25/72,27.31%,MAP3K5;MAPK8;ATP6V1B2;DAPL1;MAPK3;SESN3;ATP6V0C;FAS;RRAGB;ATP6V1D;ATF4;CDKN1A;PRKD1;RRAGC;ATP6V1G2;ATP6V0E2;LAMTOR2;ATP6V1F;MLST8;ATP6V0D2;DEPDC5;SH3GLB1;MIOS;LAMTOR4;ITFG2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2141570077229956,-0.8116974121524403,0.8642659279778393,0.9550916186726809,1.0,19/65,24.51%,PSMC3;PSMD14;PSMD3;PSMD4;PSMD6;PSMA6;PSMA4;PSMB8;PSMA8;PSME1;CHEK1;PSMD7;PSMC6;PSMB5;PSMC5;PSMB1;SKP1;PSMD11;PSMD8
prerank,nucleotide biosynthetic process (GO:0009165),0.31155871428923143,0.8116945504073819,0.7093235831809872,0.9263953829438798,1.0,4/18,11.66%,MTHFD1;RRM1;PRPSAP1;RRM2B
prerank,peptide metabolic process (GO:0006518),0.24023112682191294,0.8116141908030442,0.7899543378995434,0.92599704972867,1.0,13/75,14.01%,CPQ;ANPEP;AEBP1;MGAT3;NPEPPS;CLN5;SPPL3;GSTK1;ERAP1;NLN;GSTA3;CPXM2;LNPEP
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.34294979911222156,0.811537866987887,0.6850828729281768,0.9255963355551663,1.0,1/12,4.74%,BMP7
prerank,regulation of epidermal cell differentiation (GO:0045604),0.30319899870400346,0.8111080524460719,0.7019400352733686,0.9258418993870966,1.0,2/21,4.74%,ROCK2;ERRFI1
prerank,mesenchymal cell development (GO:0014031),-0.2962258277031523,-0.8103688484207031,0.7436974789915967,0.956783226773833,1.0,2/18,2.33%,CDH2;NOTCH1
prerank,autophagosome assembly (GO:0000045),-0.2269519906876887,-0.8103684026154043,0.8382749326145552,0.9560426824806644,1.0,13/52,19.24%,GABARAP;NSFL1C;GABARAPL1;ATG16L1;VMP1;ATG9A;MFN2;TP53INP2;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.289462118718702,0.8103517017500584,0.7295918367346939,0.9266587536425093,1.0,3/28,6.63%,PRKAG2;PRKAA2;CD47
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3107738469555721,0.8103411670299931,0.7048300536672629,0.9261357003649576,1.0,3/19,7.85%,TLR4;LY96;LGALS9
prerank,regulation of cell projection organization (GO:0031344),-0.32191461567384594,-0.8102170532645661,0.7265135699373695,0.9556124172508473,1.0,7/13,20.68%,SEMA4D;MACF1;ERMN;MFSD2A;CCL19;NTNG1;NTNG2
prerank,monosaccharide transmembrane transport (GO:0015749),-0.30234874607781426,-0.8101828843435998,0.7380952380952381,0.9549384080869688,1.0,8/16,31.97%,SLC2A9;SLC50A1;SLC45A3;SLC2A2;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,regulation of hippo signaling (GO:0035330),0.32006531966121726,0.8100928046973824,0.7057761732851986,0.926057612254459,1.0,8/17,19.69%,NEK8;WWC2;MAPK14;VGLL4;NF2;WTIP;DLG5;AJUBA
prerank,steroid hormone biosynthetic process (GO:0120178),-0.25697353839441,-0.8093434587611029,0.7837209302325582,0.955680644314073,1.0,6/29,20.59%,STARD3NL;SRD5A3;FDXR;HSD17B7;DHCR7;HSD17B8
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.2341919911212504,-0.80775961072784,0.8063660477453581,0.9578708228245396,1.0,10/45,23.15%,PIK3R1;LIN28B;SETX;BMP4;EGFR;HRAS;SIRT7;HNRNPLL;HEATR1;SLC38A2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.33951834683321547,-0.8076027276583201,0.7170626349892009,0.9574341208041525,1.0,3/10,13.69%,DIS3L2;UBB;UBA52
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.34479357113349046,0.8072150909393789,0.694,0.9306219708303978,1.0,6/12,23.92%,UBE2C;BTRC;GOLGA2;PTEN;UBE2S;GORASP1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.317040608614244,-0.8067374571437429,0.7373949579831933,0.9582433551635666,1.0,2/13,4.86%,CSPG4;HEXB
prerank,cytoplasmic microtubule organization (GO:0031122),0.25472293499572535,0.8066829906032563,0.7781350482315113,0.931061175339286,1.0,12/54,15.16%,CLASP1;CLIP4;KATNAL1;CCDC13;DLG1;TUBGCP4;FIGN;SLAIN2;FSD1;TUBGCP2;TUBGCP5;FIGNL1
prerank,dorsal/ventral pattern formation (GO:0009953),0.3161260358627342,0.8066476712843129,0.7014925373134329,0.9305923034858578,1.0,2/20,2.58%,BMPR1A;NBL1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.29041413947749334,-0.8064856108649688,0.7278761061946902,0.9579759596535601,1.0,4/17,13.08%,PDE3B;SORL1;AKT1;MFSD2A
prerank,nucleocytoplasmic transport (GO:0006913),0.26812989429096823,0.806326547867951,0.7790143084260731,0.930616562940802,1.0,2/40,2.08%,ATXN1;GEMIN4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.29625811368924065,0.8063211726424434,0.7140350877192982,0.9300896404976813,1.0,3/21,5.89%,CHST15;DCN;CHSY1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.31713952793685785,0.806071384033069,0.7368421052631579,0.9299823918134519,1.0,2/18,6.20%,SELP;VCAM1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2917765646137146,0.8057263457024209,0.7322970639032815,0.9300386134740034,1.0,4/26,9.25%,ADAMTS1;ANXA1;CCND3;ANKRD17
prerank,cellular response to starvation (GO:0009267),0.21599127682950647,0.8050631976435201,0.8559892328398385,0.9306579617783921,1.0,27/147,16.27%,RNF152;PRKAG2;PRKAA2;EIF2AK2;GCGR;WRN;LAMP2;MTMR3;CARTPT;PPARA;STK24;LRRK2;NUPR2;FNIP1;RRP8;SESN1;FOXO3;SLC38A9;TCIRG1;WDR45B;NPRL3;ATP6V0B;NUAK2;EIF2AK3;ATP6V1E1;ATP6V1C1;LARS1
prerank,outer dynein arm assembly (GO:0036158),0.32774249867868255,0.8048680880378308,0.725897920604915,0.93047943621847,1.0,3/15,10.12%,ODAD4;DNAAF1;DNAL1
prerank,regulation of establishment of protein localization (GO:0070201),0.34144243268825175,0.8046036655681361,0.7421150278293135,0.9304416110062967,1.0,4/14,17.03%,CENPJ;SPIDR;SCFD1;CORO2B
prerank,plasma membrane repair (GO:0001778),0.33962773459634105,0.8043436489220291,0.7192307692307692,0.9303451828112653,1.0,1/13,1.42%,MYOF
prerank,cell cycle G1/S phase transition (GO:0044843),-0.21912380362949171,-0.8041848274283735,0.8426966292134831,0.9613375855548815,1.0,13/61,15.60%,USP29;CDK6;MAX;MAP3K11;CAMK2A;CCND1;BCAT1;ACVR1;HINFP;USP37;CDK2;CDKN1A;CDK4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3065864983173515,-0.8041111856213654,0.734341252699784,0.9607372349549503,1.0,6/15,22.27%,REEP1;ARL6IP1;ZFYVE27;ATL2;RTN3;RAB18
prerank,histone lysine demethylation (GO:0070076),-0.2638185292866439,-0.8038947101272076,0.7738927738927739,0.960389417273229,1.0,8/25,17.19%,JMJD1C;RIOX2;KDM4D;KDM4C;KDM4A;KDM5C;PHF2;HR
prerank,regulation of gene silencing by miRNA (GO:0060964),0.24501203599648053,0.8038477637862133,0.8027950310559007,0.9306890253143654,1.0,20/62,25.23%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;POU5F1;NUP37;WTIP;PUM2;NUP85;AJUBA;POLR2K;ELAVL1;DHX9;TGFB1;NUP160;NUP107;POLR2H
prerank,negative regulation of phosphatase activity (GO:0010923),-0.26632235419305494,-0.8035136101299607,0.7394366197183099,0.9603156884836644,1.0,4/25,8.46%,TGFB2;FKBP1A;SEMA4D;PPP1R11
prerank,mitotic spindle assembly (GO:0090307),0.26370481785897804,0.803451538649026,0.7495769881556683,0.9308612408177284,1.0,12/42,22.72%,MAP9;STAG1;CLASP1;MISP;TOGARAM1;TOGARAM2;SPICE1;GOLGA2;CCDC61;OFD1;CHEK2;STAG2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.25690807021138473,0.803077076213971,0.7703583061889251,0.9309713351736082,1.0,15/52,22.31%,SHMT1;SLC19A1;MTHFD1;IDH1;ME2;MDH1B;D2HGDH;IDH2;PHYH;ADHFE1;HOGA1;ASS1;MTHFD2L;HAAO;MTHFD1L
prerank,RNA splicing (GO:0008380),0.22560787157835935,0.8027696183903394,0.8184480234260615,0.9309682178218952,1.0,27/95,20.26%,SNRPA1;ZRSR2;LSM1;NOVA1;HNRNPC;SF3B3;DDX23;SLU7;CDK12;RNPC3;SRSF4;DHX16;HNRNPH3;MAGOHB;USB1;DHX8;SRPK1;ZMAT5;FUS;TXNL4A;PPP2CA;WBP4;SCAF11;USP39;PRPF3;SNRNP40;KHSRP
prerank,protein acetylation (GO:0006473),0.28205276454238304,0.8026896342739478,0.7646048109965635,0.9305647542529102,1.0,10/30,20.12%,CREBBP;NAA16;ESCO1;NAA15;KAT6A;KAT2B;NAA35;DSCC1;CLOCK;NAA40
prerank,UV protection (GO:0009650),0.36773333986446555,0.802603195930523,0.6770186335403726,0.9301819849475389,1.0,2/10,14.03%,SCARA3;ERCC5
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.32808719243321793,0.8025468458621393,0.7061068702290076,0.9297434907539267,1.0,2/15,3.02%,FOXC1;NCOA3
prerank,lipoprotein localization (GO:0044872),0.36065243603637853,0.8020729973790528,0.6880733944954128,0.9300251135520098,1.0,5/11,20.27%,MIA3;ZDHHC3;ZDHHC17;LRP1;CD36
prerank,phospholipid catabolic process (GO:0009395),0.29902046773110347,0.8019858983672267,0.7345132743362832,0.9296405071101251,1.0,4/24,10.73%,PLA2G4A;APOA2;PLA2G4C;ENPP2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2341687568170026,-0.8012449970095834,0.837378640776699,0.9636075372732662,1.0,14/46,24.27%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;IL12RB2;MTAP
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2634652552605719,0.8004265672459435,0.7648054145516074,0.9318079866106351,1.0,7/40,11.00%,NUCKS1;WRN;TONSL;FBH1;FANCM;CENPX;RFWD3
prerank,acute inflammatory response (GO:0002526),0.28781201082322294,0.8001363676830262,0.7269503546099291,0.931789833298787,1.0,4/23,13.69%,IL6;CRP;ANO6;IL22
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.27790430882259853,-0.7997765356675772,0.7670588235294118,0.9654449847556407,1.0,5/21,16.37%,KDR;MAPK3;KARS1;EGF;HTR2B
prerank,positive regulation of telomere maintenance (GO:0032206),-0.24451170019053625,-0.7997524423099274,0.7780373831775701,0.9647507085386435,1.0,9/31,19.98%,PRKCQ;NEK7;MRE11;MAPK3;ATM;PNKP;PKIB;GNL3;PPP1R10
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.28362045642582523,0.7995647295007078,0.7304964539007093,0.9322242098790681,1.0,11/26,26.27%,PPM1B;IRAK3;TRIM21;TRIB1;MUL1;PCBP2;SIRT2;NMI;MAPKBP1;CARD16;TYRO3
prerank,glucose import (GO:0046323),-0.31580149434331417,-0.7989084552786272,0.7348178137651822,0.9654644349183469,1.0,4/13,19.14%,SLC2A1;SORT1;ZDHHC7;SLC2A4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.18570348260268926,-0.7984264829431638,0.9381818181818182,0.9655273006399262,1.0,51/148,27.66%,RPS15;RPL5;RPL11;TAF15;MRE11;JMY;RPS20;AKT1;PHF20;STK11;TAF3;SSRP1;RFFL;HDAC1;PPP1R13B;ATM;BARD1;RPL23;TAF9B;TAF11;CDK2;RMI2;BRCA1;RPL37;RAD1;CCNG1;PIP4P1;L3MBTL1;RFC4;CHEK1;NOC2L;PRMT5;MLST8;USP2;ATRIP;ATR;BRPF1;PRR5;SGK1;CDK5;RBBP7;EXO1;PIP4K2A;RHNO1;RFC5;HIPK2;RFC2;CSNK2B;BLM;CHD5;MAPK11
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.22046560698652928,0.7983583264502149,0.8531571218795888,0.9338200591302607,1.0,29/101,23.55%,PLD1;SAMD4A;VIM;DACT1;IL6;NR1H3;ZCCHC4;CSF1;VGLL4;BTRC;FBXW11;HDAC2;SOX4;CPEB3;CYFIP2;UPF3A;ATG10;FXR2;PLXNB2;ASPH;ERBB2;ELAVL1;IST1;AGT;VPS35;ATG7;METTL5;YTHDF3;TGFB1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.32202138021899085,0.7982097695976939,0.7353497164461248,0.9335540930746734,1.0,3/15,7.91%,FSTL3;DACT1;SKI
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.27753830283958275,-0.7974746545207422,0.7636761487964989,0.966399890749755,1.0,13/22,41.54%,VPS37B;MVB12B;RNF126;VPS37A;VPS28;SNF8;PLAA;PTPN23;VPS4B;STAM;UBAP1L;UBAP1;VPS25
prerank,positive regulation of translation (GO:0045727),-0.20116514590126738,-0.7970385801948864,0.9058441558441559,0.9663966754744236,1.0,32/94,27.89%,THBS1;RPS9;RPL26;RPL5;PKM;RPS4X;EEF2;CNBP;NPM1;YTHDF2;EIF5A;EIF5AL1;CDC123;FASTKD2;PASK;EIF5A2;RBM3;BCL3;POLDIP3;C1QBP;UHMK1;NIBAN1;PYM1;EIF6;RCC1L;TRMT10C;POLR2G;HNRNPD;METTL14;RPUSD3;PRR16;BOLL
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2966914966967613,0.7967855143678709,0.7518656716417911,0.9354811269161765,1.0,4/22,10.29%,PSMB10;PSMA3;PSME4;PSMA5
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2679464241735084,0.7967714129392895,0.7635135135135135,0.9349708980980567,1.0,8/36,15.39%,NRP1;NCOA3;TGFA;CCL2;HFE;ADRA2C;HDAC2;ADRA2A
prerank,atrial septum development (GO:0003283),-0.3147824537059114,-0.7964389329672493,0.7361702127659574,0.9666967827096887,1.0,3/13,9.13%,TGFB2;BMPR2;ZFPM1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2224487898991227,0.7959772755087587,0.8453038674033149,0.9357825154511339,1.0,10/107,8.35%,RASGRF1;ITPR1;CREB3L2;UBA5;BCL2;CASP4;CREB3L3;GSK3B;QRICH1;BAX
prerank,endoplasmic reticulum organization (GO:0007029),-0.2103344411644595,-0.7957103057949519,0.8496932515337423,0.9671982283439698,1.0,31/72,31.47%,REEP1;DOP1B;LMAN2L;REEP5;SHTN1;SERP1;CAV2;TRAM1;LMAN1;VCPIP1;CCDC47;TOR1B;WDR83OS;SEC61A1;ATL2;SEC61G;RTN3;CYB5A;TOR1AIP2;RAB18;HMOX1;TRAM1L1;GET1;SEC61B;STX18;REEP4;VAMP2;SPTSSB;BNIP1;TRDN;LPCAT3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.316551098581539,-0.7944707382132054,0.7505330490405118,0.9686294457102093,1.0,5/13,33.22%,CD74;PTTG1IP;MIF;YJU2;MDM2
prerank,natural killer cell activation (GO:0030101),0.2926434730730506,0.7939534825578423,0.7329545454545454,0.9387570349267575,1.0,4/23,12.03%,AXL;ELF4;PBX1;SNX27
prerank,heme biosynthetic process (GO:0006783),-0.27203962981528684,-0.7937931152034148,0.7391304347826086,0.9690094888519318,1.0,1/22,0.19%,ABCG2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2348571636050877,0.7937552428254924,0.7980456026058632,0.9385609686737054,1.0,23/69,22.92%,POLR2D;RPRD2;INTS9;NABP1;CDK7;POLR2C;INTS14;POLR2F;POU2F1;INTS3;INTS8;SNAPC3;TAF9;INTS13;SNAPC5;RPRD1B;INTS6;NABP2;POLR2K;SNAPC4;SRRT;SP1;ELL
prerank,NAD biosynthetic process (GO:0009435),0.30821087992382773,0.7935679008331658,0.7276190476190476,0.9383472863969777,1.0,7/20,22.06%,PARP9;PARP10;PARP16;PTGS2;NADSYN1;QPRT;HAAO
prerank,primary alcohol metabolic process (GO:0034308),0.29118765706074595,0.7924737097669378,0.7473684210526316,0.9396253800274058,1.0,5/25,16.06%,RDH10;RBP4;NAAA;PECR;NAPEPLD
prerank,positive regulation of T cell proliferation (GO:0042102),0.24589627472313785,0.7923672679681096,0.7971014492753623,0.9392626566057812,1.0,7/55,8.99%,IL6ST;ANXA1;IL6;VCAM1;IL18;CD274;IGF2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3389225756278652,0.792271902950984,0.7263374485596708,0.938892554393311,1.0,3/12,15.66%,HEYL;SMARCA4;DAB2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.35093177452117974,0.7922296440069194,0.7264150943396226,0.9384310974448806,1.0,5/11,23.55%,IL6;MAP2K1;DDX5;RIPK1;TGFB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3232517645491585,-0.7918684527264077,0.7367205542725174,0.9715245205057745,1.0,7/11,35.26%,ATF6;ATF4;HSPA5;CREB3L1;MBTPS2;TP53;DDIT3
prerank,regulation of myelination (GO:0031641),0.2889056318183608,0.7910954523652733,0.7481884057971014,0.9398057446892627,1.0,1/25,0.48%,PTN
prerank,positive regulation of ERAD pathway (GO:1904294),-0.31233567154098874,-0.7905575848935105,0.7618025751072961,0.9729632783667826,1.0,6/13,28.13%,BAG6;USP13;CAV1;ATXN3;TMEM259;HERPUD1
prerank,regulation of neuron projection arborization (GO:0150011),-0.3091516843432319,-0.7903903155030714,0.7644444444444445,0.9725115795720636,1.0,7/15,20.68%,MACF1;GRIP1;DVL1;MFSD2A;FZD4;NTNG1;NTNG2
prerank,protein localization to chromatin (GO:0071168),-0.2833199010531372,-0.7902434116907827,0.7584745762711864,0.972016795293259,1.0,8/18,32.70%,ESR1;MCM9;CHMP7;SGF29;RAD21;PLK1;PIH1D1;RUVBL2
prerank,regulation of protein transport (GO:0051223),-0.258230342321524,-0.7900007440672496,0.7948051948051948,0.9716852156809628,1.0,7/27,19.62%,HSPA8;SNX3;STXBP5L;RHBDF2;LCP1;PPM1F;DISP1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23250450371363374,0.7895628769157803,0.8264094955489614,0.9418499758610402,1.0,13/76,15.48%,LPAR1;FPR2;F2RL3;C5AR2;PLCE1;ACTN2;OPRD1;NMUR1;P2RY6;GPR65;P2RY1;ADRA2A;CCKBR
prerank,negative regulation of MAPK cascade (GO:0043409),0.22527761962896053,0.7891963128898601,0.8364963503649635,0.9419245707012858,1.0,13/87,12.68%,TIMP3;DAG1;FBLN1;DUSP10;TLR4;BMP7;PTPN2;PPEF2;DLG1;IRAK3;SMAD4;SH2B3;PTPN1
prerank,global genome nucleotide-excision repair (GO:0070911),0.28571083852844326,0.7891031563194777,0.7677966101694915,0.9415373596452472,1.0,7/26,19.03%,CUL4A;RNF111;GTF2H4;ERCC1;USP45;GTF2H2;XPC
prerank,nucleosome organization (GO:0034728),-0.2189274376463409,-0.7883747852209315,0.8503937007874016,0.9736267774104581,1.0,12/55,16.30%,H3-3A;ZNHIT1;LIN54;NPM1;SART3;SMARCB1;ASF1A;H1-0;ANP32B;SPTY2D1;DMAP1;SET
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.3391680462100483,-0.7882497698077102,0.7406679764243614,0.9730925003141663,1.0,4/10,35.52%,PDE6A;SAG;PDE6G;PDE6B
prerank,regulation of endocytosis (GO:0030100),-0.21205537155896773,-0.7874308924684653,0.8781869688385269,0.9737240229683615,1.0,15/61,20.22%,HIP1;RIT2;MCTP1;SNCA;SCAMP5;HIP1R;NEDD4L;RAB5C;CCL19;PRKD1;CBLL1;LRSAM1;MTMR2;SNX17;DLL1
prerank,protein heterotetramerization (GO:0051290),-0.31121601664710696,-0.7871888626982402,0.7829787234042553,0.9733929341123143,1.0,4/13,20.59%,GRIN2B;GRIN1;FARSB;HSD17B8
prerank,chromatin remodeling at centromere (GO:0031055),-0.2478193832505126,-0.7863455963357507,0.8186046511627907,0.9741018621101257,1.0,11/31,26.66%,NPM1;HELLS;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2958556851668144,0.7863269555767143,0.7785714285714286,0.9456958530162995,1.0,5/24,19.80%,PLA2G4A;SERAC1;LPGAT1;PLA2G5;SLC27A1
prerank,visual system development (GO:0150063),-0.23587415737076026,-0.7859158898968293,0.84688995215311,0.974095980402147,1.0,13/37,25.78%,MEIS2;TGFB2;PBX3;FREM2;ATF6;BMPR1B;SIPA1L3;SMOC1;SOX2;C3;RAB18;MAB21L2;HIPK2
prerank,negative regulation of bone remodeling (GO:0046851),0.3368890761422111,0.7858600001123348,0.7344064386317908,0.9459266789381054,1.0,2/11,6.28%,IL6;CARTPT
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.24914019357732545,0.7855226327410566,0.8163265306122449,0.9459317610840762,1.0,7/48,10.41%,DOCK5;NRP1;S100A10;MYADM;CUX1;TRIOBP;CUX2
prerank,error-prone translesion synthesis (GO:0042276),0.2987613516137726,0.7851094398594309,0.7450271247739603,0.9460951948748335,1.0,4/21,9.92%,POLH;RFC1;REV1;RPA3
prerank,B cell proliferation (GO:0042100),0.3103897446706999,0.7849686897751402,0.7454545454545455,0.9457969215168758,1.0,2/17,4.90%,CTPS1;BCL2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.2951199662119866,-0.7847766134157858,0.7453416149068323,0.975292760840286,1.0,4/14,13.22%,THBS1;MAPK3;CMKLR1;CSF1R
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3131844206688441,-0.7842868366634446,0.7682119205298014,0.9753892414311165,1.0,6/12,33.60%,MBTPS1;KPNB1;MBTPS2;DGKQ;LPCAT3;ABCA2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.313007913328112,0.7842044657727106,0.7178502879078695,0.9464923012429404,1.0,3/16,13.28%,WRN;MCM4;MCM6
prerank,regulation of phosphatase activity (GO:0010921),0.2910985811877976,0.7840034601594827,0.7626527050610821,0.9462997174791902,1.0,7/24,23.62%,BMP2;PPP1R35;PPP6R3;URI1;SH2D4A;CDK5RAP3;PPP1R2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.24813861549412358,-0.7833422955537136,0.7966507177033493,0.9761883951289326,1.0,13/30,30.68%,NOS3;ARHGEF2;RFFL;FAS;TMBIM1;PARK7;BRCA1;BMP5;TNFRSF10B;HMOX1;FADD;TRAF2;TRADD
prerank,protein tetramerization (GO:0051262),0.23364888277110135,0.7823525172367018,0.8400621118012422,0.9485508225397743,1.0,4/67,6.32%,ALDH1A2;SHMT1;APPL2;GBP5
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.296045120291864,-0.7810965329175226,0.7590618336886994,0.9790552323684857,1.0,7/15,37.60%,CCT5;NOP10;RUVBL2;NHP2;CCT7;SHQ1;CCT8
prerank,protein lipidation (GO:0006497),-0.21628179804591827,-0.7808405144879526,0.8912466843501327,0.9787404673668948,1.0,19/59,26.20%,MPPE1;ZDHHC14;ZDHHC20;PIGM;PIGU;ZDHHC2;PIGQ;PIGH;DPM2;PIGO;ZDHHC7;PIK3C3;ZDHHC23;PIGB;ZDHHC9;WDR45;UGCG;ZDHHC5;SELENOK
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2664599324229332,0.7794612492963254,0.7766830870279147,0.9527710603689784,1.0,7/35,12.43%,RFC1;POLG;NTHL1;RPA3;XRCC1;ADPRS;OGG1
prerank,protein-containing complex disassembly (GO:0032984),-0.21751155704070727,-0.7790361861372133,0.8823529411764706,0.9808936531925327,1.0,11/54,12.95%,HSPA8;CTNNB1;GABARAP;GABARAPL1;LRP6;VPS33B;DVL1;PPP1CA;RPL23;TECPR1;CAV1
prerank,monocyte chemotaxis (GO:0002548),0.26655318066807365,0.7787969680994814,0.7884940778341794,0.9532953907213624,1.0,4/32,7.70%,ANXA1;IL6;MSMP;CCL2
prerank,L-serine metabolic process (GO:0006563),0.3471547209134058,0.7786898382863114,0.7379182156133829,0.9529328495719968,1.0,2/10,4.12%,SHMT1;PHGDH
prerank,negative regulation of ion transport (GO:0043271),-0.2573976773603433,-0.77784122801167,0.7987012987012987,0.9819538738307122,1.0,5/24,10.30%,PTK2B;GPM6B;SNCA;INPP5K;NOS1
prerank,histone deubiquitination (GO:0016578),0.30130241528809504,0.7776580197904464,0.7623574144486692,0.9540302989045876,1.0,6/18,19.95%,ATXN7;USP36;UIMC1;USP15;BRCC3;USP7
prerank,snRNA transcription (GO:0009301),0.22927588489105463,0.7775612089517319,0.8233387358184765,0.953650674592496,1.0,23/70,22.92%,POLR2D;RPRD2;INTS9;NABP1;CDK7;POLR2C;INTS14;POLR2F;POU2F1;INTS3;INTS8;SNAPC3;TAF9;INTS13;SNAPC5;RPRD1B;INTS6;NABP2;POLR2K;SNAPC4;SRRT;SP1;ELL
prerank,inner ear morphogenesis (GO:0042472),0.2837834280236963,0.7775504987509801,0.7613019891500904,0.9531310793176083,1.0,3/22,7.71%,ZIC1;TTC39C;TIFAB
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.28018262545148565,-0.7774162813830335,0.7707423580786026,0.9819089053357788,1.0,7/17,36.75%,SEL1L;SEC61B;HERPUD1;UFD1;HM13;AUP1;DERL1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.33498573498901474,0.7773186678562263,0.7657657657657657,0.9529807504993334,1.0,4/12,15.26%,SGTA;SEC63;CHMP4A;CHMP4B
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.25876198492140595,0.7770551525612848,0.8019017432646592,0.9528591887246101,1.0,9/39,17.30%,CUL4A;RFC1;NTHL1;RPA3;OGG1;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,regulation of protein import into nucleus (GO:0042306),0.26454605804624354,0.7769501138670882,0.7913188647746243,0.9524948167613443,1.0,3/36,5.82%,SMAD3;ZIC1;TPR
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.23143563029214842,-0.7761024252599298,0.8545034642032333,0.9832555963866301,1.0,15/38,29.85%,H3-3A;NPM1;ASF1A;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;IPO4;CENPA;RBBP7;ITGB3BP;ASF1B;OIP5
prerank,autophagosome organization (GO:1905037),-0.21750584669993736,-0.7760459001212698,0.876010781671159,0.9826163057883119,1.0,19/50,30.66%,GABARAP;NSFL1C;GABARAPL1;ATG16L1;VMP1;ATG9A;TP53INP2;ULK1;ATP2A2;IRGM;RAB1B;PIK3C3;WDR45;ULK3;UBXN2B;MAP1LC3B;STX12;RAB1A;WIPI1
prerank,smooth muscle tissue development (GO:0048745),-0.32911999429641825,-0.7737349654231914,0.762396694214876,0.9855620107193186,1.0,2/10,8.07%,BMP4;MYLK
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.26718130992752875,-0.7736055409280528,0.8102345415778252,0.9850013144967704,1.0,5/21,13.56%,RPIA;PGM2L1;TKT;GPI;TALDO1
prerank,keratan sulfate catabolic process (GO:0042340),0.3440445385871275,0.7734474733510109,0.7383177570093458,0.9575907911076128,1.0,3/11,17.17%,OMD;PRELP;OGN
prerank,neuromuscular process (GO:0050905),-0.2892524410394358,-0.7734413459597606,0.7946611909650924,0.9845369289473097,1.0,6/16,22.59%,NRXN1;GCH1;SHANK1;KCNA1;DCTN1;CLN3
prerank,dendritic cell differentiation (GO:0097028),0.29534144418486064,0.7733654352658555,0.7663716814159292,0.9571829951382296,1.0,3/22,7.85%,AXL;TGFBR2;LGALS9
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.32037721046646406,0.7733052852239326,0.7650273224043715,0.9567273684864478,1.0,2/14,8.66%,OSR1;ZEB1
prerank,autophagy of mitochondrion (GO:0000422),0.2571215054063134,0.7725335892547741,0.8066666666666666,0.9574184523707463,1.0,8/38,17.87%,AMBRA1;SPATA18;PHB2;ATG12;WDR45B;ATG2A;FUNDC1;WIPI2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.2697015876141354,-0.7723608582209699,0.8111888111888111,0.9854319356289418,1.0,7/21,27.49%,ABCA3;EEPD1;CAV1;RXRA;TREM2;GPS2;NR1H2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.32515045765830203,-0.7716264690362161,0.7541666666666667,0.9858489561508037,1.0,2/11,10.16%,PRKCQ;MALT1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.32501303430080236,-0.7715945636066563,0.7546777546777547,0.9851652671773792,1.0,4/10,18.00%,SNX3;TERF1;MAPT;PPM1F
prerank,regulation of T cell proliferation (GO:0042129),0.23500828565423298,0.7714189710511332,0.8212634822804314,0.9586738671472652,1.0,6/61,7.89%,IL6ST;ANXA1;IL6;FOXP3;VCAM1;CD274
prerank,proton transmembrane transport (GO:1902600),0.2621639039488551,0.7712409929432882,0.8023450586264657,0.9584099034499565,1.0,4/36,9.79%,ATP1A2;SLC4A11;NNT;OTOP1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3475422634472265,0.7704200315124919,0.7529411764705882,0.9591678706379657,1.0,1/10,1.61%,PRKAA2
prerank,protein K63-linked deubiquitination (GO:0070536),-0.24105003145883924,-0.7701279718792607,0.8255528255528255,0.9866619415934029,1.0,11/31,22.82%,OTUD7A;PSMD14;BABAM1;USP13;ZRANB1;OTUD1;CYLD;YOD1;ATXN3;OTUB2;SHMT2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2264939936991655,-0.7701251468953194,0.8542199488491049,0.9859334080836125,1.0,12/40,28.40%,AKT1;MFF;PRELID1;PINK1;GHITM;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;CLU
prerank,carboxylic acid metabolic process (GO:0019752),0.25788888549190375,0.7696879107446905,0.8,0.9597876442845144,1.0,12/33,22.46%,PLA2G4A;DDO;LIPT1;SIRT4;PON3;HAO1;GRHPR;ST3GAL1;CARNMT1;AGXT;ST6GAL1;CYB5R3
prerank,mitotic sister chromatid segregation (GO:0000070),-0.1945101692305744,-0.7691940850560177,0.9567901234567902,0.9865864302169493,1.0,50/98,37.68%,DIS3L2;MCPH1;KPNB1;NAA50;KIF18A;SMC2;CHMP1A;SET;CHMP1B;PRC1;CHMP7;CHMP2B;NCAPH2;TUBG1;KNSTRN;NCAPH;KIF23;SPAG5;TENT4A;TTN;NUP62;NSL1;KIF22;REC8;CHMP2A;DSN1;KIF14;SPDL1;TUBG2;CEP55;SGO1;RAD21;CSNK2B;NCAPD2;CHMP6;CHMP4C;PLK1;ZW10;DLGAP5;CDK1;SMC1A;MIS12;NCAPD3;KIFC1;VPS4B;NUDC;RAB11A;CDC23;KIF2C;CCNB1
prerank,epithelial cell morphogenesis (GO:0003382),-0.28150409600317605,-0.7690668529749584,0.7758985200845666,0.9860267754745474,1.0,9/17,39.93%,MET;RILPL2;SIPA1L3;STC1;COL15A1;PKHD1;POF1B;GRHL2;RAB25
prerank,organic cation transport (GO:0015695),-0.27197316636484703,-0.7687352600816643,0.7794759825327511,0.9858062431362613,1.0,4/20,15.72%,SLC47A1;SLC25A42;SLC22A5;SLC25A19
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.24054211258265243,0.768496022305352,0.8428805237315876,0.9611138514655384,1.0,7/55,10.26%,PID1;ARF4;PDGFRB;MPV17;TGFBR2;NOXO1;MAPK14
prerank,glial cell development (GO:0021782),-0.255539049682722,-0.7682473141840845,0.8111888111888111,0.9857978866357765,1.0,11/25,35.14%,CDK6;EIF2B2;TPPP;DLL1;CSPG5;SOX11;PICK1;PRDM8;MT3;S100A9;NRROS
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2400907563561529,0.7679201817705084,0.8301886792452831,0.9614765913909935,1.0,7/52,14.94%,LEPROT;BCL2;NPEPPS;HUWE1;RHOU;USP36;CSNK2A2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24590445585251025,-0.7677732134500883,0.8190954773869347,0.9857413961510075,1.0,10/29,21.35%,MRE11;HSP90AB1;TERF1;HSP90AA1;PPIA;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,positive regulation of organelle assembly (GO:1902117),-0.22448605071089822,-0.7676497887833641,0.8689839572192514,0.985189372921754,1.0,15/44,27.63%,RAB3GAP1;CCDC88A;SDCBP;DYNC1H1;PLK4;CNOT2;LCP1;LRSAM1;SPAG5;NUP62;HTT;SDC4;PIP4K2A;SH3GLB1;STX18
prerank,regulation of double-strand break repair (GO:2000779),0.24955315488107663,0.7676200201410108,0.8084415584415584,0.9613942563904784,1.0,14/39,22.06%,TRIP12;SPIDR;PPP4R2;SLF2;PML;FIGNL1;SHLD2;MGMT;KDM1A;UBR5;SETD2;SPIRE1;RTEL1;PPP4C
prerank,lipoprotein biosynthetic process (GO:0042158),0.34445644512208684,0.767565517922831,0.7575757575757576,0.9609281945281875,1.0,6/11,26.20%,PORCN;WDR45B;ATG10;WIPI2;ATG7;APOE
prerank,cytosolic transport (GO:0016482),-0.18359983863880738,-0.7669528094850289,0.9483870967741935,0.9854401815121069,1.0,31/108,26.43%,MYO1D;EMP2;DOP1B;RAB6B;STX16;WDR81;ARL1;GCC2;CORO7;KLHL20;RGP1;WASHC1;KIF16B;EVI5;RNF126;VPS51;SORT1;VTI1A;LAMP1;UBE2O;TBC1D5;PIK3C3;DCTN1;SNF8;CLN3;VPS13C;YKT6;TBC1D10B;PHETA2;AP2A1;SNX32
prerank,receptor recycling (GO:0001881),-0.33058475687551503,-0.7669323225936442,0.763265306122449,0.9847427924430457,1.0,3/10,25.00%,SORL1;NSG1;PHETA2
prerank,regulation of tube diameter (GO:0035296),0.31854520247729057,0.7668132567889577,0.7560521415270018,0.9609983724004423,1.0,1/13,0.67%,ROCK2
prerank,vascular process in circulatory system (GO:0003018),0.31854520247729057,0.7668132567889577,0.7560521415270018,0.9609983724004423,1.0,1/13,0.67%,ROCK2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2731624602649316,-0.7667399371024728,0.7895927601809954,0.984278835030632,1.0,6/19,21.56%,MAF1;ZNF76;POLR3C;NAB2;POLR3G;ZC3H8
prerank,hyaluronan metabolic process (GO:0030212),-0.26144648150437544,-0.7658892462725975,0.8233890214797136,0.9848594484553433,1.0,10/23,28.58%,HEXB;CEMIP;FGF2;GUSB;ABCC5;HAS1;HMMR;HAS3;HYAL3;STAB2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.27755201632755894,-0.7654530047451431,0.8056155507559395,0.9848198790604521,1.0,4/17,13.86%,AKT1;CCND1;EGFR;RGCC
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.31500760324314125,0.7653514378226216,0.774074074074074,0.9627097351320577,1.0,4/14,16.92%,RPL7L1;ZNHIT3;WDR12;DDX18
prerank,negative regulation of chemokine production (GO:0032682),0.31476869743210023,0.7652462635991045,0.75,0.9623523853931639,1.0,4/14,15.52%,IL6;LGALS9;MAP2K5;MUL1
prerank,Golgi organization (GO:0007030),-0.18844754022349783,-0.7650731261128638,0.9606557377049181,0.9846336339817007,1.0,22/112,16.59%,SYNE1;CSNK1D;LMAN2L;ATP8B2;STX16;ARL1;NSFL1C;GCC2;ATP8B1;TMED2;VMP1;PI4K2A;LMAN1;ARHGEF7;CLASP2;VCPIP1;VPS51;PRKD1;VTI1A;MYO18A;VRK1;TMED7
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.29108637594765074,0.7643139760545822,0.758364312267658,0.963299399504586,1.0,2/20,9.13%,AMPD3;PAICS
prerank,endosome organization (GO:0007032),-0.2276663332501387,-0.7639049707444293,0.84375,0.9855614124970188,1.0,16/41,28.25%,RAB27A;CLCN3;SNX3;ALS2CL;VPS33B;PI4K2A;ALS2;CHMP2B;DNAJC13;SNX33;VPS18;LAPTM4B;PHETA2;PI4K2B;SNX10;SQSTM1
prerank,tRNA wobble uridine modification (GO:0002098),-0.2980090349999,-0.7635190874453766,0.8079331941544885,0.9854234816852386,1.0,7/14,32.68%,ELP1;TRMT9B;DPH3;KTI12;CTU2;ELP3;ALKBH8
prerank,regulation of urine volume (GO:0035809),0.3426788455969716,0.7633124954961054,0.7551020408163265,0.9643095699889837,1.0,4/10,20.34%,ADM;NPR3;ADCY6;HAS2
prerank,regulation of TOR signaling (GO:0032006),0.2299019251440842,0.7631978370504423,0.859304084720121,0.9639568215067954,1.0,12/67,17.01%,DEPTOR;PRKAA2;ARAF;FBXO9;FNIP1;TTI1;SLC38A9;NPRL3;TBC1D7;MAPKAPK5;LARS1;RICTOR
prerank,detection of visible light (GO:0009584),0.30537416640792214,0.762795268074041,0.759493670886076,0.9639979923273806,1.0,1/16,1.89%,ABCA4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.31605487933267595,0.7627769976202468,0.747148288973384,0.9634812055575902,1.0,4/15,12.58%,APOA2;FOXP3;IRAK3;HFE
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2861977484718355,0.7625110939493187,0.8031914893617021,0.9633770859489773,1.0,3/23,6.15%,TPTE;MTMR11;MTMR3
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3218069202581678,0.7622348022992661,0.7604355716878403,0.9632616863611592,1.0,4/14,18.46%,PPP2R2B;NCK1;PPP2CA;PPP2R2A
prerank,positive regulation of lipid transport (GO:0032370),-0.3102691354527539,-0.7620517526213378,0.7946611909650924,0.9868545402478159,1.0,3/12,9.61%,ABCA3;PRELID1;SPP1
prerank,neutrophil chemotaxis (GO:0030593),0.23700389514923798,0.7616730654901075,0.8422664624808576,0.9635949306147752,1.0,4/53,7.70%,CXADR;CXCL10;CKLF;CCL2
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.34065531911688673,0.7613665064537206,0.7416829745596869,0.9630208102457285,1.0,4/10,20.47%,MYADM;MAP2K5;WNK1;MAPK7
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.34065531911688673,0.7613665064537206,0.7416829745596869,0.9630208102457285,1.0,4/10,20.47%,MYADM;MAP2K5;WNK1;MAPK7
prerank,macrophage activation (GO:0042116),-0.23241653371229146,-0.761357878022411,0.8416075650118203,0.9871327842650158,1.0,4/34,5.89%,PLCG2;CD93;SNCA;DYSF
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2963205294506564,-0.7610032961287071,0.7760869565217391,0.9869530980962793,1.0,6/15,23.14%,PPARD;AKT1;LDLRAP1;SLC45A3;PRKCE;IRS1
prerank,regulation of TORC1 signaling (GO:1903432),-0.23260586536872047,-0.7609849967640762,0.8544152744630071,0.9862566937848479,1.0,9/33,18.16%,GPR137C;SESN3;STK11;SMCR8;RRAGB;ATM;SPAAR;RRAGC;PIP4P1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.33626263260310096,0.7607304061608423,0.7642276422764228,0.9634619226405773,1.0,10/10,66.39%,MYO9A;RAP2A;SH3BP1;CAMSAP3;RHOA;OPHN1;CDC42;EZR;SYNE4;MSN
prerank,sulfur compound catabolic process (GO:0044273),-0.22796963104734191,-0.7607155145265196,0.8790123456790123,0.985931178388985,1.0,13/38,26.33%,CSPG4;HEXB;GGT5;TXN2;GGT7;CTH;ADO;LUM;GGT1;MPST;IDS;CSPG5;BGN
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.18756525004884272,0.7604294307231326,0.9833729216152018,0.9633830517132559,1.0,56/314,17.82%,SPSB1;TBL1XR1;SMURF2;FBXL17;NEDD4;NHLRC3;KLHL22;UBE2U;SPSB4;RNF216;SIAH2;CUL4A;FBXO9;ANAPC11;KLHL15;FBXL3;PSMB10;SGTA;ANAPC1;AMFR;UBE2C;PSMA3;FBXL20;PSME4;FBXL7;FBXO4;PSMA5;WWP2;FBXO38;UBXN2A;HUWE1;SPOPL;UBXN4;CUL3;IFI27;BTRC;HECW2;FBXW11;ARRB1;CDC27;BFAR;RNF103-CHMP3;FBXL4;KCTD5;PML;FBXL13;FAF2;FBXL12;RNF185;ECPAS;TBL1X;AMN1;DNAJB2;UBE4B;PPP2R5C;TRIM3
prerank,fatty acid oxidation (GO:0019395),-0.2105207556079647,-0.7602286374934838,0.9120879120879121,0.9859077119647239,1.0,4/57,5.04%,ADIPOR2;ACAD10;ABCD4;PPARD
prerank,mitotic metaphase plate congression (GO:0007080),-0.2155004279034996,-0.7602033202176712,0.8970189701897019,0.9852347531312052,1.0,32/51,42.95%,KPNB1;KIF18A;CHMP1A;CHMP1B;CHMP7;CHMP2B;MAD1L1;NUP62;KIF22;CHMP2A;KIF14;SPDL1;CEP55;CHMP6;CHMP4C;ZW10;NUF2;MIS12;KIFC1;VPS4B;NUDC;RAB11A;CDC23;KIF2C;CCNB1;DCTN2;RRS1;BOD1;PINX1;CENPE;CHAMP1;CDT1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2840952107002457,0.7601607337150396,0.7993138936535163,0.963244234536955,1.0,7/22,18.40%,SLC16A2;APPL2;LRRK2;NES;DISP3;KDM2B;KDM1A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.2936970046790573,-0.7600971456481626,0.8099352051835853,0.9846548549909664,1.0,9/14,41.01%,AKT1;MFSD2A;ABCD2;IRS1;LONP2;MTLN;TYSND1;PLIN5;ABCD1
prerank,intracellular cholesterol transport (GO:0032367),0.3044164982536341,0.7599328555511097,0.7659176029962547,0.9630790841398411,1.0,4/15,16.25%,NPC1;STAR;ABCA1;SERAC1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.2494635597312908,0.7598935374753755,0.834983498349835,0.9626007742706237,1.0,5/38,10.73%,SP100;CFLAR;SERPINE1;GSK3B;BCL2L1
prerank,negative regulation of transport (GO:0051051),-0.21802632565921876,-0.7594045637672592,0.8943298969072165,0.9848797382580751,1.0,12/51,19.10%,MCTP1;SNCA;SCAMP5;SNX3;DYSF;RACK1;PRKD1;EGF;LRSAM1;PPM1F;YRDC;MTMR2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.22475242094295164,0.7591589725743295,0.8737300435413643,0.9631753479380322,1.0,12/72,15.40%,ENPP1;RAD50;CUL4A;RFC1;FBH1;RPA3;SPO11;OGG1;GTF2H4;ERCC5;DNASE1L1;ERCC1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2921346543584706,-0.7588915103678708,0.7991169977924945,0.9849136301268361,1.0,7/14,33.09%,FASTKD2;C1QBP;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,histone H3-K9 demethylation (GO:0033169),0.33297000864649573,0.7583487432268322,0.7387218045112782,0.9639084841094385,1.0,2/11,5.60%,KDM7A;KDM3B
prerank,regulation of leukocyte migration (GO:0002685),0.3083657161455673,0.7579107650461341,0.7553191489361702,0.9640130072633989,1.0,2/16,4.72%,ANXA1;MIA3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.307713939883665,-0.7578367975336341,0.7827956989247312,0.9856892319833362,1.0,1/12,4.35%,PRKCQ
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.20722936792327198,-0.7578093909251105,0.9018087855297158,0.9850053454936986,1.0,25/62,34.10%,TPT1;ARHGEF2;AKT1;PINK1;CXCL12;CCAR2;PTTG1IP;PLAUR;PPIA;PARK7;ENO1;NOC2L;CREB3L1;NDUFA13;EPO;DNAJA1;HERPUD1;CLU;VNN1;HSPB1;TMEM161A;SRC;MDM2;YBX3;CDKN2D
prerank,negative regulation of lymphocyte activation (GO:0051250),0.2882602015667658,0.7577786702052861,0.7981818181818182,0.9636700004526771,1.0,2/21,5.15%,TNFAIP8L2;PTPN22
prerank,regulation of lamellipodium assembly (GO:0010591),-0.231354492376351,-0.7572040929662687,0.8610421836228288,0.9850759173074015,1.0,5/34,9.64%,SLIT2;PIK3R1;NCKAP1;ARPC2;ABI3
prerank,autophagy of peroxisome (GO:0030242),-0.30383684918896003,-0.7564494545288439,0.7805907172995781,0.9854777568987009,1.0,4/12,28.25%,ATM;PIK3C3;MAP1LC3B;SQSTM1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2822235245393103,-0.7560661368229967,0.78099173553719,0.9853504053687664,1.0,6/16,22.51%,ACACA;ACLY;SCD;HSD17B8;FASN;GCDH
prerank,positive regulation of ion transport (GO:0043270),0.24263452246623146,0.756031526989252,0.8630573248407644,0.9657162204956572,1.0,18/48,24.47%,ACTN2;SCN3B;KIF5B;DLG1;GPD1L;STIM2;ANO6;ATP2B1;ADRA2A;P2RX4;GDNF;ANK2;VAMP7;WNK3;SCN4B;CNKSR3;SCN5A;FHL1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.19152406973830796,-0.7553090809677745,0.9694915254237289,0.9856906843435792,1.0,20/104,17.67%,ACTB;CALM1;SNCA;CALM2;DAB2IP;SLC8A1;CALM3;AKT1;CCND1;LRP6;ADRB2;CNPPD1;LRP5;SERTAD1;CSF1R;CDKN1A;IRGM;CCNF;PYCARD;CCNG1
prerank,positive regulation of macroautophagy (GO:0016239),0.2450373813339554,0.7552947315234909,0.8369028006589786,0.9662718830899776,1.0,10/48,14.54%,PRKAA2;DCN;OPTN;WAC;UVRAG;SESN1;MAP3K7;PIP4K2B;SLC25A4;TBK1
prerank,glycoprotein metabolic process (GO:0009100),0.23814810127078376,0.7549720016784497,0.840064620355412,0.9662360298468384,1.0,4/53,4.37%,MAN1C1;PRKCSH;MAN2A1;LARGE1
prerank,melanosome organization (GO:0032438),0.2700731444581579,0.754001504512656,0.7993079584775087,0.9671474025863996,1.0,3/26,9.35%,SHROOM2;DTNBP1;HPS1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2940842316098535,0.7538453923094486,0.767097966728281,0.9668482344694634,1.0,2/18,5.14%,FPR2;C5AR2
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.2939689574605121,-0.7538162546108451,0.8004291845493562,0.9870224096373053,1.0,5/14,28.37%,AKT1;NNMT;SLC45A3;IRS1;PMAIP1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.29650754411065666,0.7533402413742886,0.7902621722846442,0.9670426159815656,1.0,7/19,21.39%,DCP2;HNRNPC;XRN1;EXOSC10;TEN1;CTC1;TENT4B
prerank,negative regulation of cellular component organization (GO:0051129),0.22165296820003325,0.7532144259103656,0.882262996941896,0.9666976532378796,1.0,6/74,7.65%,BMP6;APOA2;EPHA3;PRKCZ;OPRD1;GSK3B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2696602237731193,0.7528151063735248,0.8033333333333333,0.9667368011508375,1.0,1/26,0.45%,ATP1A2
prerank,regulation of autophagosome maturation (GO:1901096),-0.3017964336985949,-0.7527826020392184,0.780241935483871,0.9877685542252342,1.0,5/13,22.59%,SMCR8;ADRB2;IRGM;UBQLN4;CLN3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.3194947111430402,-0.7526449541573936,0.8148936170212766,0.9872528419987915,1.0,5/10,20.65%,NOTCH1;PHACTR4;LRP6;DLL4;BMP5
prerank,nucleotide catabolic process (GO:0009166),0.3098380826952368,0.7524737368326966,0.7971014492753623,0.9667158299930588,1.0,5/16,20.56%,NT5C;DERA;ITPA;NT5C1A;XDH
prerank,positive regulation of hormone secretion (GO:0046887),-0.2833083033947296,-0.7523926917244887,0.7995391705069125,0.9868800241627945,1.0,8/17,31.34%,C1QTNF3;SPP1;GRP;EDN1;SOX11;RASL10B;NMB;VAMP8
prerank,establishment of mitotic spindle localization (GO:0040001),0.2757073973822335,0.7523406857942914,0.8204667863554758,0.9663930573818605,1.0,5/28,12.78%,GJA1;CLASP1;ESPL1;MISP;FBXW11
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.18398855845387474,-0.752315523803669,0.9592476489028213,0.9862812274977044,1.0,8/112,5.88%,PTPRJ;PLCG2;IL33;THBS1;CD34;GAS6;HMGB1;ARHGEF2
prerank,pseudouridine synthesis (GO:0001522),-0.2872566252249113,-0.752214791504613,0.7983014861995754,0.9857236398967607,1.0,7/13,33.14%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;NOP10;NHP2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2160276653624951,0.7513872470789509,0.8906942392909897,0.9672001187143606,1.0,12/87,10.29%,KANK2;DACT1;CDC73;CCL2;CDKN2B;PSMB10;PSMA3;DLG1;PSME4;USP47;FBXL7;PSMA5
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2255512577804549,0.7512659643366115,0.8738738738738738,0.9668544072909634,1.0,7/66,10.22%,IL6;TLR4;GBP5;LGALS9;RIPK2;WNT5A;PANX1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.27616640615976473,0.7511848675490331,0.8169717138103162,0.9664341432479545,1.0,4/25,11.03%,ITPR1;LRRK2;PLEK;CDH13
prerank,regulation of cell aging (GO:0090342),0.317025981022235,0.7510337994458407,0.7276341948310139,0.9661261386704418,1.0,6/11,29.72%,NEK4;PNPT1;NEK6;RSL1D1;ING2;LMNA
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.22175371048002843,0.7507229389994365,0.8830963665086888,0.9660494332398786,1.0,10/76,13.07%,MTURN;TCEAL7;BMP7;FOXP3;ANXA4;PARP10;IRAK3;MAP2K5;TRIM21;ARRB1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.32452518925752627,0.7506930487967937,0.7595419847328244,0.9655613671034863,1.0,4/12,19.26%,ACSL1;SCP2;ELOVL1;ACOX1
prerank,regulation of membrane depolarization (GO:0003254),0.2941226734344138,0.750626301426063,0.7810344827586206,0.9651240346617249,1.0,4/18,9.73%,PTPN3;SCN3B;LRRK2;GPD1L
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.20639600593676238,0.7506227386801207,0.9137199434229137,0.9646044465239991,1.0,24/122,18.19%,PLD1;SAMD4A;VIM;SLC6A9;SORBS1;IL6;TLR4;GLI1;EPM2AIP1;PDGFRB;CCL2;IGF2;SLC25A37;TLR2;ZCCHC4;SMOC2;SOX4;PRKD2;CPEB3;NOX1;UPF3A;FXR2;HSPH1;PLXNB2
prerank,glucan biosynthetic process (GO:0009250),-0.30521171591830765,-0.7503931242221513,0.7890466531440162,0.9867823957287639,1.0,3/12,17.08%,PGM2L1;PPP1R3C;PER2
prerank,glycogen biosynthetic process (GO:0005978),-0.30521171591830765,-0.7503931242221513,0.7890466531440162,0.9867823957287639,1.0,3/12,17.08%,PGM2L1;PPP1R3C;PER2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.2015706470415092,0.7503700147598266,0.9174560216508796,0.9644535189121013,1.0,34/144,22.77%,TCF7L2;LEPROT;SMAD3;ZIC1;BCL2;TPR;NPEPPS;GSK3B;HUWE1;RHOU;USP36;MYO1C;CSNK2A2;MIEF1;TM9SF4;SAR1A;RAPGEF3;RAN;YWHAE;TENM1;EFCAB7;EMD;SEC16A;UBR5;CEP131;ERBB2;TFDP2;ZFAND1;TCAF1;FBXW7;ATG13;ZC3H12A;BAG3;HPS4
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2939188234901871,-0.7499982534438508,0.7880184331797235,0.9866073143673606,1.0,5/13,21.97%,RACK1;HSPA5;PPP1R15B;UFL1;PPP1R15A
prerank,cellular component maintenance (GO:0043954),-0.3044705134971853,-0.7498425408432442,0.7885010266940452,0.9860987764895502,1.0,5/12,28.97%,INSR;ITGA3;MTMR2;TREM2;PICK1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2579622643311541,-0.749608282254669,0.8088888888888889,0.985705603319973,1.0,8/20,30.54%,HSP90AB1;HSPA4;HSP90AA1;TMEM35A;HOPX;BBS10;CLU;PSMG2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.25754626985664064,-0.7495575209604333,0.8657074340527577,0.9850608456113522,1.0,3/22,7.57%,PTPRJ;DGKZ;CEACAM1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.300538176786985,-0.7495521013404878,0.7904967602591793,0.9843605293565125,1.0,3/13,15.43%,SYBU;UBB;MAPT
prerank,response to acidic pH (GO:0010447),-0.2942468455921319,-0.749373538685992,0.8081896551724138,0.983898899583508,1.0,3/13,14.87%,LGMN;CTSS;RAB11FIP5
prerank,protein K11-linked ubiquitination (GO:0070979),0.2662279066802222,0.7487157468518325,0.809009009009009,0.966303775510713,1.0,5/27,13.47%,ANAPC11;ANAPC1;UBE2C;UBE2E3;CDC27
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3224345062798154,-0.7487075040495434,0.7983539094650206,0.9840383783636178,1.0,2/10,5.14%,SEMA6A;DAB2IP
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.1963009231353117,0.7485929715917089,0.9472990777338604,0.9659474576360478,1.0,26/185,12.57%,NINL;DYNLL1;ALMS1;SDCCAG8;CENPJ;PLK5;CLASP1;APPL2;CEP152;ANAPC11;HAUS8;KLHL18;PSMB10;ANAPC1;UBE2C;PSMA3;PSME4;APPL1;PSMA5;PTPN6;NEDD1;CDC14A;CUL3;MAD2L1BP;BTRC;HECW2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.31641544139927086,0.7484841304536529,0.7846441947565543,0.9655627673917742,1.0,1/13,0.97%,RNF152
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2172666651356782,0.7481256225688346,0.8944193061840121,0.9655319485578162,1.0,17/88,15.27%,FBXL17;CUL4A;FBXO9;FBXL3;PSMB10;PSMA3;FBXL20;PSME4;FBXL7;FBXO4;PSMA5;FBXO38;BTRC;FBXW11;FBXL4;FBXL13;FBXL12
prerank,regulation of monocyte differentiation (GO:0045655),0.30963109563140623,0.7480302124919876,0.7917414721723519,0.9651500307014294,1.0,3/14,12.03%,IL34;ACIN1;CSF1
prerank,regulation of DNA recombination (GO:0000018),0.2555255174832086,0.7474404951436278,0.8231173380035026,0.9654565864097824,1.0,13/32,24.40%,RAD50;SPIDR;PPP4R2;FIGNL1;SHLD2;KDM1A;IL7R;SETD2;RTEL1;PPP4C;MSH2;ZCWPW1;ZRANB3
prerank,protein homotrimerization (GO:0070207),-0.28452759442837294,-0.7473965810810302,0.8091286307053942,0.9844160461489432,1.0,7/14,28.96%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;STEAP4;ALOX5AP
prerank,protein trimerization (GO:0070206),-0.28452759442837294,-0.7473965810810302,0.8091286307053942,0.9844160461489432,1.0,7/14,28.96%,SLC1A2;SIGMAR1;SCARA5;DISP1;MIF;STEAP4;ALOX5AP
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.23008831259927248,-0.7466930964397711,0.8666666666666667,0.984669645904809,1.0,11/33,21.35%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;RAD51;ANKRD28;TINF2;WRAP53;ZBTB48;PPP6C
prerank,"phototransduction, visible light (GO:0007603)",0.3099286419610647,0.7461060012039623,0.7885714285714286,0.966793273246771,1.0,1/14,1.89%,ABCA4
prerank,protein kinase A signaling (GO:0010737),0.3223207266968314,0.7458674725716172,0.7874306839186691,0.9665934779620714,1.0,1/12,2.82%,TCP11X2
prerank,positive regulation of lipid localization (GO:1905954),0.32484682279746546,0.7449080057659714,0.7786407766990291,0.9674582824515422,1.0,4/11,24.41%,IKBKE;LRP1;ZC3H12A;HILPDA
prerank,plasma membrane tubulation (GO:0097320),0.31418350395968464,0.7432107813122798,0.7686567164179104,0.969300531914454,1.0,4/13,15.26%,PACSIN2;SNX9;MICALL1;CHMP4A
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.23688795764974005,-0.7431740537501749,0.8801955990220048,0.9885581132602804,1.0,7/31,18.10%,PEX26;PEX10;PEX16;DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,DNA replication (GO:0006260),0.20737369948376963,0.742698205364453,0.9205202312138728,0.9694815105286473,1.0,18/105,15.43%,RBMS1;ORC5;WRN;TOP1;RAD50;POLA2;RFC1;POLG;REV1;MCMBP;RPA3;MCM4;BAZ1A;RBBP8;MCM6;ORC3;RAD9A;ORC4
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2814743315073864,-0.7426642453766251,0.7756410256410257,0.9884600519065782,1.0,7/15,31.46%,SCARB1;SIK1;MFSD2A;CTDNEP1;C3;NR1H2;LDLR
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3074667497771456,0.7422521132426855,0.7816091954022989,0.9695541727415194,1.0,6/15,23.42%,NYNRIN;SLFN14;ZC3H12B;RNASEH1;ZC3H12A;KHNYN
prerank,negative regulation of type I interferon production (GO:0032480),0.23925384818098738,0.7416704252759418,0.8375796178343949,0.9698243398336122,1.0,11/40,23.15%,IKBKE;RNF216;NLRX1;PPM1B;IFIH1;TBK1;RNF135;PCBP2;REL;OTUD5;TAX1BP1
prerank,microtubule bundle formation (GO:0001578),-0.21747733785018786,-0.7414325371157371,0.9020618556701031,0.989407830193629,1.0,19/42,34.13%,RP1;MTCL1;AAAS;NCKAP5;CFAP46;CFAP74;SPAG16;TPPP;NAV1;CDK5RAP2;GAS2L1;DCX;TTLL3;CLIP1;PLK1;KIF20A;CFAP206;FOXJ1;CCDC40
prerank,T cell differentiation in thymus (GO:0033077),0.3110324708887605,0.7409615711170815,0.7875243664717348,0.9702355718123928,1.0,1/14,2.81%,GLI3
prerank,regulation of neurogenesis (GO:0050767),0.23283732606381538,0.7407127837278543,0.8703403565640194,0.9700526620270781,1.0,8/55,13.10%,WNT3A;NUMB;IL6;APPL2;YAP1;DOCK7;HEYL;BHLHE41
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2947640805560203,0.7406856609563223,0.7862453531598513,0.9695653291317923,1.0,3/17,11.54%,EMC2;SGTA;EMC9
prerank,protein maturation (GO:0051604),-0.185009897371603,-0.739700966957938,0.9571865443425076,0.9909132790964225,1.0,23/95,22.59%,F3;CPE;PCSK2;SORL1;TSPAN14;MMP16;ECE1;CTSS;CPD;NAA50;PCSK7;TASP1;PHEX;NNAT;MMS19;NAA10;PSENEN;ADAMTS3;CPXM1;TSPAN33;PCSK5;CPZ;CLN3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2880347539936751,0.7394942542196101,0.7874306839186691,0.9706367469500364,1.0,2/18,3.72%,NELL1;DACT1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2618286347441582,-0.7393453726891707,0.8329466357308585,0.9906587716626141,1.0,7/19,23.43%,HDAC6;PINK1;PARK7;VDAC1;CAMKK2;FZD5;HTT
prerank,positive regulation of cytokinesis (GO:0032467),-0.23117886766314538,-0.7391072011660055,0.889168765743073,0.9902490323670096,1.0,19/32,45.95%,CIT;ECT2;KIF23;PRKCE;RACGAP1;KIF14;CDC14B;CDC6;KIF20B;OPN1MW;DRD3;GIPC1;MAP10;CDC42;AURKB;CXCR5;TAS1R2;AURKC;RXFP3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3141729804971208,0.739058455988457,0.7874762808349146,0.9707069651248329,1.0,4/14,13.63%,BAX;PTPN1;TMEM33;BFAR
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18553401361018027,0.7387671524075015,0.9808429118773946,0.9705923077113443,1.0,63/264,20.79%,GEMIN4;POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;SRPK1;STRAP;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;TGS1;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;CDK13;WBP4;SCAF11;PCBP2;USP39;PRPF3;WDR33;SNRNP40;DDX5;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,glycine transport (GO:0015816),-0.32100186204554537,-0.7380440059478848,0.7636363636363637,0.9908685852030036,1.0,3/10,12.37%,SLC38A5;SLC36A1;SLC6A5
prerank,Rap protein signal transduction (GO:0032486),0.3293669910682519,0.7377170591210734,0.7947154471544715,0.9714930969483262,1.0,6/10,26.77%,RAP2C;RAPGEF3;RAP2B;RAP2A;RAPGEF1;RAP1B
prerank,sensory perception of chemical stimulus (GO:0007606),0.3012667816399132,0.7373582687599712,0.7916666666666666,0.9714704396412392,1.0,1/15,2.31%,BEST2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.30794648030459204,0.7371968382382909,0.7792706333973128,0.9711494421245563,1.0,4/12,17.35%,PLA2G6;PPP3CB;BAIAP3;C2CD2L
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.26980443837972895,-0.7370277311236986,0.8210526315789474,0.9914739976951461,1.0,3/18,10.36%,PIK3R1;BAG6;USP13
prerank,protein localization to mitochondrion (GO:0070585),-0.2982893816549407,-0.7368950677880342,0.8241758241758241,0.9909409325388356,1.0,5/11,26.29%,AKT1;PINK1;MAIP1;MTCH2;DNAJA1
prerank,regulation of nervous system development (GO:0051960),0.2518648640245973,0.7367961354916404,0.8449477351916377,0.9711665089369538,1.0,6/37,14.83%,PTN;YAP1;DOCK7;HEYL;BHLHE41;NPHP3
prerank,adenine nucleotide transport (GO:0051503),0.29192622313835365,0.7365668808365258,0.8076923076923077,0.9709487033464786,1.0,4/17,14.25%,SLC19A1;SLC17A9;SLC25A24;SLC25A4
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2846345536995154,-0.7363212553182326,0.8164948453608247,0.9910240890636791,1.0,6/13,21.34%,CA2;ACSL5;NR4A3;C2CD5;P2RX7;C3
prerank,synaptic vesicle transport (GO:0048489),0.31596747836238304,0.7359405958196623,0.7790697674418605,0.9712595325500881,1.0,3/11,11.84%,TMEM230;KIF5B;SPG11
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.31878957104054473,-0.7354071657934595,0.7987804878048781,0.9914480709007579,1.0,6/10,36.32%,E2F7;WIZ;E2F8;DBF4;CDC7;SSBP1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.22332713016680297,0.7350790210464094,0.8924731182795699,0.9719198257301513,1.0,26/68,27.67%,PCF11;POLR1C;CCNH;MNAT1;POLR1G;CDK7;MTERF2;POLR2F;GTF2H4;PABPN1;CSTF3;GTF2H2;CAVIN1;SLBP;TTF1;WDR33;POLR2K;UBTF;CLP1;PAPOLA;MAZ;POLR2H;POLR1A;ERCC2;ERCC3;TAF1D
prerank,regulation of ATP metabolic process (GO:1903578),0.23018016289569604,0.7347449486988535,0.8780889621087314,0.9718449649325073,1.0,15/54,25.39%,PRKAG2;RANBP2;TPR;JMJD8;POM121;NUP37;ATP5IF1;UQCC2;NUP85;SPHK2;HIF1A;COX7A2L;NUP160;NUP107;PRKAG1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.23966684081223022,-0.7345622251058783,0.8533007334963325,0.9917635107664102,1.0,9/27,27.49%,ABCA3;EEPD1;CAV1;RXRA;ABCB4;ABCA13;TREM2;GPS2;NR1H2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.246400528813087,-0.7343286717739503,0.8656036446469249,0.9913469562705146,1.0,8/24,32.98%,MMS19;NDOR1;HSCB;CIAO3;IBA57;ISCU;GLRX5;NUBPL
prerank,cellular response to tumor necrosis factor (GO:0071356),0.1932711295178344,0.7339114705845907,0.9753086419753086,0.9724553678697702,1.0,16/175,9.20%,PID1;ADAMTS12;ZFAND6;GBP2;TRAF5;TNFSF15;GSDME;TNFRSF12A;BIRC3;EDA;STAT1;CCL2;TNFRSF14;PSMB10;PSMA3;PSME4
prerank,cellular response to estrogen stimulus (GO:0071391),0.2983533868071287,0.733436521805694,0.781190019193858,0.9725494031998227,1.0,4/14,20.35%,SFR1;TRIM24;RARA;ARID5A
prerank,purine ribonucleotide transport (GO:0015868),0.2956846254339942,0.7329052709913321,0.8229571984435797,0.9727399162070024,1.0,4/16,14.25%,SLC19A1;SLC17A9;SLC25A24;SLC25A4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.29454564019808593,0.7328956909558353,0.7938517179023508,0.9722304056930057,1.0,2/15,13.17%,ANXA1;NR3C1
prerank,mRNA stabilization (GO:0048255),0.239200501069287,0.7324578411799656,0.8528925619834711,0.9722808917584428,1.0,9/40,17.71%,TENT5A;IGF2BP1;HNRNPC;NOCT;MAPK14;EIF4ENIF1;FUS;AXIN2;GDNF
prerank,negative regulation of intracellular protein transport (GO:0090317),0.2753497031887209,0.7317653796465108,0.8062283737024222,0.9726211179381181,1.0,3/22,10.13%,SP100;LRRK2;SUFU
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.27489604553066016,-0.7316993557751169,0.8296943231441049,0.9939892721073655,1.0,6/15,36.75%,SEL1L;SEC61B;HERPUD1;UFD1;AUP1;DERL1
prerank,receptor catabolic process (GO:0032801),-0.2430788293125275,-0.7312342632968278,0.882903981264637,0.9938435597397383,1.0,10/24,27.44%,LGMN;VLDLR;KIF16B;AP2B1;SNX25;AP2A2;AP2A1;SH3GLB1;CLTA;AP2M1
prerank,regulation of cellular catabolic process (GO:0031329),0.2231364996116992,0.7309352137744585,0.8864,0.9731689124125091,1.0,8/62,13.57%,ITPR1;NUPR1;DAPK1;MTMR3;LRRK2;KEAP1;DAPK2;PIP4K2B
prerank,ncRNA catabolic process (GO:0034661),0.25584344592412733,0.7302416766995758,0.8528368794326241,0.9735329029180979,1.0,8/28,16.37%,TUT4;SND1;XRN1;DIS3L;SLFN14;DIS3;ERN2;EXOSC10
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.23258875439723053,0.7302146466665416,0.8672,0.9730463050507899,1.0,8/48,14.99%,IKBKE;BCL2;MCL1;BAX;BCL2L1;EPHA2;HIC1;PML
prerank,DNA conformation change (GO:0071103),0.2934334454182947,0.7301581944522978,0.8041044776119403,0.9725957858770173,1.0,3/17,13.89%,TOP1;TOP2B;KAT6A
prerank,cellular response to interleukin-12 (GO:0071349),-0.20951304204946897,-0.7301371570827249,0.9196217494089834,0.9945400635265622,1.0,14/48,24.27%,PLCB1;PITPNA;RPLP0;TALDO1;PPIA;HNRNPF;SOD1;CFL1;AIP;LCP1;GSTO1;MIF;IL12RB2;MTAP
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.3217794152020919,0.7297135263934191,0.7945205479452054,0.9726736148907474,1.0,3/11,17.50%,NECAB1;SOAT1;ABCA7
prerank,mRNA processing (GO:0006397),0.18119494120775054,0.7293631528972017,0.9823899371069182,0.9725842051438838,1.0,67/287,20.79%,POLR2D;PCF11;PRCC;RBM41;RPRD2;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;CCNH;DDX23;SLU7;CWF19L1;MNAT1;CDK7;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;THOC5;GTF2H4;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;GTF2H2;WBP4;SCAF11;PCBP2;USP39;PRPF3;WDR33;RPRD1B;SNRNP40;DDX5;RNGTT;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,acyl-CoA metabolic process (GO:0006637),-0.22514913099900957,-0.7293622891023136,0.8796992481203008,0.9947387796335949,1.0,8/35,19.67%,HMGCS1;SUCLA2;HMGCS2;ACACA;ACBD6;MCEE;ACSF2;ACOT2
prerank,ruffle organization (GO:0031529),-0.2721707061498089,-0.7283481855293414,0.8506493506493507,0.9952771949232627,1.0,7/16,23.67%,PLEKHA1;INPP5K;CSF1R;RAC1;ARF6;CARMIL1;AIF1
prerank,ureteric bud morphogenesis (GO:0060675),-0.2710569622316037,-0.7283265017271816,0.8482905982905983,0.9945903207944666,1.0,4/16,11.27%,SIX1;BMP4;FGF2;PAX2
prerank,centromere complex assembly (GO:0034508),-0.2200153916283035,-0.7282686885480307,0.918918918918919,0.9939606384363844,1.0,17/36,35.41%,NPM1;HELLS;CENPU;CENPT;CENPQ;CENPL;CENPN;CENPF;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;DLGAP5;CENPW;MIS12;KNL1
prerank,positive regulation of hemostasis (GO:1900048),-0.31187735546513395,-0.7282622869853796,0.8206627680311891,0.9925588620608211,1.0,2/10,14.61%,THBS1;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),-0.31187735546513395,-0.7282622869853796,0.8206627680311891,0.9925588620608211,1.0,2/10,14.61%,THBS1;ST3GAL4
prerank,epithelial cell development (GO:0002064),-0.25576873907163516,-0.7268087534900991,0.8646288209606987,0.9935719343756888,1.0,5/20,16.60%,ACTA2;RILPL2;SIPA1L3;SLC4A7;EXPH5
prerank,apoptotic nuclear changes (GO:0030262),-0.2444455672972961,-0.7266987700034214,0.8586723768736617,0.9929942586171704,1.0,6/24,18.02%,HMGB1;KPNB1;H1-0;DEDD2;FOXL2;DICER1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3057474943272548,0.7264952808958578,0.805607476635514,0.9757307592588439,1.0,3/13,8.36%,NOS2;ALDH4A1;GLUL
prerank,cell projection assembly (GO:0030031),0.2739224124578818,0.726381510501935,0.8102836879432624,0.9753564747061695,1.0,2/22,2.06%,PARVA;QRICH2
prerank,regulation of inclusion body assembly (GO:0090083),-0.3032851248486656,-0.7262113927714812,0.836,0.9928895645004572,1.0,4/11,24.43%,DNAJA4;SACS;SNCAIP;HSPA2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.28866198076136307,0.726055786276135,0.793418647166362,0.9752193620210491,1.0,4/16,20.44%,BMP7;FTO;NAPEPLD;PTGS2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2457195761029899,0.7259114016058492,0.8543371522094927,0.9748848423521189,1.0,8/37,17.30%,CUL4A;RFC1;NTHL1;RPA3;GTF2H4;ERCC5;ERCC1;GTF2H2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.2887382134107114,0.7249473238085556,0.8300536672629696,0.9755795960295073,1.0,2/17,4.00%,EIF2AK2;TAOK3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.2875164169033874,0.7246045150729867,0.8152380952380952,0.9754998597893317,1.0,3/17,5.65%,NRP1;BAIAP2L1;HAX1
prerank,regulation of proteolysis (GO:0030162),-0.2030533782480457,-0.7242285611421165,0.9315789473684211,0.9945073158316368,1.0,18/48,31.14%,CST3;PERP;AKT1;HDAC6;SPOP;BAG6;CAV1;PLAUR;AURKAIP1;BAD;FGFR4;CLN3;CDK5;GSAP;FADD;NEDD8;PLK1;LTBP4
prerank,mRNA export from nucleus (GO:0006406),0.20442272867750957,0.7242100597714128,0.9390420899854862,0.9754649641902504,1.0,25/102,19.70%,NXF2;POLR2D;RANBP2;TPR;SLU7;SRSF4;IWS1;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;PABPN1;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,protein methylation (GO:0006479),0.2420513933090449,0.7238368623202754,0.87893864013267,0.975418142479311,1.0,4/40,7.77%,NSD3;NSD1;METTL21C;ETFBKMT
prerank,autophagy of nucleus (GO:0044804),0.2915895773063399,0.7233139074216957,0.8175046554934823,0.9755767165730643,1.0,7/16,23.93%,ATG12;WDR45B;ATG2A;WIPI2;ATG13;ATG7;ATG3
prerank,nucleosome assembly (GO:0006334),-0.23142695322331303,-0.7232888731853766,0.8768115942028986,0.9949509378057635,1.0,6/31,14.79%,H3-3A;NPM1;SART3;ASF1A;ANP32B;SPTY2D1
prerank,cellular response to estradiol stimulus (GO:0071392),0.28147891527261887,0.72318127025487,0.8131021194605009,0.9752222895466679,1.0,2/18,8.36%,NCOA3;FAM210B
prerank,negative regulation of histone modification (GO:0031057),-0.2834866619950861,-0.7230764268637847,0.8693790149892934,0.9944777351993725,1.0,5/14,19.08%,SNCA;CTBP1;SET;BRCA1;NOC2L
prerank,endocytic recycling (GO:0032456),0.22646841644370022,0.7226525301214616,0.8735632183908046,0.97537197096249,1.0,9/50,14.30%,TRARG1;SNX12;DENND1A;VPS35L;ACAP2;MICALL1;SNX27;ENTR1;VPS26C
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.26641168361877626,-0.7223895186206327,0.8577981651376146,0.9946095228262382,1.0,5/17,23.30%,NOS1AP;KCNQ1;KCNE4;GJA5;SCN1B
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.23091862967273297,-0.7221217556462208,0.8729792147806005,0.9942053735034817,1.0,7/29,17.54%,THBS1;RET;CAV1;CYLD;LTBR;DEDD2;PYCARD
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.32114056825816173,0.72203245432839,0.7898832684824902,0.9756320482420955,1.0,2/10,10.49%,ACTN2;PLEK
prerank,negative regulation of histone methylation (GO:0031061),0.3283690737880523,0.7217590104185143,0.7642585551330798,0.9754400090346071,1.0,5/10,24.08%,BCOR;JARID2;KDM1A;PHF1;WDR5
prerank,alcohol catabolic process (GO:0046164),0.3194183983062494,0.721723484418981,0.8153846153846154,0.974965598537514,1.0,1/10,3.21%,CYP27A1
prerank,toll-like receptor signaling pathway (GO:0002224),0.21142140776065024,0.7211644896899022,0.9257057949479941,0.9751565556951194,1.0,13/84,13.96%,COLEC12;TLR4;MAP3K1;SCARA3;BIRC3;LY96;LGALS9;RIPK2;TLR2;IRAK3;MAP3K7;RPS6KA3;TICAM1
prerank,regulation of protein localization to cell surface (GO:2000008),0.25122397170036287,0.7210938600554977,0.8833865814696485,0.9747247504348785,1.0,8/33,17.50%,LEPROT;ACTN2;GPD1L;HFE;BDNF;TM9SF4;GBF1;ABCA7
prerank,cellular response to ATP (GO:0071318),0.29944778862796423,0.7202922367875411,0.8018691588785046,0.9752241600610498,1.0,6/14,24.07%,SSH1;CIB2;P2RY1;P2RX4;TAF1;P2RX3
prerank,positive regulation of catalytic activity (GO:0043085),0.2414937542502773,0.7192361352160931,0.8458961474036851,0.9760267489395195,1.0,6/37,10.26%,NHEJ1;WRN;AZIN2;XRCC4;IGF2;MAPK14
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.23154643514044998,-0.7187406752285765,0.8816705336426914,0.9973501894974656,1.0,10/28,28.83%,CTSC;PSMC3;DAB2IP;TMTC3;PSMC6;CCDC22;PSMC5;TREM2;CLU;LAPTM5
prerank,apoptotic mitochondrial changes (GO:0008637),0.2445398743827391,0.7172465587489574,0.8625429553264605,0.977936151284241,1.0,5/32,10.73%,IFIT2;BCL2;BAX;DNM1L;BCL2L1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2795190770340349,0.7170664812137503,0.8240740740740741,0.977621630194948,1.0,2/18,4.00%,PTBP3;TERT
prerank,regulation of protein-containing complex assembly (GO:0043254),0.20234283744880782,0.7170074158779207,0.956268221574344,0.9771762325352248,1.0,15/110,11.96%,SELP;EIF2AK2;CDH5;PRKCZ;SPIDR;FBLIM1;OPRD1;GSK3B;BAX;SUMO1;SLF2;ATF7IP;FNIP1;HJURP;RHOC
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2206490256000237,0.7165832205653322,0.9267175572519084,0.9771830648845656,1.0,7/63,7.89%,IL6ST;ANXA1;IL6;BCL2;VCAM1;IL18;CD274
prerank,postreplication repair (GO:0006301),0.2317633732891362,0.7163955621700946,0.8878048780487805,0.976900916162869,1.0,6/45,10.87%,POLH;PARP10;RFC1;REV1;RPA3;UBE2V1
prerank,interstrand cross-link repair (GO:0036297),0.2284798543032561,0.7163732660674342,0.886435331230284,0.9764091535461606,1.0,8/53,12.35%,NUCKS1;SLX4;RPA3;FANCM;DCLRE1A;CENPX;RFWD3;FANCE
prerank,regulation of gene silencing by RNA (GO:0060966),0.22971601085787716,0.7162687866591342,0.8969404186795491,0.9755039482883365,1.0,11/50,20.48%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;NUP85;POLR2K
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.22971601085787716,0.7162687866591342,0.8969404186795491,0.9755039482883365,1.0,11/50,20.48%,POLR2D;RANBP2;TPR;TNRC6A;POLR2C;POLR2F;POM121;NUP37;PUM2;NUP85;POLR2K
prerank,hyaluronan catabolic process (GO:0030214),-0.2553756301903534,-0.7161161083994504,0.8577586206896551,0.9997434699138815,1.0,4/18,11.93%,HEXB;CEMIP;FGF2;GUSB
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.20219509461010027,-0.715317310546805,0.9453551912568307,0.9998965099324516,1.0,11/51,18.29%,PRKCQ;NEK7;CTNNB1;MAPK3;TERF1;GNL3L;ATM;PNKP;PKIB;CCT5;TINF2
prerank,negative regulation of cell cycle process (GO:0010948),0.217841984706201,0.7152861612985342,0.9025157232704403,0.9761604651776637,1.0,17/61,22.28%,SUZ12;BMP7;UXT;MGA;NANOS2;ESPL1;EPC1;RBBP8;TOM1L2;RING1;RNF2;BMI1;TOM1L1;TFDP2;PCGF2;APAF1;NME6
prerank,cellular response to interleukin-15 (GO:0071350),-0.2821621869648655,-0.7140764610977633,0.8204592901878914,0.9998862457985879,1.0,1/13,0.97%,PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2821621869648655,-0.7140764610977633,0.8204592901878914,0.9998862457985879,1.0,1/13,0.97%,PLCB1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2091841338046684,0.7139644865953511,0.9342105263157895,0.9772336867118964,1.0,8/83,7.62%,NINL;DYNLL1;ALMS1;SDCCAG8;CENPJ;CLASP1;CEP152;HAUS8
prerank,nuclear pore organization (GO:0006999),0.29836044262542377,0.7134517516051831,0.8351851851851851,0.9773109360865039,1.0,3/14,13.83%,TPR;AHCTF1;RTN4
prerank,melanosome localization (GO:0032400),-0.2433325245421168,-0.7126169030801407,0.8354430379746836,1.0,1.0,4/21,11.54%,RAB27A;RAB27B;VPS33B;MLPH
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3111375675527824,-0.711910084704944,0.8225469728601252,1.0,1.0,4/10,18.34%,ABCA3;PRELID1;TMEM30A;ABCB4
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.21951674040448757,-0.711712174864353,0.9046563192904656,1.0,1.0,13/31,33.93%,MAPK8;HIP1R;YWHAH;PPP1R13B;YWHAQ;BAD;CHCHD10;YWHAZ;PPP3CC;PMAIP1;TP53;BOK;E2F1
prerank,mitotic cytokinetic process (GO:1902410),-0.24673103448811506,-0.7116967745020738,0.8441558441558441,0.9996374351469727,1.0,10/20,30.19%,CHMP1A;CHMP1B;CHMP7;CHMP2B;CNTROB;CHMP2A;CEP55;CHMP6;CHMP4C;KIF20A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.17946827340513002,0.7116838008657339,0.982051282051282,0.9788369130617942,1.0,57/241,20.79%,POLR2D;PCF11;PRCC;RBM41;SNRPA1;ZRSR2;SRRM2;NOVA1;HNRNPH1;SNIP1;HNRNPC;RBMX2;SF3B3;DDX23;SLU7;CWF19L1;PSPC1;SNRNP27;RNPC3;PRPF38A;POLR2C;SRSF4;DHX16;HNRNPH3;MAGOHB;SF3B6;DHX8;RBM5;ZMAT5;DDX39A;PRPF19;POLR2F;RBM6;GEMIN5;RBM15;PABPN1;FUS;RBM14;SRSF5;CSTF3;HNRNPR;CCAR1;TXNL4A;HNRNPA2B1;CWC22;CTNNBL1;WBP4;PCBP2;USP39;PRPF3;WDR33;SNRNP40;DDX5;POLR2K;CWC25;ELAVL1;SNRNP200
prerank,regulation of G0 to G1 transition (GO:0070316),0.23821332050207608,0.7109960430066077,0.8657487091222031,0.9790951444928098,1.0,12/38,22.11%,SUZ12;UXT;MGA;CDKN2B;EPC1;RBBP8;RING1;RNF2;BMI1;TFDP2;PCGF2;APAF1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.29257728223274093,0.7106552343352376,0.8269581056466302,0.978960210878471,1.0,2/13,6.37%,NFATC4;PPARA
prerank,integrated stress response signaling (GO:0140467),0.29229846025201645,0.7106351099732869,0.8228782287822878,0.9784707165381075,1.0,3/14,15.08%,CCL2;QRICH1;EIF2AK3
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2905192586155471,-0.7101066964902977,0.8455114822546973,1.0,1.0,9/12,42.95%,KAT7;WRNIP1;BLM;WDR18;TICRR;NUGGC;NBN;METTL4;CDT1
prerank,lysosome organization (GO:0007040),0.24324378346141837,0.7099324178621602,0.8737373737373737,0.978760542748601,1.0,11/36,23.59%,CLN5;LRRK2;HPS1;TMEM165;ARSB;ABCA1;HOOK1;VPS33A;HPS4;TPCN2;LAMTOR1
prerank,regulation of response to stress (GO:0080134),-0.29727162077227937,-0.7099018104623106,0.8523908523908524,1.0,1.0,5/10,26.67%,OPRM1;MLC1;ADCY8;SLC38A2;EIF4G1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.252816660054496,-0.709792662372493,0.8805031446540881,0.9996424262041659,1.0,7/18,28.69%,MAF1;ATF4;SIRT7;HEATR1;RASL11A;LYAR;WDR75
prerank,protein insertion into ER membrane (GO:0045048),-0.21385643885334507,-0.7097772692662401,0.9258312020460358,0.9989611301986876,1.0,14/37,28.16%,BAG6;SERP1;TRAM1;CAMLG;CCDC47;EMC10;WDR83OS;SEC61G;CYB5A;HMOX1;TRAM1L1;GET1;SEC61B;VAMP2
prerank,negative regulation of T cell activation (GO:0050868),0.2422036058694319,0.709111129497075,0.8898026315789473,0.979191592249879,1.0,4/35,7.89%,TNFAIP8L2;PTPN22;FOXP3;CD274
prerank,cellular response to ionizing radiation (GO:0071479),0.225096371588084,0.7083410899480305,0.9081967213114754,0.9795847768723884,1.0,12/47,18.62%,PRAP1;NUCKS1;WRN;SPIDR;YAP1;TLK2;MAPK14;RAD9A;FIGNL1;NIPBL;KDM1A;CLOCK
prerank,methylguanosine-cap decapping (GO:0110156),0.314141405227047,0.7082391420175529,0.8144712430426716,0.9791876720385674,1.0,2/10,7.45%,LSM1;DCP2
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.2571653889170407,-0.7079793244786657,0.8663793103448276,1.0,1.0,3/18,13.96%,CCN3;KCNB1;INHBB
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.23115645625855663,-0.7079379545208847,0.8641686182669789,0.9995527002192741,1.0,11/26,29.51%,ST3GAL6;B3GNT2;B4GALT4;ST3GAL4;LUM;B3GNT3;B4GALT6;CHST5;B4GALT2;B4GAT1;ST3GAL2
prerank,COPII-coated vesicle budding (GO:0090114),-0.18436957054492908,-0.7078793904136763,0.9686609686609686,0.9989065831017067,1.0,17/68,21.85%,GRIA1;NSF;CTSC;CSNK1D;TMED2;TRAPPC4;CNIH1;LMAN1;NAPA;ANKRD28;TRAPPC6B;COL7A1;RAB1B;SAR1B;TRAPPC3;PPP6C;SEC22B
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.25375706567029155,-0.7078702336920276,0.8859060402684564,0.9982262611349197,1.0,8/17,35.93%,HDAC9;SORT1;LPL;PCSK5;NR1H2;LIPC;FURIN;APOH
prerank,positive regulation of cellular respiration (GO:1901857),0.3122357570217058,0.7063607221807571,0.8204158790170132,0.9808096975758552,1.0,2/11,10.65%,NUPR1;IFNLR1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.29881441295039096,-0.7060583912423901,0.842436974789916,0.9995091659365843,1.0,5/10,25.38%,ABCA3;MFSD2A;MTMR2;MTMR1;MTMR9
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24578778580327743,0.7060311943870359,0.8662207357859532,0.9806620802751539,1.0,8/31,21.18%,RBP4;IL6;PHB2;SHLD2;KMT5C;RIF1;KMT5B;XBP1
prerank,regulation of cell cycle process (GO:0010564),-0.17223300562676122,-0.7055488089533244,1.0,0.9993630607402556,1.0,24/104,20.81%,CALM1;CALM2;CTNNB1;RAB11FIP3;CALM3;YTHDF2;DYNC1H1;BORA;CAV2;CCDC8;CEP85;PLK4;RMI2;RAB11FIP4;PRC1;L3MBTL1;ECT2;CHEK1;PIK3C3;PRMT5;KNSTRN;MAD1L1;SPAG5;MKI67
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.30533584431889527,0.7053212700046294,0.8007448789571695,0.9809692866376037,1.0,11/11,69.49%,PKD1L3;RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;PKD2L1;RTP3;LPO
prerank,vitamin D metabolic process (GO:0042359),-0.275051543999579,-0.704984541471844,0.8467908902691511,0.9992700613811115,1.0,8/13,46.42%,LGMN;CYP2R1;VDR;CYP1A1;GC;CYP27B1;CYP24A1;FGF23
prerank,ncRNA 3'-end processing (GO:0043628),-0.27143410007721525,-0.7048066957376313,0.8353909465020576,0.9987492592012978,1.0,7/14,30.93%,INTS7;INTS6L;INTS12;ERI1;TOE1;INTS5;INTS2
prerank,regulation of telomere maintenance (GO:0032204),0.25570521540061436,0.7047946072216453,0.8537005163511188,0.9810589239499427,1.0,9/26,21.48%,RAD50;SMG5;SMG6;PML;ERCC1;SMG1;DHX36;USP7;RTEL1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2145784486688166,0.703671593198057,0.9149606299212598,0.981793740571768,1.0,17/58,20.15%,NHEJ1;RAD50;XRCC4;SUMO1;UVRAG;DCLRE1A;NSMCE2;KDM2A;PRPF19;ERCC6;UIMC1;ERCC1;SMARCAL1;BRCC3;CYREN;RIF1;ERCC8
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22655563535050702,-0.7035518230018013,0.9038901601830663,0.9986879188589034,1.0,13/29,35.41%,NPM1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22655563535050702,-0.7035518230018013,0.9038901601830663,0.9986879188589034,1.0,13/29,35.41%,NPM1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP;OIP5;CENPW;KNL1
prerank,defense response to fungus (GO:0050832),-0.2626566209634697,-0.7034872323062904,0.8609271523178808,0.9980573841594609,1.0,1/17,1.55%,PLCG2
prerank,neuron remodeling (GO:0016322),-0.2974908705498504,-0.7028356522617276,0.8608870967741935,0.9980126299845641,1.0,1/10,0.84%,ADGRB3
prerank,response to gamma radiation (GO:0010332),-0.2355824702260929,-0.7027456835845608,0.8960739030023095,0.9974026559011113,1.0,12/24,33.22%,RPL26;MAP3K20;ATM;HRAS;MEN1;ATR;DCUN1D3;XRCC6;MYC;TP53;TMEM109;MDM2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.23595672605633908,-0.7023458719143146,0.8783185840707964,0.9971172341182682,1.0,6/24,19.11%,NOD1;UBB;UBA52;CYLD;NOD2;IRAK1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.3086180626953145,0.7019278769131573,0.8172690763052208,0.9832820028971692,1.0,3/11,15.97%,POMT2;UGGT2;RNF185
prerank,electron transport chain (GO:0022900),0.28562650265898915,0.7017834582648279,0.8260038240917782,0.982931373670142,1.0,3/15,19.87%,POR;ETFA;UQCRFS1
prerank,translesion synthesis (GO:0019985),0.22976773100070016,0.7010396932058308,0.900990099009901,0.9832702630090174,1.0,7/42,14.52%,POLH;PARP10;RFC1;REV1;RPA3;POLDIP2;RCHY1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.23233450202788342,-0.7005567627164553,0.9024943310657596,0.9982683436843902,1.0,5/25,17.08%,DOT1L;H1-0;HEY1;PARK7;PER2
prerank,response to fatty acid (GO:0070542),0.2697354126389859,0.6995813147766182,0.8578856152512998,0.9843016716995258,1.0,1/17,1.34%,PID1
prerank,sister chromatid segregation (GO:0000819),0.2385913166564036,0.6993042831722417,0.8885017421602788,0.9841141230763755,1.0,4/31,9.25%,KLHL22;TOP2B;ESPL1;ZWINT
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.2996970813470564,0.6992352766259032,0.8248587570621468,0.9836675313408673,1.0,2/12,8.24%,MYCBP2;EPHA4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3108247908243114,0.6990831448864975,0.8306772908366534,0.9833150684525473,1.0,2/10,7.58%,TGFBR2;STAT1
prerank,plasma membrane invagination (GO:0099024),-0.22583250556223958,-0.6988732800071443,0.908235294117647,0.9992587205045884,1.0,9/29,25.04%,ELMO1;DOCK1;SNX18;FCGR1A;ITGB2;SNX33;AIF1;BIN2;MSR1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.2881631818142235,-0.6986703303475692,0.845360824742268,0.99878588516441,1.0,3/11,15.14%,TGFB2;BMP4;ZFPM2
prerank,regulation of Golgi organization (GO:1903358),0.27265402464551713,0.6986184580251359,0.8481481481481481,0.9833048719505836,1.0,5/17,18.93%,ARMH3;MAP2K1;RAB33B;MYO5A;USP6NL
prerank,cellular protein-containing complex assembly (GO:0034622),0.18205288485535395,0.6978554827039388,0.9796747967479674,0.9836369166706203,1.0,24/160,16.34%,TCF4;SMAD3;WNT3A;ANGPT1;PSMG1;TPR;PIK3C2A;POGZ;DNAAF1;SNX9;UVRAG;DNAI4;FCHO2;SMAD4;AHCTF1;DRC1;RTN4;CHMP3;NCK1;CHMP4A;CHMP4B;SRP19;SMAD2;TBCA
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.28183893291532236,-0.6977908063666601,0.8347457627118644,0.999001906588349,1.0,6/12,33.36%,CTNNB1;DDX11;RAD21;CTCF;FEN1;BUB1
prerank,response to nutrient levels (GO:0031667),0.27482568416283243,0.6970848408283434,0.8654867256637168,0.9839452368687628,1.0,1/17,1.61%,PRKAA2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.204469905178416,0.6969979130518364,0.947136563876652,0.983536467260208,1.0,6/80,7.40%,VPS54;DENND2A;SNX6;HEATR5A;SNX12;CLN5
prerank,lymphocyte proliferation (GO:0046651),0.26107251265094217,0.6964929703110804,0.8743455497382199,0.9835322697112651,1.0,4/22,11.81%,CTPS1;BCL2;ELF4;PPP3CB
prerank,RNA transport (GO:0050658),0.2059900608443028,0.695863645234381,0.9290322580645162,0.9836945234067085,1.0,11/71,15.12%,SIDT1;NXF2;TPR;TGFBR2;SLU7;SRSF4;MAGOHB;DDX39A;THOC5;POM121;SRSF5
prerank,protein modification by small protein removal (GO:0070646),0.17497399473841094,0.6949911146327078,0.995049504950495,0.9841462183416175,1.0,62/252,22.09%,SMAD3;USP18;SMURF2;SENP7;INO80D;TGFBR1;SIAH2;BIRC3;USP27X;STAMBP;USP24;USP9X;PSMB10;PSMA3;USP8;PSME4;USP47;PSMA5;STAMBPL1;KEAP1;MYSM1;ATXN7;SMAD4;SENP6;ACTL6A;SENP3;MAP3K7;USP40;SENP1;MDM4;USP35;USP34;USP36;IFIH1;UIMC1;KAT2B;USP45;INO80E;SMAD2;USP12;ASXL2;INO80C;RHOT1;USP15;USP32;USP10;JOSD1;ACTR8;BRCC3;USP4;TAB1;PSMC2;USP7;TNIP1;INO80;SENP8;HIF1A;USP26;RIPK1;PTEN;ZC3H12A;PSMD1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2540574442655795,-0.6946374673385105,0.8903225806451613,1.0,1.0,2/16,9.32%,GPR137C;RRAGB
prerank,telomere maintenance via telomerase (GO:0007004),-0.2222557204231973,-0.6945429173453073,0.9031476997578692,1.0,1.0,9/28,21.35%,MRE11;HSP90AB1;TERF1;HSP90AA1;CDK2;ANKRD28;TINF2;WRAP53;PPP6C
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2387451041613582,0.6943490620480216,0.871499176276771,0.9843176175395608,1.0,9/32,19.80%,APOA2;STARD10;CSNK2A2;PCYT1A;LPIN2;ABHD3;PEMT;SLC44A2;SLC27A1
prerank,negative regulation of RNA splicing (GO:0033119),-0.24661483951810015,-0.6941652160198029,0.8668122270742358,1.0,1.0,7/19,21.65%,PTBP1;RPS13;RPS26;RNPS1;SRSF9;C1QBP;SRSF6
prerank,regulation of dephosphorylation (GO:0035303),0.28235867276159354,0.6938843893747789,0.8412098298676749,0.9842932639602114,1.0,5/15,14.42%,MTMR3;PPP1R16A;SMG5;SMG6;SMG7
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.30905857550890103,0.6936170088171214,0.8326848249027238,0.9840552308295105,1.0,2/11,11.18%,PPARA;TRAP1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24376646198896518,-0.6935976009068676,0.8915094339622641,1.0,1.0,13/21,39.63%,RCC2;NPM1;CCND1;ATAD5;CDK4;DTL;CDK1;DYRK3;VPS4B;CDC7;RAB11A;CCNB1;CDC25C
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3094868822323526,0.6932429925575444,0.8313253012048193,0.9839272779699331,1.0,3/10,11.58%,IRAK3;MAP2K5;SH2B3
prerank,ERAD pathway (GO:0036503),-0.17512262911414933,-0.6928869203011301,0.9785276073619632,1.0,1.0,28/83,30.84%,SEL1L;ERLIN1;BAG6;USP13;UBXN8;BRSK2;CCDC47;HSPA5;TMUB2;YOD1;STT3B;FAM8A1;PSMC6;UBXN6;UBE2J1;SGTB;ATXN3;TMUB1;FBXO6;RNF121;FBXO2;SEC61B;HERPUD1;RNF5;UBE2G2;RHBDD2;UFD1;TOR1A
prerank,catecholamine metabolic process (GO:0006584),0.2862174613403896,0.6927636555285508,0.8428030303030303,0.9839198582257974,1.0,3/14,19.01%,COMT;RNF180;LRTOMT
prerank,regulation of T cell migration (GO:2000404),0.2746676731522772,0.6924510293765676,0.8475836431226765,0.9837410395271798,1.0,2/18,7.89%,CXCL10;TNFRSF14
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2674003817813824,0.6921031184887657,0.8468634686346863,0.9836099096889384,1.0,6/18,21.69%,POR;GDNF;ABL2;SIRT3;AGT;PDP2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2366217382053627,-0.6911195218202139,0.8943820224719101,1.0,1.0,8/20,33.60%,MBTPS1;KPNB1;LDLRAP1;ACADVL;MBTPS2;DGKQ;LPCAT3;ABCA2
prerank,regulation of store-operated calcium entry (GO:2001256),-0.29672696401390897,-0.6909921183136458,0.859375,1.0,1.0,5/10,25.95%,HOMER1;CD84;SLC8B1;CASQ1;HOMER2
prerank,purine nucleotide catabolic process (GO:0006195),-0.26614595052817913,-0.6907084719480436,0.8752642706131079,1.0,1.0,3/13,15.70%,HINT1;PNP;NT5C2
prerank,organelle fusion (GO:0048284),-0.23555511585281325,-0.6904756765888164,0.8935185185185185,0.9998892151136153,1.0,4/22,11.20%,MFF;MFN2;GDAP1;MFN1
prerank,positive regulation of organelle organization (GO:0010638),0.2373654289032085,0.6897026666927876,0.9166666666666666,0.9856129719921894,1.0,7/32,18.72%,ANXA2;ANXA1;GSK3B;UVRAG;TMED9;KATNBL1;PLA2G5
prerank,histone acetylation (GO:0016573),0.20448097751161595,0.6892214145565633,0.9556574923547401,0.9856062122758,1.0,24/69,24.33%,APBB1;BRD1;CREBBP;KAT6B;EPC1;JADE2;ACTL6A;MAP3K7;BRD8;KAT6A;ZZZ3;KAT2B;PHF20L1;TAF9;TRIM16;ATF2;NAA40;CPA4;DR1;SUPT7L;WDR5;ING5;EP400;TAF6
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.28826114249843066,-0.6889897396599527,0.8577586206896551,1.0,1.0,11/11,71.20%,PRDX2;PRDX5;GPX1;GPX3;PRDX4;MPO;PXDNL;PRDX1;CAT;PRDX3;PXDN
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.26872053986439587,0.6886362143346162,0.8723021582733813,0.9851766488396214,1.0,3/19,13.74%,POLR2D;POLR2C;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.26872053986439587,0.6886362143346162,0.8723021582733813,0.9851766488396214,1.0,3/19,13.74%,POLR2D;POLR2C;POLR2F
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2637992435876481,-0.6861051654338679,0.8896103896103896,1.0,1.0,3/15,19.53%,CPEB2;GSTO2;GSTO1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.30958819067466736,0.6860647099378291,0.8636363636363636,0.9873033116895745,1.0,3/10,17.52%,ZNHIT3;TAF9;NUFIP1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2679691555203724,-0.6857424612999341,0.8819742489270386,1.0,1.0,9/14,36.10%,HNRNPA0;ANGEL2;MYD88;BOLL;ZFP36;YBX3;TIRAP;TARDBP;DAZL
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.27446831655215564,0.6855218515053736,0.8484848484848485,0.987347083259989,1.0,1/17,1.32%,FGF1
prerank,axonemal dynein complex assembly (GO:0070286),0.23908173726651638,0.684774157981758,0.8996478873239436,0.9876093471888697,1.0,5/28,12.61%,ODAD4;DNAAF1;DNAL1;DNAI4;DRC1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.2564070304133449,0.6846968591781195,0.8736263736263736,0.9871818430340825,1.0,4/22,15.47%,CD55;FBXO38;MAP3K7;IL23R
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2797692461836492,-0.6846349672560972,0.8434237995824635,1.0,1.0,6/11,39.29%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2797692461836492,-0.6846349672560972,0.8434237995824635,1.0,1.0,6/11,39.29%,NOTCH4;TNRC6C;EIF6;ZFP36;AGO4;TRIM71
prerank,regulation of gluconeogenesis (GO:0006111),-0.22006795842797025,-0.683430895809962,0.9262672811059908,1.0,1.0,8/27,28.99%,C1QTNF3;SIK1;PGP;NNMT;SIRT7;ZNF692;DGKQ;GNMT
prerank,intestinal absorption (GO:0050892),-0.27260767481106174,-0.6830693384269586,0.8773784355179705,1.0,1.0,5/13,28.35%,KCNQ1;F11R;TJP2;UGCG;SLC2A2
prerank,regulation of vasculature development (GO:1901342),0.2411716797162724,0.6829429614147826,0.8761061946902655,0.9884424261644075,1.0,2/26,4.44%,SP100;IL6
prerank,tRNA modification (GO:0006400),-0.18447473462455086,-0.6825528531065808,0.9798270893371758,1.0,1.0,22/62,33.01%,PUS7;TRMT13;THUMPD1;QTRT2;PUS3;ELP5;DTWD2;WDR4;TYW5;CDKAL1;TRMT6;TRMT9B;TRUB1;PUSL1;ADAT2;CTU2;TRMT61A;THUMPD2;BCDIN3D;ALKBH8;TRMT10A;TPRKB
prerank,inner dynein arm assembly (GO:0036159),0.2976773383553044,0.6819580043670542,0.8606060606060606,0.9888741606388791,1.0,11/11,70.25%,DNAAF1;CCDC39;DNAAF4;CCDC103;DNAAF5;ZMYND10;CFAP73;DNAI3;DNAH1;CCDC40;CFAP100
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.18870648395384704,0.6816612350936399,0.9786324786324786,0.9886617389684369,1.0,19/113,15.40%,ASAP1;CDH5;TLR4;UNC13B;CUL4A;GBP5;SPIDR;GSK3B;BAX;SUMO1;SLF2;RPA3;PLEK;FNIP1;RHOC;GTF2H4;ERCC5;ABCA1;ERCC1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2636206634671622,-0.6810961837977897,0.8728070175438597,1.0,1.0,6/13,29.30%,BRSK2;YOD1;UBE2J1;UBAC2;SVIP;UBE2G2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.23157072387942956,0.6810623793809957,0.9112627986348123,0.9887187413733473,1.0,4/33,6.52%,RC3H1;UBASH3A;PTPN22;PTPN2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2430503092815112,0.6807487617308196,0.8845437616387337,0.9885196692252382,1.0,6/26,14.41%,RIPK2;MAP2K6;UBE2V1;MAP3K7;TIFA;IFIH1
prerank,response to reactive oxygen species (GO:0000302),0.21417213193457826,0.6806490794755273,0.9391025641025641,0.9881165951735472,1.0,5/54,8.56%,PDGFRA;FER;TPM1;MPV17;STK24
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2590261507513158,0.6794372458797893,0.9154411764705882,0.9888126718999357,1.0,3/21,9.25%,KLHL22;TPR;ZWINT
prerank,regulation of mitotic spindle assembly (GO:1901673),0.26128120039011243,0.6794260828029142,0.8541666666666666,0.9883156312257276,1.0,5/19,19.76%,TPR;CHMP3;CHMP4B;EML3;CHMP5
prerank,hexose metabolic process (GO:0019318),0.21980557126462338,0.6792218116958937,0.9060955518945635,0.98801497652725,1.0,9/39,20.55%,CHST15;GALK2;FPGT;SLC37A4;KHK;HK1;GALM;PGM1;SORD
prerank,tRNA 5'-leader removal (GO:0001682),-0.2637899804390082,-0.678698787285219,0.8633540372670807,1.0,1.0,4/13,26.42%,PRORP;RPP30;RPP25L;POP7
prerank,rRNA modification (GO:0000154),-0.23250604567130126,-0.6786239212418297,0.905829596412556,1.0,1.0,7/21,33.14%,FTSJ3;THUMPD1;TFB2M;TFB1M;NOP10;FBL;NHP2
prerank,negative regulation of DNA binding (GO:0043392),0.24458271510190516,0.6784071519111706,0.8841567291311755,0.9883109724889878,1.0,3/28,9.33%,SP100;CPNE1;SUMO1
prerank,negative regulation of translational initiation (GO:0045947),0.2906294476323489,0.6769788178360995,0.8639846743295019,0.9891486547582964,1.0,1/13,5.82%,TPR
prerank,positive regulation of DNA binding (GO:0043388),-0.21489583872246176,-0.6769657436150719,0.9489559164733179,1.0,1.0,7/31,17.72%,HMGB1;NGF;H1-0;PLAUR;PARK7;EGF;HES1
prerank,signal peptide processing (GO:0006465),-0.2783618116663796,-0.6769570390463556,0.8547008547008547,1.0,1.0,3/11,11.32%,SPCS2;SEC11C;SPCS1
prerank,negative regulation of ATPase activity (GO:0032780),0.27341283100605973,0.6756282850263813,0.8736059479553904,0.98991795407191,1.0,6/16,25.83%,IFIT1;ATP5IF1;PXK;OXA1L;THADA;TNNI3
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2877226869402421,-0.6755705981868931,0.8704061895551257,1.0,1.0,2/10,20.96%,ASRGL1;KYNU
prerank,chromatin organization (GO:0006325),0.18296285759409872,0.6751329752634229,0.9793956043956044,0.9898890625900432,1.0,32/132,21.54%,MYB;NUCKS1;BRWD1;TOP1;CDAN1;BAZ2A;FOXP3;HDAC4;TCF7L1;BAZ1B;JARID2;SETD7;BAZ1A;MYSM1;ACTL6A;KDM5B;BPTF;SUPV3L1;HDAC2;SETD5;SMARCA4;KAT2B;SMARCC1;LRWD1;INO80C;HCFC2;SETD2;SETDB1;PHF1;INO80;DR1;RSF1
prerank,regulation of mitochondrial translation (GO:0070129),-0.2395054750716171,-0.6746796304794281,0.8940092165898618,1.0,1.0,9/21,33.09%,FASTKD2;MALSU1;C1QBP;SHMT2;RCC1L;TRMT10C;RPUSD3;MPV17L2;COA3
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.2597390894239229,0.6746743406624232,0.9031657355679702,0.9888062117929174,1.0,3/20,9.25%,KLHL22;TPR;ZWINT
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.2597390894239229,0.6746743406624232,0.9031657355679702,0.9888062117929174,1.0,3/20,9.25%,KLHL22;TPR;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.2597390894239229,0.6746743406624232,0.9031657355679702,0.9888062117929174,1.0,3/20,9.25%,KLHL22;TPR;ZWINT
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.29934588013172375,0.6743564500954333,0.8391038696537678,0.9885878574902177,1.0,3/10,22.29%,ETFA;ACADS;IVD
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22360543261162186,-0.674024628424488,0.926605504587156,1.0,1.0,9/25,31.64%,MFF;PINK1;PLAUR;BMF;PYCARD;BAD;HRK;PMAIP1;TP53
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.24717980808080417,0.6728247648398332,0.8931159420289855,0.9894598099224,1.0,9/24,23.78%,NR1H3;LRRK2;BCL2L1;OPA1;UBXN1;XBP1;TXNDC12;SYVN1;USP25
prerank,cellular response to amino acid stimulus (GO:0071230),-0.20339073565845028,-0.6720414395045905,0.962877030162413,1.0,1.0,9/33,20.04%,SESN3;RRAGB;CPEB4;UBR1;SPAAR;RRAGC;GLRA2;GLRA1;LAMTOR2
prerank,protein palmitoylation (GO:0018345),-0.21597028219546466,-0.6720238781851015,0.9523809523809523,1.0,1.0,13/30,33.48%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;ZDHHC5;SELENOK;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.257607710065349,-0.6719222145105251,0.8834355828220859,1.0,1.0,1/14,2.14%,TFRC
prerank,cholesterol metabolic process (GO:0008203),0.20248300367080835,0.6716347095592076,0.9565217391304348,0.9900407981286442,1.0,9/68,14.75%,APOA2;APOF;CYP27A1;INSIG2;SOAT1;LBR;CH25H;OSBPL5;ABCA1
prerank,regulation of T cell activation (GO:0050863),0.21694880252960483,0.6711508534107119,0.933786078098472,0.9899800649401602,1.0,4/42,7.70%,TNFAIP8L2;PTPN22;CD47;CCL2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2127936380540995,0.6709048879510653,0.9412698412698413,0.9896998175481957,1.0,5/54,6.52%,CFLAR;CASP4;CPNE1;BIRC3;PTPN2
prerank,positive regulation of macrophage migration (GO:1905523),-0.23552364161912895,-0.6706023090395862,0.8955555555555555,1.0,1.0,4/19,13.22%,THBS1;MAPK3;CMKLR1;CSF1R
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.1766941942306576,-0.6703617496823842,0.9761194029850746,1.0,1.0,22/69,30.69%,SEL1L;ERLIN1;BAG6;UBXN8;HSPA5;TMUB2;YOD1;STT3B;FAM8A1;PSMC6;UBE2J1;SGTB;TMUB1;FBXO6;RNF121;FBXO2;SEC61B;HERPUD1;RNF5;UBE2G2;RHBDD2;UFD1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.20893752833543924,-0.6696262360086204,0.9376498800959233,1.0,1.0,4/33,12.39%,LEF1;CD74;RUNX1;FES
prerank,lipoprotein catabolic process (GO:0042159),0.2899672833112207,0.6681634982568195,0.8590998043052838,0.9917150241799717,1.0,1/11,4.99%,ABHD10
prerank,negative regulation of B cell proliferation (GO:0030889),-0.27696927542846483,-0.666997144694689,0.8925619834710744,1.0,1.0,3/11,13.40%,LYN;ATM;TNFRSF21
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.19433361717043376,0.6668762689924346,0.9564541213063764,0.9923265126947615,1.0,20/78,23.09%,NR2F2;LATS2;CCND3;CDKN2B;CCNH;MNAT1;CDK7;IPO7;PKD2;PSRC1;CDKN3;MAPRE3;CCNY;CCNG2;PKMYT1;PTEN;PKD1;CDK5RAP3;CEBPA;HEXIM1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23449569268254267,0.6668379593080243,0.9081081081081082,0.9918610591157818,1.0,5/28,12.25%,LACC1;RIPK2;MAP2K6;UBE2V1;MAP3K7
prerank,early endosome to late endosome transport (GO:0045022),-0.2323418159013045,-0.6666452384459177,0.9143518518518519,1.0,1.0,5/20,22.01%,EMP2;WDR81;KIF16B;PIK3C3;SNF8
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.2761846669865268,-0.6650665320925602,0.888015717092338,1.0,1.0,8/11,47.79%,CAMK4;ITGB2;TYROBP;STAP1;ITGAM;MAVS;F2RL1;CD177
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.20799450418716087,-0.6648679037034599,0.9459459459459459,1.0,1.0,6/31,15.29%,GPHN;FDXR;GCH1;DHRS11;PRLR;PYCR2
prerank,regulation of actin nucleation (GO:0051125),0.28706282146264933,0.6641313338768203,0.875,0.9937180607843099,1.0,4/12,20.34%,ARPIN;ARF1;ARFIP2;CORO1B
prerank,positive regulation of actin nucleation (GO:0051127),-0.2696159100739052,-0.6634813584764481,0.90020366598778,1.0,1.0,1/11,3.12%,NCKAP1
prerank,DNA methylation or demethylation (GO:0044728),-0.23256779237850128,-0.6632023444673364,0.9068181818181819,1.0,1.0,5/19,17.99%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,DNA alkylation (GO:0006305),-0.23256779237850128,-0.6632023444673364,0.9068181818181819,1.0,1.0,5/19,17.99%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1
prerank,proteasome assembly (GO:0043248),-0.27363319265357045,-0.6627914489105793,0.8559322033898306,1.0,1.0,5/11,30.81%,PSMD4;POMP;PSMD11;PSMG2;PSMD5
prerank,negative regulation of cell division (GO:0051782),-0.2778380895663408,-0.6626549434211937,0.8784067085953878,1.0,1.0,6/11,31.43%,ORC6;E2F7;BLM;CHMP4C;MYC;E2F8
prerank,covalent chromatin modification (GO:0016569),-0.2606656858942461,-0.6624846552207333,0.8896103896103896,1.0,1.0,6/14,21.96%,HDAC1;HELLS;PARK7;SIRT7;UFL1;PARP2
prerank,fatty acid metabolic process (GO:0006631),-0.16224543033087274,-0.6623471176209382,0.9900662251655629,1.0,1.0,37/115,30.41%,ADIPOR2;ACSL3;PPARD;ACSL5;GGT5;ACACA;ACLY;ABCD2;ACSBG1;CROT;AOAH;PER2;AASDH;LPL;LPIN3;ACSF2;ACOT2;GGT1;HSD17B8;PNPLA3;HPGD;FASN;MCAT;CPT1C;FAAH;FA2H;ACOT6;ALKBH7;ADIPOR1;LIPH;MSMO1;LIPC;SLC27A6;ALOX5AP;ACOX2;ALOX5;CPT1B
prerank,macroautophagy (GO:0016236),0.18091992604190618,0.6618443740930927,0.9786324786324786,0.9952195687187804,1.0,31/118,24.29%,PRKAG2;PRKAA2;DYNLL1;AMBRA1;LAMP2;MTMR3;UVRAG;SNX14;ATG12;VPS16;TCIRG1;PIP4K2B;CHMP3;CSNK2A2;CHMP4A;CHMP4B;FUNDC1;ATG10;WIPI2;RUBCNL;VPS33A;VPS39;ACBD5;VAMP7;ATG13;ATG7;PRKAA1;TOMM40;ATG3;TOMM70;VTA1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.2406648211142035,-0.6617032352185088,0.90744920993228,1.0,1.0,6/19,18.69%,GFPT2;PGM3;GFPT1;RENBP;GNPNAT1;PMM2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.24894580727012616,0.6612124925801872,0.9033391915641477,0.9952596726754491,1.0,2/24,5.95%,RBPJ;CREB3L3
prerank,sensory perception of pain (GO:0019233),-0.23026758490569665,-0.6610578667950924,0.9216494845360824,1.0,1.0,5/21,17.66%,OPRM1;SCN9A;KCNA2;P2RX7;CHRNA4
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2379313397783203,-0.6609739723503308,0.918918918918919,1.0,1.0,4/19,21.77%,PARK7;SOD1;MAOB;PRDX2
prerank,regulation of centrosome duplication (GO:0010824),0.2337591526820023,0.6606647098407563,0.9206896551724137,0.995212911914935,1.0,7/30,19.76%,ALMS1;CENPJ;CHMP3;CHMP4B;SPICE1;CEP131;CHMP5
prerank,protein prenylation (GO:0018342),-0.2711958339111442,-0.6597794536977151,0.8945054945054945,1.0,1.0,5/10,29.21%,PGGT1B;CHML;RABGGTA;RABGGTB;PTAR1
prerank,DNA strand elongation (GO:0022616),0.26083295795586015,0.6595043919474078,0.8764044943820225,0.9956918376405547,1.0,3/18,10.20%,TERT;RAD50;MCM4
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.24624897845703972,0.6593047047491871,0.9012797074954296,0.9953465332260985,1.0,2/22,6.03%,DUSP10;FOXP3
prerank,regulation of calcium ion import (GO:0090279),-0.22550162529338996,-0.657814676842924,0.9386363636363636,1.0,1.0,4/21,15.98%,CTNNB1;SLC30A1;CXCL12;EGF
prerank,phagosome-lysosome fusion (GO:0090385),-0.28563630405665064,-0.6575947635897819,0.8784860557768924,1.0,1.0,3/10,22.59%,SYT7;RAB39A;CLN3
prerank,tRNA transport (GO:0051031),-0.2052331844021112,-0.6575928025488416,0.9357326478149101,1.0,1.0,15/35,32.93%,YBX1;AAAS;NUP93;RAE1;XPOT;TOMM20;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,microglial cell activation (GO:0001774),-0.22868908202804106,-0.6572623219476523,0.920704845814978,1.0,1.0,14/21,42.83%,SNCA;GRN;MAPT;ITGB2;AIF1;TREM2;CLU;TYROBP;C1QA;CX3CR1;IL4;C5AR1;TNF;ITGAM
prerank,histone exchange (GO:0043486),-0.19909890766223046,-0.6570936993027738,0.9468599033816425,0.999911787385526,1.0,13/37,26.66%,ZNHIT1;NPM1;SPTY2D1;DMAP1;CENPU;CENPT;CENPQ;CENPL;CENPN;MIS18BP1;CENPA;RBBP7;ITGB3BP
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2514312850705591,-0.6569866417387231,0.913953488372093,0.9986473444095003,1.0,4/15,17.02%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2514312850705591,-0.6569866417387231,0.913953488372093,0.9986473444095003,1.0,4/15,17.02%,AP3S2;AP3B2;SNAPIN;AP3D1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.24999484656507875,-0.6569674179125975,0.9206680584551148,0.9979992810694863,1.0,3/14,17.30%,CTBP1;APLNR;NNMT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.2699929302403052,-0.6567185311843611,0.8854625550660793,0.9975113557565625,1.0,3/12,14.44%,RPL26;CD74;TAF9B
prerank,RNA interference (GO:0016246),0.26349074941693995,0.6563238230684545,0.8695652173913043,0.9973729805782703,1.0,4/17,23.45%,TERT;TARBP2;CLP1;DHX9
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.26728944338421295,0.6552181043596429,0.8701298701298701,0.9977669036826162,1.0,7/15,26.52%,BCL2;TAF9;MUC1;KDM1A;CD44;TRIAP1;ING2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2080279730073868,0.6544403481144013,0.9581320450885669,0.9974000721597653,1.0,20/51,25.35%,SUMO1;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,mitotic nuclear membrane organization (GO:0101024),0.2080279730073868,0.6544403481144013,0.9581320450885669,0.9974000721597653,1.0,20/51,25.35%,SUMO1;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,regulation of execution phase of apoptosis (GO:1900117),0.2820657104820372,0.6544192014491895,0.863905325443787,0.9969153611251376,1.0,2/11,10.73%,DLC1;BCL2L1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.20726348921068227,-0.6540346307163579,0.9534313725490197,0.9988214269653573,1.0,11/31,30.05%,RPS2;PINK1;DCUN1D2;DCUN1D5;DCUN1D1;SKP1;DCUN1D3;CDC14B;RAB1A;PLK1;UBE2L3
prerank,negative regulation of B cell activation (GO:0050869),0.24672522939435143,0.6539964004759967,0.8853046594982079,0.9967622086720132,1.0,2/21,5.63%,RC3H1;PARP3
prerank,protein localization to chromosome (GO:0034502),-0.2028090431766368,-0.6538737109303272,0.9501187648456056,0.9982803536635452,1.0,10/34,26.32%,ESR1;MCM9;SLF1;CHMP7;TINF2;ATR;IFFO1;CENPA;RAD21;CTCF
prerank,regulation of keratinocyte migration (GO:0051547),-0.26667861112788865,-0.6537139208483567,0.8893528183716075,0.9977297634415058,1.0,3/12,18.62%,IQSEC1;EPB41L4B;ARF6
prerank,fatty acid beta-oxidation (GO:0006635),0.20570254573136124,0.6532362128236197,0.9536321483771252,0.9968788711556605,1.0,11/51,19.43%,ACOXL;AMACR;SCP2;SLC27A2;ACAT1;ABCD3;ETFA;PEX2;ACADS;ACOX1;HADHA
prerank,regulation of T cell differentiation (GO:0045580),0.224662169348234,0.6525640443560947,0.9307958477508651,0.996927294400869,1.0,2/33,6.03%,ZMIZ1;FOXP3
prerank,protein acylation (GO:0043543),-0.2023071333608737,-0.6521589989012067,0.9578947368421052,0.9981678109614995,1.0,12/38,26.20%,FOXO1;ZDHHC14;ZDHHC20;ZDHHC2;NAA10;ZDHHC7;KAT2A;ZDHHC23;ZDHHC9;ING4;ZDHHC5;SELENOK
prerank,mismatch repair (GO:0006298),-0.2104934537936505,-0.6518909344009042,0.9394673123486683,0.9977059157857614,1.0,8/27,31.25%,MSH3;MCM9;PMS1;POLD2;POLD1;EXO1;PCNA;MSH5
prerank,regulation of lipase activity (GO:0060191),0.27732279815781674,0.6516364915418968,0.8672897196261682,0.9971927583151579,1.0,1/13,2.03%,APOA2
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21929352000601127,-0.6505158134766603,0.9287356321839081,0.9980317348026129,1.0,12/23,32.90%,NSFL1C;NDE1;INSC;CDK5RAP2;DCTN1;HTT;SPDL1;CENPA;UBXN2B;PLK1;ZW10;PKHD1
prerank,coenzyme A metabolic process (GO:0015936),0.26899964190190584,0.6503587715050058,0.8834586466165414,0.9977025503595105,1.0,2/14,11.27%,PANK2;ACAT1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.21986906494567865,0.6502047073998951,0.9396551724137931,0.9973221656837313,1.0,11/36,22.11%,SUZ12;UXT;MGA;EPC1;RBBP8;RING1;RNF2;BMI1;TFDP2;PCGF2;APAF1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.21770746900614202,-0.6489528728616922,0.9343891402714932,0.9983979495569497,1.0,13/23,43.98%,ACSBG1;HPGD;FADS1;ALOX5;CYP2E1;ACOT7;GSTM4;GPX4;CYP1A1;LTC4S;GSTP1;ELOVL6;ALOX12
prerank,histone H3 deacetylation (GO:0070932),-0.24285407019589436,-0.6482889998908237,0.9090909090909091,0.9981850122380878,1.0,4/15,18.56%,HDAC9;HDAC1;PER2;SIRT7
prerank,response to light stimulus (GO:0009416),0.20239325749854847,0.6479649517760879,0.9730586370839936,0.9985530967082279,1.0,20/55,27.64%,CRY2;CRY1;FECH;REV1;ERCC5;ERCC6;OPN3;GTF2H2;UBE4B;UVSSA;CLOCK;ERCC8;TRIM32;ZRANB3;USP1;GPR52;SPRTN;ERCC2;ERCC4;ERCC3
prerank,regulation of cytoplasmic transport (GO:1903649),0.2877046914050385,0.6476149521094126,0.8737864077669902,0.9982942876786496,1.0,4/11,19.95%,LRRK2;MAP2K1;CHMP3;USP7
prerank,regulation of endocytic recycling (GO:2001135),-0.27208885127259247,-0.6474757001714128,0.8886597938144329,0.9980640934812032,1.0,2/11,11.13%,SORL1;ARHGAP1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2401086324537699,-0.647259691033802,0.9019607843137255,0.9975501409512482,1.0,4/17,18.61%,TGFB2;RET;SYK;RAC3
prerank,pentose-phosphate shunt (GO:0006098),0.27777418821272337,0.6453145852810477,0.8846918489065606,0.9995480985637697,1.0,2/11,9.75%,PGD;DERA
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.20317804263801142,0.6449104405253498,0.9634340222575517,0.9993539799133702,1.0,5/53,7.70%,ANXA1;HRH3;MC2R;OPRD1;CCL2
prerank,glycosphingolipid metabolic process (GO:0006687),0.211480655500613,0.6443732613545197,0.9494097807757167,0.9992736274420014,1.0,4/42,7.75%,SMPD3;A4GALT;LARGE1;ESYT1
prerank,positive regulation of chromosome organization (GO:2001252),-0.24253553151873003,-0.6430796197852673,0.9253112033195021,0.9998023349023462,1.0,5/15,20.36%,MRE11;DDX11;GNL3;PPP1R10;SHCBP1L
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.2870582590729488,0.6429278677533264,0.8897058823529411,0.999872965734041,1.0,2/11,9.47%,NRP1;MST1R
prerank,Golgi inheritance (GO:0048313),0.2834070688834534,0.6422086327865987,0.8585271317829457,0.999928483640834,1.0,3/11,16.23%,PLK5;GBF1;GOLGA2
prerank,mitochondrial membrane organization (GO:0007006),0.22335990994956467,0.6421061022330158,0.9314586994727593,0.9994969634585329,1.0,7/32,18.46%,MICOS10;BCL2;BCL2L1;OPA1;SLC25A4;HSPA9;SLC25A31
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2169373646374841,-0.6414696552335942,0.9478458049886621,1.0,1.0,5/24,14.44%,TPT1;CXCL12;CD74;CCAR2;TAF9B
prerank,protein hydroxylation (GO:0018126),-0.24275495617016557,-0.6409578109684905,0.9121338912133892,0.9999134689085598,1.0,5/15,24.71%,VPS33B;PLOD2;VIPAS39;HIF1AN;JMJD7
prerank,mitotic spindle organization (GO:0007052),-0.14673455493961934,-0.6401259753483853,1.0,0.9998012935136196,1.0,69/153,38.32%,RPS27;KPNB1;EFHC2;RCC2;DYNC1H1;PCNT;AAAS;KIF18A;XPO1;KIF3B;DYNC1I2;NDE1;CLASP2;PPP1CC;NEK9;CENPU;SKA2;BUB1B;DYNLL2;PRC1;ZWILCH;CENPT;CENPQ;CENPL;STMN1;TUBG1;KIF23;MAD1L1;NSL1;CENPN;CENPF;KIF4A;DSN1;KNTC1;SPDL1;TUBG2;DCTN6;CENPA;BCCIP;MAPRE1;SGO1;STIL;BIRC5;ITGB3BP;CLIP1;TBCE;PLK1;ZW10;DLGAP5;CEP192;NUF2;AURKA;SEC13;SMC1A;CDC20;BUB1;MIS12;ABRAXAS1;KIFC1;BUB3;KNL1;NUDC;INCENP;RAB11A;MZT1;KIF2C;CCNB1;CENPM;NDEL1
prerank,tryptophan catabolic process (GO:0006569),0.28126546387167106,0.6400025302772426,0.8950495049504951,1.0,1.0,1/11,5.59%,AFMID
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.17832635806904468,-0.6399641846089147,0.9844559585492227,0.9992411847158215,1.0,11/54,21.17%,CRADD;RPL26;PLAGL1;ATM;RGCC;CDKN1A;RBL2;CNOT2;E2F4;CNOT8;E2F7
prerank,tryptophan metabolic process (GO:0006568),-0.26836825262246655,-0.6393351862001019,0.9092741935483871,0.9989983735788058,1.0,7/11,53.67%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of ATPase activity (GO:0032781),-0.1880064318792175,-0.637593646549375,0.9741602067183462,0.999460242831945,1.0,17/41,36.32%,ATP1B1;RYR2;MSH3;VMP1;DYNLL2;AHSA1;PFN2;CHTOP;TOR1AIP2;PFN1;UHRF1;FGF10;MYL4;DNAJB11;GABARAPL2;ALDOB;SSBP1
prerank,nuclear membrane reassembly (GO:0031468),0.2006478776738543,0.6374339423704083,0.9625407166123778,1.0,1.0,21/54,25.35%,SUMO1;UBXN2A;AHCTF1;LBR;CHMP3;POM121;CHMP4A;CHMP4B;NUP37;RAN;PPP2CA;PPP2R2A;EMD;NUP85;SIRT2;IST1;SPAST;RANGAP1;NUP160;NUP107;VPS4A
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2040356157799574,-0.6371424484504826,0.9496567505720824,0.9990906072834231,1.0,3/28,6.43%,SH3KBP1;PRKCQ;CYRIB
prerank,positive regulation of cell development (GO:0010720),0.22024667370734563,0.6367112801828101,0.9481865284974094,1.0,1.0,2/31,3.98%,NUMB;RFX3
prerank,indolalkylamine catabolic process (GO:0046218),-0.2757911970195997,-0.6366775140363082,0.8984375,0.9987282070353783,1.0,7/10,53.67%,KMO;KYNU;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.20383329631763,-0.6365378339141058,0.9464285714285714,0.9981598407094713,1.0,9/29,26.60%,SMAD7;DAB2IP;SPRED2;IL17RD;SPRED3;SPRED1;BMP5;ADIPOR1;SDHAF2
prerank,synaptonemal complex assembly (GO:0007130),0.25822258760595984,0.6355144059632645,0.9045045045045045,1.0,1.0,3/15,14.86%,SYCP2;TEX12;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.25822258760595984,0.6355144059632645,0.9045045045045045,1.0,1.0,3/15,14.86%,SYCP2;TEX12;P3H4
prerank,lipid droplet organization (GO:0034389),0.23852847115830708,0.6352684748217118,0.9222614840989399,1.0,1.0,4/22,15.17%,SMIM22;PLA2G4C;PPID;FAF2
prerank,P-body assembly (GO:0033962),0.273057472675473,0.6343085571871897,0.8850574712643678,1.0,1.0,4/12,18.25%,RC3H1;EIF4ENIF1;DDX6;PATL1
prerank,protein catabolic process (GO:0030163),-0.1733245090605355,-0.6338125071802858,0.989159891598916,0.9992217631085324,1.0,8/59,14.25%,HSPA8;DAB2IP;CTSD;CEACAM1;BAG6;RAB12;HSP90AA1;PSMA8
prerank,DNA replication checkpoint signaling (GO:0000076),-0.23687083589251784,-0.6338108983330378,0.9316770186335404,0.9985689236164687,1.0,7/16,35.44%,CLSPN;CDC45;HUS1B;TOPBP1;CDC6;TICRR;TIMELESS
prerank,negative regulation of interleukin-10 production (GO:0032693),0.2532579334486601,0.6336023648299806,0.9113207547169812,1.0,1.0,3/16,15.47%,FOXP3;CD274;IL23R
prerank,mRNA transport (GO:0051028),-0.15750733906417283,-0.6330577981283286,1.0,0.9983680619720317,1.0,35/101,30.56%,SRSF2;CPSF2;SRSF1;SYMPK;ZC3H11A;THOC2;HHEX;AAAS;NUP93;KIF5C;RAE1;RNPS1;SRSF9;POLDIP3;NXT1;RBM15B;UPF1;ALKBH5;NUP62;SRSF6;CHTOP;CPSF3;NUP188;U2AF1;CDC40;NUP54;NUP210;CPSF1;NUP42;NUP153;MCM3AP;UPF3B;ZFP36;NDC1;DDX25
prerank,histone H4 deacetylation (GO:0070933),-0.2702166201262561,-0.6318101622013861,0.9075975359342916,0.9984857351034145,1.0,2/10,9.20%,HDAC9;HDAC1
prerank,regulation of exit from mitosis (GO:0007096),0.20928735244076835,0.6311277312437356,0.956738768718802,1.0,1.0,7/38,13.47%,ANAPC11;PHB2;ANAPC1;UBE2C;CDC14A;MAD2L1BP;CDC27
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.22946827734171793,-0.6305119054374131,0.9317697228144989,0.9985797191765262,1.0,7/17,28.40%,NTRK2;SORL1;CHRNA7;RTN3;HAP1;RTN2;CLU
prerank,cellular response to gamma radiation (GO:0071480),-0.23408616497823814,-0.6294885765743642,0.937365010799136,0.9985795002932244,1.0,4/17,13.61%,RPL26;MAP3K20;ATM;HRAS
prerank,linoleic acid metabolic process (GO:0043651),0.254097782979357,0.6287368678075614,0.9084249084249084,1.0,1.0,2/17,8.37%,ACSL1;ALOXE3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.16898555441679491,-0.6285640246520479,0.9918256130790191,0.9984395963064019,1.0,11/63,17.56%,CRADD;RPL26;PLAGL1;CCND1;ATM;RGCC;CDK2;CDKN1A;RBL2;CNOT2;E2F4
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.24607173105393843,-0.6284749338326573,0.9186813186813186,0.9978435083343404,1.0,1/14,1.90%,ATP1B1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.23031768400761682,0.6274928154620244,0.9341421143847487,1.0,1.0,2/24,5.56%,AUTS2;PLCE1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.27503116934386074,0.6272125801562727,0.8762088974854932,1.0,1.0,4/11,19.65%,FBH1;GMNN;SMARCAL1;TIPIN
prerank,positive regulation of vacuole organization (GO:0044090),0.28362757783003867,0.6266622990899925,0.8771929824561403,1.0,1.0,3/10,18.73%,ANXA2;PIP4K2B;PIP4K2C
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.19538140728965175,-0.6258274403187077,0.9692671394799054,0.9987364574885211,1.0,5/32,16.84%,GRM5;ATXN2;PUM3;PGAM1;RBM3
prerank,purine nucleotide biosynthetic process (GO:0006164),0.26306522068956534,0.6254461815058346,0.8809073724007561,1.0,1.0,2/12,9.23%,MTHFD1;PRPSAP1
prerank,axoneme assembly (GO:0035082),-0.19507144424192016,-0.6253177251801997,0.966903073286052,0.9983748705217348,1.0,14/31,34.13%,RP1;CFAP46;CFAP74;DNAAF3;SPAG16;SPAG1;SPAG17;DCX;TTLL3;CCDC65;DNAAF2;CFAP206;FOXJ1;CCDC40
prerank,transcription by RNA polymerase III (GO:0006383),-0.20161702260101824,-0.6235137426252222,0.9518348623853211,0.9987833743863972,1.0,6/27,24.22%,IVNS1ABP;RO60;GTF3C6;POLR3G;ZC3H8;SNAPC1
prerank,regulation of isotype switching (GO:0045191),0.26171390827763896,0.623101000147178,0.8928571428571429,1.0,1.0,5/14,20.39%,PARP3;SHLD2;KMT5C;RIF1;KMT5B
prerank,ketone body metabolic process (GO:1902224),0.28188858274268513,0.6230366819789535,0.8878143133462283,1.0,1.0,3/10,17.44%,OXCT1;ACAT1;ACSS3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.21938513041135643,-0.6229354199050621,0.9220183486238532,0.9984684142287794,1.0,11/21,46.72%,SETX;MED30;SRF;MED13;PAXIP1;SUB1;JUN;HNF1B;MED24;TWIST1;MED16
prerank,RNA 3'-end processing (GO:0031123),0.18653880072567108,0.6223152183759093,0.9905660377358491,1.0,1.0,24/69,24.63%,TUT4;PCF11;RPRD2;SLU7;SRSF4;MAGOHB;SUPV3L1;DDX39A;THOC5;TENT2;PABPN1;SRSF5;CSTF3;TUT7;WDR33;RPRD1B;TENT4B;SRSF3;SRSF11;PNPT1;CLP1;DDX39B;PAPOLA;SRSF7
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.2797272662173149,0.6221251120192518,0.899009900990099,1.0,1.0,9/10,50.16%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.2797272662173149,0.6221251120192518,0.899009900990099,1.0,1.0,9/10,50.16%,CEP250;TULP1;CNGB1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1
prerank,regulation of coagulation (GO:0050818),-0.2637623875605959,-0.6220490941208068,0.9063829787234042,0.9983384927266253,1.0,2/11,12.95%,HS3ST5;CAV1
prerank,regulation of chromosome segregation (GO:0051983),-0.2292434288711663,-0.6219197931936886,0.9319727891156463,0.9977588300667101,1.0,9/16,41.47%,RMI2;MKI67;SMC5;RAD18;CDC6;BUB1;IHO1;KIF2C;AURKB
prerank,intestinal lipid absorption (GO:0098856),0.2734167969117738,0.6214514108439615,0.8909090909090909,1.0,1.0,4/11,28.25%,LIMA1;CD36;CEL;SOAT2
prerank,isotype switching (GO:0045190),-0.2688266371487364,-0.6210141707171798,0.9131313131313131,0.9976255287647553,1.0,6/10,47.33%,RNF168;EXOSC3;CCR6;LIG4;BATF;HSPD1
prerank,mitochondrial transport (GO:0006839),0.1938714356730962,0.6194219479845405,0.971107544141252,1.0,1.0,16/53,24.26%,BCL2;TIMM17A;SLC25A24;BCL2L1;COX18;TMEM14A;TIMM9;SLC25A4;TOMM34;SLC25A31;BCAP31;OXA1L;MTX2;TMEM14C;TOMM40;TOMM70
prerank,phospholipid homeostasis (GO:0055091),0.269428750784683,0.6188114947228884,0.9092627599243857,1.0,1.0,11/11,73.08%,ABCA1;ANGPTL3;RCN3;ABCG1;LIPG;ABCB11;APOA1;HNF4A;TLCD1;FABP3;TLCD2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.21341343169088273,-0.6182463781503966,0.95,0.9985452799951988,1.0,5/23,18.02%,HMGB1;KPNB1;H1-0;FOXL2;DICER1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.24734896043700616,-0.6178694996019268,0.9227642276422764,0.998116733036651,1.0,5/12,28.70%,XPR1;SLC25A30;SLC20A2;SLC37A1;SLC37A2
prerank,regulation of translational initiation (GO:0006446),-0.16493873279431134,-0.6176811618320006,0.9894179894179894,0.9975800552015919,1.0,27/63,38.08%,EIF2B2;NPM1;YTHDF2;EIF5B;EIF1B;ATF4;CDC123;EIF1;PAIP2;PPP1R15B;EIF3H;EIF4A2;PAIP1;UHMK1;CSDE1;POLR2G;EIF4G1;BOLL;HSPB1;EIF4G3;CCL5;MTIF2;DDX1;DAZL;EIF5;EIF4EBP2;EIF4EBP1
prerank,zymogen activation (GO:0031638),-0.18481235583098593,-0.6169769415730855,0.9830917874396136,0.9973039488125117,1.0,5/39,11.06%,GRIN2A;PERP;PGK1;LGMN;CTSL
prerank,Golgi to lysosome transport (GO:0090160),-0.25447500835703823,-0.616101990560898,0.9363817097415507,0.9971234260795679,1.0,4/11,28.83%,SORT1;LAMP1;CLN3;LAPTM5
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.24500575498654378,-0.6155716479617205,0.9405737704918032,0.9967674470115366,1.0,4/13,22.46%,SORL1;TMEM30A;SAR1B;CD81
prerank,membrane lipid catabolic process (GO:0046466),0.27896929164131556,0.6154293996575155,0.9075144508670521,1.0,1.0,2/10,18.66%,ENPP2;SGPL1
prerank,DNA methylation (GO:0006306),-0.20618195870305858,-0.6146409365608425,0.9586206896551724,0.9966427037917918,1.0,8/23,28.97%,HELLS;GATAD2A;MTRR;DMAP1;DNMT1;N6AMT1;FOS;PICK1
prerank,positive regulation of sodium ion transport (GO:0010765),0.2658402721758811,0.6145411240006343,0.9209558823529411,1.0,1.0,6/12,24.16%,SCN3B;GPD1L;WNK3;SCN4B;CNKSR3;SCN5A
prerank,axonal fasciculation (GO:0007413),0.2721229594211022,0.6139705016276981,0.925,1.0,1.0,3/12,13.83%,EPHA3;EPHA4;RTN4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.21620896906505976,-0.613479232912075,0.9617977528089887,0.9966178163448897,1.0,12/22,43.22%,RPS21;EXOSC2;FTSJ3;ERI1;ABT1;UTP20;EXOSC3;RRS1;EXOSC8;ERI2;EXOSC9;NOP14
prerank,protein targeting to peroxisome (GO:0006625),0.22053307447003223,0.6127950879813949,0.9484902309058615,1.0,1.0,5/29,13.46%,ZFAND6;PXMP2;HACL1;ABCD3;PEX2
prerank,natural killer cell mediated immunity (GO:0002228),-0.22916933962684494,-0.6126831563618899,0.9448123620309051,0.9963644749606978,1.0,3/15,15.54%,RAET1E;TUBB4B;LYST
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2518202046732921,0.6115200833821725,0.9122807017543859,1.0,1.0,3/14,12.16%,FASTKD5;FOXO3;MTERF2
prerank,UV-damage excision repair (GO:0070914),0.260366886366458,0.6110099907175987,0.9172932330827067,1.0,1.0,4/12,21.07%,ERCC1;XPC;POLD3;INO80
prerank,establishment of melanosome localization (GO:0032401),-0.2139039312885283,-0.610224487227374,0.945031712473573,0.9969484810886398,1.0,12/19,41.99%,RAB27A;RAB27B;MLPH;BBS2;BBS7;MREG;RAB11A;MKKS;GPR143;RAB17;BBS5;BLOC1S3
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2514553575490727,-0.6096668966773069,0.9139344262295082,0.9965824838523523,1.0,2/11,9.79%,ATG9A;MFN2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.23230202840157643,0.6087548064145217,0.9435336976320583,1.0,1.0,8/21,23.00%,HAO1;LPIN2;ACOX1;HOGA1;ACBD5;AGXT;NUDT19;LPIN1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.23236076615421566,-0.6076309400815811,0.9326315789473684,0.9969501486433194,1.0,6/15,30.50%,CSNK1D;CEP83;SPAG5;STIL;SNX10;CEP192
prerank,regulation of histone methylation (GO:0031060),0.25867954274429295,0.6068443665026431,0.925,1.0,1.0,3/13,13.46%,NSD1;JARID2;PAF1
prerank,cilium-dependent cell motility (GO:0060285),0.2223689291193876,0.6068349437413456,0.9592592592592593,1.0,1.0,5/22,18.93%,RFX3;RSPH9;DRC1;GAS8;CCDC39
prerank,glycerol metabolic process (GO:0006071),-0.25790829475247246,-0.6060791149178415,0.943359375,0.9971020296747413,1.0,4/10,24.38%,TPI1;PGP;COQ3;GK
prerank,male meiosis I (GO:0007141),0.24270015698587116,0.6060527057577121,0.933572710951526,1.0,1.0,16/16,75.75%,ZSCAN21;SLC25A31;FOXJ3;ING2;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;HSF2BP;CCNA1;BRDT;FOXJ2;MOV10L1;TDRD9;SYCP3
prerank,response to estrogen (GO:0043627),-0.19066927566124675,-0.6050794893612115,0.9765807962529274,0.9969312877646733,1.0,7/31,23.73%,SERPINB9;ESR1;CAV1;BRCA1;ASH2L;RBBP5;KRT19
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.1594085516230359,-0.6050678830715904,0.9972826086956522,0.9962949677843869,1.0,12/72,17.85%,CRADD;ACER2;RPL26;PLAGL1;TFAP4;ATM;RGCC;CDKN1A;RBL2;CNOT2;E2F4;BCL3
prerank,regulation of viral release from host cell (GO:1902186),0.22818658344931264,0.6040131485037499,0.9527410207939508,1.0,1.0,5/21,14.99%,TRIM5;TRIM21;TRIM26;CHMP3;PML
prerank,cellular macromolecule catabolic process (GO:0044265),0.19349514476155907,0.603974261419507,0.9848484848484849,1.0,1.0,14/49,23.79%,SIAH2;MANBA;SND1;SUPV3L1;DNASE1L1;RNASEH1;RNASE3;DFFB;CHEK2;RIPK1;RNASEH2B;PNPT1;ADAMTS9;RNASEH2A
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2504858715244619,0.6036960359362408,0.9236363636363636,1.0,1.0,3/13,13.87%,ALG9;ALG11;ALG1
prerank,early endosome to Golgi transport (GO:0034498),-0.2574404412251647,-0.6034075031914692,0.9454148471615721,0.9964939234624874,1.0,2/11,14.01%,LMAN1;SNX8
prerank,cellular response to hydroxyurea (GO:0072711),0.2723228492912352,0.6029891591151636,0.9099804305283757,1.0,1.0,4/10,25.09%,SPIDR;NSMCE3;ATRX;RTF2
prerank,lytic vacuole organization (GO:0080171),0.21001499914550073,0.6028460210941015,0.9510961214165261,1.0,1.0,9/32,23.59%,CLN5;LRRK2;HPS1;ARSB;ABCA1;HOOK1;HPS4;TPCN2;LAMTOR1
prerank,myelin maintenance (GO:0043217),-0.25782996045056666,-0.6024316692304988,0.9216867469879518,0.9963007723419856,1.0,5/10,41.27%,ABCD2;SOD1;CLU;ABCD1;DEGS1
prerank,sterol biosynthetic process (GO:0016126),0.20854660126514912,0.6014004834296472,0.9572649572649573,1.0,1.0,4/33,12.52%,PRKAG2;INSIG2;LBR;CH25H
prerank,protein localization to lysosome (GO:0061462),-0.19152282223384562,-0.6009698539491227,0.9715536105032823,0.9963423007798462,1.0,5/28,12.02%,SORL1;GCC2;M6PR;SCARB2;GLMP
prerank,glutamine family amino acid metabolic process (GO:0009064),0.20879707579223955,0.6007698428502272,0.9674657534246576,1.0,1.0,4/33,9.52%,ALDH4A1;GLUL;SIRT4;PYCR3
prerank,mitochondrion disassembly (GO:0061726),-0.18525776973857738,-0.6005487998871017,0.9727722772277227,0.995898053850759,1.0,5/34,11.76%,GABARAP;GABARAPL1;PINK1;ATG9A;ULK1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.21937662552224513,-0.600250191022689,0.9432624113475178,0.9953943588661245,1.0,4/18,11.83%,ZC3H11A;THOC2;HHEX;NUP93
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.251743908945097,-0.6002356382952405,0.9576271186440678,0.9947641013092242,1.0,6/10,43.62%,CEACAM1;PTPRC;LILRB1;CX3CR1;FCGR2B;KLRD1
prerank,regulation of mitotic nuclear division (GO:0007088),0.18708306660530166,0.5989176387512275,0.9819672131147541,1.0,1.0,5/55,8.99%,PHIP;TGFA;BMP7;PDGFRB;IGF2
prerank,phagolysosome assembly (GO:0001845),-0.2427970396550912,-0.5988832421540555,0.9434343434343434,0.994729440186559,1.0,3/12,22.59%,SYT7;RAB39A;CLN3
prerank,mitotic recombination (GO:0006312),0.2501624115385755,0.5986901605980312,0.9113680154142582,1.0,1.0,5/15,21.67%,RAD50;NSMCE2;ERCC1;SMC6;TEP1
prerank,protein-DNA complex disassembly (GO:0032986),-0.21871680153046924,-0.5982657950929953,0.9486607142857143,0.9943696420218158,1.0,8/16,37.36%,SMARCB1;RPL23;SET;SMARCC2;MYC;GRWD1;NFE2;HMGA1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.21103583351503852,0.5982250433740437,0.9660107334525939,1.0,1.0,8/27,23.00%,ETNK2;PLA2G6;NAAA;NAPEPLD;LPIN2;SLC27A1;PLAAT5;LPIN1
prerank,lymphocyte migration (GO:0072676),0.20584267363024505,0.5970726507039924,0.957983193277311,1.0,1.0,3/32,7.70%,CKLF;MSMP;CCL2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.21179137448458812,0.5969298068187809,0.9562841530054644,1.0,1.0,6/27,15.58%,CREBBP;KAT6B;BRD8;KAT6A;KAT2B;PHF20L1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.18682872263272315,0.5968232028291584,0.9788961038961039,1.0,1.0,15/52,24.73%,KDELR3;SRPRA;CTDSP2;DNAJC3;TSPYL2;PARP16;EXTL2;ERN2;SEC31A;SHC1;XBP1;MYDGF;SYVN1;EDEM1;YIF1A
prerank,regulation of cytokinesis (GO:0032465),0.17659559645929027,0.59625587251443,0.9908814589665653,1.0,1.0,13/78,15.71%,MAP9;PLK5;KLHL21;UVRAG;BCL2L1;CDC14A;CUL3;KLHL13;AHCTF1;ENTR1;FSD1;BIRC6;PKN2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.24854572396383234,-0.5943749580171862,0.918580375782881,0.9954864996296596,1.0,3/11,15.49%,SCARB1;MFSD2A;CTDNEP1
prerank,reticulophagy (GO:0061709),0.2528884710793377,0.5928623923969124,0.9200743494423792,1.0,1.0,2/12,15.66%,UBA5;ATG2A
prerank,phasic smooth muscle contraction (GO:0014821),0.26797785288784526,0.5916450298205957,0.9101123595505618,1.0,1.0,3/10,20.66%,TIFAB;GDNF;PTGER3
prerank,RNA export from nucleus (GO:0006405),0.16772004066572208,0.5906315500217385,0.9925925925925926,1.0,1.0,23/100,19.70%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;SRSF5;NUP37;HNRNPA2B1;RAN;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.21335935477126874,0.5905958672701288,0.965034965034965,1.0,1.0,7/26,15.86%,TTL;KLHL18;CCDC57;CUL3;SMOC2;PKN2;APP
prerank,mRNA metabolic process (GO:0016071),-0.14764842133660594,-0.5900064048030941,1.0,0.9967321012540449,1.0,27/90,31.64%,DIS3L2;PTBP1;DHX15;SRSF2;SRSF1;HNRNPA0;YTHDF2;SNRPB;NUDT16L1;AURKAIP1;SNRPF;SRSF9;RIDA;NONO;ALKBH5;CPSF3;U2AF1;LSM2;TBRG4;NUDT16;LSM3;RNH1;ZFP36;CPSF6;PRPF8;NUDT12;TP53
prerank,regulation of protein acetylation (GO:1901983),0.25374233396456947,0.5899459386427935,0.9470588235294117,1.0,1.0,2/12,16.82%,GSK3B;RAPGEF3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.18998957957129126,-0.5892146601545905,0.9837587006960556,0.9964505545577967,1.0,11/29,30.39%,EXOSC2;DCP1A;HBS1L;EXOSC4;CNOT8;LSM4;EXOSC1;EDC3;LSM2;LSM3;DCPS
prerank,regulation of histone deacetylation (GO:0031063),0.24488831043703485,0.5880767725348415,0.933852140077821,1.0,1.0,4/13,20.80%,FOXP3;SAP30BP;NIPBL;SPHK2
prerank,DNA recombination (GO:0006310),0.19607891032683042,0.5875234062879852,0.9616055846422339,1.0,1.0,6/37,15.40%,WRN;RAD50;FBH1;SUPV3L1;RAD51B;ERCC1
prerank,maturation of LSU-rRNA (GO:0000470),0.21351967162658084,0.5870325151987541,0.9634146341463414,1.0,1.0,6/26,16.92%,NSA2;RPL7L1;ZNHIT3;WDR12;RPF1;DDX18
prerank,mitochondrial transcription (GO:0006390),-0.24755912342736705,-0.5863524226584345,0.9426229508196722,0.996992066058815,1.0,4/10,23.04%,TWNK;TFB2M;TFB1M;POLRMT
prerank,regulation of cholesterol storage (GO:0010885),0.24222275756186668,0.5856759510775955,0.9351351351351351,1.0,1.0,2/15,6.37%,NR1H3;PPARA
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.16716116316142562,0.5848732282071756,0.9940387481371088,1.0,1.0,22/96,19.70%,NXF2;RANBP2;TPR;SLU7;SRSF4;SMG5;SMG6;MAGOHB;DDX39A;THOC5;POM121;SMG7;SRSF5;NUP37;HNRNPA2B1;SMG1;DDX19B;SLBP;WDR33;NUP85;UPF2;AGFG1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.2496208496563624,-0.584177648891244,0.9585798816568047,0.9972658284015858,1.0,2/10,12.97%,GFPT2;GFPT1
prerank,cellular response to interleukin-2 (GO:0071352),0.2542577162817233,0.5835265520526279,0.9285714285714286,1.0,1.0,4/11,18.45%,STAT5B;JAK1;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.2542577162817233,0.5835265520526279,0.9285714285714286,1.0,1.0,4/11,18.45%,STAT5B;JAK1;STAT5A;SHC1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.20782533674224996,-0.5819890536287644,0.9653767820773931,0.9975477669454866,1.0,2/18,5.86%,RPS3;HMGB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2291969555481076,-0.5819654178357896,0.9409282700421941,0.9969236798646623,1.0,6/14,34.25%,RFK;ADSS2;ADSS1;IMPDH1;LHPP;PFAS
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.26114384892864395,0.5812880481218017,0.9586614173228346,1.0,1.0,4/10,22.43%,AMDHD2;ST3GAL1;NAGK;ST6GAL1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.22306458807710505,-0.5807946533978341,0.9495967741935484,0.9967326295318452,1.0,6/13,45.59%,NELFCD;RNF168;NELFA;SUPT4H1;NELFB;LARP7
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.23125012554231608,0.5806623506138596,0.9587242026266416,1.0,1.0,7/16,27.36%,KIF5B;PLEKHM2;VAMP7;KLRK1;CEBPG;ULBP1;ARL8B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.19202305040387285,-0.5796833399962557,0.9764705882352941,0.9965195690271093,1.0,6/25,20.14%,CCAR2;EAF2;EAF1;KAT7;CCNK;TCEA2
prerank,determination of left/right symmetry (GO:0007368),0.19270611833937473,0.5784697609430408,0.9744897959183674,1.0,1.0,10/37,20.82%,RFX3;ODAD4;DNAAF1;NPHP3;PKD2;ARL6;CCDC39;CITED2;MEGF8;OFD1
prerank,lung epithelium development (GO:0060428),0.2543401654107499,0.5780735858489622,0.9334600760456274,1.0,1.0,1/10,4.74%,ERRFI1
prerank,carboxylic acid catabolic process (GO:0046395),-0.23624717210013846,-0.5780228983317116,0.9539748953974896,0.9965115068592643,1.0,3/12,17.92%,BCKDK;RENBP;NPL
prerank,regulation of cholesterol efflux (GO:0010874),-0.18023234548063438,-0.5768687721898687,0.9854014598540146,0.9962968960400947,1.0,7/30,27.49%,ABCA3;EEPD1;CAV1;RXRA;TREM2;GPS2;NR1H2
prerank,rRNA transcription (GO:0009303),-0.21050243907888255,-0.5768336299948865,0.9558498896247241,0.9956788471362045,1.0,7/17,33.61%,GTF3C6;SIRT7;SPIN1;POLR1E;TAF1B;NIFK;GTF3C4
prerank,regulation of chromosome organization (GO:0033044),-0.19970050562792363,-0.5763775053441137,0.9722222222222222,0.9952339310269842,1.0,14/22,45.15%,MAPT;RMI2;SHCBP1L;UPF1;HNRNPD;MYC;PIF1;BUB1;TERF2IP;HDAC8;CDT1;YLPM1;SETMAR;LIG4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2369300511810018,0.5761453268294836,0.943289224952741,1.0,1.0,2/14,12.25%,TNFSF15;MAP3K7
prerank,spinal cord development (GO:0021510),0.24866913437058963,0.5755910614116316,0.9341085271317829,1.0,1.0,3/12,15.77%,LOXL3;SOX4;PKD2
prerank,B cell activation involved in immune response (GO:0002312),0.2436589653440482,0.5755424429620907,0.958904109589041,1.0,1.0,13/13,75.65%,MSH2;RNF8;GPR183;MSH6;CD40LG;CD180;GAPT;CD19;BATF;LIG4;FCGR2B;EXOSC3;RNF168
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.22275881162474442,0.575467597044411,0.9468085106382979,1.0,1.0,4/18,15.66%,SNX12;MAP2K1;CHMP3;DAB2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.23380976247871613,0.5753452891618881,0.9411764705882353,1.0,1.0,7/14,30.70%,TERT;TNKS2;NABP2;ATRX;TNKS;TERF2;ACD
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.22965709981364185,-0.5743009693315124,0.9676025917926566,0.9953748040639258,1.0,3/13,23.52%,RPS21;BMS1;ABT1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24519134949333843,-0.5735750214172128,0.9506903353057199,0.9950036689714897,1.0,3/10,28.10%,YY1;PYCARD;LILRB1
prerank,regulation of spindle assembly (GO:0090169),-0.1929368821950938,-0.5734363962814556,0.975,0.994414717342838,1.0,9/25,29.91%,DYNC1H1;RNF4;CHMP1A;CHMP1B;CHMP2B;SPAG5;CHMP2A;CHMP4C;PLK1
prerank,kinetochore organization (GO:0051383),-0.22318956796425765,-0.5731320617595093,0.9594882729211087,0.9939092111823483,1.0,9/13,42.95%,CENPT;CENPF;CENPA;DLGAP5;NUF2;CENPW;MIS12;CENPE;CDT1
prerank,lipoxygenase pathway (GO:0019372),0.24317126955571222,0.5726770656904987,0.9535315985130112,1.0,1.0,3/14,20.44%,ALOXE3;PON3;PTGS2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.23286872029570557,-0.5715697419472229,0.9586956521739131,0.9938364595144339,1.0,3/12,19.08%,LYN;ORMDL3;NOC2L
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.23764659995996254,-0.5714649374032015,0.9646569646569647,0.9932441572711344,1.0,2/11,10.21%,H3-3A;ASF1A
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22546631665635097,0.5711542396087673,0.9611111111111111,1.0,1.0,4/18,20.84%,DCP2;EXOSC10;CCT6A;PARN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.18326703526918475,0.568730842254501,0.9869281045751634,1.0,1.0,6/50,9.67%,STOX1;CCND3;CDKN2B;CCNH;MNAT1;CDK7
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2093572371246278,-0.5675502664306477,0.9727272727272728,0.9939512138487956,1.0,4/18,23.21%,LDLRAP1;PSENEN;CLN3;NSG1
prerank,protein localization to vacuole (GO:0072665),-0.22285905409589793,-0.5664665702338355,0.9634408602150538,0.9936889059181756,1.0,6/13,32.74%,GLMP;CD81;SH3GLB1;LAMTOR4;KPTN;SZT2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.216850310531581,-0.5662749158632168,0.9507494646680942,0.9931218343685253,1.0,5/14,34.43%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.23978613829952827,-0.5647687296766999,0.9545454545454546,0.9929842860892124,1.0,4/10,37.60%,CCT5;WRAP53;CCT7;CCT8
prerank,regulation of cellular protein metabolic process (GO:0032268),0.1802512530191483,0.5639868884412903,0.9834162520729685,1.0,1.0,8/47,15.86%,PKP3;NR1H3;SSH1;FOXO3;CSF1;GEMIN5;MAPKAPK5;APP
prerank,ncRNA export from nucleus (GO:0097064),-0.17438079304883064,-0.5632051719008275,0.9925187032418953,0.9928404277401245,1.0,14/36,32.93%,NPM1;AAAS;NUP93;RAE1;XPOT;NUP62;NUP188;NUP54;NUP210;NUP42;NUP153;NDC1;SEC13;NOL6
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.23405644387556782,0.5624673658596998,0.9262948207171314,1.0,1.0,1/13,5.82%,TPR
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.19978936666907188,-0.5597367211715496,0.9775280898876404,0.9933252247794115,1.0,4/19,20.27%,RIC3;CHRNA4;CHRFAM7A;CHRNA7
prerank,peptidyl-proline hydroxylation (GO:0019511),0.2502972050910475,0.5592828777735994,0.9435483870967742,1.0,1.0,3/11,20.70%,P4HTM;OGFOD1;EGLN1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.20932017050960983,-0.5585741055916588,0.9730848861283644,0.9930699621953726,1.0,3/16,14.21%,SRSF1;WBP11;SART1
prerank,regulation of B cell differentiation (GO:0045577),0.22855980414601446,0.5580893577865879,0.9625,1.0,1.0,4/17,22.79%,MMP14;INHA;XBP1;ZFP36L2
prerank,phosphate ion transport (GO:0006817),-0.20569630449246212,-0.5578904475528623,0.9741379310344828,0.9926435393683963,1.0,4/16,22.81%,XPR1;SLC25A30;SLC20A2;SLC37A1
prerank,positive regulation of viral transcription (GO:0050434),0.20058672990429727,0.5578408256547646,0.9574105621805792,1.0,1.0,8/25,26.80%,POLR2D;POLR2C;POLR2F;POLR2K;RSF1;DHX9;POLR2H;GTF2F1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.19126274350110856,0.5550223685601657,0.9802306425041186,1.0,1.0,7/31,20.29%,RC3H1;FOXP3;CD274;DLG5;VTCN1;CEBPB;BLK
prerank,cytoplasmic translational initiation (GO:0002183),-0.2078296669583014,-0.5518044849895106,0.9717391304347827,0.9938899964292665,1.0,7/17,36.64%,EIF4A1;EIF3A;EIF4A2;EIF3I;EIF4G1;DHX29;EIF5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.19695048952708863,-0.5515991451378441,0.9725400457665904,0.9933239964297105,1.0,3/18,12.81%,CTSC;PTTG1IP;HSP90AA1
prerank,extracellular transport (GO:0006858),0.22997237569060747,0.5500156977490642,0.9628942486085343,1.0,1.0,13/13,77.02%,WWP2;SPEF2;ROPN1L;DNAAF4;TSG101;SPA17;CCDC103;ARRDC1;CCDC40;DNAAF2;CABYR;SPAG17;ADCY10
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21273281211891662,0.5487991724621709,0.9482439926062847,1.0,1.0,8/18,27.33%,AMFR;UGGT2;RNF185;EDEM2;RNF139;SYVN1;OS9;UGGT1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.1879515865408326,0.5483878131809993,0.9826086956521739,1.0,1.0,9/32,22.50%,AUTS2;PLCE1;ENPP2;AVIL;CORO1B;ACTR3;TWF2;FSCN1;CYFIP1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.22670107224402905,0.5480226656615875,0.9555555555555556,1.0,1.0,5/14,27.60%,ADAM19;ABCA7;PSEN1;NCSTN;ABCG1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.1889560977018539,-0.547433844443114,0.9887892376681614,0.9938709127421522,1.0,4/20,15.04%,CAMK2D;TMCO1;ATP2A2;CCDC47
prerank,neuromuscular synaptic transmission (GO:0007274),-0.19927100446570173,-0.5469554903049475,0.9816700610997964,0.9933785727643116,1.0,1/18,2.54%,KIF1B
prerank,regulation of mRNA metabolic process (GO:1903311),0.23361027777316806,0.5467416160053755,0.9446564885496184,1.0,1.0,2/11,13.15%,IWS1;SRPK1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2465165762397565,0.5463117728985994,0.9437386569872959,1.0,1.0,6/10,30.70%,DCLRE1A;RIF1;RTEL1;TFIP11;TERF2;ACD
prerank,neuron maturation (GO:0042551),0.21624550908307064,0.5459444835511746,0.9815157116451017,1.0,1.0,5/18,19.85%,EPHA8;CLN5;APP;FARP2;MTCH1
prerank,positive regulation of integrin activation (GO:0033625),-0.2261520376717434,-0.5442127365996601,0.9756592292089249,0.9934996676242365,1.0,1/11,5.36%,RASIP1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.23380976104756868,0.5441528280102084,0.9318181818181818,1.0,1.0,2/12,13.28%,MCM4;MCM6
prerank,chromatin assembly or disassembly (GO:0006333),0.23764946303425172,0.5428037789295128,0.9505494505494505,1.0,1.0,1/11,5.71%,CDAN1
prerank,erythrocyte development (GO:0048821),0.24332788411820575,0.5425251629789557,0.9577735124760077,1.0,1.0,3/10,18.98%,SH2B3;ALAS2;DMTN
prerank,positive regulation of protein depolymerization (GO:1901881),0.23574091089643112,0.541509726580151,0.9439071566731141,1.0,1.0,2/11,11.37%,PLEK;NES
prerank,regulation of cilium movement (GO:0003352),0.24187662924432254,0.5405555000874623,0.953307392996109,1.0,1.0,3/10,18.93%,DNAAF1;DRC1;CCDC39
prerank,protein alkylation (GO:0008213),0.20481942320518276,0.5401468314588174,0.9805309734513274,1.0,1.0,2/22,7.77%,METTL21C;ETFBKMT
prerank,amyloid-beta metabolic process (GO:0050435),0.2159361559253004,0.5372269611047364,0.9705340699815838,1.0,1.0,5/16,25.82%,MGAT3;ABCA7;APEH;PSEN1;NCSTN
prerank,RNA catabolic process (GO:0006401),0.1707587608655393,0.5344569229775988,0.9932546374367622,1.0,1.0,13/46,23.79%,NANOS2;DCP2;SND1;SLFN14;SUPV3L1;METTL16;RNASEH1;RNASE3;DNA2;RNASEH2B;PNPT1;ZFP36L2;RNASEH2A
prerank,lysosome localization (GO:0032418),0.17997630447212934,0.5339793966240076,0.9851485148514851,1.0,1.0,9/37,21.65%,KIT;MAP6;KIF5B;RAB34;PLEKHM2;VPS33A;BORCS5;DEF8;KXD1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.21849689207006956,0.5314737037758049,0.9506641366223909,1.0,1.0,14/14,78.17%,CSF1;IL23R;TRAF6;POU4F2;IFNG;IL12B;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TYROBP;ATP6AP1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.18227644363499249,0.5311266285730921,0.9983136593591906,1.0,1.0,7/32,19.55%,RANBP2;TPR;POM121;SSB;NUP37;RAN;NUP85
prerank,tRNA export from nucleus (GO:0006409),0.18227644363499249,0.5311266285730921,0.9983136593591906,1.0,1.0,7/32,19.55%,RANBP2;TPR;POM121;SSB;NUP37;RAN;NUP85
prerank,positive regulation of establishment of protein localization (GO:1904951),0.20663877564719002,0.5308901592857623,0.980701754385965,1.0,1.0,3/19,17.03%,CENPJ;CCT6A;CORO2B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.20345700218465246,-0.5308319965553829,0.9892933618843683,0.9961967049520916,1.0,7/15,38.25%,CD53;TREM2;ADGRB1;TYROBP;SCGB3A1;ADAM9;IL4
prerank,regulation of pH (GO:0006885),0.23136697624230604,0.5297881825797551,0.9576612903225806,1.0,1.0,3/11,20.71%,LACC1;SLC9A7;SLC9A1
prerank,regulation of B cell activation (GO:0050864),-0.17757887314042864,-0.5295711773510435,0.9880382775119617,0.9958687660011177,1.0,10/25,40.67%,SH3KBP1;NOD2;SAMSN1;LAPTM5;IKZF3;THEMIS2;FOXJ1;IL4;FCGR2B;CD22
prerank,nuclear body organization (GO:0030575),-0.2087700218397618,-0.5269183928498018,0.974025974025974,0.9958515786214449,1.0,5/12,34.85%,WRAP53;SRPK2;HIPK2;USPL1;DYRK3
prerank,telomere capping (GO:0016233),-0.19988134711166824,-0.5265743498385648,0.9643705463182898,0.995308705748104,1.0,8/16,35.38%,MRE11;TERF1;DCLRE1C;TINF2;STN1;DCLRE1B;PRKDC;TERF2IP
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.20693044139159955,-0.5233270423863629,0.9751131221719457,0.9953806315017407,1.0,8/12,42.95%,MAD1L1;NUF2;MIS12;KIF2C;BOD1;CENPE;CHAMP1;CDT1
prerank,alpha-amino acid metabolic process (GO:1901605),0.17000197764972286,0.5231190391127457,0.9918300653594772,1.0,1.0,11/45,22.84%,MTHFD1;ASPA;GLUL;PYCR3;THAP4;SRR;DPEP1;NAALAD2;ASS1;DDAH2;MMUT
prerank,protein localization to centrosome (GO:0071539),0.20763147141371185,0.521246826782619,0.9619047619047619,1.0,1.0,3/17,11.21%,C2CD3;NUDCD3;NEDD1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.20358298715061451,0.5205708597131008,0.9694793536804309,1.0,1.0,3/18,13.33%,STOX1;BRD4;RAD51B
prerank,transcription preinitiation complex assembly (GO:0070897),0.21898198341524752,0.5195221864990007,0.9600725952813067,1.0,1.0,4/12,23.89%,TAF7;BDP1;DR1;TAF1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.19558167854564346,-0.5165947859977124,0.9761904761904762,0.9961092633351979,1.0,5/15,34.43%,CSTF2;TSEN54;CPSF1;TSEN34;DDX1
prerank,tRNA wobble base modification (GO:0002097),0.21246939159917114,0.5142566081285428,0.9790874524714829,1.0,1.0,14/14,78.77%,CTU1;ALKBH1;URM1;ELP4;GTPBP3;MTO1;MOCS3;ALKBH8;ELP3;CTU2;ADAT2;KTI12;DPH3;TRMT9B
prerank,nuclear envelope organization (GO:0006998),0.1934704947519893,0.5134449207087156,0.9857651245551602,1.0,1.0,7/20,25.35%,TOR1AIP1;NEMP1;DMPK;EMD;LEMD3;SUN1;VPS4A
prerank,RNA methylation (GO:0001510),-0.1398093529868819,-0.5131466941397886,1.0,0.9961883073854823,1.0,18/60,32.94%,TRMT13;FTSJ3;VIRMA;ZC3H13;CBLL1;RBM15B;TRMT6;TFB2M;TFB1M;METTL8;TRMT10C;METTL14;TRMT61A;THUMPD2;BCDIN3D;FBL;ALKBH8;TRMT10A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.17038498818509773,0.5114160564171664,0.9948630136986302,1.0,1.0,12/37,23.95%,ENTPD7;SND1;SUPV3L1;DNASE1L1;RNASEH1;RNASE3;DFFB;RNASEH2B;PNPT1;ENTPD6;RNASEH2A;ENTPD5
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2024551860543864,0.5109971361287171,0.9854545454545455,1.0,1.0,2/18,9.75%,MANBA;DERA
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.19838595329044695,0.5101609995839941,0.9704251386321626,1.0,1.0,6/19,21.01%,RTN1;RTN4;FLOT2;ABCA7;ROCK1;GGA3
prerank,DNA modification (GO:0006304),0.19355658187430827,0.5098149272999507,0.9799270072992701,1.0,1.0,3/22,12.43%,PARP3;NTHL1;OGG1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.18696325953659898,-0.5075200765279425,0.9844444444444445,0.9966427390130996,1.0,4/18,18.10%,DNLZ;GRPEL2;TOMM40L;TOMM20
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.20239482930439034,-0.5052461285244031,0.9790794979079498,0.9964224335465295,1.0,8/13,50.38%,MMS19;YAE1;GLRX5;LTO1;CISD3;ISCA2;GLRX3;BOLA2
prerank,placenta development (GO:0001890),0.22042448483858237,0.5049663490391644,0.9721115537848606,1.0,1.0,2/12,11.81%,PTK2;ADAM19
prerank,positive regulation of mRNA processing (GO:0050685),0.19245577639647643,0.5029894170828406,0.9879310344827587,1.0,1.0,11/21,29.35%,CDC73;PAF1;LEO1;DHX36;NCL;DAZAP1;RBMX;SF3B4;NUP98;TRA2B;THRAP3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.20996562119956086,0.5029435446091384,0.982791586998088,1.0,1.0,3/13,20.44%,BMP7;NAPEPLD;PTGS2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.19775252683784295,-0.5028645289665972,0.9861111111111112,0.9962209929358917,1.0,12/12,80.25%,NELFCD;RNF168;NELFA;NELFB;LARP7;NELFE;RECQL5;HNRNPU;TCERG1;RNF8;HEXIM1;EAPP
prerank,respiratory chain complex IV assembly (GO:0008535),-0.17343463159840022,-0.5026485323609432,0.9952380952380953,0.9956366887648316,1.0,8/21,33.09%,COX20;COX19;BCS1L;PET100;TIMM21;COA5;SCO2;COA3
prerank,nuclear membrane organization (GO:0071763),0.19321035632060496,0.5024638663465757,0.9775700934579439,1.0,1.0,5/19,19.00%,TOR1AIP1;UBXN2A;NEMP1;CHMP4B;EMD
prerank,positive regulation of translational initiation (GO:0045948),0.19287845380669763,0.5021546631465423,0.9819819819819819,1.0,1.0,1/18,3.34%,POLR2D
prerank,adipose tissue development (GO:0060612),0.22413108840349383,0.49971492098651493,0.9673076923076923,1.0,1.0,4/11,21.18%,DGAT2;ARID5B;SH3PXD2B;XBP1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.1815978540022489,-0.4978228886945541,0.9880952380952381,0.9958131005436875,1.0,8/18,33.09%,COX20;COX19;BCS1L;PET100;TIMM21;COA5;SCO2;COA3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.19908169350160915,-0.4973974039589181,0.9813664596273292,0.995263048451743,1.0,5/13,32.29%,SART3;LSM2;SRSF12;PRPF8;DDX20
prerank,regulation of phosphate metabolic process (GO:0019220),0.2027266391757399,0.49513516086528925,0.9754253308128544,1.0,1.0,8/16,28.96%,SMG5;SMG6;SMG7;SIRT2;MCM7;PSEN1;IGBP1;GNB3
prerank,positive regulation of lipid storage (GO:0010884),0.18815890847537775,0.4944206134522014,0.9839285714285714,1.0,1.0,2/21,12.06%,IKBKE;PLIN3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1760402633675739,0.4939785467520285,0.9949832775919732,1.0,1.0,4/29,14.86%,SYCP2;MAJIN;TEX12;P3H4
prerank,spliceosomal snRNP assembly (GO:0000387),0.16564494098794783,0.49293317734369246,0.9983277591973244,1.0,1.0,7/38,19.16%,GEMIN4;STRAP;PRPF19;GEMIN5;TGS1;PRPF3;USP4
prerank,mitochondrial protein processing (GO:0034982),0.21211105748573783,0.4921981171462854,0.9734848484848485,1.0,1.0,5/11,30.78%,PMPCB;AFG3L2;STOML2;PMPCA;YME1L1
prerank,ncRNA transcription (GO:0098781),0.20538311935122816,0.48793145003924565,0.9862475442043221,1.0,1.0,3/13,17.70%,POLR1G;SNAPC3;CAVIN1
prerank,regulation of viral transcription (GO:0046782),0.163927827975666,0.48688216558096264,0.995,1.0,1.0,13/39,26.80%,POLR2D;POLR2C;TRIM21;POLR2F;TARBP2;POLR2K;RSF1;HEXIM1;DHX9;TRIM32;POLR2H;UBP1;GTF2F1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.19564389131563803,0.48628843042284026,0.9802158273381295,1.0,1.0,5/16,22.09%,NR1H3;ABHD5;SLC27A1;SREBF1;DAGLB
prerank,protein autoprocessing (GO:0016540),-0.17440366093968387,-0.48627738687374095,0.991304347826087,0.9962854866842872,1.0,5/17,30.17%,FAM111A;CTSL;CASP1;OMA1;PIDD1
prerank,cilium movement (GO:0003341),-0.13989402849260688,-0.48525671081994515,1.0,0.9958054825514261,1.0,21/48,37.76%,CFAP251;DNAH11;CFAP54;CFAP70;ODAD2;ADCY10;SPAG17;CABYR;ODAD3;DNAAF2;CFAP100;DNAH17;DNAH9;CFAP206;CFAP61;CCDC40;CCDC63;TTC29;CFAP91;TEKT5;DNAH1
prerank,regulation of microglial cell activation (GO:1903978),0.19902214362236606,0.48448967894346295,0.9843444227005871,1.0,1.0,1/15,4.44%,IL6
prerank,positive regulation of cilium assembly (GO:0045724),0.19322924083825943,0.48201494174032583,0.9963963963963964,1.0,1.0,3/18,14.43%,TAPT1;ENTR1;CROCC
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19420302226983915,0.4795995339583221,0.9856115107913669,1.0,1.0,3/17,14.03%,NTHL1;OGG1;ERCC5
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.20404831934467305,0.4795359964797966,0.988394584139265,1.0,1.0,4/12,24.58%,PAICS;GMPS;ADSL;ATIC
prerank,regulation of oxidoreductase activity (GO:0051341),-0.18745221680537444,-0.47235859634133387,0.9935483870967742,0.9967969377841265,1.0,2/13,15.58%,HDAC6;NOD2
prerank,positive regulation of cell division (GO:0051781),0.15474418582322,0.46714981853179083,0.9967266775777414,1.0,1.0,1/38,1.32%,FGF1
prerank,regulation of rRNA processing (GO:2000232),0.18697417190493004,0.4659651475525253,0.9906191369606003,1.0,1.0,3/16,15.46%,UTP15;USP36;KAT2B
prerank,glutathione derivative biosynthetic process (GO:1901687),0.1816390247203459,0.46381699092033946,0.994413407821229,1.0,1.0,2/20,11.83%,GSTK1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.1816390247203459,0.46381699092033946,0.994413407821229,1.0,1.0,2/20,11.83%,GSTK1;GSTA3
prerank,response to hydroxyurea (GO:0072710),0.20479997402640338,0.46121537979924715,0.9717171717171718,1.0,1.0,4/11,25.09%,SPIDR;NSMCE3;ATRX;RTF2
prerank,nucleosome disassembly (GO:0006337),0.18364153329502564,0.4582363649863685,0.9891107078039928,1.0,1.0,7/14,26.18%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCE1;SMARCD1;ARID1A
prerank,chromatin disassembly (GO:0031498),0.18364153329502564,0.4582363649863685,0.9891107078039928,1.0,1.0,7/14,26.18%,SMARCA4;SMARCC1;SMARCD3;ARID2;SMARCE1;SMARCD1;ARID1A
prerank,positive regulation of protein maturation (GO:1903319),0.1979212041252814,0.4576945712487624,0.9868421052631579,1.0,1.0,2/11,15.56%,CCBE1;SOX4
prerank,cellular response to UV-A (GO:0071492),-0.18904723701421322,-0.4530850329519256,0.993801652892562,0.9981560887919526,1.0,4/11,28.64%,MMP1;TIMP1;MMP2;MMP3
prerank,rRNA methylation (GO:0031167),0.17158669163130058,0.4512239485397487,0.9964221824686941,1.0,1.0,6/22,23.91%,ZCCHC4;METTL16;FDXACB1;METTL15;METTL5;MTERF4
prerank,positive regulation of DNA recombination (GO:0045911),0.15916228079108188,0.4427827741731855,0.9982698961937716,1.0,1.0,11/27,27.19%,ERCC6;FUS;SHLD2;KMT5C;RIF1;KMT5B;ARID2;ZCWPW1;SHLD1;FANCB;ERCC2
prerank,tRNA metabolic process (GO:0006399),0.17682763301875182,0.4397166896192276,0.9868913857677902,1.0,1.0,3/17,16.09%,TRPT1;DTD2;SSB
prerank,aromatic amino acid family catabolic process (GO:0009074),0.17856895311217005,0.43670967837408614,0.996,1.0,1.0,1/15,7.97%,HGD
prerank,fatty acid transport (GO:0015908),0.17516035084169898,0.4346273253469301,0.9930434782608696,1.0,1.0,4/17,20.27%,ACSL1;SLC27A3;SLC27A1;CD36
prerank,eosinophil chemotaxis (GO:0048245),0.17713825968042146,0.4298796417326406,0.994475138121547,1.0,1.0,1/14,7.70%,CCL2
prerank,eosinophil migration (GO:0072677),0.17713825968042146,0.4298796417326406,0.994475138121547,1.0,1.0,1/14,7.70%,CCL2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.1839080693176655,0.42725410324801305,0.9943074003795066,1.0,1.0,1/12,6.37%,PPARA
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.15820155676975814,0.4239757694994632,0.9964664310954063,1.0,1.0,4/22,19.03%,CUL4A;GTF2H4;GTF2H2;XPC
prerank,tRNA methylation (GO:0030488),0.14462034392963016,0.4225474802485997,1.0,1.0,1.0,11/34,24.62%,THUMPD3;WDR6;TYW3;FTSJ1;METTL1;DALRD3;METTL2A;METTL2B;METTL6;TARBP1;THADA
prerank,regulation of lymphocyte proliferation (GO:0050670),0.17122571670090206,0.4191977160461658,0.9962476547842402,1.0,1.0,1/16,5.15%,PTPN22
prerank,positive regulation of rRNA processing (GO:2000234),0.18561295587219884,0.4164121135232779,0.9961612284069098,1.0,1.0,10/10,81.45%,UTP15;RIOK2;RIOK1;TRMT112;BUD23;DIMT1;WDR43;WDR75;HEATR1;SIRT7
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.1445664006858952,-0.4163782891903985,0.9978858350951374,0.9997750883401256,1.0,5/20,31.24%,MBTPS1;PSENEN;MBTPS2;RELA;HM13
prerank,regulation of amyloid-beta clearance (GO:1900221),0.16084066274745246,0.4004916032733526,0.9923809523809524,1.0,1.0,4/16,20.24%,LRPAP1;ABCA7;LRP1;ROCK1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.16371625863151287,-0.395125590426211,0.9979757085020243,0.9998608392855449,1.0,11/11,83.65%,EXOSC2;EXOSC4;FBL;EXOSC3;FBLL1;LARP7;DKC1;EXOSC5;TENT4B;PARN;EXOSC10
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.1506085734288671,-0.39432920488243567,0.9978354978354979,0.9992596976737815,1.0,5/15,32.58%,MRE11;MDC1;HUS1B;NEK11;MUS81
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.17256748273697414,0.39166378745506913,1.0,1.0,1.0,11/11,82.76%,CCT6A;CCT3;DKC1;TCP1;MEPCE;CCT2;LARP7;CCT4;CCT8;CCT7;CCT5
prerank,regulation of protein localization to Cajal body (GO:1904869),0.17256748273697414,0.39166378745506913,1.0,1.0,1.0,11/11,82.76%,CCT6A;CCT3;DKC1;TCP1;MEPCE;CCT2;LARP7;CCT4;CCT8;CCT7;CCT5
prerank,DNA packaging (GO:0006323),0.15797445259181858,0.38907062110167684,0.9964349376114082,0.9998648851177031,1.0,2/16,13.89%,CDAN1;KAT6A
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.15658943931688313,0.38437628755823133,1.0,0.9995558217620936,1.0,14/14,84.35%,ERCC6;FUS;ARID2;FANCB;WDR48;OOEP;PARP1;MRNIP;ACTR2;WAS;TIMELESS;RAD51AP1;WRAP53;MMS19
prerank,meiosis I (GO:0007127),0.11038596547177412,0.2974536727943938,1.0,0.9999881352815201,1.0,22/23,75.75%,ZSCAN21;SLC25A31;FOXJ3;ZCWPW1;ING2;MEIOB;BCL2L11;MYBL1;DDX4;BTBD18;MEIOC;DNMT3L;MEI1;HSF2BP;CCNA1;BRDT;FOXJ2;MEIKIN;MOV10L1;TDRD9;SGO1;SYCP3
